activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	119266	CHEMBL711115	Inhibition of MAP kinase-activated protein kinase 2 at 10 uM	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	2.0	CHEMBL2208	Homo sapiens	Inhibition	%	2.0
	119266	CHEMBL711115	Inhibition of MAP kinase-activated protein kinase 2 at 10 uM	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	2.0	CHEMBL2208	Homo sapiens	Inhibition	%	2.0
	119798	CHEMBL711126	Inhibition of MAPKAP-K2 kinase at 1 uM	B	COC[C@H](C)Nc1nccc(-c2c(-c3ccc(F)cc3)c(=O)n3n2CCC3)n1		CHEMBL316065	=	Activity	%	113.0	CHEMBL2208	Homo sapiens	Activity	%	113.0
	133225	CHEMBL711115	Inhibition of MAP kinase-activated protein kinase 2 at 10 uM	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	19.0	CHEMBL2208	Homo sapiens	Inhibition	%	19.0
	134980	CHEMBL711126	Inhibition of MAPKAP-K2 kinase at 1 uM	B	C[C@H](Nc1nccc(-c2c(-c3ccc(F)cc3)c(=O)n3n2CCC3)n1)C(C)(C)O		CHEMBL93281	=	Activity	%	112.0	CHEMBL2208	Homo sapiens	Activity	%	112.0
	138050	CHEMBL711115	Inhibition of MAP kinase-activated protein kinase 2 at 10 uM	B	O=C(Nc1n[nH]c2nc(-c3ccccc3)c(Br)cc12)C1CC1		CHEMBL259270	=	Inhibition	%	12.0	CHEMBL2208	Homo sapiens	Inhibition	%	12.0
	139806	CHEMBL711126	Inhibition of MAPKAP-K2 kinase at 1 uM	B	C[C@H](Nc1nccc(-c2c(-c3ccc(F)cc3)c(=O)n3n2CCC3)n1)c1ccccc1		CHEMBL92082	=	Activity	%	91.0	CHEMBL2208	Homo sapiens	Activity	%	91.0
	144068	CHEMBL711115	Inhibition of MAP kinase-activated protein kinase 2 at 10 uM	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)ccc12)C1CC1		CHEMBL405145	=	Inhibition	%	14.0	CHEMBL2208	Homo sapiens	Inhibition	%	14.0
	177469	CHEMBL711116	Inhibition of MAP kinase-activated protein kinase 2	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1ncc(C(F)(F)F)cc1Cl		CHEMBL111620	=	Activity	%	85.0	CHEMBL2208	Homo sapiens	Activity	%	85.0
	178782	CHEMBL711116	Inhibition of MAP kinase-activated protein kinase 2	B	COCCCn1cc(C2=C(c3ccccc3O)C(=O)NC2=O)c2cccnc21		CHEMBL109944	=	Activity	%	97.0	CHEMBL2208	Homo sapiens	Activity	%	97.0
	182529	CHEMBL711116	Inhibition of MAP kinase-activated protein kinase 2	B	COc1ccccc1C1=C(c2cn(CCCNC(=O)OC(C)(C)C)c3ncccc23)C(=O)NC1=O		CHEMBL109981	=	Activity	%	85.0	CHEMBL2208	Homo sapiens	Activity	%	85.0
	554895	CHEMBL732485	Inhibition of MAPKAP-K2 in presence of 10 uM ATP	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccnc3)cc12		CHEMBL407002	=	Inhibition	%	3.0	CHEMBL2208	Homo sapiens	Inhibition	%	3.0
	559739	CHEMBL732486	Inhibition of MAPKAP-K2 in presence of 10 uM ATP	B	CCCC(=O)Nc1n[nH]c2nnc(-c3ccccc3)cc12		CHEMBL288143	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	Inhibition	%	0.0
	572982	CHEMBL732486	Inhibition of MAPKAP-K2 in presence of 10 uM ATP	B	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3ccccc3)cc12		CHEMBL259744	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	Inhibition	%	0.0
	578266	CHEMBL711117	Inhibition of MAP kinase-activated protein kinase 2	B	C[C@H](O)CNc1cc(-c2[nH]c3cccnc3c2-c2ccc(F)cc2)ccn1		CHEMBL142425	>	IC50	nM	30000.0	CHEMBL2208	Homo sapiens	IC50	uM	30.0
	586373	CHEMBL732485	Inhibition of MAPKAP-K2 in presence of 10 uM ATP	B	CCCC(=O)Nc1n[nH]c2ncc(-c3ccccc3)cc12		CHEMBL258701	=	Inhibition	%	6.0	CHEMBL2208	Homo sapiens	Inhibition	%	6.0
	590211	CHEMBL732487	Inhibition of MAPKAP-K2 in presence of 10 uM ATP	B	CCCC(=O)Nc1n[nH]c2ncc(-c3ccccc3F)cc12		CHEMBL407373	=	Inhibition	%	5.0	CHEMBL2208	Homo sapiens	Inhibition	%	5.0
	616534	CHEMBL732488	Inhibition of mitogen-activated protein kinase-activated protein kinase 2 at 100 nM	B	Cn1ccc2ccc3c4[nH]c5c(CCCN[C@H]6CC[C@H](O)CC6)cccc5c4c4c(c3c21)C(=O)NC4=O		CHEMBL307152	=	Control	%	94.0	CHEMBL2208	Homo sapiens	Control	%	94.0
	616573	CHEMBL879398	Inhibition of mitogen-activated protein kinase-activated protein kinase 2 at 500 nM	B	Cn1ccc2ccc3c4[nH]c5c(CCCN[C@H]6CC[C@H](O)CC6)cccc5c4c4c(c3c21)C(=O)NC4=O		CHEMBL307152	=	Control	%	104.0	CHEMBL2208	Homo sapiens	Control	%	104.0
	915742	CHEMBL710959	Inhibition of human MAP kinase-activated protein kinase 2 at 10 uM	B	O=C1NC(=O)C2=C1c1cn(c3ncccc13)CCOCCOCCOCCn1cc2c2cccnc21		CHEMBL340776	=	Activity	%	97.0	CHEMBL2208	Homo sapiens	Activity	%	97.0
	931203	CHEMBL710959	Inhibition of human MAP kinase-activated protein kinase 2 at 10 uM	B	O=C1NC(=O)C2=C1c1cn(c3ncccc13)CCOCCOCCOCCOCCn1cc2c2cccnc21		CHEMBL337642	=	Activity	%	85.0	CHEMBL2208	Homo sapiens	Activity	%	85.0
	1034881	CHEMBL711114	Inhibition of MAP kinase-activated protein kinase 2 at 10 uM	B	COc1ccc(C2=C(Nc3cccc(Cl)c3)C(=O)NC2=O)cc1		CHEMBL158208	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	Inhibition	%	0.0
	1036276	CHEMBL711114	Inhibition of MAP kinase-activated protein kinase 2 at 10 uM	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	Inhibition	%	4.0	CHEMBL2208	Homo sapiens	Inhibition	%	4.0
	1048342	CHEMBL711114	Inhibition of MAP kinase-activated protein kinase 2 at 10 uM	B	COc1ccccc1C1=C(N2CCc3ccccc32)C(=O)NC1=O		CHEMBL160585	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	Inhibition	%	0.0
	1055588	CHEMBL711114	Inhibition of MAP kinase-activated protein kinase 2 at 10 uM	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160586	=	Inhibition	%	6.0	CHEMBL2208	Homo sapiens	Inhibition	%	6.0
	1058274	CHEMBL711114	Inhibition of MAP kinase-activated protein kinase 2 at 10 uM	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156379	=	Inhibition	%	8.0	CHEMBL2208	Homo sapiens	Inhibition	%	8.0
	1173963	CHEMBL710958	Inhibition of MAP kinase-activated protein kinase 1b/MAP kinase-activated protein kinase 2	B	CCN(CC)C/C=C/c1nc(O)c2c(ccc3nc(Nc4c(Cl)cccc4Cl)n(C)c32)c1C		CHEMBL281957	>	IC50	nM	1000.0	CHEMBL2208	Homo sapiens	IC50	uM	1.0
	1426798	CHEMBL833469	Inhibition of TNFalpha expression in U937 cells	F	N#Cc1c(N)cc2c(c1N)Cc1cc(O)c(O)cc1O2		CHEMBL3706781	=	IC50	nM	920.0	CHEMBL2208	Homo sapiens	IC50	uM	0.92
	1426799	CHEMBL832345	Concentration of 50% inhibition by compound towards mitogen activated protein kinase -activated protein kinase 2	B	N#Cc1c(N)cc2c(c1N)Cc1ccc(O)cc1O2		CHEMBL3706766	=	IC50	nM	180.0	CHEMBL2208	Homo sapiens	IC50	uM	0.18
	1426800	CHEMBL837481	Inhibition of TNFalpha expression in U937 cells	F	N#Cc1c(N)cc2c(c1N)Cc1ccc(O)cc1O2		CHEMBL3706766	=	IC50	nM	1080.0	CHEMBL2208	Homo sapiens	IC50	uM	1.08
	1426801	CHEMBL832345	Concentration of 50% inhibition by compound towards mitogen activated protein kinase -activated protein kinase 2	B	N#Cc1c(N)cc2c(c1N)Cc1cc(O)ccc1O2		CHEMBL3706767	=	IC50	nM	470.0	CHEMBL2208	Homo sapiens	IC50	uM	0.47
	1426802	CHEMBL837481	Inhibition of TNFalpha expression in U937 cells	F	N#Cc1c(N)cc2c(c1N)Cc1cc(O)ccc1O2		CHEMBL3706767	=	IC50	nM	25400.0	CHEMBL2208	Homo sapiens	IC50	uM	25.4
	1426803	CHEMBL832345	Concentration of 50% inhibition by compound towards mitogen activated protein kinase -activated protein kinase 2	B	COc1cc2c(cc1OC)Oc1cc(N)c(C#N)c(N)c1C2		CHEMBL3706770	=	IC50	nM	330.0	CHEMBL2208	Homo sapiens	IC50	uM	0.33
	1426804	CHEMBL837481	Inhibition of TNFalpha expression in U937 cells	F	COc1cc2c(cc1OC)Oc1cc(N)c(C#N)c(N)c1C2		CHEMBL3706770	=	IC50	nM	64800.0	CHEMBL2208	Homo sapiens	IC50	uM	64.8
	1426805	CHEMBL832345	Concentration of 50% inhibition by compound towards mitogen activated protein kinase -activated protein kinase 2	B	N#Cc1c(N)cc2c(c1N)Cc1cccc(O)c1O2		CHEMBL3706771	=	IC50	nM	460.0	CHEMBL2208	Homo sapiens	IC50	uM	0.46
	1426806	CHEMBL837481	Inhibition of TNFalpha expression in U937 cells	F	N#Cc1c(N)cc2c(c1N)Cc1cccc(O)c1O2		CHEMBL3706771	=	IC50	nM	7120.0	CHEMBL2208	Homo sapiens	IC50	uM	7.12
	1426807	CHEMBL832345	Concentration of 50% inhibition by compound towards mitogen activated protein kinase -activated protein kinase 2	B	N#Cc1c(N)cc2c(c1N)Cc1cc3c(cc1O2)OCCO3		CHEMBL3706773	=	IC50	nM	490.0	CHEMBL2208	Homo sapiens	IC50	uM	0.49
	1426808	CHEMBL837481	Inhibition of TNFalpha expression in U937 cells	F	N#Cc1c(N)cc2c(c1N)Cc1cc3c(cc1O2)OCCO3		CHEMBL3706773	=	IC50	nM	55700.0	CHEMBL2208	Homo sapiens	IC50	uM	55.7
	1426809	CHEMBL832345	Concentration of 50% inhibition by compound towards mitogen activated protein kinase -activated protein kinase 2	B	N#Cc1c(N)cc2c(c1N)Cc1cc(N)ccc1O2		CHEMBL3706774	=	IC50	nM	530.0	CHEMBL2208	Homo sapiens	IC50	uM	0.53
	1426810	CHEMBL837481	Inhibition of TNFalpha expression in U937 cells	F	N#Cc1c(N)cc2c(c1N)Cc1cc(N)ccc1O2		CHEMBL3706774	>	IC50	nM	100000.0	CHEMBL2208	Homo sapiens	IC50	uM	100.0
	1426814	CHEMBL832345	Concentration of 50% inhibition by compound towards mitogen activated protein kinase -activated protein kinase 2	B	N#Cc1c(N)cc2c(c1N)Cc1ccccc1O2		CHEMBL3706775	=	IC50	nM	560.0	CHEMBL2208	Homo sapiens	IC50	uM	0.56
	1426815	CHEMBL837481	Inhibition of TNFalpha expression in U937 cells	F	N#Cc1c(N)cc2c(c1N)Cc1ccccc1O2		CHEMBL3706775	>	IC50	nM	100000.0	CHEMBL2208	Homo sapiens	IC50	uM	100.0
	1427222	CHEMBL832345	Concentration of 50% inhibition by compound towards mitogen activated protein kinase -activated protein kinase 2	B	N#Cc1c(N)cc2c(c1N)Cc1cc(O)c(C3COCCO3)cc1O2		CHEMBL3706776	=	IC50	nM	620.0	CHEMBL2208	Homo sapiens	IC50	uM	0.62
	1427223	CHEMBL837481	Inhibition of TNFalpha expression in U937 cells	F	N#Cc1c(N)cc2c(c1N)Cc1cc(O)c(C3COCCO3)cc1O2		CHEMBL3706776	=	IC50	nM	11900.0	CHEMBL2208	Homo sapiens	IC50	uM	11.9
	1427224	CHEMBL832345	Concentration of 50% inhibition by compound towards mitogen activated protein kinase -activated protein kinase 2	B	N#Cc1c(N)cc2c(c1N)Cc1c(O)cc(O)cc1O2		CHEMBL3706777	=	IC50	nM	690.0	CHEMBL2208	Homo sapiens	IC50	uM	0.69
	1427225	CHEMBL837481	Inhibition of TNFalpha expression in U937 cells	F	N#Cc1c(N)cc2c(c1N)Cc1c(O)cc(O)cc1O2		CHEMBL3706777	>	IC50	nM	100000.0	CHEMBL2208	Homo sapiens	IC50	uM	100.0
	1427226	CHEMBL832345	Concentration of 50% inhibition by compound towards mitogen activated protein kinase -activated protein kinase 2	B	CCOc1cc2c(cc1O)Cc1c(cc(N)c(C#N)c1N)O2		CHEMBL3706778	=	IC50	nM	770.0	CHEMBL2208	Homo sapiens	IC50	uM	0.77
	1427227	CHEMBL837481	Inhibition of TNFalpha expression in U937 cells	F	CCOc1cc2c(cc1O)Cc1c(cc(N)c(C#N)c1N)O2		CHEMBL3706778	=	IC50	nM	9400.0	CHEMBL2208	Homo sapiens	IC50	uM	9.4
	1427228	CHEMBL832345	Concentration of 50% inhibition by compound towards mitogen activated protein kinase -activated protein kinase 2	B	N#Cc1c(N)cc2c(c1N)Cc1ccc(O)c(O)c1O2		CHEMBL3706779	=	IC50	nM	850.0	CHEMBL2208	Homo sapiens	IC50	uM	0.85
	1427229	CHEMBL837481	Inhibition of TNFalpha expression in U937 cells	F	N#Cc1c(N)cc2c(c1N)Cc1ccc(O)c(O)c1O2		CHEMBL3706779	=	IC50	nM	6920.0	CHEMBL2208	Homo sapiens	IC50	uM	6.92
	1427230	CHEMBL832345	Concentration of 50% inhibition by compound towards mitogen activated protein kinase -activated protein kinase 2	B	N#Cc1c(N)cc2c(c1N)Cc1ccc(OCN3CCCC3)cc1O2		CHEMBL3706782	=	IC50	nM	1680.0	CHEMBL2208	Homo sapiens	IC50	uM	1.68
	1427231	CHEMBL837481	Inhibition of TNFalpha expression in U937 cells	F	N#Cc1c(N)cc2c(c1N)Cc1ccc(OCN3CCCC3)cc1O2		CHEMBL3706782	=	IC50	nM	2910.0	CHEMBL2208	Homo sapiens	IC50	uM	2.91
	1427232	CHEMBL832345	Concentration of 50% inhibition by compound towards mitogen activated protein kinase -activated protein kinase 2	B	N#Cc1c(N)cc2c(c1NCCO)Cc1cc(O)c(O)cc1O2		CHEMBL3706783	=	IC50	nM	237.0	CHEMBL2208	Homo sapiens	IC50	uM	0.237
	1427233	CHEMBL832345	Concentration of 50% inhibition by compound towards mitogen activated protein kinase -activated protein kinase 2	B	CCCNc1c(C#N)c(N)cc2c1Cc1cc(O)c(O)cc1O2		CHEMBL3706768	=	IC50	nM	403.0	CHEMBL2208	Homo sapiens	IC50	uM	0.403
	1427234	CHEMBL832345	Concentration of 50% inhibition by compound towards mitogen activated protein kinase -activated protein kinase 2	B	CCNc1c(C#N)c(N)cc2c1Cc1cc(O)c(O)cc1O2		CHEMBL3706769	=	IC50	nM	419.0	CHEMBL2208	Homo sapiens	IC50	uM	0.419
	1427342	CHEMBL832345	Concentration of 50% inhibition by compound towards mitogen activated protein kinase -activated protein kinase 2	B	CCNc1cc2c(c(NCC)c1C#N)Cc1cc(O)c(O)cc1O2	Outside typical range	CHEMBL3706772	>	IC50	nM	200000.0	CHEMBL2208	Homo sapiens	IC50	uM	200.0
	1427346	CHEMBL832345	Concentration of 50% inhibition by compound towards mitogen activated protein kinase -activated protein kinase 2	B	N#Cc1c(N)nc2c(c1N)Cc1ccccc1S2	Outside typical range	CHEMBL178952	>	IC50	nM	200000.0	CHEMBL2208	Homo sapiens	IC50	uM	200.0
	1427347	CHEMBL832345	Concentration of 50% inhibition by compound towards mitogen activated protein kinase -activated protein kinase 2	B	N#Cc1c(N)nc2c(c1N)Cc1ccccc1S2(=O)=O	Outside typical range	CHEMBL180574	>	IC50	nM	200000.0	CHEMBL2208	Homo sapiens	IC50	uM	200.0
	1427348	CHEMBL832345	Concentration of 50% inhibition by compound towards mitogen activated protein kinase -activated protein kinase 2	B	CN1c2ccccc2Cc2c1nc(N)c(C#N)c2N		CHEMBL360278	=	IC50	nM	70000.0	CHEMBL2208	Homo sapiens	IC50	uM	70.0
	1428978	CHEMBL832345	Concentration of 50% inhibition by compound towards mitogen activated protein kinase -activated protein kinase 2	B	COc1ccc2c(c1)Oc1cc(N)c(C#N)c(N)c1C2C(C#N)C#N		CHEMBL3706788	=	IC50	nM	1940.0	CHEMBL2208	Homo sapiens	IC50	uM	1.94
	1428979	CHEMBL832345	Concentration of 50% inhibition by compound towards mitogen activated protein kinase -activated protein kinase 2	B	N#Cc1c(N)cc2c(c1N)C(C(C#N)C#N)c1ccc(O)cc1O2		CHEMBL3706789	=	IC50	nM	12800.0	CHEMBL2208	Homo sapiens	IC50	uM	12.8
	1428980	CHEMBL832345	Concentration of 50% inhibition by compound towards mitogen activated protein kinase -activated protein kinase 2	B	COc1ccc2c(c1)C(C(C#N)C#N)c1c(cc(N)c(C#N)c1N)O2		CHEMBL3706784	=	IC50	nM	6180.0	CHEMBL2208	Homo sapiens	IC50	uM	6.18
	1428981	CHEMBL832345	Concentration of 50% inhibition by compound towards mitogen activated protein kinase -activated protein kinase 2	B	N#Cc1c(N)cc2c(c1N)C(C(C#N)C#N)c1cc(Br)ccc1O2		CHEMBL3706785	=	IC50	nM	4220.0	CHEMBL2208	Homo sapiens	IC50	uM	4.22
	1428986	CHEMBL832345	Concentration of 50% inhibition by compound towards mitogen activated protein kinase -activated protein kinase 2	B	N#Cc1c(N)cc2c(c1N)C(C(C#N)C#N)c1cc(O)ccc1O2		CHEMBL3706786	=	IC50	nM	3800.0	CHEMBL2208	Homo sapiens	IC50	uM	3.8
	1428987	CHEMBL832345	Concentration of 50% inhibition by compound towards mitogen activated protein kinase -activated protein kinase 2	B	N#Cc1c(N)cc2c(c1N)C(c1ccccc1)c1ccc(O)cc1O2	Outside typical range	CHEMBL3706787	>	IC50	nM	200000.0	CHEMBL2208	Homo sapiens	IC50	uM	200.0
	1428988	CHEMBL832345	Concentration of 50% inhibition by compound towards mitogen activated protein kinase -activated protein kinase 2	B	COc1ccc2c(c1)Oc1cc(N)c(C#N)c(N)c1C2c1ccccc1	Outside typical range	CHEMBL3706780	>	IC50	nM	200000.0	CHEMBL2208	Homo sapiens	IC50	uM	200.0
	1428989	CHEMBL832345	Concentration of 50% inhibition by compound towards mitogen activated protein kinase -activated protein kinase 2	B	N#Cc1c(N)cc2c(c1N)Cc1cc(O)c(O)cc1O2		CHEMBL3706781	=	IC50	nM	130.0	CHEMBL2208	Homo sapiens	IC50	uM	0.13
	1441462	CHEMBL829806	Inhibition of MAPKAP-K2 kinase at 10 uM with 100 uM ATP	B	O=C(Nc1ncnc2oc(-c3cccnc3)cc12)C1CCCC1		CHEMBL182419	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	Inhibition	%	0.0
	1475817	CHEMBL830723	Percent inhibition against MAPKAP-K2 at 10 uM using 100 uM ATP	B	CCn1c(-c2nonc2N)nc2cnccc21		CHEMBL189657	=	Inhibition	%	12.0	CHEMBL2208	Homo sapiens	Inhibition	%	12.0
	1489874	CHEMBL877004	Inhibition of MAP kinase-activated protein kinase 2	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F		CHEMBL1788116	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	1498645	CHEMBL829376	Inhibition of MAP kinase-activated protein kinase 2	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cc3)nc2n(C2CCCC2)c1=O		CHEMBL365847	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	1513460	CHEMBL830913	Inhibition of MAP kinase-activated protein kinase 2	B	O=C(Nc1ccc(Cl)c(COc2cccnc2)c1)c1cc(F)cc(N2CCOCC2)c1		CHEMBL194436	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	1601168	CHEMBL880251	Inhibitory concentration against MAPKAP kinase 2 cytoplasmic sequence; Reported as mean (variability <15%)	B	CCc1c(NC(=O)OCCn2ccnc2)cn2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c12		CHEMBL412367	>	IC50	nM	25000.0	CHEMBL2208	Homo sapiens	IC50	uM	25.0
	1606838	CHEMBL885182	Inhibitory concentration against MK2	B	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc(NC2CCCC2)c1C#N		CHEMBL383172	>	IC50	nM	50000.0	CHEMBL2208	Homo sapiens	IC50	uM	50.0
	1658909	CHEMBL860428	Inhibitory activity against MK2	B	N#Cc1cnc2cnc(NCCN3CCOCC3)cc2c1Nc1ccc(F)c(Cl)c1	Outside typical range	CHEMBL197538	>	IC50	nM	400000.0	CHEMBL2208	Homo sapiens	IC50	uM	400.0
	1658933	CHEMBL860428	Inhibitory activity against MK2	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1	Outside typical range	CHEMBL200381	=	IC50	nM	110000.0	CHEMBL2208	Homo sapiens	IC50	uM	110.0
	1658934	CHEMBL860428	Inhibitory activity against MK2	B	N#Cc1cnc2cnc(NCCN3CCOCC3)cc2c1Nc1ccc(Oc2ccccc2)cc1	Outside typical range	CHEMBL371095	>	IC50	nM	400000.0	CHEMBL2208	Homo sapiens	IC50	uM	400.0
	1658935	CHEMBL860428	Inhibitory activity against MK2	B	N#Cc1cnc2cnc(NCCN3CCOCC3)cc2c1Nc1ccc(Sc2ccccc2)cc1	Outside typical range	CHEMBL199210	>	IC50	nM	400000.0	CHEMBL2208	Homo sapiens	IC50	uM	400.0
	1658936	CHEMBL860428	Inhibitory activity against MK2	B	N#Cc1cnc2cnc(NCCN3CCOCC3)cc2c1Nc1ccc(Cc2ccccc2)cc1	Outside typical range	CHEMBL371658	>	IC50	nM	400000.0	CHEMBL2208	Homo sapiens	IC50	uM	400.0
Not Active	1660270	CHEMBL854329	Inhibitory activity against MAPKAP-K2 at 10 uM	B	O=c1cc(N2CCOCC2)oc2c(-c3cccc4c3sc3ccccc34)cccc12		CHEMBL188678		Activity			CHEMBL2208	Homo sapiens	Activity		
	1662617	CHEMBL864558	Inhibitory activity against MK2	B	Cc1n[nH]c2sc(C(N)=O)cc12		CHEMBL198022	>	IC50	nM	20000.0	CHEMBL2208	Homo sapiens	IC50	uM	20.0
	1662639	CHEMBL864558	Inhibitory activity against MK2	B	CN1CCN(C(=O)c2cc3c(-c4ccccc4)[nH]nc3s2)CC1		CHEMBL371239	>	IC50	nM	20000.0	CHEMBL2208	Homo sapiens	IC50	uM	20.0
	1662640	CHEMBL864558	Inhibitory activity against MK2	B	COc1ccc(CNC(=O)c2cc3c(-c4ccccc4)[nH]nc3s2)cc1		CHEMBL199383	=	IC50	nM	16000.0	CHEMBL2208	Homo sapiens	IC50	uM	16.0
	1662641	CHEMBL864558	Inhibitory activity against MK2	B	O=C(NCCc1ccccc1)c1cc2c(-c3ccccc3)[nH]nc2s1		CHEMBL197923	>	IC50	nM	20000.0	CHEMBL2208	Homo sapiens	IC50	uM	20.0
	1662642	CHEMBL864558	Inhibitory activity against MK2	B	O=C(NCc1ccccc1)c1cc2c(-c3ccccc3)[nH]nc2s1		CHEMBL200499	=	IC50	nM	17000.0	CHEMBL2208	Homo sapiens	IC50	uM	17.0
	1662643	CHEMBL864558	Inhibitory activity against MK2	B	O=C(NC1CCCCC1)c1cc2c(-c3ccccc3)[nH]nc2s1		CHEMBL199755	>	IC50	nM	20000.0	CHEMBL2208	Homo sapiens	IC50	uM	20.0
	1662644	CHEMBL864558	Inhibitory activity against MK2	B	CCCCN(C)C(=O)c1cc2c(-c3ccccc3)[nH]nc2s1		CHEMBL199528	>	IC50	nM	20000.0	CHEMBL2208	Homo sapiens	IC50	uM	20.0
	1662645	CHEMBL864558	Inhibitory activity against MK2	B	Cc1n[nH]c2sc(C(=O)NCc3ccccc3)cc12		CHEMBL373001	>	IC50	nM	20000.0	CHEMBL2208	Homo sapiens	IC50	uM	20.0
	1662646	CHEMBL864558	Inhibitory activity against MK2	B	Cc1n[nH]c2sc(C(=O)NC3CCCCC3)cc12		CHEMBL199951	>	IC50	nM	20000.0	CHEMBL2208	Homo sapiens	IC50	uM	20.0
	1662647	CHEMBL864558	Inhibitory activity against MK2	B	CCCCN(C)C(=O)c1cc2c(C)n[nH]c2s1		CHEMBL200657	>	IC50	nM	20000.0	CHEMBL2208	Homo sapiens	IC50	uM	20.0
	1662648	CHEMBL864558	Inhibitory activity against MK2	B	CCCCNC(=O)c1cc2c(C)n[nH]c2s1		CHEMBL371242	>	IC50	nM	20000.0	CHEMBL2208	Homo sapiens	IC50	uM	20.0
	1663213	CHEMBL863894	Inhibitory activity against MK2	B	COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL197603	>	IC50	nM	25000.0	CHEMBL2208	Homo sapiens	IC50	uM	25.0
	1665737	CHEMBL860235	Inhibition of MAPKAPK2 at 10 uM	B	CN1C(=O)C(C(=O)Nc2nncs2)c2cc3occc3cc21		CHEMBL200906	=	Inhibition	%	8.0	CHEMBL2208	Homo sapiens	Inhibition	%	8.0
	1666368	CHEMBL865764	Inhibition of MAPKAPK2 activity at 10 uM	B	Oc1cc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)ccc1Cl		CHEMBL373011	=	Inhibition	%	-1.0	CHEMBL2208	Homo sapiens	Inhibition	%	-1.0
	1666369	CHEMBL865764	Inhibition of MAPKAPK2 activity at 10 uM	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1		CHEMBL477989	=	Inhibition	%	9.0	CHEMBL2208	Homo sapiens	Inhibition	%	9.0
	1666758	CHEMBL865814	Inhibitory activity against MAPKAP2	B	COc1cc(-c2ccc3c(c2)NC(=O)/C3=C\c2ccc[nH]2)ccc1O		CHEMBL202930	>	IC50	nM	50000.0	CHEMBL2208	Homo sapiens	IC50	nM	50000.0
	1666768	CHEMBL865814	Inhibitory activity against MAPKAP2	B	COc1cc(-c2ccc3c(c2)NC(=O)/C3=C\c2c[nH]c3ncccc23)ccc1O		CHEMBL383316	>	IC50	nM	50000.0	CHEMBL2208	Homo sapiens	IC50	nM	50000.0
Not Determined	1666781	CHEMBL865814	Inhibitory activity against MAPKAP2	B	COc1cc(-c2ccc3c(c2)NC(=O)/C3=C\c2ncc[nH]2)ccc1O		CHEMBL199299		IC50			CHEMBL2208	Homo sapiens	IC50		
	1671490	CHEMBL869954	Inhibition of MAPKAP-K2 at 10 uM	B	Cc1c(Nc2ccc(Br)cc2F)c(C(=O)NOCCO)cn(C)c1=O		CHEMBL199860	=	Inhibition	%	8.0	CHEMBL2208	Homo sapiens	Inhibition	%	8.0
	1671519	CHEMBL869954	Inhibition of MAPKAP-K2 at 10 uM	B	CCONC(=O)c1cn(C)c(=O)c(F)c1Nc1ccc(Br)cc1F		CHEMBL201426	=	Inhibition	%	15.0	CHEMBL2208	Homo sapiens	Inhibition	%	15.0
	1671543	CHEMBL869954	Inhibition of MAPKAP-K2 at 10 uM	B	CONC(=O)c1cn(C)c(=O)c(C)c1Nc1ccc(Br)cc1F		CHEMBL426840	=	Inhibition	%	1.0	CHEMBL2208	Homo sapiens	Inhibition	%	1.0
	1671635	CHEMBL869954	Inhibition of MAPKAP-K2 at 10 uM	B	CCONC(=O)c1cn(C)c(=O)c(C)c1Nc1ccc(Br)cc1F		CHEMBL203138	=	Inhibition	%	14.0	CHEMBL2208	Homo sapiens	Inhibition	%	14.0
	1704941	CHEMBL864421	Inhibition of MAPKAP2 at 10 uM ATP	B	N[C@H](COc1cncc(/C=C/c2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL383541	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	nM	10000.0
	1704965	CHEMBL864421	Inhibition of MAPKAP2 at 10 uM ATP	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	110.0	CHEMBL2208	Homo sapiens	IC50	nM	110.0
	1704966	CHEMBL864421	Inhibition of MAPKAP2 at 10 uM ATP	B	N[C@H](COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL383264	>	IC50	nM	50000.0	CHEMBL2208	Homo sapiens	IC50	nM	50000.0
	1723317	CHEMBL863160	Inhibition of MAPKAPK2	B	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	>	Ki	nM	8400.0	CHEMBL2208	Homo sapiens	Ki	nM	8400.0
	1723398	CHEMBL863160	Inhibition of MAPKAPK2	B	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	>	Ki	nM	8400.0	CHEMBL2208	Homo sapiens	Ki	nM	8400.0
	1723399	CHEMBL863160	Inhibition of MAPKAPK2	B	CC(=O)Nc1cc(N)c(C#N)c(-c2ccccc2)n1		CHEMBL210032	>	Ki	nM	8400.0	CHEMBL2208	Homo sapiens	Ki	nM	8400.0
	1723400	CHEMBL863160	Inhibition of MAPKAPK2	B	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	>	Ki	nM	8400.0	CHEMBL2208	Homo sapiens	Ki	nM	8400.0
	1723401	CHEMBL863160	Inhibition of MAPKAPK2	B	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	>	Ki	nM	8400.0	CHEMBL2208	Homo sapiens	Ki	nM	8400.0
	1723402	CHEMBL863160	Inhibition of MAPKAPK2	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	>	Ki	nM	8400.0	CHEMBL2208	Homo sapiens	Ki	nM	8400.0
Not Determined	1728739	CHEMBL854329	Inhibitory activity against MAPKAP-K2 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccco3)ccc12		CHEMBL196964		Activity			CHEMBL2208	Homo sapiens	Activity		
Not Determined	1728782	CHEMBL854329	Inhibitory activity against MAPKAP-K2 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccc(F)cc3)ccc12		CHEMBL197439		Activity			CHEMBL2208	Homo sapiens	Activity		
Not Determined	1728825	CHEMBL854329	Inhibitory activity against MAPKAP-K2 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccsc3)ccc12		CHEMBL196764		Activity			CHEMBL2208	Homo sapiens	Activity		
Not Determined	1728868	CHEMBL854329	Inhibitory activity against MAPKAP-K2 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccc4c3oc3ccccc34)ccc12		CHEMBL196759		Activity			CHEMBL2208	Homo sapiens	Activity		
Not Determined	1728911	CHEMBL854329	Inhibitory activity against MAPKAP-K2 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cc4ccccc4s3)ccc12		CHEMBL381025		Activity			CHEMBL2208	Homo sapiens	Activity		
Not Determined	1728964	CHEMBL854329	Inhibitory activity against MAPKAP-K2 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccc4c3Sc3ccccc3S4)ccc12		CHEMBL199216		Activity			CHEMBL2208	Homo sapiens	Activity		
Not Determined	1729007	CHEMBL854329	Inhibitory activity against MAPKAP-K2 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)ccc12		CHEMBL436767		Activity			CHEMBL2208	Homo sapiens	Activity		
Not Determined	1729050	CHEMBL854329	Inhibitory activity against MAPKAP-K2 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccc4ccccc34)ccc12		CHEMBL199050		Activity			CHEMBL2208	Homo sapiens	Activity		
Not Determined	1729093	CHEMBL854329	Inhibitory activity against MAPKAP-K2 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(/C=C/c3ccc(Cl)cc3)ccc12		CHEMBL199051		Activity			CHEMBL2208	Homo sapiens	Activity		
Not Determined	1729136	CHEMBL854329	Inhibitory activity against MAPKAP-K2 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccc4[nH]ccc4c3)ccc12		CHEMBL369969		Activity			CHEMBL2208	Homo sapiens	Activity		
Not Determined	1729179	CHEMBL854329	Inhibitory activity against MAPKAP-K2 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccc4ncccc4c3)ccc12		CHEMBL198740		Activity			CHEMBL2208	Homo sapiens	Activity		
Not Determined	1729222	CHEMBL854329	Inhibitory activity against MAPKAP-K2 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccc4c3Oc3ccccc3S4)ccc12		CHEMBL197239		Activity			CHEMBL2208	Homo sapiens	Activity		
Not Determined	1729265	CHEMBL854329	Inhibitory activity against MAPKAP-K2 at 10 uM	B	Nc1cc(C(=O)O)cc(-c2ccc3c(=O)cc(N4CCOCC4)oc3c2)c1		CHEMBL370108		Activity			CHEMBL2208	Homo sapiens	Activity		
Not Determined	1729308	CHEMBL854329	Inhibitory activity against MAPKAP-K2 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccc4c3sc3ccccc34)ccc12		CHEMBL198801		Activity			CHEMBL2208	Homo sapiens	Activity		
Not Determined	1729354	CHEMBL854329	Inhibitory activity against MAPKAP-K2 at 10 uM	B	O=C1c2ccccc2C(=O)N1Cc1cccc(-c2ccc3c(=O)cc(N4CCOCC4)oc3c2)c1		CHEMBL197219		Activity			CHEMBL2208	Homo sapiens	Activity		
Not Determined	1729397	CHEMBL854329	Inhibitory activity against MAPKAP-K2 at 10 uM	B	O=C1c2ccccc2C(=O)N1Cc1ccc(-c2ccc3c(=O)cc(N4CCOCC4)oc3c2)cc1		CHEMBL197227		Activity			CHEMBL2208	Homo sapiens	Activity		
Not Determined	1729440	CHEMBL854329	Inhibitory activity against MAPKAP-K2 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccs3)ccc12		CHEMBL371968		Activity			CHEMBL2208	Homo sapiens	Activity		
Not Determined	1729483	CHEMBL854329	Inhibitory activity against MAPKAP-K2 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccc4ccccc4c3)ccc12		CHEMBL200299		Activity			CHEMBL2208	Homo sapiens	Activity		
Not Determined	1729526	CHEMBL854329	Inhibitory activity against MAPKAP-K2 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3csc4ccccc34)ccc12		CHEMBL199416		Activity			CHEMBL2208	Homo sapiens	Activity		
Not Determined	1729569	CHEMBL854329	Inhibitory activity against MAPKAP-K2 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccc(OCc4ccccc4)cc3)ccc12		CHEMBL382501		Activity			CHEMBL2208	Homo sapiens	Activity		
Not Determined	1729627	CHEMBL854329	Inhibitory activity against MAPKAP-K2 at 10 uM	B	Cc1ccc(-c2ccc3c(=O)cc(N4CCOCC4)oc3c2)c2ccccc12		CHEMBL200275		Activity			CHEMBL2208	Homo sapiens	Activity		
Not Determined	1729670	CHEMBL854329	Inhibitory activity against MAPKAP-K2 at 10 uM	B	COC(=O)/C=C/c1ccccc1-c1ccc2c(=O)cc(N3CCOCC3)oc2c1		CHEMBL199424		Activity			CHEMBL2208	Homo sapiens	Activity		
	1734173	CHEMBL862493	Residual activity at human MAPKAPK2 at 10 uM in presence of 10 uM ATP relative to control	B	O=C1NC(=O)/C(=C/c2ccc(-c3ccc(F)cc3O)o2)S1		CHEMBL379156	=	Activity	%	117.0	CHEMBL2208	Homo sapiens	Activity	%	117.0
	1739110	CHEMBL866211	Inhibition of MAPKAP2	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	=	Ki	nM	1100.0	CHEMBL2208	Homo sapiens	Ki	nM	1100.0
	1744556	CHEMBL866184	Inhibition of MAPKAPK2	B	O=C(NC1CC1)c1cc(NCc2cnc(Nc3ccccn3)s2)c(F)cc1F		CHEMBL377734	>	IC50	nM	50000.0	CHEMBL2208	Homo sapiens	IC50	nM	50000.0
	1751583	CHEMBL869138	Inhibition of MAPKAP-K2	B	CC(C)c1nnc2ccc(-c3ocnc3-c3ccc(F)cc3Cl)cn12		CHEMBL215652	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	1751584	CHEMBL869138	Inhibition of MAPKAP-K2	B	CC(C)c1nnc2ccc(-c3ocnc3-c3cc(F)c(F)cc3F)cn12		CHEMBL213423	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	1751585	CHEMBL869138	Inhibition of MAPKAP-K2	B	CCNc1nnc2ccc(-c3ocnc3-c3ccc(F)cc3)cn12		CHEMBL213451	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	1751586	CHEMBL869138	Inhibition of MAPKAP-K2	B	CC(C)(C)c1nnc2ccc(-c3ocnc3-c3ccc(F)cc3F)cn12		CHEMBL212382	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	1751587	CHEMBL869138	Inhibition of MAPKAP-K2	B	CC(C)(C)c1nnc2ccc(-c3ocnc3-c3cc(F)c(F)cc3F)cn12		CHEMBL212968	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	1751588	CHEMBL869138	Inhibition of MAPKAP-K2	B	CC(C)c1nnc2ccc(-c3c[nH]nc3-c3cc(F)ccc3F)cn12		CHEMBL214198	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	1751657	CHEMBL869138	Inhibition of MAPKAP-K2	B	CC(C)c1nnc2ccc(-c3ocnc3-c3ccccc3)cn12		CHEMBL379929	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	1769401	CHEMBL910921	Inhibition of MAPKAPK2	B	C[C@@H]1C[C@H]2CN1CCn1nc3c(cccc3c1O)-c1nc3c(cccc3nc1O)O2		CHEMBL215803	>	IC50	nM	1000.0	CHEMBL2208	Homo sapiens	IC50	uM	1.0
	1790027	CHEMBL854695	Percentage activity of human MAPKAP-K2 in the presence of 10uM of compound and 10uM of ATP in comparison with control	B	O=C(NCc1ccc(S(=O)(=O)N2CCC(n3nnc4ccccc43)CC2)s1)c1ccc(Cl)cc1		CHEMBL383955	=	Activity	%	74.0	CHEMBL2208	Homo sapiens	Activity	%	74.0
	1790339	CHEMBL873776	Percent residual activity, relative to control, of MAPKAP-K2 at 1 uM concentration of inhibitor in presence of 20 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)NC(=O)CCCCCNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL413460	=	Activity	%	80.0	CHEMBL2208	Homo sapiens	Activity	%	80.0
	1790393	CHEMBL873776	Percent residual activity, relative to control, of MAPKAP-K2 at 1 uM concentration of inhibitor in presence of 20 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL279185	=	Activity	%	85.0	CHEMBL2208	Homo sapiens	Activity	%	85.0
Not Active	1810253	CHEMBL855103	Inhibition of MK2	B	N#Cc1cnc2ccc(NCc3c[nH]cn3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL220037		Activity			CHEMBL2208	Homo sapiens	Activity		
	1824628	CHEMBL914406	Inhibition of MK2	B	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	>	Ki	nM	10000.0	CHEMBL2208	Homo sapiens	Ki	uM	10.0
	1824740	CHEMBL914406	Inhibition of MK2	B	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	=	Ki	nM	880.0	CHEMBL2208	Homo sapiens	Ki	uM	0.88
	1824821	CHEMBL914406	Inhibition of MK2	B	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	=	Ki	nM	1570.0	CHEMBL2208	Homo sapiens	Ki	uM	1.57
	1837916	CHEMBL920456	Inhibition of MAPKAPK2 at 10 uM relative to control	B	CN(C)c1nc2c(Br)c(Br)c(Br)c(Br)c2[nH]1		CHEMBL376505	=	Inhibition	%	101.0	CHEMBL2208	Homo sapiens	Inhibition	%	101.0
	1837955	CHEMBL920456	Inhibition of MAPKAPK2 at 10 uM relative to control	B	Brc1c(Br)c(Br)c2[nH]nnc2c1Br		CHEMBL177820	=	Inhibition	%	108.0	CHEMBL2208	Homo sapiens	Inhibition	%	108.0
	1838311	CHEMBL904280	Inhibition of MK2	B	CONC(=O)c1ccc(C)c(Nc2nc(N(C)CC(C)(C)C)nc(N3CCCN(C)CC3)n2)c1		CHEMBL225088	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	1841827	CHEMBL913899	Inhibition of MK2	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	IC50	nM	50000.0	CHEMBL2208	Homo sapiens	IC50	nM	50000.0
	1881750	CHEMBL904788	Inhibition of MK2	B	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	=	IC50	nM	171.0	CHEMBL2208	Homo sapiens	IC50	uM	0.171
	1881751	CHEMBL904788	Inhibition of MK2	B	CN(Cc1ccccc1)C(=O)c1ccc(-c2cc(-c3cc4c([nH]3)CCNC4=O)ccn2)cc1		CHEMBL376384	=	IC50	nM	56.0	CHEMBL2208	Homo sapiens	IC50	uM	0.056
	1881752	CHEMBL904788	Inhibition of MK2	B	O=C(NCCc1ccccc1)c1ccc(-c2cc(-c3cc4c([nH]3)CCNC4=O)ccn2)cc1		CHEMBL226321	=	IC50	nM	46.0	CHEMBL2208	Homo sapiens	IC50	uM	0.046
	1881753	CHEMBL904788	Inhibition of MK2	B	O=C(NCc1ccccc1)c1ccc(-c2cc(-c3cc4c([nH]3)CCNC4=O)ccn2)cc1		CHEMBL388530	=	IC50	nM	8.0	CHEMBL2208	Homo sapiens	IC50	uM	0.008
	1881754	CHEMBL904788	Inhibition of MK2	B	O=C(NC1CCCCC1)c1ccc(-c2cc(-c3cc4c([nH]3)CCNC4=O)ccn2)cc1		CHEMBL226261	=	IC50	nM	17.0	CHEMBL2208	Homo sapiens	IC50	uM	0.017
	1881755	CHEMBL904788	Inhibition of MK2	B	O=C(NC1CCCC1)c1ccc(-c2cc(-c3cc4c([nH]3)CCNC4=O)ccn2)cc1		CHEMBL388853	=	IC50	nM	8.0	CHEMBL2208	Homo sapiens	IC50	uM	0.008
	1881756	CHEMBL904788	Inhibition of MK2	B	O=C(NC1CC1)c1ccc(-c2cc(-c3cc4c([nH]3)CCNC4=O)ccn2)cc1		CHEMBL226206	=	IC50	nM	15.0	CHEMBL2208	Homo sapiens	IC50	uM	0.015
	1881757	CHEMBL904788	Inhibition of MK2	B	O=C(O)c1ccc(-c2cc(-c3cc4c([nH]3)CCNC4=O)ccn2)cc1		CHEMBL389658	=	IC50	nM	22.0	CHEMBL2208	Homo sapiens	IC50	uM	0.022
	1881758	CHEMBL904788	Inhibition of MK2	B	Nc1ccc(-c2cc(-c3cc4c([nH]3)CCNC4=O)ccn2)cc1		CHEMBL226475	=	IC50	nM	41.0	CHEMBL2208	Homo sapiens	IC50	uM	0.041
	1881759	CHEMBL904788	Inhibition of MK2	B	COc1ccc(-c2cc(-c3cc4c([nH]3)CCNC4=O)ccn2)cc1		CHEMBL226474	=	IC50	nM	55.0	CHEMBL2208	Homo sapiens	IC50	uM	0.055
	1881760	CHEMBL904788	Inhibition of MK2	B	CC(=O)c1ccc(-c2cc(-c3cc4c([nH]3)CCNC4=O)ccn2)cc1		CHEMBL226424	=	IC50	nM	51.0	CHEMBL2208	Homo sapiens	IC50	uM	0.051
	1881761	CHEMBL904788	Inhibition of MK2	B	N#Cc1ccc(-c2cc(-c3cc4c([nH]3)CCNC4=O)ccn2)cc1		CHEMBL389657	=	IC50	nM	62.0	CHEMBL2208	Homo sapiens	IC50	uM	0.062
	1881762	CHEMBL904788	Inhibition of MK2	B	O=C1NCCc2[nH]c(-c3ccnc(-c4ccc(C(F)(F)F)cc4)c3)cc21		CHEMBL226369	=	IC50	nM	171.0	CHEMBL2208	Homo sapiens	IC50	uM	0.171
	1881763	CHEMBL904788	Inhibition of MK2	B	O=C1NCCc2[nH]c(-c3ccnc(-c4ccc(F)cc4)c3)cc21		CHEMBL388307	=	IC50	nM	50.0	CHEMBL2208	Homo sapiens	IC50	uM	0.05
	1881764	CHEMBL904788	Inhibition of MK2	B	O=C1NCCc2[nH]c(-c3ccnc(-c4cccc(F)c4)c3)cc21		CHEMBL226472	=	IC50	nM	30.0	CHEMBL2208	Homo sapiens	IC50	uM	0.03
	1881765	CHEMBL904788	Inhibition of MK2	B	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	=	IC50	nM	126.0	CHEMBL2208	Homo sapiens	IC50	uM	0.126
	1881766	CHEMBL904788	Inhibition of MK2	B	O=C1NCCc2[nH]c(-c3ccnc(-c4ccc(Cl)cc4)c3)cc21		CHEMBL226470	=	IC50	nM	32.0	CHEMBL2208	Homo sapiens	IC50	uM	0.032
	1881767	CHEMBL904788	Inhibition of MK2	B	O=C1NCCc2[nH]c(-c3ccnc(-c4cccc(Cl)c4)c3)cc21		CHEMBL226420	=	IC50	nM	37.0	CHEMBL2208	Homo sapiens	IC50	uM	0.037
	1881768	CHEMBL904788	Inhibition of MK2	B	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4Cl)c3)cc21		CHEMBL426001	=	IC50	nM	606.0	CHEMBL2208	Homo sapiens	IC50	uM	0.606
	1881769	CHEMBL904788	Inhibition of MK2	B	O=C1NCCc2[nH]c(-c3ccnc(-c4ccc(O)cc4)c3)cc21		CHEMBL374177	=	IC50	nM	21.0	CHEMBL2208	Homo sapiens	IC50	uM	0.021
	1881770	CHEMBL904788	Inhibition of MK2	B	O=C1NCCc2[nH]c(-c3ccnc(-c4cccc(O)c4)c3)cc21		CHEMBL388619	=	IC50	nM	25.0	CHEMBL2208	Homo sapiens	IC50	uM	0.025
	1881771	CHEMBL904788	Inhibition of MK2	B	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4O)c3)cc21		CHEMBL226405	=	IC50	nM	410.0	CHEMBL2208	Homo sapiens	IC50	uM	0.41
	1881772	CHEMBL904788	Inhibition of MK2	B	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	=	IC50	nM	8.5	CHEMBL2208	Homo sapiens	IC50	uM	0.0085
	1881773	CHEMBL904788	Inhibition of MK2	B	O=C1NCCc2[nH]c(-c3ccnc(-c4cc5ccccc5s4)c3)cc21		CHEMBL226351	=	IC50	nM	30.0	CHEMBL2208	Homo sapiens	IC50	uM	0.03
	1881774	CHEMBL904788	Inhibition of MK2	B	O=C1NCCc2[nH]c(-c3ccnc(-c4ccc5ccccc5c4)c3)cc21		CHEMBL226350	=	IC50	nM	52.0	CHEMBL2208	Homo sapiens	IC50	uM	0.052
	1881775	CHEMBL904788	Inhibition of MK2	B	O=C1NCCc2[nH]c(-c3ccnc(-c4ccsc4)c3)cc21		CHEMBL388391	=	IC50	nM	76.0	CHEMBL2208	Homo sapiens	IC50	uM	0.076
	1881776	CHEMBL904788	Inhibition of MK2	B	O=C1NCCc2[nH]c(-c3ccnc(-c4cncnc4)c3)cc21		CHEMBL390601	=	IC50	nM	83.0	CHEMBL2208	Homo sapiens	IC50	uM	0.083
	1881777	CHEMBL904788	Inhibition of MK2	B	O=C1NCCc2[nH]c(-c3ccnc(-c4cccnc4)c3)cc21		CHEMBL225975	=	IC50	nM	48.0	CHEMBL2208	Homo sapiens	IC50	uM	0.048
	1881778	CHEMBL904788	Inhibition of MK2	B	O=C1NCCc2[nH]c(-c3ccnc(-c4ccncc4)c3)cc21		CHEMBL225973	=	IC50	nM	56.0	CHEMBL2208	Homo sapiens	IC50	uM	0.056
	1881779	CHEMBL904788	Inhibition of MK2	B	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4)c3)cc21		CHEMBL388566	=	IC50	nM	66.0	CHEMBL2208	Homo sapiens	IC50	uM	0.066
	1881780	CHEMBL904788	Inhibition of MK2	B	O=C1NCCc2[nH]c(-c3ccnc(Cl)c3)cc21		CHEMBL226232	=	IC50	nM	608.0	CHEMBL2208	Homo sapiens	IC50	uM	0.608
	1881852	CHEMBL904804	Inhibition of MK2 in LPS-stimulated U937 cells assessed as HSP27 phosphorylation after 30 mins	F	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	=	IC50	nM	4000.0	CHEMBL2208	Homo sapiens	IC50	uM	4.0
	1881875	CHEMBL904803	Ratio of IC50 for TNFalpha production inhibition in U937 cells to IC50 for MK2	F	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	=	Ratio IC50		38.0	CHEMBL2208	Homo sapiens	Ratio IC50		38.0
	1891156	CHEMBL905896	Inhibition at MK2	B	NC(=O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1		CHEMBL242237	>	IC50	nM	50000.0	CHEMBL2208	Homo sapiens	IC50	uM	50.0
	1917481	CHEMBL895135	Inhibition of MAPKAPK2 at 1 uM	B	O=c1ccc(=O)c2c1c1[nH]c3ccc(O)cc3c1c1c(=O)[nH]c(=O)c21		CHEMBL243931	=	Inhibition	%	73.0	CHEMBL2208	Homo sapiens	Inhibition	%	73.0
	1917502	CHEMBL895135	Inhibition of MAPKAPK2 at 1 uM	B	Cc1ccc2[nH]c3c4c(O)ccc(O)c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL244141	=	Inhibition	%	57.0	CHEMBL2208	Homo sapiens	Inhibition	%	57.0
	1923373	CHEMBL896201	Inhibition of MK2	B	N#Cc1cnc2c(F)cc(NCc3c[nH]cn3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL245212	>	IC50	nM	40000.0	CHEMBL2208	Homo sapiens	IC50	uM	40.0
	1923374	CHEMBL896201	Inhibition of MK2	B	Cn1cnc(CNc2cc(Br)c3ncc(C#N)c(Nc4ccc(F)c(Cl)c4)c3c2)c1		CHEMBL230761	=	IC50	nM	87100.0	CHEMBL2208	Homo sapiens	IC50	uM	87.1
	1923376	CHEMBL896201	Inhibition of MK2	B	CN(C)CCCn1cc(CNc2cc(Br)c3ncc(C#N)c(Nc4ccc(F)c(Cl)c4)c3c2)nn1		CHEMBL425834	>	IC50	nM	40000.0	CHEMBL2208	Homo sapiens	IC50	uM	40.0
	1923377	CHEMBL896201	Inhibition of MK2	B	N#Cc1cnc2c(Br)cc(NCc3c[nH]nn3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL230232	=	IC50	nM	35800.0	CHEMBL2208	Homo sapiens	IC50	uM	35.8
	1923378	CHEMBL896201	Inhibition of MK2	B	N#Cc1cnc2c(Cl)cc(NCc3cccc[n+]3[O-])cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL395573	=	IC50	nM	40100.0	CHEMBL2208	Homo sapiens	IC50	uM	40.1
	1923379	CHEMBL896201	Inhibition of MK2	B	N#Cc1cnc2c(Cl)cc(NCc3cnc[nH]3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL436817	=	IC50	nM	40200.0	CHEMBL2208	Homo sapiens	IC50	uM	40.2
	1923390	CHEMBL896201	Inhibition of MK2	B	CCCc1[nH]cnc1CNc1cc(Cl)c2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2c1		CHEMBL230654	=	IC50	nM	62700.0	CHEMBL2208	Homo sapiens	IC50	uM	62.7
	1944475	CHEMBL891251	Inhibition of MARKAP2 kinase by radiometric assay	B	O=C(N[C@H]1CC[C@H](O)CC1)c1ccc2c(c1)Cc1c(-c3ccc(-c4ccc(O)cc4)cc3)n[nH]c1-2		CHEMBL438485	>	IC50	nM	50000.0	CHEMBL2208	Homo sapiens	IC50	nM	50000.0
Not Determined	1944476	CHEMBL891251	Inhibition of MARKAP2 kinase by radiometric assay	B	O=C(NCc1ccncc1)c1ccc2c(c1)Cc1c(-c3ccc(-c4ccc(O)cc4)cc3)n[nH]c1-2		CHEMBL242753		IC50			CHEMBL2208	Homo sapiens	IC50		
	1968070	CHEMBL896386	Inhibition of MAPKAPK2 at 10 uM	B	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1cccs1)n2CCCN		CHEMBL233338	=	Inhibition	%	1.0	CHEMBL2208	Homo sapiens	Inhibition	%	1.0
	1975565	CHEMBL898645	Inhibition of MAPKAPK2 at 1 uM	B	O=C1NC(=O)c2c1c1c3cc(Cl)ccc3[nH]c1c1cccn21		CHEMBL392052	=	Inhibition	%	75.0	CHEMBL2208	Homo sapiens	Inhibition	%	75.0
	1975572	CHEMBL898645	Inhibition of MAPKAPK2 at 1 uM	B	O=C1NC(=O)c2c1c1c3cc(Br)ccc3[nH]c1c1cccn21		CHEMBL238625	=	Inhibition	%	99.0	CHEMBL2208	Homo sapiens	Inhibition	%	99.0
Not Active	1980902	CHEMBL898033	Inhibition of MK2 at 40 uM	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1NC1CCCCCC1		CHEMBL236384		Activity			CHEMBL2208	Homo sapiens	Activity		
Not Active	1980911	CHEMBL898033	Inhibition of MK2 at 40 uM	B	N#Cc1cnc2ccc(NCc3c[nH]cn3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL220037		Activity			CHEMBL2208	Homo sapiens	Activity		
	1998230	CHEMBL900112	Inhibition of MK2	B	COc1cc2ncc3c(N)nc4c(C)c(N)ccc4c3c2cc1OC		CHEMBL235157	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
Active	2002809	CHEMBL901786	Inhibition of MK2 in human TERT immortalised HCA2 cells assessed as maximal inhibition of anisomycin-induced HSP27 phosphorylation at 25 uM by ELISA	B	N#Cc1c(N)nc2c(c1N)Cc1cc(O)c(O)cc1O2.O=C(O)C(F)(F)F		CHEMBL397819		Activity			CHEMBL2208	Homo sapiens	Activity		
Active	2002813	CHEMBL901785	Inhibition of MK2 in human TERT immortalised HCA2 cells assessed as inhibition of anisomycin-induced HSP27 phosphorylation at 2.5 uM by ELISA	B	N#Cc1c(N)nc2c(c1N)Cc1cc(O)c(O)cc1O2.O=C(O)C(F)(F)F		CHEMBL397819		Activity			CHEMBL2208	Homo sapiens	Activity		
	2002814	CHEMBL901785	Inhibition of MK2 in human TERT immortalised HCA2 cells assessed as inhibition of anisomycin-induced HSP27 phosphorylation at 2.5 uM by ELISA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Ki	nM	330.0	CHEMBL2208	Homo sapiens	Ki app	nmol	330.0
	2002815	CHEMBL901788	Inhibition of MK2 in human TERT immortalised HCA2 cells assessed as inhibition of anisomycin-induced HSP27 phosphorylation by ELISA	B	N#Cc1c(N)nc2c(c1N)Cc1cc(O)c(O)cc1O2.O=C(O)C(F)(F)F		CHEMBL397819	=	IC50	nM	2500.0	CHEMBL2208	Homo sapiens	IC50	uM	2.5
Active	2002822	CHEMBL901792	Inhibition of MK2 mediated HSP27 phosphorylation in immortalised WS cells assessed as reduction in F-actin stress fibres	B	N#Cc1c(N)nc2c(c1N)Cc1cc(O)c(O)cc1O2.O=C(O)C(F)(F)F		CHEMBL397819		Activity			CHEMBL2208	Homo sapiens	Activity		
Active	2002823	CHEMBL901792	Inhibition of MK2 mediated HSP27 phosphorylation in immortalised WS cells assessed as reduction in F-actin stress fibres	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		Activity			CHEMBL2208	Homo sapiens	Activity		
Active	2002824	CHEMBL901793	Inhibition of MK2 mediated HSP27 phosphorylation in immortalised WS cells assessed as reduction in F-actin stress fibres at 25 uM after 6 days	B	N#Cc1c(N)nc2c(c1N)Cc1cc(O)c(O)cc1O2.O=C(O)C(F)(F)F		CHEMBL397819		Activity			CHEMBL2208	Homo sapiens	Activity		
	2011594	CHEMBL902112	Inhibition of MAPKAPK2	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	2011601	CHEMBL902112	Inhibition of MAPKAPK2	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL241682	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	2015693	CHEMBL885500	Inhibition of MAPK2 at 10 uM	B	NC[C@H]1CC[C@H](c2nc(-c3cccc(OCc4ccccc4)c3)c3c(N)nccn32)CC1		CHEMBL392284	<	Inhibition	%	50.0	CHEMBL2208	Homo sapiens	Inhibition	%	50.0
	2025161	CHEMBL886986	Inhibition of MAPKAPK2 at 1 uM relative to control	B	CN(C)c1cc2cc(n1)CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CCC2		CHEMBL247067	=	Inhibition	%	101.0	CHEMBL2208	Homo sapiens	Inhibition	%	101.0
	2025162	CHEMBL886987	Inhibition of MEK1 at 1 uM relative to control	B	CN(C)c1cc2cc(n1)CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CCC2		CHEMBL247067	=	Inhibition	%	93.0	CHEMBL2208	Homo sapiens	Inhibition	%	93.0
	2025369	CHEMBL886986	Inhibition of MAPKAPK2 at 1 uM relative to control	B	CN(C)c1nc2ccc1CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CC2		CHEMBL1162963	=	Inhibition	%	98.0	CHEMBL2208	Homo sapiens	Inhibition	%	98.0
	2025370	CHEMBL886986	Inhibition of MAPKAPK2 at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1ccc(c(N3CCCC3)n1)CCCn1cc2c2ccccc21		CHEMBL396327	=	Inhibition	%	95.0	CHEMBL2208	Homo sapiens	Inhibition	%	95.0
	2025371	CHEMBL886986	Inhibition of MAPKAPK2 at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1cc(nc(N3CCCC3)c1)CCCn1cc2c2ccccc21		CHEMBL397771	=	Inhibition	%	108.0	CHEMBL2208	Homo sapiens	Inhibition	%	108.0
	2025372	CHEMBL886987	Inhibition of MEK1 at 1 uM relative to control	B	CN(C)c1nc2ccc1CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CC2		CHEMBL1162963	=	Inhibition	%	76.0	CHEMBL2208	Homo sapiens	Inhibition	%	76.0
	2025373	CHEMBL886987	Inhibition of MEK1 at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1ccc(c(N3CCCC3)n1)CCCn1cc2c2ccccc21		CHEMBL396327	=	Inhibition	%	98.0	CHEMBL2208	Homo sapiens	Inhibition	%	98.0
	2025374	CHEMBL886987	Inhibition of MEK1 at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1cc(nc(N3CCCC3)c1)CCCn1cc2c2ccccc21		CHEMBL397771	=	Inhibition	%	91.0	CHEMBL2208	Homo sapiens	Inhibition	%	91.0
	2036343	CHEMBL922889	Inhibition of MK2	B	COc1ccc2[nH]c3c(c2c1)CCNC3C(=O)O		CHEMBL395157	=	IC50	nM	2500.0	CHEMBL2208	Homo sapiens	IC50	uM	2.5
	2036351	CHEMBL922889	Inhibition of MK2	B	COc1ccc2c3c([nH]c2c1)C(C(=O)O)NCC3	Outside typical range	CHEMBL247342	>	IC50	nM	200000.0	CHEMBL2208	Homo sapiens	IC50	uM	200.0
	2036352	CHEMBL922889	Inhibition of MK2	B	COc1cccc2[nH]c3c(c12)CCNC3C(=O)O		CHEMBL247138	=	IC50	nM	42000.0	CHEMBL2208	Homo sapiens	IC50	uM	42.0
	2036353	CHEMBL922889	Inhibition of MK2	B	COc1ccc2[nH]c3c(c2c1)CC(CN(C)C)NC3C(=O)O	Outside typical range	CHEMBL245461	>	IC50	nM	200000.0	CHEMBL2208	Homo sapiens	IC50	uM	200.0
	2036354	CHEMBL922889	Inhibition of MK2	B	COc1ccc2[nH]c3c(c2c1)CC(C(F)(F)F)NC3C(=O)O	Outside typical range	CHEMBL397330	>	IC50	nM	200000.0	CHEMBL2208	Homo sapiens	IC50	uM	200.0
	2036355	CHEMBL922889	Inhibition of MK2	B	COc1ccc2c(c1)c1c(n2C)C(C(=O)O)NCC1	Outside typical range	CHEMBL248512	>	IC50	nM	200000.0	CHEMBL2208	Homo sapiens	IC50	uM	200.0
	2036356	CHEMBL922889	Inhibition of MK2	B	COc1ccc2[nH]c3c(c2c1)CCNC3CC(=O)O	Outside typical range	CHEMBL248511	>	IC50	nM	200000.0	CHEMBL2208	Homo sapiens	IC50	uM	200.0
	2036357	CHEMBL922889	Inhibition of MK2	B	COc1ccc2[nH]c3c(c2c1)CCNC3(C)C(=O)O	Outside typical range	CHEMBL396151	>	IC50	nM	200000.0	CHEMBL2208	Homo sapiens	IC50	uM	200.0
	2036358	CHEMBL922889	Inhibition of MK2	B	COc1ccc2[nH]c3c(c2c1)CCNC3CN	Outside typical range	CHEMBL245705	>	IC50	nM	200000.0	CHEMBL2208	Homo sapiens	IC50	uM	200.0
	2036359	CHEMBL922889	Inhibition of MK2	B	COc1ccc2[nH]c3c(c2c1)CCNC3CO	Outside typical range	CHEMBL395133	>	IC50	nM	200000.0	CHEMBL2208	Homo sapiens	IC50	uM	200.0
	2036360	CHEMBL922889	Inhibition of MK2	B	COc1ccc2[nH]c3c(c2c1)CCNC3C(N)=O	Outside typical range	CHEMBL245704	>	IC50	nM	200000.0	CHEMBL2208	Homo sapiens	IC50	uM	200.0
	2036361	CHEMBL922889	Inhibition of MK2	B	COc1ccc2[nH]c3c(c2c1)CCOC3C(=O)O	Outside typical range	CHEMBL245503	>	IC50	nM	200000.0	CHEMBL2208	Homo sapiens	IC50	uM	200.0
	2036362	CHEMBL922889	Inhibition of MK2	B	COc1ccc2[nH]c3c(c2c1)CCCC3C(=O)O	Outside typical range	CHEMBL245502	>	IC50	nM	200000.0	CHEMBL2208	Homo sapiens	IC50	uM	200.0
	2036363	CHEMBL922889	Inhibition of MK2	B	COc1ccc2[nH]c3c(C(=O)O)nccc3c2c1	Outside typical range	CHEMBL280224	>	IC50	nM	200000.0	CHEMBL2208	Homo sapiens	IC50	uM	200.0
	2036364	CHEMBL922889	Inhibition of MK2	B	COC(=O)c1nccc2c1[nH]c1ccc(OC)cc12	Outside typical range	CHEMBL396163	>	IC50	nM	200000.0	CHEMBL2208	Homo sapiens	IC50	uM	200.0
	2036365	CHEMBL922889	Inhibition of MK2	B	COc1ccc2[nH]c3c(c2c1C)CCNC3C(=O)O	Outside typical range	CHEMBL247344	>	IC50	nM	200000.0	CHEMBL2208	Homo sapiens	IC50	uM	200.0
	2036366	CHEMBL922889	Inhibition of MK2	B	COc1cccc2c3c([nH]c12)C(C(=O)O)NCC3	Outside typical range	CHEMBL395409	>	IC50	nM	200000.0	CHEMBL2208	Homo sapiens	IC50	uM	200.0
	2036367	CHEMBL922889	Inhibition of MK2	B	COc1ccc2[nH]c3c(c2c1)C1CCN(C1)C3C(=O)OC(C)c1ccccc1		CHEMBL395352	=	IC50	nM	13000.0	CHEMBL2208	Homo sapiens	IC50	uM	13.0
	2036368	CHEMBL922889	Inhibition of MK2	B	C=CCOC(=O)C1c2[nH]c3ccc(OC)cc3c2C2CCN1C2		CHEMBL245862	=	IC50	nM	3270.0	CHEMBL2208	Homo sapiens	IC50	uM	3.27
	2036369	CHEMBL922889	Inhibition of MK2	B	CCCOC(=O)C1c2[nH]c3ccc(OC)cc3c2C2CCN1C2		CHEMBL245662	=	IC50	nM	10100.0	CHEMBL2208	Homo sapiens	IC50	uM	10.1
	2036370	CHEMBL922889	Inhibition of MK2	B	COc1ccc2[nH]c3c(c2c1)C1CCN(C1)C3C(=O)OCc1ccccc1		CHEMBL245661	=	IC50	nM	7090.0	CHEMBL2208	Homo sapiens	IC50	uM	7.09
	2036371	CHEMBL922889	Inhibition of MK2	B	CCOC(=O)C1c2[nH]c3ccc(OC)cc3c2C2CCN1C2		CHEMBL394125	=	IC50	nM	29300.0	CHEMBL2208	Homo sapiens	IC50	uM	29.3
	2036372	CHEMBL922889	Inhibition of MK2	B	COc1ccc2[nH]c3c(c2c1)C1CCCN(C1)C3C(=O)O		CHEMBL394124	=	IC50	nM	5100.0	CHEMBL2208	Homo sapiens	IC50	uM	5.1
	2036373	CHEMBL922889	Inhibition of MK2	B	COc1ccc2[nH]c3c(c2c1)C1CCN(C1)C3C(=O)O		CHEMBL392876	=	IC50	nM	290.0	CHEMBL2208	Homo sapiens	IC50	uM	0.29
	2036374	CHEMBL922889	Inhibition of MK2	B	COc1ccc2[nH]c3c(c2c1)CC(CN)NC3C(=O)O		CHEMBL248525	=	IC50	nM	5900.0	CHEMBL2208	Homo sapiens	IC50	uM	5.9
	2036375	CHEMBL922889	Inhibition of MK2	B	COc1ccc2[nH]c3c(c2c1)CC(CO)NC3C(=O)O		CHEMBL392665	=	IC50	nM	3000.0	CHEMBL2208	Homo sapiens	IC50	uM	3.0
	2036376	CHEMBL922889	Inhibition of MK2	B	CCC1Cc2c([nH]c3ccc(OC)cc23)C(C(=O)O)N1		CHEMBL247911	=	IC50	nM	64000.0	CHEMBL2208	Homo sapiens	IC50	uM	64.0
	2036377	CHEMBL922889	Inhibition of MK2	B	COc1ccc2[nH]c3c(c2c1)CC(C)NC3C(=O)O		CHEMBL247707	=	IC50	nM	7100.0	CHEMBL2208	Homo sapiens	IC50	uM	7.1
	2036378	CHEMBL922889	Inhibition of MK2	B	COc1ccc2[nH]c3c(c2c1)C(Cc1ccccc1)CNC3C(=O)O		CHEMBL248317	=	IC50	nM	16000.0	CHEMBL2208	Homo sapiens	IC50	uM	16.0
	2036379	CHEMBL922889	Inhibition of MK2	B	CCC1CNC(C(=O)O)c2[nH]c3ccc(OC)cc3c21		CHEMBL248316	=	IC50	nM	2200.0	CHEMBL2208	Homo sapiens	IC50	uM	2.2
	2036380	CHEMBL922889	Inhibition of MK2	B	COc1ccc2[nH]c3c(c2c1)C(C)CNC3C(=O)O		CHEMBL248110	=	IC50	nM	2200.0	CHEMBL2208	Homo sapiens	IC50	uM	2.2
	2036381	CHEMBL922889	Inhibition of MK2	B	COc1ccc2[nH]c3c(c2c1)CCNC3c1nn[nH]n1	Outside typical range	CHEMBL248313	=	IC50	nM	130000.0	CHEMBL2208	Homo sapiens	IC50	uM	130.0
	2036382	CHEMBL922889	Inhibition of MK2	B	COc1ccc2[nH]c3c(c2c1)CCNC3C(=O)NO		CHEMBL248312	=	IC50	nM	88000.0	CHEMBL2208	Homo sapiens	IC50	uM	88.0
	2036383	CHEMBL922889	Inhibition of MK2	B	COC(=O)C1NCCc2c1[nH]c1ccc(OC)cc21		CHEMBL395132	=	IC50	nM	47000.0	CHEMBL2208	Homo sapiens	IC50	uM	47.0
	2036384	CHEMBL922889	Inhibition of MK2	B	COc1ccc2[nH]c3c(c2c1)CCN(Cc1ccccc1)C3C(=O)O	Outside typical range	CHEMBL248164	=	IC50	nM	130000.0	CHEMBL2208	Homo sapiens	IC50	uM	130.0
	2036385	CHEMBL922889	Inhibition of MK2	B	COc1ccc2[nH]c3c(c2c1)CCN(C(C)C)C3C(=O)O	Outside typical range	CHEMBL437766	=	IC50	nM	170000.0	CHEMBL2208	Homo sapiens	IC50	uM	170.0
	2036386	CHEMBL922889	Inhibition of MK2	B	CCN1CCc2c([nH]c3ccc(OC)cc23)C1C(=O)O		CHEMBL245505	=	IC50	nM	5800.0	CHEMBL2208	Homo sapiens	IC50	uM	5.8
	2036387	CHEMBL922889	Inhibition of MK2	B	COc1ccc2[nH]c3c(c2c1)CCN(C)C3C(=O)O		CHEMBL397649	=	IC50	nM	1000.0	CHEMBL2208	Homo sapiens	IC50	uM	1.0
	2036388	CHEMBL922889	Inhibition of MK2	B	O=C(COc1ccc2[nH]c3c(c2c1)CCNC3C(=O)O)c1ccccc1		CHEMBL245296	=	IC50	nM	1100.0	CHEMBL2208	Homo sapiens	IC50	uM	1.1
	2036389	CHEMBL922889	Inhibition of MK2	B	O=C(O)C1NCCc2c1[nH]c1ccc(OCc3ccccc3)cc21		CHEMBL396314	=	IC50	nM	12000.0	CHEMBL2208	Homo sapiens	IC50	uM	12.0
	2036390	CHEMBL922889	Inhibition of MK2	B	NC(=O)c1ccc2[nH]c3c(c2c1)CCNC3C(=O)O		CHEMBL246309	=	IC50	nM	28000.0	CHEMBL2208	Homo sapiens	IC50	uM	28.0
	2036391	CHEMBL922889	Inhibition of MK2	B	O=C(O)C1NCCc2c1[nH]c1ccc(Cl)cc21		CHEMBL246102	=	IC50	nM	19000.0	CHEMBL2208	Homo sapiens	IC50	uM	19.0
	2036392	CHEMBL922889	Inhibition of MK2	B	O=C(O)C1NCCc2c1[nH]c1ccc(F)cc21		CHEMBL391830	=	IC50	nM	26000.0	CHEMBL2208	Homo sapiens	IC50	uM	26.0
	2036393	CHEMBL922889	Inhibition of MK2	B	O=C(O)C1NCCc2c1[nH]c1ccccc21		CHEMBL246101	=	IC50	nM	87000.0	CHEMBL2208	Homo sapiens	IC50	uM	87.0
	2036394	CHEMBL922889	Inhibition of MK2	B	CC(=O)Oc1ccc2[nH]c3c(c2c1)CCNC3C(=O)O	Outside typical range	CHEMBL437554	=	IC50	nM	170000.0	CHEMBL2208	Homo sapiens	IC50	uM	170.0
	2036395	CHEMBL922889	Inhibition of MK2	B	COC(=O)c1ccc2[nH]c3c(c2c1)CCNC3C(=O)O		CHEMBL246100	=	IC50	nM	6600.0	CHEMBL2208	Homo sapiens	IC50	uM	6.6
	2036396	CHEMBL922889	Inhibition of MK2	B	O=C(O)C1NCCc2c1[nH]c1ccc(O)cc21		CHEMBL246099	=	IC50	nM	4500.0	CHEMBL2208	Homo sapiens	IC50	uM	4.5
	2036397	CHEMBL922889	Inhibition of MK2	B	COc1cc2c3c([nH]c2cc1O)C(C(=O)O)NCC3		CHEMBL247343	=	IC50	nM	53000.0	CHEMBL2208	Homo sapiens	IC50	uM	53.0
	2037087	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	COc1ccc2[nH]c3c(c2c1)C(C)(C)CNC3=O		CHEMBL248364	=	IC50	nM	2700.0	CHEMBL2208	Homo sapiens	IC50	uM	2.7
	2037088	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4ncc(C(=O)NCCCN(C)C)s4)cc3c21		CHEMBL246508	=	IC50	nM	480.0	CHEMBL2208	Homo sapiens	IC50	uM	0.48
	2037089	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4nc(C(=O)NC5CCN(C)CC5)cs4)cc3c21		CHEMBL246301	=	IC50	nM	10.0	CHEMBL2208	Homo sapiens	IC50	uM	0.01
	2037090	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4nc(C(=O)N5CCC(N(C)C)CC5)cs4)cc3c21		CHEMBL397642	=	IC50	nM	250.0	CHEMBL2208	Homo sapiens	IC50	uM	0.25
	2037091	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4nc(C(=O)NC5CCCCC5)cs4)cc3c21		CHEMBL246300	=	IC50	nM	44.0	CHEMBL2208	Homo sapiens	IC50	uM	0.044
	2037092	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CCCNC(=O)c1csc(NC(=O)c2ccc3[nH]c4c(c3c2)C(C)CNC4=O)n1		CHEMBL246299	=	IC50	nM	45.0	CHEMBL2208	Homo sapiens	IC50	uM	0.045
	2037093	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4nc(C(=O)NCCC(N)=O)cs4)cc3c21		CHEMBL246090	=	IC50	nM	21.0	CHEMBL2208	Homo sapiens	IC50	uM	0.021
	2037094	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4nc(C(=O)NCC(N)=O)cs4)cc3c21		CHEMBL246089	=	IC50	nM	124.0	CHEMBL2208	Homo sapiens	IC50	uM	0.124
	2037095	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4nc(C(=O)NCCCN(C)C)cs4)cc3c21		CHEMBL246088	=	IC50	nM	35.0	CHEMBL2208	Homo sapiens	IC50	uM	0.035
	2037096	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4nc(C(=O)NCCN)cs4)cc3c21		CHEMBL396160	=	IC50	nM	17.0	CHEMBL2208	Homo sapiens	IC50	uM	0.017
	2037097	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4nc(C(=O)NCCN(C)C)cs4)cc3c21		CHEMBL245884	=	IC50	nM	34.0	CHEMBL2208	Homo sapiens	IC50	uM	0.034
	2037098	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4nc(C(=O)N(C)C)cs4)cc3c21		CHEMBL245883	=	IC50	nM	333.0	CHEMBL2208	Homo sapiens	IC50	uM	0.333
	2037099	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CNC(=O)c1csc(NC(=O)c2ccc3[nH]c4c(c3c2)C(C)CNC4=O)n1		CHEMBL396159	=	IC50	nM	72.0	CHEMBL2208	Homo sapiens	IC50	uM	0.072
	2037100	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4ncc(C(N)=O)s4)cc3c21		CHEMBL245682	=	IC50	nM	120.0	CHEMBL2208	Homo sapiens	IC50	uM	0.12
	2037101	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	COC(=O)c1cnc(NC(=O)c2ccc3[nH]c4c(c3c2)C(C)CNC4=O)s1		CHEMBL245680	=	IC50	nM	770.0	CHEMBL2208	Homo sapiens	IC50	uM	0.77
	2037102	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4nc(C(N)=O)cs4)cc3c21		CHEMBL397332	=	IC50	nM	83.0	CHEMBL2208	Homo sapiens	IC50	uM	0.083
	2037103	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	COC(=O)c1csc(NC(=O)c2ccc3[nH]c4c(c3c2)C(C)CNC4=O)n1		CHEMBL245485	=	IC50	nM	750.0	CHEMBL2208	Homo sapiens	IC50	uM	0.75
	2037104	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4ccc(C(N)=O)nc4)cc3c21		CHEMBL247333	=	IC50	nM	620.0	CHEMBL2208	Homo sapiens	IC50	uM	0.62
	2037105	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	COC(=O)c1ccc(NC(=O)c2ccc3[nH]c4c(c3c2)C(C)CNC4=O)cn1		CHEMBL394926	=	IC50	nM	760.0	CHEMBL2208	Homo sapiens	IC50	uM	0.76
	2037106	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4ccc(C(N)=O)cc4)cc3c21		CHEMBL442419	=	IC50	nM	620.0	CHEMBL2208	Homo sapiens	IC50	uM	0.62
	2037107	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	COC(=O)c1ccc(NC(=O)c2ccc3[nH]c4c(c3c2)C(C)CNC4=O)cc1		CHEMBL246082	=	IC50	nM	930.0	CHEMBL2208	Homo sapiens	IC50	uM	0.93
	2037108	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4ccc(C#N)cc4)cc3c21		CHEMBL245475	=	IC50	nM	1700.0	CHEMBL2208	Homo sapiens	IC50	uM	1.7
	2037109	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4ccc(Cl)cc4)cc3c21		CHEMBL245473	=	IC50	nM	1700.0	CHEMBL2208	Homo sapiens	IC50	uM	1.7
	2037110	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC(C)c1ccc(NC(=O)c2ccc3[nH]c4c(c3c2)C(C)CNC4=O)cc1		CHEMBL248335	=	IC50	nM	7700.0	CHEMBL2208	Homo sapiens	IC50	uM	7.7
	2037111	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	Cc1ccc(NC(=O)c2ccc3[nH]c4c(c3c2)C(C)CNC4=O)cc1		CHEMBL248533	=	IC50	nM	3000.0	CHEMBL2208	Homo sapiens	IC50	uM	3.0
	2037112	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CCOC(=O)c1cccc(NC(=O)c2ccc3[nH]c4c(c3c2)C(C)CNC4=O)c1		CHEMBL248331	=	IC50	nM	7400.0	CHEMBL2208	Homo sapiens	IC50	uM	7.4
	2037113	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4cccc(C#N)c4)cc3c21		CHEMBL246910	=	IC50	nM	770.0	CHEMBL2208	Homo sapiens	IC50	uM	0.77
	2037114	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4cccc(Cl)c4)cc3c21		CHEMBL395592	=	IC50	nM	1300.0	CHEMBL2208	Homo sapiens	IC50	uM	1.3
	2037115	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4ccccc4F)cc3c21		CHEMBL394262	=	IC50	nM	9700.0	CHEMBL2208	Homo sapiens	IC50	uM	9.7
	2037116	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4nc5ccccc5s4)cc3c21		CHEMBL392597	=	IC50	nM	1500.0	CHEMBL2208	Homo sapiens	IC50	uM	1.5
	2037117	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4cnccn4)cc3c21		CHEMBL392596	=	IC50	nM	440.0	CHEMBL2208	Homo sapiens	IC50	uM	0.44
	2037118	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4ccncn4)cc3c21		CHEMBL246480	=	IC50	nM	1500.0	CHEMBL2208	Homo sapiens	IC50	uM	1.5
	2037119	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4ccon4)cc3c21		CHEMBL394735	=	IC50	nM	1500.0	CHEMBL2208	Homo sapiens	IC50	uM	1.5
	2037120	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4nccs4)cc3c21		CHEMBL247510	=	IC50	nM	820.0	CHEMBL2208	Homo sapiens	IC50	uM	0.82
	2037121	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4ccncc4)cc3c21		CHEMBL247509	=	IC50	nM	760.0	CHEMBL2208	Homo sapiens	IC50	uM	0.76
	2037122	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4cccnc4)cc3c21		CHEMBL437943	=	IC50	nM	520.0	CHEMBL2208	Homo sapiens	IC50	uM	0.52
	2037123	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4ccccc4)cc3c21		CHEMBL393057	=	IC50	nM	2900.0	CHEMBL2208	Homo sapiens	IC50	uM	2.9
	2037124	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CNC(=O)c1ccc2[nH]c3c(c2c1)C(C)CNC3=O		CHEMBL393056	=	IC50	nM	12000.0	CHEMBL2208	Homo sapiens	IC50	uM	12.0
	2037125	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(N)=O)cc3c21		CHEMBL246892	=	IC50	nM	5400.0	CHEMBL2208	Homo sapiens	IC50	uM	5.4
	2037126	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(Br)cc3c21		CHEMBL394494	=	IC50	nM	15000.0	CHEMBL2208	Homo sapiens	IC50	uM	15.0
	2037127	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	COc1ccc2[nH]c3c(c2c1)C(C)CNC3=O		CHEMBL246526	=	IC50	nM	4500.0	CHEMBL2208	Homo sapiens	IC50	uM	4.5
	2037128	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	COc1ccc2[nH]c3c(c2c1)C1(CCC1)CNC3=O		CHEMBL248366	=	IC50	nM	1100.0	CHEMBL2208	Homo sapiens	IC50	uM	1.1
	2037129	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	COc1ccc2[nH]c3c(c2c1)C(C)(C)CNC3		CHEMBL395194	>	IC50	nM	40000.0	CHEMBL2208	Homo sapiens	IC50	uM	40.0
	2037130	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)N(C)C)cc3c21		CHEMBL246893	>	IC50	nM	20000.0	CHEMBL2208	Homo sapiens	IC50	uM	20.0
	2037131	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC(=O)Nc1ccc2[nH]c3c(c2c1)C(C)CNC3=O		CHEMBL246891	>	IC50	nM	40000.0	CHEMBL2208	Homo sapiens	IC50	uM	40.0
	2037132	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(OCc4ccccc4)cc3c21		CHEMBL248104	>	IC50	nM	40000.0	CHEMBL2208	Homo sapiens	IC50	uM	40.0
	2037133	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(O)cc3c21		CHEMBL247907	>	IC50	nM	40000.0	CHEMBL2208	Homo sapiens	IC50	uM	40.0
	2037134	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(-c4ccccc4)cc3c21		CHEMBL247906	>	IC50	nM	40000.0	CHEMBL2208	Homo sapiens	IC50	uM	40.0
	2037135	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	Cc1ccc2[nH]c3c(c2c1)C(C)CNC3=O		CHEMBL394493	>	IC50	nM	40000.0	CHEMBL2208	Homo sapiens	IC50	uM	40.0
	2037136	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccccc3c21		CHEMBL247905	>	IC50	nM	40000.0	CHEMBL2208	Homo sapiens	IC50	uM	40.0
	2037137	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	COc1ccc2[nH]c3c(c2c1)C(CCOC(C)=O)CNC3=O		CHEMBL247904	>	IC50	nM	40000.0	CHEMBL2208	Homo sapiens	IC50	uM	40.0
	2037138	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CCC1(CC)CNC(=O)c2[nH]c3ccc(OC)cc3c21		CHEMBL394492	>	IC50	nM	40000.0	CHEMBL2208	Homo sapiens	IC50	uM	40.0
	2037139	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	COc1ccc2c(c1)c1c(n2C)C(=O)NCC1(C)C		CHEMBL396919	>	IC50	nM	40000.0	CHEMBL2208	Homo sapiens	IC50	uM	40.0
	2037140	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	COc1ccc2[nH]c3c(c2c1)C(C)(C)CN(C)C3=O		CHEMBL248365	>	IC50	nM	40000.0	CHEMBL2208	Homo sapiens	IC50	uM	40.0
	2037141	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4ccc(C(C)(C)C)cc4)cc3c21		CHEMBL248336	>	IC50	nM	20000.0	CHEMBL2208	Homo sapiens	IC50	uM	20.0
	2037142	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4cccc(C(C)(C)C)c4)cc3c21		CHEMBL246696	>	IC50	nM	20000.0	CHEMBL2208	Homo sapiens	IC50	uM	20.0
	2037143	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC(C)c1cccc(NC(=O)c2ccc3[nH]c4c(c3c2)C(C)CNC4=O)c1		CHEMBL246907	>	IC50	nM	20000.0	CHEMBL2208	Homo sapiens	IC50	uM	20.0
	2037144	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4ccccc4C(N)=O)cc3c21		CHEMBL391983	=	IC50	nM	3000.0	CHEMBL2208	Homo sapiens	IC50	uM	3.0
	2037145	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4ccccc4C#N)cc3c21		CHEMBL429474	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	2037146	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4ccccc4Br)cc3c21		CHEMBL246695	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	2037147	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	Cc1ccccc1NC(=O)c1ccc2[nH]c3c(c2c1)C(C)CNC3=O		CHEMBL246482	>	IC50	nM	20000.0	CHEMBL2208	Homo sapiens	IC50	uM	20.0
	2037148	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4ncccn4)cc3c21		CHEMBL246481	>	IC50	nM	20000.0	CHEMBL2208	Homo sapiens	IC50	uM	20.0
	2037149	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)NCCc4ccccc4)cc3c21		CHEMBL247306	>	IC50	nM	20000.0	CHEMBL2208	Homo sapiens	IC50	uM	20.0
	2037150	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)NCc4ccccc4)cc3c21		CHEMBL247305	>	IC50	nM	20000.0	CHEMBL2208	Homo sapiens	IC50	uM	20.0
	2037151	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)N4CCCCC4)cc3c21		CHEMBL247095	>	IC50	nM	20000.0	CHEMBL2208	Homo sapiens	IC50	uM	20.0
	2037152	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)NC4CCCCC4)cc3c21		CHEMBL246894	>	IC50	nM	20000.0	CHEMBL2208	Homo sapiens	IC50	uM	20.0
	2037153	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4ncc(C(=O)NCCN(C)C)s4)cc3c21		CHEMBL246507	=	IC50	nM	1300.0	CHEMBL2208	Homo sapiens	IC50	uM	1.3
	2037154	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4nc(C(=O)NCCO)cs4)cc3c21		CHEMBL395932	=	IC50	nM	31.0	CHEMBL2208	Homo sapiens	IC50	uM	0.031
	2037155	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC(=O)Nc1ccc(NC(=O)c2ccc3[nH]c4c(c3c2)C(C)CNC4=O)cc1		CHEMBL397388	=	IC50	nM	1800.0	CHEMBL2208	Homo sapiens	IC50	uM	1.8
	2037156	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4ccc(Br)cc4)cc3c21		CHEMBL245474	=	IC50	nM	7000.0	CHEMBL2208	Homo sapiens	IC50	uM	7.0
	2037157	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4ccc(F)cc4)cc3c21		CHEMBL395593	=	IC50	nM	3000.0	CHEMBL2208	Homo sapiens	IC50	uM	3.0
	2037158	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4cccc(C(N)=O)c4)cc3c21		CHEMBL248532	=	IC50	nM	2700.0	CHEMBL2208	Homo sapiens	IC50	uM	2.7
	2037159	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC(=O)Nc1cccc(NC(=O)c2ccc3[nH]c4c(c3c2)C(C)CNC4=O)c1		CHEMBL248333	=	IC50	nM	4400.0	CHEMBL2208	Homo sapiens	IC50	uM	4.4
	2037160	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4cccc(Br)c4)cc3c21		CHEMBL246699	=	IC50	nM	2700.0	CHEMBL2208	Homo sapiens	IC50	uM	2.7
	2037161	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4cccc(F)c4)cc3c21		CHEMBL246697	=	IC50	nM	1700.0	CHEMBL2208	Homo sapiens	IC50	uM	1.7
	2037162	CHEMBL923957	Inhibition of MK2 after 30 mins by DELFIA	B	Cc1cccc(NC(=O)c2ccc3[nH]c4c(c3c2)C(C)CNC4=O)c1		CHEMBL246906	=	IC50	nM	3400.0	CHEMBL2208	Homo sapiens	IC50	uM	3.4
	2051579	CHEMBL942721	Inhibition of MK2	B	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	=	Ki	nM	3886.0	CHEMBL2208	Homo sapiens	Ki	uM	3.886
	2068378	CHEMBL944945	Inhibition of MK2	B	Oc1cc(O)c(-c2noc3ccc(NCCN4CCOCC4)cc23)cc1Cl		CHEMBL404630	>	IC50	nM	20000.0	CHEMBL2208	Homo sapiens	IC50	uM	20.0
	2081378	CHEMBL928653	Inhibition of MK2	B	NC1CCN(Cc2ccn3ncnc(Oc4ccc(NC(=O)NC(=O)Cc5ccc(F)cc5)cc4F)c23)CC1		CHEMBL253881	>	IC50	nM	5000.0	CHEMBL2208	Homo sapiens	IC50	uM	5.0
	2081822	CHEMBL928826	Inhibition of MAPKAP-K2 at 10 uM	B	CC[C@@H](C)Nc1nc2ccc(-c3c(-c4ccccc4F)n[nH]c3N)cc2s1		CHEMBL404115	<=	Inhibition	%	20.0	CHEMBL2208	Homo sapiens	Inhibition	%	20.0
	2099516	CHEMBL948230	Inhibition of MAPKAP-K2 at 10 uM	B	CN(C)CCCOc1cc2c(cc1O)c1c3c(c(-c4ccccc4Cl)cc1n2C)C(=O)NC3=O		CHEMBL410261	=	Inhibition	%	47.0	CHEMBL2208	Homo sapiens	Inhibition	%	47.0
	2099576	CHEMBL948230	Inhibition of MAPKAP-K2 at 10 uM	B	Cn1c2cc(C(=O)NCCN3CCCC3)c(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL272267	=	Inhibition	%	57.0	CHEMBL2208	Homo sapiens	Inhibition	%	57.0
	2099577	CHEMBL948230	Inhibition of MAPKAP-K2 at 10 uM	B	Cn1c2cc(SCCCN3CCCC3)c(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL404335	=	Inhibition	%	76.0	CHEMBL2208	Homo sapiens	Inhibition	%	76.0
	2099578	CHEMBL948230	Inhibition of MAPKAP-K2 at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1c2c2cc(O)c(OCCCN3CCOCC3)cc2n1CCO		CHEMBL271715	=	Inhibition	%	92.0	CHEMBL2208	Homo sapiens	Inhibition	%	92.0
	2099579	CHEMBL948230	Inhibition of MAPKAP-K2 at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1c2c2cc(O)c(OCCCN3CCCC3)cc2n1CCO		CHEMBL270021	=	Inhibition	%	82.0	CHEMBL2208	Homo sapiens	Inhibition	%	82.0
	2099580	CHEMBL948230	Inhibition of MAPKAP-K2 at 10 uM	B	Cn1c2cc(OCCCN3CCCC3)c(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL255427	=	Inhibition	%	10.0	CHEMBL2208	Homo sapiens	Inhibition	%	10.0
	2101274	CHEMBL949020	Inhibition of MK2	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4nc(C(=O)NC5CCCCC5)cs4)cc3c21		CHEMBL246300	=	IC50	nM	44.0	CHEMBL2208	Homo sapiens	IC50	nM	44.0
	2101275	CHEMBL949020	Inhibition of MK2	B	O=C(Nc1nc(C(=O)NC2CCN(Cc3ccccc3)CC2)cs1)c1ccc2cc3n(c2c1)C1(CCC1)CNC3=O		CHEMBL403258	=	IC50	nM	3.0	CHEMBL2208	Homo sapiens	IC50	nM	3.0
	2101276	CHEMBL949020	Inhibition of MK2	B	CC1(C)CNC(=O)c2cc3ccc(C(=O)Nc4nc(C(=O)NC5CCN(Cc6ccccc6)CC5)cs4)cc3n21		CHEMBL429504	=	IC50	nM	5.0	CHEMBL2208	Homo sapiens	IC50	nM	5.0
	2101277	CHEMBL949020	Inhibition of MK2	B	CC(C)(C)CN1CCC(NC(=O)c2csc(NC(=O)c3ccc4cc5n(c4c3)C3(CCC3)CNC5=O)n2)CC1		CHEMBL257834	=	IC50	nM	2.0	CHEMBL2208	Homo sapiens	IC50	nM	2.0
	2101278	CHEMBL949020	Inhibition of MK2	B	CC(C)(C)CN1CCC(NC(=O)c2csc(NC(=O)c3ccc4cc5n(c4c3)C(C)(C)CNC5=O)n2)CC1		CHEMBL403154	=	IC50	nM	2.0	CHEMBL2208	Homo sapiens	IC50	nM	2.0
	2101279	CHEMBL949020	Inhibition of MK2	B	CN1CCC(NC(=O)c2csc(NC(=O)c3ccc4cc5n(c4c3)C3(CCC3)CNC5=O)n2)CC1		CHEMBL258045	=	IC50	nM	2.0	CHEMBL2208	Homo sapiens	IC50	nM	2.0
	2101280	CHEMBL949020	Inhibition of MK2	B	CN1CCC(NC(=O)c2csc(NC(=O)c3ccc4cc5n(c4c3)C(C)(C)CNC5=O)n2)CC1		CHEMBL270148	=	IC50	nM	5.0	CHEMBL2208	Homo sapiens	IC50	nM	5.0
	2101281	CHEMBL949020	Inhibition of MK2	B	CC1(C)CNC(=O)c2cc3ccc(C(=O)Nc4nc(C(=O)NC5CCCCC5)cs4)cc3n21		CHEMBL270150	=	IC50	nM	19.0	CHEMBL2208	Homo sapiens	IC50	nM	19.0
	2101282	CHEMBL949020	Inhibition of MK2	B	CC1CNC(=O)c2cc3ccc(C(=O)Nc4nc(C(=O)NC5CCN(Cc6ccccc6)CC5)cs4)cc3n21		CHEMBL403286	=	IC50	nM	9.0	CHEMBL2208	Homo sapiens	IC50	nM	9.0
	2101283	CHEMBL949020	Inhibition of MK2	B	CC1CNC(=O)c2cc3ccc(C(=O)Nc4nc(C(=O)NC5CCN(CC(C)(C)C)CC5)cs4)cc3n21		CHEMBL256194	=	IC50	nM	3.0	CHEMBL2208	Homo sapiens	IC50	nM	3.0
	2101284	CHEMBL949020	Inhibition of MK2	B	CC(C)CN1CCC(NC(=O)c2csc(NC(=O)c3ccc4cc5n(c4c3)C(C)CNC5=O)n2)CC1		CHEMBL255991	=	IC50	nM	4.0	CHEMBL2208	Homo sapiens	IC50	nM	4.0
	2101285	CHEMBL949020	Inhibition of MK2	B	CCN1CCC(NC(=O)c2csc(NC(=O)c3ccc4cc5n(c4c3)C(C)CNC5=O)n2)CC1		CHEMBL256196	=	IC50	nM	7.0	CHEMBL2208	Homo sapiens	IC50	nM	7.0
	2101286	CHEMBL949020	Inhibition of MK2	B	CC1CNC(=O)c2cc3ccc(C(=O)Nc4nc(C(=O)NCC(C)(C)C)cs4)cc3n21		CHEMBL271863	=	IC50	nM	46.0	CHEMBL2208	Homo sapiens	IC50	nM	46.0
	2101287	CHEMBL949020	Inhibition of MK2	B	CC1CCC(NC(=O)c2csc(NC(=O)c3ccc4cc5n(c4c3)C(C)CNC5=O)n2)CC1		CHEMBL437033	=	IC50	nM	45.0	CHEMBL2208	Homo sapiens	IC50	nM	45.0
	2101288	CHEMBL949020	Inhibition of MK2	B	CC1CNC(=O)c2cc3ccc(C(=O)Nc4nc(C(=O)NC5CCOCC5)cs4)cc3n21		CHEMBL272072	=	IC50	nM	12.0	CHEMBL2208	Homo sapiens	IC50	nM	12.0
	2101289	CHEMBL949020	Inhibition of MK2	B	CC1CNC(=O)c2cc3ccc(C(=O)Nc4nc(C(=O)NC5CCN(C)CC5)cs4)cc3n21		CHEMBL271309	=	IC50	nM	5.0	CHEMBL2208	Homo sapiens	IC50	nM	5.0
	2101290	CHEMBL949020	Inhibition of MK2	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4nc(C(=O)NC5CCN(C)CC5)cs4)cc3c21		CHEMBL246301	=	IC50	nM	10.0	CHEMBL2208	Homo sapiens	IC50	nM	10.0
	2101291	CHEMBL949020	Inhibition of MK2	B	CC1CNC(=O)c2cc3ccc(C(=O)Nc4nc(C(=O)NC5CCCCC5)cs4)cc3n21		CHEMBL409727	=	IC50	nM	20.0	CHEMBL2208	Homo sapiens	IC50	nM	20.0
	2101330	CHEMBL949038	Inhibition of MK2-mediated anisomycin-stimulated p38alpha phosphorylation in HeLa cells by flow cytometry	B	CC(C)(C)CN1CCC(NC(=O)c2csc(NC(=O)c3ccc4cc5n(c4c3)C3(CCC3)CNC5=O)n2)CC1		CHEMBL257834	>	IC50	nM	30000.0	CHEMBL2208	Homo sapiens	IC50	nM	30000.0
	2101331	CHEMBL949039	Inhibition of MK2-mediated HSP27 phosphorylation in THP1 cells	B	CC(C)(C)CN1CCC(NC(=O)c2csc(NC(=O)c3ccc4cc5n(c4c3)C3(CCC3)CNC5=O)n2)CC1		CHEMBL257834	=	IC50	nM	710.0	CHEMBL2208	Homo sapiens	IC50	nM	710.0
	2110291	CHEMBL950981	Inhibition of MK2	B	COC[C@H]1OC(=O)/C(=C/N(C)CCCN(C)C)C2=C(O)C(=O)C3=C([C@H](OC(C)=O)C[C@]4(C)[C@@H](O)CC[C@@H]34)[C@]21C	Outside typical range	CHEMBL410643	>	IC50	nM	200000.0	CHEMBL2208	Homo sapiens	IC50	uM	200.0
	2110303	CHEMBL950981	Inhibition of MK2	B	COC[C@H]1OC(=O)/C(=C/N(CCO)C(C)(C)C)C2=C(O)C(=O)C3=C([C@H](OC(C)=O)C[C@]4(C)[C@@H](O)CC[C@@H]34)[C@]21C	Outside typical range	CHEMBL271190	>	IC50	nM	200000.0	CHEMBL2208	Homo sapiens	IC50	uM	200.0
	2115014	CHEMBL933195	Inhibition of MK2 by DELFIA assay	B	O=C(Nc1cccnc1)c1ccc2[nH]c3c(c2c1)CCNC3=O		CHEMBL255207	=	IC50	nM	2600.0	CHEMBL2208	Homo sapiens	IC50	nM	2600.0
	2115015	CHEMBL933195	Inhibition of MK2 by DELFIA assay	B	CC(=O)NCC1CNC(=O)c2cc3ccc(C(=O)Nc4nccs4)cc3n2C1		CHEMBL404756	=	IC50	nM	1200.0	CHEMBL2208	Homo sapiens	IC50	nM	1200.0
	2115016	CHEMBL933195	Inhibition of MK2 by DELFIA assay	B	CN(C)CC1CNC(=O)c2cc3ccc(C(=O)Nc4nccs4)cc3n2C1		CHEMBL271713	=	IC50	nM	310.0	CHEMBL2208	Homo sapiens	IC50	nM	310.0
	2115017	CHEMBL933195	Inhibition of MK2 by DELFIA assay	B	CCNCC1CNC(=O)c2cc3ccc(C(=O)Nc4nccs4)cc3n2C1		CHEMBL271714	=	IC50	nM	560.0	CHEMBL2208	Homo sapiens	IC50	nM	560.0
	2115018	CHEMBL933195	Inhibition of MK2 by DELFIA assay	B	CNCC1CNC(=O)c2cc3ccc(C(=O)Nc4nccs4)cc3n2C1		CHEMBL409876	=	IC50	nM	690.0	CHEMBL2208	Homo sapiens	IC50	nM	690.0
	2115019	CHEMBL933195	Inhibition of MK2 by DELFIA assay	B	CC1CNC(=O)c2cc3ccc(C(=O)Nc4nccs4)cc3n2C1		CHEMBL410902	=	IC50	nM	530.0	CHEMBL2208	Homo sapiens	IC50	nM	530.0
	2115020	CHEMBL933195	Inhibition of MK2 by DELFIA assay	B	O=C(Nc1nccs1)c1ccc2cc3n(c2c1)CC(CO)CNC3=O		CHEMBL403193	=	IC50	nM	52.0	CHEMBL2208	Homo sapiens	IC50	nM	52.0
	2115021	CHEMBL933195	Inhibition of MK2 by DELFIA assay	B	NCC1CNC(=O)c2cc3ccc(C(=O)Nc4nccs4)cc3n2C1		CHEMBL429922	=	IC50	nM	35.0	CHEMBL2208	Homo sapiens	IC50	nM	35.0
	2115022	CHEMBL933195	Inhibition of MK2 by DELFIA assay	B	CC1CNC(=O)c2cc3ccc(C(=O)Nc4cccnc4)cc3n2C1		CHEMBL272096	=	IC50	nM	320.0	CHEMBL2208	Homo sapiens	IC50	nM	320.0
	2115023	CHEMBL933195	Inhibition of MK2 by DELFIA assay	B	NCC1CNC(=O)c2cc3ccc(C(=O)Nc4cccnc4)cc3n2C1		CHEMBL272309	=	IC50	nM	29.0	CHEMBL2208	Homo sapiens	IC50	nM	29.0
	2115024	CHEMBL933195	Inhibition of MK2 by DELFIA assay	B	O=C(Nc1nccs1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL403436	=	IC50	nM	190.0	CHEMBL2208	Homo sapiens	IC50	nM	190.0
	2115025	CHEMBL933195	Inhibition of MK2 by DELFIA assay	B	O=C(Nc1cccnc1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL255210	=	IC50	nM	270.0	CHEMBL2208	Homo sapiens	IC50	nM	270.0
	2115026	CHEMBL933195	Inhibition of MK2 by DELFIA assay	B	CC(=O)NCC1Cn2c(cc3ccc(C(=O)Nc4nccs4)cc32)C(=O)N1		CHEMBL436652	=	IC50	nM	6900.0	CHEMBL2208	Homo sapiens	IC50	nM	6900.0
	2115027	CHEMBL933195	Inhibition of MK2 by DELFIA assay	B	CN(C)CC1Cn2c(cc3ccc(C(=O)Nc4nccs4)cc32)C(=O)N1		CHEMBL408956	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	nM	10000.0
	2115028	CHEMBL933195	Inhibition of MK2 by DELFIA assay	B	CC(C)NCC1Cn2c(cc3ccc(C(=O)Nc4nccs4)cc32)C(=O)N1		CHEMBL272148	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	nM	10000.0
	2115029	CHEMBL933195	Inhibition of MK2 by DELFIA assay	B	CCCNCC1Cn2c(cc3ccc(C(=O)Nc4nccs4)cc32)C(=O)N1		CHEMBL272147	=	IC50	nM	4000.0	CHEMBL2208	Homo sapiens	IC50	nM	4000.0
	2115030	CHEMBL933195	Inhibition of MK2 by DELFIA assay	B	CCNCC1Cn2c(cc3ccc(C(=O)Nc4nccs4)cc32)C(=O)N1		CHEMBL401748	=	IC50	nM	3000.0	CHEMBL2208	Homo sapiens	IC50	nM	3000.0
	2115031	CHEMBL933195	Inhibition of MK2 by DELFIA assay	B	CNCC1Cn2c(cc3ccc(C(=O)Nc4nccs4)cc32)C(=O)N1		CHEMBL258107	=	IC50	nM	580.0	CHEMBL2208	Homo sapiens	IC50	nM	580.0
	2115032	CHEMBL933195	Inhibition of MK2 by DELFIA assay	B	CC1Cn2c(cc3ccc(C(=O)Nc4nccs4)cc32)C(=O)N1		CHEMBL272364	=	IC50	nM	4000.0	CHEMBL2208	Homo sapiens	IC50	nM	4000.0
	2115033	CHEMBL933195	Inhibition of MK2 by DELFIA assay	B	O=C(Nc1nccs1)c1ccc2cc3n(c2c1)CC(CO)NC3=O		CHEMBL272572	=	IC50	nM	550.0	CHEMBL2208	Homo sapiens	IC50	nM	550.0
	2115034	CHEMBL933195	Inhibition of MK2 by DELFIA assay	B	NC[C@H]1Cn2c(cc3ccc(C(=O)Nc4nccs4)cc32)C(=O)N1		CHEMBL257888	=	IC50	nM	1400.0	CHEMBL2208	Homo sapiens	IC50	nM	1400.0
	2115035	CHEMBL933195	Inhibition of MK2 by DELFIA assay	B	NC[C@@H]1Cn2c(cc3ccc(C(=O)Nc4nccs4)cc32)C(=O)N1		CHEMBL404224	=	IC50	nM	160.0	CHEMBL2208	Homo sapiens	IC50	nM	160.0
	2115036	CHEMBL933195	Inhibition of MK2 by DELFIA assay	B	O=C(Nc1nccs1)c1ccc2cc3n(c2c1)CCNC3=O		CHEMBL257887	=	IC50	nM	1100.0	CHEMBL2208	Homo sapiens	IC50	nM	1100.0
	2115037	CHEMBL933195	Inhibition of MK2 by DELFIA assay	B	CC1Cn2c(cc3ccc(C(=O)Nc4cccnc4)cc32)C(=O)N1		CHEMBL257321	=	IC50	nM	1200.0	CHEMBL2208	Homo sapiens	IC50	nM	1200.0
	2115038	CHEMBL933195	Inhibition of MK2 by DELFIA assay	B	NC[C@H]1Cn2c(cc3ccc(C(=O)Nc4cccnc4)cc32)C(=O)N1		CHEMBL255180	=	IC50	nM	2300.0	CHEMBL2208	Homo sapiens	IC50	nM	2300.0
	2115039	CHEMBL933195	Inhibition of MK2 by DELFIA assay	B	NC[C@@H]1Cn2c(cc3ccc(C(=O)Nc4cccnc4)cc32)C(=O)N1		CHEMBL402957	=	IC50	nM	320.0	CHEMBL2208	Homo sapiens	IC50	nM	320.0
	2115040	CHEMBL933195	Inhibition of MK2 by DELFIA assay	B	O=C(Nc1cccnc1)c1ccc2cc3n(c2c1)CCNC3=O		CHEMBL404908	=	IC50	nM	1700.0	CHEMBL2208	Homo sapiens	IC50	nM	1700.0
	2115041	CHEMBL933195	Inhibition of MK2 by DELFIA assay	B	CN(C)CC1Cc2c([nH]c3ccc(C(=O)Nc4nccs4)cc23)C(=O)N1		CHEMBL437210	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	nM	10000.0
	2115042	CHEMBL933195	Inhibition of MK2 by DELFIA assay	B	CNCC1Cc2c([nH]c3ccc(C(=O)Nc4nccs4)cc23)C(=O)N1		CHEMBL269988	=	IC50	nM	210.0	CHEMBL2208	Homo sapiens	IC50	nM	210.0
	2115043	CHEMBL933195	Inhibition of MK2 by DELFIA assay	B	O=C(Nc1nccs1)c1ccc2[nH]c3c(c2c1)CC(CO)NC3=O		CHEMBL269791	=	IC50	nM	1000.0	CHEMBL2208	Homo sapiens	IC50	nM	1000.0
	2115044	CHEMBL933195	Inhibition of MK2 by DELFIA assay	B	NCC1Cc2c([nH]c3ccc(C(=O)Nc4nccs4)cc23)C(=O)N1		CHEMBL270203	=	IC50	nM	140.0	CHEMBL2208	Homo sapiens	IC50	nM	140.0
	2115045	CHEMBL933195	Inhibition of MK2 by DELFIA assay	B	O=C(Nc1cccnc1)c1ccc2[nH]c3c(c2c1)CC(CO)NC3=O		CHEMBL255606	=	IC50	nM	1200.0	CHEMBL2208	Homo sapiens	IC50	nM	1200.0
	2115046	CHEMBL933195	Inhibition of MK2 by DELFIA assay	B	NCC1Cc2c([nH]c3ccc(C(=O)Nc4cccnc4)cc23)C(=O)N1		CHEMBL255605	=	IC50	nM	260.0	CHEMBL2208	Homo sapiens	IC50	nM	260.0
	2132663	CHEMBL921287	Inhibition of MAPK2	B	Nc1nccn2c1c(-c1ccc3ccc(-c4ccccc4)nc3c1)nc2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL410659	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	2137156	CHEMBL920953	Inhibition of MK2	B	CN(c1cccnc1)c1cc2c(Nc3ccc(F)c(Cl)c3)c(C#N)cnc2cn1	Outside typical range	CHEMBL261238	=	IC50	nM	110000000.0	CHEMBL2208	Homo sapiens	IC50	uM	110000.0
	2147301	CHEMBL921986	Activity of human MAPK2 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	96.0	CHEMBL2208	Homo sapiens	Activity	%	96.0
	2147303	CHEMBL921988	Activity of human MAPKAP-K2 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	101.0	CHEMBL2208	Homo sapiens	Activity	%	101.0
	2153708	CHEMBL928275	Inhibition of MAPK2 at 20 uM	B	CN(C)CCOc1ccc2c(-c3c(-c4ccccn4)nn4c3CCC4)ccnc2c1		CHEMBL409525	<	Inhibition	%	50.0	CHEMBL2208	Homo sapiens	Inhibition	%	50.0
	2153728	CHEMBL935765	Inhibition of MAPKAPK2 at 20 uM	B	CN(C)CCOc1ccc2c(-c3c(-c4ccccn4)nn4c3CCC4)ccnc2c1		CHEMBL409525	<	Inhibition	%	50.0	CHEMBL2208	Homo sapiens	Inhibition	%	50.0
	2153743	CHEMBL928275	Inhibition of MAPK2 at 20 uM	B	c1ccc(-c2nn3c(c2-c2ccnc4cc(OCCN5CCOCC5)ccc24)CCC3)nc1		CHEMBL260015	<	Inhibition	%	50.0	CHEMBL2208	Homo sapiens	Inhibition	%	50.0
	2153763	CHEMBL935765	Inhibition of MAPKAPK2 at 20 uM	B	c1ccc(-c2nn3c(c2-c2ccnc4cc(OCCN5CCOCC5)ccc24)CCC3)nc1		CHEMBL260015	<	Inhibition	%	50.0	CHEMBL2208	Homo sapiens	Inhibition	%	50.0
Not Active	2170333	CHEMBL927892	Activity at MAPKAP-K2 at 3 uM	B	COc1c(NC(=O)c2ccc(C)c(N3C=C(C(=O)NCC(C)(C)CN(C)C)NN3)c2)cc(C(C)(C)C)cc1NS(C)(=O)=O		CHEMBL254992		Activity			CHEMBL2208	Homo sapiens	Activity		
	2182823	CHEMBL941449	Inhibition of MAPKAPK2 at 5 uM	B	O=c1cc(N2CCOCC2)nc2c3ccccc3ccn12		CHEMBL179242	=	Inhibition	%	40.0	CHEMBL2208	Homo sapiens	INH	%	40.0
	2185571	CHEMBL950672	Inhibition of MAPKAPK2 assessed as [33P] incorporation by scintillation proximity assay	B	C=C1CC[C@@H]2[C@@]3(C)CCCC(C)(C)[C@@H]3CC[C@@]2(C)[C@@H]1/C=C/C1=CC(=O)OC1O		CHEMBL478798	=	IC50	nM	90000.0	CHEMBL2208	Homo sapiens	IC50	uM	90.0
	2185575	CHEMBL950672	Inhibition of MAPKAPK2 assessed as [33P] incorporation by scintillation proximity assay	B	C=C1CC[C@@H]2[C@@]3(C)CCCC(C)(C)[C@@H]3CC[C@@]2(C)[C@@H]1CC(O)C1=CC(=O)OC1O		CHEMBL476479	=	IC50	nM	90000.0	CHEMBL2208	Homo sapiens	IC50	uM	90.0
	2185576	CHEMBL950672	Inhibition of MAPKAPK2 assessed as [33P] incorporation by scintillation proximity assay	B	C=C1CC[C@@H]2[C@@]3(C)CCCC(C)(C)[C@@H]3CC[C@@]2(C)[C@@H]1CC1OC(=O)C=C1CO		CHEMBL515940	=	IC50	nM	90000.0	CHEMBL2208	Homo sapiens	IC50	uM	90.0
	2185577	CHEMBL950672	Inhibition of MAPKAPK2 assessed as [33P] incorporation by scintillation proximity assay	B	CC1(C)CCC[C@@]2(C)[C@H]1CC[C@@]1(C)[C@@H]3C[C@H](C4=CC(=O)OC4O)O[C@@]3(C)CC[C@H]21		CHEMBL476478	=	IC50	nM	90000.0	CHEMBL2208	Homo sapiens	IC50	uM	90.0
	2186738	CHEMBL966660	Inhibition of human MK2 by scintiplate assay	B	N#Cc1cnc2c(Cl)cc(NCc3cnc[nH]3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL436817	=	IC50	nM	48000.0	CHEMBL2208	Homo sapiens	IC50	uM	48.0
Not Active	2186757	CHEMBL966674	Inhibition of LPS-induced MK2 phosphorylation in primary human monocytes upto 5 uM by immunoblot analysis	B	N#Cc1cnc2c(Cl)cc(NCc3cnc[nH]3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL436817		Activity			CHEMBL2208	Homo sapiens	Activity		
	2206782	CHEMBL966740	Inhibition of MK2	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	2236203	CHEMBL1003899	Inhibition of MK2	B	O=C(Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL509101	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	nM	10000.0
	2239707	CHEMBL1000373	Inhibition of MAPK2/ERK2 at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1c2c2cc(O)ccc2n1CCCc1nnn[nH]1		CHEMBL471329	=	Inhibition	%	101.0	CHEMBL2208	Homo sapiens	INH	%	101.0
	2239733	CHEMBL996962	Inhibition of MAPKAP-K2 at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1c2c2cc(O)ccc2n1CCCc1nnn[nH]1		CHEMBL471329	=	Inhibition	%	100.0	CHEMBL2208	Homo sapiens	INH	%	100.0
	2239735	CHEMBL1000373	Inhibition of MAPK2/ERK2 at 10 uM	B	CS(=O)(=O)NC(=O)CCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL460940	=	Inhibition	%	54.0	CHEMBL2208	Homo sapiens	INH	%	54.0
	2239761	CHEMBL996962	Inhibition of MAPKAP-K2 at 10 uM	B	CS(=O)(=O)NC(=O)CCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL460940	=	Inhibition	%	102.0	CHEMBL2208	Homo sapiens	INH	%	102.0
	2239763	CHEMBL1000373	Inhibition of MAPK2/ERK2 at 10 uM	B	CN(C)CCNC(=O)CCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL462011	=	Inhibition	%	114.0	CHEMBL2208	Homo sapiens	INH	%	114.0
	2239789	CHEMBL996962	Inhibition of MAPKAP-K2 at 10 uM	B	CN(C)CCNC(=O)CCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL462011	=	Inhibition	%	90.0	CHEMBL2208	Homo sapiens	INH	%	90.0
	2239791	CHEMBL1000373	Inhibition of MAPK2/ERK2 at 10 uM	B	CNCCCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL508541	=	Inhibition	%	42.0	CHEMBL2208	Homo sapiens	INH	%	42.0
	2239817	CHEMBL996962	Inhibition of MAPKAP-K2 at 10 uM	B	CNCCCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL508541	=	Inhibition	%	71.0	CHEMBL2208	Homo sapiens	INH	%	71.0
	2239819	CHEMBL1000373	Inhibition of MAPK2/ERK2 at 10 uM	B	CNCCCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4)cc21)C(=O)NC3=O		CHEMBL455192	=	Inhibition	%	11.0	CHEMBL2208	Homo sapiens	INH	%	11.0
	2239845	CHEMBL996962	Inhibition of MAPKAP-K2 at 10 uM	B	CNCCCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4)cc21)C(=O)NC3=O		CHEMBL455192	=	Inhibition	%	100.0	CHEMBL2208	Homo sapiens	INH	%	100.0
	2239847	CHEMBL1000373	Inhibition of MAPK2/ERK2 at 10 uM	B	O=C1NC(=O)c2c1c(-c1c(Cl)cccc1Cl)cc1c2c2cc(O)ccc2n1CCCO		CHEMBL471163	=	Inhibition	%	14.0	CHEMBL2208	Homo sapiens	INH	%	14.0
	2239873	CHEMBL996962	Inhibition of MAPKAP-K2 at 10 uM	B	O=C1NC(=O)c2c1c(-c1c(Cl)cccc1Cl)cc1c2c2cc(O)ccc2n1CCCO		CHEMBL471163	=	Inhibition	%	90.0	CHEMBL2208	Homo sapiens	INH	%	90.0
	2239875	CHEMBL1000373	Inhibition of MAPK2/ERK2 at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1c2c2cc(O)ccc2n1CCCO		CHEMBL411662	=	Inhibition	%	36.0	CHEMBL2208	Homo sapiens	INH	%	36.0
	2239900	CHEMBL996962	Inhibition of MAPKAP-K2 at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1c2c2cc(O)ccc2n1CCCO		CHEMBL411662	=	Inhibition	%	93.0	CHEMBL2208	Homo sapiens	INH	%	93.0
	2239902	CHEMBL1000373	Inhibition of MAPK2/ERK2 at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1[nH]c3ccc(O)cc3c21		CHEMBL379975	=	Inhibition	%	54.0	CHEMBL2208	Homo sapiens	INH	%	54.0
	2239928	CHEMBL996962	Inhibition of MAPKAP-K2 at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1[nH]c3ccc(O)cc3c21		CHEMBL379975	=	Inhibition	%	93.0	CHEMBL2208	Homo sapiens	INH	%	93.0
	2248253	CHEMBL1012701	Inhibition of MAPKAPK2 at 5 uM	B	O=C1NC(=O)/C(=C/c2cccc(C(F)(F)F)c2)S1		CHEMBL183906	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	2248254	CHEMBL1012701	Inhibition of MAPKAPK2 at 5 uM	B	CCCOc1ccc(/C=C2\SC(=O)NC2=O)cc1		CHEMBL84558	=	Inhibition	%	5.0	CHEMBL2208	Homo sapiens	INH	%	5.0
	2250922	CHEMBL1022466	Inhibition of MK2	B	Nc1nccc(-c2cc3c([nH]2)[C@@H](CCF)CNC3=O)n1		CHEMBL524266	=	IC50	nM	510.0	CHEMBL2208	Homo sapiens	IC50	uM	0.51
	2264697	CHEMBL1011756	Binding affinity to MK2 at 10 uM	B	O=C(NOCCO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL244488	=	Inhibition	%	9.0	CHEMBL2208	Homo sapiens	INH	%	9.0
	2264698	CHEMBL1011756	Binding affinity to MK2 at 10 uM	B	O=C(NOCCO)c1cc(COCCO)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL464238	=	Inhibition	%	5.0	CHEMBL2208	Homo sapiens	INH	%	5.0
	2264699	CHEMBL1011756	Binding affinity to MK2 at 10 uM	B	O=C(NOCCO)c1cc(/C=N/OCCO)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL464239	=	Inhibition	%	2.0	CHEMBL2208	Homo sapiens	INH	%	2.0
	2264700	CHEMBL1011756	Binding affinity to MK2 at 10 uM	B	COCCCNC(=O)N/N=C/c1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)c(F)c1F		CHEMBL518248	=	Inhibition	%	1.0	CHEMBL2208	Homo sapiens	INH	%	1.0
	2264701	CHEMBL1011756	Binding affinity to MK2 at 10 uM	B	O=C(O)CCCO/N=C/c1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)c(F)c1F		CHEMBL464257	=	Inhibition	%	18.0	CHEMBL2208	Homo sapiens	INH	%	18.0
	2264702	CHEMBL1011756	Binding affinity to MK2 at 10 uM	B	O=C(O)c1ccc(CO/N=C/c2cc(C(=O)NOCCO)c(Nc3ccc(I)cc3F)c(F)c2F)o1		CHEMBL464258	=	Inhibition	%	28.0	CHEMBL2208	Homo sapiens	INH	%	28.0
	2279723	CHEMBL960137	Inhibition of MAPKAP-K2 at 10 uM	B	CN1CCCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1		CHEMBL493937	>	Inhibition	%	50.0	CHEMBL2208	Homo sapiens	INH	%	50.0
	2279727	CHEMBL958292	Inhibition of MAPK2 at 10 uM	B	CN1CCCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1		CHEMBL493937	>	Inhibition	%	50.0	CHEMBL2208	Homo sapiens	INH	%	50.0
Not Active	2298915	CHEMBL1018061	Inhibition of human MAPK2 at 10 umol/L	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C(=O)N(C)C)cc1)c1ccccc1		CHEMBL525203		Activity			CHEMBL2208	Homo sapiens	Activity		
Not Active	2298923	CHEMBL1020718	Inhibition of human MAPKAPK2 at 10 umol/L	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C(=O)N(C)C)cc1)c1ccccc1		CHEMBL525203		Activity			CHEMBL2208	Homo sapiens	Activity		
Not Active	2298942	CHEMBL1018061	Inhibition of human MAPK2 at 10 umol/L	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL497049		Activity			CHEMBL2208	Homo sapiens	Activity		
Not Active	2298943	CHEMBL1018061	Inhibition of human MAPK2 at 10 umol/L	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835		Activity			CHEMBL2208	Homo sapiens	Activity		
Not Active	2298952	CHEMBL1020718	Inhibition of human MAPKAPK2 at 10 umol/L	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL497049		Activity			CHEMBL2208	Homo sapiens	Activity		
Not Active	2298953	CHEMBL1020718	Inhibition of human MAPKAPK2 at 10 umol/L	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835		Activity			CHEMBL2208	Homo sapiens	Activity		
Not Active	2302153	CHEMBL950822	Inhibition of MAPKAP-K2 (delta 1-45) at 10 uM	B	Nc1ncnc2ncn(CC(=O)c3c[nH]c4ccccc34)c12		CHEMBL485246		Inhibition	%		CHEMBL2208	Homo sapiens	INH		
	2327561	CHEMBL998215	Inhibition of human recombinant MK2 by ELISA	B	CCCc1cc(O)c2c(O)cccc2c1-c1cc(O)cc(=O)o1		CHEMBL487190	=	IC50	nM	39000.0	CHEMBL2208	Homo sapiens	IC50	uM	39.0
	2327562	CHEMBL998215	Inhibition of human recombinant MK2 by ELISA	B	CCCc1cc(=O)c2c(Cc3cc(O)cc(=O)o3)cccc2o1	Outside typical range	CHEMBL487191	=	IC50	nM	130000.0	CHEMBL2208	Homo sapiens	IC50	uM	130.0
	2341423	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(N3CCN(C(=O)Cc4c[nH]c5ccccc45)CC3)ncn2)c1		CHEMBL524898	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	2341463	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL501459	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	2341504	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	Nc1nc(N2CCOCC2)cc(N2CCC(C(=O)NCCc3ccc(O)cc3)CC2)n1		CHEMBL501728	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	2341545	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	O=C(NCCc1ccc(O)cc1)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL499617	=	Inhibition	%	2.0	CHEMBL2208	Homo sapiens	INH	%	2.0
	2341586	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	O=C(c1nc(SCc2ccc(Cl)cc2)n2ccccc12)N1CCN(c2cc(Nc3cccc(Br)c3)ncn2)CC1		CHEMBL501200	=	Inhibition	%	2.0	CHEMBL2208	Homo sapiens	INH	%	2.0
	2341627	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc3ncsc3c2)cc(N2CCC[C@H]2C(=O)N[C@@H](CO)c2ccccc2)n1		CHEMBL525070	=	Inhibition	%	1.0	CHEMBL2208	Homo sapiens	INH	%	1.0
	2341709	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	O=C(NC1Cc2ccccc2C1)c1cccc(Nc2ccnc(N3CCN(c4ccccc4)CC3)n2)c1		CHEMBL499624	=	Inhibition	%	4.0	CHEMBL2208	Homo sapiens	INH	%	4.0
	2341750	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCc4ccc(N(C)C)cc4)c3)ncn2)c1		CHEMBL502826	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	2341791	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3ccc(CC(=O)Nc4ccc5ncsc5c4)cc3)ncn2)c1		CHEMBL502827	=	Inhibition	%	3.0	CHEMBL2208	Homo sapiens	INH	%	3.0
	2341832	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	COc1ccc(NC(=O)Cc2ccc(Nc3cc(N(C)c4cccc(C)c4)ncn3)cc2)cn1		CHEMBL526914	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	2341873	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc(Nc3cccc(C(=O)NCc4ccc(N(C)C)cc4)c3)n2)c1		CHEMBL501471	=	Inhibition	%	4.0	CHEMBL2208	Homo sapiens	INH	%	4.0
	2341914	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	O=C(NCc1cccnc1)c1cccc(-c2ccc(Nc3ccc4ncsc4c3)nn2)c1		CHEMBL501182	=	Inhibition	%	6.0	CHEMBL2208	Homo sapiens	INH	%	6.0
	2341955	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N4CCCC5CCCCC54)c3)ncn2)c1		CHEMBL499606	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	2341996	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)nc(N)n2)c1		CHEMBL499865	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	2342037	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)n2)c1		CHEMBL499866	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	2342078	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	O=C(CN1CCN(c2ncnc3c2CN(Cc2ccccc2)CC3)CC1)Nc1cc(F)ccc1F		CHEMBL520451	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	2342119	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	O=C(NCc1ccncc1)c1cccc(Nc2cc(Nc3cccc(Br)c3)ncn2)c1		CHEMBL482513	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	2342160	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2cc(Nc3cccc(C(=O)N(CC(C)O)CC(C)O)c3)ncn2)c1		CHEMBL483318	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	2342201	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCCCn4ccnc4)c3)ncn2)c1		CHEMBL520971	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	2342242	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)ncn2)c1		CHEMBL521469	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	2342283	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	CC(=O)N1CCN(C(=O)c2cccc(Nc3cc(N(C)c4cccc(C)c4)ncn3)c2)CC1		CHEMBL521478	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	2342324	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCc4ccncc4)c3)ncn2)c1		CHEMBL483506	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	2342365	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	CN(CCc1ccccn1)C(=O)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL483507	=	Inhibition	%	1.0	CHEMBL2208	Homo sapiens	INH	%	1.0
	2342406	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(Nc3cccc(C(=O)NCCCn4ccnc4)c3)nc(N)n2)c1		CHEMBL520980	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	2342447	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)[C@@H]1CCCN1c1cc(Nc2cccc(OC)c2)nc(N)n1		CHEMBL519962	=	Inhibition	%	2.0	CHEMBL2208	Homo sapiens	INH	%	2.0
	2342488	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(N3CCC[C@H]3C(=O)NCCN3CCCCC3)nc(N)n2)c1		CHEMBL526526	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	2342529	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	O=C(COc1ccccc1)N1CCN(c2nccc(Nc3ccc4ncsc4c3)n2)CC1		CHEMBL482488	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	2342802	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	O=C(NC[C@@H]1CCCO1)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL500661	=	Inhibition	%	1.0	CHEMBL2208	Homo sapiens	INH	%	1.0
	2342835	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	Clc1ccc2sc(CN3CCN(c4ncnc5c4CN(Cc4ccccc4)CC5)CC3)cc2c1		CHEMBL483710	=	Inhibition	%	1.0	CHEMBL2208	Homo sapiens	INH	%	1.0
	2342878	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc3ncsc3c2)cc(N2CCC[C@H]2C(=O)NCCc2cccc(I)c2)n1		CHEMBL501463	=	Inhibition	%	3.0	CHEMBL2208	Homo sapiens	INH	%	3.0
	2343110	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccccc2)cc(N2CCC(C(=O)NCCc3ccccn3)CC2)n1		CHEMBL521002	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	2343134	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	CC(=O)CCCCC(=O)N1CCN(c2nccc(Oc3cccc(C)c3)n2)CC1		CHEMBL484713	=	Inhibition	%	1.0	CHEMBL2208	Homo sapiens	INH	%	1.0
	2343156	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	COc1ccc(-c2noc(CN3CCN(c4cc(Nc5cccc(O)c5)ncn4)CC3)n2)cc1		CHEMBL483715	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	2343180	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCN(CC(=O)Nc4cccc5c4CCCC5)CC3)n2)c1		CHEMBL520512	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	2343204	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(N3CCN(CC(=O)Nc4nc(-c5ccccc5)cs4)CC3)ncn2)c1		CHEMBL519534	=	Inhibition	%	3.0	CHEMBL2208	Homo sapiens	INH	%	3.0
	2343228	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc(C(=O)NCCc3ccncc3)cc2)cc(N2CCOCC2)n1		CHEMBL485524	=	Inhibition	%	1.0	CHEMBL2208	Homo sapiens	INH	%	1.0
	2343252	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc3c2CN(C(=O)c2cc(C)n(C)c2C)CC3)c1		CHEMBL519146	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	2343276	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	Cc1cc(C(=O)N2CCN(c3ncnc4c3CN(Cc3ccccc3)CC4)CC2)c(C)n1C		CHEMBL482710	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	2343637	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	Nc1nc(N2CCOCC2)cc(N2CCC(C(=O)NCc3cccs3)CC2)n1		CHEMBL482910	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	2343698	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(N3CCC[C@H]3C(=O)NCCc3ccc(O)cc3)nc(N)n2)c1		CHEMBL483518	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	2343719	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCC[C@H]3C(=O)NCc3cccnc3)n2)c1		CHEMBL482717	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	2343741	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	COC(=O)C(CO)NC(=O)[C@@H]1CCCN1c1nccc(Oc2cccc(C)c2)n1		CHEMBL519310	=	Inhibition	%	1.0	CHEMBL2208	Homo sapiens	INH	%	1.0
	2343763	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCN(C(=O)c4c(C)noc4C)CC3)n2)c1		CHEMBL482721	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	2343785	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)C1CCN(c2cc(N3CCOCC3)nc(N)n2)CC1		CHEMBL519311	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	2343807	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCC[C@H]3C(=O)NCCCn3ccnc3)n2)c1		CHEMBL482722	=	Inhibition	%	2.0	CHEMBL2208	Homo sapiens	INH	%	2.0
	2343828	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	O=C(c1nc(SCc2ccc(Cl)cc2)n2ccccc12)N1CCN(c2ncnc3c2CN(Cc2ccccc2)CC3)CC1		CHEMBL446637	=	Inhibition	%	1.0	CHEMBL2208	Homo sapiens	INH	%	1.0
	2343850	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	CN(C)c1ccc(C(=O)N2CCN(c3ncnc4c3CN(Cc3ccccc3)CC4)CC2)c2ccccc12		CHEMBL520331	=	Inhibition	%	3.0	CHEMBL2208	Homo sapiens	INH	%	3.0
	2343872	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2ncnc3c2CN(C(=O)c2ccc(N(C)C)c4ccccc24)CC3)c1		CHEMBL484324	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	2343894	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)C1CCCN1c1cc(Nc2cccc(Br)c2)ncn1		CHEMBL484521	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	2343916	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL519349	=	Inhibition	%	1.0	CHEMBL2208	Homo sapiens	INH	%	1.0
	2343938	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL521000	=	Inhibition	%	4.0	CHEMBL2208	Homo sapiens	INH	%	4.0
	2343959	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	O=C(C1CCN(c2nccc(Nc3ccccc3)n2)CC1)N1CC[C@@H](O)C1		CHEMBL484706	=	Inhibition	%	4.0	CHEMBL2208	Homo sapiens	INH	%	4.0
	2343981	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N(CC(C)C)CC(C)C)c3)ncn2)c1		CHEMBL484707	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	2344003	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	CN(CCc1ccccn1)C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL521479	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	2344711	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	CN(CCCn1ccnc1)C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL519658	=	Inhibition	%	2.0	CHEMBL2208	Homo sapiens	INH	%	2.0
	2344733	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(CN2CCN(c3cc(N(C)c4cccc(C)c4)ncn3)CC2)c1		CHEMBL446087	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	2344756	CHEMBL953383	Inhibition of MAPKAPK2 at 10 uM by HTRF assay relative to control	B	Cc1ccc(CN2CCN(c3nccc(C(C#N)c4ccccn4)n3)CC2)cc1		CHEMBL521145	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	2356945	CHEMBL955835	Inhibition of MAPKAPK2 at 1 uM relative to control	B	Cc1ccn(-c2cccc(C(F)(F)F)c2)c(=O)c1-c1ccc2nc(N)ncc2c1		CHEMBL504805	>	Inhibition	%	50.0	CHEMBL2208	Homo sapiens	INH	%	50.0
	2356973	CHEMBL955835	Inhibition of MAPKAPK2 at 1 uM relative to control	B	Cc1ccn(-c2ccc(-c3ncco3)cc2)c(=O)c1-c1ccc2nc(N)ncc2c1		CHEMBL525893	>	Inhibition	%	50.0	CHEMBL2208	Homo sapiens	INH	%	50.0
	2361599	CHEMBL980901	Inhibition of MK2	B	Cc1cc(C2CCN(CCCF)CC2)cc2[nH]c(-c3c(NCCn4cc(Cl)cn4)cc[nH]c3=O)nc12		CHEMBL459729	>	IC50	nM	50000.0	CHEMBL2208	Homo sapiens	IC50	uM	50.0
	2361922	CHEMBL1027395	Inhibition of human recombinant MK2 expressed in Escherichia coli BL21(DE3) after 60 mins	B	Oc1cccc2cnccc12		CHEMBL57481	=	IC50	nM	85000.0	CHEMBL2208	Homo sapiens	IC50	uM	85.0
	2361923	CHEMBL1027395	Inhibition of human recombinant MK2 expressed in Escherichia coli BL21(DE3) after 60 mins	B	O=C1NCCc2[nH]c(-c3ccnc(/C=C/c4ccccc4)c3)cc21		CHEMBL510545	=	IC50	nM	49.0	CHEMBL2208	Homo sapiens	IC50	nM	49.0
	2361924	CHEMBL1027395	Inhibition of human recombinant MK2 expressed in Escherichia coli BL21(DE3) after 60 mins	B	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	=	IC50	nM	8.5	CHEMBL2208	Homo sapiens	IC50	nM	8.5
	2361925	CHEMBL1027395	Inhibition of human recombinant MK2 expressed in Escherichia coli BL21(DE3) after 60 mins	B	Oc1cccc2ccccc12		CHEMBL122617	>	IC50	nM	100000.0	CHEMBL2208	Homo sapiens	IC50	uM	100.0
	2362677	CHEMBL1034883	Inhibition of MK2	B	COc1ccc(-c2cncc(C#N)c2Nc2ccc3[nH]ccc3c2)cc1OC		CHEMBL492251	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	2395414	CHEMBL957084	Inhibition of MK2	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	IC50	nM	2000.0	CHEMBL2208	Homo sapiens	IC50	nM	2000.0
	2401982	CHEMBL1011853	Inhibition of MK2	B	O=C1NC(=O)c2ccc(I)cc2/C1=C/NCc1ccc(-c2ccoc2)c(O)c1		CHEMBL504547	=	IC50	nM	19000.0	CHEMBL2208	Homo sapiens	IC50	uM	19.0
	2409519	CHEMBL959254	Inhibition of MAPKAPK2	B	NC[C@H](Cc1cccc(F)c1)NC(=O)c1cc(Br)c(-c2ccnc3[nH]ccc23)s1		CHEMBL523586	=	IC50	nM	2500.0	CHEMBL2208	Homo sapiens	IC50	nM	2500.0
	2413029	CHEMBL965854	Inhibition of MK2	B	NC(=O)c1cc2c(-c3cccc(-c4ccccc4)c3)cnc(N)c2s1		CHEMBL445178	>	IC50	nM	50000.0	CHEMBL2208	Homo sapiens	IC50	uM	50.0
	2417665	CHEMBL955066	Inhibition of human MAPK2 at 10 uM	B	O=C1NN(c2ccc(Cl)c(Cl)c2)C(=O)/C1=C/c1ccc(O)c([N+](=O)[O-])c1		CHEMBL511636	=	Activity	%	105.0	CHEMBL2208	Homo sapiens	Activity	%	105.0
	2417666	CHEMBL955066	Inhibition of human MAPK2 at 10 uM	B	COc1cc(/C=C2\C(=O)NN(c3ccc(C#N)cc3)C2=O)ccc1O		CHEMBL498718	=	Activity	%	110.0	CHEMBL2208	Homo sapiens	Activity	%	110.0
	2435017	CHEMBL955274	Inhibition of MK2	B	CC1=CC[C@@H]2[C@@]3(C)CCCC(C)(C)[C@@H]3CC[C@@]2(C)[C@@H]1Cc1cc(C(=O)O)ccc1O		CHEMBL454582	=	IC50	nM	20000.0	CHEMBL2208	Homo sapiens	IC50	uM	20.0
	2435018	CHEMBL955274	Inhibition of MK2	B	CC1=C(CC/C(C)=C/Cc2cc(C(=O)O)ccc2O)[C@@]2(C)CCCC(C)(C)[C@@H]2CC1		CHEMBL455101	=	IC50	nM	9600.0	CHEMBL2208	Homo sapiens	IC50	uM	9.6
	2451249	CHEMBL1013121	Inhibition of human MAPK2/ERK2 at 10 uM	B	CCC(Nc1cc(-c2[nH]c(SC)nc2-c2ccc(F)cc2)ccn1)c1ccccc1		CHEMBL494666	=	Inhibition	%	21.0	CHEMBL2208	Homo sapiens	INH	%	21.0
	2451285	CHEMBL1013121	Inhibition of human MAPK2/ERK2 at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Inhibition	%	28.0	CHEMBL2208	Homo sapiens	INH	%	28.0
	2451286	CHEMBL1013121	Inhibition of human MAPK2/ERK2 at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Inhibition	%	11.0	CHEMBL2208	Homo sapiens	INH	%	11.0
	2451287	CHEMBL1013121	Inhibition of human MAPK2/ERK2 at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Inhibition	%	15.0	CHEMBL2208	Homo sapiens	INH	%	15.0
	2451288	CHEMBL1013121	Inhibition of human MAPK2/ERK2 at 10 uM	B	COCCn1c(SC)nc(-c2ccc(F)cc2)c1-c1ccnc(NC2CCCCC2)c1		CHEMBL481943	=	Inhibition	%	5.0	CHEMBL2208	Homo sapiens	INH	%	5.0
	2451289	CHEMBL1013121	Inhibition of human MAPK2/ERK2 at 10 uM	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NCC3CCCO3)c2)[nH]1		CHEMBL480952	=	Inhibition	%	8.0	CHEMBL2208	Homo sapiens	INH	%	8.0
	2451290	CHEMBL1013121	Inhibition of human MAPK2/ERK2 at 10 uM	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)CCCC(C)C)c2)[nH]1		CHEMBL518964	=	Inhibition	%	6.0	CHEMBL2208	Homo sapiens	INH	%	6.0
	2451291	CHEMBL1013121	Inhibition of human MAPK2/ERK2 at 10 uM	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NCCc3cccs3)c2)[nH]1		CHEMBL519617	=	Inhibition	%	31.0	CHEMBL2208	Homo sapiens	INH	%	31.0
	2451292	CHEMBL1013121	Inhibition of human MAPK2/ERK2 at 10 uM	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)CCc3ccccc3)c2)[nH]1		CHEMBL493669	=	Inhibition	%	17.0	CHEMBL2208	Homo sapiens	INH	%	17.0
	2451293	CHEMBL1013121	Inhibition of human MAPK2/ERK2 at 10 uM	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCc4ccccc43)c2)[nH]1		CHEMBL494871	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	2467263	CHEMBL991666	Inhibition of MK2 in presence of 1 uM ATP	B	CCN1CCN(CC/C=C/c2ccc3c(Nc4ccc(Sc5nccn5C)c(Cl)c4)c(C#N)cnc3c2)CC1		CHEMBL489058	>	IC50	nM	100000.0	CHEMBL2208	Homo sapiens	IC50	uM	100.0
	2470258	CHEMBL987177	Inhibition of MAPKAPK2 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL2208	Homo sapiens	INH	%	10.0
	2489355	CHEMBL991260	Inhibition of MK2	B	COc1ccc(CN(C)C)c(-c2cc3c(Nc4ccc5[nH]ccc5c4C)c(C#N)cnc3s2)c1		CHEMBL479835	>	IC50	nM	5000.0	CHEMBL2208	Homo sapiens	IC50	uM	5.0
	2511990	CHEMBL973479	Inhibition of MAPKAPK2 at 1 uM	B	CC(=O)N1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL508307	=	Inhibition	%	9.0	CHEMBL2208	Homo sapiens	INH	%	9.0
Not Active	2527100	CHEMBL984156	Inhibition of MAPKAPK2 at => 3 ug/mL	B	COc1c(NC(=O)Nc2ccc(-c3ccc(CN4CCOCC4)nc3)c3ccccc23)cc(C(C)(C)C)cc1NS(C)(=O)=O		CHEMBL451523		Activity			CHEMBL2208	Homo sapiens	Activity		
	2528142	CHEMBL985025	Inhibition of MK2	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OC2CCNCC2)cc1		CHEMBL519693	<	IC50	nM	25118.86	CHEMBL2208	Homo sapiens	pIC50		4.6
	2528143	CHEMBL985025	Inhibition of MK2	B	NCc1ccc(-c2cc3ccncc3cc2OC2CCNCC2)cc1		CHEMBL484967	<	IC50	nM	25118.86	CHEMBL2208	Homo sapiens	pIC50		4.6
	2528144	CHEMBL985025	Inhibition of MK2	B	c1ccc(-c2cc3ccncc3cc2OC2CCNCC2)cc1		CHEMBL484968	<	IC50	nM	25118.86	CHEMBL2208	Homo sapiens	pIC50		4.6
	2528950	CHEMBL985885	Inhibition of MAPK2	B	O[C@H]1CC[C@H](c2n[nH]cc2-c2ccnc(NC3CCCC3)n2)CC1		CHEMBL507249	=	IC50	nM	13000.0	CHEMBL2208	Homo sapiens	IC50	uM	13.0
	2528955	CHEMBL985890	Inhibition of MAPKAP-K2	B	O[C@H]1CC[C@H](c2n[nH]cc2-c2ccnc(NC3CCCC3)n2)CC1		CHEMBL507249	>	IC50	nM	30000.0	CHEMBL2208	Homo sapiens	IC50	uM	30.0
	2559681	CHEMBL982982	Inhibition of MK2	B	Cc1c(Nc2c(C#N)cnc3sc(/C=C/C(=O)N4CCCC4)cc23)ccc2[nH]ccc12		CHEMBL477817	>	IC50	nM	50000.0	CHEMBL2208	Homo sapiens	IC50	nM	50000.0
	2562277	CHEMBL984690	Inhibition of human MAPKAPK2 expressed in Escherichia coli at 10 uM	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1		CHEMBL477989	=	Inhibition	%	9.0	CHEMBL2208	Homo sapiens	INH	%	9.0
	2562299	CHEMBL984690	Inhibition of human MAPKAPK2 expressed in Escherichia coli at 10 uM	B	O/N=C1\CCc2cc(-c3cc(CN4CCOCC4)oc3-c3ccncc3)ccc21		CHEMBL476732	=	Inhibition	%	4.0	CHEMBL2208	Homo sapiens	INH	%	4.0
	2567256	CHEMBL970764	Inhibition of human MAPKAP-K2 kinase assessed as residual enzyme activity at 0.1 uM	B	CCN1C(=O)C(C)(C)c2cc3[nH]c4c(c3cc21)CCCc1c(C)n[nH]c1-4		CHEMBL223147	=	Activity	%	104.0	CHEMBL2208	Homo sapiens	Activity	%	104.0
	2584828	CHEMBL955774	Inhibition of human MK2	B	O=c1[nH]cnc2[nH]c(-c3ccnc(-c4ccc(F)cc4)c3)cc12		CHEMBL462578	=	IC50	nM	1300.0	CHEMBL2208	Homo sapiens	IC50	uM	1.3
	2584829	CHEMBL955774	Inhibition of human MK2	B	O=c1[nH]cnc2[nH]c(-c3ccnc(-c4cccc(F)c4)c3)cc12		CHEMBL462579	=	IC50	nM	1230.0	CHEMBL2208	Homo sapiens	IC50	uM	1.23
	2584830	CHEMBL955774	Inhibition of human MK2	B	COc1ccc(-c2cc(-c3cc4c(=O)[nH]cnc4[nH]3)ccn2)cc1		CHEMBL455396	=	IC50	nM	550.0	CHEMBL2208	Homo sapiens	IC50	uM	0.55
	2584831	CHEMBL955774	Inhibition of human MK2	B	COc1cccc(-c2cc(-c3cc4c(=O)[nH]cnc4[nH]3)ccn2)c1		CHEMBL452085	=	IC50	nM	5200.0	CHEMBL2208	Homo sapiens	IC50	uM	5.2
	2584832	CHEMBL955774	Inhibition of human MK2	B	O=c1[nH]cnc2[nH]c(-c3ccnc(-c4ccc(CN5CCOCC5)cc4)c3)cc12		CHEMBL452086	=	IC50	nM	1450.0	CHEMBL2208	Homo sapiens	IC50	uM	1.45
	2584833	CHEMBL955774	Inhibition of human MK2	B	O=C(Nc1cc(-c2cc3c(=O)[nH]cnc3[nH]2)ccn1)c1ccc(C2CCCC2)cc1		CHEMBL455156	=	IC50	nM	190.0	CHEMBL2208	Homo sapiens	IC50	uM	0.19
	2584834	CHEMBL955774	Inhibition of human MK2	B	O=c1[nH]cnc2[nH]c(-c3ccnc(/C=C/c4ccccc4)c3)cc12		CHEMBL507348	=	IC50	nM	170.0	CHEMBL2208	Homo sapiens	IC50	uM	0.17
	2584835	CHEMBL955774	Inhibition of human MK2	B	O=c1[nH]cnc2[nH]c(-c3ccnc(/C=C/c4ccc(F)cc4)c3)cc12		CHEMBL516504	=	IC50	nM	200.0	CHEMBL2208	Homo sapiens	IC50	uM	0.2
	2584836	CHEMBL955774	Inhibition of human MK2	B	Nc1nc2[nH]c(-c3ccnc(/C=C/c4ccccc4)c3)cc2c(=O)[nH]1		CHEMBL518824	=	IC50	nM	290.0	CHEMBL2208	Homo sapiens	IC50	uM	0.29
	2584837	CHEMBL955774	Inhibition of human MK2	B	O=c1[nH]c(C(F)(F)F)nc2[nH]c(-c3ccnc(/C=C/c4ccccc4)c3)cc12		CHEMBL462371	=	IC50	nM	1700.0	CHEMBL2208	Homo sapiens	IC50	uM	1.7
	2584838	CHEMBL955774	Inhibition of human MK2	B	Cc1nc2[nH]c(-c3ccnc(/C=C/c4ccccc4)c3)cc2c(=O)[nH]1		CHEMBL504267	=	IC50	nM	350.0	CHEMBL2208	Homo sapiens	IC50	uM	0.35
	2584839	CHEMBL955774	Inhibition of human MK2	B	CCCCc1nc2[nH]c(-c3ccnc(/C=C/c4ccccc4)c3)cc2c(=O)[nH]1		CHEMBL462372	=	IC50	nM	1260.0	CHEMBL2208	Homo sapiens	IC50	uM	1.26
	2584840	CHEMBL955774	Inhibition of human MK2	B	O=c1[nH]c(Cc2ccccc2)nc2[nH]c(-c3ccnc(/C=C/c4ccccc4)c3)cc12		CHEMBL460091	=	IC50	nM	340.0	CHEMBL2208	Homo sapiens	IC50	uM	0.34
	2584841	CHEMBL955774	Inhibition of human MK2	B	O=C(c1ccc(/C=C/c2cc(-c3cc4c(=O)[nH]cnc4[nH]3)ccn2)cc1)N1CCOCC1		CHEMBL516802	=	IC50	nM	42.0	CHEMBL2208	Homo sapiens	IC50	uM	0.042
	2584842	CHEMBL955774	Inhibition of human MK2	B	O=c1[nH]cnc2[nH]c(-c3ccnc(/C=C/c4ccc(CN5CCOCC5)cc4)c3)cc12		CHEMBL461139	=	IC50	nM	51.0	CHEMBL2208	Homo sapiens	IC50	uM	0.051
	2584843	CHEMBL955774	Inhibition of human MK2	B	CN(C)CCOc1ccc(/C=C/c2cc(-c3cc4c(=O)[nH]cnc4[nH]3)ccn2)cc1		CHEMBL461140	=	IC50	nM	82.0	CHEMBL2208	Homo sapiens	IC50	uM	0.082
	2584844	CHEMBL955774	Inhibition of human MK2	B	CCN(CC)Cc1ccc(/C=C/c2cc(-c3cc4c(=O)[nH]cnc4[nH]3)ccn2)cc1		CHEMBL461316	=	IC50	nM	150.0	CHEMBL2208	Homo sapiens	IC50	uM	0.15
	2613324	CHEMBL1016945	Inhibition of MAPK2/ERK2	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	nM	10000.0
	2613331	CHEMBL1016939	Inhibition of MAPKAPK2	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	nM	10000.0
	2624357	CHEMBL1007484	Inhibition of MK2	B	Cc1c(Nc2c(C#N)cncc2-c2ccc(OCCN3CCN(C)CC3)cc2)ccc2[nH]ccc12		CHEMBL467069	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	2629162	CHEMBL1008389	Inhibition of MK2	B	CC(C)N1CCC(n2cc(CNc3cc(Cl)c4ncc(C#N)c(Nc5ccc(F)c(Cl)c5)c4c3)nn2)CC1	Outside typical range	CHEMBL523059	>	IC50	nM	200000.0	CHEMBL2208	Homo sapiens	IC50	uM	200.0
	2629163	CHEMBL1008389	Inhibition of MK2	B	CCCN1CCC(n2cc(CNc3cc(Cl)c4ncc(C#N)c(Nc5ccc(F)c(Cl)c5)c4c3)nn2)CC1	Outside typical range	CHEMBL495617	>	IC50	nM	200000.0	CHEMBL2208	Homo sapiens	IC50	uM	200.0
	2629903	CHEMBL1008389	Inhibition of MK2	B	N#Cc1cnc2c(Cl)cc(NCc3cn(C4CCN(C5CCC5)CC4)nn3)cc2c1Nc1ccc(F)c(Cl)c1	Outside typical range	CHEMBL501709	=	IC50	nM	131000.0	CHEMBL2208	Homo sapiens	IC50	uM	131.0
	2629912	CHEMBL1008389	Inhibition of MK2	B	CCN1CCC(n2cc(CNc3cc(Cl)c4ncc(C#N)c(Nc5ccc(F)c(Cl)c5)c4c3)nn2)CC1		CHEMBL527026	=	IC50	nM	63000.0	CHEMBL2208	Homo sapiens	IC50	uM	63.0
	2629917	CHEMBL1008389	Inhibition of MK2	B	N#Cc1cnc2c(Br)cc(NCc3c[nH]nn3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL230232	=	IC50	nM	49000.0	CHEMBL2208	Homo sapiens	IC50	uM	49.0
	2635199	CHEMBL1000638	Inhibition of MAPKAP-K2 at 1 uM relative to control	B	CSc1cc(Oc2ccnc3[nH]c(=O)[nH]c23)ccc1NC(=O)Nc1cccc(C(F)(F)F)c1		CHEMBL496009	=	Residual_activity	%	100.0	CHEMBL2208	Homo sapiens	Residual_activity	%	100.0
	2635942	CHEMBL1000638	Inhibition of MAPKAP-K2 at 1 uM relative to control	B	O=C(Nc1cc(C(F)(F)F)ccc1F)Nc1ccc(Oc2ccnc3[nH]c(=O)[nH]c23)c2ccccc12		CHEMBL498112	=	Residual_activity	%	100.0	CHEMBL2208	Homo sapiens	Residual_activity	%	100.0
	2636010	CHEMBL1000638	Inhibition of MAPKAP-K2 at 1 uM relative to control	B	CC(C)(C)c1cccc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c3ccccc23)c1		CHEMBL496073	=	Residual_activity	%	75.0	CHEMBL2208	Homo sapiens	Residual_activity	%	75.0
	2637216	CHEMBL1011420	Inhibition of human recombinant MK2	B	C[C@@H](Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1		CHEMBL466496	=	IC50	nM	8900.0	CHEMBL2208	Homo sapiens	IC50	uM	8.9
	2637217	CHEMBL1011420	Inhibition of human recombinant MK2	B	C[C@H](Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1		CHEMBL512784	>	IC50	nM	100000.0	CHEMBL2208	Homo sapiens	IC50	uM	100.0
	2637218	CHEMBL1011420	Inhibition of human recombinant MK2	B	O=c1c(NCc2ccccc2)c(Nc2ccncc2)c1=O		CHEMBL466700	=	IC50	nM	88000.0	CHEMBL2208	Homo sapiens	IC50	uM	88.0
	2637219	CHEMBL1011420	Inhibition of human recombinant MK2	B	CC(C)(Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1		CHEMBL504830	=	IC50	nM	2300.0	CHEMBL2208	Homo sapiens	IC50	uM	2.3
	2637220	CHEMBL1011420	Inhibition of human recombinant MK2	B	C[C@@H](Nc1c(Nc2ccncc2)c(=O)c1=O)C1CCCCC1		CHEMBL466701	=	IC50	nM	65000.0	CHEMBL2208	Homo sapiens	IC50	uM	65.0
	2637221	CHEMBL1011420	Inhibition of human recombinant MK2	B	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)c1nccs1		CHEMBL467729	=	IC50	nM	81000.0	CHEMBL2208	Homo sapiens	IC50	uM	81.0
	2637222	CHEMBL1011420	Inhibition of human recombinant MK2	B	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1F		CHEMBL467730	=	IC50	nM	9300.0	CHEMBL2208	Homo sapiens	IC50	uM	9.3
	2637223	CHEMBL1011420	Inhibition of human recombinant MK2	B	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1O		CHEMBL513154	=	IC50	nM	33000.0	CHEMBL2208	Homo sapiens	IC50	uM	33.0
	2637224	CHEMBL1011420	Inhibition of human recombinant MK2	B	Cc1cccc(C(C)Nc2c(Nc3ccncc3)c(=O)c2=O)c1		CHEMBL467731	=	IC50	nM	49000.0	CHEMBL2208	Homo sapiens	IC50	uM	49.0
	2637225	CHEMBL1011420	Inhibition of human recombinant MK2	B	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)c1cccc(N)c1		CHEMBL467732	=	IC50	nM	14000.0	CHEMBL2208	Homo sapiens	IC50	uM	14.0
	2637226	CHEMBL1011420	Inhibition of human recombinant MK2	B	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)c1cccc(O)c1		CHEMBL467532	=	IC50	nM	380.0	CHEMBL2208	Homo sapiens	IC50	uM	0.38
	2637227	CHEMBL1011420	Inhibition of human recombinant MK2	B	CC(=O)Nc1cccc(C(C)Nc2c(Nc3ccncc3)c(=O)c2=O)c1		CHEMBL452699	=	IC50	nM	5500.0	CHEMBL2208	Homo sapiens	IC50	uM	5.5
	2637228	CHEMBL1011420	Inhibition of human recombinant MK2	B	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)c1cccc(NS(C)(=O)=O)c1		CHEMBL511219	=	IC50	nM	24000.0	CHEMBL2208	Homo sapiens	IC50	uM	24.0
	2637229	CHEMBL1011420	Inhibition of human recombinant MK2	B	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccc(F)cc1		CHEMBL467078	=	IC50	nM	8200.0	CHEMBL2208	Homo sapiens	IC50	uM	8.2
	2637230	CHEMBL1011420	Inhibition of human recombinant MK2	B	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccc(O)cc1		CHEMBL512791	=	IC50	nM	5000.0	CHEMBL2208	Homo sapiens	IC50	uM	5.0
	2637231	CHEMBL1011420	Inhibition of human recombinant MK2	B	NC(=O)C(Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1		CHEMBL467079	=	IC50	nM	4500.0	CHEMBL2208	Homo sapiens	IC50	uM	4.5
	2637232	CHEMBL1011420	Inhibition of human recombinant MK2	B	NC(=O)C(Nc1c(Nc2ccncc2)c(=O)c1=O)c1cccc(O)c1		CHEMBL511410	=	IC50	nM	390.0	CHEMBL2208	Homo sapiens	IC50	uM	0.39
	2637233	CHEMBL1011420	Inhibition of human recombinant MK2	B	O=c1c(Nc2ccncc2)c(NC(CO)c2ccccc2)c1=O		CHEMBL467911	=	IC50	nM	5300.0	CHEMBL2208	Homo sapiens	IC50	uM	5.3
	2637234	CHEMBL1011420	Inhibition of human recombinant MK2	B	C[C@H](c1ccccc1)N(C)c1c(Nc2ccncc2)c(=O)c1=O		CHEMBL467912	>	IC50	nM	100000.0	CHEMBL2208	Homo sapiens	IC50	uM	100.0
	2637235	CHEMBL1011420	Inhibition of human recombinant MK2	B	C[C@@H](Nc1c(N(C)c2ccncc2)c(=O)c1=O)c1ccccc1		CHEMBL467913	>	IC50	nM	100000.0	CHEMBL2208	Homo sapiens	IC50	uM	100.0
	2637236	CHEMBL1011420	Inhibition of human recombinant MK2	B	C[C@@H](Nc1c(Nc2cccnc2)c(=O)c1=O)c1ccccc1		CHEMBL505335	>	IC50	nM	100000.0	CHEMBL2208	Homo sapiens	IC50	uM	100.0
	2637237	CHEMBL1011420	Inhibition of human recombinant MK2	B	C[C@@H](Nc1c(Nc2ccncn2)c(=O)c1=O)c1ccccc1		CHEMBL512454	>	IC50	nM	100000.0	CHEMBL2208	Homo sapiens	IC50	uM	100.0
	2637238	CHEMBL1011420	Inhibition of human recombinant MK2	B	C[C@@H](Nc1c(Nc2ccn[nH]2)c(=O)c1=O)c1ccccc1		CHEMBL524472	>	IC50	nM	100000.0	CHEMBL2208	Homo sapiens	IC50	uM	100.0
	2637239	CHEMBL1011420	Inhibition of human recombinant MK2	B	C[C@@H](Nc1c(Nc2ccnc(Cl)c2)c(=O)c1=O)c1ccccc1		CHEMBL468321	>	IC50	nM	100000.0	CHEMBL2208	Homo sapiens	IC50	uM	100.0
	2637240	CHEMBL1011420	Inhibition of human recombinant MK2	B	C[C@@H](Nc1c(Nc2ccnc(-c3ccccc3)c2)c(=O)c1=O)c1ccccc1		CHEMBL511419	=	IC50	nM	2600.0	CHEMBL2208	Homo sapiens	IC50	uM	2.6
	2637241	CHEMBL1011420	Inhibition of human recombinant MK2	B	C[C@@H](Nc1c(Nc2ccnc(-c3ccccc3F)c2)c(=O)c1=O)c1ccccc1		CHEMBL468125	=	IC50	nM	5800.0	CHEMBL2208	Homo sapiens	IC50	uM	5.8
	2637242	CHEMBL1011420	Inhibition of human recombinant MK2	B	C[C@@H](Nc1c(Nc2ccnc(-c3cccc(F)c3)c2)c(=O)c1=O)c1ccccc1		CHEMBL449692	=	IC50	nM	6600.0	CHEMBL2208	Homo sapiens	IC50	uM	6.6
	2637243	CHEMBL1011420	Inhibition of human recombinant MK2	B	COc1cccc(-c2cc(Nc3c(N[C@H](C)c4ccccc4)c(=O)c3=O)ccn2)c1		CHEMBL479290	=	IC50	nM	3700.0	CHEMBL2208	Homo sapiens	IC50	uM	3.7
	2637244	CHEMBL1011420	Inhibition of human recombinant MK2	B	C[C@@H](Nc1c(Nc2ccnc(-c3ccncc3)c2)c(=O)c1=O)c1ccccc1		CHEMBL469490	=	IC50	nM	3600.0	CHEMBL2208	Homo sapiens	IC50	uM	3.6
	2637245	CHEMBL1011420	Inhibition of human recombinant MK2	B	C[C@@H](Nc1c(Nc2ccnc(-c3ccco3)c2)c(=O)c1=O)c1ccccc1		CHEMBL519113	=	IC50	nM	5300.0	CHEMBL2208	Homo sapiens	IC50	uM	5.3
	2637246	CHEMBL1011420	Inhibition of human recombinant MK2	B	C[C@@H](Nc1c(Nc2ccnc(-c3ccsc3)c2)c(=O)c1=O)c1ccccc1		CHEMBL481248	=	IC50	nM	5400.0	CHEMBL2208	Homo sapiens	IC50	uM	5.4
	2637247	CHEMBL1011420	Inhibition of human recombinant MK2	B	C[C@@H](Nc1c(Nc2ccnc(Nc3ccccc3)c2)c(=O)c1=O)c1ccccc1		CHEMBL481249	=	IC50	nM	9100.0	CHEMBL2208	Homo sapiens	IC50	uM	9.1
	2637248	CHEMBL1011420	Inhibition of human recombinant MK2	B	C[C@@H](Nc1c(Nc2ccnc(Nc3cccc(C(N)=O)c3)c2)c(=O)c1=O)c1ccccc1		CHEMBL513870	=	IC50	nM	2400.0	CHEMBL2208	Homo sapiens	IC50	uM	2.4
	2637249	CHEMBL1011420	Inhibition of human recombinant MK2	B	C[C@@H](Nc1c(Nc2ccnc(Nc3ccncn3)c2)c(=O)c1=O)c1ccccc1		CHEMBL469124	=	IC50	nM	670.0	CHEMBL2208	Homo sapiens	IC50	uM	0.67
	2637250	CHEMBL1011420	Inhibition of human recombinant MK2	B	C[C@@H](Nc1c(Nc2ccnc(Nc3cnccn3)c2)c(=O)c1=O)c1ccccc1		CHEMBL525927	=	IC50	nM	1600.0	CHEMBL2208	Homo sapiens	IC50	uM	1.6
	2637251	CHEMBL1011420	Inhibition of human recombinant MK2	B	C[C@@H](Nc1c(Nc2ccnc(Nc3ncccn3)c2)c(=O)c1=O)c1ccccc1		CHEMBL466009	=	IC50	nM	2300.0	CHEMBL2208	Homo sapiens	IC50	uM	2.3
	2637252	CHEMBL1011420	Inhibition of human recombinant MK2	B	CC(=O)Nc1cc(Nc2c(N[C@H](C)c3ccccc3)c(=O)c2=O)ccn1		CHEMBL468292	=	IC50	nM	3800.0	CHEMBL2208	Homo sapiens	IC50	uM	3.8
	2637253	CHEMBL1011420	Inhibition of human recombinant MK2	B	C[C@@H](Nc1c(Nc2ccnc(NC(=O)c3cccnc3)c2)c(=O)c1=O)c1ccccc1		CHEMBL468322	=	IC50	nM	1300.0	CHEMBL2208	Homo sapiens	IC50	uM	1.3
	2661419	CHEMBL1058625	Inhibition of MAPKAPK2	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	2661592	CHEMBL1060456	Inhibition of MK2 after 1 hr by mobility shift electrophoresis assay	B	COC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(C(=O)OC)CC4)c3n2)cc1		CHEMBL561708	>	IC50	nM	50000.0	CHEMBL2208	Homo sapiens	IC50	uM	50.0
	2684793	CHEMBL1053843	Inhibition of MK2-mediated inhibition of biotinylated substrate phosphorylation	B	CC(=O)/C1=C/Cn2c3ccccc3c3c4c(c5c6ccccc6n(c5c32)C1)C(=O)NC4=O		CHEMBL557101	=	IC50	nM	540.0	CHEMBL2208	Homo sapiens	IC50	nM	540.0
	2684794	CHEMBL1053843	Inhibition of MK2-mediated inhibition of biotinylated substrate phosphorylation	B	COC(=O)[C@]1(O)Cn2c3ccccc3c3c4c(c5c6ccccc6n(c5c32)C[C@H]1O)C(=O)NC4=O		CHEMBL564940	>	IC50	nM	1000.0	CHEMBL2208	Homo sapiens	IC50	nM	1000.0
	2684795	CHEMBL1053843	Inhibition of MK2-mediated inhibition of biotinylated substrate phosphorylation	B	O=C1NCc2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C[C@@H](O)[C@@H](O)C3		CHEMBL559787	>	IC50	nM	1000.0	CHEMBL2208	Homo sapiens	IC50	nM	1000.0
	2691843	CHEMBL1051583	Inhibition of human MK2	B	Cc1ccccc1-c1c(N)c(C(=O)c2ccc(F)cc2F)cc[n+]1[O-]		CHEMBL551717	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	2691866	CHEMBL1054690	Inhibition of human MAPKAP-K2 assessed as remaining activity at 10 uM	B	Cc1ccccc1-c1c(N)c(C(=O)c2ccc(F)cc2F)cc[n+]1[O-]		CHEMBL551717	=	Activity	%	123.0	CHEMBL2208	Homo sapiens	Activity	%	123.0
	2701536	CHEMBL1061558	Inhibition of MK2	B	COc1ccc2sc3c(c2c1)NC[C@@H](C)NC3=O		CHEMBL99780	=	IC50	nM	40.0	CHEMBL2208	Homo sapiens	IC50	uM	0.04
	2701537	CHEMBL1061558	Inhibition of MK2	B	C[C@@H]1CNc2c(sc3ccc4occc4c23)C(=O)N1		CHEMBL557318	=	IC50	nM	16.0	CHEMBL2208	Homo sapiens	IC50	uM	0.016
	2701538	CHEMBL1061558	Inhibition of MK2	B	C[C@@H]1CNc2c(sc3ccc4c(c23)CCO4)C(=O)N1		CHEMBL562754	=	IC50	nM	28.0	CHEMBL2208	Homo sapiens	IC50	uM	0.028
	2701539	CHEMBL1061558	Inhibition of MK2	B	C[C@@H]1CNc2c(sc3ccc4ncccc4c23)C(=O)N1		CHEMBL561334	=	IC50	nM	1.0	CHEMBL2208	Homo sapiens	IC50	uM	0.001
	2701540	CHEMBL1061558	Inhibition of MK2	B	C[C@@H]1CNc2c(sc3ccc4oc(-c5ccccc5)cc4c23)C(=O)N1		CHEMBL562194	=	IC50	nM	150.0	CHEMBL2208	Homo sapiens	IC50	uM	0.15
	2701541	CHEMBL1061558	Inhibition of MK2	B	C[C@@H]1CNc2c(sc3ccc4nc(Cl)ccc4c23)C(=O)N1		CHEMBL556392	=	IC50	nM	2.0	CHEMBL2208	Homo sapiens	IC50	uM	0.002
	2701542	CHEMBL1061558	Inhibition of MK2	B	C[C@@H]1CNc2c(sc3ccc4nc(-c5ccccc5)ccc4c23)C(=O)N1		CHEMBL564076	=	IC50	nM	9.0	CHEMBL2208	Homo sapiens	IC50	uM	0.009
	2701543	CHEMBL1061558	Inhibition of MK2	B	C[C@@H]1CNc2c(sc3ccc4nc(-c5ccncc5)ccc4c23)C(=O)N1		CHEMBL552339	=	IC50	nM	14.0	CHEMBL2208	Homo sapiens	IC50	uM	0.014
	2701544	CHEMBL1061558	Inhibition of MK2	B	C[C@@H]1CNc2c(sc3ccc4nc(-c5cccnc5)ccc4c23)C(=O)N1		CHEMBL560075	=	IC50	nM	5.0	CHEMBL2208	Homo sapiens	IC50	uM	0.005
	2701545	CHEMBL1061558	Inhibition of MK2	B	C[C@@H]1CNc2c(sc3ccc4nc(-c5cncnc5)ccc4c23)C(=O)N1		CHEMBL549585	=	IC50	nM	23.0	CHEMBL2208	Homo sapiens	IC50	uM	0.023
	2701546	CHEMBL1061558	Inhibition of MK2	B	COc1ccccc1-c1ccc2c(ccc3sc4c(c32)NC[C@@H](C)NC4=O)n1		CHEMBL562137	=	IC50	nM	20.0	CHEMBL2208	Homo sapiens	IC50	uM	0.02
	2701547	CHEMBL1061558	Inhibition of MK2	B	COc1cccc(-c2ccc3c(ccc4sc5c(c43)NC[C@@H](C)NC5=O)n2)c1		CHEMBL563307	=	IC50	nM	41.0	CHEMBL2208	Homo sapiens	IC50	uM	0.041
	2701548	CHEMBL1061558	Inhibition of MK2	B	C[C@@H]1CNc2c(sc3ccc4nc(-c5ccccc5F)ccc4c23)C(=O)N1		CHEMBL554286	=	IC50	nM	14.0	CHEMBL2208	Homo sapiens	IC50	uM	0.014
	2701549	CHEMBL1061558	Inhibition of MK2	B	Cc1ccccc1-c1ccc2c(ccc3sc4c(c32)NC[C@@H](C)NC4=O)n1		CHEMBL562606	=	IC50	nM	30.0	CHEMBL2208	Homo sapiens	IC50	uM	0.03
	2701550	CHEMBL1061558	Inhibition of MK2	B	Cc1ccncc1-c1ccc2c(ccc3sc4c(c32)NC[C@@H](C)NC4=O)n1		CHEMBL549915	=	IC50	nM	5.0	CHEMBL2208	Homo sapiens	IC50	uM	0.005
	2701566	CHEMBL1061560	Inhibition of MK2 in human U937 cells assessed as blockade of LPS-stimulated TNFalpha production	B	COc1ccc2sc3c(c2c1)NC[C@@H](C)NC3=O		CHEMBL99780	=	IC50	nM	700.0	CHEMBL2208	Homo sapiens	IC50	uM	0.7
	2701567	CHEMBL1061560	Inhibition of MK2 in human U937 cells assessed as blockade of LPS-stimulated TNFalpha production	B	C[C@@H]1CNc2c(sc3ccc4occc4c23)C(=O)N1		CHEMBL557318	=	IC50	nM	90.0	CHEMBL2208	Homo sapiens	IC50	uM	0.09
	2701568	CHEMBL1061560	Inhibition of MK2 in human U937 cells assessed as blockade of LPS-stimulated TNFalpha production	B	C[C@@H]1CNc2c(sc3ccc4c(c23)CCO4)C(=O)N1		CHEMBL562754	=	IC50	nM	260.0	CHEMBL2208	Homo sapiens	IC50	uM	0.26
	2701569	CHEMBL1061560	Inhibition of MK2 in human U937 cells assessed as blockade of LPS-stimulated TNFalpha production	B	C[C@@H]1CNc2c(sc3ccc4ncccc4c23)C(=O)N1		CHEMBL561334	=	IC50	nM	50.0	CHEMBL2208	Homo sapiens	IC50	uM	0.05
	2701570	CHEMBL1061560	Inhibition of MK2 in human U937 cells assessed as blockade of LPS-stimulated TNFalpha production	B	C[C@@H]1CNc2c(sc3ccc4oc(-c5ccccc5)cc4c23)C(=O)N1		CHEMBL562194	=	IC50	nM	6800.0	CHEMBL2208	Homo sapiens	IC50	uM	6.8
	2701571	CHEMBL1061560	Inhibition of MK2 in human U937 cells assessed as blockade of LPS-stimulated TNFalpha production	B	C[C@@H]1CNc2c(sc3ccc4nc(Cl)ccc4c23)C(=O)N1		CHEMBL556392	=	IC50	nM	130.0	CHEMBL2208	Homo sapiens	IC50	uM	0.13
	2701572	CHEMBL1061560	Inhibition of MK2 in human U937 cells assessed as blockade of LPS-stimulated TNFalpha production	B	C[C@@H]1CNc2c(sc3ccc4nc(-c5ccccc5)ccc4c23)C(=O)N1		CHEMBL564076	=	IC50	nM	180.0	CHEMBL2208	Homo sapiens	IC50	uM	0.18
	2701573	CHEMBL1061560	Inhibition of MK2 in human U937 cells assessed as blockade of LPS-stimulated TNFalpha production	B	C[C@@H]1CNc2c(sc3ccc4nc(-c5ccncc5)ccc4c23)C(=O)N1		CHEMBL552339	=	IC50	nM	740.0	CHEMBL2208	Homo sapiens	IC50	uM	0.74
	2701574	CHEMBL1061560	Inhibition of MK2 in human U937 cells assessed as blockade of LPS-stimulated TNFalpha production	B	C[C@@H]1CNc2c(sc3ccc4nc(-c5cccnc5)ccc4c23)C(=O)N1		CHEMBL560075	=	IC50	nM	220.0	CHEMBL2208	Homo sapiens	IC50	uM	0.22
	2701575	CHEMBL1061560	Inhibition of MK2 in human U937 cells assessed as blockade of LPS-stimulated TNFalpha production	B	C[C@@H]1CNc2c(sc3ccc4nc(-c5cncnc5)ccc4c23)C(=O)N1		CHEMBL549585	=	IC50	nM	640.0	CHEMBL2208	Homo sapiens	IC50	uM	0.64
	2701576	CHEMBL1061560	Inhibition of MK2 in human U937 cells assessed as blockade of LPS-stimulated TNFalpha production	B	COc1ccccc1-c1ccc2c(ccc3sc4c(c32)NC[C@@H](C)NC4=O)n1		CHEMBL562137	=	IC50	nM	1040.0	CHEMBL2208	Homo sapiens	IC50	uM	1.04
	2701577	CHEMBL1061560	Inhibition of MK2 in human U937 cells assessed as blockade of LPS-stimulated TNFalpha production	B	COc1cccc(-c2ccc3c(ccc4sc5c(c43)NC[C@@H](C)NC5=O)n2)c1		CHEMBL563307	=	IC50	nM	690.0	CHEMBL2208	Homo sapiens	IC50	uM	0.69
	2701578	CHEMBL1061560	Inhibition of MK2 in human U937 cells assessed as blockade of LPS-stimulated TNFalpha production	B	C[C@@H]1CNc2c(sc3ccc4nc(-c5ccccc5F)ccc4c23)C(=O)N1		CHEMBL554286	=	IC50	nM	930.0	CHEMBL2208	Homo sapiens	IC50	uM	0.93
	2701579	CHEMBL1061560	Inhibition of MK2 in human U937 cells assessed as blockade of LPS-stimulated TNFalpha production	B	Cc1ccccc1-c1ccc2c(ccc3sc4c(c32)NC[C@@H](C)NC4=O)n1		CHEMBL562606	=	IC50	nM	3360.0	CHEMBL2208	Homo sapiens	IC50	uM	3.36
	2701580	CHEMBL1061560	Inhibition of MK2 in human U937 cells assessed as blockade of LPS-stimulated TNFalpha production	B	Cc1ccncc1-c1ccc2c(ccc3sc4c(c32)NC[C@@H](C)NC4=O)n1		CHEMBL549915	=	IC50	nM	150.0	CHEMBL2208	Homo sapiens	IC50	uM	0.15
Active	2701595	CHEMBL1061566	Inhibition of MK2-mediated HSP27 Ser78 phosphorylation in human LPS-stimulated U937 cells after 30 mins	B	C[C@@H]1CNc2c(sc3ccc4nc(-c5cccnc5)ccc4c23)C(=O)N1		CHEMBL560075		Inhibition	%		CHEMBL2208	Homo sapiens	INH		
Active	2701597	CHEMBL1061566	Inhibition of MK2-mediated HSP27 Ser78 phosphorylation in human LPS-stimulated U937 cells after 30 mins	B	Cc1ccncc1-c1ccc2c(ccc3sc4c(c32)NC[C@@H](C)NC4=O)n1		CHEMBL549915		Inhibition	%		CHEMBL2208	Homo sapiens	INH		
	2701733	CHEMBL1063344	Inhibition of MK2	B	COc1ccc2sc3c(c2c1)NCCNC3=O		CHEMBL319171	=	IC50	nM	180.0	CHEMBL2208	Homo sapiens	IC50	uM	0.18
	2701735	CHEMBL1063346	Inhibition of MK2 in human U937 cells assessed as blockade of LPS-stimulated TNFalpha production	B	COc1ccc2sc3c(c2c1)NCCNC3=O		CHEMBL319171	=	IC50	nM	1400.0	CHEMBL2208	Homo sapiens	IC50	uM	1.4
	2701736	CHEMBL1063344	Inhibition of MK2	B	COc1ccc2sc3c(c2c1)NC[C@@H](C)NC3=O		CHEMBL99780	=	IC50	nM	40.0	CHEMBL2208	Homo sapiens	IC50	uM	0.04
	2701738	CHEMBL1063346	Inhibition of MK2 in human U937 cells assessed as blockade of LPS-stimulated TNFalpha production	B	COc1ccc2sc3c(c2c1)NC[C@@H](C)NC3=O		CHEMBL99780	=	IC50	nM	700.0	CHEMBL2208	Homo sapiens	IC50	uM	0.7
	2701739	CHEMBL1063344	Inhibition of MK2	B	COc1ccc2sc3c(c2c1)NC[C@H](C)NC3=O		CHEMBL100818	=	IC50	nM	300.0	CHEMBL2208	Homo sapiens	IC50	uM	0.3
	2701741	CHEMBL1063346	Inhibition of MK2 in human U937 cells assessed as blockade of LPS-stimulated TNFalpha production	B	COc1ccc2sc3c(c2c1)NC[C@H](C)NC3=O		CHEMBL100818	=	IC50	nM	3800.0	CHEMBL2208	Homo sapiens	IC50	uM	3.8
	2701742	CHEMBL1063344	Inhibition of MK2	B	CCC[C@@H]1CNc2c(sc3ccc(OC)cc23)C(=O)N1		CHEMBL539450	=	IC50	nM	1520.0	CHEMBL2208	Homo sapiens	IC50	uM	1.52
	2701743	CHEMBL1063346	Inhibition of MK2 in human U937 cells assessed as blockade of LPS-stimulated TNFalpha production	B	CCC[C@@H]1CNc2c(sc3ccc(OC)cc23)C(=O)N1		CHEMBL539450	=	IC50	nM	5450.0	CHEMBL2208	Homo sapiens	IC50	uM	5.45
	2701744	CHEMBL1063344	Inhibition of MK2	B	COc1ccc2sc3c(c2c1)NC[C@@H](CO)NC3=O		CHEMBL553397	=	IC50	nM	14.0	CHEMBL2208	Homo sapiens	IC50	uM	0.014
	2701746	CHEMBL1063346	Inhibition of MK2 in human U937 cells assessed as blockade of LPS-stimulated TNFalpha production	B	COc1ccc2sc3c(c2c1)NC[C@@H](CO)NC3=O		CHEMBL553397	=	IC50	nM	400.0	CHEMBL2208	Homo sapiens	IC50	uM	0.4
	2701747	CHEMBL1063344	Inhibition of MK2	B	COc1ccc2sc3c(c2c1)SCCNC3=O		CHEMBL319170	=	IC50	nM	1090.0	CHEMBL2208	Homo sapiens	IC50	uM	1.09
	2701749	CHEMBL1063346	Inhibition of MK2 in human U937 cells assessed as blockade of LPS-stimulated TNFalpha production	B	COc1ccc2sc3c(c2c1)SCCNC3=O		CHEMBL319170	=	IC50	nM	5500.0	CHEMBL2208	Homo sapiens	IC50	uM	5.5
	2701750	CHEMBL1063344	Inhibition of MK2	B	COc1ccc2sc3c(c2c1)CCCNC3=O		CHEMBL571897	=	IC50	nM	500.0	CHEMBL2208	Homo sapiens	IC50	uM	0.5
	2701752	CHEMBL1063346	Inhibition of MK2 in human U937 cells assessed as blockade of LPS-stimulated TNFalpha production	B	COc1ccc2sc3c(c2c1)CCCNC3=O		CHEMBL571897	=	IC50	nM	4700.0	CHEMBL2208	Homo sapiens	IC50	uM	4.7
	2701753	CHEMBL1063344	Inhibition of MK2	B	COc1ccc2sc3c(c2c1)NC[C@@H](CN)NC3=O		CHEMBL555205	=	IC50	nM	5.0	CHEMBL2208	Homo sapiens	IC50	uM	0.005
	2701755	CHEMBL1063346	Inhibition of MK2 in human U937 cells assessed as blockade of LPS-stimulated TNFalpha production	B	COc1ccc2sc3c(c2c1)NC[C@@H](CN)NC3=O		CHEMBL555205	=	IC50	nM	2600.0	CHEMBL2208	Homo sapiens	IC50	uM	2.6
	2701756	CHEMBL1063344	Inhibition of MK2	B	CCNC[C@@H]1CNc2c(sc3ccc(OC)cc23)C(=O)N1		CHEMBL550060	=	IC50	nM	570.0	CHEMBL2208	Homo sapiens	IC50	uM	0.57
	2701758	CHEMBL1063346	Inhibition of MK2 in human U937 cells assessed as blockade of LPS-stimulated TNFalpha production	B	CCNC[C@@H]1CNc2c(sc3ccc(OC)cc23)C(=O)N1		CHEMBL550060	=	IC50	nM	21600.0	CHEMBL2208	Homo sapiens	IC50	uM	21.6
	2701759	CHEMBL1063344	Inhibition of MK2	B	CCCNC[C@@H]1CNc2c(sc3ccc(OC)cc23)C(=O)N1		CHEMBL560737	=	IC50	nM	450.0	CHEMBL2208	Homo sapiens	IC50	uM	0.45
	2701761	CHEMBL1063346	Inhibition of MK2 in human U937 cells assessed as blockade of LPS-stimulated TNFalpha production	B	CCCNC[C@@H]1CNc2c(sc3ccc(OC)cc23)C(=O)N1		CHEMBL560737	=	IC50	nM	14900.0	CHEMBL2208	Homo sapiens	IC50	uM	14.9
	2701762	CHEMBL1063344	Inhibition of MK2	B	COc1ccc2sc3c(c2c1)NC[C@@H](CNCc1ccccc1)NC3=O		CHEMBL551534	=	IC50	nM	570.0	CHEMBL2208	Homo sapiens	IC50	uM	0.57
	2701764	CHEMBL1063346	Inhibition of MK2 in human U937 cells assessed as blockade of LPS-stimulated TNFalpha production	B	COc1ccc2sc3c(c2c1)NC[C@@H](CNCc1ccccc1)NC3=O		CHEMBL551534	=	IC50	nM	21000.0	CHEMBL2208	Homo sapiens	IC50	uM	21.0
	2701765	CHEMBL1063344	Inhibition of MK2	B	COc1ccc2sc3c(c2c1)NC[C@@H](CN1CCCC1)NC3=O		CHEMBL550260	>	IC50	nM	20000.0	CHEMBL2208	Homo sapiens	IC50	uM	20.0
	2701766	CHEMBL1063344	Inhibition of MK2	B	COc1ccc2sc3c(c2c1)NC[C@@H](CN1CCOCC1)NC3=O		CHEMBL558162	>	IC50	nM	20000.0	CHEMBL2208	Homo sapiens	IC50	uM	20.0
	2701767	CHEMBL1063344	Inhibition of MK2	B	COc1ccc2sc3c(c2c1)NC[C@@H](CN(C)Cc1ccccc1)NC3=O		CHEMBL562002	=	IC50	nM	1910.0	CHEMBL2208	Homo sapiens	IC50	uM	1.91
	2701769	CHEMBL1063346	Inhibition of MK2 in human U937 cells assessed as blockade of LPS-stimulated TNFalpha production	B	COc1ccc2sc3c(c2c1)NC[C@@H](CN(C)Cc1ccccc1)NC3=O		CHEMBL562002	=	IC50	nM	24000.0	CHEMBL2208	Homo sapiens	IC50	uM	24.0
	2701770	CHEMBL1063344	Inhibition of MK2	B	C[C@@H]1CNc2c(sc3ccc(O)cc23)C(=O)N1		CHEMBL559487	=	IC50	nM	190.0	CHEMBL2208	Homo sapiens	IC50	uM	0.19
	2701772	CHEMBL1063346	Inhibition of MK2 in human U937 cells assessed as blockade of LPS-stimulated TNFalpha production	B	C[C@@H]1CNc2c(sc3ccc(O)cc23)C(=O)N1		CHEMBL559487	=	IC50	nM	3500.0	CHEMBL2208	Homo sapiens	IC50	uM	3.5
	2701773	CHEMBL1063344	Inhibition of MK2	B	COc1cccc(COc2ccc3sc4c(c3c2)NC[C@@H](C)NC4=O)c1		CHEMBL541448	=	IC50	nM	110.0	CHEMBL2208	Homo sapiens	IC50	uM	0.11
	2701775	CHEMBL1063346	Inhibition of MK2 in human U937 cells assessed as blockade of LPS-stimulated TNFalpha production	B	COc1cccc(COc2ccc3sc4c(c3c2)NC[C@@H](C)NC4=O)c1		CHEMBL541448	=	IC50	nM	4600.0	CHEMBL2208	Homo sapiens	IC50	uM	4.6
	2701776	CHEMBL1063344	Inhibition of MK2	B	C[C@@H]1CNc2c(sc3ccc(OCC4CC4)cc23)C(=O)N1		CHEMBL563672	=	IC50	nM	1320.0	CHEMBL2208	Homo sapiens	IC50	uM	1.32
	2701778	CHEMBL1063346	Inhibition of MK2 in human U937 cells assessed as blockade of LPS-stimulated TNFalpha production	B	C[C@@H]1CNc2c(sc3ccc(OCC4CC4)cc23)C(=O)N1		CHEMBL563672	=	IC50	nM	27000.0	CHEMBL2208	Homo sapiens	IC50	uM	27.0
	2701779	CHEMBL1063344	Inhibition of MK2	B	COCCOc1ccc2sc3c(c2c1)NC[C@@H](C)NC3=O		CHEMBL559411	=	IC50	nM	270.0	CHEMBL2208	Homo sapiens	IC50	uM	0.27
	2701781	CHEMBL1063346	Inhibition of MK2 in human U937 cells assessed as blockade of LPS-stimulated TNFalpha production	B	COCCOc1ccc2sc3c(c2c1)NC[C@@H](C)NC3=O		CHEMBL559411	=	IC50	nM	3100.0	CHEMBL2208	Homo sapiens	IC50	uM	3.1
	2701782	CHEMBL1063344	Inhibition of MK2	B	CC(C)COc1ccc2sc3c(c2c1)NC[C@@H](C)NC3=O		CHEMBL563308	=	IC50	nM	30.0	CHEMBL2208	Homo sapiens	IC50	uM	0.03
	2701784	CHEMBL1063346	Inhibition of MK2 in human U937 cells assessed as blockade of LPS-stimulated TNFalpha production	B	CC(C)COc1ccc2sc3c(c2c1)NC[C@@H](C)NC3=O		CHEMBL563308	=	IC50	nM	1800.0	CHEMBL2208	Homo sapiens	IC50	uM	1.8
	2701785	CHEMBL1063344	Inhibition of MK2	B	COC(=O)COc1ccc2sc3c(c2c1)NC[C@@H](C)NC3=O		CHEMBL559881	=	IC50	nM	3440.0	CHEMBL2208	Homo sapiens	IC50	uM	3.44
	2701787	CHEMBL1063346	Inhibition of MK2 in human U937 cells assessed as blockade of LPS-stimulated TNFalpha production	B	COC(=O)COc1ccc2sc3c(c2c1)NC[C@@H](C)NC3=O		CHEMBL559881	=	IC50	nM	78000.0	CHEMBL2208	Homo sapiens	IC50	uM	78.0
Dose-dependent effect	2701790	CHEMBL1063348	Inhibition of MK2-mediated HSP27 Ser78 phosphorylation in human LPS-stimulated U937 cells after 30 mins	B	COc1ccc2sc3c(c2c1)NC[C@@H](CO)NC3=O		CHEMBL553397		Activity			CHEMBL2208	Homo sapiens	Activity		
	2721644	CHEMBL1057473	Inhibition of MAPK2 at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL2208	Homo sapiens	INH	%	50.0
	2721645	CHEMBL1057474	Inhibition of MAPKAP-K2 at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL2208	Homo sapiens	INH	%	50.0
	2897159	CHEMBL1062862	Percent residual MAPKAPK2 activity in the presence of 10uM inhibitor	B	O=C(O)Cc1c2ccccc2n2c1[nH]c(=O)c1ccccc12		CHEMBL92361	=	Activity	%	70.0	CHEMBL2208	Homo sapiens	Activity	%	70.0
	2897160	CHEMBL1062862	Percent residual MAPKAPK2 activity in the presence of 10uM inhibitor	B	O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12		CHEMBL28	=	Activity	%	91.0	CHEMBL2208	Homo sapiens	Activity	%	91.0
	2897161	CHEMBL1062862	Percent residual MAPKAPK2 activity in the presence of 10uM inhibitor	B	Cc1cc(O)c2c(c1)C(=O)c1cc(O)cc(O)c1C2=O		CHEMBL289277	=	Activity	%	82.0	CHEMBL2208	Homo sapiens	Activity	%	82.0
	2900304	CHEMBL1061090	Binding constant for MAPKAPK2 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	uM	10.0
	2900305	CHEMBL1061090	Binding constant for MAPKAPK2 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	uM	10.0
	2900306	CHEMBL1061090	Binding constant for MAPKAPK2 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	uM	10.0
	2900307	CHEMBL1061090	Binding constant for MAPKAPK2 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	uM	10.0
	2900308	CHEMBL1061090	Binding constant for MAPKAPK2 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	uM	10.0
	2900309	CHEMBL1061090	Binding constant for MAPKAPK2 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	uM	10.0
	2900310	CHEMBL1061090	Binding constant for MAPKAPK2 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	uM	10.0
	2900311	CHEMBL1061090	Binding constant for MAPKAPK2 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	uM	10.0
	2900312	CHEMBL1061090	Binding constant for MAPKAPK2 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	uM	10.0
	2900313	CHEMBL1061090	Binding constant for MAPKAPK2 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	uM	10.0
	2900314	CHEMBL1061090	Binding constant for MAPKAPK2 kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	uM	10.0
	2900315	CHEMBL1061090	Binding constant for MAPKAPK2 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	uM	10.0
	2900316	CHEMBL1061090	Binding constant for MAPKAPK2 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	uM	10.0
	2900317	CHEMBL1061090	Binding constant for MAPKAPK2 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	uM	10.0
	2900318	CHEMBL1061090	Binding constant for MAPKAPK2 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	uM	10.0
	2900319	CHEMBL1061090	Binding constant for MAPKAPK2 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	uM	10.0
	2900320	CHEMBL1061090	Binding constant for MAPKAPK2 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	uM	10.0
	2900321	CHEMBL1061090	Binding constant for MAPKAPK2 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	uM	10.0
	2900322	CHEMBL1061090	Binding constant for MAPKAPK2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	uM	10.0
	2900323	CHEMBL1061090	Binding constant for MAPKAPK2 kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	uM	10.0
	2900324	CHEMBL1061090	Binding constant for MAPKAPK2 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	uM	10.0
	2900325	CHEMBL1061090	Binding constant for MAPKAPK2 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	uM	10.0
	2900326	CHEMBL1061090	Binding constant for MAPKAPK2 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	uM	10.0
	2900327	CHEMBL1061090	Binding constant for MAPKAPK2 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	uM	10.0
	2900328	CHEMBL1061090	Binding constant for MAPKAPK2 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	uM	10.0
	2900329	CHEMBL1061090	Binding constant for MAPKAPK2 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	uM	10.0
	2900330	CHEMBL1061090	Binding constant for MAPKAPK2 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	uM	10.0
	2900331	CHEMBL1061090	Binding constant for MAPKAPK2 kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	uM	10.0
	2900332	CHEMBL1061090	Binding constant for MAPKAPK2 kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	uM	10.0
	2900333	CHEMBL1061090	Binding constant for MAPKAPK2 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	uM	10.0
	2900334	CHEMBL1061090	Binding constant for MAPKAPK2 kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	uM	10.0
	2900335	CHEMBL1061090	Binding constant for MAPKAPK2 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	uM	10.0
	2900336	CHEMBL1061090	Binding constant for MAPKAPK2 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	880.0	CHEMBL2208	Homo sapiens	Kd	nM	880.0
	2900337	CHEMBL1061090	Binding constant for MAPKAPK2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	uM	10.0
	2900338	CHEMBL1061090	Binding constant for MAPKAPK2 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	uM	10.0
	2900339	CHEMBL1061090	Binding constant for MAPKAPK2 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	uM	10.0
	2900340	CHEMBL1061090	Binding constant for MAPKAPK2 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	uM	10.0
	2900341	CHEMBL1061090	Binding constant for MAPKAPK2 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	uM	10.0
	2905733	CHEMBL1060125	Percentage MAPKAPK2 activity remaining in the presence of 0.01uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	108.0	CHEMBL2208	Homo sapiens	Activity	%	108.0
	2905734	CHEMBL1060125	Percentage MAPKAPK2 activity remaining in the presence of 0.01uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	92.0	CHEMBL2208	Homo sapiens	Activity	%	92.0
	2905735	CHEMBL1060125	Percentage MAPKAPK2 activity remaining in the presence of 0.01uM inhibitor	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Activity	%	75.0	CHEMBL2208	Homo sapiens	Activity	%	75.0
	2905736	CHEMBL1060140	Percentage MAPKAPK2 activity remaining in the presence of 0.1uM inhibitor	B	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C		CHEMBL573107	=	Activity	%	89.0	CHEMBL2208	Homo sapiens	Activity	%	89.0
	2905737	CHEMBL1060140	Percentage MAPKAPK2 activity remaining in the presence of 0.1uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	108.0	CHEMBL2208	Homo sapiens	Activity	%	108.0
	2905738	CHEMBL1060140	Percentage MAPKAPK2 activity remaining in the presence of 0.1uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	73.0	CHEMBL2208	Homo sapiens	Activity	%	73.0
	2905739	CHEMBL1060140	Percentage MAPKAPK2 activity remaining in the presence of 0.1uM inhibitor	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Activity	%	106.0	CHEMBL2208	Homo sapiens	Activity	%	106.0
	2905740	CHEMBL1060140	Percentage MAPKAPK2 activity remaining in the presence of 0.1uM inhibitor	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	Activity	%	90.0	CHEMBL2208	Homo sapiens	Activity	%	90.0
	2905741	CHEMBL1060140	Percentage MAPKAPK2 activity remaining in the presence of 0.1uM inhibitor	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Activity	%	118.0	CHEMBL2208	Homo sapiens	Activity	%	118.0
	2905742	CHEMBL1060140	Percentage MAPKAPK2 activity remaining in the presence of 0.1uM inhibitor	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Activity	%	114.0	CHEMBL2208	Homo sapiens	Activity	%	114.0
	2905743	CHEMBL1060141	Percentage MAPKAPK2 activity remaining in the presence of 10uM inhibitor	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	=	Activity	%	81.0	CHEMBL2208	Homo sapiens	Activity	%	81.0
	2905744	CHEMBL1060141	Percentage MAPKAPK2 activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	=	Activity	%	112.0	CHEMBL2208	Homo sapiens	Activity	%	112.0
	2905745	CHEMBL1060141	Percentage MAPKAPK2 activity remaining in the presence of 10uM inhibitor	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Activity	%	103.0	CHEMBL2208	Homo sapiens	Activity	%	103.0
	2905746	CHEMBL1060141	Percentage MAPKAPK2 activity remaining in the presence of 10uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	68.0	CHEMBL2208	Homo sapiens	Activity	%	68.0
	2905747	CHEMBL1060141	Percentage MAPKAPK2 activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Activity	%	99.0	CHEMBL2208	Homo sapiens	Activity	%	99.0
	2905748	CHEMBL1060141	Percentage MAPKAPK2 activity remaining in the presence of 10uM inhibitor	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	=	Activity	%	100.0	CHEMBL2208	Homo sapiens	Activity	%	100.0
	2905749	CHEMBL1060141	Percentage MAPKAPK2 activity remaining in the presence of 10uM inhibitor	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Activity	%	103.0	CHEMBL2208	Homo sapiens	Activity	%	103.0
	2905750	CHEMBL1060141	Percentage MAPKAPK2 activity remaining in the presence of 10uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	54.0	CHEMBL2208	Homo sapiens	Activity	%	54.0
Antagonist	2905751	CHEMBL1060141	Percentage MAPKAPK2 activity remaining in the presence of 10uM inhibitor	B	CC(=O)c1c(O)c(C)c(O)c(Cc2c(O)c3c(c(C(=O)/C=C/c4ccccc4)c2O)OC(C)(C)C=C3)c1O		CHEMBL34241	=	Activity	%	43.0	CHEMBL2208	Homo sapiens	Activity	%	43.0
	2905752	CHEMBL1060141	Percentage MAPKAPK2 activity remaining in the presence of 10uM inhibitor	B	C[C@H]1CNCCN1S(=O)(=O)c1cccc2cnccc12		CHEMBL1233654	=	Activity	%	82.0	CHEMBL2208	Homo sapiens	Activity	%	82.0
	2905753	CHEMBL1060141	Percentage MAPKAPK2 activity remaining in the presence of 10uM inhibitor	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	Activity	%	85.0	CHEMBL2208	Homo sapiens	Activity	%	85.0
	2905754	CHEMBL1060141	Percentage MAPKAPK2 activity remaining in the presence of 10uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	115.0	CHEMBL2208	Homo sapiens	Activity	%	115.0
	2905755	CHEMBL1060141	Percentage MAPKAPK2 activity remaining in the presence of 10uM inhibitor	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Activity	%	75.0	CHEMBL2208	Homo sapiens	Activity	%	75.0
	2905756	CHEMBL1060141	Percentage MAPKAPK2 activity remaining in the presence of 10uM inhibitor	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Activity	%	91.0	CHEMBL2208	Homo sapiens	Activity	%	91.0
	2905757	CHEMBL1060141	Percentage MAPKAPK2 activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1sc(-c2ccsc2)cc1N		CHEMBL193093	=	Activity	%	97.0	CHEMBL2208	Homo sapiens	Activity	%	97.0
	2905758	CHEMBL1060141	Percentage MAPKAPK2 activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	98.0	CHEMBL2208	Homo sapiens	Activity	%	98.0
	2905759	CHEMBL1060141	Percentage MAPKAPK2 activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	115.0	CHEMBL2208	Homo sapiens	Activity	%	115.0
	2905760	CHEMBL1060141	Percentage MAPKAPK2 activity remaining in the presence of 10uM inhibitor	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Activity	%	89.0	CHEMBL2208	Homo sapiens	Activity	%	89.0
	2905761	CHEMBL1060141	Percentage MAPKAPK2 activity remaining in the presence of 10uM inhibitor	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Activity	%	104.0	CHEMBL2208	Homo sapiens	Activity	%	104.0
	2905762	CHEMBL1060141	Percentage MAPKAPK2 activity remaining in the presence of 10uM inhibitor	B	CC(=O)O[C@H]1[C@H](C)O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H]1OC(C)=O		CHEMBL240954	=	Activity	%	95.0	CHEMBL2208	Homo sapiens	Activity	%	95.0
	2905763	CHEMBL1060141	Percentage MAPKAPK2 activity remaining in the presence of 10uM inhibitor	B	O=C(Nc1cc(Cl)cc2c1[nH]c1cnccc12)c1cccnc1		CHEMBL79004	=	Activity	%	83.0	CHEMBL2208	Homo sapiens	Activity	%	83.0
	2905764	CHEMBL1060141	Percentage MAPKAPK2 activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl.O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL540501	=	Activity	%	106.0	CHEMBL2208	Homo sapiens	Activity	%	106.0
	2905765	CHEMBL1060141	Percentage MAPKAPK2 activity remaining in the presence of 10uM inhibitor	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N		CHEMBL34704	=	Activity	%	95.0	CHEMBL2208	Homo sapiens	Activity	%	95.0
	2905766	CHEMBL1060141	Percentage MAPKAPK2 activity remaining in the presence of 10uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	60.0	CHEMBL2208	Homo sapiens	Activity	%	60.0
	2905767	CHEMBL1051342	Percentage MAPKAPK2 activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Activity	%	105.0	CHEMBL2208	Homo sapiens	Activity	%	105.0
	2905768	CHEMBL1051342	Percentage MAPKAPK2 activity remaining in the presence of 1uM inhibitor	B	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	=	Activity	%	110.0	CHEMBL2208	Homo sapiens	Activity	%	110.0
	2905769	CHEMBL1051342	Percentage MAPKAPK2 activity remaining in the presence of 1uM inhibitor	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Activity	%	99.0	CHEMBL2208	Homo sapiens	Activity	%	99.0
	2905770	CHEMBL1051342	Percentage MAPKAPK2 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	103.0	CHEMBL2208	Homo sapiens	Activity	%	103.0
	2905771	CHEMBL1051342	Percentage MAPKAPK2 activity remaining in the presence of 1uM inhibitor	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	83.0	CHEMBL2208	Homo sapiens	Activity	%	83.0
	2905772	CHEMBL1051342	Percentage MAPKAPK2 activity remaining in the presence of 1uM inhibitor	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	Activity	%	104.0	CHEMBL2208	Homo sapiens	Activity	%	104.0
	2905773	CHEMBL1051342	Percentage MAPKAPK2 activity remaining in the presence of 1uM inhibitor	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Activity	%	118.0	CHEMBL2208	Homo sapiens	Activity	%	118.0
	2905774	CHEMBL1051342	Percentage MAPKAPK2 activity remaining in the presence of 1uM inhibitor	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Activity	%	84.0	CHEMBL2208	Homo sapiens	Activity	%	84.0
	2905775	CHEMBL1051342	Percentage MAPKAPK2 activity remaining in the presence of 1uM inhibitor	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Activity	%	122.0	CHEMBL2208	Homo sapiens	Activity	%	122.0
	2905776	CHEMBL1051342	Percentage MAPKAPK2 activity remaining in the presence of 1uM inhibitor	B	COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O		CHEMBL428496	=	Activity	%	125.0	CHEMBL2208	Homo sapiens	Activity	%	125.0
	2905777	CHEMBL1051342	Percentage MAPKAPK2 activity remaining in the presence of 1uM inhibitor	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Activity	%	97.0	CHEMBL2208	Homo sapiens	Activity	%	97.0
	2905778	CHEMBL1051342	Percentage MAPKAPK2 activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Activity	%	95.0	CHEMBL2208	Homo sapiens	Activity	%	95.0
	2905779	CHEMBL1051342	Percentage MAPKAPK2 activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Activity	%	92.0	CHEMBL2208	Homo sapiens	Activity	%	92.0
	2905780	CHEMBL1051342	Percentage MAPKAPK2 activity remaining in the presence of 1uM inhibitor	B	CC(=O)O.O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL265470	=	Activity	%	95.0	CHEMBL2208	Homo sapiens	Activity	%	95.0
	2905781	CHEMBL1051342	Percentage MAPKAPK2 activity remaining in the presence of 1uM inhibitor	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Activity	%	102.0	CHEMBL2208	Homo sapiens	Activity	%	102.0
	2905782	CHEMBL1051342	Percentage MAPKAPK2 activity remaining in the presence of 1uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	85.0	CHEMBL2208	Homo sapiens	Activity	%	85.0
	2905783	CHEMBL1051342	Percentage MAPKAPK2 activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	Activity	%	110.0	CHEMBL2208	Homo sapiens	Activity	%	110.0
	2905784	CHEMBL1051342	Percentage MAPKAPK2 activity remaining in the presence of 1uM inhibitor	B	CC1=NCCc2c1[nH]c1cc(O)ccc21		CHEMBL129177	=	Activity	%	88.0	CHEMBL2208	Homo sapiens	Activity	%	88.0
	2905785	CHEMBL1051342	Percentage MAPKAPK2 activity remaining in the presence of 1uM inhibitor	B	Cc1nccc2c1[nH]c1ccccc12		CHEMBL12014	=	Activity	%	109.0	CHEMBL2208	Homo sapiens	Activity	%	109.0
	2905786	CHEMBL1051342	Percentage MAPKAPK2 activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c3c([nH]c2c1)C(C)=NCC3		CHEMBL340807	=	Activity	%	89.0	CHEMBL2208	Homo sapiens	Activity	%	89.0
	2905787	CHEMBL1051342	Percentage MAPKAPK2 activity remaining in the presence of 1uM inhibitor	B	Oc1c(Br)cc(C=C2c3cc(I)ccc3NC2O)cc1Br		CHEMBL1794051	=	Activity	%	84.0	CHEMBL2208	Homo sapiens	Activity	%	84.0
	2905788	CHEMBL1051342	Percentage MAPKAPK2 activity remaining in the presence of 1uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	111.0	CHEMBL2208	Homo sapiens	Activity	%	111.0
	2905789	CHEMBL1051342	Percentage MAPKAPK2 activity remaining in the presence of 1uM inhibitor	B	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12		CHEMBL406821	=	Activity	%	93.0	CHEMBL2208	Homo sapiens	Activity	%	93.0
	2905790	CHEMBL1051342	Percentage MAPKAPK2 activity remaining in the presence of 1uM inhibitor	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Activity	%	80.0	CHEMBL2208	Homo sapiens	Activity	%	80.0
	2905791	CHEMBL1051342	Percentage MAPKAPK2 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	117.0	CHEMBL2208	Homo sapiens	Activity	%	117.0
	2905792	CHEMBL1051342	Percentage MAPKAPK2 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Activity	%	72.0	CHEMBL2208	Homo sapiens	Activity	%	72.0
	2905793	CHEMBL1051342	Percentage MAPKAPK2 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	99.0	CHEMBL2208	Homo sapiens	Activity	%	99.0
	2905794	CHEMBL1051342	Percentage MAPKAPK2 activity remaining in the presence of 1uM inhibitor	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Activity	%	108.0	CHEMBL2208	Homo sapiens	Activity	%	108.0
	2905795	CHEMBL1051342	Percentage MAPKAPK2 activity remaining in the presence of 1uM inhibitor	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Activity	%	107.0	CHEMBL2208	Homo sapiens	Activity	%	107.0
Antagonist	2905796	CHEMBL1051342	Percentage MAPKAPK2 activity remaining in the presence of 1uM inhibitor	B	CCCCCCOC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608532	=	Activity	%	43.0	CHEMBL2208	Homo sapiens	Activity	%	43.0
	2905797	CHEMBL1051342	Percentage MAPKAPK2 activity remaining in the presence of 1uM inhibitor	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Activity	%	81.0	CHEMBL2208	Homo sapiens	Activity	%	81.0
	2905798	CHEMBL1051342	Percentage MAPKAPK2 activity remaining in the presence of 1uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	84.0	CHEMBL2208	Homo sapiens	Activity	%	84.0
	2905799	CHEMBL1051342	Percentage MAPKAPK2 activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Activity	%	101.0	CHEMBL2208	Homo sapiens	Activity	%	101.0
	2905800	CHEMBL1063753	Percentage MAPKAPK2 activity remaining in the presence of 25uM inhibitor	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349	=	Activity	%	88.0	CHEMBL2208	Homo sapiens	Activity	%	88.0
	2905801	CHEMBL1063753	Percentage MAPKAPK2 activity remaining in the presence of 25uM inhibitor	B	NCCNS(=O)(=O)c1ccc(Cl)c2ccncc12		CHEMBL489157	=	Activity	%	85.0	CHEMBL2208	Homo sapiens	Activity	%	85.0
	2905802	CHEMBL1052101	Percentage MAPKAPK2 activity remaining in the presence of 2uM inhibitor	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	Activity	%	82.0	CHEMBL2208	Homo sapiens	Activity	%	82.0
	2905803	CHEMBL1063754	Percentage MAPKAPK2 activity remaining in the presence of 3uM inhibitor	B	Cc1ccc(-c2c(C(=O)CF)n(CCCO)c3ncnc(N)c23)cc1		CHEMBL515414	=	Activity	%	94.0	CHEMBL2208	Homo sapiens	Activity	%	94.0
	2921279	CHEMBL1049120	Inhibition of MAPKAPK2 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	100.0	CHEMBL2208	Homo sapiens	Activity	%	100.0
	2924769	CHEMBL1056865	Inhibition of MAPKAPK2 assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c3cc[nH]c3ccc21		CHEMBL567173	=	Activity	%	95.0	CHEMBL2208	Homo sapiens	Activity	%	95.0
	2924770	CHEMBL1056865	Inhibition of MAPKAPK2 assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c2ccc2cc[nH]c21		CHEMBL584980	=	Activity	%	118.0	CHEMBL2208	Homo sapiens	Activity	%	118.0
	2924771	CHEMBL1056865	Inhibition of MAPKAPK2 assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2ccc3c4ccccc4[nH]c3c12		CHEMBL575754	=	Activity	%	95.0	CHEMBL2208	Homo sapiens	Activity	%	95.0
	2924772	CHEMBL1056865	Inhibition of MAPKAPK2 assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2c1ccc1c3ccccc3[nH]c12		CHEMBL583972	=	Activity	%	84.0	CHEMBL2208	Homo sapiens	Activity	%	84.0
	2926213	CHEMBL1050225	Inhibition of MAPKAPK2 assessed as remaining enzyme activity at 3 uM relative to DMSO	B	COc1ccccc1-n1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL574236	=	Activity	%	96.0	CHEMBL2208	Homo sapiens	Activity	%	96.0
	2928399	CHEMBL1060297	Inhibition of MAPKAPK2 assessed as remaining enzyme activity at 1 uM relative to DMSO	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	90.0	CHEMBL2208	Homo sapiens	Activity	%	90.0
	2938487	CHEMBL1041378	Inhibition of MAPKAPK-2 at 1 uM	B	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL583042	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
Not Active	2938589	CHEMBL1040602	Inhibition of MAPKAPK2 at 10 uM	B	O=C1OC(/C=C/c2ccccc2)=N/C1=C\c1cccnc1		CHEMBL565286		Inhibition	%		CHEMBL2208	Homo sapiens	INH		
	2946937	CHEMBL1054417	Inhibition of MAPK2 at 2 uM	B	c1ccc2c(c1)CC(Nc1nc(Nc3ccncc3)nc(N3CCNCC3)n1)C2		CHEMBL575741	<	Inhibition	%	50.0	CHEMBL2208	Homo sapiens	INH	%	50.0
	2978606	CHEMBL1038200	Inhibition of MK2	B	CCOc1ccc(Nc2c(C)c(NCC3CCNC3)c(C#N)c3ccnn23)cc1		CHEMBL566502	=	Activity	uM	1.0	CHEMBL2208	Homo sapiens	Activity	uM	1.0
	2978607	CHEMBL1038200	Inhibition of MK2	B	CCOc1ccc(Nc2c(C)c(N[C@H]3CCCNC3)c(C#N)c3ccnn23)cc1		CHEMBL566499	<	Activity	uM	0.2	CHEMBL2208	Homo sapiens	Activity	uM	0.2
	2978608	CHEMBL1038200	Inhibition of MK2	B	CCOc1ccc(Nc2c(CC)c(N[C@H]3CC[C@H](N)CC3)c(C#N)c3ccnn23)cc1		CHEMBL566935	<	Activity	uM	0.2	CHEMBL2208	Homo sapiens	Activity	uM	0.2
	2978609	CHEMBL1038200	Inhibition of MK2	B	CCOc1ccc(Nc2c(CC)c(N[C@@H]3CCCNC3)c(C#N)c3ccnn23)cc1		CHEMBL582782	<	Activity	uM	0.2	CHEMBL2208	Homo sapiens	Activity	uM	0.2
	2978610	CHEMBL1038200	Inhibition of MK2	B	Cc1c(N[C@@H]2CCCNC2)c(C#N)c2ccnn2c1Nc1ccccc1		CHEMBL567114	<	Activity	uM	0.2	CHEMBL2208	Homo sapiens	Activity	uM	0.2
	2978611	CHEMBL1038200	Inhibition of MK2	B	COCCOc1ccc(Nc2c(C)c(N[C@@H]3CCCNC3)c(C#N)c3ccnn23)cc1		CHEMBL565860	<	Activity	uM	0.2	CHEMBL2208	Homo sapiens	Activity	uM	0.2
	2978612	CHEMBL1038200	Inhibition of MK2	B	Cc1c(N[C@@H]2CCCNC2)c(C#N)c2ccnn2c1Nc1nc2ccccc2s1		CHEMBL585516	<	Activity	uM	0.2	CHEMBL2208	Homo sapiens	Activity	uM	0.2
	2978613	CHEMBL1038200	Inhibition of MK2	B	Cc1c(N[C@@H]2CCCNC2)c(C#N)c2ccnn2c1NCc1nc2ccccc2s1		CHEMBL567129	<	Activity	uM	0.2	CHEMBL2208	Homo sapiens	Activity	uM	0.2
	2978614	CHEMBL1038200	Inhibition of MK2	B	C=CCc1c(N[C@@H]2CCCNC2)c(C#N)c2ccnn2c1Nc1ccc(OCC)cc1		CHEMBL566705	<	Activity	uM	0.2	CHEMBL2208	Homo sapiens	Activity	uM	0.2
	2978615	CHEMBL1038200	Inhibition of MK2	B	CCCc1c(N[C@@H]2CCCNC2)c(C#N)c2ccnn2c1Nc1ccc(OCC)cc1		CHEMBL583018	<	Activity	uM	0.2	CHEMBL2208	Homo sapiens	Activity	uM	0.2
	2978616	CHEMBL1038200	Inhibition of MK2	B	CCOc1ccc(Nc2c(CC(C)C)c(N[C@@H]3CCCNC3)c(C#N)c3ccnn23)cc1		CHEMBL585864	<	Activity	uM	0.2	CHEMBL2208	Homo sapiens	Activity	uM	0.2
	2978617	CHEMBL1038200	Inhibition of MK2	B	CCOc1ccc(Nc2c(CCO)c(N[C@@H]3CCCNC3)c(C#N)c3ccnn23)cc1		CHEMBL568206	<	Activity	uM	0.2	CHEMBL2208	Homo sapiens	Activity	uM	0.2
	2978618	CHEMBL1038200	Inhibition of MK2	B	CCOc1ccc(Nc2c(C)c(N[C@H]3CC[C@H](N)CC3)c(C#N)c3ccnn23)cc1		CHEMBL567162	<	Activity	uM	0.2	CHEMBL2208	Homo sapiens	Activity	uM	0.2
	2978619	CHEMBL1038200	Inhibition of MK2	B	CCOc1ccc(Nc2c(C)c(N[C@H]3CC[C@H](NCC(C)C)CC3)c(C#N)c3ccnn23)cc1		CHEMBL567115	<	Activity	uM	0.2	CHEMBL2208	Homo sapiens	Activity	uM	0.2
	2978620	CHEMBL1038200	Inhibition of MK2	B	CCOc1ccc(Nc2c(C(C)C)c(N[C@H]3CC[C@H](N)CC3)c(C#N)c3ccnn23)cc1		CHEMBL583643	<	Activity	uM	0.2	CHEMBL2208	Homo sapiens	Activity	uM	0.2
	2978621	CHEMBL1038200	Inhibition of MK2	B	CCOc1ccc(Nc2c(C3CC3)c(N[C@H]3CC[C@H](N)CC3)c(C#N)c3ccnn23)cc1		CHEMBL568001	<	Activity	uM	0.2	CHEMBL2208	Homo sapiens	Activity	uM	0.2
	2978622	CHEMBL1038200	Inhibition of MK2	B	COCCOc1ccc(Nc2c(C)c(N[C@H]3CC[C@H](N)CC3)c(C#N)c3ccnn23)cc1		CHEMBL567773	<	Activity	uM	0.2	CHEMBL2208	Homo sapiens	Activity	uM	0.2
	2978623	CHEMBL1038200	Inhibition of MK2	B	Cc1c(N[C@H]2CC[C@H](N)CC2)c(C#N)c2ccnn2c1Nc1ccc(-c2ccccc2)cc1		CHEMBL566063	<	Activity	uM	0.2	CHEMBL2208	Homo sapiens	Activity	uM	0.2
	2978624	CHEMBL1038200	Inhibition of MK2	B	CCOc1ccc(Nc2c(C)c(NC3CCC(N)CC3)c(C#N)c3ccnn23)cc1		CHEMBL585866	<	Activity	uM	0.2	CHEMBL2208	Homo sapiens	Activity	uM	0.2
	2978625	CHEMBL1038200	Inhibition of MK2	B	CCOc1ccc(Nc2c(C3CC3)c(N[C@@H]3CCCNC3)c(C#N)c3ccnn23)cc1		CHEMBL568383	=	Activity	uM	0.2	CHEMBL2208	Homo sapiens	Activity	uM	0.2
	2978626	CHEMBL1038200	Inhibition of MK2	B	CCOc1ccc(Nc2cc(N[C@@H]3CCCNC3)c(C#N)c3ccnn23)cc1		CHEMBL568594	=	Activity	uM	0.2	CHEMBL2208	Homo sapiens	Activity	uM	0.2
	2978627	CHEMBL1038200	Inhibition of MK2	B	CCOc1ccc(Nc2c(-c3ccccc3)c(NC3CCCNC3)c(C#N)c3ccnn23)cc1		CHEMBL566915	=	Activity	uM	0.2	CHEMBL2208	Homo sapiens	Activity	uM	0.2
	2978628	CHEMBL1038200	Inhibition of MK2	B	CCOc1ccc(Nc2c(C)c(NCCN)c(C#N)c3ccnn23)cc1		CHEMBL567334	=	Activity	uM	0.2	CHEMBL2208	Homo sapiens	Activity	uM	0.2
	2978629	CHEMBL1038200	Inhibition of MK2	B	CCOc1ccc(Nc2c(C)c(NCCCN)c(C#N)c3ccnn23)cc1		CHEMBL584101	=	Activity	uM	0.2	CHEMBL2208	Homo sapiens	Activity	uM	0.2
	2978630	CHEMBL1038200	Inhibition of MK2	B	CCOc1ccc(Nc2c(C)c(NCCCCCN)c(C#N)c3ccnn23)cc1		CHEMBL566718	=	Activity	uM	0.2	CHEMBL2208	Homo sapiens	Activity	uM	0.2
	2978631	CHEMBL1038200	Inhibition of MK2	B	CCOc1ccc(Nc2c(C)c(N[C@H]3CC[C@H](NCC4CCCCC4)CC3)c(C#N)c3ccnn23)cc1		CHEMBL585682	=	Activity	uM	0.2	CHEMBL2208	Homo sapiens	Activity	uM	0.2
	2978632	CHEMBL1038200	Inhibition of MK2	B	CCOc1ccc(Nc2c(C)c(N[C@H]3CC[C@H](NCc4ccccc4)CC3)c(C#N)c3ccnn23)cc1		CHEMBL566500	=	Activity	uM	0.2	CHEMBL2208	Homo sapiens	Activity	uM	0.2
	2978633	CHEMBL1038200	Inhibition of MK2	B	CCOc1ccc(Nc2c(C)c(N[C@H]3CC[C@H](NCCc4ccccc4)CC3)c(C#N)c3ccnn23)cc1		CHEMBL566936	=	Activity	uM	0.2	CHEMBL2208	Homo sapiens	Activity	uM	0.2
	2978634	CHEMBL1038200	Inhibition of MK2	B	CCOc1ccc(Nc2c(C)c(N[C@H]3CC[C@H](NCCCc4ccccc4)CC3)c(C#N)c3ccnn23)cc1		CHEMBL582785	=	Activity	uM	0.2	CHEMBL2208	Homo sapiens	Activity	uM	0.2
	2978635	CHEMBL1038200	Inhibition of MK2	B	CCOc1ccc(Nc2c(C)c(NC3CCNCC3)c(C#N)c3ccnn23)cc1		CHEMBL566916	=	Activity	uM	0.2	CHEMBL2208	Homo sapiens	Activity	uM	0.2
	2978636	CHEMBL1038200	Inhibition of MK2	B	N#Cc1c(N[C@H]2CC[C@H](N)CC2)cc(Nc2ccccc2Cl)n2nccc12		CHEMBL570607	=	Activity	uM	0.2	CHEMBL2208	Homo sapiens	Activity	uM	0.2
	2978637	CHEMBL1038200	Inhibition of MK2	B	N#Cc1c(N[C@H]2CC[C@H](N)CC2)cc(Nc2nc3ccccc3s2)n2nccc12		CHEMBL585305	=	Activity	uM	0.2	CHEMBL2208	Homo sapiens	Activity	uM	0.2
	2978638	CHEMBL1038200	Inhibition of MK2	B	Cc1c(N[C@H]2CC[C@H](N)CC2)c(C#N)c2ccnn2c1NOc1ccccc1		CHEMBL567116	=	Activity	uM	0.2	CHEMBL2208	Homo sapiens	Activity	uM	0.2
	2978639	CHEMBL1038200	Inhibition of MK2	B	COCCOc1ccc(Nc2c(C)c(N[C@H]3CCNC3)c(C#N)c3ccnn23)cc1		CHEMBL567127	=	Activity	uM	0.2	CHEMBL2208	Homo sapiens	Activity	uM	0.2
	2978640	CHEMBL1038200	Inhibition of MK2	B	N#Cc1c(N[C@@H]2CCCNC2)cc(Nc2ccccc2Cl)n2nccc12		CHEMBL566492	=	Activity	uM	0.2	CHEMBL2208	Homo sapiens	Activity	uM	0.2
	2978641	CHEMBL1038200	Inhibition of MK2	B	N#Cc1c(N[C@@H]2CCCNC2)cc(Nc2ccc(-c3ccccc3)cc2)n2nccc12		CHEMBL566493	=	Activity	uM	0.2	CHEMBL2208	Homo sapiens	Activity	uM	0.2
	2978642	CHEMBL1038200	Inhibition of MK2	B	CCOc1ccc(Nc2c(C)c(NC3CCC(NCc4ccccc4)CC3)c(C#N)c3ccnn23)cc1		CHEMBL567999	=	Activity	uM	0.2	CHEMBL2208	Homo sapiens	Activity	uM	0.2
	2978643	CHEMBL1038200	Inhibition of MK2	B	CCOc1ccc(Nc2c(C)c(OC3CCC(N)CC3)nc3ccnn23)cc1		CHEMBL566710	=	Activity	uM	0.2	CHEMBL2208	Homo sapiens	Activity	uM	0.2
	2978644	CHEMBL1038200	Inhibition of MK2	B	CCOc1ccc(Nc2c(C)c(NCC3CCCN3)c(C#N)c3ccnn23)cc1		CHEMBL583891	=	Activity	uM	1.0	CHEMBL2208	Homo sapiens	Activity	uM	1.0
	2978645	CHEMBL1038200	Inhibition of MK2	B	CCOc1ccc(Nc2c(C)c(NCC3CCCCN3)c(C#N)c3ccnn23)cc1		CHEMBL566703	=	Activity	uM	1.0	CHEMBL2208	Homo sapiens	Activity	uM	1.0
	2978646	CHEMBL1038200	Inhibition of MK2	B	CCOc1ccc(Nc2c(C)c(NCC3CCCNC3)c(C#N)c3ccnn23)cc1		CHEMBL566704	=	Activity	uM	1.0	CHEMBL2208	Homo sapiens	Activity	uM	1.0
	2978647	CHEMBL1038200	Inhibition of MK2	B	CCOc1ccc(Nc2c(C)c(NCCCNC3CCCCC3)c(C#N)c3ccnn23)cc1		CHEMBL566719	=	Activity	uM	1.0	CHEMBL2208	Homo sapiens	Activity	uM	1.0
	2978648	CHEMBL1038200	Inhibition of MK2	B	CCOc1ccc(Nc2c(C)c(NCCC3CCCN3)c(C#N)c3ccnn23)cc1		CHEMBL566937	=	Activity	uM	1.0	CHEMBL2208	Homo sapiens	Activity	uM	1.0
	2978649	CHEMBL1038200	Inhibition of MK2	B	CCOc1ccc(Nc2c(C)c(NC3CNCc4ccccc43)c(C#N)c3ccnn23)cc1		CHEMBL567148	=	Activity	uM	1.0	CHEMBL2208	Homo sapiens	Activity	uM	1.0
	2978650	CHEMBL1038200	Inhibition of MK2	B	CCOc1ccc(Nc2c(C)c(NC3CCCC(N)C3)c(C#N)c3ccnn23)cc1		CHEMBL568000	=	Activity	uM	1.0	CHEMBL2208	Homo sapiens	Activity	uM	1.0
	2978651	CHEMBL1038200	Inhibition of MK2	B	CCOc1ccc(Nc2c(C)c(OC3CCCNC3)nc3ccnn23)cc1		CHEMBL577055	=	Activity	uM	1.0	CHEMBL2208	Homo sapiens	Activity	uM	1.0
	2978652	CHEMBL1038200	Inhibition of MK2	B	CCOc1ccc(Nc2c(C)c(N[C@@H]3CCCC[C@H]3N)c(C#N)c3ccnn23)cc1		CHEMBL567369	=	Activity	uM	10.0	CHEMBL2208	Homo sapiens	Activity	uM	10.0
	2978653	CHEMBL1038200	Inhibition of MK2	B	CCOc1ccc(Nc2c(C)c(NCCC3CCCCN3)c(C#N)c3ccnn23)cc1		CHEMBL582987	=	Activity	uM	10.0	CHEMBL2208	Homo sapiens	Activity	uM	10.0
	2978654	CHEMBL1038200	Inhibition of MK2	B	CCOc1ccc(Nc2c(C)c(NCCCCCCN)c(C#N)c3ccnn23)cc1		CHEMBL585680	=	Activity	uM	10.0	CHEMBL2208	Homo sapiens	Activity	uM	10.0
	2978655	CHEMBL1038200	Inhibition of MK2	B	CCOc1ccc(Nc2c(C)c(NCCC3CCCN3C)c(C#N)c3ccnn23)cc1		CHEMBL567149	=	Activity	uM	10.0	CHEMBL2208	Homo sapiens	Activity	uM	10.0
	2978656	CHEMBL1038200	Inhibition of MK2	B	CCOc1ccc(Nc2c(C)c(NC3CCCCC3N)c(C#N)c3ccnn23)cc1		CHEMBL568595	=	Activity	uM	10.0	CHEMBL2208	Homo sapiens	Activity	uM	10.0
	2978657	CHEMBL1038200	Inhibition of MK2	B	CCOc1ccc(Nc2c(C)c(OCCN)nc3ccnn23)cc1		CHEMBL567984	=	Activity	uM	10.0	CHEMBL2208	Homo sapiens	Activity	uM	10.0
	2978658	CHEMBL1038200	Inhibition of MK2	B	NC(=O)n1ncc2ccccc21		CHEMBL570840	<	Activity	uM	150.0	CHEMBL2208	Homo sapiens	Activity	uM	150.0
	2978659	CHEMBL1038200	Inhibition of MK2	B	c1ccn2nccc2c1		CHEMBL577543	<	Activity	uM	0.2	CHEMBL2208	Homo sapiens	Activity	uM	0.2
	2983219	CHEMBL1046252	Inhibition of MK2	B	CC1(C)CC(NC(=O)c2cccc(-c3cc4nccc(Nc5cccc(O)c5)n4n3)c2)CC(C)(C)N1[O]		CHEMBL1163016	>	IC50	nM	50000.0	CHEMBL2208	Homo sapiens	IC50	uM	50.0
	2992226	CHEMBL1044529	Inhibition of human MAPKAPK2 at 20 uM by FRET assay	B	C#Cn1c(C#CCCO)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL576620	=	Inhibition	%	3.0	CHEMBL2208	Homo sapiens	INH	%	3.0
	2999005	CHEMBL1041977	Inhibition of MAPKAPK2 assessed as residual activity at 10 uM by Cherenkov counting relative to control in presence of 20 uM ATP	B	CC(C)c1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL220227	=	Activity	%	105.0	CHEMBL2208	Homo sapiens	Activity	%	105.0
	2999795	CHEMBL1041977	Inhibition of MAPKAPK2 assessed as residual activity at 10 uM by Cherenkov counting relative to control in presence of 20 uM ATP	B	CC(C)c1noc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL375428	=	Activity	%	100.0	CHEMBL2208	Homo sapiens	Activity	%	100.0
	2999872	CHEMBL1049874	Inhibition of MAPKAPK2 assessed as residual activity at 0.1 uM by Cherenkov counting relative to control in presence of 20 uM ATP	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL569114	=	Activity	%	82.0	CHEMBL2208	Homo sapiens	Activity	%	82.0
	2999948	CHEMBL1049874	Inhibition of MAPKAPK2 assessed as residual activity at 0.1 uM by Cherenkov counting relative to control in presence of 20 uM ATP	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c([S+](C)[O-])nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL572006	=	Activity	%	78.0	CHEMBL2208	Homo sapiens	Activity	%	78.0
	3001933	CHEMBL1047197	Inhibition of MK2	B	Cc1c(Nc2c(C#N)cncc2-c2cc3cc(CN4CCN(C)CC4)ccc3o2)ccc2[nH]ccc12		CHEMBL571581	>	IC50	nM	9000.0	CHEMBL2208	Homo sapiens	IC50	uM	9.0
Not Active	3006199	CHEMBL1047299	Inhibition of MAPKAP-K2 at 10 uM	B	CCCc1cc(N2CCC(N)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL578601		Activity			CHEMBL2208	Homo sapiens	Activity		
Not Active	3006200	CHEMBL1047299	Inhibition of MAPKAP-K2 at 10 uM	B	CCCc1cc(N2CCNCC2)nc2sc(C(N)=O)c(N)c12		CHEMBL568922		Activity			CHEMBL2208	Homo sapiens	Activity		
Not Active	3006201	CHEMBL1047299	Inhibition of MAPKAP-K2 at 10 uM	B	CCCc1cc(N2CCC(O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL576887		Activity			CHEMBL2208	Homo sapiens	Activity		
Not Active	3006202	CHEMBL1047299	Inhibition of MAPKAP-K2 at 10 uM	B	CCCc1cc(N2CCCC(O)C2)nc2sc(C(N)=O)c(N)c12		CHEMBL576989		Activity			CHEMBL2208	Homo sapiens	Activity		
	3011620	CHEMBL1037494	Inhibition of MK2	B	C#Cc1cccc(-c2ccc(CN3CCN(C)CC3)o2)c1Cc1ccc2c(c1C)C=CC2		CHEMBL570865	>	IC50	nM	5000.0	CHEMBL2208	Homo sapiens	IC50	uM	5.0
	3018991	CHEMBL1039943	Inhibition of MK2	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2cccc(OCCN3CCN(C)CC3)c2)ccc2[nH]ccc12		CHEMBL567124	>	IC50	nM	8000.0	CHEMBL2208	Homo sapiens	IC50	uM	8.0
	3062482	CHEMBL1037969	Binding affinity to human MAPKAPK2 at 200 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CSSC[C@@H](C(=O)NCC(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595545	=	Activity	%	100.0	CHEMBL2208	Homo sapiens	Activity	%	100.0
	3063617	CHEMBL1074883	Binding affinity to human MAPKAPK2 at 500 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(N)=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595546	=	Activity	%	100.0	CHEMBL2208	Homo sapiens	Activity	%	100.0
	3063707	CHEMBL1040859	Binding affinity to human MAPKAPK2 at 50 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CNC(=O)C[C@@H](C(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL609010	=	Activity	%	100.0	CHEMBL2208	Homo sapiens	Activity	%	100.0
	3066862	CHEMBL1066068	Inhibition of MAPKAPK2 at 10 uM	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	3066952	CHEMBL1066068	Inhibition of MAPKAPK2 at 10 uM	B	O=C1Nc2ccccc2/C1=C1\C(=O)N(CCCc2ccccc2)c2ccccc21		CHEMBL607196	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	3083424	CHEMBL1071871	Inhibition of human recombinant phospho-MK2 (36-400) by HTRF assay	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O		CHEMBL14249	=	IC50	nM	2800.0	CHEMBL2208	Homo sapiens	IC50	uM	2.8
	3083425	CHEMBL1071872	Displacement of [8-3H]ATP from human recombinant MK2 (36-400) by scintillation proximity assay	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O		CHEMBL14249	=	IC50	nM	6300.0	CHEMBL2208	Homo sapiens	IC50	uM	6.3
	3083426	CHEMBL1071873	Displacement of [8-3H]ATP from human recombinant MK2 (41-364) by scintillation proximity assay	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O		CHEMBL14249	=	IC50	nM	12000.0	CHEMBL2208	Homo sapiens	IC50	uM	12.0
	3083427	CHEMBL1071870	Displacement of [8-3H]ATP from human recombinant phospho-MK2 (36-400) by scintillation proximity assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	700.0	CHEMBL2208	Homo sapiens	IC50	uM	0.7
	3083428	CHEMBL1071871	Inhibition of human recombinant phospho-MK2 (36-400) by HTRF assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	660.0	CHEMBL2208	Homo sapiens	IC50	uM	0.66
	3083429	CHEMBL1071872	Displacement of [8-3H]ATP from human recombinant MK2 (36-400) by scintillation proximity assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1700.0	CHEMBL2208	Homo sapiens	IC50	uM	1.7
	3083430	CHEMBL1071873	Displacement of [8-3H]ATP from human recombinant MK2 (41-364) by scintillation proximity assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	3400.0	CHEMBL2208	Homo sapiens	IC50	uM	3.4
	3084337	CHEMBL1072653	Inhibition of MK2	B	Nc1nccc(Nc2ccc3[nH]ncc3c2)n1		CHEMBL584423	=	IC50	nM	24000.0	CHEMBL2208	Homo sapiens	IC50	uM	24.0
	3084338	CHEMBL1072653	Inhibition of MK2	B	Nc1nccc(Nc2ccc3[nH]nc(I)c3c2)n1		CHEMBL584617	=	IC50	nM	14000.0	CHEMBL2208	Homo sapiens	IC50	uM	14.0
	3084339	CHEMBL1072653	Inhibition of MK2	B	Nc1nccc(Nc2cc(-c3ccsc3)c3[nH]ncc3c2)n1		CHEMBL591328	=	IC50	nM	5400.0	CHEMBL2208	Homo sapiens	IC50	uM	5.4
	3084340	CHEMBL1072653	Inhibition of MK2	B	Nc1nccc(Nc2cc(-c3ccc4ccccc4c3)c3[nH]ncc3c2)n1		CHEMBL589650	=	IC50	nM	720.0	CHEMBL2208	Homo sapiens	IC50	uM	0.72
	3084341	CHEMBL1072653	Inhibition of MK2	B	Nc1nccc(Nc2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)n1		CHEMBL591305	=	IC50	nM	1600.0	CHEMBL2208	Homo sapiens	IC50	uM	1.6
	3084342	CHEMBL1072653	Inhibition of MK2	B	Nc1nccc(Nc2cc(-c3cc4ccccc4o3)c3[nH]ncc3c2)n1		CHEMBL590110	=	IC50	nM	1300.0	CHEMBL2208	Homo sapiens	IC50	uM	1.3
	3084343	CHEMBL1072653	Inhibition of MK2	B	Nc1nccc(Nc2cc(I)c3[nH]ncc3c2)n1		CHEMBL585958	=	IC50	nM	9100.0	CHEMBL2208	Homo sapiens	IC50	uM	9.1
	3084344	CHEMBL1072653	Inhibition of MK2	B	Nc1nccc(Nc2ccc3[nH]nc(-c4ccsc4)c3c2)n1		CHEMBL589626	=	IC50	nM	3400.0	CHEMBL2208	Homo sapiens	IC50	uM	3.4
	3084345	CHEMBL1072653	Inhibition of MK2	B	Nc1nccc(Nc2ccc3[nH]nc(-c4ccc5ccccc5c4)c3c2)n1		CHEMBL590834	=	IC50	nM	310.0	CHEMBL2208	Homo sapiens	IC50	uM	0.31
	3084346	CHEMBL1072653	Inhibition of MK2	B	Nc1nccc(Nc2ccc3[nH]nc(-c4cc5ccccc5s4)c3c2)n1		CHEMBL600081	=	IC50	nM	160.0	CHEMBL2208	Homo sapiens	IC50	uM	0.16
	3084347	CHEMBL1072653	Inhibition of MK2	B	Nc1nccc(Nc2ccc3[nH]nc(-c4ccc[nH]4)c3c2)n1		CHEMBL592288	=	IC50	nM	160.0	CHEMBL2208	Homo sapiens	IC50	uM	0.16
	3084348	CHEMBL1072653	Inhibition of MK2	B	Nc1ncc2[nH]cc(-c3ccc4[nH]ncc4c3)c2n1		CHEMBL591071	=	IC50	nM	1400.0	CHEMBL2208	Homo sapiens	IC50	uM	1.4
	3084349	CHEMBL1072653	Inhibition of MK2	B	Nc1ncc2[nH]cc(-c3cc(-c4cc5ccccc5s4)c4[nH]ncc4c3)c2n1		CHEMBL591797	=	IC50	nM	56.0	CHEMBL2208	Homo sapiens	IC50	uM	0.056
	3084350	CHEMBL1072653	Inhibition of MK2	B	Nc1ncc2ccn(-c3ccc4[nH]ncc4c3)c2n1		CHEMBL584640	=	IC50	nM	49000.0	CHEMBL2208	Homo sapiens	IC50	uM	49.0
	3084351	CHEMBL1072653	Inhibition of MK2	B	Cn1cc(-c2ccc3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL589853	=	IC50	nM	1900.0	CHEMBL2208	Homo sapiens	IC50	uM	1.9
	3084352	CHEMBL1072653	Inhibition of MK2	B	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	=	IC50	nM	19.0	CHEMBL2208	Homo sapiens	IC50	uM	0.019
	3084353	CHEMBL1072653	Inhibition of MK2	B	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	=	IC50	nM	35.0	CHEMBL2208	Homo sapiens	IC50	uM	0.035
	3084354	CHEMBL1072653	Inhibition of MK2	B	NCCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL591329	=	IC50	nM	260.0	CHEMBL2208	Homo sapiens	IC50	uM	0.26
	3084355	CHEMBL1072653	Inhibition of MK2	B	Nc1ncc2c(n1)c(-c1cc(-c3cc4ccccc4s3)c3[nH]ncc3c1)cn2CCC1CCNCC1		CHEMBL592031	=	IC50	nM	960.0	CHEMBL2208	Homo sapiens	IC50	uM	0.96
	3084356	CHEMBL1072653	Inhibition of MK2	B	Nc1ncc2c(n1)c(-c1cc(-c3cc4ccccc4s3)c3[nH]ncc3c1)cn2CCCO		CHEMBL590612	=	IC50	nM	37.0	CHEMBL2208	Homo sapiens	IC50	uM	0.037
	3084357	CHEMBL1072653	Inhibition of MK2	B	COCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL591783	=	IC50	nM	820.0	CHEMBL2208	Homo sapiens	IC50	uM	0.82
	3084358	CHEMBL1072653	Inhibition of MK2	B	Nc1ncc2c(n1)c(-c1cc(-c3cc4ccccc4s3)c3[nH]ncc3c1)cn2CC(=O)O		CHEMBL596588	=	IC50	nM	1900.0	CHEMBL2208	Homo sapiens	IC50	uM	1.9
	3084359	CHEMBL1072653	Inhibition of MK2	B	Nc1ncc2c(n1)c(-c1cc(-c3cc4ccccc4s3)c3[nH]ncc3c1)cn2CCC(=O)O		CHEMBL594090	=	IC50	nM	20.0	CHEMBL2208	Homo sapiens	IC50	uM	0.02
	3084360	CHEMBL1072653	Inhibition of MK2	B	NC(=O)CCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL603322	=	IC50	nM	41.0	CHEMBL2208	Homo sapiens	IC50	uM	0.041
	3084361	CHEMBL1072653	Inhibition of MK2	B	Nc1ncc2c(n1)c(-c1cc(-c3cc4ccccc4s3)c3[nH]ncc3c1)cn2C1C=CC=C1		CHEMBL605922	>	IC50	nM	50000.0	CHEMBL2208	Homo sapiens	IC50	uM	50.0
	3084362	CHEMBL1072653	Inhibition of MK2	B	CC(C)n1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL595933	=	IC50	nM	490.0	CHEMBL2208	Homo sapiens	IC50	uM	0.49
	3089491	CHEMBL1067361	Inhibition of MK2	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CCC[C@@H](N)C2)ccc2[nH]ccc12		CHEMBL606245	=	IC50	nM	22000.0	CHEMBL2208	Homo sapiens	IC50	nM	22000.0
	3094766	CHEMBL1068403	Inhibition of MAPKAPK2 at 1 uM by microfluidic substrate phosphorylation assay	B	NCCNC(=O)c1cc(-c2ccsc2)cnc1N		CHEMBL610226	=	Inhibition	%	2.0	CHEMBL2208	Homo sapiens	INH	%	2.0
	3094791	CHEMBL1068403	Inhibition of MAPKAPK2 at 1 uM by microfluidic substrate phosphorylation assay	B	NCCNC(=O)c1cc(-c2scc3c2OCCO3)cnc1N		CHEMBL599171	=	Inhibition	%	12.0	CHEMBL2208	Homo sapiens	INH	%	12.0
	3094794	CHEMBL1068403	Inhibition of MAPKAPK2 at 1 uM by microfluidic substrate phosphorylation assay	B	NC(=O)c1ccc(-c2cc(-c3cccc4c3OCO4)cnc2N)cc1		CHEMBL590335	=	Inhibition	%	16.0	CHEMBL2208	Homo sapiens	INH	%	16.0
	3094805	CHEMBL1068403	Inhibition of MAPKAPK2 at 1 uM by microfluidic substrate phosphorylation assay	B	NC(=O)c1ccc(-c2cc(-c3scc4c3OCCO4)cnc2N)cc1		CHEMBL602931	=	Inhibition	%	22.0	CHEMBL2208	Homo sapiens	INH	%	22.0
	3110832	CHEMBL1071091	Inhibition of human MK2 by FRET assay	B	COc1ccc(-c2cc(-c3cc4c(=O)[nH]cnc4[nH]3)ccn2)cc1		CHEMBL455396	=	IC50	nM	540.0	CHEMBL2208	Homo sapiens	IC50	uM	0.54
	3110833	CHEMBL1071091	Inhibition of human MK2 by FRET assay	B	COc1ccc(-n2cc(-c3ccc(C(N)=O)cc3)cn2)cc1		CHEMBL598506	=	IC50	nM	22600.0	CHEMBL2208	Homo sapiens	IC50	uM	22.6
	3110834	CHEMBL1071091	Inhibition of human MK2 by FRET assay	B	COc1ccc(-n2cc(-c3ccc(C(N)=O)cc3)c(N)n2)cc1		CHEMBL598237	=	IC50	nM	2000.0	CHEMBL2208	Homo sapiens	IC50	uM	2.0
	3110835	CHEMBL1071091	Inhibition of human MK2 by FRET assay	B	COc1ccc(-n2ncc(-c3ccc(C(N)=O)cc3)c2N)cc1		CHEMBL598449	=	IC50	nM	22500.0	CHEMBL2208	Homo sapiens	IC50	uM	22.5
	3110836	CHEMBL1071091	Inhibition of human MK2 by FRET assay	B	COc1ccc(-n2cc(-c3ccc(C#N)cc3)c(N)n2)cc1		CHEMBL597628	=	IC50	nM	31200.0	CHEMBL2208	Homo sapiens	IC50	uM	31.2
	3110837	CHEMBL1071091	Inhibition of human MK2 by FRET assay	B	COc1ccc(-n2cc(-c3ccc(S(N)(=O)=O)cc3)c(N)n2)cc1		CHEMBL597629	=	IC50	nM	15400.0	CHEMBL2208	Homo sapiens	IC50	uM	15.4
	3110838	CHEMBL1071091	Inhibition of human MK2 by FRET assay	B	COc1ccc(-n2cc(-c3ccc4c(c3)CNC4=O)c(N)n2)cc1		CHEMBL590491	=	IC50	nM	6000.0	CHEMBL2208	Homo sapiens	IC50	uM	6.0
	3110839	CHEMBL1071091	Inhibition of human MK2 by FRET assay	B	COc1ccc(-n2cc(-c3ccc4c(c3)C(=O)NCC4)c(N)n2)cc1		CHEMBL610780	=	IC50	nM	84.0	CHEMBL2208	Homo sapiens	IC50	uM	0.084
	3110840	CHEMBL1071091	Inhibition of human MK2 by FRET assay	B	COc1ccc(-n2cc(-c3ccc4c(c3)C(=O)NCCC4)c(N)n2)cc1		CHEMBL599478	=	IC50	nM	1100.0	CHEMBL2208	Homo sapiens	IC50	uM	1.1
	3110841	CHEMBL1071091	Inhibition of human MK2 by FRET assay	B	COc1ccc(-n2cc(-c3ccc4c(c3)C(=O)NCCO4)c(N)n2)cc1		CHEMBL599479	=	IC50	nM	350.0	CHEMBL2208	Homo sapiens	IC50	uM	0.35
	3110842	CHEMBL1071091	Inhibition of human MK2 by FRET assay	B	Nc1nn(-c2cccc(-c3cccc(O)c3)c2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL603694	=	IC50	nM	180.0	CHEMBL2208	Homo sapiens	IC50	uM	0.18
	3110843	CHEMBL1071091	Inhibition of human MK2 by FRET assay	B	COc1cccc(-c2cccc(-n3cc(-c4ccc5c(c4)CCNC5=O)c(N)n3)c2)c1		CHEMBL599682	=	IC50	nM	180.0	CHEMBL2208	Homo sapiens	IC50	uM	0.18
	3110844	CHEMBL1071091	Inhibition of human MK2 by FRET assay	B	CS(=O)(=O)Nc1cccc(-c2cccc(-n3cc(-c4ccc5c(c4)CCNC5=O)c(N)n3)c2)c1		CHEMBL605125	=	IC50	nM	180.0	CHEMBL2208	Homo sapiens	IC50	uM	0.18
	3110845	CHEMBL1071091	Inhibition of human MK2 by FRET assay	B	Nc1nn(-c2cccc(-c3ccc4nc[nH]c4c3)c2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL597640	=	IC50	nM	82.0	CHEMBL2208	Homo sapiens	IC50	uM	0.082
	3110846	CHEMBL1071091	Inhibition of human MK2 by FRET assay	B	Nc1nn(-c2cccc(-c3ccc4cc[nH]c4c3)c2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL597839	=	IC50	nM	61.0	CHEMBL2208	Homo sapiens	IC50	uM	0.061
	3110847	CHEMBL1071091	Inhibition of human MK2 by FRET assay	B	Cn1ccc2ccc(-c3cccc(-n4cc(-c5ccc6c(c5)CCNC6=O)c(N)n4)c3)cc21		CHEMBL604510	=	IC50	nM	290.0	CHEMBL2208	Homo sapiens	IC50	uM	0.29
	3110848	CHEMBL1071091	Inhibition of human MK2 by FRET assay	B	Nc1nn(-c2cccc(-c3ccc4c(c3)NC(=O)C4)c2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL598324	=	IC50	nM	220.0	CHEMBL2208	Homo sapiens	IC50	uM	0.22
	3117935	CHEMBL1072211	Inhibition of MAPKAPK2	B	CC(=O)N1CCC(Nc2ncc3c(n2)-c2c(c(C(N)=O)nn2C)CC3)CC1		CHEMBL599224	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	3117988	CHEMBL1072211	Inhibition of MAPKAPK2	B	Cn1nc(C(N)=O)c2c1-c1nc(NC3CCN(C(=O)c4ccccc4)CC3)ncc1CC2		CHEMBL599428	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	3118041	CHEMBL1072211	Inhibition of MAPKAPK2	B	CNC(=O)c1nn(C)c2c1CCc1cnc(NC3CCN(C(=O)C4CCN(S(C)(=O)=O)CC4)CC3)nc1-2		CHEMBL597754	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	3127300	CHEMBL1074378	Inhibition of MAPKAPK2 at 1 uM	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL263664	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	3127319	CHEMBL1074378	Inhibition of MAPKAPK2 at 1 uM	B	CC(C)(C)c1ccc(CC2(N)CCN(c3ncnc4[nH]ccc34)CC2)cc1		CHEMBL597211	=	Inhibition	%	1.0	CHEMBL2208	Homo sapiens	INH	%	1.0
	3127338	CHEMBL1074378	Inhibition of MAPKAPK2 at 1 uM	B	NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL598194	=	Inhibition	%	25.0	CHEMBL2208	Homo sapiens	INH	%	25.0
	3127422	CHEMBL1064440	Inhibition of MAPKAPK2 by scintillation proximity assay	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	3127456	CHEMBL1064440	Inhibition of MAPKAPK2 by scintillation proximity assay	B	CC(C)(C)C(=O)N1Cc2c(NC(=O)c3cc(F)cc(F)c3)n[nH]c2C1(C)C		CHEMBL604712	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	3130803	CHEMBL1065090	Inhibition of MAPKAPK2 at 3 to 6 uM relative to control	B	COc1ccc(C(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1OC		CHEMBL604087	>	Inhibition	%	50.0	CHEMBL2208	Homo sapiens	INH	%	50.0
	3131761	CHEMBL1065765	Inhibition of MAPKAPK2 at 3 uM relative to control	B	NC(=O)c1ccc(NC(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1		CHEMBL600852	>	Inhibition	%	50.0	CHEMBL2208	Homo sapiens	INH	%	50.0
	3213957	CHEMBL1116705	Inhibition of MAPKAPK2 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	-2.0	CHEMBL2208	Homo sapiens	INH	%	-2.0
	3219870	CHEMBL1113988	Inhibition of MK2	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2cccc(S(=O)(=O)N3CCN(C)CC3)c2)ccc2[nH]ccc12		CHEMBL1080994	>	IC50	nM	50000.0	CHEMBL2208	Homo sapiens	IC50	nM	50000.0
	3219871	CHEMBL1113988	Inhibition of MK2	B	Cc1ncc(C#N)c(Nc2ccc3[nH]ccc3c2C)c1/C=C/c1cccc(S(=O)(=O)N2CCN(C)CC2)c1		CHEMBL1080995	>	IC50	nM	50000.0	CHEMBL2208	Homo sapiens	IC50	nM	50000.0
	3220010	CHEMBL1115859	Inhibition of MK2	B	CN1C[C@@H]2C[C@H]1CN2c1ccc(-c2ccnc3c(-c4cccc(O)c4)c(-c4ccncc4)nn23)cc1		CHEMBL1087650	=	IC50	nM	17100.0	CHEMBL2208	Homo sapiens	IC50	uM	17.1
	3224878	CHEMBL1100956	Inhibition of MAPKAPK2 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL2208	Homo sapiens	INH	%	50.0
	3225128	CHEMBL1100956	Inhibition of MAPKAPK2 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL2208	Homo sapiens	INH	%	50.0
	3228115	CHEMBL1114827	Inhibition of MK2	B	CN(C)Cc1ccc(-c2cnn3c(-c4cccc(NC(=O)c5cccc(C(F)(F)F)c5)c4)ccnc23)cc1		CHEMBL1087397	>	IC50	nM	2000.0	CHEMBL2208	Homo sapiens	IC50	uM	2.0
	3230726	CHEMBL1100030	Inhibition of GST-tagged MAPKAPK2 assessed as [33P] incorporation after 40 mins by scintillation proximity assay	B	CC(C)=CCC/C(C)=C/C[C@]12C(=O)C(C(=O)c3ccc(O)c(O)c3)=C(O)[C@](C/C=C(\C)CCC=C(C)C)(C[C@@H](CC=C(C)C)C1(C)C)C2=O		CHEMBL1078219	=	IC50	nM	22000.0	CHEMBL2208	Homo sapiens	IC50	uM	22.0
	3230727	CHEMBL1100030	Inhibition of GST-tagged MAPKAPK2 assessed as [33P] incorporation after 40 mins by scintillation proximity assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	150.0	CHEMBL2208	Homo sapiens	IC50	uM	0.15
	3230728	CHEMBL1100030	Inhibition of GST-tagged MAPKAPK2 assessed as [33P] incorporation after 40 mins by scintillation proximity assay	B	CC(C)=CCC/C(C)=C/C[C@]12C[C@@H](CC=C(C)C)[C@](C)(CCC=C(C)C)[C@](CC=C(C)C)(C(=O)C(C(=O)c3ccc(O)c(O)c3)=C1O)C2=O		CHEMBL1078220	=	IC50	nM	22000.0	CHEMBL2208	Homo sapiens	IC50	uM	22.0
	3242222	CHEMBL1111608	Inhibition of MK2	B	CC(C)N1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(C5CCOCC5)nc(N5C6CCC5COC6)n4)cc3)cc2)CC1		CHEMBL1091356	<	IC50	nM	50000.0	CHEMBL2208	Homo sapiens	IC50	uM	50.0
	3251258	CHEMBL1107913	Inhibition of MK2	B	Cn1cc(/C=C2\Oc3cccc(O)c3C2=O)c2c(-c3ccc(C(=O)NCCO)cc3)ccnc21		CHEMBL1092754	=	IC50	nM	6.5	CHEMBL2208	Homo sapiens	IC50	nM	6.5
	3251635	CHEMBL1104503	Inhibition of LPS-induced MK2 phosphorylation in human whole blood treated 30 mins before LPS challenge measured after 45 mins by FACS analysis	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cc2cnn(-c3ccc(F)cc3F)c2n(C)c1=O		CHEMBL1091199	=	IC50	nM	5.7	CHEMBL2208	Homo sapiens	IC50	nM	5.7
	3251636	CHEMBL1104503	Inhibition of LPS-induced MK2 phosphorylation in human whole blood treated 30 mins before LPS challenge measured after 45 mins by FACS analysis	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cc2cnn(-c3c(F)cccc3F)c2n(C)c1=O		CHEMBL1089865	=	IC50	nM	4.3	CHEMBL2208	Homo sapiens	IC50	nM	4.3
	3251637	CHEMBL1104503	Inhibition of LPS-induced MK2 phosphorylation in human whole blood treated 30 mins before LPS challenge measured after 45 mins by FACS analysis	B	Cn1c(=O)c(-c2cc(C(=O)NC3CC3)ccc2Cl)cc2cnn(-c3c(F)cccc3F)c21		CHEMBL1091928	=	IC50	nM	7.0	CHEMBL2208	Homo sapiens	IC50	nM	7.0
	3260038	CHEMBL1104350	Inhibition of MAPKAP-K2 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2nccc(Nc3cccc(Br)c3)c2c1		CHEMBL1089524	=	Activity	%	86.0	CHEMBL2208	Homo sapiens	Activity	%	86.0
	3260511	CHEMBL1109846	Inhibition of MK2	B	O=C(Nc1cccc(-c2ccnc3cc(-c4ccncc4)nn23)c1)c1cccc(C(F)(F)F)c1		CHEMBL1089082	>	IC50	nM	50000.0	CHEMBL2208	Homo sapiens	IC50	uM	50.0
	3261146	CHEMBL1112577	Inhibition of MAPKAPK2 at 10 uM	B	O=C1OC(c2ccccc2)=N/C1=C\c1cccnc1		CHEMBL579387	=	Inhibition	%	5.0	CHEMBL2208	Homo sapiens	INH	%	5.0
	3261147	CHEMBL1112577	Inhibition of MAPKAPK2 at 10 uM	B	Cc1cccc(C2=N/C(=C\c3cccnc3)C(=O)O2)c1		CHEMBL1091786	=	Inhibition	%	3.0	CHEMBL2208	Homo sapiens	INH	%	3.0
Not Determined	3261148	CHEMBL1112577	Inhibition of MAPKAPK2 at 10 uM	B	O=C1OC(c2ccc(Cl)cc2)=N/C1=C\c1cccnc1		CHEMBL1091787		Inhibition	%		CHEMBL2208	Homo sapiens	INH		
	3261149	CHEMBL1112577	Inhibition of MAPKAPK2 at 10 uM	B	O=C1OC(/C=C/c2ccccc2)=N/C1=C\c1cccnc1		CHEMBL565286	=	Inhibition	%	46.0	CHEMBL2208	Homo sapiens	INH	%	46.0
Not Determined	3261150	CHEMBL1112577	Inhibition of MAPKAPK2 at 10 uM	B	O=C1OC(c2ccc(F)c(F)c2)=N/C1=C\c1cccnc1		CHEMBL1091764		Inhibition	%		CHEMBL2208	Homo sapiens	INH		
	3261151	CHEMBL1112577	Inhibition of MAPKAPK2 at 10 uM	B	Cc1cc(C2=N/C(=C\c3cccnc3)C(=O)O2)ccc1Br		CHEMBL1091766	=	Inhibition	%	2.0	CHEMBL2208	Homo sapiens	INH	%	2.0
	3261432	CHEMBL1104350	Inhibition of MAPKAP-K2 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL1088901	=	Activity	%	90.0	CHEMBL2208	Homo sapiens	Activity	%	90.0
	3264377	CHEMBL1104646	Inhibition of MK2	B	CC(C)(C)OC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(N)cc4)nc32)CC1		CHEMBL1095627	>	IC50	nM	50000.0	CHEMBL2208	Homo sapiens	IC50	uM	50.0
	3271021	CHEMBL1104646	Inhibition of MK2	B	COC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(N)cc4)nc32)CC1		CHEMBL1095626	>	IC50	nM	50000.0	CHEMBL2208	Homo sapiens	IC50	uM	50.0
Not Active	3272036	CHEMBL1108305	Inhibition of MAPKAPK2	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349		Inhibition	%		CHEMBL2208	Homo sapiens	INH		
Not Active	3272037	CHEMBL1108305	Inhibition of MAPKAPK2	B	COc1ccccc1/C=C1/C(=O)Nc2ccccc21		CHEMBL444673		Inhibition	%		CHEMBL2208	Homo sapiens	INH		
Not Active	3272038	CHEMBL1108305	Inhibition of MAPKAPK2	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1F		CHEMBL1088391		Inhibition	%		CHEMBL2208	Homo sapiens	INH		
Not Active	3272039	CHEMBL1108305	Inhibition of MAPKAPK2	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1[N+](=O)[O-]		CHEMBL1088392		Inhibition	%		CHEMBL2208	Homo sapiens	INH		
Not Active	3272040	CHEMBL1108305	Inhibition of MAPKAPK2	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1S(=O)(=O)O		CHEMBL1088529		Inhibition	%		CHEMBL2208	Homo sapiens	INH		
Not Active	3272041	CHEMBL1108305	Inhibition of MAPKAPK2	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccc2c(c1)OCO2		CHEMBL1086669		Inhibition	%		CHEMBL2208	Homo sapiens	INH		
Not Active	3272042	CHEMBL1108305	Inhibition of MAPKAPK2	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1cc(F)cc(F)c1		CHEMBL1086670		Inhibition	%		CHEMBL2208	Homo sapiens	INH		
Not Active	3272043	CHEMBL1108305	Inhibition of MAPKAPK2	B	NC(=O)Cc1ccc(/C=C2/C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL1086795		Inhibition	%		CHEMBL2208	Homo sapiens	INH		
Not Active	3272044	CHEMBL1108305	Inhibition of MAPKAPK2	B	COc1ccc(/C=C2/C(=O)Nc3ccc(Cl)cc32)c(OC)c1OC		CHEMBL1086796		Inhibition	%		CHEMBL2208	Homo sapiens	INH		
Not Active	3272045	CHEMBL1108305	Inhibition of MAPKAPK2	B	COc1cc(/C=C2/C(=O)Nc3ccc(Cl)cc32)cc(OC)c1OC		CHEMBL383871		Inhibition	%		CHEMBL2208	Homo sapiens	INH		
	3272046	CHEMBL1108305	Inhibition of MAPKAPK2	B	COc1cc(OC)c(/C=C2/C(=O)Nc3ccc(Cl)cc32)c(OC)c1		CHEMBL1086939	<	Inhibition	%	20.0	CHEMBL2208	Homo sapiens	INH	%	20.0
Not Active	3272047	CHEMBL1108305	Inhibition of MAPKAPK2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Inhibition	%		CHEMBL2208	Homo sapiens	INH		
	3291460	CHEMBL1111959	Inhibition of MAPKAPK2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	3293538	CHEMBL1120764	Inhibition of MK2	B	O=C(Nc1ccc(F)cc1F)c1cccnc1Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1		CHEMBL1095873	>	IC50	nM	50000.0	CHEMBL2208	Homo sapiens	IC50	uM	50.0
	3306937	CHEMBL1118061	Inhibition of MAPKAPK2 at 3 uM	B	O=C(Nc1cc2cc[nH]c(=O)c2cc1Cl)C(NC1CC1)c1ccccc1		CHEMBL1084106	=	Inhibition	%	95.0	CHEMBL2208	Homo sapiens	INH	%	95.0
	3332014	CHEMBL1166064	Inhibition of MAPKAPK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL2208	Homo sapiens	INH	%	50.0
	3333429	CHEMBL1166064	Inhibition of MAPKAPK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL2208	Homo sapiens	INH	%	50.0
	3334834	CHEMBL1166064	Inhibition of MAPKAPK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL2208	Homo sapiens	INH	%	50.0
	3336254	CHEMBL1166064	Inhibition of MAPKAPK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL2208	Homo sapiens	INH	%	50.0
	3341796	CHEMBL1166064	Inhibition of MAPKAPK2 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL2208	Homo sapiens	INH	%	50.0
	3343243	CHEMBL1166064	Inhibition of MAPKAPK2 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL2208	Homo sapiens	INH	%	50.0
	3354419	CHEMBL1173992	Inhibition of MAPKAP2 at 10 uM by mobility shift assay	B	c1ccc(-c2cnc3cnc(-c4cc[nH]n4)cn23)cc1		CHEMBL1170750	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	3354420	CHEMBL1173992	Inhibition of MAPKAP2 at 10 uM by mobility shift assay	B	c1ccc(-c2cnc3cnc(-c4cn[nH]c4)cn23)cc1		CHEMBL1172464	=	Inhibition	%	-5.0	CHEMBL2208	Homo sapiens	INH	%	-5.0
	3354421	CHEMBL1173992	Inhibition of MAPKAP2 at 10 uM by mobility shift assay	B	c1ccc(-c2cnc3cnc(-c4ccncc4)cn23)cc1		CHEMBL1170317	=	Inhibition	%	-2.0	CHEMBL2208	Homo sapiens	INH	%	-2.0
	3354422	CHEMBL1173992	Inhibition of MAPKAP2 at 10 uM by mobility shift assay	B	c1n[nH]cc1-c1cnc2ncc(-c3cn[nH]c3)n2c1		CHEMBL1171532	=	Inhibition	%	-2.0	CHEMBL2208	Homo sapiens	INH	%	-2.0
	3354423	CHEMBL1173992	Inhibition of MAPKAP2 at 10 uM by mobility shift assay	B	Cn1cc(-c2cnc3ncc(-c4cn[nH]c4)cn23)cn1		CHEMBL1171533	=	Inhibition	%	1.0	CHEMBL2208	Homo sapiens	INH	%	1.0
	3354424	CHEMBL1173992	Inhibition of MAPKAP2 at 10 uM by mobility shift assay	B	c1cc(-c2cnc3ncc(-c4cn[nH]c4)cn23)n[nH]1		CHEMBL1171534	=	Inhibition	%	13.0	CHEMBL2208	Homo sapiens	INH	%	13.0
	3354425	CHEMBL1173992	Inhibition of MAPKAP2 at 10 uM by mobility shift assay	B	OCc1cccc(-c2cnc3ncc(-c4cn[nH]c4)cn23)c1		CHEMBL1171699	=	Inhibition	%	4.0	CHEMBL2208	Homo sapiens	INH	%	4.0
	3354426	CHEMBL1173992	Inhibition of MAPKAP2 at 10 uM by mobility shift assay	B	c1ccc2c(-c3cnc4cnc(-c5cn[nH]c5)cn34)c[nH]c2c1		CHEMBL1170126	=	Inhibition	%	35.0	CHEMBL2208	Homo sapiens	INH	%	35.0
	3354427	CHEMBL1173992	Inhibition of MAPKAP2 at 10 uM by mobility shift assay	B	NCc1ccc(-c2cn3c(-c4cn[nH]c4)cnc3cn2)cc1		CHEMBL1170747	=	Inhibition	%	5.0	CHEMBL2208	Homo sapiens	INH	%	5.0
	3354428	CHEMBL1173992	Inhibition of MAPKAP2 at 10 uM by mobility shift assay	B	OCc1cccc(-c2cn3c(-c4cn[nH]c4)cnc3cn2)c1		CHEMBL1170748	=	Inhibition	%	-6.0	CHEMBL2208	Homo sapiens	INH	%	-6.0
	3354429	CHEMBL1173992	Inhibition of MAPKAP2 at 10 uM by mobility shift assay	B	OCc1ccc(-c2cn3c(-c4cn[nH]c4)cnc3cn2)cc1		CHEMBL1170749	=	Inhibition	%	2.0	CHEMBL2208	Homo sapiens	INH	%	2.0
	3354935	CHEMBL1173992	Inhibition of MAPKAP2 at 10 uM by mobility shift assay	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Inhibition	%	47.0	CHEMBL2208	Homo sapiens	INH	%	47.0
	3358655	CHEMBL1174897	Inhibition of MAPKAPK2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	85.0	CHEMBL2208	Homo sapiens	INH	%	85.0
	3359097	CHEMBL1174897	Inhibition of MAPKAPK2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	100.0	CHEMBL2208	Homo sapiens	INH	%	100.0
	3368323	CHEMBL1176566	Inhibition of MAPKAPK2 at 1 M	B	Cc1c[nH]c2ncnc(N3CC[C@@H](N)C3)c12		CHEMBL1173273	<	Inhibition	%	2.0	CHEMBL2208	Homo sapiens	INH	%	2.0
	3368324	CHEMBL1176566	Inhibition of MAPKAPK2 at 1 M	B	N#Cc1c[nH]c2ncnc(N3CC4(CCNCC4)c4ccccc43)c12		CHEMBL258837	=	Inhibition	%	43.0	CHEMBL2208	Homo sapiens	INH	%	43.0
	3370969	CHEMBL1211276	Inhibition of MAPKAPK2 assessed as residual activity at 10 uM relative to control	B	c1ccc(Nc2ncnc3[nH]c(-c4ccccc4)nc23)cc1		CHEMBL1210175	=	Activity	%	78.23	CHEMBL2208	Homo sapiens	Activity	%	78.23
	3370970	CHEMBL1211276	Inhibition of MAPKAPK2 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1ncnc2[nH]c(-c3ccc4ccccc4c3)nc12)C1CC1		CHEMBL1210406	=	Activity	%	101.44	CHEMBL2208	Homo sapiens	Activity	%	101.44
	3370978	CHEMBL1211284	Inhibition of MAPKAPK2	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	36.25	CHEMBL2208	Homo sapiens	IC50	nM	36.25
	3383562	CHEMBL1211491	Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation counting	B	c1ccc(Nc2ccnc3ccc(-c4ccccc4)cc23)cc1	Outside typical range	CHEMBL1209750	>	IC50	nM	200000.0	CHEMBL2208	Homo sapiens	IC50	uM	200.0
	3383563	CHEMBL1211491	Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation counting	B	OCCc1ccc(Nc2ccnc3ccc(-c4ccccc4)cc23)cc1		CHEMBL1209751	=	IC50	nM	22000.0	CHEMBL2208	Homo sapiens	IC50	uM	22.0
	3383564	CHEMBL1211491	Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation counting	B	CCc1ccc(Nc2ccnc3ccc(-c4ccccc4)cc23)cc1		CHEMBL1209752	=	IC50	nM	41000.0	CHEMBL2208	Homo sapiens	IC50	uM	41.0
	3383565	CHEMBL1211491	Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation counting	B	c1ccc(-c2ccc3nccc(Nc4ccc(N5CCOCC5)cc4)c3c2)cc1	Outside typical range	CHEMBL1209832	=	IC50	nM	120000.0	CHEMBL2208	Homo sapiens	IC50	uM	120.0
	3383566	CHEMBL1211491	Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation counting	B	O=C(O)c1ccc(Nc2ccnc3ccc(-c4ccc(Cl)cc4)cc23)cc1		CHEMBL1209833	=	IC50	nM	12000.0	CHEMBL2208	Homo sapiens	IC50	uM	12.0
	3383567	CHEMBL1211491	Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation counting	B	Oc1ccc(Nc2ccnc3ccc(-c4ccc(Cl)cc4)cc23)cc1		CHEMBL1209834	=	IC50	nM	23000.0	CHEMBL2208	Homo sapiens	IC50	uM	23.0
	3383568	CHEMBL1211491	Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation counting	B	Clc1ccc(-c2ccc3nccc(Nc4ccc(N5CCOCC5)cc4)c3c2)cc1		CHEMBL1209835	=	IC50	nM	24000.0	CHEMBL2208	Homo sapiens	IC50	uM	24.0
	3383569	CHEMBL1211491	Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation counting	B	OCCc1ccc(Nc2ccnc3ccc(-c4ccc(Cl)cc4)cc23)cc1		CHEMBL1209836	=	IC50	nM	29000.0	CHEMBL2208	Homo sapiens	IC50	uM	29.0
	3383570	CHEMBL1211491	Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation counting	B	N#Cc1ccc(Nc2ccnc3ccc(-c4ccc(Cl)cc4)cc23)cc1		CHEMBL1208823	=	IC50	nM	27000.0	CHEMBL2208	Homo sapiens	IC50	uM	27.0
	3383571	CHEMBL1211491	Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation counting	B	CN1CCN(C(=O)c2ccc(Nc3ccnc4ccc(-c5ccc(Cl)cc5)cc34)cc2)CC1		CHEMBL1208824	=	IC50	nM	15000.0	CHEMBL2208	Homo sapiens	IC50	uM	15.0
	3383572	CHEMBL1211491	Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation counting	B	Cc1ccc(-c2ccc3nccc(Nc4cc(Cl)ccc4O)c3c2)cc1		CHEMBL1208825	=	IC50	nM	33000.0	CHEMBL2208	Homo sapiens	IC50	uM	33.0
	3383573	CHEMBL1211491	Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation counting	B	Cc1ccc(-c2ccc3nccc(Nc4ccc(O)cc4)c3c2)cc1		CHEMBL1208826	=	IC50	nM	25000.0	CHEMBL2208	Homo sapiens	IC50	uM	25.0
	3383574	CHEMBL1211491	Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation counting	B	Cc1ccc(-c2ccc3nccc(Nc4ccc(C#N)cc4)c3c2)cc1		CHEMBL1208827	=	IC50	nM	27000.0	CHEMBL2208	Homo sapiens	IC50	uM	27.0
	3383575	CHEMBL1211491	Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation counting	B	Cc1ccc(-c2ccc3nccc(Nc4cccc(C)c4C)c3c2)cc1		CHEMBL1208885	=	IC50	nM	35000.0	CHEMBL2208	Homo sapiens	IC50	uM	35.0
	3383576	CHEMBL1211491	Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation counting	B	Oc1ccc(Cl)cc1Nc1ccnc2ccc(-c3ccccc3)cc12		CHEMBL1208886	=	IC50	nM	43000.0	CHEMBL2208	Homo sapiens	IC50	uM	43.0
	3383577	CHEMBL1211491	Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation counting	B	Fc1cc(Cl)ccc1Nc1ccnc2ccc(-c3ccc(Cl)cc3)cc12	Outside typical range	CHEMBL1208887	=	IC50	nM	121000.0	CHEMBL2208	Homo sapiens	IC50	uM	121.0
	3383578	CHEMBL1211491	Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation counting	B	CN1CCN(c2ccc(Nc3ccnc4ccc(-c5ccccc5)cc34)cc2)CC1		CHEMBL549224	=	IC50	nM	5200.0	CHEMBL2208	Homo sapiens	IC50	uM	5.2
	3383579	CHEMBL1211491	Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation counting	B	CN1CCN(c2ccc(Nc3ccnc4ccc(-c5ccsc5)cc34)cc2)CC1		CHEMBL1208888	=	IC50	nM	26000.0	CHEMBL2208	Homo sapiens	IC50	uM	26.0
	3383580	CHEMBL1211491	Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation counting	B	CN1CCN(c2ccc(Nc3ccnc4ccccc34)cc2)CC1	Outside typical range	CHEMBL217665	>	IC50	nM	200000.0	CHEMBL2208	Homo sapiens	IC50	uM	200.0
	3383581	CHEMBL1211491	Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation counting	B	CN1CCN(c2ccc(Nc3ccnc4ccc(Br)cc34)cc2)CC1	Outside typical range	CHEMBL1208948	>	IC50	nM	200000.0	CHEMBL2208	Homo sapiens	IC50	uM	200.0
	3383582	CHEMBL1211491	Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation counting	B	CN1CCN(c2ccc(Nc3ccnc4ccc(-c5cccs5)cc34)cc2)CC1	Outside typical range	CHEMBL1208949	>	IC50	nM	200000.0	CHEMBL2208	Homo sapiens	IC50	uM	200.0
	3383583	CHEMBL1211491	Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation counting	B	CN1CCN(c2ccc(Nc3ccnc4ccc(-c5ccc(Br)cc5)cc34)cc2)CC1		CHEMBL1208950	=	IC50	nM	400.0	CHEMBL2208	Homo sapiens	IC50	uM	0.4
	3383584	CHEMBL1211491	Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation counting	B	CN1CCN(c2ccc(Nc3ccnc4ccc(-c5ccc(Cl)cc5)cc34)cc2)CC1		CHEMBL1208951	=	IC50	nM	600.0	CHEMBL2208	Homo sapiens	IC50	uM	0.6
	3383585	CHEMBL1211491	Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation counting	B	CN1CCN(c2ccc(Nc3ccnc4ccc(-c5ccc(F)cc5)cc34)cc2)CC1		CHEMBL1209008	=	IC50	nM	700.0	CHEMBL2208	Homo sapiens	IC50	uM	0.7
	3383586	CHEMBL1211491	Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation counting	B	CN1CCN(c2ccc(Nc3ccnc4ccc(-c5ccc(C(=O)O)cc5)cc34)cc2)CC1	Outside typical range	CHEMBL1209009	>	IC50	nM	200000.0	CHEMBL2208	Homo sapiens	IC50	uM	200.0
	3383587	CHEMBL1211491	Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation counting	B	CN1CCN(c2ccc(Nc3ccnc4ccc(-c5cccc([N+](=O)[O-])c5)cc34)cc2)CC1		CHEMBL1209010	=	IC50	nM	9000.0	CHEMBL2208	Homo sapiens	IC50	uM	9.0
	3383588	CHEMBL1211491	Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation counting	B	CN1CCN(c2ccc(Nc3ccnc4ccc(-c5cccc(N)c5)cc34)cc2)CC1		CHEMBL1209011	=	IC50	nM	14000.0	CHEMBL2208	Homo sapiens	IC50	uM	14.0
	3383589	CHEMBL1211491	Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation counting	B	CN1CCN(c2ccc(Nc3ccnc4ccc(-c5cccc(C(F)(F)F)c5)cc34)cc2)CC1		CHEMBL1209066	=	IC50	nM	1500.0	CHEMBL2208	Homo sapiens	IC50	uM	1.5
	3383590	CHEMBL1211491	Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation counting	B	CN1CCN(c2ccc(Nc3ccnc4ccc(-c5cccc(Cl)c5)cc34)cc2)CC1		CHEMBL1209067	=	IC50	nM	2600.0	CHEMBL2208	Homo sapiens	IC50	uM	2.6
	3383591	CHEMBL1211491	Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation counting	B	COc1cccc(-c2ccc3nccc(Nc4ccc(N5CCN(C)CC5)cc4)c3c2)c1		CHEMBL1209068	=	IC50	nM	8000.0	CHEMBL2208	Homo sapiens	IC50	uM	8.0
	3383592	CHEMBL1211491	Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation counting	B	CN1CCN(c2ccc(Nc3ccnc4ccc(-c5ccc(C=O)cc5)cc34)cc2)CC1		CHEMBL1209069	=	IC50	nM	1800.0	CHEMBL2208	Homo sapiens	IC50	uM	1.8
	3383593	CHEMBL1211491	Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation counting	B	CN1CCN(c2ccc(Nc3ccnc4ccc(-c5ccc(C(F)(F)F)cc5)cc34)cc2)CC1		CHEMBL1209119	=	IC50	nM	1400.0	CHEMBL2208	Homo sapiens	IC50	uM	1.4
	3383594	CHEMBL1211491	Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation counting	B	CSc1ccc(-c2ccc3nccc(Nc4ccc(N5CCN(C)CC5)cc4)c3c2)cc1		CHEMBL1209120	=	IC50	nM	700.0	CHEMBL2208	Homo sapiens	IC50	uM	0.7
	3383595	CHEMBL1211491	Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation counting	B	Cc1ccc(-c2ccc3nccc(Nc4ccc(N5CCN(C)CC5)cc4)c3c2)cc1		CHEMBL1209121	=	IC50	nM	800.0	CHEMBL2208	Homo sapiens	IC50	uM	0.8
	3383596	CHEMBL1211491	Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation counting	B	Cc1cccc(-c2ccc3nccc(Nc4ccc(N5CCN(C)CC5)cc4)c3c2)c1		CHEMBL1209122	=	IC50	nM	1400.0	CHEMBL2208	Homo sapiens	IC50	uM	1.4
Active	3383606	CHEMBL1211551	Uncompetitive inhibition of MK2 at 0.25 to 2 uM in presence of increasing concentration of ATP	B	CN1CCN(c2ccc(Nc3ccnc4ccc(-c5ccc(Cl)cc5)cc34)cc2)CC1		CHEMBL1208951		Inhibition	%		CHEMBL2208	Homo sapiens	INH		
	3383607	CHEMBL1211552	Mixed inhibition of MK2 ATP-binding site assessed as dissociation constant of enzyme-ATP complex	B	CN1CCN(c2ccc(Nc3ccnc4ccc(-c5ccc(Cl)cc5)cc34)cc2)CC1		CHEMBL1208951	=	Km	nM	12600.0	CHEMBL2208	Homo sapiens	Km	uM	12.6
	3383608	CHEMBL1211553	Uncompetitive inhibition of MK2 ATP-binding site assessed as dissociation constant of enzyme-ATP complex	B	CN1CCN(c2ccc(Nc3ccnc4ccc(-c5ccc(Cl)cc5)cc34)cc2)CC1		CHEMBL1208951	=	Km	nM	13300.0	CHEMBL2208	Homo sapiens	Km	uM	13.3
	3383609	CHEMBL1211554	Noncompetitive inhibition of MK2 ATP-binding site assessed as dissociation constant of enzyme-ATP complex	B	CN1CCN(c2ccc(Nc3ccnc4ccc(-c5ccc(Cl)cc5)cc34)cc2)CC1		CHEMBL1208951	=	Km	nM	8800.0	CHEMBL2208	Homo sapiens	Km	uM	8.8
	3383610	CHEMBL1211555	Competitive inhibition of MK2 ATP-binding site assessed as dissociation constant of enzyme-ATP complex	B	CN1CCN(c2ccc(Nc3ccnc4ccc(-c5ccc(Cl)cc5)cc34)cc2)CC1		CHEMBL1208951	=	Km	nM	7210.0	CHEMBL2208	Homo sapiens	Km	uM	7.21
	3383611	CHEMBL1211556	Competitive inhibition of MK2 ATP-binding site	B	CN1CCN(c2ccc(Nc3ccnc4ccc(-c5ccc(Cl)cc5)cc34)cc2)CC1		CHEMBL1208951	=	Ki	nM	96.0	CHEMBL2208	Homo sapiens	Ki	uM	0.096
	3383612	CHEMBL1211557	Uncompetitive inhibition of MK2 ATP-binding site	B	CN1CCN(c2ccc(Nc3ccnc4ccc(-c5ccc(Cl)cc5)cc34)cc2)CC1		CHEMBL1208951	=	Ki	nM	310.0	CHEMBL2208	Homo sapiens	Ki	uM	0.31
	3383616	CHEMBL1211561	Noncompetitive inhibition of MK2 ATP-binding site	B	CN1CCN(c2ccc(Nc3ccnc4ccc(-c5ccc(Cl)cc5)cc34)cc2)CC1		CHEMBL1208951	=	Ki	nM	480.0	CHEMBL2208	Homo sapiens	Ki	uM	0.48
	3383617	CHEMBL1211562	Mixed inhibition of MK2 ATP-binding site	B	CN1CCN(c2ccc(Nc3ccnc4ccc(-c5ccc(Cl)cc5)cc34)cc2)CC1		CHEMBL1208951	=	Ki	nM	320.0	CHEMBL2208	Homo sapiens	Ki	uM	0.32
	3400026	CHEMBL1217223	Inhibition of human MAPKAP-K2 at 10 uM	B	Cc1ccc(Nc2ncc3c(n2)N(C)C(=O)N(c2cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc2C)C3)cn1		CHEMBL1214141	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	3419127	CHEMBL1228795	Inhibition of MAPKAP-K2 at 100 uM relative to control	B	NC(=O)c1sc2c([N+](=O)[O-])cc(C(F)(F)F)cc2[n+]1[O-]		CHEMBL476124	=	Inhibition	%	96.0	CHEMBL2208	Homo sapiens	INH	%	96.0
	3420222	CHEMBL1226916	Inhibition of Mk2	B	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	=	IC50	nM	470.0	CHEMBL2208	Homo sapiens	IC50	nM	470.0
	3443447	CHEMBL1244213	Inhibition of MAPKAPK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	-1.0	CHEMBL2208	Homo sapiens	INH	%	-1.0
	3443664	CHEMBL1244213	Inhibition of MAPKAPK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	-3.0	CHEMBL2208	Homo sapiens	INH	%	-3.0
	3444819	CHEMBL1244213	Inhibition of MAPKAPK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	-1.0	CHEMBL2208	Homo sapiens	INH	%	-1.0
	3445186	CHEMBL1244498	Binding affinity to MAPKAPK2	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	230.0	CHEMBL2208	Homo sapiens	Kd	nM	230.0
	3445443	CHEMBL1244213	Inhibition of MAPKAPK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	-2.0	CHEMBL2208	Homo sapiens	INH	%	-2.0
	3445660	CHEMBL1244213	Inhibition of MAPKAPK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	3445863	CHEMBL1244213	Inhibition of MAPKAPK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	1.0	CHEMBL2208	Homo sapiens	INH	%	1.0
	3446053	CHEMBL1244213	Inhibition of MAPKAPK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	-4.0	CHEMBL2208	Homo sapiens	INH	%	-4.0
	3446542	CHEMBL1249574	Inhibition of His-tagged human MAPKAPK2 expressed in Escherichia coli at 1 uM	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Inhibition	%	90.0	CHEMBL2208	Homo sapiens	INH	%	90.0
	3446571	CHEMBL1249574	Inhibition of His-tagged human MAPKAPK2 expressed in Escherichia coli at 1 uM	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	Inhibition	%	103.0	CHEMBL2208	Homo sapiens	INH	%	103.0
	3446595	CHEMBL1249574	Inhibition of His-tagged human MAPKAPK2 expressed in Escherichia coli at 1 uM	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Inhibition	%	125.0	CHEMBL2208	Homo sapiens	INH	%	125.0
	3446620	CHEMBL1247638	Inhibition of His-tagged human MAPKAPK2 expressed in Escherichia coli at 20 uM	B	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12		CHEMBL50	=	Inhibition	%	90.0	CHEMBL2208	Homo sapiens	INH	%	90.0
	3446647	CHEMBL1249550	Inhibition of His-tagged human MAPKAPK2 expressed in Escherichia coli at 50 uM	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Inhibition	%	74.0	CHEMBL2208	Homo sapiens	INH	%	74.0
	3446675	CHEMBL1249574	Inhibition of His-tagged human MAPKAPK2 expressed in Escherichia coli at 1 uM	B	COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O		CHEMBL428496	=	Inhibition	%	102.0	CHEMBL2208	Homo sapiens	INH	%	102.0
	3446701	CHEMBL1247614	Inhibition of Gst-tagged human MAPKAPK2 expressed in Escherichia coli at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Inhibition	%	97.0	CHEMBL2208	Homo sapiens	INH	%	97.0
	3446725	CHEMBL1247614	Inhibition of Gst-tagged human MAPKAPK2 expressed in Escherichia coli at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Inhibition	%	93.0	CHEMBL2208	Homo sapiens	INH	%	93.0
	3446749	CHEMBL1249550	Inhibition of His-tagged human MAPKAPK2 expressed in Escherichia coli at 50 uM	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Inhibition	%	95.0	CHEMBL2208	Homo sapiens	INH	%	95.0
	3446774	CHEMBL1247614	Inhibition of Gst-tagged human MAPKAPK2 expressed in Escherichia coli at 10 uM	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	=	Inhibition	%	98.0	CHEMBL2208	Homo sapiens	INH	%	98.0
	3446806	CHEMBL1247614	Inhibition of Gst-tagged human MAPKAPK2 expressed in Escherichia coli at 10 uM	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N		CHEMBL34704	=	Inhibition	%	102.0	CHEMBL2208	Homo sapiens	INH	%	102.0
	3446833	CHEMBL1247614	Inhibition of Gst-tagged human MAPKAPK2 expressed in Escherichia coli at 10 uM	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Inhibition	%	59.0	CHEMBL2208	Homo sapiens	INH	%	59.0
	3446842	CHEMBL1249806	Inhibition of His-tagged human MAPKAPK2 expressed in Escherichia coli at 10 uM	B	CC(=O)c1c(O)c(C)c(O)c(Cc2c(O)c3c(c(C(=O)/C=C/c4ccccc4)c2O)OC(C)(C)C=C3)c1O		CHEMBL34241	=	IC50	nM	5400.0	CHEMBL2208	Homo sapiens	IC50	uM	5.4
	3446860	CHEMBL1247638	Inhibition of His-tagged human MAPKAPK2 expressed in Escherichia coli at 20 uM	B	CC(=O)c1c(O)c(C)c(O)c(Cc2c(O)c3c(c(C(=O)/C=C/c4ccccc4)c2O)OC(C)(C)C=C3)c1O		CHEMBL34241	=	Inhibition	%	5.0	CHEMBL2208	Homo sapiens	INH	%	5.0
	3446891	CHEMBL1247638	Inhibition of His-tagged human MAPKAPK2 expressed in Escherichia coli at 20 uM	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Inhibition	%	90.0	CHEMBL2208	Homo sapiens	INH	%	90.0
	3447268	CHEMBL1247614	Inhibition of Gst-tagged human MAPKAPK2 expressed in Escherichia coli at 10 uM	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Inhibition	%	99.0	CHEMBL2208	Homo sapiens	INH	%	99.0
	3447302	CHEMBL1247614	Inhibition of Gst-tagged human MAPKAPK2 expressed in Escherichia coli at 10 uM	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Inhibition	%	99.0	CHEMBL2208	Homo sapiens	INH	%	99.0
	3447327	CHEMBL1249574	Inhibition of His-tagged human MAPKAPK2 expressed in Escherichia coli at 1 uM	B	NCCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL270875	=	Inhibition	%	97.0	CHEMBL2208	Homo sapiens	INH	%	97.0
	3447351	CHEMBL1249574	Inhibition of His-tagged human MAPKAPK2 expressed in Escherichia coli at 1 uM	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Inhibition	%	113.0	CHEMBL2208	Homo sapiens	INH	%	113.0
	3447375	CHEMBL1249574	Inhibition of His-tagged human MAPKAPK2 expressed in Escherichia coli at 1 uM	B	CN1C(=O)C(c2c[nH]c3ccccc23)=C(c2c[nH]c3ccccc23)C1=O		CHEMBL291725	=	Inhibition	%	124.0	CHEMBL2208	Homo sapiens	INH	%	124.0
	3447399	CHEMBL1249574	Inhibition of His-tagged human MAPKAPK2 expressed in Escherichia coli at 1 uM	B	Cn1cc(C2=C(c3cn(CCCN)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL269264	=	Inhibition	%	104.0	CHEMBL2208	Homo sapiens	INH	%	104.0
	3447423	CHEMBL1249574	Inhibition of His-tagged human MAPKAPK2 expressed in Escherichia coli at 1 uM	B	Cn1cc(C2=C(c3c4n(c5ccccc35)CCC(CN)C4)C(=O)NC2=O)c2ccccc21		CHEMBL421565	=	Inhibition	%	105.0	CHEMBL2208	Homo sapiens	INH	%	105.0
	3447447	CHEMBL1249574	Inhibition of His-tagged human MAPKAPK2 expressed in Escherichia coli at 1 uM	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Inhibition	%	80.0	CHEMBL2208	Homo sapiens	INH	%	80.0
	3447471	CHEMBL1247614	Inhibition of Gst-tagged human MAPKAPK2 expressed in Escherichia coli at 10 uM	B	O=C1NCc2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21		CHEMBL16958	=	Inhibition	%	83.0	CHEMBL2208	Homo sapiens	INH	%	83.0
	3447495	CHEMBL1247614	Inhibition of Gst-tagged human MAPKAPK2 expressed in Escherichia coli at 10 uM	B	CCCCCCOC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608532	=	Inhibition	%	62.0	CHEMBL2208	Homo sapiens	INH	%	62.0
	3447521	CHEMBL1249574	Inhibition of His-tagged human MAPKAPK2 expressed in Escherichia coli at 1 uM	B	CC[C@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@@H]4O		CHEMBL1242366	=	Inhibition	%	90.0	CHEMBL2208	Homo sapiens	INH	%	90.0
	3448029	CHEMBL1249696	Inhibition of human MAPKAP-K2 activity at 10 uM by radiometric assay	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	3448105	CHEMBL1249696	Inhibition of human MAPKAP-K2 activity at 10 uM by radiometric assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Inhibition	%	19.0	CHEMBL2208	Homo sapiens	INH	%	19.0
	3448490	CHEMBL1244498	Binding affinity to MAPKAPK2	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	uM	10.0
	3448774	CHEMBL1244498	Binding affinity to MAPKAPK2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	uM	10.0
	3449723	CHEMBL1244498	Binding affinity to MAPKAPK2	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	uM	10.0
	3450127	CHEMBL1244498	Binding affinity to MAPKAPK2	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	uM	10.0
	3450356	CHEMBL1244498	Binding affinity to MAPKAPK2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	uM	10.0
	3451046	CHEMBL1244498	Binding affinity to MAPKAPK2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	uM	10.0
	3463281	CHEMBL1252484	Inhibition of MAPKAPK2 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	3.0	CHEMBL2208	Homo sapiens	INH	%	3.0
	3463825	CHEMBL1252484	Inhibition of MAPKAPK2 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	-5.0	CHEMBL2208	Homo sapiens	INH	%	-5.0
	3464044	CHEMBL1252484	Inhibition of MAPKAPK2 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	2.0	CHEMBL2208	Homo sapiens	INH	%	2.0
	3504307	CHEMBL1260189	Inhibition of MAPKAPK2	B	O=C(Nc1n[nH]c2cc(C(=O)N[C@H](CN3CCCC3)c3ccccc3)sc12)c1ccc(N2CCOCC2)cc1		CHEMBL1258913	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	3523911	CHEMBL1273647	Inhibition of MAPK2	B	CC(C)c1n[nH]c(Cl)c1-c1ccnc(Nc2ccc(N3CCC(N(C)C)CC3)cn2)n1		CHEMBL1272116	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	3523912	CHEMBL1273647	Inhibition of MAPK2	B	CC(C)c1n[nH]c(C(F)(F)F)c1-c1ccnc(Nc2ccc(N3CCC(N(C)C)CC3)cn2)n1		CHEMBL1272171	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	3526977	CHEMBL1275097	Inhibition of MK2	B	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccccc1		CHEMBL1270230	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	3556616	CHEMBL1285601	Inhibition of MAPKAPK2 at 1 uM	B	CN1C[C@@H]2C[C@H]1CN2c1cc(F)c(-c2ccnc3c(-c4cccc5[nH]ncc45)c(-c4ccncc4)nn23)c(F)c1		CHEMBL1276179	=	Inhibition	%	-1.0	CHEMBL2208	Homo sapiens	INH	%	-1.0
	3590866	CHEMBL1292164	Inhibition of MK2	B	Cc1ccc(C(=O)Nc2ccon2)cc1NC(=O)c1cnn(-c2ccccc2F)c1N		CHEMBL1290746	>	IC50	nM	30000.0	CHEMBL2208	Homo sapiens	IC50	uM	30.0
	5120378	CHEMBL1646189	Inhibition of human MAPKAP-K2 at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	106.0	CHEMBL2208	Homo sapiens	INH	%	106.0
	5132604	CHEMBL1648761	Inhibition of MAPKAPK2 assessed as residual activity at 10 uM	B	CN(C)C/C=C/C(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641990	=	Activity	%	97.0	CHEMBL2208	Homo sapiens	Activity	%	97.0
	5133747	CHEMBL1648761	Inhibition of MAPKAPK2 assessed as residual activity at 10 uM	B	CN(C)CCCC(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641989	=	Activity	%	100.0	CHEMBL2208	Homo sapiens	Activity	%	100.0
	5133924	CHEMBL1648761	Inhibition of MAPKAPK2 assessed as residual activity at 10 uM	B	CN1CCN(CCC(=O)Nc2ccc3c(C#N)cnc(Nc4cccc(Br)c4)c3c2)CC1		CHEMBL1641992	=	Activity	%	100.0	CHEMBL2208	Homo sapiens	Activity	%	100.0
	5140484	CHEMBL1646803	Inhibition of MAPKAPK2 at 10 uM	B	CC(C)(C)c1cc(C(=O)O)c(NC(=O)Nc2ccc3[nH]ncc3c2)s1		CHEMBL1641799	=	Inhibition	%	10.0	CHEMBL2208	Homo sapiens	INH	%	10.0
	5140527	CHEMBL1646067	Inhibition of MAPKAPK2 at 1 uM	B	CC(C)(C)c1cc(C(=O)O)c(NC(=O)Nc2ccc3[nH]ncc3c2)s1		CHEMBL1641799	=	Inhibition	%	10.0	CHEMBL2208	Homo sapiens	INH	%	10.0
	5191379	CHEMBL1664046	Inhibition of MAPKAP-K2 at 1 uM	B	COc1cc2nc(-c3cc(F)ccc3O)nc(N[C@@H]3CNC[C@H]3C(C)(C)O)c2cc1OC		CHEMBL1236782	=	Inhibition	%	10.0	CHEMBL2208	Homo sapiens	INH	%	10.0
	5191380	CHEMBL1664046	Inhibition of MAPKAP-K2 at 1 uM	B	CC(C)(O)[C@@H]1CNC[C@H]1Nc1nc(-c2cc(-c3cc[nH]n3)ccc2O)nc2ccccc12		CHEMBL1650131	=	Inhibition	%	27.0	CHEMBL2208	Homo sapiens	INH	%	27.0
	5243732	CHEMBL1685695	Inhibition of MAPK2 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	100.0	CHEMBL2208	Homo sapiens	INH	%	100.0
	5243733	CHEMBL1685696	Inhibition of MAPKAP-K2 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	104.0	CHEMBL2208	Homo sapiens	INH	%	104.0
	5243840	CHEMBL1686052	Inhibition of MAPK2 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	84.0	CHEMBL2208	Homo sapiens	INH	%	84.0
	5243841	CHEMBL1686053	Inhibition of MAPKAP-K2 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	93.0	CHEMBL2208	Homo sapiens	INH	%	93.0
	5243953	CHEMBL1685695	Inhibition of MAPK2 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	108.0	CHEMBL2208	Homo sapiens	INH	%	108.0
	5243954	CHEMBL1685696	Inhibition of MAPKAP-K2 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	98.0	CHEMBL2208	Homo sapiens	INH	%	98.0
	5244061	CHEMBL1686052	Inhibition of MAPK2 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	64.0	CHEMBL2208	Homo sapiens	INH	%	64.0
	5244062	CHEMBL1686053	Inhibition of MAPKAP-K2 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	48.0	CHEMBL2208	Homo sapiens	INH	%	48.0
	5244934	CHEMBL1685695	Inhibition of MAPK2 at 0.1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	92.0	CHEMBL2208	Homo sapiens	INH	%	92.0
	5244935	CHEMBL1685696	Inhibition of MAPKAP-K2 at 0.1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	92.0	CHEMBL2208	Homo sapiens	INH	%	92.0
	5245042	CHEMBL1686052	Inhibition of MAPK2 at 1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	91.0	CHEMBL2208	Homo sapiens	INH	%	91.0
	5245043	CHEMBL1686053	Inhibition of MAPKAP-K2 at 1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	95.0	CHEMBL2208	Homo sapiens	INH	%	95.0
	5245193	CHEMBL1685695	Inhibition of MAPK2 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	106.0	CHEMBL2208	Homo sapiens	INH	%	106.0
	5245194	CHEMBL1685696	Inhibition of MAPKAP-K2 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	115.0	CHEMBL2208	Homo sapiens	INH	%	115.0
	5246023	CHEMBL1686052	Inhibition of MAPK2 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	109.0	CHEMBL2208	Homo sapiens	INH	%	109.0
	5246024	CHEMBL1686053	Inhibition of MAPKAP-K2 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	113.0	CHEMBL2208	Homo sapiens	INH	%	113.0
	6198130	CHEMBL1776221	Inhibition of MAPKAPK2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCO)CC4)c2)CC1		CHEMBL1738758	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	6202022	CHEMBL1780645	Inhibition of MK2 pretreated for 30 mins before fluorescein labeled substrate peptide addition measured after 2 hrs by IMAP assay	B	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	=	EC50	nM	372.0	CHEMBL2208	Homo sapiens	EC50	nM	372.0
	6202023	CHEMBL1780645	Inhibition of MK2 pretreated for 30 mins before fluorescein labeled substrate peptide addition measured after 2 hrs by IMAP assay	B	O=C1NCC2(CCNCC2)c2[nH]c(-c3ccnc(-c4ccc5c(c4)OCO5)n3)cc21		CHEMBL1738702	=	EC50	nM	4.3	CHEMBL2208	Homo sapiens	EC50	nM	4.3
	6202024	CHEMBL1780645	Inhibition of MK2 pretreated for 30 mins before fluorescein labeled substrate peptide addition measured after 2 hrs by IMAP assay	B	O=C1NCC2(CCOCC2)c2[nH]c(-c3ccnc(-c4ccc5c(c4)OCO5)n3)cc21		CHEMBL1779351	=	EC50	nM	724.0	CHEMBL2208	Homo sapiens	EC50	nM	724.0
	6202025	CHEMBL1780645	Inhibition of MK2 pretreated for 30 mins before fluorescein labeled substrate peptide addition measured after 2 hrs by IMAP assay	B	O=C1NCC2(CCNCC2)c2[nH]c(-c3ccnc(-c4cc5ccccc5o4)n3)cc21		CHEMBL1779352	=	EC50	nM	5.9	CHEMBL2208	Homo sapiens	EC50	nM	5.9
	6202026	CHEMBL1780645	Inhibition of MK2 pretreated for 30 mins before fluorescein labeled substrate peptide addition measured after 2 hrs by IMAP assay	B	CN1CCC2(CC1)CNC(=O)c1cc(-c3ccnc(-c4cc5ccccc5o4)n3)[nH]c12		CHEMBL1779353	=	EC50	nM	13.0	CHEMBL2208	Homo sapiens	EC50	nM	13.0
	6202027	CHEMBL1780645	Inhibition of MK2 pretreated for 30 mins before fluorescein labeled substrate peptide addition measured after 2 hrs by IMAP assay	B	CCN1CCC2(CC1)CNC(=O)c1cc(-c3ccnc(-c4cc5ccccc5o4)n3)[nH]c12		CHEMBL1779354	=	EC50	nM	59.0	CHEMBL2208	Homo sapiens	EC50	nM	59.0
	6202028	CHEMBL1780645	Inhibition of MK2 pretreated for 30 mins before fluorescein labeled substrate peptide addition measured after 2 hrs by IMAP assay	B	CC(=O)c1cccc(-c2nccc(-c3cc4c([nH]3)C3(CCNCC3)CNC4=O)n2)c1		CHEMBL1779355	=	EC50	nM	11.0	CHEMBL2208	Homo sapiens	EC50	nM	11.0
	6202029	CHEMBL1780645	Inhibition of MK2 pretreated for 30 mins before fluorescein labeled substrate peptide addition measured after 2 hrs by IMAP assay	B	CC(=O)c1ccc(-c2nccc(-c3cc4c([nH]3)C3(CCNCC3)CNC4=O)n2)cc1		CHEMBL1779346	=	EC50	nM	9.8	CHEMBL2208	Homo sapiens	EC50	nM	9.8
	6202030	CHEMBL1780645	Inhibition of MK2 pretreated for 30 mins before fluorescein labeled substrate peptide addition measured after 2 hrs by IMAP assay	B	O=C1NCC2(CCNCC2)c2[nH]c(-c3ccnc(-c4ccc5c(c4)OCCCO5)n3)cc21		CHEMBL1779347	=	EC50	nM	10.0	CHEMBL2208	Homo sapiens	EC50	nM	10.0
	6202031	CHEMBL1780645	Inhibition of MK2 pretreated for 30 mins before fluorescein labeled substrate peptide addition measured after 2 hrs by IMAP assay	B	CC(C)c1cccc(-c2nccc(-c3cc4c([nH]3)C3(CCNCC3)CNC4=O)n2)c1		CHEMBL1779348	=	EC50	nM	112.0	CHEMBL2208	Homo sapiens	EC50	nM	112.0
	6202032	CHEMBL1780645	Inhibition of MK2 pretreated for 30 mins before fluorescein labeled substrate peptide addition measured after 2 hrs by IMAP assay	B	O=C1NCC2(CCNCC2)c2[nH]c(-c3ccnc(-c4ccccc4F)n3)cc21		CHEMBL1779349	=	EC50	nM	29.0	CHEMBL2208	Homo sapiens	EC50	nM	29.0
	6202033	CHEMBL1780645	Inhibition of MK2 pretreated for 30 mins before fluorescein labeled substrate peptide addition measured after 2 hrs by IMAP assay	B	O=C1NCC2(CCNCC2)c2[nH]c(-c3ccnc(-c4cccc(F)c4)n3)cc21		CHEMBL1779350	=	EC50	nM	8.3	CHEMBL2208	Homo sapiens	EC50	nM	8.3
	6202034	CHEMBL1780645	Inhibition of MK2 pretreated for 30 mins before fluorescein labeled substrate peptide addition measured after 2 hrs by IMAP assay	B	O=C1NCC2(CCNCC2)c2[nH]c(-c3ccnc(-c4cccc(C(F)(F)F)c4)n3)cc21		CHEMBL1779356	=	EC50	nM	15.0	CHEMBL2208	Homo sapiens	EC50	nM	15.0
	6202035	CHEMBL1780645	Inhibition of MK2 pretreated for 30 mins before fluorescein labeled substrate peptide addition measured after 2 hrs by IMAP assay	B	O=C1NCC2(CCNCC2)c2[nH]c(-c3ccnc(-c4ccc(C(F)(F)F)cc4)n3)cc21		CHEMBL1779357	=	EC50	nM	6.9	CHEMBL2208	Homo sapiens	EC50	nM	6.9
	6202036	CHEMBL1780645	Inhibition of MK2 pretreated for 30 mins before fluorescein labeled substrate peptide addition measured after 2 hrs by IMAP assay	B	CC(C)(C)c1ccc(-c2nccc(-c3cc4c([nH]3)C3(CCNCC3)CNC4=O)n2)cc1		CHEMBL1779358	=	EC50	nM	6.2	CHEMBL2208	Homo sapiens	EC50	nM	6.2
	6202037	CHEMBL1780645	Inhibition of MK2 pretreated for 30 mins before fluorescein labeled substrate peptide addition measured after 2 hrs by IMAP assay	B	O=C1NCC2(CCNCC2)c2[nH]c(-c3ccnc(-c4ccc5ccccc5c4)n3)cc21		CHEMBL1779359	=	EC50	nM	5.1	CHEMBL2208	Homo sapiens	EC50	nM	5.1
	6202038	CHEMBL1780645	Inhibition of MK2 pretreated for 30 mins before fluorescein labeled substrate peptide addition measured after 2 hrs by IMAP assay	B	O=C1NCC2(CCNCC2)c2[nH]c(-c3ccnc(-c4cc(Cl)cc(Cl)c4)n3)cc21		CHEMBL1779360	=	EC50	nM	4.5	CHEMBL2208	Homo sapiens	EC50	nM	4.5
	6202039	CHEMBL1780645	Inhibition of MK2 pretreated for 30 mins before fluorescein labeled substrate peptide addition measured after 2 hrs by IMAP assay	B	O=C1NCC2(CCNCC2)c2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)n3)cc21		CHEMBL1779361	=	EC50	nM	6.3	CHEMBL2208	Homo sapiens	EC50	nM	6.3
	6202040	CHEMBL1780645	Inhibition of MK2 pretreated for 30 mins before fluorescein labeled substrate peptide addition measured after 2 hrs by IMAP assay	B	O=C1NCC2(CCNCC2)c2[nH]c(-c3ccnc(-c4cccnc4)n3)cc21		CHEMBL1779362	=	EC50	nM	1.1	CHEMBL2208	Homo sapiens	EC50	nM	1.1
	6202041	CHEMBL1780645	Inhibition of MK2 pretreated for 30 mins before fluorescein labeled substrate peptide addition measured after 2 hrs by IMAP assay	B	COc1cncc(-c2nccc(-c3cc4c([nH]3)C3(CCNCC3)CNC4=O)n2)c1		CHEMBL1779363	=	EC50	nM	6.9	CHEMBL2208	Homo sapiens	EC50	nM	6.9
	6202042	CHEMBL1780645	Inhibition of MK2 pretreated for 30 mins before fluorescein labeled substrate peptide addition measured after 2 hrs by IMAP assay	B	Nc1ccc(-c2nccc(-c3cc4c([nH]3)C3(CCNCC3)CNC4=O)n2)cn1		CHEMBL1779364	=	EC50	nM	15.0	CHEMBL2208	Homo sapiens	EC50	nM	15.0
	6202043	CHEMBL1780645	Inhibition of MK2 pretreated for 30 mins before fluorescein labeled substrate peptide addition measured after 2 hrs by IMAP assay	B	CCC(=O)Nc1ccc(-c2nccc(-c3cc4c([nH]3)C3(CCNCC3)CNC4=O)n2)cn1		CHEMBL1779365	=	EC50	nM	3.6	CHEMBL2208	Homo sapiens	EC50	nM	3.6
	6202044	CHEMBL1780645	Inhibition of MK2 pretreated for 30 mins before fluorescein labeled substrate peptide addition measured after 2 hrs by IMAP assay	B	Nc1ncc(-c2nccc(-c3cc4c([nH]3)C3(CCNCC3)CNC4=O)n2)cn1		CHEMBL1779366	=	EC50	nM	2.1	CHEMBL2208	Homo sapiens	EC50	nM	2.1
	6202045	CHEMBL1780645	Inhibition of MK2 pretreated for 30 mins before fluorescein labeled substrate peptide addition measured after 2 hrs by IMAP assay	B	O=C1NCC2(CCNCC2)c2[nH]c(-c3ccnc(-c4cnc(NC5CCCC5)nc4)n3)cc21		CHEMBL1779367	=	EC50	nM	1.7	CHEMBL2208	Homo sapiens	EC50	nM	1.7
	6202046	CHEMBL1780645	Inhibition of MK2 pretreated for 30 mins before fluorescein labeled substrate peptide addition measured after 2 hrs by IMAP assay	B	O=C1NCC2(CCCNC2)c2[nH]c(-c3ccnc(-c4cc5ccccc5o4)n3)cc21		CHEMBL1779368	=	EC50	nM	11.0	CHEMBL2208	Homo sapiens	EC50	nM	11.0
	6202047	CHEMBL1780645	Inhibition of MK2 pretreated for 30 mins before fluorescein labeled substrate peptide addition measured after 2 hrs by IMAP assay	B	O=C1NCC2(CCCNC2)c2[nH]c(-c3ccnc(-c4ccc5c(c4)OCO5)n3)cc21		CHEMBL1779369	=	EC50	nM	28.0	CHEMBL2208	Homo sapiens	EC50	nM	28.0
	6202048	CHEMBL1780645	Inhibition of MK2 pretreated for 30 mins before fluorescein labeled substrate peptide addition measured after 2 hrs by IMAP assay	B	COc1cncc(-c2nccc(-c3cc4c([nH]3)C3(CCCNC3)CNC4=O)n2)c1		CHEMBL1779370	=	EC50	nM	24.0	CHEMBL2208	Homo sapiens	EC50	nM	24.0
	6202049	CHEMBL1780645	Inhibition of MK2 pretreated for 30 mins before fluorescein labeled substrate peptide addition measured after 2 hrs by IMAP assay	B	COCCCOc1ccc(-c2nccc(-c3cc4c([nH]3)C3(CCCNC3)CNC4=O)n2)cn1		CHEMBL1779371	=	EC50	nM	21.0	CHEMBL2208	Homo sapiens	EC50	nM	21.0
	6202050	CHEMBL1780645	Inhibition of MK2 pretreated for 30 mins before fluorescein labeled substrate peptide addition measured after 2 hrs by IMAP assay	B	O=C1NC[C@@]2(CCCNC2)c2[nH]c(-c3ccnc(-c4ccc5c(c4)OCO5)n3)cc21		CHEMBL1779372	=	EC50	nM	7.4	CHEMBL2208	Homo sapiens	EC50	nM	7.4
	6202051	CHEMBL1780645	Inhibition of MK2 pretreated for 30 mins before fluorescein labeled substrate peptide addition measured after 2 hrs by IMAP assay	B	O=C1NC[C@]2(CCCNC2)c2[nH]c(-c3ccnc(-c4ccc5c(c4)OCO5)n3)cc21		CHEMBL1779373	=	EC50	nM	91.0	CHEMBL2208	Homo sapiens	EC50	nM	91.0
	6202052	CHEMBL1780645	Inhibition of MK2 pretreated for 30 mins before fluorescein labeled substrate peptide addition measured after 2 hrs by IMAP assay	B	COc1cncc(-c2nccc(-c3cc4c([nH]3)[C@]3(CCCNC3)CNC4=O)n2)c1		CHEMBL1779374	=	EC50	nM	9.3	CHEMBL2208	Homo sapiens	EC50	nM	9.3
	6202053	CHEMBL1780645	Inhibition of MK2 pretreated for 30 mins before fluorescein labeled substrate peptide addition measured after 2 hrs by IMAP assay	B	COc1cncc(-c2nccc(-c3cc4c([nH]3)[C@@]3(CCCNC3)CNC4=O)n2)c1		CHEMBL1779375	=	EC50	nM	126.0	CHEMBL2208	Homo sapiens	EC50	nM	126.0
	6202054	CHEMBL1780645	Inhibition of MK2 pretreated for 30 mins before fluorescein labeled substrate peptide addition measured after 2 hrs by IMAP assay	B	COCCCOc1ccc(-c2nccc(-c3cc4c([nH]3)[C@]3(CCCNC3)CNC4=O)n2)cn1		CHEMBL1779485	=	EC50	nM	6.9	CHEMBL2208	Homo sapiens	EC50	nM	6.9
	6202055	CHEMBL1780645	Inhibition of MK2 pretreated for 30 mins before fluorescein labeled substrate peptide addition measured after 2 hrs by IMAP assay	B	COCCCOc1ccc(-c2nccc(-c3cc4c([nH]3)[C@@]3(CCCNC3)CNC4=O)n2)cn1		CHEMBL1779486	=	EC50	nM	129.0	CHEMBL2208	Homo sapiens	EC50	nM	129.0
	6202056	CHEMBL1780645	Inhibition of MK2 pretreated for 30 mins before fluorescein labeled substrate peptide addition measured after 2 hrs by IMAP assay	B	O=C1NCC2(CCCNC2)c2[nH]c(-c3ccnc(-c4cccnc4)n3)cc21		CHEMBL1779487	=	EC50	nM	18.0	CHEMBL2208	Homo sapiens	EC50	nM	18.0
	6202057	CHEMBL1780645	Inhibition of MK2 pretreated for 30 mins before fluorescein labeled substrate peptide addition measured after 2 hrs by IMAP assay	B	O=C1NC[C@@]2(CCCNC2)c2[nH]c(-c3ccnc(-c4cccnc4)n3)cc21		CHEMBL1779488	=	EC50	nM	6.5	CHEMBL2208	Homo sapiens	EC50	nM	6.5
	6202058	CHEMBL1780645	Inhibition of MK2 pretreated for 30 mins before fluorescein labeled substrate peptide addition measured after 2 hrs by IMAP assay	B	O=C1NC[C@]2(CCCNC2)c2[nH]c(-c3ccnc(-c4cccnc4)n3)cc21		CHEMBL1779489	=	EC50	nM	288.0	CHEMBL2208	Homo sapiens	EC50	nM	288.0
	6202090	CHEMBL1780647	Inhibition of MK2 in LPS-stimulated human THP1 cells assessed as inhibition of Hsp27 phosphorylation pretreated 60 mins before LPS challenge measured after 10 mins	B	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	=	EC50	nM	2700.0	CHEMBL2208	Homo sapiens	EC50	uM	2.7
	6202091	CHEMBL1780647	Inhibition of MK2 in LPS-stimulated human THP1 cells assessed as inhibition of Hsp27 phosphorylation pretreated 60 mins before LPS challenge measured after 10 mins	B	O=C1NCC2(CCNCC2)c2[nH]c(-c3ccnc(-c4ccc5c(c4)OCO5)n3)cc21		CHEMBL1738702	=	EC50	nM	620.0	CHEMBL2208	Homo sapiens	EC50	uM	0.62
Not Determined	6202092	CHEMBL1780647	Inhibition of MK2 in LPS-stimulated human THP1 cells assessed as inhibition of Hsp27 phosphorylation pretreated 60 mins before LPS challenge measured after 10 mins	B	O=C1NCC2(CCOCC2)c2[nH]c(-c3ccnc(-c4ccc5c(c4)OCO5)n3)cc21		CHEMBL1779351		EC50			CHEMBL2208	Homo sapiens	EC50		
	6202093	CHEMBL1780647	Inhibition of MK2 in LPS-stimulated human THP1 cells assessed as inhibition of Hsp27 phosphorylation pretreated 60 mins before LPS challenge measured after 10 mins	B	O=C1NCC2(CCNCC2)c2[nH]c(-c3ccnc(-c4cc5ccccc5o4)n3)cc21		CHEMBL1779352	=	EC50	nM	1200.0	CHEMBL2208	Homo sapiens	EC50	uM	1.2
	6202094	CHEMBL1780647	Inhibition of MK2 in LPS-stimulated human THP1 cells assessed as inhibition of Hsp27 phosphorylation pretreated 60 mins before LPS challenge measured after 10 mins	B	CN1CCC2(CC1)CNC(=O)c1cc(-c3ccnc(-c4cc5ccccc5o4)n3)[nH]c12		CHEMBL1779353	=	EC50	nM	1600.0	CHEMBL2208	Homo sapiens	EC50	uM	1.6
	6202095	CHEMBL1780647	Inhibition of MK2 in LPS-stimulated human THP1 cells assessed as inhibition of Hsp27 phosphorylation pretreated 60 mins before LPS challenge measured after 10 mins	B	CCN1CCC2(CC1)CNC(=O)c1cc(-c3ccnc(-c4cc5ccccc5o4)n3)[nH]c12		CHEMBL1779354	>	EC50	nM	10000.0	CHEMBL2208	Homo sapiens	EC50	uM	10.0
	6202096	CHEMBL1780647	Inhibition of MK2 in LPS-stimulated human THP1 cells assessed as inhibition of Hsp27 phosphorylation pretreated 60 mins before LPS challenge measured after 10 mins	B	O=C1NCC2(CCCNC2)c2[nH]c(-c3ccnc(-c4ccc5c(c4)OCO5)n3)cc21		CHEMBL1779369	=	EC50	nM	930.0	CHEMBL2208	Homo sapiens	EC50	uM	0.93
	6202097	CHEMBL1780647	Inhibition of MK2 in LPS-stimulated human THP1 cells assessed as inhibition of Hsp27 phosphorylation pretreated 60 mins before LPS challenge measured after 10 mins	B	COc1cncc(-c2nccc(-c3cc4c([nH]3)C3(CCCNC3)CNC4=O)n2)c1		CHEMBL1779370	=	EC50	nM	900.0	CHEMBL2208	Homo sapiens	EC50	uM	0.9
	6202098	CHEMBL1780647	Inhibition of MK2 in LPS-stimulated human THP1 cells assessed as inhibition of Hsp27 phosphorylation pretreated 60 mins before LPS challenge measured after 10 mins	B	COCCCOc1ccc(-c2nccc(-c3cc4c([nH]3)C3(CCCNC3)CNC4=O)n2)cn1		CHEMBL1779371	=	EC50	nM	1400.0	CHEMBL2208	Homo sapiens	EC50	uM	1.4
	6202099	CHEMBL1780647	Inhibition of MK2 in LPS-stimulated human THP1 cells assessed as inhibition of Hsp27 phosphorylation pretreated 60 mins before LPS challenge measured after 10 mins	B	O=C1NC[C@@]2(CCCNC2)c2[nH]c(-c3ccnc(-c4ccc5c(c4)OCO5)n3)cc21		CHEMBL1779372	=	EC50	nM	500.0	CHEMBL2208	Homo sapiens	EC50	uM	0.5
	6202100	CHEMBL1780647	Inhibition of MK2 in LPS-stimulated human THP1 cells assessed as inhibition of Hsp27 phosphorylation pretreated 60 mins before LPS challenge measured after 10 mins	B	O=C1NC[C@]2(CCCNC2)c2[nH]c(-c3ccnc(-c4ccc5c(c4)OCO5)n3)cc21		CHEMBL1779373	=	EC50	nM	7700.0	CHEMBL2208	Homo sapiens	EC50	uM	7.7
	6202101	CHEMBL1780647	Inhibition of MK2 in LPS-stimulated human THP1 cells assessed as inhibition of Hsp27 phosphorylation pretreated 60 mins before LPS challenge measured after 10 mins	B	COc1cncc(-c2nccc(-c3cc4c([nH]3)[C@]3(CCCNC3)CNC4=O)n2)c1		CHEMBL1779374	=	EC50	nM	1100.0	CHEMBL2208	Homo sapiens	EC50	uM	1.1
	6202102	CHEMBL1780647	Inhibition of MK2 in LPS-stimulated human THP1 cells assessed as inhibition of Hsp27 phosphorylation pretreated 60 mins before LPS challenge measured after 10 mins	B	COc1cncc(-c2nccc(-c3cc4c([nH]3)[C@@]3(CCCNC3)CNC4=O)n2)c1		CHEMBL1779375	=	EC50	nM	2300.0	CHEMBL2208	Homo sapiens	EC50	uM	2.3
	6202103	CHEMBL1780647	Inhibition of MK2 in LPS-stimulated human THP1 cells assessed as inhibition of Hsp27 phosphorylation pretreated 60 mins before LPS challenge measured after 10 mins	B	COCCCOc1ccc(-c2nccc(-c3cc4c([nH]3)[C@]3(CCCNC3)CNC4=O)n2)cn1		CHEMBL1779485	=	EC50	nM	400.0	CHEMBL2208	Homo sapiens	EC50	uM	0.4
	6202104	CHEMBL1780647	Inhibition of MK2 in LPS-stimulated human THP1 cells assessed as inhibition of Hsp27 phosphorylation pretreated 60 mins before LPS challenge measured after 10 mins	B	COCCCOc1ccc(-c2nccc(-c3cc4c([nH]3)[C@@]3(CCCNC3)CNC4=O)n2)cn1		CHEMBL1779486	>	EC50	nM	10000.0	CHEMBL2208	Homo sapiens	EC50	uM	10.0
	6202105	CHEMBL1780647	Inhibition of MK2 in LPS-stimulated human THP1 cells assessed as inhibition of Hsp27 phosphorylation pretreated 60 mins before LPS challenge measured after 10 mins	B	O=C1NCC2(CCCNC2)c2[nH]c(-c3ccnc(-c4cccnc4)n3)cc21		CHEMBL1779487	=	EC50	nM	2100.0	CHEMBL2208	Homo sapiens	EC50	uM	2.1
	6202106	CHEMBL1780647	Inhibition of MK2 in LPS-stimulated human THP1 cells assessed as inhibition of Hsp27 phosphorylation pretreated 60 mins before LPS challenge measured after 10 mins	B	O=C1NC[C@@]2(CCCNC2)c2[nH]c(-c3ccnc(-c4cccnc4)n3)cc21		CHEMBL1779488	=	EC50	nM	1200.0	CHEMBL2208	Homo sapiens	EC50	uM	1.2
	6202107	CHEMBL1780647	Inhibition of MK2 in LPS-stimulated human THP1 cells assessed as inhibition of Hsp27 phosphorylation pretreated 60 mins before LPS challenge measured after 10 mins	B	O=C1NC[C@]2(CCCNC2)c2[nH]c(-c3ccnc(-c4cccnc4)n3)cc21		CHEMBL1779489	=	EC50	nM	5800.0	CHEMBL2208	Homo sapiens	EC50	uM	5.8
	6203012	CHEMBL1780728	Inhibition of MK2 pretreated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	=	EC50	nM	49.0	CHEMBL2208	Homo sapiens	EC50	nM	49.0
	6203013	CHEMBL1780728	Inhibition of MK2 pretreated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	NCCn1nc(-c2ccnc(-c3cnc4ccccc4c3)c2)cc1C(=O)O		CHEMBL1738780	=	EC50	nM	28.0	CHEMBL2208	Homo sapiens	EC50	nM	28.0
	6203014	CHEMBL1780728	Inhibition of MK2 pretreated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	O=C1NCC2(CCCC2)c2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)n3)cc21		CHEMBL1779516	=	EC50	nM	234.0	CHEMBL2208	Homo sapiens	EC50	nM	234.0
	6203015	CHEMBL1780728	Inhibition of MK2 pretreated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	O=C1NCC2(CCNCC2)c2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)n3)cc21		CHEMBL1779361	=	EC50	nM	6.0	CHEMBL2208	Homo sapiens	EC50	nM	6.0
	6203016	CHEMBL1780728	Inhibition of MK2 pretreated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	O=C1NCC2(CCNCC2)c2[nH]c(-c3ccnc(-c4ccc5c(c4)OCO5)n3)cc21		CHEMBL1738702	=	EC50	nM	4.0	CHEMBL2208	Homo sapiens	EC50	nM	4.0
	6203050	CHEMBL1780896	Inhibition of MK2 in human THP1 cells assessed as Hsp27 phosphorylation	B	O=C1NCC2(CCNCC2)c2[nH]c(-c3ccnc(-c4ccc5c(c4)OCO5)n3)cc21		CHEMBL1738702	=	EC50	nM	620.0	CHEMBL2208	Homo sapiens	EC50	uM	0.62
	6203061	CHEMBL1780728	Inhibition of MK2 pretreated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	NCC1CNC(=O)c2cc(-c3ccnc(-c4cnc5ccccc5c4)c3)nn21		CHEMBL1779517	=	EC50	nM	151.0	CHEMBL2208	Homo sapiens	EC50	nM	151.0
	6218767	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	Nc1ncc(Cl)nc1CNC(=S)Nc1ccccc1		CHEMBL1783545	=	IC50	nM	2000.0	CHEMBL2208	Homo sapiens	IC50	uM	2.0
	6218768	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	CCNC(=S)NCc1nc(Cl)cnc1N		CHEMBL1783546	=	IC50	nM	20000.0	CHEMBL2208	Homo sapiens	IC50	uM	20.0
	6218769	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	CC(C)NC(=S)NCc1nc(Cl)cnc1N		CHEMBL1783547	=	IC50	nM	13000.0	CHEMBL2208	Homo sapiens	IC50	uM	13.0
	6218770	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	CC(C)(C)NC(=S)NCc1nc(Cl)cnc1N		CHEMBL1783548	=	IC50	nM	2500.0	CHEMBL2208	Homo sapiens	IC50	uM	2.5
	6218771	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	Nc1ncc(Cl)nc1CNC(=S)NC1CC1		CHEMBL1783549	=	IC50	nM	12000.0	CHEMBL2208	Homo sapiens	IC50	uM	12.0
	6218772	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	Nc1ncc(Cl)nc1CNC(=S)NC1CCCC1		CHEMBL1783550	=	IC50	nM	53000.0	CHEMBL2208	Homo sapiens	IC50	uM	53.0
	6218773	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	Nc1ncc(Cl)nc1CNC(=S)NC1CCCCCC1		CHEMBL1783551	=	IC50	nM	35000.0	CHEMBL2208	Homo sapiens	IC50	uM	35.0
	6218774	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	Nc1ncc(Cl)nc1CNC(=S)NCc1ccccc1		CHEMBL1783552	=	IC50	nM	36000.0	CHEMBL2208	Homo sapiens	IC50	uM	36.0
	6218775	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	Nc1ncc(Cl)nc1CNC(=S)NCCc1ccccc1		CHEMBL1783553	>	IC50	nM	50000.0	CHEMBL2208	Homo sapiens	IC50	uM	50.0
	6218776	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	COCCNC(=S)NCc1nc(Cl)cnc1N		CHEMBL1783554	=	IC50	nM	22000.0	CHEMBL2208	Homo sapiens	IC50	uM	22.0
	6218777	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	CCN(CC)CCCNC(=S)NCc1nc(Cl)cnc1N		CHEMBL1783555	>	IC50	nM	50000.0	CHEMBL2208	Homo sapiens	IC50	uM	50.0
	6219979	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	Nc1ncc(Cl)nc1CNC(=S)NC(=O)c1ccccc1		CHEMBL1783556	=	IC50	nM	91000.0	CHEMBL2208	Homo sapiens	IC50	uM	91.0
	6219980	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	Nc1ncc(Cl)nc1CNC(=S)Nc1cccc2ccccc12		CHEMBL1783557	=	IC50	nM	3200.0	CHEMBL2208	Homo sapiens	IC50	uM	3.2
	6219981	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	Nc1nccnc1CNC(=S)Nc1ccccc1		CHEMBL1783558	=	IC50	nM	32000.0	CHEMBL2208	Homo sapiens	IC50	uM	32.0
	6219982	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	Cc1cnc(N)c(CNC(=S)Nc2ccccc2)n1		CHEMBL1783559	=	IC50	nM	4000.0	CHEMBL2208	Homo sapiens	IC50	uM	4.0
	6219983	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	CCc1cnc(N)c(CNC(=S)Nc2ccccc2)n1		CHEMBL1783560	=	IC50	nM	1500.0	CHEMBL2208	Homo sapiens	IC50	uM	1.5
	6219984	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	CCCc1cnc(N)c(CNC(=S)Nc2ccccc2)n1		CHEMBL1783561	=	IC50	nM	2300.0	CHEMBL2208	Homo sapiens	IC50	uM	2.3
	6219985	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	Nc1ncc(C(F)(F)F)nc1CNC(=S)Nc1ccccc1		CHEMBL1783562	>	IC50	nM	50000.0	CHEMBL2208	Homo sapiens	IC50	uM	50.0
	6219986	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	Nc1ncc(C2CC2)nc1CNC(=S)Nc1ccccc1		CHEMBL1783563	=	IC50	nM	470.0	CHEMBL2208	Homo sapiens	IC50	uM	0.47
	6219987	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	Nc1ncc(-c2ccccc2)nc1CNC(=S)Nc1ccccc1		CHEMBL1783564	=	IC50	nM	50000.0	CHEMBL2208	Homo sapiens	IC50	uM	50.0
	6219988	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	CN(C)c1nc(N)c(CNC(=S)Nc2ccccc2)nc1Cl		CHEMBL1783565	>	IC50	nM	50000.0	CHEMBL2208	Homo sapiens	IC50	uM	50.0
	6219989	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	CCOc1nc(N)c(CNC(=S)Nc2ccccc2)nc1Cl		CHEMBL1783566	>	IC50	nM	50000.0	CHEMBL2208	Homo sapiens	IC50	uM	50.0
	6219990	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	CSc1nc(N)c(CNC(=S)Nc2ccccc2)nc1Cl		CHEMBL1783567	>	IC50	nM	50000.0	CHEMBL2208	Homo sapiens	IC50	uM	50.0
	6219991	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	Cc1ccc(NC(=S)NCc2nc(Cl)cnc2N)cc1		CHEMBL1783568	=	IC50	nM	2700.0	CHEMBL2208	Homo sapiens	IC50	uM	2.7
	6219992	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	Nc1ncc(Cl)nc1CNC(=S)Nc1ccc(Cl)cc1		CHEMBL1783569	=	IC50	nM	3700.0	CHEMBL2208	Homo sapiens	IC50	uM	3.7
	6219993	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	COc1ccc(NC(=S)NCc2nc(Cl)cnc2N)cc1		CHEMBL1783570	=	IC50	nM	1900.0	CHEMBL2208	Homo sapiens	IC50	uM	1.9
	6219994	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	CC(C)c1ccc(NC(=S)NCc2nc(Cl)cnc2N)cc1		CHEMBL1783571	=	IC50	nM	2600.0	CHEMBL2208	Homo sapiens	IC50	uM	2.6
	6219995	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	CC(C)(C)c1ccc(NC(=S)NCc2nc(Cl)cnc2N)cc1		CHEMBL1783572	=	IC50	nM	13700.0	CHEMBL2208	Homo sapiens	IC50	uM	13.7
	6219996	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	Nc1ncc(Cl)nc1CNC(=S)Nc1ccc(Br)cc1		CHEMBL1783573	=	IC50	nM	3100.0	CHEMBL2208	Homo sapiens	IC50	uM	3.1
	6219997	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	Nc1ncc(Cl)nc1CNC(=S)Nc1ccc([N+](=O)[O-])cc1		CHEMBL1783574	=	IC50	nM	9900.0	CHEMBL2208	Homo sapiens	IC50	uM	9.9
	6219998	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	N#Cc1ccc(NC(=S)NCc2nc(Cl)cnc2N)cc1		CHEMBL1783575	=	IC50	nM	6900.0	CHEMBL2208	Homo sapiens	IC50	uM	6.9
	6219999	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	Nc1ncc(Cl)nc1CNC(=S)Nc1ccc(-n2cnnn2)cc1		CHEMBL1783576	>	IC50	nM	40000.0	CHEMBL2208	Homo sapiens	IC50	uM	40.0
	6220000	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	Nc1ncc(Cl)nc1CNC(=S)Nc1ccc(OCc2ccccc2)cc1		CHEMBL1783577	=	IC50	nM	2700.0	CHEMBL2208	Homo sapiens	IC50	uM	2.7
	6220001	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	CC(=O)c1ccc(NC(=S)NCc2nc(Cl)cnc2N)cc1		CHEMBL1783578	=	IC50	nM	6900.0	CHEMBL2208	Homo sapiens	IC50	uM	6.9
	6220002	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	CCOC(=O)c1ccc(NC(=S)NCc2nc(Cl)cnc2N)cc1		CHEMBL1783579	=	IC50	nM	10700.0	CHEMBL2208	Homo sapiens	IC50	uM	10.7
	6220003	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	CN(C)c1ccc(NC(=S)NCc2nc(Cl)cnc2N)cc1		CHEMBL1783580	=	IC50	nM	7000.0	CHEMBL2208	Homo sapiens	IC50	uM	7.0
	6220004	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	CC(=O)Nc1ccc(NC(=S)NCc2nc(Cl)cnc2N)cc1		CHEMBL1783581	=	IC50	nM	5200.0	CHEMBL2208	Homo sapiens	IC50	uM	5.2
	6220005	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	Nc1ccc(NC(=S)NCc2nc(Cl)cnc2N)cc1		CHEMBL1783669	=	IC50	nM	2000.0	CHEMBL2208	Homo sapiens	IC50	uM	2.0
	6220006	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	Nc1ncc(Cl)nc1CNC(=S)Nc1ccc(NC(=O)OCc2ccccc2)cc1		CHEMBL1783670	=	IC50	nM	460.0	CHEMBL2208	Homo sapiens	IC50	uM	0.46
	6220007	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	Cc1ccccc1NC(=S)NCc1nc(Cl)cnc1N		CHEMBL1783671	=	IC50	nM	3600.0	CHEMBL2208	Homo sapiens	IC50	uM	3.6
	6220008	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	Nc1ncc(Cl)nc1CNC(=S)Nc1ccccc1Cl		CHEMBL1783672	=	IC50	nM	1100.0	CHEMBL2208	Homo sapiens	IC50	uM	1.1
	6220009	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	COc1ccccc1NC(=S)NCc1nc(Cl)cnc1N		CHEMBL1783673	=	IC50	nM	2600.0	CHEMBL2208	Homo sapiens	IC50	uM	2.6
	6220010	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	Nc1ncc(Cl)nc1CNC(=S)Nc1ccccc1F		CHEMBL1783674	=	IC50	nM	2000.0	CHEMBL2208	Homo sapiens	IC50	uM	2.0
	6220011	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	CSc1ccccc1NC(=S)NCc1nc(Cl)cnc1N		CHEMBL1783675	=	IC50	nM	2500.0	CHEMBL2208	Homo sapiens	IC50	uM	2.5
	6220012	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	Nc1ncc(Cl)nc1CNC(=S)Nc1ccccc1-c1ccccc1		CHEMBL1783676	>	IC50	nM	20000.0	CHEMBL2208	Homo sapiens	IC50	uM	20.0
	6220013	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	Cc1cccc(NC(=S)NCc2nc(Cl)cnc2N)c1		CHEMBL1783677	=	IC50	nM	9300.0	CHEMBL2208	Homo sapiens	IC50	uM	9.3
	6220014	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	Nc1ncc(Cl)nc1CNC(=S)Nc1cccc(Cl)c1		CHEMBL1783678	=	IC50	nM	11300.0	CHEMBL2208	Homo sapiens	IC50	uM	11.3
	6220015	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	COc1cccc(NC(=S)NCc2nc(Cl)cnc2N)c1		CHEMBL1783679	=	IC50	nM	14500.0	CHEMBL2208	Homo sapiens	IC50	uM	14.5
	6220016	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	COc1ccc(NC(=S)NCc2nc(Cl)cnc2N)c(OC)c1		CHEMBL1783680	=	IC50	nM	2500.0	CHEMBL2208	Homo sapiens	IC50	uM	2.5
	6220017	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	Nc1ncc(Cl)nc1CNC(=S)Nc1ccc(Cl)cc1Cl		CHEMBL1783681	=	IC50	nM	4300.0	CHEMBL2208	Homo sapiens	IC50	uM	4.3
	6220018	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	COc1ccc(NC(=S)NCc2nc(Cl)cnc2N)cc1OC		CHEMBL1783682	=	IC50	nM	40000.0	CHEMBL2208	Homo sapiens	IC50	uM	40.0
	6220019	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	Nc1ncc(Cl)nc1CNC(=S)Nc1ccc(Cl)c(Cl)c1		CHEMBL1783683	=	IC50	nM	40000.0	CHEMBL2208	Homo sapiens	IC50	uM	40.0
	6220020	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	Nc1ncc(Cl)nc1CNC(=S)Nc1cc(Cl)cc(Cl)c1		CHEMBL1783684	=	IC50	nM	27000.0	CHEMBL2208	Homo sapiens	IC50	uM	27.0
	6220021	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	COC(=O)Nc1ccc(NC(=S)NCc2nc(Cl)cnc2N)cc1		CHEMBL1783685	=	IC50	nM	940.0	CHEMBL2208	Homo sapiens	IC50	uM	0.94
	6220022	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	CCOC(=O)Nc1ccc(NC(=S)NCc2nc(Cl)cnc2N)cc1		CHEMBL1783686	=	IC50	nM	310.0	CHEMBL2208	Homo sapiens	IC50	uM	0.31
	6220023	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	CCCCOC(=O)Nc1ccc(NC(=S)NCc2nc(Cl)cnc2N)cc1		CHEMBL1783687	=	IC50	nM	230.0	CHEMBL2208	Homo sapiens	IC50	uM	0.23
	6220024	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	CC(C)COC(=O)Nc1ccc(NC(=S)NCc2nc(Cl)cnc2N)cc1		CHEMBL1783688	=	IC50	nM	150.0	CHEMBL2208	Homo sapiens	IC50	uM	0.15
	6220025	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	CC(C)(C)OC(=O)Nc1ccc(NC(=S)NCc2nc(Cl)cnc2N)cc1		CHEMBL1783689	=	IC50	nM	190.0	CHEMBL2208	Homo sapiens	IC50	uM	0.19
	6220026	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	CC(C)COC(=O)N(c1ccccc1)c1ccc(NC(=S)NCc2nc(Cl)cnc2N)cc1		CHEMBL1783668	=	IC50	nM	1500.0	CHEMBL2208	Homo sapiens	IC50	uM	1.5
	6220027	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	CNC(=O)Nc1ccc(NC(=S)NCc2nc(Cl)cnc2N)cc1		CHEMBL1783690	=	IC50	nM	1700.0	CHEMBL2208	Homo sapiens	IC50	uM	1.7
	6220028	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	CC(C)(C)NC(=O)Nc1ccc(NC(=S)NCc2nc(Cl)cnc2N)cc1		CHEMBL1783691	=	IC50	nM	700.0	CHEMBL2208	Homo sapiens	IC50	uM	0.7
	6220029	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	Cc1cnc(N)c(CNC(=S)Nc2ccc(NC(=O)OC(C)(C)C)cc2)n1		CHEMBL1783692	=	IC50	nM	210.0	CHEMBL2208	Homo sapiens	IC50	uM	0.21
	6220030	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	Cc1cnc(N)c(CNC(=S)Nc2ccc(NC(=O)Oc3ccccc3)cc2)n1		CHEMBL1783693	=	IC50	nM	730.0	CHEMBL2208	Homo sapiens	IC50	uM	0.73
	6220031	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	CCOC(=O)N(C)c1ccc(NC(=S)NCc2nc(C)cnc2N)cc1		CHEMBL1783694	=	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	6220032	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	Cc1cnc(N)c(CNC(=S)Nc2ccc(OC(=O)OC(C)(C)C)cc2)n1		CHEMBL1783695	=	IC50	nM	2900.0	CHEMBL2208	Homo sapiens	IC50	uM	2.9
	6220033	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	CCC(=O)Nc1ccc(NC(=S)NCc2nc(C)cnc2N)cc1		CHEMBL1783696	=	IC50	nM	13300.0	CHEMBL2208	Homo sapiens	IC50	uM	13.3
	6220034	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	CCCC(=O)Nc1ccc(NC(=S)NCc2nc(C)cnc2N)cc1		CHEMBL1783697	=	IC50	nM	2300.0	CHEMBL2208	Homo sapiens	IC50	uM	2.3
	6220035	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	CCCCC(=O)Nc1ccc(NC(=S)NCc2nc(C)cnc2N)cc1		CHEMBL1783698	=	IC50	nM	1500.0	CHEMBL2208	Homo sapiens	IC50	uM	1.5
	6220036	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	Cc1cnc(N)c(CNC(=S)Nc2ccc(NC(=O)Cc3ccccc3)cc2)n1		CHEMBL1783699	=	IC50	nM	3800.0	CHEMBL2208	Homo sapiens	IC50	uM	3.8
	6220037	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	Cc1cnc(N)c(CNC(=S)Nc2ccc(NC(=O)c3ccccc3)cc2)n1		CHEMBL1783700	=	IC50	nM	580.0	CHEMBL2208	Homo sapiens	IC50	uM	0.58
	6220038	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	Cc1cnc(N)c(CNC(=S)Nc2ccc3[nH]c(=O)oc3c2)n1		CHEMBL1783701	=	IC50	nM	210.0	CHEMBL2208	Homo sapiens	IC50	uM	0.21
	6220039	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	Cc1cnc(N)c(CNC(=S)Nc2ccc3[nH]c(=O)[nH]c3c2)n1		CHEMBL1783702	=	IC50	nM	15000.0	CHEMBL2208	Homo sapiens	IC50	uM	15.0
	6220040	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	Cc1cnc(N)c(CNC(=S)Nc2ccc3c(c2)CC(=O)N3)n1		CHEMBL1783703	=	IC50	nM	27000.0	CHEMBL2208	Homo sapiens	IC50	uM	27.0
	6220041	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	Cc1cnc(N)c(CNC(=S)Nc2ccc3[nH]c(=O)sc3c2)n1		CHEMBL1783704	=	IC50	nM	15000.0	CHEMBL2208	Homo sapiens	IC50	uM	15.0
	6220042	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	Cc1cnc(N)c(CNC(=S)Nc2ccc3oc(=O)[nH]c3c2)n1		CHEMBL1783705	=	IC50	nM	14000.0	CHEMBL2208	Homo sapiens	IC50	uM	14.0
	6220043	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	Cc1cnc(N)c(CNC(=S)Nc2ccc3c(c2)[nH]c(=O)n3C)n1		CHEMBL1783706	>	IC50	nM	20000.0	CHEMBL2208	Homo sapiens	IC50	uM	20.0
	6220044	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	CCc1cnc(N)c(CNC(=S)Nc2ccc(NC(=O)OC(C)(C)C)cc2)n1		CHEMBL1783707	=	IC50	nM	140.0	CHEMBL2208	Homo sapiens	IC50	uM	0.14
	6220045	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	CCCc1cnc(N)c(CNC(=S)Nc2ccc(NC(=O)OC(C)(C)C)cc2)n1		CHEMBL1783708	=	IC50	nM	45.0	CHEMBL2208	Homo sapiens	IC50	uM	0.045
	6220046	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	CC(C)(C)OC(=O)Nc1ccc(NC(=S)NCc2nc(C3CC3)cnc2N)cc1		CHEMBL1783709	=	IC50	nM	103.0	CHEMBL2208	Homo sapiens	IC50	uM	0.103
	6220047	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	CCCc1cnc(N)c(CNC(=S)Nc2ccc3[nH]c(=O)oc3c2)n1		CHEMBL1783710	=	IC50	nM	20.0	CHEMBL2208	Homo sapiens	IC50	uM	0.02
	6220048	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	CCCCc1cnc(N)c(CNC(=S)Nc2ccc3[nH]c(=O)oc3c2)n1		CHEMBL1783711	=	IC50	nM	30.0	CHEMBL2208	Homo sapiens	IC50	uM	0.03
	6220049	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	Nc1ncc(C2CC2)nc1CNC(=S)Nc1ccc2[nH]c(=O)oc2c1		CHEMBL1783712	=	IC50	nM	15.0	CHEMBL2208	Homo sapiens	IC50	uM	0.015
	6220050	CHEMBL1786602	Inhibition of MK2 using biotin-LCAYSRALSRQLSSGVSEIRH substrate	B	CC(C)(C)NC(=O)Nc1ccc(NC(=S)NCc2nc(C3CC3)cnc2N)cc1		CHEMBL1783713	=	IC50	nM	83.0	CHEMBL2208	Homo sapiens	IC50	uM	0.083
	6262749	CHEMBL1798618	Inhibition of MK2	B	Cc1ccc(C(=O)NCCO)cc1-n1cnc(OCc2ccc(F)cc2F)c(Cl)c1=O		CHEMBL1738710	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	6267529	CHEMBL1799037	Inhibition of MK2 at 10 uM	B	O=c1c(Cl)c(OCc2ccc(F)cc2F)cc(CO)n1-c1c(F)cccc1F		CHEMBL1797211	<	Inhibition	%	50.0	CHEMBL2208	Homo sapiens	INH	%	50.0
	6267530	CHEMBL1799037	Inhibition of MK2 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cccc(C(N)=O)c1		CHEMBL1797224	<	Inhibition	%	50.0	CHEMBL2208	Homo sapiens	INH	%	50.0
	6274422	CHEMBL1806147	Inhibition of MAPKAPK2 assessed as residual enzyme activity at 10 uM	B	CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12		CHEMBL1234833	=	Activity	%	111.0	CHEMBL2208	Homo sapiens	Activity	%	111.0
	6278377	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	O=C1NCC2(CNC2)c2[nH]c3c(c21)CCc1cnc(-c2cccc(F)c2)cc1-3		CHEMBL1801285	<	IC50	nM	3.0	CHEMBL2208	Homo sapiens	IC50	uM	0.003
	6278378	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	CN1CC2(CNC(=O)c3c2[nH]c2c3CCc3cnc(-c4ccccc4F)cc3-2)C1		CHEMBL1233942	<	IC50	nM	3.0	CHEMBL2208	Homo sapiens	IC50	uM	0.003
	6278379	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	COCCCOc1cncc(-c2cc3c(cn2)CCc2c-3[nH]c3c2C(=O)NCC32CN(C)C2)c1		CHEMBL1801286	<	IC50	nM	3.0	CHEMBL2208	Homo sapiens	IC50	uM	0.003
	6278380	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	CN1CC2(CNC(=O)c3c2[nH]c2c3CCc3cnc(-c4cccc(F)c4)cc3-2)C1		CHEMBL1801287	<	IC50	nM	3.0	CHEMBL2208	Homo sapiens	IC50	uM	0.003
	6278381	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	COc1ccc(-c2cc3c(cn2)CCc2c-3[nH]c3c2C(=O)NCC32CN(C)C2)cc1		CHEMBL1801288	<	IC50	nM	3.0	CHEMBL2208	Homo sapiens	IC50	uM	0.003
	6278382	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	CN1CC2(CNC(=O)c3c2[nH]c2c3CCc3cnc(-c4ccc(F)nc4)cc3-2)C1		CHEMBL1801289	<	IC50	nM	3.0	CHEMBL2208	Homo sapiens	IC50	uM	0.003
	6278383	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	CN1CC2(CNC(=O)c3c2[nH]c2c3CCc3cnc(-c4ccc(OCCN5CCOCC5)cc4)cc3-2)C1		CHEMBL1801290	<	IC50	nM	3.0	CHEMBL2208	Homo sapiens	IC50	uM	0.003
	6278384	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	CCN1CC2(CNC(=O)c3c2[nH]c2c3CCc3cnc(-c4ccccc4F)cc3-2)C1		CHEMBL1801291	<	IC50	nM	3.0	CHEMBL2208	Homo sapiens	IC50	uM	0.003
	6278385	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	COc1ccc(-c2ncc3c(n2)-c2[nH]c4c(c2CC3)C(=O)NCC42CN(C)C2)cc1		CHEMBL1801306	<	IC50	nM	3.0	CHEMBL2208	Homo sapiens	IC50	uM	0.003
	6278386	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	CN1CC2(CNC(=O)c3c2[nH]c2c3CCc3cnc(-c4ccc(OCCN5CCOCC5)cc4)nc3-2)C1		CHEMBL1801308	<	IC50	nM	3.0	CHEMBL2208	Homo sapiens	IC50	uM	0.003
	6278387	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	CN1CCC2(CC1)CNC(=O)c1c2[nH]c2c1CCc1cnc(-c3ccccc3F)cc1-2		CHEMBL1801296	=	IC50	nM	4.0	CHEMBL2208	Homo sapiens	IC50	uM	0.004
	6278388	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	COCCOc1cncc(-c2ncc3c(n2)-c2[nH]c4c(c2CC3)C(=O)NCC42CN(C)C2)c1		CHEMBL1801304	=	IC50	nM	6.0	CHEMBL2208	Homo sapiens	IC50	uM	0.006
	6278389	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	CN1CC2(CNC(=O)c3c2[nH]c2c3CCc3cnc(-c4cccc(F)c4)nc3-2)C1		CHEMBL1801305	=	IC50	nM	6.0	CHEMBL2208	Homo sapiens	IC50	uM	0.006
	6278390	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	CN1CC2(CNC(=O)c3c2[nH]c2c3CCc3cnc(-c4ccc(F)nc4)nc3-2)C1		CHEMBL1801307	=	IC50	nM	7.0	CHEMBL2208	Homo sapiens	IC50	uM	0.007
	6278391	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	O=C1NCCc2[nH]c3c(c21)CCc1cnc(-c2cccc(F)c2)cc1-3		CHEMBL1801274	=	IC50	nM	8.0	CHEMBL2208	Homo sapiens	IC50	uM	0.008
	6278392	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	COCCOc1cncc(-c2cc3c(ccc4c5c([nH]c43)CCNC5=O)cn2)c1		CHEMBL1614995	=	IC50	nM	10.0	CHEMBL2208	Homo sapiens	IC50	uM	0.01
	6278393	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	COc1ccc(-c2cc3c(cn2)CCc2c-3[nH]c3c2C(=O)NC2(CNC2)C3)cc1		CHEMBL1801294	=	IC50	nM	12.0	CHEMBL2208	Homo sapiens	IC50	uM	0.012
	6278394	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	CN1CC2(CNC(=O)c3c4c(n(C)c32)-c2cc(-c3ccccc3F)ncc2CC4)C1		CHEMBL1801312	=	IC50	nM	13.0	CHEMBL2208	Homo sapiens	IC50	uM	0.013
	6278395	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	O=C1NCC2(CNC2)c2[nH]c3c(c21)CCc1cnc(-c2ccccc2F)cc1-3		CHEMBL1801284	=	IC50	nM	17.0	CHEMBL2208	Homo sapiens	IC50	uM	0.017
	6278396	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	Cn1c2c(c3c1C1(CNC1)CNC3=O)CCc1cnc(-c3ccccc3F)cc1-2		CHEMBL1801311	=	IC50	nM	20.0	CHEMBL2208	Homo sapiens	IC50	uM	0.02
	6278397	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	O=C1NCC2(CC2)c2[nH]c3c(c21)CCc1cnc(-c2ccc(F)nc2)cc1-3		CHEMBL1801283	=	IC50	nM	27.0	CHEMBL2208	Homo sapiens	IC50	uM	0.027
	6278398	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	CN1CC2(CNC(=O)c3c2[nH]c2c3CCc3cnc(-c4ccccc4F)nc3-2)C1		CHEMBL1801303	=	IC50	nM	34.0	CHEMBL2208	Homo sapiens	IC50	uM	0.034
	6278399	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	O=C1NCCc2[nH]c3c(c21)CCc1cnc(-c2ccccc2F)cc1-3		CHEMBL1801194	=	IC50	nM	37.0	CHEMBL2208	Homo sapiens	IC50	uM	0.037
	6278400	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	COCCOc1cncc(-c2cc3c(cn2)CCc2c-3[nH]c3c2C(=O)NCC3)c1		CHEMBL1801195	=	IC50	nM	40.0	CHEMBL2208	Homo sapiens	IC50	uM	0.04
	6278401	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	COc1ccc(-c2cc3c(cn2)CCc2c-3[nH]c3c2C(=O)NC2(C3)CN(C)C2)cc1		CHEMBL1801295	=	IC50	nM	45.0	CHEMBL2208	Homo sapiens	IC50	uM	0.045
	6278402	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	O=C1NC2(CC2)Cc2[nH]c3c(c21)CCc1cnc(-c2ccc(F)nc2)cc1-3		CHEMBL1801279	=	IC50	nM	50.0	CHEMBL2208	Homo sapiens	IC50	uM	0.05
	6278404	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	COc1ccc(-c2cc3c(cn2)CCc2c-3[nH]c3c2C(=O)NCC3)cc1		CHEMBL1801275	=	IC50	nM	80.0	CHEMBL2208	Homo sapiens	IC50	uM	0.08
	6278406	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	O=C1NC2(CC2)Cc2[nH]c3c(c21)CCc1cnc(-c2ccc(OCCN4CCOCC4)cc2)cc1-3		CHEMBL1801280	=	IC50	nM	100.0	CHEMBL2208	Homo sapiens	IC50	uM	0.1
	6278407	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	O=C1NCC2(CC2)c2[nH]c3c(c21)CCc1cnc(-c2cccc(F)c2)cc1-3		CHEMBL1801281	=	IC50	nM	100.0	CHEMBL2208	Homo sapiens	IC50	uM	0.1
	6278409	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	O=C1NCC2(CNC2)c2[nH]c3c(c21)CCc1cnc(-c2ccccc2F)cc1-3		CHEMBL1801284	=	IC50	nM	100.0	CHEMBL2208	Homo sapiens	IC50	uM	0.1
	6278414	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	CC(=O)N1CC2(CNC(=O)c3c2[nH]c2c3CCc3cnc(-c4ccccc4F)cc3-2)C1		CHEMBL1801293	=	IC50	nM	120.0	CHEMBL2208	Homo sapiens	IC50	uM	0.12
	6278415	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	O=C1NC2(CC2)Cc2[nH]c3c(c21)CCc1cnc(-c2ccc(F)nc2)nc1-3		CHEMBL1801300	=	IC50	nM	120.0	CHEMBL2208	Homo sapiens	IC50	uM	0.12
	6278416	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	COc1ccc(-c2cc3c(cn2)CCc2c-3[nH]c3c2C(=O)NCC32CC2)cc1		CHEMBL1801282	=	IC50	nM	130.0	CHEMBL2208	Homo sapiens	IC50	uM	0.13
	6278417	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	O=C1NC2(CC2)Cc2[nH]c3c(c21)CCc1cnc(-c2ccccc2F)cc1-3		CHEMBL1801276	=	IC50	nM	140.0	CHEMBL2208	Homo sapiens	IC50	uM	0.14
	6278418	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	COc1ccc(-c2ncc3c(n2)-c2[nH]c4c(c2CC3)C(=O)NCC42CC2)cc1		CHEMBL1801302	=	IC50	nM	150.0	CHEMBL2208	Homo sapiens	IC50	uM	0.15
	6278419	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	COc1ccc(-c2cc3c(cn2)CCc2c-3[nH]c3c2C(=O)NC2(CC2)C3)cc1		CHEMBL1801278	=	IC50	nM	175.0	CHEMBL2208	Homo sapiens	IC50	uM	0.175
	6278420	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	COCCOc1cncc(-c2cc3c(cn2)CCCc2c-3[nH]c3c2C(=O)NCC3)c1		CHEMBL1801196	=	IC50	nM	180.0	CHEMBL2208	Homo sapiens	IC50	uM	0.18
	6278421	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	O=C1NC2(CC2)Cc2[nH]c3c(c21)CCc1cnc(-c2ccc(OCCN4CCOCC4)cc2)nc1-3		CHEMBL1801301	=	IC50	nM	180.0	CHEMBL2208	Homo sapiens	IC50	uM	0.18
	6278425	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	O=C1NCC2(CNC2)c2[nH]c3c(c21)CCc1cnc(-c2cccc(F)c2)cc1-3		CHEMBL1801285	=	IC50	nM	200.0	CHEMBL2208	Homo sapiens	IC50	uM	0.2
	6278427	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	CN1CC2(CNC(=O)c3c2[nH]c2c3CCc3cnc(-c4cccc(F)c4)cc3-2)C1		CHEMBL1801287	=	IC50	nM	200.0	CHEMBL2208	Homo sapiens	IC50	uM	0.2
	6278429	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	O=C1NCC2(CNC2)c2oc3c(c21)CCc1cnc(-c2cccc(F)c2)cc1-3		CHEMBL1801309	=	IC50	nM	200.0	CHEMBL2208	Homo sapiens	IC50	uM	0.2
	6278430	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	CN1CC2(CNC(=O)c3c2[nH]c2c3Cc3cnc(-c4ccccc4F)cc3-2)C1		CHEMBL1801273	=	IC50	nM	230.0	CHEMBL2208	Homo sapiens	IC50	uM	0.23
	6278431	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	O=C1NC2(CC2)Cc2[nH]c3c(c21)CCc1cnc(-c2cccc(F)c2)cc1-3		CHEMBL1801277	=	IC50	nM	230.0	CHEMBL2208	Homo sapiens	IC50	uM	0.23
	6278432	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	O=C1NCC2(CN(CCF)C2)c2[nH]c3c(c21)CCc1cnc(-c2ccccc2F)cc1-3		CHEMBL1801292	=	IC50	nM	230.0	CHEMBL2208	Homo sapiens	IC50	uM	0.23
	6278433	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	COc1ccc(-c2ncc3c(n2)-c2[nH]c4c(c2CC3)C(=O)NCC4)cc1		CHEMBL1801297	=	IC50	nM	270.0	CHEMBL2208	Homo sapiens	IC50	uM	0.27
	6278436	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	CN1CC2(CNC(=O)c3c2[nH]c2c3CCc3cnc(-c4ccccc4F)cc3-2)C1		CHEMBL1233942	=	IC50	nM	300.0	CHEMBL2208	Homo sapiens	IC50	uM	0.3
	6278441	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	O=C1NC2(CC2)Cc2[nH]c3c(c21)CCc1cnc(-c2cccc(F)c2)cc1-3		CHEMBL1801277	=	IC50	nM	500.0	CHEMBL2208	Homo sapiens	IC50	uM	0.5
	6278443	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	=	IC50	nM	560.0	CHEMBL2208	Homo sapiens	IC50	uM	0.56
	6278445	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	COc1ccc(-c2cc3c(cn2)CCc2c-3[nH]c3c2C(=O)NCC3)cc1		CHEMBL1801275	=	IC50	nM	700.0	CHEMBL2208	Homo sapiens	IC50	uM	0.7
	6278446	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	O=C1NC2(CC2)Cc2[nH]c3c(c21)CCc1cnc(-c2ccccc2F)cc1-3		CHEMBL1801276	=	IC50	nM	700.0	CHEMBL2208	Homo sapiens	IC50	uM	0.7
	6278447	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	COc1ccc(-c2cc3c(cn2)CCc2c-3[nH]c3c2C(=O)NC2(CC2)C3)cc1		CHEMBL1801278	=	IC50	nM	700.0	CHEMBL2208	Homo sapiens	IC50	uM	0.7
	6278450	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	COc1ccc(-c2cc3c(cn2)CCc2c-3[nH]c3c2C(=O)NCC32CN(C)C2)cc1		CHEMBL1801288	=	IC50	nM	700.0	CHEMBL2208	Homo sapiens	IC50	uM	0.7
	6278452	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	CN1CCC2(CC1)CNC(=O)c1c2[nH]c2c1CCc1cnc(-c3ccccc3F)cc1-2		CHEMBL1801296	=	IC50	nM	700.0	CHEMBL2208	Homo sapiens	IC50	uM	0.7
	6278456	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	O=C1NC2(CC2)Cc2[nH]c3c(c21)CCc1cnc(-c2ccccc2F)nc1-3		CHEMBL1801298	=	IC50	nM	860.0	CHEMBL2208	Homo sapiens	IC50	uM	0.86
	6278459	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	O=C1NCC2(CC2)c2[nH]c3c(c21)CCc1cnc(-c2cccc(F)c2)cc1-3		CHEMBL1801281	=	IC50	nM	900.0	CHEMBL2208	Homo sapiens	IC50	uM	0.9
	6278461	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	COc1ccc(-c2ncc3c(n2)-c2[nH]c4c(c2CC3)C(=O)NC2(CC2)C4)cc1		CHEMBL1801299	=	IC50	nM	900.0	CHEMBL2208	Homo sapiens	IC50	uM	0.9
	6278463	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	O=C1NC2(CC2)Cc2[nH]c3c(c21)CCc1cnc(-c2ccc(F)nc2)cc1-3		CHEMBL1801279	=	IC50	nM	1100.0	CHEMBL2208	Homo sapiens	IC50	uM	1.1
	6278466	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	COc1ccc(-c2cc3c(cn2)CCc2c-3[nH]c3c2C(=O)NCC32CC2)cc1		CHEMBL1801282	=	IC50	nM	1200.0	CHEMBL2208	Homo sapiens	IC50	uM	1.2
	6278467	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	CN1CC2(CNC(=O)c3c2[nH]c2c3CCc3cnc(-c4ccc(F)nc4)cc3-2)C1		CHEMBL1801289	=	IC50	nM	1200.0	CHEMBL2208	Homo sapiens	IC50	uM	1.2
	6278468	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	CN1CC2(CNC(=O)c3c2[nH]c2c3CCc3cnc(-c4ccc(OCCN5CCOCC5)cc4)cc3-2)C1		CHEMBL1801290	=	IC50	nM	1200.0	CHEMBL2208	Homo sapiens	IC50	uM	1.2
	6278469	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	O=C1NCCc2[nH]c3c(c21)CCc1cnc(-c2cccc(F)c2)cc1-3		CHEMBL1801274	=	IC50	nM	1300.0	CHEMBL2208	Homo sapiens	IC50	uM	1.3
	6278471	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	Cn1c2c(c3c1C1(CNC1)CNC3=O)CCc1cnc(-c3ccccc3F)cc1-2		CHEMBL1801311	=	IC50	nM	1300.0	CHEMBL2208	Homo sapiens	IC50	uM	1.3
	6278472	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	O=C1NC2(CC2)Cc2[nH]c3c(c21)CCc1cnc(-c2ccc(OCCN4CCOCC4)cc2)cc1-3		CHEMBL1801280	=	IC50	nM	1400.0	CHEMBL2208	Homo sapiens	IC50	uM	1.4
	6278473	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	O=C1NCC2(CC2)c2[nH]c3c(c21)CCc1cnc(-c2ccc(F)nc2)cc1-3		CHEMBL1801283	=	IC50	nM	1400.0	CHEMBL2208	Homo sapiens	IC50	uM	1.4
	6278474	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	COCCCOc1cncc(-c2cc3c(cn2)CCc2c-3[nH]c3c2C(=O)NCC32CN(C)C2)c1		CHEMBL1801286	=	IC50	nM	1400.0	CHEMBL2208	Homo sapiens	IC50	uM	1.4
	6278475	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	COCCOc1cncc(-c2cc3c(ccc4c5c([nH]c43)CCNC5=O)cn2)c1		CHEMBL1614995	=	IC50	nM	1500.0	CHEMBL2208	Homo sapiens	IC50	uM	1.5
	6278477	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	CCN1CC2(CNC(=O)c3c2[nH]c2c3CCc3cnc(-c4ccccc4F)cc3-2)C1		CHEMBL1801291	=	IC50	nM	1500.0	CHEMBL2208	Homo sapiens	IC50	uM	1.5
	6279106	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	COCCOc1cncc(-c2cc3c(cn2)CCc2c-3[nH]c3c2C(=O)NCC3)c1		CHEMBL1801195	=	IC50	nM	1700.0	CHEMBL2208	Homo sapiens	IC50	uM	1.7
	6279108	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	CN1CC2(CNC(=O)c3c4c(n(C)c32)-c2cc(-c3ccccc3F)ncc2CC4)C1		CHEMBL1801312	=	IC50	nM	1700.0	CHEMBL2208	Homo sapiens	IC50	uM	1.7
	6279109	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	CN1CC2(CNC(=O)c3c2[nH]c2c3CCc3cnc(-c4ccc(F)nc4)nc3-2)C1		CHEMBL1801307	=	IC50	nM	1800.0	CHEMBL2208	Homo sapiens	IC50	uM	1.8
	6279112	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	COc1ccc(-c2ncc3c(n2)-c2[nH]c4c(c2CC3)C(=O)NC2(CC2)C4)cc1		CHEMBL1801299	=	IC50	nM	2500.0	CHEMBL2208	Homo sapiens	IC50	uM	2.5
	6279114	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	O=C1NCCc2[nH]c3c(c21)CCc1cnc(-c2ccccc2F)cc1-3		CHEMBL1801194	=	IC50	nM	2700.0	CHEMBL2208	Homo sapiens	IC50	uM	2.7
	6279115	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	CN1CC2(CNC(=O)c3c2[nH]c2c3CCc3cnc(-c4ccc(OCCN5CCOCC5)cc4)nc3-2)C1		CHEMBL1801308	=	IC50	nM	2800.0	CHEMBL2208	Homo sapiens	IC50	uM	2.8
	6279116	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	COc1ccc(-c2ncc3c(n2)-c2[nH]c4c(c2CC3)C(=O)NCC42CN(C)C2)cc1		CHEMBL1801306	=	IC50	nM	3000.0	CHEMBL2208	Homo sapiens	IC50	uM	3.0
	6279117	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	COc1ccc(-c2cc3c(cn2)CCc2c-3[nH]c3c2C(=O)NC2(CNC2)C3)cc1		CHEMBL1801294	=	IC50	nM	3100.0	CHEMBL2208	Homo sapiens	IC50	uM	3.1
	6279118	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	O=C1NC2(CC2)Cc2[nH]c3c(c21)CCc1cnc(-c2ccc(OCCN4CCOCC4)cc2)nc1-3		CHEMBL1801301	=	IC50	nM	3200.0	CHEMBL2208	Homo sapiens	IC50	uM	3.2
	6279119	CHEMBL1805885	Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis	B	CN1CC2(CNC(=O)c3c2oc2c3CCc3cnc(-c4cccc(F)c4)cc3-2)C1		CHEMBL1801310	=	IC50	nM	3300.0	CHEMBL2208	Homo sapiens	IC50	uM	3.3
	6279133	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	COCCOc1cncc(-c2cc3c(cn2)CCCc2c-3[nH]c3c2C(=O)NCC3)c1		CHEMBL1801196	=	IC50	nM	4300.0	CHEMBL2208	Homo sapiens	IC50	uM	4.3
	6279134	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	COc1ccc(-c2ncc3c(n2)-c2[nH]c4c(c2CC3)C(=O)NCC4)cc1		CHEMBL1801297	=	IC50	nM	4300.0	CHEMBL2208	Homo sapiens	IC50	uM	4.3
	6279135	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	CN1CC2(CNC(=O)c3c2[nH]c2c3CCc3cnc(-c4cccc(F)c4)nc3-2)C1		CHEMBL1801305	=	IC50	nM	4500.0	CHEMBL2208	Homo sapiens	IC50	uM	4.5
	6279138	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	COc1ccc(-c2ncc3c(n2)-c2[nH]c4c(c2CC3)C(=O)NCC42CC2)cc1		CHEMBL1801302	=	IC50	nM	5600.0	CHEMBL2208	Homo sapiens	IC50	uM	5.6
	6279139	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	CN1CC2(CNC(=O)c3c2[nH]c2c3CCc3cnc(-c4ccccc4F)nc3-2)C1		CHEMBL1801303	=	IC50	nM	5600.0	CHEMBL2208	Homo sapiens	IC50	uM	5.6
	6279140	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	O=C1NCC2(CN(CCF)C2)c2[nH]c3c(c21)CCc1cnc(-c2ccccc2F)cc1-3		CHEMBL1801292	=	IC50	nM	6500.0	CHEMBL2208	Homo sapiens	IC50	uM	6.5
	6279142	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	COCCOc1cncc(-c2ncc3c(n2)-c2[nH]c4c(c2CC3)C(=O)NCC42CN(C)C2)c1		CHEMBL1801304	=	IC50	nM	6700.0	CHEMBL2208	Homo sapiens	IC50	uM	6.7
	6279145	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	=	IC50	nM	8900.0	CHEMBL2208	Homo sapiens	IC50	uM	8.9
	6279149	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	CN1CC2(CNC(=O)c3c2[nH]c2c3Cc3cnc(-c4ccccc4F)cc3-2)C1		CHEMBL1801273	=	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	6279153	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	O=C1NC2(CC2)Cc2[nH]c3c(c21)CCc1cnc(-c2ccc(F)nc2)nc1-3		CHEMBL1801300	=	IC50	nM	12000.0	CHEMBL2208	Homo sapiens	IC50	uM	12.0
	6279154	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	O=C1NC2(CC2)Cc2[nH]c3c(c21)CCc1cnc(-c2ccccc2F)nc1-3		CHEMBL1801298	=	IC50	nM	15300.0	CHEMBL2208	Homo sapiens	IC50	uM	15.3
	6279155	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	COc1ccc(-c2cc3c(cn2)CCc2c-3[nH]c3c2C(=O)NC2(C3)CN(C)C2)cc1		CHEMBL1801295	=	IC50	nM	17000.0	CHEMBL2208	Homo sapiens	IC50	uM	17.0
	6279156	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	O=C1NCC2(CNC2)c2oc3c(c21)CCc1cnc(-c2cccc(F)c2)cc1-3		CHEMBL1801309	=	IC50	nM	17000.0	CHEMBL2208	Homo sapiens	IC50	uM	17.0
	6279159	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	CC(=O)N1CC2(CNC(=O)c3c2[nH]c2c3CCc3cnc(-c4ccccc4F)cc3-2)C1		CHEMBL1801293	=	IC50	nM	25000.0	CHEMBL2208	Homo sapiens	IC50	uM	25.0
Not Determined	6279183	CHEMBL1805887	Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysis	B	CN1CC2(CNC(=O)c3c2oc2c3CCc3cnc(-c4cccc(F)c4)cc3-2)C1		CHEMBL1801310		IC50			CHEMBL2208	Homo sapiens	IC50		
	6279225	CHEMBL1805901	Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET assay	B	NCc1[nH]c2c(ccc3cnc(/C=C/c4ccccc4)cc32)c1C(=O)O		CHEMBL1801313	=	IC50	nM	14.0	CHEMBL2208	Homo sapiens	IC50	uM	0.014
	6279226	CHEMBL1805901	Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET assay	B	CNCc1[nH]c2c(ccc3cnc(/C=C/c4ccccc4)cc32)c1C(=O)O		CHEMBL1801314	=	IC50	nM	60.0	CHEMBL2208	Homo sapiens	IC50	uM	0.06
	6279227	CHEMBL1805901	Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET assay	B	O=C1NOCc2[nH]c3c(ccc4cnc(/C=C/c5ccccc5)cc43)c21		CHEMBL1801315	=	IC50	nM	25.0	CHEMBL2208	Homo sapiens	IC50	uM	0.025
	6279228	CHEMBL1805901	Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET assay	B	COc1ccc(-c2cc3c(ccc4c5c([nH]c43)CN(C)NC5=O)cn2)cc1		CHEMBL1801316	=	IC50	nM	23.0	CHEMBL2208	Homo sapiens	IC50	uM	0.023
	6279229	CHEMBL1805901	Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET assay	B	O=C1NCc2[nH]c3c(ccc4cnc(/C=C/c5ccccc5)cc43)c21		CHEMBL1801373	=	IC50	nM	10.0	CHEMBL2208	Homo sapiens	IC50	uM	0.01
	6279230	CHEMBL1805901	Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET assay	B	O=C1NCc2[nH]c3c(ccc4cnc(/C=C/c5ccc(CN6CCOCC6)cc5)cc43)c21		CHEMBL1801374	=	IC50	nM	8.0	CHEMBL2208	Homo sapiens	IC50	uM	0.008
	6279231	CHEMBL1805901	Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET assay	B	O=C1NCc2[nH]c3c(ccc4cnc(/C=C/c5cccc(CCN6CCOCC6)c5)cc43)c21		CHEMBL1801375	=	IC50	nM	10.0	CHEMBL2208	Homo sapiens	IC50	uM	0.01
	6279232	CHEMBL1805901	Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET assay	B	O=C1NCc2[nH]c3c(ccc4cnc(Nc5cccc(F)c5)cc43)c21		CHEMBL1801376	=	IC50	nM	73.0	CHEMBL2208	Homo sapiens	IC50	uM	0.073
	6279233	CHEMBL1805901	Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET assay	B	COc1ccc(-c2cc3c(ccc4c5c([nH]c43)CNC5=O)cn2)cc1		CHEMBL1801377	=	IC50	nM	27.0	CHEMBL2208	Homo sapiens	IC50	uM	0.027
	6279234	CHEMBL1805901	Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET assay	B	O=C1NCc2[nH]c3c(ccc4cnc(-c5ccccc5F)cc43)c21		CHEMBL1801378	=	IC50	nM	85.0	CHEMBL2208	Homo sapiens	IC50	uM	0.085
	6279235	CHEMBL1805901	Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET assay	B	O=C1NCc2[nH]c3c(ccc4cnc(-c5ccccc5C(F)(F)F)cc43)c21		CHEMBL1801379	=	IC50	nM	900.0	CHEMBL2208	Homo sapiens	IC50	uM	0.9
	6279236	CHEMBL1805901	Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET assay	B	O=C1NCc2[nH]c3c(ccc4cnc(-c5cccc(OCCN6CCOCC6)c5)cc43)c21		CHEMBL1801380	=	IC50	nM	32.0	CHEMBL2208	Homo sapiens	IC50	uM	0.032
	6279237	CHEMBL1805901	Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET assay	B	O=C1NCc2[nH]c3c(ccc4cnc(-c5cncc(OCCN6CCOCC6)c5)cc43)c21		CHEMBL1801381	=	IC50	nM	5.0	CHEMBL2208	Homo sapiens	IC50	uM	0.005
	6279238	CHEMBL1805901	Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET assay	B	COCCOc1cncc(-c2cc3c(ccc4c5c([nH]c43)CNC5=O)cn2)c1		CHEMBL1801382	=	IC50	nM	5.0	CHEMBL2208	Homo sapiens	IC50	uM	0.005
	6279239	CHEMBL1805901	Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET assay	B	CN1Cc2[nH]c3c(ccc4cnc(/C=C/c5ccccc5)cc43)c2C1=O		CHEMBL1801383	=	IC50	nM	1189.0	CHEMBL2208	Homo sapiens	IC50	uM	1.189
	6279240	CHEMBL1805901	Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET assay	B	O=C1NCCc2[nH]c3c(ccc4cnc(/C=C/c5ccc(CN6CCOCC6)cc5)cc43)c21		CHEMBL1801384	=	IC50	nM	1.0	CHEMBL2208	Homo sapiens	IC50	uM	0.001
	6279241	CHEMBL1805901	Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET assay	B	O=C1NCCc2[nH]c3c(ccc4cnc(/C=C/c5cccc(CCN6CCOCC6)c5)cc43)c21		CHEMBL1801385	=	IC50	nM	5.0	CHEMBL2208	Homo sapiens	IC50	uM	0.005
	6279242	CHEMBL1805901	Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET assay	B	COc1ccc(-c2cc3c(ccc4c5c([nH]c43)CCNC5=O)cn2)cc1F		CHEMBL1801386	=	IC50	nM	15.0	CHEMBL2208	Homo sapiens	IC50	uM	0.015
	6279243	CHEMBL1805901	Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET assay	B	O=C1NCCc2[nH]c3c(ccc4cnc(-c5cccc(OCCN6CCOCC6)c5)cc43)c21		CHEMBL1801387	=	IC50	nM	16.0	CHEMBL2208	Homo sapiens	IC50	uM	0.016
	6279244	CHEMBL1805901	Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET assay	B	O=C1NCCc2[nH]c3c(ccc4cnc(-c5cncc(OCCN6CCOCC6)c5)cc43)c21		CHEMBL1801388	=	IC50	nM	10.0	CHEMBL2208	Homo sapiens	IC50	uM	0.01
	6279245	CHEMBL1805901	Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET assay	B	COCCOc1cncc(-c2cc3c(ccc4c5c([nH]c43)CCNC5=O)cn2)c1		CHEMBL1614995	=	IC50	nM	12.0	CHEMBL2208	Homo sapiens	IC50	uM	0.012
	6279246	CHEMBL1805901	Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET assay	B	COc1ccc(-c2cc3c(ccc4c5c([nH]c43)CCC5=O)cn2)cc1F		CHEMBL1801389	=	IC50	nM	160.0	CHEMBL2208	Homo sapiens	IC50	uM	0.16
	6279247	CHEMBL1805901	Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET assay	B	O=C1NCCCc2[nH]c3c(ccc4cnc(/C=C/c5ccccc5)cc43)c21		CHEMBL1801390	=	IC50	nM	116.0	CHEMBL2208	Homo sapiens	IC50	uM	0.116
	6279248	CHEMBL1805901	Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET assay	B	O=C1NCCCc2[nH]c3c(ccc4cnc(/C=C/c5ccc(CN6CCOCC6)cc5)cc43)c21		CHEMBL1801391	=	IC50	nM	253.0	CHEMBL2208	Homo sapiens	IC50	uM	0.253
	6279249	CHEMBL1805901	Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET assay	B	O=C1NCCCc2[nH]c3c(ccc4cnc(/C=C/c5cccc(CCN6CCOCC6)c5)cc43)c21		CHEMBL1801392	=	IC50	nM	172.0	CHEMBL2208	Homo sapiens	IC50	uM	0.172
	6279250	CHEMBL1805901	Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET assay	B	COc1ccc(-c2cc3c(ccc4c5c([nH]c43)CCCNC5=O)cn2)cc1		CHEMBL1801091	=	IC50	nM	72.0	CHEMBL2208	Homo sapiens	IC50	uM	0.072
	6279251	CHEMBL1805901	Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET assay	B	O=C1NCCCc2[nH]c3c(ccc4cnc(-c5ccccc5OCCN5CCOCC5)cc43)c21		CHEMBL1801088	=	IC50	nM	167.0	CHEMBL2208	Homo sapiens	IC50	uM	0.167
	6279252	CHEMBL1805901	Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET assay	B	O=C1NCCCc2[nH]c3c(ccc4cnc(-c5cncc(OCCN6CCOCC6)c5)cc43)c21		CHEMBL1801089	=	IC50	nM	80.0	CHEMBL2208	Homo sapiens	IC50	uM	0.08
	6279253	CHEMBL1805901	Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET assay	B	COCCOc1cncc(-c2cc3c(ccc4c5c([nH]c43)CCCNC5=O)cn2)c1		CHEMBL1801090	=	IC50	nM	96.0	CHEMBL2208	Homo sapiens	IC50	uM	0.096
Not Determined	6279283	CHEMBL1805903	Inhibition of MK2 in human THP-1 cells assessed as inhibition of anisomycin stimulated ser78-hsp27 phosphorylation after 10 mins by FACS analysis	B	NCc1[nH]c2c(ccc3cnc(/C=C/c4ccccc4)cc32)c1C(=O)O		CHEMBL1801313		IC50			CHEMBL2208	Homo sapiens	IC50		
Not Determined	6279284	CHEMBL1805903	Inhibition of MK2 in human THP-1 cells assessed as inhibition of anisomycin stimulated ser78-hsp27 phosphorylation after 10 mins by FACS analysis	B	CNCc1[nH]c2c(ccc3cnc(/C=C/c4ccccc4)cc32)c1C(=O)O		CHEMBL1801314		IC50			CHEMBL2208	Homo sapiens	IC50		
Not Determined	6279285	CHEMBL1805903	Inhibition of MK2 in human THP-1 cells assessed as inhibition of anisomycin stimulated ser78-hsp27 phosphorylation after 10 mins by FACS analysis	B	O=C1NOCc2[nH]c3c(ccc4cnc(/C=C/c5ccccc5)cc43)c21		CHEMBL1801315		IC50			CHEMBL2208	Homo sapiens	IC50		
	6279286	CHEMBL1805903	Inhibition of MK2 in human THP-1 cells assessed as inhibition of anisomycin stimulated ser78-hsp27 phosphorylation after 10 mins by FACS analysis	B	COc1ccc(-c2cc3c(ccc4c5c([nH]c43)CN(C)NC5=O)cn2)cc1		CHEMBL1801316	=	IC50	nM	875.0	CHEMBL2208	Homo sapiens	IC50	uM	0.875
Not Determined	6279287	CHEMBL1805903	Inhibition of MK2 in human THP-1 cells assessed as inhibition of anisomycin stimulated ser78-hsp27 phosphorylation after 10 mins by FACS analysis	B	O=C1NCc2[nH]c3c(ccc4cnc(/C=C/c5ccccc5)cc43)c21		CHEMBL1801373		IC50			CHEMBL2208	Homo sapiens	IC50		
Not Determined	6279288	CHEMBL1805903	Inhibition of MK2 in human THP-1 cells assessed as inhibition of anisomycin stimulated ser78-hsp27 phosphorylation after 10 mins by FACS analysis	B	O=C1NCc2[nH]c3c(ccc4cnc(/C=C/c5ccc(CN6CCOCC6)cc5)cc43)c21		CHEMBL1801374		IC50			CHEMBL2208	Homo sapiens	IC50		
Not Determined	6279289	CHEMBL1805903	Inhibition of MK2 in human THP-1 cells assessed as inhibition of anisomycin stimulated ser78-hsp27 phosphorylation after 10 mins by FACS analysis	B	O=C1NCc2[nH]c3c(ccc4cnc(/C=C/c5cccc(CCN6CCOCC6)c5)cc43)c21		CHEMBL1801375		IC50			CHEMBL2208	Homo sapiens	IC50		
Not Determined	6279290	CHEMBL1805903	Inhibition of MK2 in human THP-1 cells assessed as inhibition of anisomycin stimulated ser78-hsp27 phosphorylation after 10 mins by FACS analysis	B	O=C1NCc2[nH]c3c(ccc4cnc(Nc5cccc(F)c5)cc43)c21		CHEMBL1801376		IC50			CHEMBL2208	Homo sapiens	IC50		
Not Determined	6279291	CHEMBL1805903	Inhibition of MK2 in human THP-1 cells assessed as inhibition of anisomycin stimulated ser78-hsp27 phosphorylation after 10 mins by FACS analysis	B	COc1ccc(-c2cc3c(ccc4c5c([nH]c43)CNC5=O)cn2)cc1		CHEMBL1801377		IC50			CHEMBL2208	Homo sapiens	IC50		
	6279292	CHEMBL1805903	Inhibition of MK2 in human THP-1 cells assessed as inhibition of anisomycin stimulated ser78-hsp27 phosphorylation after 10 mins by FACS analysis	B	O=C1NCc2[nH]c3c(ccc4cnc(-c5ccccc5F)cc43)c21		CHEMBL1801378	=	IC50	nM	5078.0	CHEMBL2208	Homo sapiens	IC50	uM	5.078
Not Determined	6279293	CHEMBL1805903	Inhibition of MK2 in human THP-1 cells assessed as inhibition of anisomycin stimulated ser78-hsp27 phosphorylation after 10 mins by FACS analysis	B	O=C1NCc2[nH]c3c(ccc4cnc(-c5ccccc5C(F)(F)F)cc43)c21		CHEMBL1801379		IC50			CHEMBL2208	Homo sapiens	IC50		
	6279294	CHEMBL1805903	Inhibition of MK2 in human THP-1 cells assessed as inhibition of anisomycin stimulated ser78-hsp27 phosphorylation after 10 mins by FACS analysis	B	O=C1NCc2[nH]c3c(ccc4cnc(-c5cccc(OCCN6CCOCC6)c5)cc43)c21		CHEMBL1801380	=	IC50	nM	1280.0	CHEMBL2208	Homo sapiens	IC50	uM	1.28
	6279295	CHEMBL1805903	Inhibition of MK2 in human THP-1 cells assessed as inhibition of anisomycin stimulated ser78-hsp27 phosphorylation after 10 mins by FACS analysis	B	O=C1NCc2[nH]c3c(ccc4cnc(-c5cncc(OCCN6CCOCC6)c5)cc43)c21		CHEMBL1801381	=	IC50	nM	9330.0	CHEMBL2208	Homo sapiens	IC50	uM	9.33
	6279296	CHEMBL1805903	Inhibition of MK2 in human THP-1 cells assessed as inhibition of anisomycin stimulated ser78-hsp27 phosphorylation after 10 mins by FACS analysis	B	COCCOc1cncc(-c2cc3c(ccc4c5c([nH]c43)CNC5=O)cn2)c1		CHEMBL1801382	=	IC50	nM	1680.0	CHEMBL2208	Homo sapiens	IC50	uM	1.68
Not Determined	6279297	CHEMBL1805903	Inhibition of MK2 in human THP-1 cells assessed as inhibition of anisomycin stimulated ser78-hsp27 phosphorylation after 10 mins by FACS analysis	B	CN1Cc2[nH]c3c(ccc4cnc(/C=C/c5ccccc5)cc43)c2C1=O		CHEMBL1801383		IC50			CHEMBL2208	Homo sapiens	IC50		
Not Determined	6279298	CHEMBL1805903	Inhibition of MK2 in human THP-1 cells assessed as inhibition of anisomycin stimulated ser78-hsp27 phosphorylation after 10 mins by FACS analysis	B	O=C1NCCc2[nH]c3c(ccc4cnc(/C=C/c5ccc(CN6CCOCC6)cc5)cc43)c21		CHEMBL1801384		IC50			CHEMBL2208	Homo sapiens	IC50		
Not Determined	6279299	CHEMBL1805903	Inhibition of MK2 in human THP-1 cells assessed as inhibition of anisomycin stimulated ser78-hsp27 phosphorylation after 10 mins by FACS analysis	B	O=C1NCCc2[nH]c3c(ccc4cnc(/C=C/c5cccc(CCN6CCOCC6)c5)cc43)c21		CHEMBL1801385		IC50			CHEMBL2208	Homo sapiens	IC50		
	6279300	CHEMBL1805903	Inhibition of MK2 in human THP-1 cells assessed as inhibition of anisomycin stimulated ser78-hsp27 phosphorylation after 10 mins by FACS analysis	B	COc1ccc(-c2cc3c(ccc4c5c([nH]c43)CCNC5=O)cn2)cc1F		CHEMBL1801386	=	IC50	nM	500.0	CHEMBL2208	Homo sapiens	IC50	uM	0.5
	6279301	CHEMBL1805903	Inhibition of MK2 in human THP-1 cells assessed as inhibition of anisomycin stimulated ser78-hsp27 phosphorylation after 10 mins by FACS analysis	B	O=C1NCCc2[nH]c3c(ccc4cnc(-c5cccc(OCCN6CCOCC6)c5)cc43)c21		CHEMBL1801387	=	IC50	nM	1300.0	CHEMBL2208	Homo sapiens	IC50	uM	1.3
	6279302	CHEMBL1805903	Inhibition of MK2 in human THP-1 cells assessed as inhibition of anisomycin stimulated ser78-hsp27 phosphorylation after 10 mins by FACS analysis	B	O=C1NCCc2[nH]c3c(ccc4cnc(-c5cncc(OCCN6CCOCC6)c5)cc43)c21		CHEMBL1801388	=	IC50	nM	2500.0	CHEMBL2208	Homo sapiens	IC50	uM	2.5
	6279303	CHEMBL1805903	Inhibition of MK2 in human THP-1 cells assessed as inhibition of anisomycin stimulated ser78-hsp27 phosphorylation after 10 mins by FACS analysis	B	COCCOc1cncc(-c2cc3c(ccc4c5c([nH]c43)CCNC5=O)cn2)c1		CHEMBL1614995	=	IC50	nM	700.0	CHEMBL2208	Homo sapiens	IC50	uM	0.7
	6279304	CHEMBL1805903	Inhibition of MK2 in human THP-1 cells assessed as inhibition of anisomycin stimulated ser78-hsp27 phosphorylation after 10 mins by FACS analysis	B	COc1ccc(-c2cc3c(ccc4c5c([nH]c43)CCC5=O)cn2)cc1F		CHEMBL1801389	=	IC50	nM	5800.0	CHEMBL2208	Homo sapiens	IC50	uM	5.8
Not Determined	6279305	CHEMBL1805903	Inhibition of MK2 in human THP-1 cells assessed as inhibition of anisomycin stimulated ser78-hsp27 phosphorylation after 10 mins by FACS analysis	B	O=C1NCCCc2[nH]c3c(ccc4cnc(/C=C/c5ccccc5)cc43)c21		CHEMBL1801390		IC50			CHEMBL2208	Homo sapiens	IC50		
Not Determined	6279306	CHEMBL1805903	Inhibition of MK2 in human THP-1 cells assessed as inhibition of anisomycin stimulated ser78-hsp27 phosphorylation after 10 mins by FACS analysis	B	O=C1NCCCc2[nH]c3c(ccc4cnc(/C=C/c5ccc(CN6CCOCC6)cc5)cc43)c21		CHEMBL1801391		IC50			CHEMBL2208	Homo sapiens	IC50		
Not Determined	6279307	CHEMBL1805903	Inhibition of MK2 in human THP-1 cells assessed as inhibition of anisomycin stimulated ser78-hsp27 phosphorylation after 10 mins by FACS analysis	B	O=C1NCCCc2[nH]c3c(ccc4cnc(/C=C/c5cccc(CCN6CCOCC6)c5)cc43)c21		CHEMBL1801392		IC50			CHEMBL2208	Homo sapiens	IC50		
Not Determined	6279308	CHEMBL1805903	Inhibition of MK2 in human THP-1 cells assessed as inhibition of anisomycin stimulated ser78-hsp27 phosphorylation after 10 mins by FACS analysis	B	COc1ccc(-c2cc3c(ccc4c5c([nH]c43)CCCNC5=O)cn2)cc1		CHEMBL1801091		IC50			CHEMBL2208	Homo sapiens	IC50		
Not Determined	6279309	CHEMBL1805903	Inhibition of MK2 in human THP-1 cells assessed as inhibition of anisomycin stimulated ser78-hsp27 phosphorylation after 10 mins by FACS analysis	B	O=C1NCCCc2[nH]c3c(ccc4cnc(-c5ccccc5OCCN5CCOCC5)cc43)c21		CHEMBL1801088		IC50			CHEMBL2208	Homo sapiens	IC50		
	6279310	CHEMBL1805903	Inhibition of MK2 in human THP-1 cells assessed as inhibition of anisomycin stimulated ser78-hsp27 phosphorylation after 10 mins by FACS analysis	B	O=C1NCCCc2[nH]c3c(ccc4cnc(-c5cncc(OCCN6CCOCC6)c5)cc43)c21		CHEMBL1801089	>	IC50	nM	30000.0	CHEMBL2208	Homo sapiens	IC50	uM	30.0
	6279311	CHEMBL1805903	Inhibition of MK2 in human THP-1 cells assessed as inhibition of anisomycin stimulated ser78-hsp27 phosphorylation after 10 mins by FACS analysis	B	COCCOc1cncc(-c2cc3c(ccc4c5c([nH]c43)CCCNC5=O)cn2)c1		CHEMBL1801090	=	IC50	nM	8300.0	CHEMBL2208	Homo sapiens	IC50	uM	8.3
	6299687	CHEMBL1811584	Inhibition of MK2	B	Cc1ccc(C(=O)NC2CC2)cc1Nc1ncnn2cc(C(=O)c3ccccc3)c(C)c12		CHEMBL1807446	>	IC50	nM	25000.0	CHEMBL2208	Homo sapiens	IC50	uM	25.0
	6313963	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]nc(N)c2c(=O)[nH]1		CHEMBL1813604	=	Inhibition	%	30.0	CHEMBL2208	Homo sapiens	INH	%	30.0
	6313964	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3cccnc3)[nH]c(=O)c12		CHEMBL1813606	=	Inhibition	%	40.0	CHEMBL2208	Homo sapiens	INH	%	40.0
	6313965	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3ccccn3)[nH]c(=O)c12		CHEMBL1813607	=	Inhibition	%	41.0	CHEMBL2208	Homo sapiens	INH	%	41.0
	6313966	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3ccncc3)[nH]c(=O)c12		CHEMBL1813608	=	Inhibition	%	37.0	CHEMBL2208	Homo sapiens	INH	%	37.0
	6313967	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	COc1cccc(-c2cc3[nH]nc(N)c3c(=O)[nH]2)c1		CHEMBL1813609	=	Inhibition	%	56.0	CHEMBL2208	Homo sapiens	INH	%	56.0
	6313968	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	COc1ccc(-c2cc3[nH]nc(N)c3c(=O)[nH]2)cc1		CHEMBL1813610	=	Inhibition	%	59.0	CHEMBL2208	Homo sapiens	INH	%	59.0
	6313969	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	CN1CCN(c2ccc(-c3cc4[nH]nc(N)c4c(=O)[nH]3)cc2)CC1		CHEMBL1813611	=	Inhibition	%	55.0	CHEMBL2208	Homo sapiens	INH	%	55.0
	6313970	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3cccs3)[nH]c(=O)c12		CHEMBL1813612	=	Inhibition	%	58.0	CHEMBL2208	Homo sapiens	INH	%	58.0
	6313971	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	CC(C)(C)c1cc2[nH]nc(N)c2c(=O)[nH]1		CHEMBL1813613	=	Inhibition	%	39.0	CHEMBL2208	Homo sapiens	INH	%	39.0
	6313972	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3ccc(N4CCOCC4)cc3)[nH]c(=O)c12		CHEMBL1813614	=	Inhibition	%	55.0	CHEMBL2208	Homo sapiens	INH	%	55.0
	6313973	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(CC3CCNCC3)[nH]c(=O)c12		CHEMBL1813615	=	Inhibition	%	35.0	CHEMBL2208	Homo sapiens	INH	%	35.0
	6313974	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2c3c([nH]c(=O)c12)CCCC3		CHEMBL1813617	=	Inhibition	%	5.0	CHEMBL2208	Homo sapiens	INH	%	5.0
	6313975	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]nc(N)c2c(N2CCCCC2)n1		CHEMBL1813618	=	Inhibition	%	-1.0	CHEMBL2208	Homo sapiens	INH	%	-1.0
	6313976	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]nc(N)c2c(N2CCOCC2)n1		CHEMBL1813619	=	Inhibition	%	1.0	CHEMBL2208	Homo sapiens	INH	%	1.0
	6313977	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(N)nn2C)c(=O)[nH]1		CHEMBL1813620	=	Inhibition	%	29.0	CHEMBL2208	Homo sapiens	INH	%	29.0
	6313978	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	Cn1nc(N)c2c(=O)[nH]c(-c3ccccc3)cc21		CHEMBL1813621	=	Inhibition	%	37.0	CHEMBL2208	Homo sapiens	INH	%	37.0
	6313979	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	Cn1nc(N)c2c(=O)[nH]c(-c3ccccn3)cc21		CHEMBL1813622	=	Inhibition	%	36.0	CHEMBL2208	Homo sapiens	INH	%	36.0
	6313980	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	COc1ccc(-c2cc3c(c(N)nn3C)c(=O)[nH]2)cc1		CHEMBL1813623	=	Inhibition	%	51.0	CHEMBL2208	Homo sapiens	INH	%	51.0
	6313981	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	COc1cccc(-c2cc3c(c(N)nn3C)c(=O)[nH]2)c1		CHEMBL1813624	=	Inhibition	%	47.0	CHEMBL2208	Homo sapiens	INH	%	47.0
	6313982	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	CN1CCN(c2ccc(-c3cc4c(c(N)nn4C)c(=O)[nH]3)cc2)CC1		CHEMBL1813625	=	Inhibition	%	45.0	CHEMBL2208	Homo sapiens	INH	%	45.0
	6313983	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	COC(=O)CCc1c(C)[nH]c(=O)c2c(N)nn(C)c12		CHEMBL1813627	=	Inhibition	%	11.0	CHEMBL2208	Homo sapiens	INH	%	11.0
	6313984	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	COc1ccc(-c2c(C)[nH]c(=O)c3c(N)nn(C)c23)cc1		CHEMBL1813628	=	Inhibition	%	24.0	CHEMBL2208	Homo sapiens	INH	%	24.0
	6313985	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(NC(=O)Nc3ccccc3)nn2C)c(=O)[nH]1		CHEMBL1813630	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	6313986	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	CC(=O)Nc1nn(C)c2cc(-c3ccccc3)[nH]c(=O)c12		CHEMBL1813777	=	Inhibition	%	9.0	CHEMBL2208	Homo sapiens	INH	%	9.0
	6313987	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(NS(C)(=O)=O)nn2C)c(=O)[nH]1		CHEMBL1813778	=	Inhibition	%	1.0	CHEMBL2208	Homo sapiens	INH	%	1.0
	6313988	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	COc1ccc(S(=O)(=O)Nc2nn(C)c3cc(C)[nH]c(=O)c23)c(OC)c1		CHEMBL1813779	=	Inhibition	%	2.0	CHEMBL2208	Homo sapiens	INH	%	2.0
	6313989	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	CC(=O)Nc1nn(C)c2cc(-c3ccc(N4CCN(C)CC4)cc3)[nH]c(=O)c12		CHEMBL1813780	=	Inhibition	%	5.0	CHEMBL2208	Homo sapiens	INH	%	5.0
	6313990	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(N)nn2C)c(N2CCCCC2)n1		CHEMBL1813781	=	Inhibition	%	7.0	CHEMBL2208	Homo sapiens	INH	%	7.0
	6313991	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(N)nn2C)c(N2CCOCC2)n1		CHEMBL1813782	=	Inhibition	%	-2.0	CHEMBL2208	Homo sapiens	INH	%	-2.0
	6313992	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(N)nn2C)c(N2CC[C@H](O)C2)n1		CHEMBL1813784	=	Inhibition	%	2.0	CHEMBL2208	Homo sapiens	INH	%	2.0
	6313993	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	COCCNc1nc(C)cc2c1c(N)nn2C		CHEMBL1813785	=	Inhibition	%	6.0	CHEMBL2208	Homo sapiens	INH	%	6.0
	6313994	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	COCCNc1nc(-c2ccccc2)cc2c1c(N)nn2C		CHEMBL1813786	=	Inhibition	%	2.0	CHEMBL2208	Homo sapiens	INH	%	2.0
	6313995	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	COCCNc1nc(C)cc2nn(-c3ccccc3)c(N)c12		CHEMBL1813787	=	Inhibition	%	3.0	CHEMBL2208	Homo sapiens	INH	%	3.0
	6313996	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2nn(-c3ccccc3)c(N)c2c(=O)[nH]1		CHEMBL1813788	=	Inhibition	%	-4.0	CHEMBL2208	Homo sapiens	INH	%	-4.0
	6313997	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	CC(C)(C)c1cc2nn(-c3ccccc3)c(N)c2c(=O)[nH]1		CHEMBL1813789	=	Inhibition	%	6.0	CHEMBL2208	Homo sapiens	INH	%	6.0
	6313998	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	Nc1c2c(=O)[nH]c(-c3ccccc3)cc2nn1-c1ccccc1		CHEMBL1813790	=	Inhibition	%	2.0	CHEMBL2208	Homo sapiens	INH	%	2.0
	6313999	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	Nc1c2c(=O)[nH]c(-c3ccccn3)cc2nn1-c1ccccc1		CHEMBL1813791	=	Inhibition	%	4.0	CHEMBL2208	Homo sapiens	INH	%	4.0
	6314000	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	COc1ccccc1-c1cc2nn(-c3ccccc3)c(N)c2c(=O)[nH]1		CHEMBL1813792	=	Inhibition	%	-1.0	CHEMBL2208	Homo sapiens	INH	%	-1.0
	6314001	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	COc1ccc(-c2cc3nn(-c4ccccc4)c(N)c3c(=O)[nH]2)cc1		CHEMBL1813793	=	Inhibition	%	7.0	CHEMBL2208	Homo sapiens	INH	%	7.0
	6314002	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	CN1CCN(c2ccc(-c3cc4nn(-c5ccccc5)c(N)c4c(=O)[nH]3)cc2)CC1		CHEMBL1813795	=	Inhibition	%	4.0	CHEMBL2208	Homo sapiens	INH	%	4.0
	6314003	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	Nc1c2c(=O)[nH]c(-c3ccccc3)cc2nn1-c1ccccn1		CHEMBL1813796	=	Inhibition	%	6.0	CHEMBL2208	Homo sapiens	INH	%	6.0
	6314004	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2nn(-c3ccccc3)c(N)c2c(N2CCCCC2)n1		CHEMBL1813797	=	Inhibition	%	7.0	CHEMBL2208	Homo sapiens	INH	%	7.0
	6314005	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	Cc1[nH]c(=O)c2c(N)n(-c3ccccc3)nc2c1-c1ccccc1		CHEMBL1813798	=	Inhibition	%	9.0	CHEMBL2208	Homo sapiens	INH	%	9.0
	6314006	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	Cn1nc2c3c(nc(-c4ccccc4)cc31)NCC(=O)N2		CHEMBL1813799	=	Inhibition	%	8.0	CHEMBL2208	Homo sapiens	INH	%	8.0
	6314007	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	Cn1nc(N)c2cnc(-c3ccccc3)cc21		CHEMBL1813800	=	Inhibition	%	7.0	CHEMBL2208	Homo sapiens	INH	%	7.0
	6314008	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(cn1)c(N)nn2C		CHEMBL1813801	=	Inhibition	%	-2.0	CHEMBL2208	Homo sapiens	INH	%	-2.0
	6314009	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	Nc1c2cnc(-c3ccccc3)cc2nn1-c1ccccc1		CHEMBL1813802	=	Inhibition	%	1.0	CHEMBL2208	Homo sapiens	INH	%	1.0
	6314010	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]nc(N)c2cn1		CHEMBL1813803	=	Inhibition	%	7.0	CHEMBL2208	Homo sapiens	INH	%	7.0
	6314011	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]ncc2c(=O)[nH]1		CHEMBL1813804	=	Inhibition	%	11.0	CHEMBL2208	Homo sapiens	INH	%	11.0
	6314012	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2nc(N)nc(N)c2c(=O)[nH]1		CHEMBL1813805	=	Inhibition	%	26.0	CHEMBL2208	Homo sapiens	INH	%	26.0
	6314013	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2nc(-c3ccccc3)nc(N)c2c(=O)[nH]1		CHEMBL1813806	=	Inhibition	%	22.0	CHEMBL2208	Homo sapiens	INH	%	22.0
	6314014	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	Cc1nc(N)c2c(=O)[nH]c(C)cc2n1		CHEMBL1813807	=	Inhibition	%	18.0	CHEMBL2208	Homo sapiens	INH	%	18.0
	6314015	CHEMBL1815689	Inhibition of MAPKAPK2 at 30 uM by microfluidic mobility shift assay	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Inhibition	%	41.0	CHEMBL2208	Homo sapiens	INH	%	41.0
	6318843	CHEMBL1815741	Inhibition of MAPKAPK2 by microfluidic mobility shift assay	B	CN1CCN(c2ccc(-c3cc4c(c(N)nn4C)c(=O)[nH]3)cc2)CC1		CHEMBL1813625	=	IC50	nM	35000.0	CHEMBL2208	Homo sapiens	IC50	uM	35.0
	6325319	CHEMBL1819996	Inhibition of MK2 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by IMAP assay	B	Nc1ncnc2[nH]cnc12		CHEMBL226345	=	Inhibition	%	80.0	CHEMBL2208	Homo sapiens	INH	%	80.0
	6325348	CHEMBL1819996	Inhibition of MK2 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by IMAP assay	B	c1ccc(Nc2ncccn2)cc1		CHEMBL1650061	=	Inhibition	%	24.0	CHEMBL2208	Homo sapiens	INH	%	24.0
	6325380	CHEMBL1819996	Inhibition of MK2 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by IMAP assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	42.0	CHEMBL2208	Homo sapiens	INH	%	42.0
	6325412	CHEMBL1819996	Inhibition of MK2 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by IMAP assay	B	c1ccc2[nH]ncc2c1		CHEMBL86795	=	Inhibition	%	42.0	CHEMBL2208	Homo sapiens	INH	%	42.0
	6325444	CHEMBL1819996	Inhibition of MK2 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by IMAP assay	B	Nc1ncccc1OCc1ccccc1		CHEMBL194009	=	Inhibition	%	54.0	CHEMBL2208	Homo sapiens	INH	%	54.0
	6325473	CHEMBL1819996	Inhibition of MK2 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by IMAP assay	B	Nc1[nH]nc2ccccc12		CHEMBL1331627	=	Inhibition	%	54.0	CHEMBL2208	Homo sapiens	INH	%	54.0
	6325502	CHEMBL1819996	Inhibition of MK2 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by IMAP assay	B	Nc1n[nH]c2ncccc12		CHEMBL1817865	=	Inhibition	%	47.0	CHEMBL2208	Homo sapiens	INH	%	47.0
	6325531	CHEMBL1819996	Inhibition of MK2 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by IMAP assay	B	c1n[nH]c2c1CCCC2		CHEMBL1817866	=	Inhibition	%	24.0	CHEMBL2208	Homo sapiens	INH	%	24.0
	6325874	CHEMBL1819996	Inhibition of MK2 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by IMAP assay	B	Nc1ccc2ncc(-c3ccccc3)n2n1		CHEMBL1817867	=	Inhibition	%	28.0	CHEMBL2208	Homo sapiens	INH	%	28.0
	6325904	CHEMBL1819996	Inhibition of MK2 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by IMAP assay	B	c1ccc(-c2cnc3nccnn23)cc1		CHEMBL1817868	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	6325934	CHEMBL1819996	Inhibition of MK2 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by IMAP assay	B	Cc1ccc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)cc1		CHEMBL1817869	=	Inhibition	%	24.0	CHEMBL2208	Homo sapiens	INH	%	24.0
	6325963	CHEMBL1819996	Inhibition of MK2 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by IMAP assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)no1		CHEMBL292785	=	Inhibition	%	28.0	CHEMBL2208	Homo sapiens	INH	%	28.0
	6325992	CHEMBL1819996	Inhibition of MK2 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by IMAP assay	B	Cc1ccc(NC(=O)Nc2cccc(C(F)(F)F)c2)cc1		CHEMBL1817870	=	Inhibition	%	13.0	CHEMBL2208	Homo sapiens	INH	%	13.0
	6326021	CHEMBL1819996	Inhibition of MK2 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by IMAP assay	B	O=C(Nc1ccccc1)Nc1cccc(C(F)(F)F)c1		CHEMBL1605296	=	Inhibition	%	16.0	CHEMBL2208	Homo sapiens	INH	%	16.0
	6326050	CHEMBL1819996	Inhibition of MK2 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by IMAP assay	B	O=C(Nc1ccccc1)Nc1ccccc1		CHEMBL354676	=	Inhibition	%	18.0	CHEMBL2208	Homo sapiens	INH	%	18.0
	6326079	CHEMBL1819996	Inhibition of MK2 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by IMAP assay	B	Cc1ccc(C(=O)NC2CC2)cc1F		CHEMBL1817871	=	Inhibition	%	8.0	CHEMBL2208	Homo sapiens	INH	%	8.0
	6326108	CHEMBL1819996	Inhibition of MK2 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by IMAP assay	B	c1ccc(Nc2ccccc2)cc1		CHEMBL38688	=	Inhibition	%	7.0	CHEMBL2208	Homo sapiens	INH	%	7.0
	6341084	CHEMBL1828397	Activity of MAPKAPK2 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL2208	Homo sapiens	Activity	%	100.0
	6352230	CHEMBL1825837	Inhibition of MAPKAP-K2 assessed as residual activity at 10 uM by radioactivity assay in presence of 20 uM ATP	B	Nc1n[nH]c(N)c1/N=N/c1ccc(O)cc1		CHEMBL215205	=	Activity	%	26.0	CHEMBL2208	Homo sapiens	Activity	%	26.0
	6375118	CHEMBL1838161	Inhibition of MK2 at 1 uM	B	CC(=O)Nc1ccc(-c2cc3ncnc(SCC(=O)O)c3s2)cc1		CHEMBL1836724	=	Inhibition	%	3.3	CHEMBL2208	Homo sapiens	INH	%	3.3
	6375142	CHEMBL1838161	Inhibition of MK2 at 1 uM	B	O=C(O)COc1ncnc2cc(-c3ccc4[nH]ncc4c3)sc12		CHEMBL1836641	=	Inhibition	%	25.3	CHEMBL2208	Homo sapiens	INH	%	25.3
	6386364	CHEMBL1839851	Inhibition of recombinant MK2	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	7567105	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7567564	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7568035	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7568503	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7568935	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7569078	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7569538	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7570010	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7570473	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7570900	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7571054	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7571511	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7571987	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7573035	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7573492	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7573968	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7573995	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7574403	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7575013	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7575474	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7575968	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7576376	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7576987	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7577446	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7577482	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7577952	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7578357	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7578995	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7579369	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7579851	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7580320	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7580723	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7581741	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7582212	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7582676	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7583076	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	3800.0	CHEMBL2208	Homo sapiens	Kd	nM	3800.0
	7583257	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7583654	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7584099	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7584570	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7585032	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7585436	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7585587	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7585995	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7586441	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7586912	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7587366	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7587548	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7587967	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7588420	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7588891	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7589513	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7589937	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	230.0	CHEMBL2208	Homo sapiens	Kd	nM	230.0
	7590404	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7590887	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7591486	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7591908	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7592380	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7592411	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7592864	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7593453	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7593888	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7594391	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7594843	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7595421	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7595897	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7596368	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7596815	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7597404	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7597877	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7598347	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL2208	Homo sapiens	Kd	nM	10000.0
	7598789	CHEMBL1908400	Binding constant for MAPKAPK2 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	880.0	CHEMBL2208	Homo sapiens	Kd	nM	880.0
	7922741	CHEMBL1919422	Inhibition of human recombinant MAPKAPK2 at 0.5 uM by radiometric filter-binding assay	B	Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12	Outside typical range	CHEMBL1915438	=	Inhibition	%	-36.0	CHEMBL2208	Homo sapiens	INH	%	-36.0
	7939650	CHEMBL1919610	Inhibition of human MAPK2	B	[O-][n+]1ccc2c(-c3ccc(F)cc3Cl)ccnc2c1-c1c(Cl)cccc1Cl		CHEMBL1916359	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	7939651	CHEMBL1919611	Inhibition of human MAPKAP-K2	B	[O-][n+]1ccc2c(-c3ccc(F)cc3Cl)ccnc2c1-c1c(Cl)cccc1Cl		CHEMBL1916359	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	7961049	CHEMBL1932887	Inhibition of MAPKAPK2	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	>	IC50	nM	30000.0	CHEMBL2208	Homo sapiens	IC50	uM	30.0
	7961050	CHEMBL1932887	Inhibition of MAPKAPK2	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	IC50	nM	30000.0	CHEMBL2208	Homo sapiens	IC50	uM	30.0
	7969743	CHEMBL1931442	Inhibition of MAPKAP-K2 assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay	B	Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2		CHEMBL1927262	=	Activity	%	89.0	CHEMBL2208	Homo sapiens	Activity	%	89.0
	7970437	CHEMBL1930180	Inhibition of MAPKAPK2 at 10 uM	B	NCCN1C(=O)S/C(=C\CCC2CCCCC2)C1=O		CHEMBL1929247	=	Inhibition	%	3.0	CHEMBL2208	Homo sapiens	INH	%	3.0
	7984094	CHEMBL1936523	Inhibition of MAP-KAPK2	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3nccc(-c4cc(C(N)=O)cn4C)n3)c2)CC1		CHEMBL1933576	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	7984095	CHEMBL1936523	Inhibition of MAP-KAPK2	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3nccc(-c4cc5c(n4C)CCNC5=O)n3)c2)CC1		CHEMBL1933582	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	7985459	CHEMBL1937262	Inhibition of MK2-mediated HSP27 phosphorylation in LPS-stimulated human THP1 cells pre-incubated for 60 mins prior to LPS-induction measured after 60 mins by multi-spot assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCNC2)CNC3=O)ccn1)c1ccccn1		CHEMBL1933193	=	EC50	nM	660.0	CHEMBL2208	Homo sapiens	EC50	uM	0.66
	7985460	CHEMBL1937262	Inhibition of MK2-mediated HSP27 phosphorylation in LPS-stimulated human THP1 cells pre-incubated for 60 mins prior to LPS-induction measured after 60 mins by multi-spot assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCNC2)CNC3=O)ccn1)c1cccc(OC(F)(F)F)c1		CHEMBL1933192	=	EC50	nM	400.0	CHEMBL2208	Homo sapiens	EC50	uM	0.4
	7985461	CHEMBL1937262	Inhibition of MK2-mediated HSP27 phosphorylation in LPS-stimulated human THP1 cells pre-incubated for 60 mins prior to LPS-induction measured after 60 mins by multi-spot assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCNC2)CNC3=O)ccn1)c1cccc(F)c1		CHEMBL1933191	=	EC50	nM	480.0	CHEMBL2208	Homo sapiens	EC50	uM	0.48
	7985462	CHEMBL1937262	Inhibition of MK2-mediated HSP27 phosphorylation in LPS-stimulated human THP1 cells pre-incubated for 60 mins prior to LPS-induction measured after 60 mins by multi-spot assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCNC2)CNC3=O)ccn1)c1ccc(F)cc1		CHEMBL1933190	=	EC50	nM	840.0	CHEMBL2208	Homo sapiens	EC50	uM	0.84
	7985463	CHEMBL1937262	Inhibition of MK2-mediated HSP27 phosphorylation in LPS-stimulated human THP1 cells pre-incubated for 60 mins prior to LPS-induction measured after 60 mins by multi-spot assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCNC2)CNC3=O)ccn1)c1ccc2ccccc2c1		CHEMBL1933189	=	EC50	nM	390.0	CHEMBL2208	Homo sapiens	EC50	uM	0.39
	7985464	CHEMBL1937262	Inhibition of MK2-mediated HSP27 phosphorylation in LPS-stimulated human THP1 cells pre-incubated for 60 mins prior to LPS-induction measured after 60 mins by multi-spot assay	B	Cc1ccc(C(=O)Nc2cc(-c3cc4c([nH]3)C3(CCNC3)CNC4=O)ccn2)cc1C		CHEMBL1933188	=	EC50	nM	240.0	CHEMBL2208	Homo sapiens	EC50	uM	0.24
	7985465	CHEMBL1937262	Inhibition of MK2-mediated HSP27 phosphorylation in LPS-stimulated human THP1 cells pre-incubated for 60 mins prior to LPS-induction measured after 60 mins by multi-spot assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCCNC2)CNC3=O)ccn1)c1cccc(C(F)(F)F)c1		CHEMBL1933187	=	EC50	nM	590.0	CHEMBL2208	Homo sapiens	EC50	uM	0.59
	7985466	CHEMBL1937262	Inhibition of MK2-mediated HSP27 phosphorylation in LPS-stimulated human THP1 cells pre-incubated for 60 mins prior to LPS-induction measured after 60 mins by multi-spot assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCCNC2)CNC3=O)ccn1)c1cc(F)cc(F)c1		CHEMBL1933186	=	EC50	nM	590.0	CHEMBL2208	Homo sapiens	EC50	uM	0.59
	7985467	CHEMBL1937262	Inhibition of MK2-mediated HSP27 phosphorylation in LPS-stimulated human THP1 cells pre-incubated for 60 mins prior to LPS-induction measured after 60 mins by multi-spot assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCCNC2)CNC3=O)ccn1)c1ccccn1		CHEMBL1933185	=	EC50	nM	660.0	CHEMBL2208	Homo sapiens	EC50	uM	0.66
	7985468	CHEMBL1937262	Inhibition of MK2-mediated HSP27 phosphorylation in LPS-stimulated human THP1 cells pre-incubated for 60 mins prior to LPS-induction measured after 60 mins by multi-spot assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCCNC2)CNC3=O)ccn1)c1ccc(C(F)(F)F)cc1		CHEMBL1933184	=	EC50	nM	1200.0	CHEMBL2208	Homo sapiens	EC50	uM	1.2
	7985469	CHEMBL1937262	Inhibition of MK2-mediated HSP27 phosphorylation in LPS-stimulated human THP1 cells pre-incubated for 60 mins prior to LPS-induction measured after 60 mins by multi-spot assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCCNC2)CNC3=O)ccn1)c1cccc(OC(F)(F)F)c1		CHEMBL1933183	=	EC50	nM	610.0	CHEMBL2208	Homo sapiens	EC50	uM	0.61
Not Determined	7985470	CHEMBL1937262	Inhibition of MK2-mediated HSP27 phosphorylation in LPS-stimulated human THP1 cells pre-incubated for 60 mins prior to LPS-induction measured after 60 mins by multi-spot assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCCNC2)CNC3=O)ccn1)c1cccc(F)c1		CHEMBL1933182		EC50			CHEMBL2208	Homo sapiens	EC50		
	7985471	CHEMBL1937262	Inhibition of MK2-mediated HSP27 phosphorylation in LPS-stimulated human THP1 cells pre-incubated for 60 mins prior to LPS-induction measured after 60 mins by multi-spot assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCCNC2)CNC3=O)ccn1)c1ccc(F)cc1		CHEMBL1933181	=	EC50	nM	7400.0	CHEMBL2208	Homo sapiens	EC50	uM	7.4
	7985472	CHEMBL1937262	Inhibition of MK2-mediated HSP27 phosphorylation in LPS-stimulated human THP1 cells pre-incubated for 60 mins prior to LPS-induction measured after 60 mins by multi-spot assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCCNC2)CNC3=O)ccn1)c1ccc(F)cc1		CHEMBL1933181	=	EC50	nM	320.0	CHEMBL2208	Homo sapiens	EC50	uM	0.32
	7985473	CHEMBL1937262	Inhibition of MK2-mediated HSP27 phosphorylation in LPS-stimulated human THP1 cells pre-incubated for 60 mins prior to LPS-induction measured after 60 mins by multi-spot assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCCNC2)CNC3=O)ccn1)c1ccc(F)cc1		CHEMBL1933181	=	EC50	nM	870.0	CHEMBL2208	Homo sapiens	EC50	uM	0.87
	7985474	CHEMBL1937262	Inhibition of MK2-mediated HSP27 phosphorylation in LPS-stimulated human THP1 cells pre-incubated for 60 mins prior to LPS-induction measured after 60 mins by multi-spot assay	B	O=C1NCC2(CCCNC2)c2[nH]c(-c3ccnc(NC(=O)c4cccc5ccccc45)c3)cc21		CHEMBL1933180	=	EC50	nM	1100.0	CHEMBL2208	Homo sapiens	EC50	uM	1.1
Not Determined	7985475	CHEMBL1937262	Inhibition of MK2-mediated HSP27 phosphorylation in LPS-stimulated human THP1 cells pre-incubated for 60 mins prior to LPS-induction measured after 60 mins by multi-spot assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCCNC2)CNC3=O)ccn1)c1ccc2ccccc2c1		CHEMBL1933179		EC50			CHEMBL2208	Homo sapiens	EC50		
	7985476	CHEMBL1937262	Inhibition of MK2-mediated HSP27 phosphorylation in LPS-stimulated human THP1 cells pre-incubated for 60 mins prior to LPS-induction measured after 60 mins by multi-spot assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCCNC2)CNC3=O)ccn1)c1ccc2ccccc2c1		CHEMBL1933179	=	EC50	nM	530.0	CHEMBL2208	Homo sapiens	EC50	uM	0.53
	7985477	CHEMBL1937262	Inhibition of MK2-mediated HSP27 phosphorylation in LPS-stimulated human THP1 cells pre-incubated for 60 mins prior to LPS-induction measured after 60 mins by multi-spot assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCCNC2)CNC3=O)ccn1)c1ccc2ccccc2c1		CHEMBL1933179	=	EC50	nM	1100.0	CHEMBL2208	Homo sapiens	EC50	uM	1.1
	7985478	CHEMBL1937262	Inhibition of MK2-mediated HSP27 phosphorylation in LPS-stimulated human THP1 cells pre-incubated for 60 mins prior to LPS-induction measured after 60 mins by multi-spot assay	B	Cc1ccc(C(=O)Nc2cc(-c3cc4c([nH]3)C3(CCCNC3)CNC4=O)ccn2)cc1C		CHEMBL1933178	=	EC50	nM	5300.0	CHEMBL2208	Homo sapiens	EC50	uM	5.3
Not Determined	7985479	CHEMBL1937262	Inhibition of MK2-mediated HSP27 phosphorylation in LPS-stimulated human THP1 cells pre-incubated for 60 mins prior to LPS-induction measured after 60 mins by multi-spot assay	B	Cc1ccc(C(=O)Nc2cc(-c3cc4c([nH]3)C3(CCCNC3)CNC4=O)ccn2)cc1C		CHEMBL1933178		EC50			CHEMBL2208	Homo sapiens	EC50		
	7985480	CHEMBL1937262	Inhibition of MK2-mediated HSP27 phosphorylation in LPS-stimulated human THP1 cells pre-incubated for 60 mins prior to LPS-induction measured after 60 mins by multi-spot assay	B	Cc1ccc(C(=O)Nc2cc(-c3cc4c([nH]3)C3(CCCNC3)CNC4=O)ccn2)cc1C		CHEMBL1933178	=	EC50	nM	690.0	CHEMBL2208	Homo sapiens	EC50	uM	0.69
	7985481	CHEMBL1937262	Inhibition of MK2-mediated HSP27 phosphorylation in LPS-stimulated human THP1 cells pre-incubated for 60 mins prior to LPS-induction measured after 60 mins by multi-spot assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCNCC2)CNC3=O)ccn1)c1ccncc1		CHEMBL1933177	>	EC50	nM	10000.0	CHEMBL2208	Homo sapiens	EC50	uM	10.0
	7985482	CHEMBL1937262	Inhibition of MK2-mediated HSP27 phosphorylation in LPS-stimulated human THP1 cells pre-incubated for 60 mins prior to LPS-induction measured after 60 mins by multi-spot assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCNCC2)CNC3=O)ccn1)c1ccccn1		CHEMBL1933176	=	EC50	nM	550.0	CHEMBL2208	Homo sapiens	EC50	uM	0.55
	7985483	CHEMBL1937262	Inhibition of MK2-mediated HSP27 phosphorylation in LPS-stimulated human THP1 cells pre-incubated for 60 mins prior to LPS-induction measured after 60 mins by multi-spot assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCNCC2)CNC3=O)ccn1)c1ccc(C(F)(F)F)cc1		CHEMBL1933175	=	EC50	nM	1300.0	CHEMBL2208	Homo sapiens	EC50	uM	1.3
	7985484	CHEMBL1937262	Inhibition of MK2-mediated HSP27 phosphorylation in LPS-stimulated human THP1 cells pre-incubated for 60 mins prior to LPS-induction measured after 60 mins by multi-spot assay	B	CN1CCC2(CC1)CNC(=O)c1cc(-c3ccnc(NC(=O)c4cccc(OC(F)(F)F)c4)c3)[nH]c12		CHEMBL1933174	=	EC50	nM	830.0	CHEMBL2208	Homo sapiens	EC50	uM	0.83
	7985485	CHEMBL1937262	Inhibition of MK2-mediated HSP27 phosphorylation in LPS-stimulated human THP1 cells pre-incubated for 60 mins prior to LPS-induction measured after 60 mins by multi-spot assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCNCC2)CNC3=O)ccn1)c1cccc(OC(F)(F)F)c1		CHEMBL1933173	=	EC50	nM	130.0	CHEMBL2208	Homo sapiens	EC50	uM	0.13
	7985486	CHEMBL1937262	Inhibition of MK2-mediated HSP27 phosphorylation in LPS-stimulated human THP1 cells pre-incubated for 60 mins prior to LPS-induction measured after 60 mins by multi-spot assay	B	CN1CCC2(CC1)CNC(=O)c1cc(-c3ccnc(NC(=O)c4cccc(F)c4)c3)[nH]c12		CHEMBL1933172	=	EC50	nM	640.0	CHEMBL2208	Homo sapiens	EC50	uM	0.64
	7985487	CHEMBL1937262	Inhibition of MK2-mediated HSP27 phosphorylation in LPS-stimulated human THP1 cells pre-incubated for 60 mins prior to LPS-induction measured after 60 mins by multi-spot assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCNCC2)CNC3=O)ccn1)c1cccc(F)c1		CHEMBL1933171	=	EC50	nM	680.0	CHEMBL2208	Homo sapiens	EC50	uM	0.68
	7985488	CHEMBL1937262	Inhibition of MK2-mediated HSP27 phosphorylation in LPS-stimulated human THP1 cells pre-incubated for 60 mins prior to LPS-induction measured after 60 mins by multi-spot assay	B	CN1CCC2(CC1)CNC(=O)c1cc(-c3ccnc(NC(=O)c4ccc5ccccc5c4)c3)[nH]c12		CHEMBL1933170	=	EC50	nM	730.0	CHEMBL2208	Homo sapiens	EC50	uM	0.73
	7985489	CHEMBL1937262	Inhibition of MK2-mediated HSP27 phosphorylation in LPS-stimulated human THP1 cells pre-incubated for 60 mins prior to LPS-induction measured after 60 mins by multi-spot assay	B	Cc1ccc(C(=O)Nc2cc(-c3cc4c([nH]3)C3(CCN(C)CC3)CNC4=O)ccn2)cc1C		CHEMBL1933169	=	EC50	nM	920.0	CHEMBL2208	Homo sapiens	EC50	uM	0.92
	7985490	CHEMBL1937262	Inhibition of MK2-mediated HSP27 phosphorylation in LPS-stimulated human THP1 cells pre-incubated for 60 mins prior to LPS-induction measured after 60 mins by multi-spot assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCNCC2)CNC3=O)ccn1)c1ccc(F)cc1		CHEMBL1933168	=	EC50	nM	3700.0	CHEMBL2208	Homo sapiens	EC50	uM	3.7
Not Determined	7985491	CHEMBL1937262	Inhibition of MK2-mediated HSP27 phosphorylation in LPS-stimulated human THP1 cells pre-incubated for 60 mins prior to LPS-induction measured after 60 mins by multi-spot assay	B	O=C(Nc1nccc(-c2cc3c([nH]2)C2(CCNCC2)CNC3=O)n1)c1ccc(F)cc1		CHEMBL1933167		EC50			CHEMBL2208	Homo sapiens	EC50		
	7985492	CHEMBL1937262	Inhibition of MK2-mediated HSP27 phosphorylation in LPS-stimulated human THP1 cells pre-incubated for 60 mins prior to LPS-induction measured after 60 mins by multi-spot assay	B	O=C1NCC2(CCNCC2)c2[nH]c(-c3ccnc(NC(=O)c4cccc5ccccc45)c3)cc21		CHEMBL1933166	=	EC50	nM	520.0	CHEMBL2208	Homo sapiens	EC50	uM	0.52
Not Determined	7985493	CHEMBL1937262	Inhibition of MK2-mediated HSP27 phosphorylation in LPS-stimulated human THP1 cells pre-incubated for 60 mins prior to LPS-induction measured after 60 mins by multi-spot assay	B	O=C1NCC2(CCNCC2)c2[nH]c(-c3ccnc(NC(=O)c4cccc5ccccc45)n3)cc21		CHEMBL1933165		EC50			CHEMBL2208	Homo sapiens	EC50		
	7985494	CHEMBL1937262	Inhibition of MK2-mediated HSP27 phosphorylation in LPS-stimulated human THP1 cells pre-incubated for 60 mins prior to LPS-induction measured after 60 mins by multi-spot assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCNCC2)CNC3=O)ccn1)c1ccc2ccccc2c1		CHEMBL1933164	=	EC50	nM	280.0	CHEMBL2208	Homo sapiens	EC50	uM	0.28
Not Determined	7985495	CHEMBL1937262	Inhibition of MK2-mediated HSP27 phosphorylation in LPS-stimulated human THP1 cells pre-incubated for 60 mins prior to LPS-induction measured after 60 mins by multi-spot assay	B	O=C(Nc1nccc(-c2cc3c([nH]2)C2(CCNCC2)CNC3=O)n1)c1ccc2ccccc2c1		CHEMBL1933163		EC50			CHEMBL2208	Homo sapiens	EC50		
	7985496	CHEMBL1937262	Inhibition of MK2-mediated HSP27 phosphorylation in LPS-stimulated human THP1 cells pre-incubated for 60 mins prior to LPS-induction measured after 60 mins by multi-spot assay	B	Cc1ccc(C(=O)Nc2cc(-c3cc4c([nH]3)C3(CCNCC3)CNC4=O)ccn2)cc1C		CHEMBL1933162	=	EC50	nM	350.0	CHEMBL2208	Homo sapiens	EC50	uM	0.35
Not Determined	7985497	CHEMBL1937262	Inhibition of MK2-mediated HSP27 phosphorylation in LPS-stimulated human THP1 cells pre-incubated for 60 mins prior to LPS-induction measured after 60 mins by multi-spot assay	B	Cc1ccc(C(=O)Nc2nccc(-c3cc4c([nH]3)C3(CCNCC3)CNC4=O)n2)cc1C		CHEMBL1933161		EC50			CHEMBL2208	Homo sapiens	EC50		
	7985498	CHEMBL1937262	Inhibition of MK2-mediated HSP27 phosphorylation in LPS-stimulated human THP1 cells pre-incubated for 60 mins prior to LPS-induction measured after 60 mins by multi-spot assay	B	O=C1NCC2(CCNCC2)c2[nH]c(-c3ccnc(-c4ccc5c(c4)OCO5)n3)cc21		CHEMBL1738702	=	EC50	nM	620.0	CHEMBL2208	Homo sapiens	EC50	uM	0.62
	7985539	CHEMBL1937260	Inhibition of MK2 using Fluo-betaA-11A NeoMPS as substrate pre-incubated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCNC2)CNC3=O)ccn1)c1ccccn1		CHEMBL1933193	=	EC50	nM	4.1	CHEMBL2208	Homo sapiens	EC50	nM	4.1
	7985540	CHEMBL1937260	Inhibition of MK2 using Fluo-betaA-11A NeoMPS as substrate pre-incubated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCNC2)CNC3=O)ccn1)c1cccc(OC(F)(F)F)c1		CHEMBL1933192	=	EC50	nM	1.6	CHEMBL2208	Homo sapiens	EC50	nM	1.6
	7985541	CHEMBL1937260	Inhibition of MK2 using Fluo-betaA-11A NeoMPS as substrate pre-incubated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCNC2)CNC3=O)ccn1)c1cccc(F)c1		CHEMBL1933191	=	EC50	nM	1.9	CHEMBL2208	Homo sapiens	EC50	nM	1.9
	7985542	CHEMBL1937260	Inhibition of MK2 using Fluo-betaA-11A NeoMPS as substrate pre-incubated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCNC2)CNC3=O)ccn1)c1ccc(F)cc1		CHEMBL1933190	=	EC50	nM	1.3	CHEMBL2208	Homo sapiens	EC50	nM	1.3
	7985543	CHEMBL1937260	Inhibition of MK2 using Fluo-betaA-11A NeoMPS as substrate pre-incubated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCNC2)CNC3=O)ccn1)c1ccc2ccccc2c1		CHEMBL1933189	=	EC50	nM	0.62	CHEMBL2208	Homo sapiens	EC50	nM	0.62
	7985544	CHEMBL1937260	Inhibition of MK2 using Fluo-betaA-11A NeoMPS as substrate pre-incubated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	Cc1ccc(C(=O)Nc2cc(-c3cc4c([nH]3)C3(CCNC3)CNC4=O)ccn2)cc1C		CHEMBL1933188	=	EC50	nM	0.71	CHEMBL2208	Homo sapiens	EC50	nM	0.71
	7985545	CHEMBL1937260	Inhibition of MK2 using Fluo-betaA-11A NeoMPS as substrate pre-incubated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCCNC2)CNC3=O)ccn1)c1cccc(C(F)(F)F)c1		CHEMBL1933187	=	EC50	nM	3.3	CHEMBL2208	Homo sapiens	EC50	nM	3.3
	7985546	CHEMBL1937260	Inhibition of MK2 using Fluo-betaA-11A NeoMPS as substrate pre-incubated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCCNC2)CNC3=O)ccn1)c1cc(F)cc(F)c1		CHEMBL1933186	=	EC50	nM	2.5	CHEMBL2208	Homo sapiens	EC50	nM	2.5
	7985547	CHEMBL1937260	Inhibition of MK2 using Fluo-betaA-11A NeoMPS as substrate pre-incubated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCCNC2)CNC3=O)ccn1)c1ccccn1		CHEMBL1933185	=	EC50	nM	4.2	CHEMBL2208	Homo sapiens	EC50	nM	4.2
	7985548	CHEMBL1937260	Inhibition of MK2 using Fluo-betaA-11A NeoMPS as substrate pre-incubated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCCNC2)CNC3=O)ccn1)c1ccc(C(F)(F)F)cc1		CHEMBL1933184	=	EC50	nM	9.1	CHEMBL2208	Homo sapiens	EC50	nM	9.1
	7985549	CHEMBL1937260	Inhibition of MK2 using Fluo-betaA-11A NeoMPS as substrate pre-incubated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCCNC2)CNC3=O)ccn1)c1cccc(OC(F)(F)F)c1		CHEMBL1933183	=	EC50	nM	11.0	CHEMBL2208	Homo sapiens	EC50	nM	11.0
	7985550	CHEMBL1937260	Inhibition of MK2 using Fluo-betaA-11A NeoMPS as substrate pre-incubated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCCNC2)CNC3=O)ccn1)c1cccc(F)c1		CHEMBL1933182	=	EC50	nM	6.2	CHEMBL2208	Homo sapiens	EC50	nM	6.2
	7985551	CHEMBL1937260	Inhibition of MK2 using Fluo-betaA-11A NeoMPS as substrate pre-incubated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCCNC2)CNC3=O)ccn1)c1ccc(F)cc1		CHEMBL1933181	=	EC50	nM	31.0	CHEMBL2208	Homo sapiens	EC50	nM	31.0
	7985552	CHEMBL1937260	Inhibition of MK2 using Fluo-betaA-11A NeoMPS as substrate pre-incubated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCCNC2)CNC3=O)ccn1)c1ccc(F)cc1		CHEMBL1933181	=	EC50	nM	2.4	CHEMBL2208	Homo sapiens	EC50	nM	2.4
	7985553	CHEMBL1937260	Inhibition of MK2 using Fluo-betaA-11A NeoMPS as substrate pre-incubated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCCNC2)CNC3=O)ccn1)c1ccc(F)cc1		CHEMBL1933181	=	EC50	nM	8.9	CHEMBL2208	Homo sapiens	EC50	nM	8.9
	7985554	CHEMBL1937260	Inhibition of MK2 using Fluo-betaA-11A NeoMPS as substrate pre-incubated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	O=C1NCC2(CCCNC2)c2[nH]c(-c3ccnc(NC(=O)c4cccc5ccccc45)c3)cc21		CHEMBL1933180	=	EC50	nM	5.1	CHEMBL2208	Homo sapiens	EC50	nM	5.1
	7985555	CHEMBL1937260	Inhibition of MK2 using Fluo-betaA-11A NeoMPS as substrate pre-incubated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCCNC2)CNC3=O)ccn1)c1ccc2ccccc2c1		CHEMBL1933179	=	EC50	nM	129.0	CHEMBL2208	Homo sapiens	EC50	nM	129.0
	7985556	CHEMBL1937260	Inhibition of MK2 using Fluo-betaA-11A NeoMPS as substrate pre-incubated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCCNC2)CNC3=O)ccn1)c1ccc2ccccc2c1		CHEMBL1933179	=	EC50	nM	2.5	CHEMBL2208	Homo sapiens	EC50	nM	2.5
	7985557	CHEMBL1937260	Inhibition of MK2 using Fluo-betaA-11A NeoMPS as substrate pre-incubated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCCNC2)CNC3=O)ccn1)c1ccc2ccccc2c1		CHEMBL1933179	=	EC50	nM	7.6	CHEMBL2208	Homo sapiens	EC50	nM	7.6
	7985558	CHEMBL1937260	Inhibition of MK2 using Fluo-betaA-11A NeoMPS as substrate pre-incubated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	Cc1ccc(C(=O)Nc2cc(-c3cc4c([nH]3)C3(CCCNC3)CNC4=O)ccn2)cc1C		CHEMBL1933178	=	EC50	nM	32.0	CHEMBL2208	Homo sapiens	EC50	nM	32.0
	7985559	CHEMBL1937260	Inhibition of MK2 using Fluo-betaA-11A NeoMPS as substrate pre-incubated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	Cc1ccc(C(=O)Nc2cc(-c3cc4c([nH]3)C3(CCCNC3)CNC4=O)ccn2)cc1C		CHEMBL1933178	=	EC50	nM	5.5	CHEMBL2208	Homo sapiens	EC50	nM	5.5
	7985560	CHEMBL1937260	Inhibition of MK2 using Fluo-betaA-11A NeoMPS as substrate pre-incubated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	Cc1ccc(C(=O)Nc2cc(-c3cc4c([nH]3)C3(CCCNC3)CNC4=O)ccn2)cc1C		CHEMBL1933178	=	EC50	nM	8.1	CHEMBL2208	Homo sapiens	EC50	nM	8.1
	7985561	CHEMBL1937260	Inhibition of MK2 using Fluo-betaA-11A NeoMPS as substrate pre-incubated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCNCC2)CNC3=O)ccn1)c1ccncc1		CHEMBL1933177	=	EC50	nM	2.6	CHEMBL2208	Homo sapiens	EC50	nM	2.6
	7985562	CHEMBL1937260	Inhibition of MK2 using Fluo-betaA-11A NeoMPS as substrate pre-incubated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCNCC2)CNC3=O)ccn1)c1ccccn1		CHEMBL1933176	=	EC50	nM	1.4	CHEMBL2208	Homo sapiens	EC50	nM	1.4
	7985563	CHEMBL1937260	Inhibition of MK2 using Fluo-betaA-11A NeoMPS as substrate pre-incubated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCNCC2)CNC3=O)ccn1)c1ccc(C(F)(F)F)cc1		CHEMBL1933175	=	EC50	nM	1.6	CHEMBL2208	Homo sapiens	EC50	nM	1.6
	7985564	CHEMBL1937260	Inhibition of MK2 using Fluo-betaA-11A NeoMPS as substrate pre-incubated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	CN1CCC2(CC1)CNC(=O)c1cc(-c3ccnc(NC(=O)c4cccc(OC(F)(F)F)c4)c3)[nH]c12		CHEMBL1933174	=	EC50	nM	2.7	CHEMBL2208	Homo sapiens	EC50	nM	2.7
	7985565	CHEMBL1937260	Inhibition of MK2 using Fluo-betaA-11A NeoMPS as substrate pre-incubated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCNCC2)CNC3=O)ccn1)c1cccc(OC(F)(F)F)c1		CHEMBL1933173	=	EC50	nM	1.5	CHEMBL2208	Homo sapiens	EC50	nM	1.5
	7985566	CHEMBL1937260	Inhibition of MK2 using Fluo-betaA-11A NeoMPS as substrate pre-incubated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	CN1CCC2(CC1)CNC(=O)c1cc(-c3ccnc(NC(=O)c4cccc(F)c4)c3)[nH]c12		CHEMBL1933172	=	EC50	nM	2.5	CHEMBL2208	Homo sapiens	EC50	nM	2.5
	7985567	CHEMBL1937260	Inhibition of MK2 using Fluo-betaA-11A NeoMPS as substrate pre-incubated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCNCC2)CNC3=O)ccn1)c1cccc(F)c1		CHEMBL1933171	=	EC50	nM	1.1	CHEMBL2208	Homo sapiens	EC50	nM	1.1
	7985568	CHEMBL1937260	Inhibition of MK2 using Fluo-betaA-11A NeoMPS as substrate pre-incubated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	CN1CCC2(CC1)CNC(=O)c1cc(-c3ccnc(NC(=O)c4ccc5ccccc5c4)c3)[nH]c12		CHEMBL1933170	=	EC50	nM	2.6	CHEMBL2208	Homo sapiens	EC50	nM	2.6
	7985569	CHEMBL1937260	Inhibition of MK2 using Fluo-betaA-11A NeoMPS as substrate pre-incubated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	Cc1ccc(C(=O)Nc2cc(-c3cc4c([nH]3)C3(CCN(C)CC3)CNC4=O)ccn2)cc1C		CHEMBL1933169	=	EC50	nM	2.3	CHEMBL2208	Homo sapiens	EC50	nM	2.3
	7985570	CHEMBL1937260	Inhibition of MK2 using Fluo-betaA-11A NeoMPS as substrate pre-incubated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCNCC2)CNC3=O)ccn1)c1ccc(F)cc1		CHEMBL1933168	=	EC50	nM	1.6	CHEMBL2208	Homo sapiens	EC50	nM	1.6
	7985571	CHEMBL1937260	Inhibition of MK2 using Fluo-betaA-11A NeoMPS as substrate pre-incubated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	O=C(Nc1nccc(-c2cc3c([nH]2)C2(CCNCC2)CNC3=O)n1)c1ccc(F)cc1		CHEMBL1933167	=	EC50	nM	15.0	CHEMBL2208	Homo sapiens	EC50	nM	15.0
	7985572	CHEMBL1937260	Inhibition of MK2 using Fluo-betaA-11A NeoMPS as substrate pre-incubated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	O=C1NCC2(CCNCC2)c2[nH]c(-c3ccnc(NC(=O)c4cccc5ccccc45)c3)cc21		CHEMBL1933166	=	EC50	nM	0.96	CHEMBL2208	Homo sapiens	EC50	nM	0.96
	7985573	CHEMBL1937260	Inhibition of MK2 using Fluo-betaA-11A NeoMPS as substrate pre-incubated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	O=C1NCC2(CCNCC2)c2[nH]c(-c3ccnc(NC(=O)c4cccc5ccccc45)n3)cc21		CHEMBL1933165	=	EC50	nM	14.0	CHEMBL2208	Homo sapiens	EC50	nM	14.0
	7985574	CHEMBL1937260	Inhibition of MK2 using Fluo-betaA-11A NeoMPS as substrate pre-incubated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	O=C(Nc1cc(-c2cc3c([nH]2)C2(CCNCC2)CNC3=O)ccn1)c1ccc2ccccc2c1		CHEMBL1933164	=	EC50	nM	0.72	CHEMBL2208	Homo sapiens	EC50	nM	0.72
	7985575	CHEMBL1937260	Inhibition of MK2 using Fluo-betaA-11A NeoMPS as substrate pre-incubated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	O=C(Nc1nccc(-c2cc3c([nH]2)C2(CCNCC2)CNC3=O)n1)c1ccc2ccccc2c1		CHEMBL1933163	=	EC50	nM	5.1	CHEMBL2208	Homo sapiens	EC50	nM	5.1
	7985576	CHEMBL1937260	Inhibition of MK2 using Fluo-betaA-11A NeoMPS as substrate pre-incubated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	Cc1ccc(C(=O)Nc2cc(-c3cc4c([nH]3)C3(CCNCC3)CNC4=O)ccn2)cc1C		CHEMBL1933162	=	EC50	nM	1.0	CHEMBL2208	Homo sapiens	EC50	nM	1.0
	7986165	CHEMBL1937260	Inhibition of MK2 using Fluo-betaA-11A NeoMPS as substrate pre-incubated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	Cc1ccc(C(=O)Nc2nccc(-c3cc4c([nH]3)C3(CCNCC3)CNC4=O)n2)cc1C		CHEMBL1933161	=	EC50	nM	3.1	CHEMBL2208	Homo sapiens	EC50	nM	3.1
	7986166	CHEMBL1937260	Inhibition of MK2 using Fluo-betaA-11A NeoMPS as substrate pre-incubated for 30 mins before substrate addition measured after 2 hrs by IMAP assay	B	O=C1NCC2(CCNCC2)c2[nH]c(-c3ccnc(-c4ccc5c(c4)OCO5)n3)cc21		CHEMBL1738702	=	EC50	nM	4.3	CHEMBL2208	Homo sapiens	EC50	nM	4.3
	7987124	CHEMBL1936077	Inhibition of MAPKAP-2	B	O=C(c1cc2cc(F)ccc2[nH]1)N1C[C@]2(CCN(C3CCCNC3)C2)c2ccccc21		CHEMBL1933538	>	IC50	nM	30000.0	CHEMBL2208	Homo sapiens	IC50	uM	30.0
	7987146	CHEMBL1936077	Inhibition of MAPKAP-2	B	O=C(c1cc2ccc(F)cc2[nH]1)N1C[C@]2(CCN(C3CCNC3)C2)c2ccccc21		CHEMBL1933550	>	IC50	nM	30000.0	CHEMBL2208	Homo sapiens	IC50	uM	30.0
	7987168	CHEMBL1936077	Inhibition of MAPKAP-2	B	C[C@@H]1CCC(N2CC[C@]3(CN(C(=O)c4cc5ccccc5[nH]4)c4ccccc43)C2)CN1		CHEMBL1933551	>	IC50	nM	30000.0	CHEMBL2208	Homo sapiens	IC50	uM	30.0
	7987200	CHEMBL1936077	Inhibition of MAPKAP-2	B	C[C@@H]1CCC(N2CC[C@]3(CN(C(=O)c4cc5ccc(F)cc5[nH]4)c4ccccc43)C2)CN1		CHEMBL1933552	>	IC50	nM	30000.0	CHEMBL2208	Homo sapiens	IC50	uM	30.0
	7992204	CHEMBL1935874	Inhibition of MAPKAPK2 at 1 uM	B	CN(c1ccccc1-c1cc(Cl)c2cnc(Nc3ccc(C4CCN(CC(N)=O)CC4)cc3)nn12)S(C)(=O)=O		CHEMBL1934353	=	Inhibition	%	1.0	CHEMBL2208	Homo sapiens	INH	%	1.0
Active	7996808	CHEMBL1941726	Inhibition of MAPKAPK2 at 10 uM by colorimetric analysis	B	Clc1ccc(-n2cc(-c3ccncc3)nn2)cc1		CHEMBL1938953		Inhibition	%		CHEMBL2208	Homo sapiens	INH		
Active	7996809	CHEMBL1941726	Inhibition of MAPKAPK2 at 10 uM by colorimetric analysis	B	Clc1cccc(-n2cc(-c3ccncc3)nn2)c1		CHEMBL1938954		Inhibition	%		CHEMBL2208	Homo sapiens	INH		
Active	7996810	CHEMBL1941726	Inhibition of MAPKAPK2 at 10 uM by colorimetric analysis	B	Clc1ccc(-n2nncc2-c2ccncc2)cc1		CHEMBL62965		Inhibition	%		CHEMBL2208	Homo sapiens	INH		
Active	7996811	CHEMBL1941726	Inhibition of MAPKAPK2 at 10 uM by colorimetric analysis	B	Clc1cccc(-n2nncc2-c2ccncc2)c1		CHEMBL303351		Inhibition	%		CHEMBL2208	Homo sapiens	INH		
	8002143	CHEMBL1942197	Inhibition of MAPKAPK2 at 1 uM	B	CC(C)n1cc(C(=O)c2cncc(N[C@@H]3CCN(C=O)[C@@H]3c3ccc(F)cc3)n2)c2c(N)ncnc21		CHEMBL1940251	=	Inhibition	%	6.0	CHEMBL2208	Homo sapiens	INH	%	6.0
	8002144	CHEMBL1942197	Inhibition of MAPKAPK2 at 1 uM	B	CC(=O)N1CC[C@@H](Nc2cncc(C(=O)c3cn(C(C)C)c4ncnc(N)c34)n2)[C@H]1c1ccc(F)cc1		CHEMBL1940252	=	Inhibition	%	2.0	CHEMBL2208	Homo sapiens	INH	%	2.0
	8002145	CHEMBL1942197	Inhibition of MAPKAPK2 at 1 uM	B	CC(=O)N1CC[C@@H](Nc2cncc(C(=O)c3cn(C(C)C)c4ncnc(N)c34)n2)[C@H]1c1ccccc1		CHEMBL1940253	=	Inhibition	%	6.0	CHEMBL2208	Homo sapiens	INH	%	6.0
	8006953	CHEMBL1943215	Inhibition of human MK2	B	O=C(c1ccc(-c2ccc(Cl)cc2)o1)N(Cc1ccccn1)c1ccc(N2CCNCC2)cc1		CHEMBL1938681	=	IC50	nM	110.0	CHEMBL2208	Homo sapiens	IC50	nM	110.0
	8006954	CHEMBL1943215	Inhibition of human MK2	B	N#Cc1ccc(-c2ccc(C(=O)N(Cc3ccccn3)c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL1940509	=	IC50	nM	115.0	CHEMBL2208	Homo sapiens	IC50	nM	115.0
	8006955	CHEMBL1943215	Inhibition of human MK2	B	O=C(c1ccc(-c2ccc(Cl)cc2)o1)N(Cc1ccccn1)C1CCC(N2CCNCC2)CC1		CHEMBL1940510	=	IC50	nM	4743.0	CHEMBL2208	Homo sapiens	IC50	nM	4743.0
	8006956	CHEMBL1943215	Inhibition of human MK2	B	CN1CCN(CCCN(Cc2ccccn2)C(=O)c2ccc(-c3ccc(C#N)cc3)o2)CC1		CHEMBL1940511	=	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	nM	10000.0
	8006957	CHEMBL1943215	Inhibition of human MK2	B	N#Cc1ccc(-c2ccc(C(=O)N(Cc3ccccn3)C3CCNCC3)o2)cc1		CHEMBL1940512	=	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	nM	10000.0
	8006958	CHEMBL1943215	Inhibition of human MK2	B	Cc1cccc(CN(C(=O)c2ccc(-c3ccc(C#N)cc3)o2)c2ccc(N3CCNCC3)cc2)n1		CHEMBL1940513	=	IC50	nM	79.0	CHEMBL2208	Homo sapiens	IC50	nM	79.0
Not Active	8006959	CHEMBL1943215	Inhibition of human MK2	B	Cc1cccc(CN(C(=O)c2ccc(-c3ccc(Cl)cc3)o2)c2cccc(N3CCNCC3)c2)n1		CHEMBL1940514		IC50			CHEMBL2208	Homo sapiens	IC50		
Not Active	8006960	CHEMBL1943215	Inhibition of human MK2	B	Cc1cccc(CN(C(=O)c2ccc(-c3ccc(Cl)cc3)o2)c2ccccc2N2CCNCC2)n1		CHEMBL1940515		IC50			CHEMBL2208	Homo sapiens	IC50		
	8006961	CHEMBL1943215	Inhibition of human MK2	B	N#Cc1ccc(-c2ccc(C(=O)N(Cc3ccc(-c4ccccc4)cc3)c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL1940516	=	IC50	nM	41.0	CHEMBL2208	Homo sapiens	IC50	nM	41.0
	8006962	CHEMBL1943215	Inhibition of human MK2	B	N#Cc1ccc(-c2ccc(C(=O)N(Cc3cccc(-c4ccccc4)c3)c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL1940517	=	IC50	nM	70.0	CHEMBL2208	Homo sapiens	IC50	nM	70.0
	8006963	CHEMBL1943215	Inhibition of human MK2	B	N#Cc1ccc(-c2ccc(C(=O)N(Cc3ccccc3-c3ccccc3)c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL1940518	=	IC50	nM	9.0	CHEMBL2208	Homo sapiens	IC50	nM	9.0
	8006964	CHEMBL1943215	Inhibition of human MK2	B	N#Cc1ccc(-c2ccc(C(=O)N(Cc3ccc(-c4ccccc4F)cc3)c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL1940519	=	IC50	nM	1920.0	CHEMBL2208	Homo sapiens	IC50	nM	1920.0
	8006965	CHEMBL1943215	Inhibition of human MK2	B	N#Cc1ccc(-c2ccc(C(=O)N(Cc3cccc(-c4ccccc4F)c3)c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL1940520	=	IC50	nM	1450.0	CHEMBL2208	Homo sapiens	IC50	nM	1450.0
	8006966	CHEMBL1943215	Inhibition of human MK2	B	N#Cc1ccc(-c2ccc(C(=O)N(Cc3ccccc3-c3ccccc3F)c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL1940521	=	IC50	nM	12.0	CHEMBL2208	Homo sapiens	IC50	nM	12.0
	8006967	CHEMBL1943215	Inhibition of human MK2	B	N#Cc1ccc(-c2ccc(C(=O)N(Cc3ccc(-c4ccncc4)cc3)c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL1940522	=	IC50	nM	128.0	CHEMBL2208	Homo sapiens	IC50	nM	128.0
	8006968	CHEMBL1943215	Inhibition of human MK2	B	N#Cc1ccc(-c2ccc(C(=O)N(Cc3cccc(-c4ccncc4)c3)c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL1940523	=	IC50	nM	110.0	CHEMBL2208	Homo sapiens	IC50	nM	110.0
	8006969	CHEMBL1943215	Inhibition of human MK2	B	N#Cc1ccc(-c2ccc(C(=O)N(Cc3ccccc3-c3ccncc3)c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL1940524	=	IC50	nM	12.0	CHEMBL2208	Homo sapiens	IC50	nM	12.0
	8006970	CHEMBL1943215	Inhibition of human MK2	B	Cc1ccccc1-c1ccccc1CN(C(=O)c1ccc(-c2ccc(C#N)cc2)o1)c1ccc(N2CCNCC2)cc1		CHEMBL1940643	=	IC50	nM	285.0	CHEMBL2208	Homo sapiens	IC50	nM	285.0
	8006971	CHEMBL1943215	Inhibition of human MK2	B	Cc1cccc(C)c1-c1ccccc1CN(C(=O)c1ccc(-c2ccc(C#N)cc2)o1)c1ccc(N2CCNCC2)cc1		CHEMBL1938419	=	IC50	nM	258.0	CHEMBL2208	Homo sapiens	IC50	nM	258.0
	8006972	CHEMBL1943215	Inhibition of human MK2	B	Cc1noc(C)c1-c1ccccc1CN(C(=O)c1ccc(-c2ccc(C#N)cc2)o1)c1ccc(N2CCNCC2)cc1		CHEMBL1940644	=	IC50	nM	21.0	CHEMBL2208	Homo sapiens	IC50	nM	21.0
	8006973	CHEMBL1943215	Inhibition of human MK2	B	N#Cc1ccc(-c2ccc(C(=O)N(Cc3ccccc3-c3ccc(C#N)cc3)c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL1940645	=	IC50	nM	8.0	CHEMBL2208	Homo sapiens	IC50	nM	8.0
	8006974	CHEMBL1943215	Inhibition of human MK2	B	N#Cc1ccc(-c2ccc(C(=O)N(Cc3ccccc3-c3cccc(C#N)c3)c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL1940646	=	IC50	nM	19.0	CHEMBL2208	Homo sapiens	IC50	nM	19.0
	8006975	CHEMBL1943215	Inhibition of human MK2	B	COc1cccc(-c2ccccc2CN(C(=O)c2ccc(-c3ccc(C#N)cc3)o2)c2ccc(N3CCNCC3)cc2)c1		CHEMBL1940647	=	IC50	nM	12.0	CHEMBL2208	Homo sapiens	IC50	nM	12.0
	8006976	CHEMBL1943215	Inhibition of human MK2	B	N#Cc1ccc(-c2ccc(C(=O)N(Cc3ccccc3-c3cccnc3)c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL1940648	=	IC50	nM	9.0	CHEMBL2208	Homo sapiens	IC50	nM	9.0
	8006977	CHEMBL1943215	Inhibition of human MK2	B	N#Cc1ccc(-c2ccc(C(=O)N(Cc3ccccc3-c3ccccn3)c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL1940649	=	IC50	nM	14.0	CHEMBL2208	Homo sapiens	IC50	nM	14.0
	8006978	CHEMBL1943215	Inhibition of human MK2	B	N#Cc1ccc(-c2ccc(C(=O)N(Cc3ccccc3-c3cncnc3)c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL1940650	=	IC50	nM	27.0	CHEMBL2208	Homo sapiens	IC50	nM	27.0
	8006979	CHEMBL1943215	Inhibition of human MK2	B	COc1cncc(-c2ccccc2CN(C(=O)c2ccc(-c3ccc(C#N)cc3)o2)c2ccc(N3CCNCC3)cc2)c1		CHEMBL1940651	=	IC50	nM	20.0	CHEMBL2208	Homo sapiens	IC50	nM	20.0
	8006980	CHEMBL1943215	Inhibition of human MK2	B	COc1ccncc1-c1ccccc1CN(C(=O)c1ccc(-c2ccc(C#N)cc2)o1)c1ccc(N2CCNCC2)cc1		CHEMBL1940652	=	IC50	nM	8.0	CHEMBL2208	Homo sapiens	IC50	nM	8.0
	8006981	CHEMBL1943215	Inhibition of human MK2	B	COc1ccc(-c2ccccc2CN(C(=O)c2ccc(-c3ccc(C#N)cc3)o2)c2ccc(N3CCNCC3)cc2)cn1		CHEMBL1940653	=	IC50	nM	43.0	CHEMBL2208	Homo sapiens	IC50	nM	43.0
	8006982	CHEMBL1943215	Inhibition of human MK2	B	COc1cc(-c2ccccc2CN(C(=O)c2ccc(-c3ccc(C#N)cc3)o2)c2ccc(N3CCNCC3)cc2)ccn1		CHEMBL1940654	=	IC50	nM	24.0	CHEMBL2208	Homo sapiens	IC50	nM	24.0
	8006983	CHEMBL1943215	Inhibition of human MK2	B	COc1ncc(-c2ccccc2CN(C(=O)c2ccc(-c3ccc(C#N)cc3)o2)c2ccc(N3CCNCC3)cc2)cn1		CHEMBL1940655	=	IC50	nM	52.0	CHEMBL2208	Homo sapiens	IC50	nM	52.0
	8006984	CHEMBL1943215	Inhibition of human MK2	B	COc1ccccc1-c1ccccc1CN(C(=O)c1ccc(-c2ccc(C#N)cc2)o1)c1ccc(N2CCNCC2)cc1		CHEMBL1940656	=	IC50	nM	20.0	CHEMBL2208	Homo sapiens	IC50	nM	20.0
	8006985	CHEMBL1943215	Inhibition of human MK2	B	COc1ccccc1-c1ncccc1CN(C(=O)c1ccc(-c2ccc(C#N)cc2)o1)c1ccc(N2CCNCC2)cc1		CHEMBL1940657	=	IC50	nM	12.0	CHEMBL2208	Homo sapiens	IC50	nM	12.0
	8006986	CHEMBL1943215	Inhibition of human MK2	B	COc1ccncc1-c1ncccc1CN(C(=O)c1ccc(-c2ccc(C#N)cc2)o1)c1ccc(N2CCNCC2)cc1		CHEMBL1940658	=	IC50	nM	9.0	CHEMBL2208	Homo sapiens	IC50	nM	9.0
	8006987	CHEMBL1943215	Inhibition of human MK2	B	N#Cc1ccc(-c2ccc(C(=O)N(Cc3cccnc3-c3cncnc3)c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL1940659	=	IC50	nM	100.0	CHEMBL2208	Homo sapiens	IC50	nM	100.0
	8006988	CHEMBL1943215	Inhibition of human MK2	B	N#Cc1ccc(-c2ccc(C(=O)N(Cc3ccccc3-c3ccccc3)c3ccc(N4CCNCC4)cc3)o2)cn1		CHEMBL1940660	=	IC50	nM	258.0	CHEMBL2208	Homo sapiens	IC50	nM	258.0
	8006989	CHEMBL1943215	Inhibition of human MK2	B	N#Cc1ccc(-c2ccc(C(=O)N(Cc3ccccc3-c3cccnc3)c3ccc(N4CCNCC4)cc3)o2)cn1		CHEMBL1940661	=	IC50	nM	177.0	CHEMBL2208	Homo sapiens	IC50	nM	177.0
	8007006	CHEMBL1943217	Inhibition of MK2-mediated HSP27 phosphorylation by cell-based assay	B	O=C(c1ccc(-c2ccc(Cl)cc2)o1)N(Cc1ccccn1)c1ccc(N2CCNCC2)cc1		CHEMBL1938681	=	EC50	nM	350.0	CHEMBL2208	Homo sapiens	EC50	nM	350.0
	8009922	CHEMBL1942718	Inhibition of MK2 using TAMRA-labeled peptide as substrate pre-incubated for 30 mins prior substrate addition measured after 30 mins incubation in dark using fluorescence polarization assay	B	O=C(Nc1ccc(N2CCNCC2)cc1)c1ccc(-c2ccc(Cl)cc2)o1		CHEMBL1938680	=	IC50	nM	5500.0	CHEMBL2208	Homo sapiens	IC50	uM	5.5
	8009923	CHEMBL1942718	Inhibition of MK2 using TAMRA-labeled peptide as substrate pre-incubated for 30 mins prior substrate addition measured after 30 mins incubation in dark using fluorescence polarization assay	B	O=C(c1ccc(-c2ccc(Cl)cc2)o1)N(Cc1ccccn1)c1ccc(N2CCNCC2)cc1		CHEMBL1938681	=	IC50	nM	110.0	CHEMBL2208	Homo sapiens	IC50	nM	110.0
	8009924	CHEMBL1942718	Inhibition of MK2 using TAMRA-labeled peptide as substrate pre-incubated for 30 mins prior substrate addition measured after 30 mins incubation in dark using fluorescence polarization assay	B	O=C1Nc2ccc(N3CCNCC3)cc2Cc2cc(-c3ccc(Cl)cc3)oc21		CHEMBL1938682	=	IC50	nM	96.0	CHEMBL2208	Homo sapiens	IC50	nM	96.0
	8009925	CHEMBL1942718	Inhibition of MK2 using TAMRA-labeled peptide as substrate pre-incubated for 30 mins prior substrate addition measured after 30 mins incubation in dark using fluorescence polarization assay	B	N#Cc1ccc(-c2cc3c(o2)C(=O)Nc2ccc(N4CCNCC4)cc2C3)cc1		CHEMBL1938683	=	IC50	nM	110.0	CHEMBL2208	Homo sapiens	IC50	nM	110.0
	8009926	CHEMBL1942718	Inhibition of MK2 using TAMRA-labeled peptide as substrate pre-incubated for 30 mins prior substrate addition measured after 30 mins incubation in dark using fluorescence polarization assay	B	Clc1ccc(-c2cc3c(o2)-c2nccn2-c2ccc(N4CCNCC4)cc2C3)cc1		CHEMBL1938684	=	IC50	nM	7.0	CHEMBL2208	Homo sapiens	IC50	nM	7.0
	8009927	CHEMBL1942718	Inhibition of MK2 using TAMRA-labeled peptide as substrate pre-incubated for 30 mins prior substrate addition measured after 30 mins incubation in dark using fluorescence polarization assay	B	N#Cc1ccc(-c2cc3c(o2)-c2nccn2-c2ccc(N4CCNCC4)cc2C3)cc1		CHEMBL1938685	=	IC50	nM	2.9	CHEMBL2208	Homo sapiens	IC50	nM	2.9
	8009928	CHEMBL1942718	Inhibition of MK2 using TAMRA-labeled peptide as substrate pre-incubated for 30 mins prior substrate addition measured after 30 mins incubation in dark using fluorescence polarization assay	B	Clc1ccc(-c2cc3c(o2)-c2nncn2-c2ccc(N4CCNCC4)cc2C3)cc1		CHEMBL1938686	=	IC50	nM	9.3	CHEMBL2208	Homo sapiens	IC50	nM	9.3
	8009929	CHEMBL1942718	Inhibition of MK2 using TAMRA-labeled peptide as substrate pre-incubated for 30 mins prior substrate addition measured after 30 mins incubation in dark using fluorescence polarization assay	B	N#Cc1ccc(-c2cc3c(o2)-c2nncn2-c2ccc(N4CCNCC4)cc2C3)cc1		CHEMBL1938687	=	IC50	nM	3.8	CHEMBL2208	Homo sapiens	IC50	nM	3.8
	8009930	CHEMBL1942718	Inhibition of MK2 using TAMRA-labeled peptide as substrate pre-incubated for 30 mins prior substrate addition measured after 30 mins incubation in dark using fluorescence polarization assay	B	Fc1ccc(-c2cc3c(o2)-c2nncn2-c2ccc(N4CCNCC4)cc2C3)cc1		CHEMBL1938688	=	IC50	nM	15.0	CHEMBL2208	Homo sapiens	IC50	nM	15.0
	8009931	CHEMBL1942718	Inhibition of MK2 using TAMRA-labeled peptide as substrate pre-incubated for 30 mins prior substrate addition measured after 30 mins incubation in dark using fluorescence polarization assay	B	Cc1cnc2n1-c1ccc(N3CCNCC3)cc1Cc1cc(-c3ccc(Cl)cc3)oc1-2		CHEMBL1938689	=	IC50	nM	9.2	CHEMBL2208	Homo sapiens	IC50	nM	9.2
	8009932	CHEMBL1942718	Inhibition of MK2 using TAMRA-labeled peptide as substrate pre-incubated for 30 mins prior substrate addition measured after 30 mins incubation in dark using fluorescence polarization assay	B	Cc1nnc2n1-c1ccc(N3CCNCC3)cc1Cc1cc(-c3ccc(Cl)cc3)oc1-2		CHEMBL1938690	=	IC50	nM	880.0	CHEMBL2208	Homo sapiens	IC50	nM	880.0
	8009933	CHEMBL1942718	Inhibition of MK2 using TAMRA-labeled peptide as substrate pre-incubated for 30 mins prior substrate addition measured after 30 mins incubation in dark using fluorescence polarization assay	B	Clc1ccc(-c2cc3c(o2)-c2nccn2-c2ccc(N4CCNCC4)cc2OC3)cc1		CHEMBL1938691	=	IC50	nM	18.0	CHEMBL2208	Homo sapiens	IC50	nM	18.0
	8009934	CHEMBL1942718	Inhibition of MK2 using TAMRA-labeled peptide as substrate pre-incubated for 30 mins prior substrate addition measured after 30 mins incubation in dark using fluorescence polarization assay	B	O=C1Nc2ccc(N3CCNCC3)cc2OCc2cc(-c3ccc(Cl)cc3)oc21		CHEMBL1938692	=	IC50	nM	110.0	CHEMBL2208	Homo sapiens	IC50	nM	110.0
	8009935	CHEMBL1942719	Inhibition of MK2-mediated HSP27 phosphorylation at Ser78 in LPS-stimulated human THP-1 cells pre-incubated for 60 mins before LPS treatment measured after 60 mins	B	O=C(Nc1ccc(N2CCNCC2)cc1)c1ccc(-c2ccc(Cl)cc2)o1		CHEMBL1938680	=	EC50	nM	2000.0	CHEMBL2208	Homo sapiens	EC50	uM	2.0
	8009936	CHEMBL1942719	Inhibition of MK2-mediated HSP27 phosphorylation at Ser78 in LPS-stimulated human THP-1 cells pre-incubated for 60 mins before LPS treatment measured after 60 mins	B	O=C(c1ccc(-c2ccc(Cl)cc2)o1)N(Cc1ccccn1)c1ccc(N2CCNCC2)cc1		CHEMBL1938681	=	EC50	nM	350.0	CHEMBL2208	Homo sapiens	EC50	uM	0.35
Not Determined	8009937	CHEMBL1942719	Inhibition of MK2-mediated HSP27 phosphorylation at Ser78 in LPS-stimulated human THP-1 cells pre-incubated for 60 mins before LPS treatment measured after 60 mins	B	O=C1Nc2ccc(N3CCNCC3)cc2Cc2cc(-c3ccc(Cl)cc3)oc21		CHEMBL1938682		EC50			CHEMBL2208	Homo sapiens	EC50		
Not Determined	8009938	CHEMBL1942719	Inhibition of MK2-mediated HSP27 phosphorylation at Ser78 in LPS-stimulated human THP-1 cells pre-incubated for 60 mins before LPS treatment measured after 60 mins	B	N#Cc1ccc(-c2cc3c(o2)C(=O)Nc2ccc(N4CCNCC4)cc2C3)cc1		CHEMBL1938683		EC50			CHEMBL2208	Homo sapiens	EC50		
	8009939	CHEMBL1942719	Inhibition of MK2-mediated HSP27 phosphorylation at Ser78 in LPS-stimulated human THP-1 cells pre-incubated for 60 mins before LPS treatment measured after 60 mins	B	Clc1ccc(-c2cc3c(o2)-c2nccn2-c2ccc(N4CCNCC4)cc2C3)cc1		CHEMBL1938684	=	EC50	nM	1500.0	CHEMBL2208	Homo sapiens	EC50	uM	1.5
	8009940	CHEMBL1942719	Inhibition of MK2-mediated HSP27 phosphorylation at Ser78 in LPS-stimulated human THP-1 cells pre-incubated for 60 mins before LPS treatment measured after 60 mins	B	N#Cc1ccc(-c2cc3c(o2)-c2nccn2-c2ccc(N4CCNCC4)cc2C3)cc1		CHEMBL1938685	=	EC50	nM	260.0	CHEMBL2208	Homo sapiens	EC50	uM	0.26
	8009941	CHEMBL1942719	Inhibition of MK2-mediated HSP27 phosphorylation at Ser78 in LPS-stimulated human THP-1 cells pre-incubated for 60 mins before LPS treatment measured after 60 mins	B	Clc1ccc(-c2cc3c(o2)-c2nncn2-c2ccc(N4CCNCC4)cc2C3)cc1		CHEMBL1938686	=	EC50	nM	2100.0	CHEMBL2208	Homo sapiens	EC50	uM	2.1
	8009942	CHEMBL1942719	Inhibition of MK2-mediated HSP27 phosphorylation at Ser78 in LPS-stimulated human THP-1 cells pre-incubated for 60 mins before LPS treatment measured after 60 mins	B	N#Cc1ccc(-c2cc3c(o2)-c2nncn2-c2ccc(N4CCNCC4)cc2C3)cc1		CHEMBL1938687	=	EC50	nM	260.0	CHEMBL2208	Homo sapiens	EC50	uM	0.26
Not Determined	8009943	CHEMBL1942719	Inhibition of MK2-mediated HSP27 phosphorylation at Ser78 in LPS-stimulated human THP-1 cells pre-incubated for 60 mins before LPS treatment measured after 60 mins	B	Fc1ccc(-c2cc3c(o2)-c2nncn2-c2ccc(N4CCNCC4)cc2C3)cc1		CHEMBL1938688		EC50			CHEMBL2208	Homo sapiens	EC50		
	8009944	CHEMBL1942719	Inhibition of MK2-mediated HSP27 phosphorylation at Ser78 in LPS-stimulated human THP-1 cells pre-incubated for 60 mins before LPS treatment measured after 60 mins	B	Cc1cnc2n1-c1ccc(N3CCNCC3)cc1Cc1cc(-c3ccc(Cl)cc3)oc1-2		CHEMBL1938689	=	EC50	nM	2500.0	CHEMBL2208	Homo sapiens	EC50	uM	2.5
Not Determined	8009945	CHEMBL1942719	Inhibition of MK2-mediated HSP27 phosphorylation at Ser78 in LPS-stimulated human THP-1 cells pre-incubated for 60 mins before LPS treatment measured after 60 mins	B	Cc1nnc2n1-c1ccc(N3CCNCC3)cc1Cc1cc(-c3ccc(Cl)cc3)oc1-2		CHEMBL1938690		EC50			CHEMBL2208	Homo sapiens	EC50		
Not Determined	8009946	CHEMBL1942719	Inhibition of MK2-mediated HSP27 phosphorylation at Ser78 in LPS-stimulated human THP-1 cells pre-incubated for 60 mins before LPS treatment measured after 60 mins	B	Clc1ccc(-c2cc3c(o2)-c2nccn2-c2ccc(N4CCNCC4)cc2OC3)cc1		CHEMBL1938691		EC50			CHEMBL2208	Homo sapiens	EC50		
Not Determined	8009947	CHEMBL1942719	Inhibition of MK2-mediated HSP27 phosphorylation at Ser78 in LPS-stimulated human THP-1 cells pre-incubated for 60 mins before LPS treatment measured after 60 mins	B	O=C1Nc2ccc(N3CCNCC3)cc2OCc2cc(-c3ccc(Cl)cc3)oc21		CHEMBL1938692		EC50			CHEMBL2208	Homo sapiens	EC50		
Active	8009960	CHEMBL1942721	Noncompetitive inhibition of MK2 using TAMRA-labeled peptide as substrate by fluorescence-based thermal shift assay	B	N#Cc1ccc(-c2cc3c(o2)-c2nncn2-c2ccc(N4CCNCC4)cc2C3)cc1		CHEMBL1938687		Inhibition	%		CHEMBL2208	Homo sapiens	INH		
Active	8009961	CHEMBL1942721	Noncompetitive inhibition of MK2 using TAMRA-labeled peptide as substrate by fluorescence-based thermal shift assay	B	Clc1ccc(-c2cc3c(o2)-c2nccn2-c2ccc(N4CCNCC4)cc2OC3)cc1		CHEMBL1938691		Inhibition	%		CHEMBL2208	Homo sapiens	INH		
	8013113	CHEMBL1948132	Inhibition of MK2 using ATP as substrate	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCNCC1)NC2=O		CHEMBL1945559	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	8018825	CHEMBL1948947	Inhibition of MAPKAP-K2 assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CC1CCOCC1		CHEMBL1945953	=	Activity	%	93.0	CHEMBL2208	Homo sapiens	Activity	%	93.0
	8018826	CHEMBL1948947	Inhibition of MAPKAP-K2 assessed as activity remaining at 10 uM	B	CC(C)(O)c1ccc(-c2cnc3[nH]c(=O)n(CC4CCCCC4)c3n2)cc1		CHEMBL1945950	=	Activity	%	99.0	CHEMBL2208	Homo sapiens	Activity	%	99.0
	8018827	CHEMBL1948947	Inhibition of MAPKAP-K2 assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc4[nH]cnc4c3)nc2n1CC1CCCCC1		CHEMBL1946262	=	Activity	%	89.0	CHEMBL2208	Homo sapiens	Activity	%	89.0
	8045859	CHEMBL1959338	Inhibition of human His-tagged MK2 using K(biotin)KLNRTLSVA as substrate after 2 hrs by scintillation counting	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	8061265	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	-0.41	CHEMBL2208	Homo sapiens	Inhibition	%	-0.41
	8061442	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-2.27	CHEMBL2208	Homo sapiens	Inhibition	%	-2.27
	8061773	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	0.41	CHEMBL2208	Homo sapiens	Inhibition	%	0.41
	8061964	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	0.71	CHEMBL2208	Homo sapiens	Inhibition	%	0.71
	8062188	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	1.83	CHEMBL2208	Homo sapiens	Inhibition	%	1.83
	8062304	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	1.66	CHEMBL2208	Homo sapiens	Inhibition	%	1.66
	8062690	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	2.96	CHEMBL2208	Homo sapiens	Inhibition	%	2.96
	8062788	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	0.49	CHEMBL2208	Homo sapiens	Inhibition	%	0.49
	8063012	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	-2.43	CHEMBL2208	Homo sapiens	Inhibition	%	-2.43
	8063144	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	-0.56	CHEMBL2208	Homo sapiens	Inhibition	%	-0.56
	8063311	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	1.23	CHEMBL2208	Homo sapiens	Inhibition	%	1.23
	8063535	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	0.64	CHEMBL2208	Homo sapiens	Inhibition	%	0.64
	8063643	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	1.1	CHEMBL2208	Homo sapiens	Inhibition	%	1.1
	8064049	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	0.54	CHEMBL2208	Homo sapiens	Inhibition	%	0.54
	8064164	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	1.06	CHEMBL2208	Homo sapiens	Inhibition	%	1.06
	8064388	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	1.12	CHEMBL2208	Homo sapiens	Inhibition	%	1.12
	8064598	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	-0.13	CHEMBL2208	Homo sapiens	Inhibition	%	-0.13
	8064736	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	-0.12	CHEMBL2208	Homo sapiens	Inhibition	%	-0.12
	8065126	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	1.32	CHEMBL2208	Homo sapiens	Inhibition	%	1.32
	8065242	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	0.74	CHEMBL2208	Homo sapiens	Inhibition	%	0.74
	8065466	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	1.26	CHEMBL2208	Homo sapiens	Inhibition	%	1.26
	8065641	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	0.88	CHEMBL2208	Homo sapiens	Inhibition	%	0.88
	8065980	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	0.16	CHEMBL2208	Homo sapiens	Inhibition	%	0.16
	8066190	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	-0.33	CHEMBL2208	Homo sapiens	Inhibition	%	-0.33
	8066326	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	-0.35	CHEMBL2208	Homo sapiens	Inhibition	%	-0.35
	8066550	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	0.26	CHEMBL2208	Homo sapiens	Inhibition	%	0.26
	8066716	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	1.4	CHEMBL2208	Homo sapiens	Inhibition	%	1.4
	8067064	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	1.19	CHEMBL2208	Homo sapiens	Inhibition	%	1.19
	8067239	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	0.59	CHEMBL2208	Homo sapiens	Inhibition	%	0.59
	8067584	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	0.22	CHEMBL2208	Homo sapiens	Inhibition	%	0.22
	8067794	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	-0.34	CHEMBL2208	Homo sapiens	Inhibition	%	-0.34
	8068153	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	0.15	CHEMBL2208	Homo sapiens	Inhibition	%	0.15
	8068317	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	0.9	CHEMBL2208	Homo sapiens	Inhibition	%	0.9
	8068666	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.34	CHEMBL2208	Homo sapiens	Inhibition	%	0.34
	8068840	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	1.63	CHEMBL2208	Homo sapiens	Inhibition	%	1.63
	8069064	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	1.0	CHEMBL2208	Homo sapiens	Inhibition	%	1.0
	8069189	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	Inhibition	%	0.0
	8069484	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	0.52	CHEMBL2208	Homo sapiens	Inhibition	%	0.52
	8069645	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	1.11	CHEMBL2208	Homo sapiens	Inhibition	%	1.11
	8069869	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	1.56	CHEMBL2208	Homo sapiens	Inhibition	%	1.56
	8069995	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	-0.56	CHEMBL2208	Homo sapiens	Inhibition	%	-0.56
	8070391	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	0.92	CHEMBL2208	Homo sapiens	Inhibition	%	0.92
	8070516	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	0.58	CHEMBL2208	Homo sapiens	Inhibition	%	0.58
	8070814	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	0.62	CHEMBL2208	Homo sapiens	Inhibition	%	0.62
	8071195	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	1.44	CHEMBL2208	Homo sapiens	Inhibition	%	1.44
	8071321	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.61	CHEMBL2208	Homo sapiens	Inhibition	%	0.61
	8071545	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	-0.07	CHEMBL2208	Homo sapiens	Inhibition	%	-0.07
	8071718	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	1.86	CHEMBL2208	Homo sapiens	Inhibition	%	1.86
	8071843	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	-0.11	CHEMBL2208	Homo sapiens	Inhibition	%	-0.11
	8072067	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	0.26	CHEMBL2208	Homo sapiens	Inhibition	%	0.26
	8072157	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-0.06	CHEMBL2208	Homo sapiens	Inhibition	%	-0.06
	8072381	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-0.64	CHEMBL2208	Homo sapiens	Inhibition	%	-0.64
	8072538	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	1.49	CHEMBL2208	Homo sapiens	Inhibition	%	1.49
	8072887	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-0.07	CHEMBL2208	Homo sapiens	Inhibition	%	-0.07
	8073054	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	1.26	CHEMBL2208	Homo sapiens	Inhibition	%	1.26
	8073403	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	-0.42	CHEMBL2208	Homo sapiens	Inhibition	%	-0.42
	8073522	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	-0.81	CHEMBL2208	Homo sapiens	Inhibition	%	-0.81
	8073746	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	-0.37	CHEMBL2208	Homo sapiens	Inhibition	%	-0.37
	8073979	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-0.49	CHEMBL2208	Homo sapiens	Inhibition	%	-0.49
	8074131	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	1.44	CHEMBL2208	Homo sapiens	Inhibition	%	1.44
	8074485	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-0.4	CHEMBL2208	Homo sapiens	Inhibition	%	-0.4
	8074642	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	0.74	CHEMBL2208	Homo sapiens	Inhibition	%	0.74
	8074993	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-0.17	CHEMBL2208	Homo sapiens	Inhibition	%	-0.17
	8075328	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-0.27	CHEMBL2208	Homo sapiens	Inhibition	%	-0.27
	8075565	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-0.42	CHEMBL2208	Homo sapiens	Inhibition	%	-0.42
	8075706	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	1.73	CHEMBL2208	Homo sapiens	Inhibition	%	1.73
	8075930	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	1.21	CHEMBL2208	Homo sapiens	Inhibition	%	1.21
	8076072	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-0.39	CHEMBL2208	Homo sapiens	Inhibition	%	-0.39
	8076220	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	0.89	CHEMBL2208	Homo sapiens	Inhibition	%	0.89
	8076444	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	0.61	CHEMBL2208	Homo sapiens	Inhibition	%	0.61
	8076578	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-0.87	CHEMBL2208	Homo sapiens	Inhibition	%	-0.87
	8076904	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-0.32	CHEMBL2208	Homo sapiens	Inhibition	%	-0.32
	8077151	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	-0.97	CHEMBL2208	Homo sapiens	Inhibition	%	-0.97
	8077503	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	1.02	CHEMBL2208	Homo sapiens	Inhibition	%	1.02
	8077654	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-0.49	CHEMBL2208	Homo sapiens	Inhibition	%	-0.49
	8078021	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	1.03	CHEMBL2208	Homo sapiens	Inhibition	%	1.03
	8078160	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-1.97	CHEMBL2208	Homo sapiens	Inhibition	%	-1.97
	8078486	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-0.64	CHEMBL2208	Homo sapiens	Inhibition	%	-0.64
	8078736	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	-1.0	CHEMBL2208	Homo sapiens	Inhibition	%	-1.0
	8079076	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	0.1	CHEMBL2208	Homo sapiens	Inhibition	%	0.1
	8079234	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-0.75	CHEMBL2208	Homo sapiens	Inhibition	%	-0.75
	8079458	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-0.94	CHEMBL2208	Homo sapiens	Inhibition	%	-0.94
	8079600	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	0.41	CHEMBL2208	Homo sapiens	Inhibition	%	0.41
	8079739	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-1.79	CHEMBL2208	Homo sapiens	Inhibition	%	-1.79
	8079963	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	1.84	CHEMBL2208	Homo sapiens	Inhibition	%	1.84
	8080068	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-0.71	CHEMBL2208	Homo sapiens	Inhibition	%	-0.71
	8080320	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	-0.97	CHEMBL2208	Homo sapiens	Inhibition	%	-0.97
	8080544	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	-1.28	CHEMBL2208	Homo sapiens	Inhibition	%	-1.28
	8080659	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	1.42	CHEMBL2208	Homo sapiens	Inhibition	%	1.42
	8081047	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-1.56	CHEMBL2208	Homo sapiens	Inhibition	%	-1.56
	8081182	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	0.42	CHEMBL2208	Homo sapiens	Inhibition	%	0.42
	8081550	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	3.23	CHEMBL2208	Homo sapiens	Inhibition	%	3.23
	8081653	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	0.03	CHEMBL2208	Homo sapiens	Inhibition	%	0.03
	8081877	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	0.04	CHEMBL2208	Homo sapiens	Inhibition	%	0.04
	8082129	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-1.18	CHEMBL2208	Homo sapiens	Inhibition	%	-1.18
	8082242	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	-2.28	CHEMBL2208	Homo sapiens	Inhibition	%	-2.28
	8082639	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-1.96	CHEMBL2208	Homo sapiens	Inhibition	%	-1.96
	8082762	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	1.17	CHEMBL2208	Homo sapiens	Inhibition	%	1.17
	8082986	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	0.94	CHEMBL2208	Homo sapiens	Inhibition	%	0.94
	8083142	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	4.69	CHEMBL2208	Homo sapiens	Inhibition	%	4.69
	8083465	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	0.07	CHEMBL2208	Homo sapiens	Inhibition	%	0.07
	8083719	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-1.08	CHEMBL2208	Homo sapiens	Inhibition	%	-1.08
	8083829	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	0.99	CHEMBL2208	Homo sapiens	Inhibition	%	0.99
	8084053	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	0.33	CHEMBL2208	Homo sapiens	Inhibition	%	0.33
	8084238	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	0.89	CHEMBL2208	Homo sapiens	Inhibition	%	0.89
	8084580	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	1.53	CHEMBL2208	Homo sapiens	Inhibition	%	1.53
	8084741	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	5.55	CHEMBL2208	Homo sapiens	Inhibition	%	5.55
	8085063	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	0.38	CHEMBL2208	Homo sapiens	Inhibition	%	0.38
	8085319	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-2.2	CHEMBL2208	Homo sapiens	Inhibition	%	-2.2
	8085651	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	1.0	CHEMBL2208	Homo sapiens	Inhibition	%	1.0
	8085840	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	1.9	CHEMBL2208	Homo sapiens	Inhibition	%	1.9
	8086179	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	1.29	CHEMBL2208	Homo sapiens	Inhibition	%	1.29
	8086341	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	1.56	CHEMBL2208	Homo sapiens	Inhibition	%	1.56
	8086565	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	1.12	CHEMBL2208	Homo sapiens	Inhibition	%	1.12
	8086664	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	-0.18	CHEMBL2208	Homo sapiens	Inhibition	%	-0.18
	8086875	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	0.7	CHEMBL2208	Homo sapiens	Inhibition	%	0.7
	8087099	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	2.98	CHEMBL2208	Homo sapiens	Inhibition	%	2.98
	8087257	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	0.77	CHEMBL2208	Homo sapiens	Inhibition	%	0.77
	8087595	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	-0.33	CHEMBL2208	Homo sapiens	Inhibition	%	-0.33
	8087733	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.32	CHEMBL2208	Homo sapiens	Inhibition	%	3.32
	8087957	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	0.07	CHEMBL2208	Homo sapiens	Inhibition	%	0.07
	8088099	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	5.04	CHEMBL2208	Homo sapiens	Inhibition	%	5.04
	8088247	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.59	CHEMBL2208	Homo sapiens	Inhibition	%	1.59
	8088471	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.42	CHEMBL2208	Homo sapiens	Inhibition	%	1.42
	8088599	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	5.43	CHEMBL2208	Homo sapiens	Inhibition	%	5.43
	8088916	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	1.12	CHEMBL2208	Homo sapiens	Inhibition	%	1.12
	8089044	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	-0.08	CHEMBL2208	Homo sapiens	Inhibition	%	-0.08
	8089268	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	-0.66	CHEMBL2208	Homo sapiens	Inhibition	%	-0.66
	8089416	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	3.53	CHEMBL2208	Homo sapiens	Inhibition	%	3.53
	8089760	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	0.24	CHEMBL2208	Homo sapiens	Inhibition	%	0.24
	8089940	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-1.14	CHEMBL2208	Homo sapiens	Inhibition	%	-1.14
	8090329	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	2.85	CHEMBL2208	Homo sapiens	Inhibition	%	2.85
	8090496	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	1.25	CHEMBL2208	Homo sapiens	Inhibition	%	1.25
	8090859	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	0.67	CHEMBL2208	Homo sapiens	Inhibition	%	0.67
	8091064	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	1.2	CHEMBL2208	Homo sapiens	Inhibition	%	1.2
	8091425	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	2.63	CHEMBL2208	Homo sapiens	Inhibition	%	2.63
	8091580	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	1.21	CHEMBL2208	Homo sapiens	Inhibition	%	1.21
	8091920	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	-1.84	CHEMBL2208	Homo sapiens	Inhibition	%	-1.84
	8092281	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-0.82	CHEMBL2208	Homo sapiens	Inhibition	%	-0.82
	8092432	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	2.75	CHEMBL2208	Homo sapiens	Inhibition	%	2.75
	8092804	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	-2.05	CHEMBL2208	Homo sapiens	Inhibition	%	-2.05
	8092933	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	5.0	CHEMBL2208	Homo sapiens	Inhibition	%	5.0
	8093245	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	0.94	CHEMBL2208	Homo sapiens	Inhibition	%	0.94
	8093609	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-3.81	CHEMBL2208	Homo sapiens	Inhibition	%	-3.81
	8093748	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	3.71	CHEMBL2208	Homo sapiens	Inhibition	%	3.71
	8094092	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	-0.21	CHEMBL2208	Homo sapiens	Inhibition	%	-0.21
	8094272	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	0.52	CHEMBL2208	Homo sapiens	Inhibition	%	0.52
	8094496	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	0.01	CHEMBL2208	Homo sapiens	Inhibition	%	0.01
	8094671	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	0.94	CHEMBL2208	Homo sapiens	Inhibition	%	0.94
	8094827	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	2.01	CHEMBL2208	Homo sapiens	Inhibition	%	2.01
	8095051	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	1.33	CHEMBL2208	Homo sapiens	Inhibition	%	1.33
	8095191	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	-0.37	CHEMBL2208	Homo sapiens	Inhibition	%	-0.37
	8095394	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	0.72	CHEMBL2208	Homo sapiens	Inhibition	%	0.72
	8095759	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	4.94	CHEMBL2208	Homo sapiens	Inhibition	%	4.94
	8095907	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	2.78	CHEMBL2208	Homo sapiens	Inhibition	%	2.78
	8096131	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	4.35	CHEMBL2208	Homo sapiens	Inhibition	%	4.35
	8096248	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	1.76	CHEMBL2208	Homo sapiens	Inhibition	%	1.76
	8096611	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	1.0	CHEMBL2208	Homo sapiens	Inhibition	%	1.0
	8096767	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	3.42	CHEMBL2208	Homo sapiens	Inhibition	%	3.42
	8097138	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	-2.63	CHEMBL2208	Homo sapiens	Inhibition	%	-2.63
	8097445	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	0.71	CHEMBL2208	Homo sapiens	Inhibition	%	0.71
	8097669	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	2.94	CHEMBL2208	Homo sapiens	Inhibition	%	2.94
	8097819	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-3.91	CHEMBL2208	Homo sapiens	Inhibition	%	-3.91
	8097952	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	0.64	CHEMBL2208	Homo sapiens	Inhibition	%	0.64
	8098176	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	0.43	CHEMBL2208	Homo sapiens	Inhibition	%	0.43
	8098296	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-0.08	CHEMBL2208	Homo sapiens	Inhibition	%	-0.08
	8098700	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	2.44	CHEMBL2208	Homo sapiens	Inhibition	%	2.44
	8098885	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	5.03	CHEMBL2208	Homo sapiens	Inhibition	%	5.03
	8099253	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	1.98	CHEMBL2208	Homo sapiens	Inhibition	%	1.98
	8099395	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	1.03	CHEMBL2208	Homo sapiens	Inhibition	%	1.03
	8099589	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	0.5	CHEMBL2208	Homo sapiens	Inhibition	%	0.5
	8099813	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	-0.23	CHEMBL2208	Homo sapiens	Inhibition	%	-0.23
	8099960	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	-0.94	CHEMBL2208	Homo sapiens	Inhibition	%	-0.94
	8100330	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	-0.59	CHEMBL2208	Homo sapiens	Inhibition	%	-0.59
	8100446	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	1.85	CHEMBL2208	Homo sapiens	Inhibition	%	1.85
	8100670	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	1.77	CHEMBL2208	Homo sapiens	Inhibition	%	1.77
	8100810	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	0.44	CHEMBL2208	Homo sapiens	Inhibition	%	0.44
	8100970	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	5.44	CHEMBL2208	Homo sapiens	Inhibition	%	5.44
	8101194	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	6.42	CHEMBL2208	Homo sapiens	Inhibition	%	6.42
	8101336	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-1.14	CHEMBL2208	Homo sapiens	Inhibition	%	-1.14
	8101521	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	1.56	CHEMBL2208	Homo sapiens	Inhibition	%	1.56
	8101745	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	1.62	CHEMBL2208	Homo sapiens	Inhibition	%	1.62
	8101998	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	3.56	CHEMBL2208	Homo sapiens	Inhibition	%	3.56
	8102153	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	-2.49	CHEMBL2208	Homo sapiens	Inhibition	%	-2.49
	8102508	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	2.65	CHEMBL2208	Homo sapiens	Inhibition	%	2.65
	8102628	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-1.3	CHEMBL2208	Homo sapiens	Inhibition	%	-1.3
	8102852	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-0.39	CHEMBL2208	Homo sapiens	Inhibition	%	-0.39
	8103030	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	0.12	CHEMBL2208	Homo sapiens	Inhibition	%	0.12
	8103226	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	0.63	CHEMBL2208	Homo sapiens	Inhibition	%	0.63
	8103588	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	0.22	CHEMBL2208	Homo sapiens	Inhibition	%	0.22
	8103738	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	0.77	CHEMBL2208	Homo sapiens	Inhibition	%	0.77
	8103962	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	1.17	CHEMBL2208	Homo sapiens	Inhibition	%	1.17
	8104147	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	-0.07	CHEMBL2208	Homo sapiens	Inhibition	%	-0.07
	8104295	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	0.98	CHEMBL2208	Homo sapiens	Inhibition	%	0.98
	8104519	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	2.09	CHEMBL2208	Homo sapiens	Inhibition	%	2.09
	8104665	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	0.18	CHEMBL2208	Homo sapiens	Inhibition	%	0.18
	8105003	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	1.32	CHEMBL2208	Homo sapiens	Inhibition	%	1.32
	8105143	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-3.24	CHEMBL2208	Homo sapiens	Inhibition	%	-3.24
	8105533	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	1.32	CHEMBL2208	Homo sapiens	Inhibition	%	1.32
	8105671	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-0.59	CHEMBL2208	Homo sapiens	Inhibition	%	-0.59
	8105895	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	2.4	CHEMBL2208	Homo sapiens	Inhibition	%	2.4
	8105951	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	-2.08	CHEMBL2208	Homo sapiens	Inhibition	%	-2.08
	8106175	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	-2.08	CHEMBL2208	Homo sapiens	Inhibition	%	-2.08
	8106340	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	-0.13	CHEMBL2208	Homo sapiens	Inhibition	%	-0.13
	8106496	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	-2.06	CHEMBL2208	Homo sapiens	Inhibition	%	-2.06
	8106720	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-0.73	CHEMBL2208	Homo sapiens	Inhibition	%	-0.73
	8106849	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	1.48	CHEMBL2208	Homo sapiens	Inhibition	%	1.48
	8107194	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-0.71	CHEMBL2208	Homo sapiens	Inhibition	%	-0.71
	8107366	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	0.61	CHEMBL2208	Homo sapiens	Inhibition	%	0.61
	8107567	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	2.99	CHEMBL2208	Homo sapiens	Inhibition	%	2.99
	8107791	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	1.15	CHEMBL2208	Homo sapiens	Inhibition	%	1.15
	8107926	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	0.05	CHEMBL2208	Homo sapiens	Inhibition	%	0.05
	8108308	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	1.2	CHEMBL2208	Homo sapiens	Inhibition	%	1.2
	8108483	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	-0.56	CHEMBL2208	Homo sapiens	Inhibition	%	-0.56
	8108854	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	4.06	CHEMBL2208	Homo sapiens	Inhibition	%	4.06
	8108996	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.69	CHEMBL2208	Homo sapiens	Inhibition	%	0.69
	8109334	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	5.06	CHEMBL2208	Homo sapiens	Inhibition	%	5.06
	8109464	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-3.38	CHEMBL2208	Homo sapiens	Inhibition	%	-3.38
	8109688	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-2.03	CHEMBL2208	Homo sapiens	Inhibition	%	-2.03
	8109859	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	2.41	CHEMBL2208	Homo sapiens	Inhibition	%	2.41
	8110215	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	1.2	CHEMBL2208	Homo sapiens	Inhibition	%	1.2
	8110494	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	0.37	CHEMBL2208	Homo sapiens	Inhibition	%	0.37
	8110660	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	0.05	CHEMBL2208	Homo sapiens	Inhibition	%	0.05
	8111042	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-0.87	CHEMBL2208	Homo sapiens	Inhibition	%	-0.87
	8111165	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	-0.49	CHEMBL2208	Homo sapiens	Inhibition	%	-0.49
	8111516	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	-0.56	CHEMBL2208	Homo sapiens	Inhibition	%	-0.56
	8111682	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	0.42	CHEMBL2208	Homo sapiens	Inhibition	%	0.42
	8111906	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-0.45	CHEMBL2208	Homo sapiens	Inhibition	%	-0.45
	8112111	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	3.82	CHEMBL2208	Homo sapiens	Inhibition	%	3.82
	8112248	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.1	CHEMBL2208	Homo sapiens	Inhibition	%	0.1
	8112640	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	1.76	CHEMBL2208	Homo sapiens	Inhibition	%	1.76
	8112812	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-0.61	CHEMBL2208	Homo sapiens	Inhibition	%	-0.61
	8113188	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	1.85	CHEMBL2208	Homo sapiens	Inhibition	%	1.85
	8113324	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.79	CHEMBL2208	Homo sapiens	Inhibition	%	0.79
	8113548	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	-3.32	CHEMBL2208	Homo sapiens	Inhibition	%	-3.32
	8113672	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	4.26	CHEMBL2208	Homo sapiens	Inhibition	%	4.26
	8114012	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-1.25	CHEMBL2208	Homo sapiens	Inhibition	%	-1.25
	8114188	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	3.06	CHEMBL2208	Homo sapiens	Inhibition	%	3.06
	8114544	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	5.73	CHEMBL2208	Homo sapiens	Inhibition	%	5.73
	8114820	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	0.95	CHEMBL2208	Homo sapiens	Inhibition	%	0.95
	8114986	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	1.16	CHEMBL2208	Homo sapiens	Inhibition	%	1.16
	8115375	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	2.15	CHEMBL2208	Homo sapiens	Inhibition	%	2.15
	8115495	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	-1.61	CHEMBL2208	Homo sapiens	Inhibition	%	-1.61
	8115719	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	1.59	CHEMBL2208	Homo sapiens	Inhibition	%	1.59
	8115852	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	-0.71	CHEMBL2208	Homo sapiens	Inhibition	%	-0.71
	8116235	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-1.03	CHEMBL2208	Homo sapiens	Inhibition	%	-1.03
	8116438	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	1.3	CHEMBL2208	Homo sapiens	Inhibition	%	1.3
	8116572	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.45	CHEMBL2208	Homo sapiens	Inhibition	%	0.45
	8116796	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-1.01	CHEMBL2208	Homo sapiens	Inhibition	%	-1.01
	8116968	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	1.12	CHEMBL2208	Homo sapiens	Inhibition	%	1.12
	8117139	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-0.91	CHEMBL2208	Homo sapiens	Inhibition	%	-0.91
	8117363	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	-0.02	CHEMBL2208	Homo sapiens	Inhibition	%	-0.02
	8117521	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	2.88	CHEMBL2208	Homo sapiens	Inhibition	%	2.88
	8117875	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	-3.36	CHEMBL2208	Homo sapiens	Inhibition	%	-3.36
	8118013	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	1.11	CHEMBL2208	Homo sapiens	Inhibition	%	1.11
	8118353	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	2.42	CHEMBL2208	Homo sapiens	Inhibition	%	2.42
	8118525	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	3.74	CHEMBL2208	Homo sapiens	Inhibition	%	3.74
	8118749	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	-0.26	CHEMBL2208	Homo sapiens	Inhibition	%	-0.26
	8118885	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	4.4	CHEMBL2208	Homo sapiens	Inhibition	%	4.4
	8119156	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	0.89	CHEMBL2208	Homo sapiens	Inhibition	%	0.89
	8119315	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	1.1	CHEMBL2208	Homo sapiens	Inhibition	%	1.1
	8119539	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	-1.87	CHEMBL2208	Homo sapiens	Inhibition	%	-1.87
	8119706	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	2.54	CHEMBL2208	Homo sapiens	Inhibition	%	2.54
	8120049	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	0.26	CHEMBL2208	Homo sapiens	Inhibition	%	0.26
	8120188	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	0.41	CHEMBL2208	Homo sapiens	Inhibition	%	0.41
	8120572	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-0.79	CHEMBL2208	Homo sapiens	Inhibition	%	-0.79
	8120773	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	3.78	CHEMBL2208	Homo sapiens	Inhibition	%	3.78
	8121125	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-0.9	CHEMBL2208	Homo sapiens	Inhibition	%	-0.9
	8121297	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	0.76	CHEMBL2208	Homo sapiens	Inhibition	%	0.76
	8121688	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	-0.84	CHEMBL2208	Homo sapiens	Inhibition	%	-0.84
	8121851	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	4.58	CHEMBL2208	Homo sapiens	Inhibition	%	4.58
	8122196	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-1.74	CHEMBL2208	Homo sapiens	Inhibition	%	-1.74
	8122334	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	0.66	CHEMBL2208	Homo sapiens	Inhibition	%	0.66
	8122558	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	2.68	CHEMBL2208	Homo sapiens	Inhibition	%	2.68
	8122678	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	3.46	CHEMBL2208	Homo sapiens	Inhibition	%	3.46
	8123069	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	0.16	CHEMBL2208	Homo sapiens	Inhibition	%	0.16
	8123211	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	2.27	CHEMBL2208	Homo sapiens	Inhibition	%	2.27
	8123489	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	0.73	CHEMBL2208	Homo sapiens	Inhibition	%	0.73
	8123863	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	-2.21	CHEMBL2208	Homo sapiens	Inhibition	%	-2.21
	8124030	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-0.39	CHEMBL2208	Homo sapiens	Inhibition	%	-0.39
	8124373	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	1.39	CHEMBL2208	Homo sapiens	Inhibition	%	1.39
	8124512	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	-0.12	CHEMBL2208	Homo sapiens	Inhibition	%	-0.12
	8124736	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	0.37	CHEMBL2208	Homo sapiens	Inhibition	%	0.37
	8124901	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-0.97	CHEMBL2208	Homo sapiens	Inhibition	%	-0.97
	8125102	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	1.96	CHEMBL2208	Homo sapiens	Inhibition	%	1.96
	8125326	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	3.67	CHEMBL2208	Homo sapiens	Inhibition	%	3.67
	8125456	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-0.72	CHEMBL2208	Homo sapiens	Inhibition	%	-0.72
	8125624	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	-0.1	CHEMBL2208	Homo sapiens	Inhibition	%	-0.1
	8125848	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	1.0	CHEMBL2208	Homo sapiens	Inhibition	%	1.0
	8126012	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-0.95	CHEMBL2208	Homo sapiens	Inhibition	%	-0.95
	8126176	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	6.13	CHEMBL2208	Homo sapiens	Inhibition	%	6.13
	8126400	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	0.69	CHEMBL2208	Homo sapiens	Inhibition	%	0.69
	8126515	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-1.65	CHEMBL2208	Homo sapiens	Inhibition	%	-1.65
	8126875	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	2.48	CHEMBL2208	Homo sapiens	Inhibition	%	2.48
	8126997	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	5.15	CHEMBL2208	Homo sapiens	Inhibition	%	5.15
	8127221	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	7.84	CHEMBL2208	Homo sapiens	Inhibition	%	7.84
	8127388	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	2.52	CHEMBL2208	Homo sapiens	Inhibition	%	2.52
	8127530	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	1.47	CHEMBL2208	Homo sapiens	Inhibition	%	1.47
	8127754	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	3.79	CHEMBL2208	Homo sapiens	Inhibition	%	3.79
	8127818	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	3.12	CHEMBL2208	Homo sapiens	Inhibition	%	3.12
	8128042	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	3.35	CHEMBL2208	Homo sapiens	Inhibition	%	3.35
	8128194	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	0.52	CHEMBL2208	Homo sapiens	Inhibition	%	0.52
	8128361	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-0.48	CHEMBL2208	Homo sapiens	Inhibition	%	-0.48
	8128585	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	0.55	CHEMBL2208	Homo sapiens	Inhibition	%	0.55
	8128704	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	-0.06	CHEMBL2208	Homo sapiens	Inhibition	%	-0.06
	8129065	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	0.31	CHEMBL2208	Homo sapiens	Inhibition	%	0.31
	8129236	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-1.35	CHEMBL2208	Homo sapiens	Inhibition	%	-1.35
	8129649	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	0.81	CHEMBL2208	Homo sapiens	Inhibition	%	0.81
	8129788	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-0.2	CHEMBL2208	Homo sapiens	Inhibition	%	-0.2
	8130173	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	-0.08	CHEMBL2208	Homo sapiens	Inhibition	%	-0.08
	8130345	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-0.88	CHEMBL2208	Homo sapiens	Inhibition	%	-0.88
	8130729	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	2.01	CHEMBL2208	Homo sapiens	Inhibition	%	2.01
	8130845	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	2.08	CHEMBL2208	Homo sapiens	Inhibition	%	2.08
	8131208	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	-0.91	CHEMBL2208	Homo sapiens	Inhibition	%	-0.91
	8131552	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	1.74	CHEMBL2208	Homo sapiens	Inhibition	%	1.74
	8131719	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	3.2	CHEMBL2208	Homo sapiens	Inhibition	%	3.2
	8132084	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	3.15	CHEMBL2208	Homo sapiens	Inhibition	%	3.15
	8132370	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-0.22	CHEMBL2208	Homo sapiens	Inhibition	%	-0.22
	8132517	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	0.82	CHEMBL2208	Homo sapiens	Inhibition	%	0.82
	8132909	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	1.05	CHEMBL2208	Homo sapiens	Inhibition	%	1.05
	8133030	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	3.88	CHEMBL2208	Homo sapiens	Inhibition	%	3.88
	8133254	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	3.81	CHEMBL2208	Homo sapiens	Inhibition	%	3.81
	8133392	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	1.15	CHEMBL2208	Homo sapiens	Inhibition	%	1.15
	8133564	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-1.61	CHEMBL2208	Homo sapiens	Inhibition	%	-1.61
	8133788	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-1.29	CHEMBL2208	Homo sapiens	Inhibition	%	-1.29
	8133968	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	1.86	CHEMBL2208	Homo sapiens	Inhibition	%	1.86
	8134116	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-1.21	CHEMBL2208	Homo sapiens	Inhibition	%	-1.21
	8134340	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-0.76	CHEMBL2208	Homo sapiens	Inhibition	%	-0.76
	8134500	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	0.09	CHEMBL2208	Homo sapiens	Inhibition	%	0.09
	8134684	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-1.85	CHEMBL2208	Homo sapiens	Inhibition	%	-1.85
	8135068	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	2.23	CHEMBL2208	Homo sapiens	Inhibition	%	2.23
	8135183	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	0.58	CHEMBL2208	Homo sapiens	Inhibition	%	0.58
	8135407	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	4.99	CHEMBL2208	Homo sapiens	Inhibition	%	4.99
	8135548	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	-1.38	CHEMBL2208	Homo sapiens	Inhibition	%	-1.38
	8135893	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	4.04	CHEMBL2208	Homo sapiens	Inhibition	%	4.04
	8136061	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	2.15	CHEMBL2208	Homo sapiens	Inhibition	%	2.15
	8136285	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	2.31	CHEMBL2208	Homo sapiens	Inhibition	%	2.31
	8136429	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	Inhibition	%	0.0
	8136719	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	0.04	CHEMBL2208	Homo sapiens	Inhibition	%	0.04
	8136854	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	0.89	CHEMBL2208	Homo sapiens	Inhibition	%	0.89
	8137078	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	-0.26	CHEMBL2208	Homo sapiens	Inhibition	%	-0.26
	8137241	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	-2.72	CHEMBL2208	Homo sapiens	Inhibition	%	-2.72
	8137585	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	0.41	CHEMBL2208	Homo sapiens	Inhibition	%	0.41
	8137733	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	0.52	CHEMBL2208	Homo sapiens	Inhibition	%	0.52
	8138123	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-0.76	CHEMBL2208	Homo sapiens	Inhibition	%	-0.76
	8138302	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	0.97	CHEMBL2208	Homo sapiens	Inhibition	%	0.97
	8138674	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-1.44	CHEMBL2208	Homo sapiens	Inhibition	%	-1.44
	8138832	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	-0.32	CHEMBL2208	Homo sapiens	Inhibition	%	-0.32
	8139017	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-1.69	CHEMBL2208	Homo sapiens	Inhibition	%	-1.69
	8139241	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	1.65	CHEMBL2208	Homo sapiens	Inhibition	%	1.65
	8139400	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	2.74	CHEMBL2208	Homo sapiens	Inhibition	%	2.74
	8139738	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	3.73	CHEMBL2208	Homo sapiens	Inhibition	%	3.73
	8139879	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	1.68	CHEMBL2208	Homo sapiens	Inhibition	%	1.68
	8140103	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	1.59	CHEMBL2208	Homo sapiens	Inhibition	%	1.59
	8140226	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	3.56	CHEMBL2208	Homo sapiens	Inhibition	%	3.56
	8140609	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	4.47	CHEMBL2208	Homo sapiens	Inhibition	%	4.47
	8140752	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	-0.67	CHEMBL2208	Homo sapiens	Inhibition	%	-0.67
	8141054	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	1.24	CHEMBL2208	Homo sapiens	Inhibition	%	1.24
	8141408	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	3.08	CHEMBL2208	Homo sapiens	Inhibition	%	3.08
	8141568	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	-2.37	CHEMBL2208	Homo sapiens	Inhibition	%	-2.37
	8141911	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-0.68	CHEMBL2208	Homo sapiens	Inhibition	%	-0.68
	8142072	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	0.19	CHEMBL2208	Homo sapiens	Inhibition	%	0.19
	8142296	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	0.03	CHEMBL2208	Homo sapiens	Inhibition	%	0.03
	8142464	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-1.73	CHEMBL2208	Homo sapiens	Inhibition	%	-1.73
	8142640	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	1.7	CHEMBL2208	Homo sapiens	Inhibition	%	1.7
	8143013	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-1.8	CHEMBL2208	Homo sapiens	Inhibition	%	-1.8
	8143168	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	2.17	CHEMBL2208	Homo sapiens	Inhibition	%	2.17
	8143392	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	0.48	CHEMBL2208	Homo sapiens	Inhibition	%	0.48
	8143579	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	4.08	CHEMBL2208	Homo sapiens	Inhibition	%	4.08
	8143738	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	-1.16	CHEMBL2208	Homo sapiens	Inhibition	%	-1.16
	8144076	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	1.3	CHEMBL2208	Homo sapiens	Inhibition	%	1.3
	8144439	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	1.56	CHEMBL2208	Homo sapiens	Inhibition	%	1.56
	8144569	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	5.11	CHEMBL2208	Homo sapiens	Inhibition	%	5.11
	8144946	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	5.35	CHEMBL2208	Homo sapiens	Inhibition	%	5.35
	8145083	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	2.31	CHEMBL2208	Homo sapiens	Inhibition	%	2.31
	8145307	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	2.57	CHEMBL2208	Homo sapiens	Inhibition	%	2.57
	8145396	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	1.57	CHEMBL2208	Homo sapiens	Inhibition	%	1.57
	8145744	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	2.89	CHEMBL2208	Homo sapiens	Inhibition	%	2.89
	8145905	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	0.46	CHEMBL2208	Homo sapiens	Inhibition	%	0.46
	8146129	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	1.08	CHEMBL2208	Homo sapiens	Inhibition	%	1.08
	8146249	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	0.97	CHEMBL2208	Homo sapiens	Inhibition	%	0.97
	8146633	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	-0.32	CHEMBL2208	Homo sapiens	Inhibition	%	-0.32
	8146800	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-1.24	CHEMBL2208	Homo sapiens	Inhibition	%	-1.24
	8146969	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	-0.15	CHEMBL2208	Homo sapiens	Inhibition	%	-0.15
	8147193	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	1.12	CHEMBL2208	Homo sapiens	Inhibition	%	1.12
	8147335	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	1.22	CHEMBL2208	Homo sapiens	Inhibition	%	1.22
	8147712	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	1.58	CHEMBL2208	Homo sapiens	Inhibition	%	1.58
	8147899	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	4.54	CHEMBL2208	Homo sapiens	Inhibition	%	4.54
	8148057	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	-0.78	CHEMBL2208	Homo sapiens	Inhibition	%	-0.78
	8148281	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	1.35	CHEMBL2208	Homo sapiens	Inhibition	%	1.35
	8148395	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	0.14	CHEMBL2208	Homo sapiens	Inhibition	%	0.14
	8148758	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	0.83	CHEMBL2208	Homo sapiens	Inhibition	%	0.83
	8148896	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	0.01	CHEMBL2208	Homo sapiens	Inhibition	%	0.01
	8149120	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	1.79	CHEMBL2208	Homo sapiens	Inhibition	%	1.79
	8149279	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	0.26	CHEMBL2208	Homo sapiens	Inhibition	%	0.26
	8149637	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	2.34	CHEMBL2208	Homo sapiens	Inhibition	%	2.34
	8149735	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	-2.03	CHEMBL2208	Homo sapiens	Inhibition	%	-2.03
	8149959	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	-2.01	CHEMBL2208	Homo sapiens	Inhibition	%	-2.01
	8150084	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-0.82	CHEMBL2208	Homo sapiens	Inhibition	%	-0.82
	8150468	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	1.01	CHEMBL2208	Homo sapiens	Inhibition	%	1.01
	8150588	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	0.6	CHEMBL2208	Homo sapiens	Inhibition	%	0.6
	8150977	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	-2.2	CHEMBL2208	Homo sapiens	Inhibition	%	-2.2
	8151140	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-2.72	CHEMBL2208	Homo sapiens	Inhibition	%	-2.72
	8151541	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	1.44	CHEMBL2208	Homo sapiens	Inhibition	%	1.44
	8151679	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	-0.44	CHEMBL2208	Homo sapiens	Inhibition	%	-0.44
	8152057	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	0.39	CHEMBL2208	Homo sapiens	Inhibition	%	0.39
	8152245	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	7.08	CHEMBL2208	Homo sapiens	Inhibition	%	7.08
	8152627	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	2.04	CHEMBL2208	Homo sapiens	Inhibition	%	2.04
	8152741	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	2.62	CHEMBL2208	Homo sapiens	Inhibition	%	2.62
	8152965	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	1.63	CHEMBL2208	Homo sapiens	Inhibition	%	1.63
	8153104	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.34	CHEMBL2208	Homo sapiens	Inhibition	%	3.34
	8153465	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	2.84	CHEMBL2208	Homo sapiens	Inhibition	%	2.84
	8153622	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	0.64	CHEMBL2208	Homo sapiens	Inhibition	%	0.64
	8153979	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	1.53	CHEMBL2208	Homo sapiens	Inhibition	%	1.53
	8154300	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	0.79	CHEMBL2208	Homo sapiens	Inhibition	%	0.79
	8154426	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-1.43	CHEMBL2208	Homo sapiens	Inhibition	%	-1.43
	8154809	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	0.58	CHEMBL2208	Homo sapiens	Inhibition	%	0.58
	8154929	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	-2.74	CHEMBL2208	Homo sapiens	Inhibition	%	-2.74
	8155153	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	-3.41	CHEMBL2208	Homo sapiens	Inhibition	%	-3.41
	8155329	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-0.92	CHEMBL2208	Homo sapiens	Inhibition	%	-0.92
	8155490	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-1.94	CHEMBL2208	Homo sapiens	Inhibition	%	-1.94
	8155714	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	1.04	CHEMBL2208	Homo sapiens	Inhibition	%	1.04
	8155892	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	2.07	CHEMBL2208	Homo sapiens	Inhibition	%	2.07
	8156030	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	0.79	CHEMBL2208	Homo sapiens	Inhibition	%	0.79
	8156254	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	-0.24	CHEMBL2208	Homo sapiens	Inhibition	%	-0.24
	8156466	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	1.78	CHEMBL2208	Homo sapiens	Inhibition	%	1.78
	8156616	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	1.71	CHEMBL2208	Homo sapiens	Inhibition	%	1.71
	8156840	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	1.97	CHEMBL2208	Homo sapiens	Inhibition	%	1.97
	8156983	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	1.99	CHEMBL2208	Homo sapiens	Inhibition	%	1.99
	8157327	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	0.92	CHEMBL2208	Homo sapiens	Inhibition	%	0.92
	8157468	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	1.86	CHEMBL2208	Homo sapiens	Inhibition	%	1.86
	8157822	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	-1.03	CHEMBL2208	Homo sapiens	Inhibition	%	-1.03
	8157983	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	3.22	CHEMBL2208	Homo sapiens	Inhibition	%	3.22
	8158207	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-0.45	CHEMBL2208	Homo sapiens	Inhibition	%	-0.45
	8158233	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	-1.32	CHEMBL2208	Homo sapiens	Inhibition	%	-1.32
	8158457	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	1.77	CHEMBL2208	Homo sapiens	Inhibition	%	1.77
	8158615	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	1.5	CHEMBL2208	Homo sapiens	Inhibition	%	1.5
	8158784	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	1.65	CHEMBL2208	Homo sapiens	Inhibition	%	1.65
	8159008	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	1.03	CHEMBL2208	Homo sapiens	Inhibition	%	1.03
	8159143	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	-0.11	CHEMBL2208	Homo sapiens	Inhibition	%	-0.11
	8159487	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	0.4	CHEMBL2208	Homo sapiens	Inhibition	%	0.4
	8159618	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	2.79	CHEMBL2208	Homo sapiens	Inhibition	%	2.79
	8159842	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	2.17	CHEMBL2208	Homo sapiens	Inhibition	%	2.17
	8159983	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.27	CHEMBL2208	Homo sapiens	Inhibition	%	1.27
	8160344	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	2.0	CHEMBL2208	Homo sapiens	Inhibition	%	2.0
	8160494	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-1.26	CHEMBL2208	Homo sapiens	Inhibition	%	-1.26
	8160788	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	1.3	CHEMBL2208	Homo sapiens	Inhibition	%	1.3
	8161162	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	2.7	CHEMBL2208	Homo sapiens	Inhibition	%	2.7
	8161305	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	2.05	CHEMBL2208	Homo sapiens	Inhibition	%	2.05
	8161654	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	1.27	CHEMBL2208	Homo sapiens	Inhibition	%	1.27
	8161792	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	2.09	CHEMBL2208	Homo sapiens	Inhibition	%	2.09
	8162016	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	4.39	CHEMBL2208	Homo sapiens	Inhibition	%	4.39
	8162146	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	-1.51	CHEMBL2208	Homo sapiens	Inhibition	%	-1.51
	8162530	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-0.49	CHEMBL2208	Homo sapiens	Inhibition	%	-0.49
	8162783	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	1.78	CHEMBL2208	Homo sapiens	Inhibition	%	1.78
	8162931	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	2.28	CHEMBL2208	Homo sapiens	Inhibition	%	2.28
	8163324	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	4.07	CHEMBL2208	Homo sapiens	Inhibition	%	4.07
	8163458	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	0.31	CHEMBL2208	Homo sapiens	Inhibition	%	0.31
	8163682	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	2.81	CHEMBL2208	Homo sapiens	Inhibition	%	2.81
	8163805	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	0.36	CHEMBL2208	Homo sapiens	Inhibition	%	0.36
	8164163	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	3.54	CHEMBL2208	Homo sapiens	Inhibition	%	3.54
	8164303	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-2.49	CHEMBL2208	Homo sapiens	Inhibition	%	-2.49
	8164682	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	2.34	CHEMBL2208	Homo sapiens	Inhibition	%	2.34
	8164826	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-1.57	CHEMBL2208	Homo sapiens	Inhibition	%	-1.57
	8165050	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	1.53	CHEMBL2208	Homo sapiens	Inhibition	%	1.53
	8165120	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	2.23	CHEMBL2208	Homo sapiens	Inhibition	%	2.23
	8165485	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	1.89	CHEMBL2208	Homo sapiens	Inhibition	%	1.89
	8165628	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	2.24	CHEMBL2208	Homo sapiens	Inhibition	%	2.24
	8165852	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	0.92	CHEMBL2208	Homo sapiens	Inhibition	%	0.92
	8165978	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	1.05	CHEMBL2208	Homo sapiens	Inhibition	%	1.05
	8166340	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	4.71	CHEMBL2208	Homo sapiens	Inhibition	%	4.71
	8166470	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	1.62	CHEMBL2208	Homo sapiens	Inhibition	%	1.62
	8166795	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	0.86	CHEMBL2208	Homo sapiens	Inhibition	%	0.86
	8167107	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	1.4	CHEMBL2208	Homo sapiens	Inhibition	%	1.4
	8167248	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	4.38	CHEMBL2208	Homo sapiens	Inhibition	%	4.38
	8167472	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	-0.48	CHEMBL2208	Homo sapiens	Inhibition	%	-0.48
	8167636	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	3.83	CHEMBL2208	Homo sapiens	Inhibition	%	3.83
	8167993	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	3.62	CHEMBL2208	Homo sapiens	Inhibition	%	3.62
	8168117	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	1.48	CHEMBL2208	Homo sapiens	Inhibition	%	1.48
	8168482	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	5.03	CHEMBL2208	Homo sapiens	Inhibition	%	5.03
	8168618	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-2.73	CHEMBL2208	Homo sapiens	Inhibition	%	-2.73
	8168842	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-1.6	CHEMBL2208	Homo sapiens	Inhibition	%	-1.6
	8169006	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	1.6	CHEMBL2208	Homo sapiens	Inhibition	%	1.6
	8169372	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	1.14	CHEMBL2208	Homo sapiens	Inhibition	%	1.14
	8169452	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	1.51	CHEMBL2208	Homo sapiens	Inhibition	%	1.51
	8169676	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	2.48	CHEMBL2208	Homo sapiens	Inhibition	%	2.48
	8169810	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	2.62	CHEMBL2208	Homo sapiens	Inhibition	%	2.62
	8170179	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	0.1	CHEMBL2208	Homo sapiens	Inhibition	%	0.1
	8170304	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	1.37	CHEMBL2208	Homo sapiens	Inhibition	%	1.37
	8170528	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	1.1	CHEMBL2208	Homo sapiens	Inhibition	%	1.1
	8170668	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	0.79	CHEMBL2208	Homo sapiens	Inhibition	%	0.79
	8170803	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	1.79	CHEMBL2208	Homo sapiens	Inhibition	%	1.79
	8171027	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	0.86	CHEMBL2208	Homo sapiens	Inhibition	%	0.86
	8171224	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	0.91	CHEMBL2208	Homo sapiens	Inhibition	%	0.91
	8171441	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	0.54	CHEMBL2208	Homo sapiens	Inhibition	%	0.54
	8171806	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	-0.86	CHEMBL2208	Homo sapiens	Inhibition	%	-0.86
	8171959	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	-0.12	CHEMBL2208	Homo sapiens	Inhibition	%	-0.12
	8172315	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	2.44	CHEMBL2208	Homo sapiens	Inhibition	%	2.44
	8172443	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	1.87	CHEMBL2208	Homo sapiens	Inhibition	%	1.87
	8172667	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	-2.58	CHEMBL2208	Homo sapiens	Inhibition	%	-2.58
	8172809	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	5.02	CHEMBL2208	Homo sapiens	Inhibition	%	5.02
	8173169	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-1.12	CHEMBL2208	Homo sapiens	Inhibition	%	-1.12
	8173334	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	2.5	CHEMBL2208	Homo sapiens	Inhibition	%	2.5
	8173699	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	1.36	CHEMBL2208	Homo sapiens	Inhibition	%	1.36
	8174010	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	2.03	CHEMBL2208	Homo sapiens	Inhibition	%	2.03
	8174142	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	1.83	CHEMBL2208	Homo sapiens	Inhibition	%	1.83
	8174514	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	0.95	CHEMBL2208	Homo sapiens	Inhibition	%	0.95
	8174860	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	1.55	CHEMBL2208	Homo sapiens	Inhibition	%	1.55
	8175003	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	1.63	CHEMBL2208	Homo sapiens	Inhibition	%	1.63
	8175363	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	0.39	CHEMBL2208	Homo sapiens	Inhibition	%	0.39
	8175619	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	2.54	CHEMBL2208	Homo sapiens	Inhibition	%	2.54
	8175782	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	3.83	CHEMBL2208	Homo sapiens	Inhibition	%	3.83
	8176006	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	3.29	CHEMBL2208	Homo sapiens	Inhibition	%	3.29
	8176159	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	1.78	CHEMBL2208	Homo sapiens	Inhibition	%	1.78
	8176308	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	0.02	CHEMBL2208	Homo sapiens	Inhibition	%	0.02
	8176532	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	0.97	CHEMBL2208	Homo sapiens	Inhibition	%	0.97
	8176664	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	2.97	CHEMBL2208	Homo sapiens	Inhibition	%	2.97
	8177018	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	-2.83	CHEMBL2208	Homo sapiens	Inhibition	%	-2.83
	8177160	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	2.39	CHEMBL2208	Homo sapiens	Inhibition	%	2.39
	8177384	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	1.49	CHEMBL2208	Homo sapiens	Inhibition	%	1.49
	8177522	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	2.61	CHEMBL2208	Homo sapiens	Inhibition	%	2.61
	8177686	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	1.87	CHEMBL2208	Homo sapiens	Inhibition	%	1.87
	8177910	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	2.16	CHEMBL2208	Homo sapiens	Inhibition	%	2.16
	8178050	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	1.49	CHEMBL2208	Homo sapiens	Inhibition	%	1.49
	8178362	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	1.5	CHEMBL2208	Homo sapiens	Inhibition	%	1.5
	8178489	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	2.28	CHEMBL2208	Homo sapiens	Inhibition	%	2.28
	8178713	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	1.96	CHEMBL2208	Homo sapiens	Inhibition	%	1.96
	8178862	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	1.17	CHEMBL2208	Homo sapiens	Inhibition	%	1.17
	8179209	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	1.53	CHEMBL2208	Homo sapiens	Inhibition	%	1.53
	8179353	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	2.73	CHEMBL2208	Homo sapiens	Inhibition	%	2.73
	8179577	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	3.71	CHEMBL2208	Homo sapiens	Inhibition	%	3.71
	8179714	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	3.34	CHEMBL2208	Homo sapiens	Inhibition	%	3.34
	8179971	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	-0.36	CHEMBL2208	Homo sapiens	Inhibition	%	-0.36
	8180349	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-0.38	CHEMBL2208	Homo sapiens	Inhibition	%	-0.38
	8180505	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	1.8	CHEMBL2208	Homo sapiens	Inhibition	%	1.8
	8180877	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	1.33	CHEMBL2208	Homo sapiens	Inhibition	%	1.33
	8181010	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	4.78	CHEMBL2208	Homo sapiens	Inhibition	%	4.78
	8181365	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-0.92	CHEMBL2208	Homo sapiens	Inhibition	%	-0.92
	8181729	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	3.04	CHEMBL2208	Homo sapiens	Inhibition	%	3.04
	8181868	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	5.29	CHEMBL2208	Homo sapiens	Inhibition	%	5.29
	8182255	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	1.53	CHEMBL2208	Homo sapiens	Inhibition	%	1.53
	8182395	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	1.35	CHEMBL2208	Homo sapiens	Inhibition	%	1.35
	8182711	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	0.84	CHEMBL2208	Homo sapiens	Inhibition	%	0.84
	8183057	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	2.72	CHEMBL2208	Homo sapiens	Inhibition	%	2.72
	8183206	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	0.86	CHEMBL2208	Homo sapiens	Inhibition	%	0.86
	8183430	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	0.67	CHEMBL2208	Homo sapiens	Inhibition	%	0.67
	8183559	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	3.11	CHEMBL2208	Homo sapiens	Inhibition	%	3.11
	8183925	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	-0.88	CHEMBL2208	Homo sapiens	Inhibition	%	-0.88
	8184061	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	3.18	CHEMBL2208	Homo sapiens	Inhibition	%	3.18
	8184327	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	-0.73	CHEMBL2208	Homo sapiens	Inhibition	%	-0.73
	8184698	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-0.64	CHEMBL2208	Homo sapiens	Inhibition	%	-0.64
	8184855	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	1.56	CHEMBL2208	Homo sapiens	Inhibition	%	1.56
	8185079	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	1.39	CHEMBL2208	Homo sapiens	Inhibition	%	1.39
	8185228	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-2.58	CHEMBL2208	Homo sapiens	Inhibition	%	-2.58
	8185359	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	5.17	CHEMBL2208	Homo sapiens	Inhibition	%	5.17
	8185583	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	2.15	CHEMBL2208	Homo sapiens	Inhibition	%	2.15
	8185714	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-0.57	CHEMBL2208	Homo sapiens	Inhibition	%	-0.57
	8186077	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	2.8	CHEMBL2208	Homo sapiens	Inhibition	%	2.8
	8186218	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	2.31	CHEMBL2208	Homo sapiens	Inhibition	%	2.31
	8186442	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	2.82	CHEMBL2208	Homo sapiens	Inhibition	%	2.82
	8186606	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	2.76	CHEMBL2208	Homo sapiens	Inhibition	%	2.76
	8186745	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	0.53	CHEMBL2208	Homo sapiens	Inhibition	%	0.53
	8186969	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	1.53	CHEMBL2208	Homo sapiens	Inhibition	%	1.53
	8187067	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	1.06	CHEMBL2208	Homo sapiens	Inhibition	%	1.06
	8187291	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	0.98	CHEMBL2208	Homo sapiens	Inhibition	%	0.98
	8187415	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	2.32	CHEMBL2208	Homo sapiens	Inhibition	%	2.32
	8187787	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	0.82	CHEMBL2208	Homo sapiens	Inhibition	%	0.82
	8187916	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	3.56	CHEMBL2208	Homo sapiens	Inhibition	%	3.56
	8188283	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	-0.73	CHEMBL2208	Homo sapiens	Inhibition	%	-0.73
	8188418	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	-0.57	CHEMBL2208	Homo sapiens	Inhibition	%	-0.57
	8188642	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	-0.87	CHEMBL2208	Homo sapiens	Inhibition	%	-0.87
	8188692	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.08	CHEMBL2208	Homo sapiens	Inhibition	%	2.08
	8188916	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.11	CHEMBL2208	Homo sapiens	Inhibition	%	2.11
	8189064	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	0.78	CHEMBL2208	Homo sapiens	Inhibition	%	0.78
	8189444	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	4.22	CHEMBL2208	Homo sapiens	Inhibition	%	4.22
	8189593	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-3.05	CHEMBL2208	Homo sapiens	Inhibition	%	-3.05
	8189949	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	1.98	CHEMBL2208	Homo sapiens	Inhibition	%	1.98
	8190081	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	1.81	CHEMBL2208	Homo sapiens	Inhibition	%	1.81
	8190305	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	1.69	CHEMBL2208	Homo sapiens	Inhibition	%	1.69
	8190445	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	-0.48	CHEMBL2208	Homo sapiens	Inhibition	%	-0.48
	8190806	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	2.06	CHEMBL2208	Homo sapiens	Inhibition	%	2.06
	8190970	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	1.74	CHEMBL2208	Homo sapiens	Inhibition	%	1.74
	8191332	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	1.45	CHEMBL2208	Homo sapiens	Inhibition	%	1.45
	8191652	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	1.36	CHEMBL2208	Homo sapiens	Inhibition	%	1.36
	8191774	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	2.88	CHEMBL2208	Homo sapiens	Inhibition	%	2.88
	8192147	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	0.99	CHEMBL2208	Homo sapiens	Inhibition	%	0.99
	8192276	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	4.31	CHEMBL2208	Homo sapiens	Inhibition	%	4.31
	8192500	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	5.53	CHEMBL2208	Homo sapiens	Inhibition	%	5.53
	8192644	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	1.99	CHEMBL2208	Homo sapiens	Inhibition	%	1.99
	8193004	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	0.58	CHEMBL2208	Homo sapiens	Inhibition	%	0.58
	8193276	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	2.21	CHEMBL2208	Homo sapiens	Inhibition	%	2.21
	8193421	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	0.4	CHEMBL2208	Homo sapiens	Inhibition	%	0.4
	8193802	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	4.45	CHEMBL2208	Homo sapiens	Inhibition	%	4.45
	8193951	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-1.28	CHEMBL2208	Homo sapiens	Inhibition	%	-1.28
	8194175	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-1.63	CHEMBL2208	Homo sapiens	Inhibition	%	-1.63
	8194306	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	3.52	CHEMBL2208	Homo sapiens	Inhibition	%	3.52
	8194661	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	4.64	CHEMBL2208	Homo sapiens	Inhibition	%	4.64
	8194804	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	-0.33	CHEMBL2208	Homo sapiens	Inhibition	%	-0.33
	8195161	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	2.43	CHEMBL2208	Homo sapiens	Inhibition	%	2.43
	8195325	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	1.24	CHEMBL2208	Homo sapiens	Inhibition	%	1.24
	8195549	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	0.24	CHEMBL2208	Homo sapiens	Inhibition	%	0.24
	8195688	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	1.95	CHEMBL2208	Homo sapiens	Inhibition	%	1.95
	8196010	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	0.33	CHEMBL2208	Homo sapiens	Inhibition	%	0.33
	8196127	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	1.39	CHEMBL2208	Homo sapiens	Inhibition	%	1.39
	8196351	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	1.85	CHEMBL2208	Homo sapiens	Inhibition	%	1.85
	8196501	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	1.27	CHEMBL2208	Homo sapiens	Inhibition	%	1.27
	8196853	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	0.78	CHEMBL2208	Homo sapiens	Inhibition	%	0.78
	8196994	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	2.51	CHEMBL2208	Homo sapiens	Inhibition	%	2.51
	8197355	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	-0.09	CHEMBL2208	Homo sapiens	Inhibition	%	-0.09
	8197630	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	1.35	CHEMBL2208	Homo sapiens	Inhibition	%	1.35
	8197770	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	-2.81	CHEMBL2208	Homo sapiens	Inhibition	%	-2.81
	8197994	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	-3.53	CHEMBL2208	Homo sapiens	Inhibition	%	-3.53
	8198151	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	0.87	CHEMBL2208	Homo sapiens	Inhibition	%	0.87
	8198513	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	2.53	CHEMBL2208	Homo sapiens	Inhibition	%	2.53
	8198643	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	3.42	CHEMBL2208	Homo sapiens	Inhibition	%	3.42
	8198998	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	5.01	CHEMBL2208	Homo sapiens	Inhibition	%	5.01
	8199146	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	2.01	CHEMBL2208	Homo sapiens	Inhibition	%	2.01
	8199370	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	2.85	CHEMBL2208	Homo sapiens	Inhibition	%	2.85
	8199504	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	2.63	CHEMBL2208	Homo sapiens	Inhibition	%	2.63
	8199891	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	1.72	CHEMBL2208	Homo sapiens	Inhibition	%	1.72
	8200029	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	1.87	CHEMBL2208	Homo sapiens	Inhibition	%	1.87
	8200357	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	0.42	CHEMBL2208	Homo sapiens	Inhibition	%	0.42
	8200696	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	2.01	CHEMBL2208	Homo sapiens	Inhibition	%	2.01
	8200846	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	1.49	CHEMBL2208	Homo sapiens	Inhibition	%	1.49
	8201200	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	1.78	CHEMBL2208	Homo sapiens	Inhibition	%	1.78
	8201335	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	1.47	CHEMBL2208	Homo sapiens	Inhibition	%	1.47
	8201559	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	1.1	CHEMBL2208	Homo sapiens	Inhibition	%	1.1
	8201692	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-3.43	CHEMBL2208	Homo sapiens	Inhibition	%	-3.43
	8201971	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	4.67	CHEMBL2208	Homo sapiens	Inhibition	%	4.67
	8202335	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-1.56	CHEMBL2208	Homo sapiens	Inhibition	%	-1.56
	8202502	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	0.79	CHEMBL2208	Homo sapiens	Inhibition	%	0.79
	8202851	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	2.72	CHEMBL2208	Homo sapiens	Inhibition	%	2.72
	8202981	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	0.27	CHEMBL2208	Homo sapiens	Inhibition	%	0.27
	8203205	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	0.09	CHEMBL2208	Homo sapiens	Inhibition	%	0.09
	8203336	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	2.01	CHEMBL2208	Homo sapiens	Inhibition	%	2.01
	8203706	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	1.81	CHEMBL2208	Homo sapiens	Inhibition	%	1.81
	8203840	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	2.47	CHEMBL2208	Homo sapiens	Inhibition	%	2.47
	8204064	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	2.82	CHEMBL2208	Homo sapiens	Inhibition	%	2.82
	8204230	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	1.0	CHEMBL2208	Homo sapiens	Inhibition	%	1.0
	8204367	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	1.91	CHEMBL2208	Homo sapiens	Inhibition	%	1.91
	8204591	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	1.68	CHEMBL2208	Homo sapiens	Inhibition	%	1.68
	8204696	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	-0.09	CHEMBL2208	Homo sapiens	Inhibition	%	-0.09
	8205035	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	2.3	CHEMBL2208	Homo sapiens	Inhibition	%	2.3
	8205184	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	1.29	CHEMBL2208	Homo sapiens	Inhibition	%	1.29
	8205408	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	1.97	CHEMBL2208	Homo sapiens	Inhibition	%	1.97
	8205544	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	2.38	CHEMBL2208	Homo sapiens	Inhibition	%	2.38
	8205907	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	4.17	CHEMBL2208	Homo sapiens	Inhibition	%	4.17
	8206039	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-3.96	CHEMBL2208	Homo sapiens	Inhibition	%	-3.96
	8206263	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-2.22	CHEMBL2208	Homo sapiens	Inhibition	%	-2.22
	8206315	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	4.5	CHEMBL2208	Homo sapiens	Inhibition	%	4.5
	8206539	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	1.41	CHEMBL2208	Homo sapiens	Inhibition	%	1.41
	8206682	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-1.55	CHEMBL2208	Homo sapiens	Inhibition	%	-1.55
	8206862	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	2.54	CHEMBL2208	Homo sapiens	Inhibition	%	2.54
	8207086	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	1.94	CHEMBL2208	Homo sapiens	Inhibition	%	1.94
	8207212	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	4.89	CHEMBL2208	Homo sapiens	Inhibition	%	4.89
	8207566	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	2.43	CHEMBL2208	Homo sapiens	Inhibition	%	2.43
	8207698	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	1.4	CHEMBL2208	Homo sapiens	Inhibition	%	1.4
	8207922	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	2.83	CHEMBL2208	Homo sapiens	Inhibition	%	2.83
	8208067	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	2.19	CHEMBL2208	Homo sapiens	Inhibition	%	2.19
	8208423	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	2.73	CHEMBL2208	Homo sapiens	Inhibition	%	2.73
	8208589	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	0.66	CHEMBL2208	Homo sapiens	Inhibition	%	0.66
	8208946	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	1.36	CHEMBL2208	Homo sapiens	Inhibition	%	1.36
	8209051	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	0.06	CHEMBL2208	Homo sapiens	Inhibition	%	0.06
	8209275	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	-0.23	CHEMBL2208	Homo sapiens	Inhibition	%	-0.23
	8209391	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	2.05	CHEMBL2208	Homo sapiens	Inhibition	%	2.05
	8209765	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	1.09	CHEMBL2208	Homo sapiens	Inhibition	%	1.09
	8209901	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	2.83	CHEMBL2208	Homo sapiens	Inhibition	%	2.83
	8210125	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	-0.8	CHEMBL2208	Homo sapiens	Inhibition	%	-0.8
	8210266	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	4.27	CHEMBL2208	Homo sapiens	Inhibition	%	4.27
	8210626	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-2.04	CHEMBL2208	Homo sapiens	Inhibition	%	-2.04
	8210885	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	0.78	CHEMBL2208	Homo sapiens	Inhibition	%	0.78
	8211029	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	1.81	CHEMBL2208	Homo sapiens	Inhibition	%	1.81
	8211423	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	-0.3	CHEMBL2208	Homo sapiens	Inhibition	%	-0.3
	8211546	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	6.05	CHEMBL2208	Homo sapiens	Inhibition	%	6.05
	8211899	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	2.69	CHEMBL2208	Homo sapiens	Inhibition	%	2.69
	8212255	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	3.32	CHEMBL2208	Homo sapiens	Inhibition	%	3.32
	8212396	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	4.23	CHEMBL2208	Homo sapiens	Inhibition	%	4.23
	8212753	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	2.92	CHEMBL2208	Homo sapiens	Inhibition	%	2.92
	8212923	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	0.45	CHEMBL2208	Homo sapiens	Inhibition	%	0.45
	8213276	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	1.45	CHEMBL2208	Homo sapiens	Inhibition	%	1.45
	8213604	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-1.23	CHEMBL2208	Homo sapiens	Inhibition	%	-1.23
	8213717	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	2.02	CHEMBL2208	Homo sapiens	Inhibition	%	2.02
	8213941	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	1.68	CHEMBL2208	Homo sapiens	Inhibition	%	1.68
	8214088	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	0.96	CHEMBL2208	Homo sapiens	Inhibition	%	0.96
	8214449	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	-0.71	CHEMBL2208	Homo sapiens	Inhibition	%	-0.71
	8214583	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	1.02	CHEMBL2208	Homo sapiens	Inhibition	%	1.02
	8214959	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	0.95	CHEMBL2208	Homo sapiens	Inhibition	%	0.95
	8215210	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	2.78	CHEMBL2208	Homo sapiens	Inhibition	%	2.78
	8215363	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	1.73	CHEMBL2208	Homo sapiens	Inhibition	%	1.73
	8215587	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	3.78	CHEMBL2208	Homo sapiens	Inhibition	%	3.78
	8215751	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	-1.2	CHEMBL2208	Homo sapiens	Inhibition	%	-1.2
	8215870	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	1.77	CHEMBL2208	Homo sapiens	Inhibition	%	1.77
	8216094	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	2.39	CHEMBL2208	Homo sapiens	Inhibition	%	2.39
	8216213	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	1.86	CHEMBL2208	Homo sapiens	Inhibition	%	1.86
	8216573	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	-0.94	CHEMBL2208	Homo sapiens	Inhibition	%	-0.94
	8216711	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	4.01	CHEMBL2208	Homo sapiens	Inhibition	%	4.01
	8216935	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	1.4	CHEMBL2208	Homo sapiens	Inhibition	%	1.4
	8217069	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	2.7	CHEMBL2208	Homo sapiens	Inhibition	%	2.7
	8217243	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	0.81	CHEMBL2208	Homo sapiens	Inhibition	%	0.81
	8217467	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	0.09	CHEMBL2208	Homo sapiens	Inhibition	%	0.09
	8217598	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	1.6	CHEMBL2208	Homo sapiens	Inhibition	%	1.6
	8217923	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-1.83	CHEMBL2208	Homo sapiens	Inhibition	%	-1.83
	8218262	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	2.27	CHEMBL2208	Homo sapiens	Inhibition	%	2.27
	8218389	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	0.79	CHEMBL2208	Homo sapiens	Inhibition	%	0.79
	8218756	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	2.26	CHEMBL2208	Homo sapiens	Inhibition	%	2.26
	8218887	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	0.74	CHEMBL2208	Homo sapiens	Inhibition	%	0.74
	8219111	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	1.97	CHEMBL2208	Homo sapiens	Inhibition	%	1.97
	8219271	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	0.98	CHEMBL2208	Homo sapiens	Inhibition	%	0.98
	8219521	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	2.33	CHEMBL2208	Homo sapiens	Inhibition	%	2.33
	8219906	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	4.6	CHEMBL2208	Homo sapiens	Inhibition	%	4.6
	8220075	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	2.24	CHEMBL2208	Homo sapiens	Inhibition	%	2.24
	8220428	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	3.16	CHEMBL2208	Homo sapiens	Inhibition	%	3.16
	8220542	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	0.94	CHEMBL2208	Homo sapiens	Inhibition	%	0.94
	8220766	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	4.51	CHEMBL2208	Homo sapiens	Inhibition	%	4.51
	8220904	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	-0.15	CHEMBL2208	Homo sapiens	Inhibition	%	-0.15
	8221264	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	0.82	CHEMBL2208	Homo sapiens	Inhibition	%	0.82
	8221397	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	2.14	CHEMBL2208	Homo sapiens	Inhibition	%	2.14
	8221786	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-0.23	CHEMBL2208	Homo sapiens	Inhibition	%	-0.23
	8221917	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	1.54	CHEMBL2208	Homo sapiens	Inhibition	%	1.54
	8222141	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	1.66	CHEMBL2208	Homo sapiens	Inhibition	%	1.66
	8222239	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	2.19	CHEMBL2208	Homo sapiens	Inhibition	%	2.19
	8222597	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	1.62	CHEMBL2208	Homo sapiens	Inhibition	%	1.62
	8222715	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	1.08	CHEMBL2208	Homo sapiens	Inhibition	%	1.08
	8222939	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	1.67	CHEMBL2208	Homo sapiens	Inhibition	%	1.67
	8223083	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	2.83	CHEMBL2208	Homo sapiens	Inhibition	%	2.83
	8223436	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	1.81	CHEMBL2208	Homo sapiens	Inhibition	%	1.81
	8223597	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	2.95	CHEMBL2208	Homo sapiens	Inhibition	%	2.95
	8223847	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	-0.32	CHEMBL2208	Homo sapiens	Inhibition	%	-0.32
	8224233	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	0.7	CHEMBL2208	Homo sapiens	Inhibition	%	0.7
	8224403	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	1.36	CHEMBL2208	Homo sapiens	Inhibition	%	1.36
	8224762	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	3.91	CHEMBL2208	Homo sapiens	Inhibition	%	3.91
	8225100	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	4.3	CHEMBL2208	Homo sapiens	Inhibition	%	4.3
	8225234	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	1.88	CHEMBL2208	Homo sapiens	Inhibition	%	1.88
	8225596	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.38	CHEMBL2208	Homo sapiens	Inhibition	%	1.38
	8225731	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	1.32	CHEMBL2208	Homo sapiens	Inhibition	%	1.32
	8225955	CHEMBL1961968	GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	2.32	CHEMBL2208	Homo sapiens	Inhibition	%	2.32
	8226113	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-0.84	CHEMBL2208	Homo sapiens	Inhibition	%	-0.84
	8226462	CHEMBL1961969	GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	1.43	CHEMBL2208	Homo sapiens	Inhibition	%	1.43
inactive	9597601	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cccc(-c2[nH]c(-c3ccnc(N)n3)cc2C(N)=O)c1C		CHEMBL1964290	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597602	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)c(OC)c1		CHEMBL2003768	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9597603	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1ncnc2onc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL213505	=	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9597604	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1ccc(OC)c(Nc2ccc3nnc(-c4ccccc4)n3n2)c1		CHEMBL1982880	=	Ki	nM	6309.57	CHEMBL2208	Homo sapiens	pKi		5.2
inactive	9597605	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597606	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	N#CCOc1ccc(Nc2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2Br)cc1		CHEMBL1987034	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597607	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCCn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1993941	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597608	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597609	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	c1ccc(Nc2ccnc(Nc3ccccc3)n2)cc1		CHEMBL578061	<	Ki	nM	19952.62	CHEMBL2208	Homo sapiens	pKi		4.7
inactive	9597610	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4cccc(Cl)c4)cc[nH]c3=O)nc12		CHEMBL2005886	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597611	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL481491	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597612	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682345	<	Ki	nM	3981.07	CHEMBL2208	Homo sapiens	pKi		5.4
inactive	9597613	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(=O)Nc1c(C(N)=O)sc2ccc(Cl)c(Cl)c12		CHEMBL1973142	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597614	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4nc(N)nc(N)c34)cc2)c1		CHEMBL1973145	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597615	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982924	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597616	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCCC(=O)Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL2005936	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9597617	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NC1CCC(Nc2nccc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1966628	=	Ki	nM	794.33	CHEMBL2208	Homo sapiens	pKi		6.1
inactive	9597618	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc(C(N)=O)c3)cc2)c1		CHEMBL1971141	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597619	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NC1CCCCC1Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL1995813	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597620	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1c(C)n(Cc2ccccc2)c2ccc(C(=O)Nc3nc[nH]n3)cc12		CHEMBL1979718	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597621	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NC(COCc1ccccc1)COc1cncc(C=Cc2ccncc2)c1		CHEMBL1993781	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597622	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCn1c2cc(Cl)c(O)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL523823	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597623	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC1(C)CC2=Nc3cc(Cl)ccc3SC2=C(O)C1		CHEMBL1562756	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9597624	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3cn[nH]c3c2)n1		CHEMBL244378	=	Ki	nM	2511.89	CHEMBL2208	Homo sapiens	pKi		5.6
inactive	9597625	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL362558	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597626	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(OCC(F)(F)F)nccn23)n1		CHEMBL2001957	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597627	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1969372	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597628	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1ncnn2ccc(C(=O)Nc3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1990583	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9597629	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	3981.07	CHEMBL2208	Homo sapiens	pKi		5.4
active	9597630	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1nc2ccc(NS(=O)(=O)c3ccc(N)cc3)cc2nc1C		CHEMBL2006263	=	Ki	nM	1000.0	CHEMBL2208	Homo sapiens	pKi		6.0
inactive	9597631	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	OC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1993584	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597632	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCn1c(C)c(-c2ccnc(Nc3cccc(OC)c3)n2)sc1=O		CHEMBL1986263	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597633	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CSc1c[nH]c2ncnc(NCCCO)c12		CHEMBL2000114	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597634	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597635	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cccc12		CHEMBL1975647	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597636	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1968380	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597637	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(NCc1ccccc1)Nc1ncc([N+](=O)[O-])s1		CHEMBL1964644	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597638	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(NCc1ccc(Cl)c(Cl)c1)Nc1ccc2[nH]ncc2c1		CHEMBL1981782	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597639	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CNC(=O)c1cc2c(-c3ccccc3F)n[nH]c2s1		CHEMBL1977681	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597640	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CNC(=O)C(C)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(C)cc5)cc4)csc23)cn1		CHEMBL1970142	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597641	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597642	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	OCCNc1cc2cc(-c3cccnc3)ccc2cn1		CHEMBL1990912	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597643	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597644	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(-c4ccccc4)c3n2)c1		CHEMBL1988163	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597645	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cc(O)ccc1-n1c2cc(Cl)ccc2c(=O)c2c(N)nc(N)nc21		CHEMBL1995592	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597646	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C1CCCc2oc3cc(C(F)(F)F)ccc3c(=O)c21		CHEMBL2006493	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597647	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1ccc(OC)c(CNC(=O)c2cc(N)c(C#N)c(OC(C)C)n2)c1		CHEMBL1982541	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597648	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Clc1cc2nn[nH]c2cc1Cl		CHEMBL1996923	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597649	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1C		CHEMBL1983449	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597650	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=c1[nH]cnc2c1oc1ccc(Cl)cc12		CHEMBL1992323	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597651	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(Cl)nccn23)n1		CHEMBL1969735	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9597652	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCc1nc2c(c3cc(OC)c(OC)cc13)C(=O)NC2=O		CHEMBL2003524	=	Ki	nM	3162.28	CHEMBL2208	Homo sapiens	pKi		5.5
inactive	9597653	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1ccc2c(c1)C(=Cc1c[nH]cn1)C(=O)N2		CHEMBL2002649	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597654	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCCn1c(C2CCNCC2)nc(-c2ccc(Cl)c(Cl)c2)c1-c1ccnc(NC2CCCCC2)n1		CHEMBL437747	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597655	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Brc1ccc2c(c1)-c1[nH]ncc1C2		CHEMBL1995172	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597656	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL507936	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597657	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=S(=O)(NCCNCC=Cc1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL1987756	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597658	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCNS(C)(=O)=O)cnc(N)c34)cc2)c1		CHEMBL1994321	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9597659	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C1NCCc2[nH]c(-c3ccnc(C=Cc4ccccc4)c3)cc21		CHEMBL1997129	=	Ki	nM	1258.93	CHEMBL2208	Homo sapiens	pKi		5.9
inactive	9597660	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NC(=O)c1cc(Cl)cc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1984788	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597661	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	FC(F)(F)c1ccc(-c2nnc3ccc(NC4CC4)nn23)cc1		CHEMBL451964	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597662	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cccc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL1964307	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597663	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Fc1ccc(-c2nc3sccn3c2-c2ccncc2)cc1		CHEMBL2000508	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597664	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCCCNc1n[s+]([O-])nc1Nc1ccc(F)cc1		CHEMBL1971694	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597665	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2001547	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597666	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597667	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1F		CHEMBL1994361	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597668	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cc(NC(=O)CCNC(=O)Nc2nc(C)c(-c3ccc(-n4cccn4)cc3)s2)no1		CHEMBL1986603	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597669	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597670	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NC(COc1cncc(-c2cc3cnccc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1972840	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9597671	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2)cc1		CHEMBL1977148	=	Ki	nM	3162.28	CHEMBL2208	Homo sapiens	pKi		5.5
inactive	9597672	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cc(C=C2SC(=O)NC2=O)ccc1O		CHEMBL2003286	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597673	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccn1		CHEMBL1992306	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597674	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(O)Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL2002165	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597675	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=c1[nH]cc(I)c2nc(-c3ccccc3)cn12		CHEMBL2001668	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597676	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1n[nH]c2c1C(c1ccccc1I)C(C#N)=C(N)O2		CHEMBL1979318	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597677	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1989518	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597678	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1998585	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597679	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cn1cncc1C(OCc1c(-c2ccc(OC(F)(F)F)cc2)cc(C#N)c(=O)n1C)c1ccc(C#N)cc1		CHEMBL127898	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597680	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2C		CHEMBL519697	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9597681	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(F)c2)c1		CHEMBL2004934	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9601249	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3I)cc12		CHEMBL1975128	=	Ki	nM	1584.89	CHEMBL2208	Homo sapiens	pKi		5.8
inactive	9601250	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NC(=O)C1CCCN(C(=O)c2cc(-c3ccc4[nH]ncc4c3)on2)C1		CHEMBL1970369	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601251	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C(C)C(=O)N(C)C)c5)cnc(N)c34)cc2)cc1		CHEMBL2001485	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601252	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601253	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cc(C)c2c(n1)sc1c(N)ncnc12		CHEMBL504950	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9601254	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CN(C)CCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1966425	=	Ki	nM	1995.26	CHEMBL2208	Homo sapiens	pKi		5.7
inactive	9601255	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL1984363	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601256	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CNC(=O)COc1ccc(Nc2nc(Nc3ccc(C)c(S(N)(=O)=O)c3)ncc2F)cc1		CHEMBL1978099	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601257	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COC(=O)c1c(-c2ccc(NC(=O)Nc3ccccc3)cc2)c2c(N)ncnn2c1C		CHEMBL1977041	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601258	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NC(=O)c1cccc2c1Nc1nnc(Cl)cc1C(=O)N2		CHEMBL1968070	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601259	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(=O)Nc1cccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)c1		CHEMBL1988608	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601260	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1ccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)cc1C		CHEMBL184847	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9601261	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CN(C)c1ccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)cc1		CHEMBL1984367	=	Ki	nM	3162.28	CHEMBL2208	Homo sapiens	pKi		5.5
inactive	9601262	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cccc13)CN(C(=O)N1CCOCC1)CC2		CHEMBL178737	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9601263	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1n[nH]c2cnc(-c3cncc(OCC(N)Cc4cccc(C(F)(F)F)c4)c3)cc12		CHEMBL1998159	=	Ki	nM	1584.89	CHEMBL2208	Homo sapiens	pKi		5.8
inactive	9601264	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COCC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(C)nccn23)n1		CHEMBL1982563	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9601265	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C1CCCN1Cc1ccc2c(c1)[nH]c(=O)c1cccn12		CHEMBL539474	=	Ki	nM	251.19	CHEMBL2208	Homo sapiens	pKi		6.6
inactive	9601266	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NC(COc1cncc(-c2ccc3[nH]c(=O)oc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1987679	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9601267	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(OC(F)F)cc5)cc4)csc23)cn1		CHEMBL1988387	=	Ki	nM	5011.87	CHEMBL2208	Homo sapiens	pKi		5.3
inactive	9601268	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cccc(NC(=O)c2cnn3c(-c4ccccc4)ccnc23)c1		CHEMBL1997759	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9601269	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cccc(CNC(=O)c2cnn3c(-c4ccccc4)ccnc23)c1C		CHEMBL1994968	=	Ki	nM	2511.89	CHEMBL2208	Homo sapiens	pKi		5.6
inactive	9601270	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601271	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601272	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=c1[nH]c2cc(Cl)cc(Cl)c2c(-c2cc(Cl)ccc2O)c1O		CHEMBL1974803	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9601273	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL1970074	=	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9601274	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1ccc2[nH]c(=O)cnc2c1		CHEMBL2002635	=	Ki	nM	10000.0	CHEMBL2208	Homo sapiens	pKi		5.0
inactive	9601275	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COCCN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1986970	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601276	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC1=NN(c2cccc(Br)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2005112	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601277	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=c1cc(-c2ccncc2)nc(NC2CCCCC2)[nH]1		CHEMBL1958401	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601278	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCN(CC)CCOc1ccc(-c2nc3c(C(N)=O)cccc3[nH]2)cc1		CHEMBL1984044	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601279	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=c1[nH]c2cc(-c3ccccc3)cnc2[nH]1		CHEMBL2003456	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9601280	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)cccc12		CHEMBL1966816	=	Ki	nM	3162.28	CHEMBL2208	Homo sapiens	pKi		5.5
inactive	9601281	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601282	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1		CHEMBL2002992	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601283	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	N#Cc1cnc(NC(=O)Nc2ccc3cc(C(=O)O)ccc3c2)cn1		CHEMBL560813	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601284	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCCOn1c2ccc(Cl)cc2c(=O)c2c(C)nn(C)c21		CHEMBL207253	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601285	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(=NNC(=O)c1nnn(-c2nonc2N)c1-c1ccccc1)c1ccco1		CHEMBL1890036	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601286	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CC(CN2CCCC2)C1		CHEMBL1968791	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601287	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C1CC(c2ccc(Cl)cc2Cl)Cc2nc3cc(Cl)ccc3c(O)c21		CHEMBL326282	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601288	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cccc(Cl)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)NCCOCCOCCN)[nH]c12		CHEMBL2002682	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601289	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCOc1ccccc1C=NNC(=O)c1nnn(-c2nonc2N)c1N1CCCC1		CHEMBL1992732	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601290	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Fc1ccc(-c2nc3occn3c2-c2ccnc(NC3CCNCC3)n2)cc1		CHEMBL1971186	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601291	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(Cc1ccc(Cl)cc1)Nc1[nH]nc2c1CCC2		CHEMBL2003482	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601292	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCCC5)cnc(N)c34)cc2)c1		CHEMBL1973211	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601293	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1984700	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601294	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601295	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CCC(N2CCCC2)CC1		CHEMBL2007151	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601296	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1		CHEMBL1972125	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601297	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(Nc1ccc2[nH]ncc2c1)c1cccc(F)c1		CHEMBL1461728	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601298	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601299	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	c1cc2cc(-c3ccc4cn[nH]c4c3)cnc2[nH]1		CHEMBL1976134	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601300	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1ccc(C(=O)Nc2c(C(N)=O)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL1965131	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601301	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NCCOc1cccc(Nc2ccnc(N)n2)c1		CHEMBL1995448	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9601302	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL1972158	=	Ki	nM	6309.57	CHEMBL2208	Homo sapiens	pKi		5.2
inactive	9601303	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1974457	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601304	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601305	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Oc1ccc(Nc2ncnc3scc(Cl)c23)cc1		CHEMBL2006580	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601306	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1Cl		CHEMBL2006581	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601307	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCCC1		CHEMBL2006481	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601308	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCC#N)c2)n1		CHEMBL1979855	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601309	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1noc2cccc(-c3cccc(O)c3)c12		CHEMBL1970340	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601310	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1		CHEMBL2005186	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601311	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCNc1nc2cc(Cl)c(OC)cc2nc1NCC		CHEMBL1995927	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601312	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NCC(O)C(O)Cn1cc(I)c2c(N)ncnc21		CHEMBL1975534	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601313	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(Cc4ccccc4)c3n2)c1		CHEMBL1993424	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601314	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1n[nH]c2c1C(c1ccccc1F)C1=C(CC(C)(C)CC1=O)N2		CHEMBL1966703	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601315	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(C)N(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1969561	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601316	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601317	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CN(C)c1cc2sncc2cc1NC(=O)C(=O)O		CHEMBL1997023	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9601318	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cc(C)cc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1964687	=	Ki	nM	5011.87	CHEMBL2208	Homo sapiens	pKi		5.3
inactive	9601319	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601320	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NC(=O)c1cc2c(-c3ccc(Br)c(F)c3F)cncc2s1		CHEMBL1999918	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9601321	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCOc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1974254	=	Ki	nM	6309.57	CHEMBL2208	Homo sapiens	pKi		5.2
inactive	9601322	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1ccc(C(=O)N2c3ccccc3Sc3c(Cl)cncc32)cc1		CHEMBL1988537	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601323	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(C)c2)c1		CHEMBL1969049	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601324	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1ccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)cc1		CHEMBL2005828	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601325	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccc3ccccc3c2)n1		CHEMBL2002240	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601326	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9601327	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1ccc(-n2nc(C)c3c(=O)c4cc(Cl)ccc4n(O)c32)cc1		CHEMBL1991143	=	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601328	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601329	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NC(=O)c1sc2c(Br)ccc(Cl)c2c1N		CHEMBL1998611	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601330	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2CCC(N)=O		CHEMBL485556	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601331	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=c1c(NCc2ccc(Cl)c(Cl)c2)c(Nc2ccncc2)c1=O		CHEMBL1975900	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601332	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cc(C=C2SC(=S)NC2=O)ccc1O		CHEMBL1973098	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601333	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(=O)CC)c3c2)cc1		CHEMBL1972221	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601334	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CNC(=O)C=Cc1cnc(N)c2c(-c3cc(F)c4[nH]c(C)cc4c3)csc12		CHEMBL2006778	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601335	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601336	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1c(F)cccc1F		CHEMBL1996979	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601337	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NC(=O)c1cccc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1997025	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9601338	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1968406	=	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9601339	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)csc12		CHEMBL1982476	=	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9601340	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C1C(=NNc2cccc3c(=O)[nH][nH]c(=O)c23)C(c2ccccc2)=NN1c1ccccc1		CHEMBL1984274	=	Ki	nM	1258.93	CHEMBL2208	Homo sapiens	pKi		5.9
inactive	9601341	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1998545	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601342	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1csc(NC(=O)c2sc3nc(-c4ccncc4)ccc3c2N)n1		CHEMBL1986869	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9601343	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)c(Cl)ccc12		CHEMBL2006010	=	Ki	nM	794.33	CHEMBL2208	Homo sapiens	pKi		6.1
inactive	9601344	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Fc1ccc(-c2ncn(CCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1		CHEMBL1682558	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601345	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601346	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1n[nH]c2cc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ccc12		CHEMBL1997623	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9601347	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccc(Cl)cc5o4)cc3)c1)CNC2=O		CHEMBL2002479	=	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9601348	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCN(C)CCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1993166	=	Ki	nM	1584.89	CHEMBL2208	Homo sapiens	pKi		5.8
inactive	9601349	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(NCc1ccc(Cl)cc1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL1967094	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601350	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1		CHEMBL1966035	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601351	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(NC(CO)c1cc(Cl)cc(Cl)c1)c1ccc(-c2ccncc2)cc1		CHEMBL2003341	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601352	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	c1ccc(-c2n[nH]cc2-c2ccncc2)cc1		CHEMBL1992644	<	Ki	nM	19952.62	CHEMBL2208	Homo sapiens	pKi		4.7
inactive	9601353	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(NS(=O)(=O)c1ccc(NCCSc2ccc(O)cc2)c([N+](=O)[O-])c1)c1ccc(-c2ccc(F)cc2)cc1		CHEMBL1992645	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601354	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Oc1cccc(Nc2ncnc3scc(Cl)c23)c1		CHEMBL1982992	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601355	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cc(-c2ccccc2)n(-c2cc(NN=Cc3ccco3)ncn2)n1		CHEMBL1999590	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601356	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1F		CHEMBL1981079	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601357	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCN(CC)CCCNc1cccc(-c2nc3c(C(N)=O)cccc3[nH]2)n1		CHEMBL1972276	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601358	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=c1c(NCc2ccc(Cl)cc2)c(Nc2ccncc2)c1=O		CHEMBL1980489	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9601359	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCc4cccc(F)c4)cc2NC3=O)ccc1O		CHEMBL2000832	=	Ki	nM	1584.89	CHEMBL2208	Homo sapiens	pKi		5.8
inactive	9601360	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)c1		CHEMBL1967116	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601361	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1nn(C)c2c1c(=O)c1cc(Cl)ccc1n2OCC(C)C		CHEMBL1977814	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601362	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1nc2ccccn2c1-c1csc(Nc2ccc(O)cc2)n1		CHEMBL513846	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601363	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(NCc1ccc(Br)cc1)Nc1ccc2[nH]ncc2c1		CHEMBL1970709	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601364	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601365	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1ccc(-c2cc3nccn3c(Nc3ccccc3C(N)=O)n2)cc1OC		CHEMBL1998112	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601366	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(C)n1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)cc21		CHEMBL1969126	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601367	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1ncnc2sc(Br)c(-c3ccc(NC(=O)Cc4cccc(Cl)c4)cc3)c12		CHEMBL1980896	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601368	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(=O)NC1CCN(c2nc3[nH]cc(C(=O)O)c(=O)c3c(C)c2F)C1		CHEMBL1975208	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601369	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601370	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1		CHEMBL1991429	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601371	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NC(=O)c1cc2c(Oc3cccc(F)c3)cncc2s1		CHEMBL1964777	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601372	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)C(=O)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1971149	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601373	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1ccc2c(c1)NC(=O)c1ccccc1N2		CHEMBL1999714	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601374	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(Cc1ccccc1Cl)Nc1ccc2cn[nH]c2c1		CHEMBL1987533	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601375	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(C)(O)CNc1nccc(-c2c(-c3ccc(F)cc3F)nc3c(CC4CC4)nccn23)n1		CHEMBL1994040	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9601376	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CNC1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL1980995	=	Ki	nM	79.43	CHEMBL2208	Homo sapiens	pKi		7.1
active	9601377	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NC(COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL1967302	=	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601378	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCCCN4CCOCC4)cc2-3)cn1		CHEMBL398951	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9601379	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cc2cnc3c(c2cc1OC)C(=O)NC3=O		CHEMBL1982506	=	Ki	nM	3981.07	CHEMBL2208	Homo sapiens	pKi		5.4
inactive	9601380	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCN(CC)CCNC(=O)C=Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2004716	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601381	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1		CHEMBL1968127	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9601382	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cc(C)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1975233	=	Ki	nM	3162.28	CHEMBL2208	Homo sapiens	pKi		5.5
inactive	9601383	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL1985406	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601384	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cn1nc(C(F)(F)F)c2c(=O)c3cc(Cl)ccc3n(O)c21		CHEMBL207400	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601385	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cc(O)ccc1-n1cc(C(=O)NN)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL2000894	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601386	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1ccccc1NC(=O)Nc1ccc2c(c1)CCc1sc3ncnc(N)c3c1-2		CHEMBL1982135	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601387	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1ncnc2c1sc1ncnc(N)c12		CHEMBL1976090	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601388	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4c(c3)OCO4)csc12		CHEMBL1993243	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9601389	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	OCC(CO)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1992922	=	Ki	nM	1995.26	CHEMBL2208	Homo sapiens	pKi		5.7
inactive	9601390	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3o2)cc1		CHEMBL2004771	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601391	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CC(CN2CCCC2)C1		CHEMBL1988370	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601392	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1997597	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9601393	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	S=c1[nH]nc2c3c4c(sc3n3c(=S)[nH]nc3n12)CCC4		CHEMBL1969537	=	Ki	nM	1995.26	CHEMBL2208	Homo sapiens	pKi		5.7
inactive	9601394	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601395	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1976093	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601396	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccccc2)n1		CHEMBL210032	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601397	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NC(COc1cncc(-c2ccc(F)cc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1996543	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601398	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1cccs1		CHEMBL1975256	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601399	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cnn(C)c5)cnn4c3N)cc2)c1		CHEMBL508928	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601400	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cccc(-c2cc3c(=O)[nH]c4ccccc4n3c2)c1		CHEMBL1991356	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601401	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1ccc(C(=O)Nc2nc3ccc(Cl)cc3s2)c(OC)c1		CHEMBL1983309	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601402	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL2004892	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601403	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC1=NN(c2ccccc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1999126	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601404	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(C)Oc1ccc(-c2noc(-c3ccc(NC4CCC(C(=O)O)C4)cc3)n2)cc1Cl		CHEMBL1997503	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601405	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NC(=O)c1cc2c(Oc3ccc(Br)cc3)cncc2s1		CHEMBL116070	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601406	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cc(C)c(C)c(OCCCc2c(C(=O)O)[nH]c3c(-c4ccccc4C)cccc23)c1		CHEMBL1990821	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601407	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NC(=O)c1cc(-c2cccc(N)c2)cc2cccnc12		CHEMBL1970314	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601408	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	OCCCn1cnc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL2004871	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601409	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncn3)cc2)c1		CHEMBL2004872	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601410	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C1Nc2ccccc2Nc2ccccc21		CHEMBL1727312	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601411	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC1CCN(C(=O)CO)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1969879	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601412	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(Nc1cnccn1)Nc1ccnc2ccccc12		CHEMBL1981720	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601413	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(N)COc1cnc(Cl)c(C=Cc2ccncc2)c1		CHEMBL1993548	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601414	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1		CHEMBL262433	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601415	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9601416	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(NNC(=S)Nc1ccc(Cl)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1966722	=	Ki	nM	1258.93	CHEMBL2208	Homo sapiens	pKi		5.9
inactive	9601417	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCNC(C)=O)cc2NC3=O)ccc1O		CHEMBL1975500	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601418	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4snc(N)c34)cc2)c1		CHEMBL1976328	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601419	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1		CHEMBL394619	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9601420	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1ccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)cc1OC		CHEMBL1964399	=	Ki	nM	794.33	CHEMBL2208	Homo sapiens	pKi		6.1
active	9601421	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(O)c1c2c(nc3ccccc13)C(=C1CCCC1)CC2		CHEMBL1996831	=	Ki	nM	3162.28	CHEMBL2208	Homo sapiens	pKi		5.5
inactive	9601422	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc1)CCN2		CHEMBL411903	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601423	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN)cnc(N)c34)cc2)c1		CHEMBL1965988	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601424	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9601425	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL1989646	=	Ki	nM	1258.93	CHEMBL2208	Homo sapiens	pKi		5.9
inactive	9601426	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	c1ccc(Cc2cc(-c3ccc4[nH]ncc4c3)on2)cc1		CHEMBL1682357	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9601427	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	=	Ki	nM	794.33	CHEMBL2208	Homo sapiens	pKi		6.1
inactive	9601428	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCOc1nc(C(=O)NCc2cccnc2)cc(N)c1C#N		CHEMBL209534	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601429	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1nccn2c(-c3ccnc(NCCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1978200	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601430	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601431	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CN(C)S(=O)(=O)c1ccccc1-c1ccc2c(c1)Nc1ccccc1NC2=O		CHEMBL2006631	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601432	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cc(C=C2SC(=Nc3ccccc3)NC2=O)ccc1O		CHEMBL1970522	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601433	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(Nc1n[nH]c2nc3ccccc3cc12)c1ccncc1		CHEMBL1990415	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601434	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	C(=Cc1cncc(OC2CCNC2)c1)c1ccncc1		CHEMBL1966087	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601435	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cncc21		CHEMBL1964692	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601436	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(NC(CO)Cc1ccc(Cl)cc1)c1ccc(-c2ccncc2)cc1		CHEMBL1996931	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601437	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	FC(F)(F)c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C(F)(F)F)c1		CHEMBL1964413	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9601438	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL1973483	=	Ki	nM	3162.28	CHEMBL2208	Homo sapiens	pKi		5.5
inactive	9601439	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C)c1		CHEMBL1984432	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601440	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL1970735	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601441	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL219722	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601442	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCC(O)C1		CHEMBL1997340	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9601443	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCOC(=O)C1=C(N)n2c(sc(=Cc3cccs3)c2=O)=C(C(N)=O)C1c1cccs1		CHEMBL2004365	=	Ki	nM	1584.89	CHEMBL2208	Homo sapiens	pKi		5.8
inactive	9601444	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601445	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601446	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cn1cc(-c2ccncn2)c(-c2ccc(F)cc2)n1		CHEMBL1989474	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601447	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601448	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(Nc1nc2ccccc2n1CCCO)c1cccc([N+](=O)[O-])c1		CHEMBL210887	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601449	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601450	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C(F)(F)F)c2)c1		CHEMBL1971021	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9601451	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(OC(F)(F)F)c4)c3)cc12		CHEMBL1965836	=	Ki	nM	3981.07	CHEMBL2208	Homo sapiens	pKi		5.4
inactive	9601452	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12		CHEMBL583144	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601453	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NC(=O)c1cc2c(-c3ccc(F)cc3)cncc2s1		CHEMBL1974310	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601454	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601455	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1ncnc2sc3c(c12)-c1ccc(NC(=O)Nc2ccccc2)cc1CC3		CHEMBL1994693	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601456	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NC(=O)c1cccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982957	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601457	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9601458	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(NNC(=S)Nc1ccc(F)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1975138	=	Ki	nM	5011.87	CHEMBL2208	Homo sapiens	pKi		5.3
inactive	9601459	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N		CHEMBL424872	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601460	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC1=NN(c2ccc(C(=O)O)cc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2006836	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601461	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#Cc5cccnc5)cnc(N)c34)cc2)c1		CHEMBL1971947	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601462	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601463	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601464	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cc2nnc(SCc3cn4ccccc4n3)n2c2ccccc12		CHEMBL1980704	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601465	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NC(=O)c1sc2ccc(Cl)c(Cl)c2c1NC(=O)c1ccc(Cl)cc1		CHEMBL2003271	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601466	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccncc4)nn12)CCCC3		CHEMBL1966808	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601467	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(C)(C)c1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2		CHEMBL2004447	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601468	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601469	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	OCCNc1cc2cc(-c3ccsc3)ccc2cn1		CHEMBL1973860	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601470	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(NCc1ccc(Cl)cc1)Nc1cccc2[nH]ncc12		CHEMBL1977713	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601471	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL260135	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601472	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21		CHEMBL220241	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9601473	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=S(=O)(O)c1ccc(NCc2ccc3c(c2)OCO3)c2c(O)cccc12		CHEMBL2004544	=	Ki	nM	1995.26	CHEMBL2208	Homo sapiens	pKi		5.7
inactive	9601474	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=c1[nH]cc(I)c2nc(-c3cccc(Cl)c3)cn12		CHEMBL1982610	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601475	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cccc(C2(c3cccc(C)c3)CC2C(=O)Nc2ccncc2)c1		CHEMBL1999496	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601476	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CSc1cnc2c(ccc3cnccc32)c1O		CHEMBL2006933	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601477	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1ccc(-c2csc3c(C=Cc4nc5ccccc5[nH]4)cnc(N)c23)cc1		CHEMBL1988300	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9601478	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1OC		CHEMBL1991078	=	Ki	nM	1995.26	CHEMBL2208	Homo sapiens	pKi		5.7
inactive	9601479	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9601480	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCCCNc1ccc2c3c(cccc13)C(=O)N(CCNCCO)C2=O		CHEMBL1987359	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9601481	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(=NNC(=N)N)c1cc(NC(=O)c2cccc(C(=O)Nc3cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c3)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL2000685	=	Ki	nM	199.53	CHEMBL2208	Homo sapiens	pKi		6.7
inactive	9605046	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9605047	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(CO)ccc4F)cc3)c12		CHEMBL1985311	=	Ki	nM	6309.57	CHEMBL2208	Homo sapiens	pKi		5.2
inactive	9605048	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)cc3n21		CHEMBL1989265	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605049	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605050	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CNC1CCN(c2nc3[nH]cc(C(=O)O)c(=O)c3c(C)c2Br)C1		CHEMBL2004647	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605051	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C1NN=Cc2c[nH]c3cc(NC(=O)C4CC4c4ccccc4)cc1c23		CHEMBL1969502	<	Ki	nM	6309.57	CHEMBL2208	Homo sapiens	pKi		5.2
inactive	9605052	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CCC(N2CCCC2)CC1		CHEMBL1965910	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605053	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(C)Nc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682553	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605054	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cccc(-c2c(-c3ccncc3)nc(NCC(N)Cc3ccccc3)n(C)c2=O)c1		CHEMBL1971430	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605055	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1ccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)cc1		CHEMBL1997764	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605056	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL1983963	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9605057	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(CN)Cc4ccccc4)c3)cc12		CHEMBL2000271	=	Ki	nM	2511.89	CHEMBL2208	Homo sapiens	pKi		5.6
inactive	9605058	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Oc1ccc(-c2n[nH]c(Nc3cccc(Cl)c3)c2-c2ccc(O)cc2)cc1		CHEMBL1985092	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605059	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1ccccc1		CHEMBL2004692	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605060	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CNc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL1981410	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605061	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC1(O)CC(c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn23)C1		CHEMBL1996234	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605062	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1ccc(C=C2C(=O)ON=C2c2ccc(Br)cc2)cc1OC		CHEMBL1991434	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605063	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CN(C)c1cccc2c(S(=O)(=O)N(CCN)c3cncc(-c4ccc5cnccc5c4)c3)cccc12		CHEMBL1967544	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9605064	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	=	Ki	nM	1584.89	CHEMBL2208	Homo sapiens	pKi		5.8
inactive	9605065	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL340384	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605066	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1996587	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605067	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CS(=O)(=O)NCCOc1cncc(-c2ccc3cnccc3c2)c1		CHEMBL1964804	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605068	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1ccc(-c2cnc3c(Br)cnn3c2)cc1		CHEMBL443962	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605069	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1O		CHEMBL2000354	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605070	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1965507	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605071	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cn1ncc2c1CCCC2=O		CHEMBL1981107	<	Ki	nM	19952.62	CHEMBL2208	Homo sapiens	pKi		4.7
inactive	9605072	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605073	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCCC(=O)Nc1n[nH]c2nc3ccccc3cc12		CHEMBL1967564	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9605074	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	=	Ki	nM	3.162	CHEMBL2208	Homo sapiens	pKi		8.5
inactive	9605075	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	OCCCNc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL2000071	<	Ki	nM	5011.87	CHEMBL2208	Homo sapiens	pKi		5.3
inactive	9605076	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1ccc2c(NC(=O)Nc3cc(C(F)(F)F)ccn3)ccnc2c1		CHEMBL1979176	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605077	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1970317	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605078	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc2c(C)n1		CHEMBL2000408	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9605079	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	=	Ki	nM	3981.07	CHEMBL2208	Homo sapiens	pKi		5.4
inactive	9605080	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CN1CCC(C(=O)n2nc(N)c3cc(-c4cn(Cc5ccccc5)nn4)ccc32)CC1		CHEMBL1978014	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605081	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(Nc1cnccn1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1994538	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9605082	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCN(CC)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1983195	=	Ki	nM	1995.26	CHEMBL2208	Homo sapiens	pKi		5.7
inactive	9605083	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1975490	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605084	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1964444	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605085	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	OCCNc1cc2cc(-c3ccccc3)ccc2cn1		CHEMBL1989957	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605086	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccsc2)n1		CHEMBL2006567	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605087	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Clc1csc2ncnc(Nc3ccccc3)c12		CHEMBL1986139	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605088	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NC(Cc1cccc2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1985580	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605089	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)cccc12		CHEMBL1980540	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605090	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN(C)C)cnc(N)c34)cc2)c1		CHEMBL1979883	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605091	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(C)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1984162	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605092	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Fc1cnc(Nc2ccccc2)nc1Nc1ccccc1		CHEMBL491758	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605093	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C(C)(C)C		CHEMBL1986186	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605094	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	c1cc2[nH]ncc2cc1-c1cc(CN2CCCCC2)no1		CHEMBL1682360	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605095	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1n[nH]c2c1C(c1ccccc1Cl)C(C#N)=C(N)O2		CHEMBL1970189	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605096	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1ncnc2c1c(I)nn2C1CCC(O)CC1		CHEMBL1996791	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605097	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371206	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605098	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1ccc(C=NNc2ncnc3c2[nH]c2ccccc23)cc1OC		CHEMBL1974664	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605099	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605100	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(NC(CO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1974288	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605101	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605102	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC		CHEMBL1190711	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605103	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1n[nH]c2cccc(-c3ccc(Br)cc3)c12		CHEMBL1990346	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9605104	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(C)Cn1c(=O)n(C)c(=O)c2c(SCCCO)c(Cc3cccc4ccccc34)sc21		CHEMBL205526	=	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9605105	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCCC4)ccc3n2)c1		CHEMBL1968705	=	Ki	nM	6309.57	CHEMBL2208	Homo sapiens	pKi		5.2
inactive	9605106	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL404367	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605107	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(C)Cc1cc(-c2ccc3[nH]nc(N)c3c2)on1		CHEMBL1966343	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605108	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1n[nH]c2ccc(-c3cncc(OCCN)c3)cc12		CHEMBL1967887	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605109	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605110	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)cc1C		CHEMBL2000335	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605111	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)c(F)c3n21		CHEMBL1977604	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605112	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605113	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cn1cc(-c2cnn3c(N)c(-c4ccc(NC(=O)Nc5cccc(C(F)(F)F)c5)cc4)cnc23)cn1		CHEMBL1988717	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9605114	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1		CHEMBL1974328	=	Ki	nM	3981.07	CHEMBL2208	Homo sapiens	pKi		5.4
inactive	9605115	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605116	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605117	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(Nc1ccc2[nH]ncc2c1)c1ccc(Cl)cc1		CHEMBL1973808	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605118	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2000429	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9605119	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1ccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)cc1		CHEMBL1972576	=	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605120	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(NN=Cc1ccc(Sc2nc3ccccc3[nH]2)o1)c1cccc([N+](=O)[O-])c1		CHEMBL1992555	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9605121	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	=	Ki	nM	2511.89	CHEMBL2208	Homo sapiens	pKi		5.6
inactive	9605122	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1992342	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9605123	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cc(Cl)ccc1NC(=S)NNC(=O)C(O)(c1ccccc1)c1ccccc1		CHEMBL1988173	=	Ki	nM	1584.89	CHEMBL2208	Homo sapiens	pKi		5.8
inactive	9605124	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	C(=NNc1nc2ccccc2[nH]1)c1c[nH]c2ccccc12		CHEMBL535331	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9605125	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	N#CC1=C(N)n2c(sc(=Cc3ccco3)c2=O)=C(C(N)=O)C1c1ccco1		CHEMBL1989805	=	Ki	nM	794.33	CHEMBL2208	Homo sapiens	pKi		6.1
inactive	9605126	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605127	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(C)Cn1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL1965423	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605128	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(C)=C(C)c1cccc2c(CCCOc3cccc(Cl)c3Cl)c(C(=O)O)[nH]c12		CHEMBL1982980	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605129	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCC(N)(C#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12)CC		CHEMBL1983025	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605130	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605131	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(NCc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1977135	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605132	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C1NC(=S)SC1=C1C(=O)Nc2ccc(Br)cc21		CHEMBL2001920	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9605133	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NC(=O)c1cc2c(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)cncc2s1		CHEMBL2002322	=	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605134	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1ccc(F)c(-c2ccc3nnc(N)n3c2)c1		CHEMBL2002323	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9605135	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3C(N)=O)n2)cc(OC)c1OC		CHEMBL1241473	=	Ki	nM	6.31	CHEMBL2208	Homo sapiens	pKi		8.2
active	9605136	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CS(=O)(=O)N(Cc1ccc2[nH]c(=O)c3cccn3c2c1)C1CC1		CHEMBL1978448	=	Ki	nM	79.43	CHEMBL2208	Homo sapiens	pKi		7.1
inactive	9605137	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COC(=O)c1ccccc1-c1ccc2c(c1)Nc1ccccc1NC2=O		CHEMBL2004513	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605138	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NCCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1972258	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605139	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCN(CC)CC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2001257	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605140	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(Cl)cc4Cl)c(=O)c3=O)ccc21		CHEMBL2005548	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605141	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1ccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)cc1		CHEMBL1992536	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9605142	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1ccccc1-c1c(C(=O)O)n(CCCOc2cccc3ccccc23)c2ccccc12		CHEMBL1987793	=	Ki	nM	6309.57	CHEMBL2208	Homo sapiens	pKi		5.2
inactive	9605143	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCN1CCN(CCCC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1		CHEMBL1992740	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605144	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	OCCCn1cnc(-c2ccccc2)c1-c1ccncc1		CHEMBL2002373	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605145	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1cccc(Cl)c1		CHEMBL1973348	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605146	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2NCCCN)c1		CHEMBL2006188	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605147	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1967531	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605148	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCCC(=O)Nc1nn(C(=O)CC)c2nc3ccccc3cc12		CHEMBL1970913	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605149	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(C)=O)c3c2)cc1		CHEMBL1973893	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605150	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCOC(=O)c1cccc2[nH]c(-c3ccc(N4CCC(N)C4)cc3)nc12		CHEMBL1995736	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605151	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605152	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cccc(C(C)NC(=O)c2cc(C)c(-c3ccc4[nH]nc(C)c4c3)s2)c1		CHEMBL1997534	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605153	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9605154	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NC(=O)Cn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL1985095	=	Ki	nM	25.12	CHEMBL2208	Homo sapiens	pKi		7.6
inactive	9605155	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(C)(O)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1998551	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605156	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1977374	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9605157	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COCc1nnn(-c2nonc2N)c1C(=O)NN=C(C)c1ccc(O)cc1O		CHEMBL1991180	=	Ki	nM	1995.26	CHEMBL2208	Homo sapiens	pKi		5.7
inactive	9605158	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605159	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)cn2c1		CHEMBL1682540	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605160	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1c(O)cccc1NC(=O)c1cnn2c(-c3ccccc3)ccnc12		CHEMBL1978656	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605161	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCc1c(-c2ccc(C(C)(C)O)cc2)[nH]c2nccnc12		CHEMBL1976420	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605162	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1		CHEMBL1994864	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9605163	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCO)c(Cl)cc1NC(=O)N2		CHEMBL413779	=	Ki	nM	501.19	CHEMBL2208	Homo sapiens	pKi		6.3
active	9605164	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOCC5CC5)c4)n[nH]c2-3)CC1		CHEMBL2002446	=	Ki	nM	6309.57	CHEMBL2208	Homo sapiens	pKi		5.2
inactive	9605165	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=c1nc(-c2cc3c(Oc4ccc(I)cc4)cncc3s2)[nH]o1		CHEMBL497151	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605166	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NCC1CCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246970	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605167	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cc(O)ccc1-n1cc(C(N)=O)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL340921	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9605168	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	=	Ki	nM	794.33	CHEMBL2208	Homo sapiens	pKi		6.1
inactive	9605169	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	N#Cc1ccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)nc1		CHEMBL1999718	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9605170	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C1Nc2ccc3ncsc3c2C1=CNc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1973540	=	Ki	nM	1258.93	CHEMBL2208	Homo sapiens	pKi		5.9
inactive	9605171	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C1Nc2ccccc2Nc2nnc(I)cc21		CHEMBL1977346	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605172	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL1971649	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605173	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2003657	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605174	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605175	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	OCCNc1cc2cc(-c3ccncc3)ccc2cn1		CHEMBL1998435	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605176	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCCCC2)n1		CHEMBL2006439	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9605177	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(C)N(C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1)C(C)C		CHEMBL2006156	=	Ki	nM	5011.87	CHEMBL2208	Homo sapiens	pKi		5.3
inactive	9605178	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1ccc(-c2ccc(NC(=O)Nc3cc(F)cc(F)c3)cc2)c2c(N)noc12		CHEMBL1969190	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9605179	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)n[nH]c12		CHEMBL1973937	=	Ki	nM	6309.57	CHEMBL2208	Homo sapiens	pKi		5.2
inactive	9605180	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9605181	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1991674	=	Ki	nM	1258.93	CHEMBL2208	Homo sapiens	pKi		5.9
active	9605182	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	=	Ki	nM	1995.26	CHEMBL2208	Homo sapiens	pKi		5.7
inactive	9605183	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	FC(F)(F)Oc1ccc(-c2ccc3[nH]cc(C4=CCNCC4)c3c2)cc1		CHEMBL1987982	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605184	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(C)COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1984842	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605185	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cn[nH]c5)cnc(N)c34)cc2)c1		CHEMBL1969102	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9605186	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1682346	=	Ki	nM	3162.28	CHEMBL2208	Homo sapiens	pKi		5.5
inactive	9605187	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCN(CC)CC#Cc1ccc2c(c1)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL2007044	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605188	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CNC(=O)N1CCN(CCCOc2ccc3c(c2)-c2[nH]nc(-c4ccc(C#N)nc4)c2C3)CC1		CHEMBL2001998	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605189	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cc(C=C(C#N)c2nc3ccccc3[nH]2)c(Br)cc1O		CHEMBL1994241	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605190	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605191	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1ccc(Cl)cc1		CHEMBL1998829	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605192	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605193	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cnc(Nc2cccc(S(N)(=O)=O)c2)nc1Nc1ccc(OCC(N)=O)cc1		CHEMBL1988838	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605194	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccc(C(=O)Nc6ccccc6F)c5)nc5ccccn45)n3)cc2)CC1		CHEMBL1981725	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605195	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]ncc34)cc2)c1		CHEMBL375284	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605196	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COCCn1cc(-c2ccncn2)c(-c2ccc(Cl)cc2)n1		CHEMBL1982866	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605197	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2005792	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605198	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	c1ccc(CSc2nc(-c3ccncc3)n[nH]2)cc1		CHEMBL1968926	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605199	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCOc1nc(C(=O)NCc2ccncc2)cc(N)c1C#N		CHEMBL1984206	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605200	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1c(-c2ccccc2)c2cc(Cl)ccc2[nH]c1=O		CHEMBL462120	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605201	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C1CCCCC1		CHEMBL1991577	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605202	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4ccccc4F)cc3)c12		CHEMBL1965570	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605203	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccccc4)nn12)CCCC3		CHEMBL2007592	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605204	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605205	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cncc2cccc(S(=O)(=O)N3CCCNCC3C)c12		CHEMBL1082440	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605206	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3F)c2-c2ccncn2)CC1		CHEMBL1614705	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605207	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL1972362	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605208	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)s2)c1		CHEMBL1984633	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605209	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605210	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CNc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2007372	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605211	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cccc(C(C)NC(=O)N2CC=C(c3c[nH]c4ncccc34)CC2)c1		CHEMBL1965845	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605212	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1ccc(OC)c(NC(=O)c2cnn3c(-c4ccccc4)ccnc23)c1		CHEMBL1982167	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605213	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1)c1c(F)cccc1F		CHEMBL2006715	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605214	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NC(=O)c1cccc2[nH]c(-c3ccc(NC(=O)c4cccc(S(=O)(=O)N5CCOCC5)c4)cc3)nc12		CHEMBL1986597	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605215	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NC(=O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1971017	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605216	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL1990482	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605217	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Fc1ccc(-c2nc3cnccn3c2-c2ccnc(NCC3CC3)n2)cc1		CHEMBL1990904	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605218	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605219	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(NCC1CCCCC1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL2005475	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605220	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL2000104	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605221	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9605222	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC1=NN(c2ccc(Cl)c(Cl)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1997349	=	Ki	nM	1258.93	CHEMBL2208	Homo sapiens	pKi		5.9
inactive	9605223	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2C)c1		CHEMBL183844	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605224	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL220057	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605225	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682545	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605226	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1974935	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605227	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cc(OC2CCCC2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL2001224	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605228	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605229	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(C)(O)Cc1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1976732	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605230	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(S(N)(=O)=O)cc4)c(=O)c3=O)ccc21		CHEMBL1969506	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605231	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(NC(CO)c1ccccc1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1964937	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605232	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	c1ccc(COc2ccc(Nc3ncnc4ccccc34)cc2)cc1		CHEMBL1980163	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9605233	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	=	Ki	nM	251.19	CHEMBL2208	Homo sapiens	pKi		6.6
inactive	9605234	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cc(-c2nn(C3CCC(N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL1970879	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605235	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1c(C=O)c(O)n2c(nc3ccccc32)c1C#N		CHEMBL1989856	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605236	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(=O)N(c1ccncc1)c1c(NC(C)C(C)(C)C)c(=O)c1=O		CHEMBL2005899	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605237	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1		CHEMBL1682552	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605238	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605239	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cncc(C=Cc2ccncc2)c1		CHEMBL1972568	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605240	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CN1CCC1COc1cncc(CCc2ccncc2)c1		CHEMBL1996155	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9605241	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(Cl)c4)c3)cc12		CHEMBL1974870	=	Ki	nM	630.96	CHEMBL2208	Homo sapiens	pKi		6.2
inactive	9605242	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCCc1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1682359	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605243	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1		CHEMBL2002702	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9605244	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL1970903	=	Ki	nM	2511.89	CHEMBL2208	Homo sapiens	pKi		5.6
inactive	9605245	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1ccccc1		CHEMBL1991846	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9605246	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)c1		CHEMBL1969523	=	Ki	nM	1584.89	CHEMBL2208	Homo sapiens	pKi		5.8
active	9605247	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cc(C=O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL207995	=	Ki	nM	3981.07	CHEMBL2208	Homo sapiens	pKi		5.4
inactive	9605248	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1988995	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605249	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C1Nc2cc(CCOc3ccc(N4CCOCC4)cc3)ccc2Nc2cc(-c3cn(Cc4cc(F)c(F)c(F)c4)c4cnccc34)ccc21		CHEMBL2001923	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605250	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(=O)N1CCC(Nc2nccc(-c3c(-c4ccc(F)cc4)nc4occn34)n2)CC1		CHEMBL1986781	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9605251	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=c1nc(-c2ccc3[nH]ncc3c2)cc(-c2ccccc2)[nH]1		CHEMBL526133	=	Ki	nM	3981.07	CHEMBL2208	Homo sapiens	pKi		5.4
inactive	9605252	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605253	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3[nH]2)cc1		CHEMBL1979057	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605254	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1OCC(O)CO		CHEMBL1981045	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605255	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1		CHEMBL387971	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9605256	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	c1ccc(Cn2nnc(-c3ccc4[nH]ncc4c3)c2C2CC2)cc1		CHEMBL1975418	=	Ki	nM	1584.89	CHEMBL2208	Homo sapiens	pKi		5.8
inactive	9605257	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=c1[nH]c2ccc(Cl)cc2c(-c2ccccc2)c1C1=NNC(c2ccccc2)C1		CHEMBL1992796	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605258	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1999428	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605259	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCC(O)CO)c(Cl)cc1NC(=O)N2		CHEMBL223257	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605260	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCN1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1967560	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605261	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605262	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3noc4ncnc(N)c34)cc2)c1		CHEMBL211378	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605263	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1982465	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9605264	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccco2)C(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL2001751	=	Ki	nM	1995.26	CHEMBL2208	Homo sapiens	pKi		5.7
inactive	9605265	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(NCCCCCCNC(=O)NCc1cccnc1)NCc1cccnc1		CHEMBL2003420	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605266	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1ccccc1NC(=O)Nc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL1984586	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605267	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1c(Cl)c(N2CCC(CN)C2)nc2[nH]cc(C(=O)O)c(=O)c12		CHEMBL1999774	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605268	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1c(O)ccc2c1CCCC2=NNC(=O)Cc1cccc2ccccc12		CHEMBL1972659	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9605269	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	OC1CCN(c2ncnc3[nH]cc(-c4ccccc4)c23)CC1		CHEMBL1973395	=	Ki	nM	1258.93	CHEMBL2208	Homo sapiens	pKi		5.9
inactive	9605270	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1ccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)cc1Cl		CHEMBL272453	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605271	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3C)cc2)c1		CHEMBL1970217	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605272	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C1Nc2ccccc2Nc2nnccc21		CHEMBL1971801	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605273	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C1Nc2ccccc2Nc2nnc(Cl)cc21		CHEMBL1968850	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605274	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCOC(=O)c1ccc2[nH]c3c(c2c1)CCNC3=O		CHEMBL2005528	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605275	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)c1		CHEMBL185569	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605276	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	c1cc2[nH]ncc2cc1-c1cn(CC2CCOCC2)nn1		CHEMBL1969843	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605277	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4)c3c2)ccc1O		CHEMBL2007002	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9605278	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608849	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CN1CCC(NC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)CC1		CHEMBL1987007	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9608850	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Clc1cc(-c2c[nH]c3ncccc23)cc(NCc2ccccc2)n1		CHEMBL1969588	=	Ki	nM	6309.57	CHEMBL2208	Homo sapiens	pKi		5.2
inactive	9608851	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cc(Nc2nccc(Nc3cc(C4CCCCC4)no3)n2)cc(OC)c1OC		CHEMBL1984711	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608852	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1		CHEMBL1967878	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9608853	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cc(OC)c(Nc2ccc3nnc(-c4ccccc4)n3n2)cc1Cl		CHEMBL1990212	=	Ki	nM	6309.57	CHEMBL2208	Homo sapiens	pKi		5.2
active	9608854	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	=	Ki	nM	794.33	CHEMBL2208	Homo sapiens	pKi		6.1
inactive	9608855	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCCCn1c(NC(=O)c2ccc(C#N)cc2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL484390	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608856	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=c1c(NCc2cccc(C(F)(F)F)c2)c(Nc2ccncc2)c1=O		CHEMBL1979252	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608857	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	c1ccc(Cc2cn(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682341	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608858	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608859	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccc(F)cc3)cc12		CHEMBL1986499	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608860	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cccc(C=C2SC(=Nc3ccccc3)NC2=O)c1		CHEMBL1972937	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608861	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	C#Cc1cc2c(cc1OC)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL1972250	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608862	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1C1CCOc2c(F)cccc21		CHEMBL2000393	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608863	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COC(=O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL2004072	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608864	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C)c2)c1		CHEMBL2004311	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608865	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Brc1cnc2[nH]cc(-c3ccccc3)c2c1		CHEMBL1992634	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608866	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1242373	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9608867	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCNNc1cc(C)c(C#N)c2nc3ccccc3n12		CHEMBL2000433	=	Ki	nM	5011.87	CHEMBL2208	Homo sapiens	pKi		5.3
active	9608868	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	N#CC(=Cc1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL1974157	=	Ki	nM	5011.87	CHEMBL2208	Homo sapiens	pKi		5.3
inactive	9608869	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Fc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL316264	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608870	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1ccc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1988075	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608871	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1991678	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9608872	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1ncnc(Nc2cc(CNC(=O)C(F)(F)F)c(O)c(-c3ccc(Cl)cc3)c2)n1		CHEMBL2001239	=	Ki	nM	5011.87	CHEMBL2208	Homo sapiens	pKi		5.3
inactive	9608873	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1ncnc2scc(C(=O)Nc3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1988594	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608874	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1ncnc2c1c(I)nn2C1OC(CO)C(O)C1O		CHEMBL2001288	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608875	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL260092	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608876	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608877	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(NN=Cc1ccc(O)cc1O)Nc1cccc2nsnc12		CHEMBL1999811	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608878	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1n[nH]c2ncc(C#N)c(-c3ccccc3)c12		CHEMBL1965495	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608879	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CSc1ccc2nc3c(c(Cl)c2c1)CCNC3=O		CHEMBL1985074	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608880	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc2n1CC1CC1		CHEMBL1982874	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9608881	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL2000481	=	Ki	nM	3981.07	CHEMBL2208	Homo sapiens	pKi		5.4
inactive	9608882	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1		CHEMBL1173055	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608883	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CN(C)CC(=O)NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1991725	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608884	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4sncc34)cc2)c1		CHEMBL1992242	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608885	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2007296	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608886	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9608887	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3[nH]ncc3c2)n1		CHEMBL396523	=	Ki	nM	6309.57	CHEMBL2208	Homo sapiens	pKi		5.2
inactive	9608888	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C1NC(=O)C(Nc2ccccc2)=C1Cl		CHEMBL2007138	<	Ki	nM	19952.62	CHEMBL2208	Homo sapiens	pKi		4.7
active	9608889	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1970203	=	Ki	nM	6309.57	CHEMBL2208	Homo sapiens	pKi		5.2
inactive	9608890	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(c1cc(Cc2n[nH]c(=O)c3c2CCCC3)ccc1F)N1CCN(c2ncccn2)CC1		CHEMBL1986530	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608891	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cccc(C=NNc2cc(N3CCOCC3)nc(OCCc3ccccn3)n2)c1		CHEMBL1965351	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608892	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=c1c(NCCc2ccc(Oc3ccccc3)cc2)c(Nc2ccncc2)c1=O		CHEMBL1999321	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608893	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4sc(C)nc4c3)csc12		CHEMBL1968590	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608894	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cc(Nc2ncnc3ccc(-c4ccc(CN5CC6C(CO)C6C5)cc4)cc23)ccc1Oc1ccccc1		CHEMBL1999749	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608895	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCCC4)cc3OC)nc2N1C1CCCC1		CHEMBL2005375	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608896	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Clc1ccc(-c2n[nH]cc2-c2ccncn2)cc1Cl		CHEMBL1984191	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608897	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cc(C(=O)O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1983006	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608898	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CN1CCCC1COc1cncc(CCc2ccccc2)c1		CHEMBL1972183	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608899	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(N3CCN(C(C)=O)CC3)ccc2OC)ncc1Br		CHEMBL1971029	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608900	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(C)Nc1n[nH]c2ccc(N)cc12		CHEMBL1995391	<	Ki	nM	19952.62	CHEMBL2208	Homo sapiens	pKi		4.7
inactive	9608901	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NC(Cc1cccc2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1985580	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608902	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL394790	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608903	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608904	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1nc2c(sc3c(Br)ccc(Cl)c32)c(=O)o1		CHEMBL1974702	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608905	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1996111	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608906	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1nccn2c(-c3ccnc(NCC4(O)CC4)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1965589	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608907	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(NCCCCCCNC(=O)Nc1cccnc1)Nc1cccnc1		CHEMBL1998193	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9608908	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)O)s3)c2cc1OC		CHEMBL474432	=	Ki	nM	1995.26	CHEMBL2208	Homo sapiens	pKi		5.7
inactive	9608909	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1nnc(-c2cc3c(Oc4ccc(C(F)(F)F)cc4)cncc3s2)o1		CHEMBL1988153	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608910	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608911	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608912	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NC(=O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1999556	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608913	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1		CHEMBL1988437	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608914	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NC(COc1cc(C=Cc2ccncc2)cnc1Cl)Cc1c[nH]c2ccccc12		CHEMBL1968245	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608915	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NCCC(C(=O)Nc1ccc2[nH]ncc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL1998121	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608916	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CC(C)(C)N)cnc(N)c34)cc2)c1		CHEMBL1979577	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608917	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CC4CC4)nccn23)n1		CHEMBL1991800	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608918	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1CC#N		CHEMBL1985566	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608919	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL52387	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608920	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1nn(-c2ccccc2)c2c1c(=O)c1cc(Cl)ccc1n2O		CHEMBL379835	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608921	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cn1cc(C(CN)c2cncc(C=Cc3ccncc3)c2)c2ccccc21		CHEMBL1979357	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608922	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	N#Cc1ncc2nc1OCC(O)C(O)COc1ccc(Cl)cc1NC(=O)N2		CHEMBL1980802	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608923	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=c1c(NCc2ccc(Cl)cc2Cl)c(Nc2ccc3[nH]ncc3c2)c1=O		CHEMBL1979554	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608924	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCCCOc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1996817	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608925	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2ccncc2)c1-c1ccccc1		CHEMBL1419458	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608926	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCOc1nc(C(=O)NCc2ccc(S(N)(=O)=O)cc2)cc(N)c1C#N		CHEMBL2004355	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608927	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608928	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL468280	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608929	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cc(C)c2oc(Nc3ccc(-c4cccc(C(N)=O)c4N)cc3F)nc2c1		CHEMBL1990884	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608930	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608931	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL256835	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608932	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1980142	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608933	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL41783	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608934	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccc2nccnc12		CHEMBL2004438	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608935	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cccc2c1Nc1cc(Nc3ccncc3)ccc1C(=O)N2		CHEMBL2006276	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608936	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)noc12		CHEMBL271381	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608937	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1ccc(C(=O)Nc2c(C#N)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL2006785	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608938	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1982466	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9608939	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cc(-c2ccc3c(c2)Nc2ccc([N+](=O)[O-])cc2NC3=O)ccc1O		CHEMBL1995740	=	Ki	nM	5011.87	CHEMBL2208	Homo sapiens	pKi		5.3
inactive	9608940	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1996390	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9608941	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	3981.07	CHEMBL2208	Homo sapiens	pKi		5.4
inactive	9608942	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608943	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1995832	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608944	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1n[nH]c2sc(C(=O)NCCc3ccc(Cl)cc3)cc12		CHEMBL1998414	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608945	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Oc1ccc(Nc2[nH]nc(-c3ccc(O)cc3)c2-c2ccc(O)cc2)cc1		CHEMBL1969042	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608946	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cc(C=C(C#N)c2nc3cc(C)ccc3[nH]2)c(Br)cc1O		CHEMBL2000345	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9608947	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccccc1		CHEMBL1999931	=	Ki	nM	251.19	CHEMBL2208	Homo sapiens	pKi		6.6
active	9608948	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9608949	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=c1[nH]sc2c1c(=O)c1cc(F)c(NCc3ccccc3)c(F)c1n2C1CC1		CHEMBL1991640	=	Ki	nM	1995.26	CHEMBL2208	Homo sapiens	pKi		5.7
inactive	9608950	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1375418	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608951	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608952	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL2007064	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608953	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9608954	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccc(Cl)c(Cl)c4)c3)cc12		CHEMBL1991063	=	Ki	nM	3981.07	CHEMBL2208	Homo sapiens	pKi		5.4
inactive	9608955	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cccc(C(CN)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1976240	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608956	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1ccc(-c2ccc(NC(=O)Nc3ccc(F)c(C)c3)cc2)c2c(N)noc12		CHEMBL1979093	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608957	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=c1[nH]c2sccc2c2nc(-c3ccncc3)nn12		CHEMBL1968151	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608958	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Clc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1381197	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9608959	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)c1		CHEMBL1987009	=	Ki	nM	6309.57	CHEMBL2208	Homo sapiens	pKi		5.2
active	9608960	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccccc4)c3)cc12		CHEMBL2002726	=	Ki	nM	1258.93	CHEMBL2208	Homo sapiens	pKi		5.9
inactive	9608961	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(Nc1cnccn1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL2003817	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608962	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ncccc2N1		CHEMBL336961	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608963	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1nnc(-c2cc3c(Oc4ccc(Cl)cc4)cncc3s2)o1		CHEMBL1994830	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608964	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(Cl)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1987054	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608965	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1ncc(-c2ccncc2)c2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1970083	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9608966	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	=	Ki	nM	31.62	CHEMBL2208	Homo sapiens	pKi		7.5
inactive	9608967	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)csc12		CHEMBL2005631	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608968	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1ncc(C=CC(=O)NCCCn2ccnc2)c2scc(-c3ccc(Br)cc3)c12		CHEMBL1994938	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608969	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9608970	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1977223	=	Ki	nM	3162.28	CHEMBL2208	Homo sapiens	pKi		5.5
inactive	9608971	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(C)(C)C(=O)Oc1ccc2c(c1)nc(NC(=O)c1cccc([N+](=O)[O-])c1)n2CCCO		CHEMBL1236126	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608972	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NCCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL1966279	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9608973	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Clc1cc(NC2CCCCC2)nc(-c2c[nH]c3ncccc23)n1		CHEMBL1997846	=	Ki	nM	2511.89	CHEMBL2208	Homo sapiens	pKi		5.6
inactive	9608974	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(C)Cn1c(N)nc2c(F)cc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2004419	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9608975	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCCCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1991728	=	Ki	nM	630.96	CHEMBL2208	Homo sapiens	pKi		6.2
inactive	9608976	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NC(=O)c1cc2c(-c3ccc(F)cc3F)cncc2s1		CHEMBL1975787	<	Ki	nM	5011.87	CHEMBL2208	Homo sapiens	pKi		5.3
inactive	9608977	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cc(C=C(C#N)c2n[nH]c(N)c2C#N)ccc1O		CHEMBL2002407	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608978	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(Nc1ccc2cn[nH]c2c1)c1ccc(Cl)cc1		CHEMBL1972489	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608979	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Brc1ccc2[nH]nc(-c3ccccc3)c2c1		CHEMBL1994074	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608980	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)nc1		CHEMBL1992937	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9608981	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCOC(=O)c1c(NC(=O)C2C(C)(C)C2(C)C)sc2cnccc12		CHEMBL1990541	=	Ki	nM	6309.57	CHEMBL2208	Homo sapiens	pKi		5.2
inactive	9608982	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(Nc1cccc(N2CCOCC2)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1972119	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9608983	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CN(C)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1986328	=	Ki	nM	3162.28	CHEMBL2208	Homo sapiens	pKi		5.5
inactive	9608984	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608985	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1090356	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608986	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(C(F)(F)F)cc12		CHEMBL1976455	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608987	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1		CHEMBL1983923	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608988	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608989	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	c1ccc(CNc2nc3ccc(-c4ccncc4)cc3s2)cc1		CHEMBL1983534	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608990	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=c1c(NCc2ccccc2F)c(Nc2ccncc2)c1=O		CHEMBL1982361	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608991	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCOC(=O)C1=c2sc(=Cc3ccco3)c(=O)n2C(N)=C(C#N)C1c1ccco1		CHEMBL1999112	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608992	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	OCCC(Nc1nc2ccc(-c3ccncc3)cc2s1)c1ccccc1		CHEMBL1982122	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608993	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(Nc1ccc(-c2cccc3sncc23)cc1)Nc1ccc(F)c(C(F)(F)F)c1		CHEMBL2000801	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608994	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682546	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608995	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1991395	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608996	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CN1CCN(c2cccc(Nc3nccc(-c4c(C(N)=O)nc5ccccn45)n3)c2)CC1		CHEMBL1971245	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608997	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1987648	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608998	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCOC(=O)c1cn(-c2ccc(O)cc2C)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL1996780	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9608999	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(NCc1ccccc1)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL1972142	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609000	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1966514	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9609001	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCCCCCCCCCCCOc1ccc(NC(=N)N)cc1NC(=N)N		CHEMBL1980715	=	Ki	nM	3981.07	CHEMBL2208	Homo sapiens	pKi		5.4
active	9609002	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cccc(F)c1		CHEMBL2003638	=	Ki	nM	316.23	CHEMBL2208	Homo sapiens	pKi		6.5
inactive	9609003	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609004	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	N#Cc1ccc2nc(N)n(-c3nc(-c4ccccc4)cs3)c2c1		CHEMBL1996066	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609005	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NC(COc1cncc(-c2cc3ccncc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1966524	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609006	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=c1c2c([nH]c3cc(-c4ccco4)nn13)CSC2		CHEMBL1972152	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609007	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(C(=O)O)ccc4F)cc3)c12		CHEMBL1993722	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609008	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=c1[nH]c2sc3c(c2c2nc(-c4cccnc4)nn12)CCCC3		CHEMBL1970806	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609009	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1nc(COc2ccccc2Cl)sc1-c1ccnc(N)n1		CHEMBL1375640	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609010	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL1979970	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609011	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCN4CCOCC4)cc2-3)cn1		CHEMBL249282	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609012	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(C)(C)NC(=O)c1ccc2nc3[nH]c4ccccc4c3nc2c1		CHEMBL1969264	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9609013	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	N#Cc1c(O)[nH]c(=O)c2c(=N)oc3ccc(Cl)cc3c12		CHEMBL1973711	=	Ki	nM	3981.07	CHEMBL2208	Homo sapiens	pKi		5.4
inactive	9609014	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CN1CCN(CCCNc2cccc(-c3nc4c(C(N)=O)cccc4[nH]3)n2)CC1		CHEMBL2006237	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609015	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(C)(C(N)=O)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1967720	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609016	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NC1C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)CC12		CHEMBL1624529	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609017	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1nccn2c(C3CC(CN4CCCC4)C3)nc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL1991138	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609018	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1F		CHEMBL1969755	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609019	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1979516	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609020	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(N)C1CCC(C(=O)Nc2ccncc2)CC1		CHEMBL1994526	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609021	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(O)c1ccc(N2C(=O)c3ccccc3C2=O)cc1O		CHEMBL1972820	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609022	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	NNc1cc(N2CCOCC2)nc(OCCc2ccccn2)n1		CHEMBL1996208	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609023	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(C)OC1=NNC(=O)C1=Cc1c[nH]c2ccccc12		CHEMBL1989029	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609024	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CSc1ccccc1CNc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1		CHEMBL392642	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609025	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609026	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CN(C)CC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1965631	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9609027	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1ccccc1NC(=O)Nc1ccc(NC(=O)c2csc3ncnc(N)c23)cc1		CHEMBL1980144	=	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609028	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2OC)c1		CHEMBL1991188	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609029	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1972849	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609030	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1C#N		CHEMBL377408	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609031	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609032	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL231209	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609033	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(C)(C)OC(=O)n1cc(-c2cncn2C2CCCCC2)c2ccccc21		CHEMBL1975357	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609034	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c12		CHEMBL1976220	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609035	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609036	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CN1CCN(C2CCC(n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1997617	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609037	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CCN)nccn23)n1		CHEMBL1982383	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609038	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CCCCn1c(NC(=O)c2cccc(C#N)c2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL1969301	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609039	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17370	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609040	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4ccccc4C(F)(F)F)cc3)c12		CHEMBL1987910	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9609041	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1ccc2c(NC(=O)Nc3cccc(Br)n3)ccnc2c1		CHEMBL1983932	=	Ki	nM	5011.87	CHEMBL2208	Homo sapiens	pKi		5.3
inactive	9609042	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609043	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	c1ccc2c(c1)nnn2Cc1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL1966069	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609044	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609045	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cc2cc(-c3csc4c(-c5cccc(S(C)(=O)=O)c5)cnc(N)c34)ccc2[nH]1		CHEMBL1997822	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609046	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1cc(OCC2CCC(C(=O)O)C2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL1991285	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
active	9609047	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1		CHEMBL243088	=	Ki	nM	3162.28	CHEMBL2208	Homo sapiens	pKi		5.5
inactive	9609048	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609049	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl		CHEMBL1993661	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609050	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1cccc(F)c1F		CHEMBL1974416	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609051	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	CSc1nn(-c2ccccn2)c(N)c1C(N)=O		CHEMBL2004615	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609052	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	Cc1nn(C)c(C)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)O)[nH]c12		CHEMBL1984039	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609053	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
inactive	9609054	CHEMBL1963729	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2	F	O=C(c1cccc(-c2cnc3[nH]ccc3c2)c1)N1CCOCC1		CHEMBL1997872	<	Ki	nM	7943.28	CHEMBL2208	Homo sapiens	pKi		5.1
	10839393	CHEMBL2014959	Inhibition of MAPKAPK2 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	7.0	CHEMBL2208	Homo sapiens	INH	%	7.0
	10839616	CHEMBL2016281	Inhibition of MAPKAP-K2 assessed as residual activity at 1 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	115.0	CHEMBL2208	Homo sapiens	Activity	%	115.0
	10840378	CHEMBL2015149	Inhibition of MAPKAPK2- assessed as residual activity at 10 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	118.0	CHEMBL2208	Homo sapiens	Activity	%	118.0
	10850550	CHEMBL2019903	Inhibition of MK2 using Acam peptide as substrate incubated for 30 mins prior to substrate addition measured after 10 mins using 2 uM ATP by DELFIA assay	B	O=C(Nc1ccc(N2CCNCC2)cc1)c1ccc(-c2ccc(Cl)cc2)o1		CHEMBL1938680	=	IC50	nM	5000.0	CHEMBL2208	Homo sapiens	IC50	uM	5.0
	10850551	CHEMBL2019904	Inhibition of MK2 using Acam peptide as substrate incubated for 30 mins prior to substrate addition measured after 10 mins using 100 uM ATP by DELFIA assay	B	O=C(Nc1ccc(N2CCNCC2)cc1)c1ccc(-c2ccc(Cl)cc2)o1		CHEMBL1938680	=	IC50	nM	5500.0	CHEMBL2208	Homo sapiens	IC50	uM	5.5
	10850552	CHEMBL2019904	Inhibition of MK2 using Acam peptide as substrate incubated for 30 mins prior to substrate addition measured after 10 mins using 100 uM ATP by DELFIA assay	B	O=C(Nc1ccc(N2CCNCC2)cc1)c1ccc(-c2ccccc2Cl)o1		CHEMBL2017442	=	IC50	nM	8000.0	CHEMBL2208	Homo sapiens	IC50	uM	8.0
	10850553	CHEMBL2019904	Inhibition of MK2 using Acam peptide as substrate incubated for 30 mins prior to substrate addition measured after 10 mins using 100 uM ATP by DELFIA assay	B	O=C(Nc1ccc(N2CCNCC2)cc1)c1ccc(-c2cccc(Cl)c2)o1		CHEMBL2017443	>	IC50	nM	20000.0	CHEMBL2208	Homo sapiens	IC50	uM	20.0
	10850554	CHEMBL2019904	Inhibition of MK2 using Acam peptide as substrate incubated for 30 mins prior to substrate addition measured after 10 mins using 100 uM ATP by DELFIA assay	B	O=C(Nc1ccc(N2CCNCC2)cc1)c1ccc(-c2ccc(Cl)cc2Cl)o1		CHEMBL2017444	=	IC50	nM	7600.0	CHEMBL2208	Homo sapiens	IC50	uM	7.6
	10850555	CHEMBL2019904	Inhibition of MK2 using Acam peptide as substrate incubated for 30 mins prior to substrate addition measured after 10 mins using 100 uM ATP by DELFIA assay	B	Cc1cc(Cl)ccc1-c1ccc(C(=O)Nc2ccc(N3CCNCC3)cc2)o1		CHEMBL2017445	=	IC50	nM	5900.0	CHEMBL2208	Homo sapiens	IC50	uM	5.9
	10850556	CHEMBL2019904	Inhibition of MK2 using Acam peptide as substrate incubated for 30 mins prior to substrate addition measured after 10 mins using 100 uM ATP by DELFIA assay	B	O=C(Nc1ccc(N2CCNCC2)cc1)c1ccc(-c2ccc(C(F)(F)F)cc2)o1		CHEMBL2017446	=	IC50	nM	20000.0	CHEMBL2208	Homo sapiens	IC50	uM	20.0
	10850557	CHEMBL2019904	Inhibition of MK2 using Acam peptide as substrate incubated for 30 mins prior to substrate addition measured after 10 mins using 100 uM ATP by DELFIA assay	B	COc1ccc(-c2ccc(C(=O)Nc3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2017447	=	IC50	nM	22000.0	CHEMBL2208	Homo sapiens	IC50	uM	22.0
	10850558	CHEMBL2019904	Inhibition of MK2 using Acam peptide as substrate incubated for 30 mins prior to substrate addition measured after 10 mins using 100 uM ATP by DELFIA assay	B	O=C(Nc1ccc(N2CCNCC2)cc1)c1ccc(-c2ccc(Cl)s2)o1		CHEMBL2017448	=	IC50	nM	6900.0	CHEMBL2208	Homo sapiens	IC50	uM	6.9
	10850559	CHEMBL2019904	Inhibition of MK2 using Acam peptide as substrate incubated for 30 mins prior to substrate addition measured after 10 mins using 100 uM ATP by DELFIA assay	B	O=C(Nc1ccc(N2CCNCC2)c(F)c1)c1ccc(-c2ccc(Cl)cc2)o1		CHEMBL2017449	=	IC50	nM	6700.0	CHEMBL2208	Homo sapiens	IC50	uM	6.7
	10850560	CHEMBL2019904	Inhibition of MK2 using Acam peptide as substrate incubated for 30 mins prior to substrate addition measured after 10 mins using 100 uM ATP by DELFIA assay	B	O=C(Nc1ccc(N2CCNCC2)cc1C(F)(F)F)c1ccc(-c2ccc(Cl)cc2)o1		CHEMBL2017450	>	IC50	nM	20000.0	CHEMBL2208	Homo sapiens	IC50	uM	20.0
	10850561	CHEMBL2019904	Inhibition of MK2 using Acam peptide as substrate incubated for 30 mins prior to substrate addition measured after 10 mins using 100 uM ATP by DELFIA assay	B	CN1CCN(c2ccc(NC(=O)c3ccc(-c4ccc(Cl)cc4)o3)cc2)CC1		CHEMBL1392696	=	IC50	nM	6000.0	CHEMBL2208	Homo sapiens	IC50	uM	6.0
	10850562	CHEMBL2019904	Inhibition of MK2 using Acam peptide as substrate incubated for 30 mins prior to substrate addition measured after 10 mins using 100 uM ATP by DELFIA assay	B	O=C(Nc1ccc(N2CCC(O)CC2)cc1)c1ccc(-c2ccc(Cl)cc2)o1		CHEMBL2017451	>	IC50	nM	20000.0	CHEMBL2208	Homo sapiens	IC50	uM	20.0
	10850563	CHEMBL2019904	Inhibition of MK2 using Acam peptide as substrate incubated for 30 mins prior to substrate addition measured after 10 mins using 100 uM ATP by DELFIA assay	B	O=C(Nc1ccc(C2=CCNCC2)cc1)c1ccc(-c2ccc(Cl)cc2)o1		CHEMBL2017452	=	IC50	nM	2100.0	CHEMBL2208	Homo sapiens	IC50	uM	2.1
	10850564	CHEMBL2019904	Inhibition of MK2 using Acam peptide as substrate incubated for 30 mins prior to substrate addition measured after 10 mins using 100 uM ATP by DELFIA assay	B	O=C(Nc1ccc(N2CCNCC2=O)cc1)c1ccc(-c2ccc(Cl)cc2)o1		CHEMBL2017453	=	IC50	nM	15000.0	CHEMBL2208	Homo sapiens	IC50	uM	15.0
	10850565	CHEMBL2019904	Inhibition of MK2 using Acam peptide as substrate incubated for 30 mins prior to substrate addition measured after 10 mins using 100 uM ATP by DELFIA assay	B	O=C(Nc1ccc(N2CCNCC2)cc1)c1ccc(-c2ccc(Cl)cc2)s1		CHEMBL2017454	=	IC50	nM	9000.0	CHEMBL2208	Homo sapiens	IC50	uM	9.0
	10850566	CHEMBL2019904	Inhibition of MK2 using Acam peptide as substrate incubated for 30 mins prior to substrate addition measured after 10 mins using 100 uM ATP by DELFIA assay	B	O=C(Nc1ccc(N2CCNCC2)cc1)c1csc(-c2ccc(Cl)cc2)n1		CHEMBL2017455	=	IC50	nM	9500.0	CHEMBL2208	Homo sapiens	IC50	uM	9.5
	10850567	CHEMBL2019904	Inhibition of MK2 using Acam peptide as substrate incubated for 30 mins prior to substrate addition measured after 10 mins using 100 uM ATP by DELFIA assay	B	O=C(Nc1ccc(N2CCNCC2)cc1)c1cc(-c2ccc(Cl)cc2)on1		CHEMBL2017456	=	IC50	nM	7500.0	CHEMBL2208	Homo sapiens	IC50	uM	7.5
	10850568	CHEMBL2019904	Inhibition of MK2 using Acam peptide as substrate incubated for 30 mins prior to substrate addition measured after 10 mins using 100 uM ATP by DELFIA assay	B	O=C(Nc1ccc(N2CCNCC2)cc1)c1cccc(-c2ccc(Cl)cc2)n1		CHEMBL2017457	=	IC50	nM	11000.0	CHEMBL2208	Homo sapiens	IC50	uM	11.0
	10850569	CHEMBL2019904	Inhibition of MK2 using Acam peptide as substrate incubated for 30 mins prior to substrate addition measured after 10 mins using 100 uM ATP by DELFIA assay	B	CN(C(=O)c1ccc(-c2ccc(Cl)cc2)o1)c1ccc(N2CCNCC2)cc1		CHEMBL2017458	=	IC50	nM	600.0	CHEMBL2208	Homo sapiens	IC50	uM	0.6
	10850570	CHEMBL2019904	Inhibition of MK2 using Acam peptide as substrate incubated for 30 mins prior to substrate addition measured after 10 mins using 100 uM ATP by DELFIA assay	B	CCN(C(=O)c1ccc(-c2ccc(Cl)cc2)o1)c1ccc(N2CCNCC2)cc1		CHEMBL2017459	=	IC50	nM	130.0	CHEMBL2208	Homo sapiens	IC50	uM	0.13
	10850571	CHEMBL2019904	Inhibition of MK2 using Acam peptide as substrate incubated for 30 mins prior to substrate addition measured after 10 mins using 100 uM ATP by DELFIA assay	B	CCCN(C(=O)c1ccc(-c2ccc(Cl)cc2)o1)c1ccc(N2CCNCC2)cc1		CHEMBL2017460	=	IC50	nM	650.0	CHEMBL2208	Homo sapiens	IC50	uM	0.65
	10850572	CHEMBL2019904	Inhibition of MK2 using Acam peptide as substrate incubated for 30 mins prior to substrate addition measured after 10 mins using 100 uM ATP by DELFIA assay	B	CC(C)N(C(=O)c1ccc(-c2ccc(Cl)cc2)o1)c1ccc(N2CCNCC2)cc1		CHEMBL2017461	=	IC50	nM	1200.0	CHEMBL2208	Homo sapiens	IC50	uM	1.2
	10850573	CHEMBL2019904	Inhibition of MK2 using Acam peptide as substrate incubated for 30 mins prior to substrate addition measured after 10 mins using 100 uM ATP by DELFIA assay	B	CCCCN(C(=O)c1ccc(-c2ccc(Cl)cc2)o1)c1ccc(N2CCNCC2)cc1		CHEMBL2017462	=	IC50	nM	440.0	CHEMBL2208	Homo sapiens	IC50	uM	0.44
	10850574	CHEMBL2019904	Inhibition of MK2 using Acam peptide as substrate incubated for 30 mins prior to substrate addition measured after 10 mins using 100 uM ATP by DELFIA assay	B	Cn1ccnc1CN(C(=O)c1ccc(-c2ccc(Cl)cc2)o1)c1ccc(N2CCNCC2)cc1		CHEMBL2017463	=	IC50	nM	100.0	CHEMBL2208	Homo sapiens	IC50	uM	0.1
	10850575	CHEMBL2019904	Inhibition of MK2 using Acam peptide as substrate incubated for 30 mins prior to substrate addition measured after 10 mins using 100 uM ATP by DELFIA assay	B	O=C(c1ccc(-c2ccc(Cl)cc2)o1)N(Cc1ccccn1)c1ccc(N2CCNCC2)cc1		CHEMBL1938681	=	IC50	nM	110.0	CHEMBL2208	Homo sapiens	IC50	uM	0.11
	10850576	CHEMBL2019904	Inhibition of MK2 using Acam peptide as substrate incubated for 30 mins prior to substrate addition measured after 10 mins using 100 uM ATP by DELFIA assay	B	O=C(c1ccc(-c2ccc(Cl)cc2)o1)N(Cc1ccncc1)c1ccc(N2CCNCC2)cc1		CHEMBL2017619	=	IC50	nM	90.0	CHEMBL2208	Homo sapiens	IC50	uM	0.09
	10850577	CHEMBL2019905	Inhibition of MK2-mediated HSP27 phosphorylation in IL-1beta stimulated human SW1353 cells incubated for 30 mins prior to IL-1beta-stimulation measured after 27 mins by ELISA	B	O=C(Nc1ccc(N2CCNCC2)cc1)c1ccc(-c2ccc(Cl)cc2)o1		CHEMBL1938680	=	EC50	nM	2000.0	CHEMBL2208	Homo sapiens	EC50	uM	2.0
	10850578	CHEMBL2019905	Inhibition of MK2-mediated HSP27 phosphorylation in IL-1beta stimulated human SW1353 cells incubated for 30 mins prior to IL-1beta-stimulation measured after 27 mins by ELISA	B	O=C(Nc1ccc(N2CCNCC2)cc1)c1ccc(-c2ccccc2Cl)o1		CHEMBL2017442	>	EC50	nM	8000.0	CHEMBL2208	Homo sapiens	EC50	uM	8.0
	10850579	CHEMBL2019905	Inhibition of MK2-mediated HSP27 phosphorylation in IL-1beta stimulated human SW1353 cells incubated for 30 mins prior to IL-1beta-stimulation measured after 27 mins by ELISA	B	O=C(Nc1ccc(N2CCNCC2)cc1)c1ccc(-c2cccc(Cl)c2)o1		CHEMBL2017443	>	EC50	nM	5000.0	CHEMBL2208	Homo sapiens	EC50	uM	5.0
	10850580	CHEMBL2019905	Inhibition of MK2-mediated HSP27 phosphorylation in IL-1beta stimulated human SW1353 cells incubated for 30 mins prior to IL-1beta-stimulation measured after 27 mins by ELISA	B	O=C(Nc1ccc(N2CCNCC2)cc1)c1ccc(-c2ccc(Cl)cc2Cl)o1		CHEMBL2017444	=	EC50	nM	1600.0	CHEMBL2208	Homo sapiens	EC50	uM	1.6
	10850581	CHEMBL2019905	Inhibition of MK2-mediated HSP27 phosphorylation in IL-1beta stimulated human SW1353 cells incubated for 30 mins prior to IL-1beta-stimulation measured after 27 mins by ELISA	B	Cc1cc(Cl)ccc1-c1ccc(C(=O)Nc2ccc(N3CCNCC3)cc2)o1		CHEMBL2017445	=	EC50	nM	1400.0	CHEMBL2208	Homo sapiens	EC50	uM	1.4
	10850582	CHEMBL2019905	Inhibition of MK2-mediated HSP27 phosphorylation in IL-1beta stimulated human SW1353 cells incubated for 30 mins prior to IL-1beta-stimulation measured after 27 mins by ELISA	B	O=C(Nc1ccc(N2CCNCC2)cc1)c1ccc(-c2ccc(C(F)(F)F)cc2)o1		CHEMBL2017446	>	EC50	nM	7700.0	CHEMBL2208	Homo sapiens	EC50	uM	7.7
	10850583	CHEMBL2019905	Inhibition of MK2-mediated HSP27 phosphorylation in IL-1beta stimulated human SW1353 cells incubated for 30 mins prior to IL-1beta-stimulation measured after 27 mins by ELISA	B	COc1ccc(-c2ccc(C(=O)Nc3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2017447	=	EC50	nM	8000.0	CHEMBL2208	Homo sapiens	EC50	uM	8.0
	10850584	CHEMBL2019905	Inhibition of MK2-mediated HSP27 phosphorylation in IL-1beta stimulated human SW1353 cells incubated for 30 mins prior to IL-1beta-stimulation measured after 27 mins by ELISA	B	O=C(Nc1ccc(N2CCNCC2)cc1)c1ccc(-c2ccc(Cl)s2)o1		CHEMBL2017448	>	EC50	nM	8000.0	CHEMBL2208	Homo sapiens	EC50	uM	8.0
	10850585	CHEMBL2019905	Inhibition of MK2-mediated HSP27 phosphorylation in IL-1beta stimulated human SW1353 cells incubated for 30 mins prior to IL-1beta-stimulation measured after 27 mins by ELISA	B	O=C(Nc1ccc(N2CCNCC2)c(F)c1)c1ccc(-c2ccc(Cl)cc2)o1		CHEMBL2017449	>	EC50	nM	3400.0	CHEMBL2208	Homo sapiens	EC50	uM	3.4
	10850586	CHEMBL2019905	Inhibition of MK2-mediated HSP27 phosphorylation in IL-1beta stimulated human SW1353 cells incubated for 30 mins prior to IL-1beta-stimulation measured after 27 mins by ELISA	B	O=C(Nc1ccc(N2CCNCC2)cc1C(F)(F)F)c1ccc(-c2ccc(Cl)cc2)o1		CHEMBL2017450	>	EC50	nM	8000.0	CHEMBL2208	Homo sapiens	EC50	uM	8.0
	10850587	CHEMBL2019905	Inhibition of MK2-mediated HSP27 phosphorylation in IL-1beta stimulated human SW1353 cells incubated for 30 mins prior to IL-1beta-stimulation measured after 27 mins by ELISA	B	CN1CCN(c2ccc(NC(=O)c3ccc(-c4ccc(Cl)cc4)o3)cc2)CC1		CHEMBL1392696	=	EC50	nM	20000.0	CHEMBL2208	Homo sapiens	EC50	uM	20.0
Not Determined	10850588	CHEMBL2019905	Inhibition of MK2-mediated HSP27 phosphorylation in IL-1beta stimulated human SW1353 cells incubated for 30 mins prior to IL-1beta-stimulation measured after 27 mins by ELISA	B	O=C(Nc1ccc(N2CCC(O)CC2)cc1)c1ccc(-c2ccc(Cl)cc2)o1		CHEMBL2017451		EC50			CHEMBL2208	Homo sapiens	EC50		
	10850589	CHEMBL2019905	Inhibition of MK2-mediated HSP27 phosphorylation in IL-1beta stimulated human SW1353 cells incubated for 30 mins prior to IL-1beta-stimulation measured after 27 mins by ELISA	B	O=C(Nc1ccc(C2=CCNCC2)cc1)c1ccc(-c2ccc(Cl)cc2)o1		CHEMBL2017452	=	EC50	nM	1300.0	CHEMBL2208	Homo sapiens	EC50	uM	1.3
Not Determined	10850590	CHEMBL2019905	Inhibition of MK2-mediated HSP27 phosphorylation in IL-1beta stimulated human SW1353 cells incubated for 30 mins prior to IL-1beta-stimulation measured after 27 mins by ELISA	B	O=C(Nc1ccc(N2CCNCC2=O)cc1)c1ccc(-c2ccc(Cl)cc2)o1		CHEMBL2017453		EC50			CHEMBL2208	Homo sapiens	EC50		
	10850591	CHEMBL2019905	Inhibition of MK2-mediated HSP27 phosphorylation in IL-1beta stimulated human SW1353 cells incubated for 30 mins prior to IL-1beta-stimulation measured after 27 mins by ELISA	B	O=C(Nc1ccc(N2CCNCC2)cc1)c1ccc(-c2ccc(Cl)cc2)s1		CHEMBL2017454	=	EC50	nM	5000.0	CHEMBL2208	Homo sapiens	EC50	uM	5.0
	10850592	CHEMBL2019905	Inhibition of MK2-mediated HSP27 phosphorylation in IL-1beta stimulated human SW1353 cells incubated for 30 mins prior to IL-1beta-stimulation measured after 27 mins by ELISA	B	O=C(Nc1ccc(N2CCNCC2)cc1)c1csc(-c2ccc(Cl)cc2)n1		CHEMBL2017455	=	EC50	nM	900.0	CHEMBL2208	Homo sapiens	EC50	uM	0.9
	10850593	CHEMBL2019905	Inhibition of MK2-mediated HSP27 phosphorylation in IL-1beta stimulated human SW1353 cells incubated for 30 mins prior to IL-1beta-stimulation measured after 27 mins by ELISA	B	O=C(Nc1ccc(N2CCNCC2)cc1)c1cc(-c2ccc(Cl)cc2)on1		CHEMBL2017456	=	EC50	nM	1900.0	CHEMBL2208	Homo sapiens	EC50	uM	1.9
	10850594	CHEMBL2019905	Inhibition of MK2-mediated HSP27 phosphorylation in IL-1beta stimulated human SW1353 cells incubated for 30 mins prior to IL-1beta-stimulation measured after 27 mins by ELISA	B	O=C(Nc1ccc(N2CCNCC2)cc1)c1cccc(-c2ccc(Cl)cc2)n1		CHEMBL2017457	=	EC50	nM	3900.0	CHEMBL2208	Homo sapiens	EC50	uM	3.9
	10850595	CHEMBL2019905	Inhibition of MK2-mediated HSP27 phosphorylation in IL-1beta stimulated human SW1353 cells incubated for 30 mins prior to IL-1beta-stimulation measured after 27 mins by ELISA	B	CN(C(=O)c1ccc(-c2ccc(Cl)cc2)o1)c1ccc(N2CCNCC2)cc1		CHEMBL2017458	=	EC50	nM	9000.0	CHEMBL2208	Homo sapiens	EC50	uM	9.0
	10850596	CHEMBL2019905	Inhibition of MK2-mediated HSP27 phosphorylation in IL-1beta stimulated human SW1353 cells incubated for 30 mins prior to IL-1beta-stimulation measured after 27 mins by ELISA	B	CCN(C(=O)c1ccc(-c2ccc(Cl)cc2)o1)c1ccc(N2CCNCC2)cc1		CHEMBL2017459	=	EC50	nM	800.0	CHEMBL2208	Homo sapiens	EC50	uM	0.8
	10850597	CHEMBL2019905	Inhibition of MK2-mediated HSP27 phosphorylation in IL-1beta stimulated human SW1353 cells incubated for 30 mins prior to IL-1beta-stimulation measured after 27 mins by ELISA	B	CCCN(C(=O)c1ccc(-c2ccc(Cl)cc2)o1)c1ccc(N2CCNCC2)cc1		CHEMBL2017460	=	EC50	nM	3000.0	CHEMBL2208	Homo sapiens	EC50	uM	3.0
	10850598	CHEMBL2019905	Inhibition of MK2-mediated HSP27 phosphorylation in IL-1beta stimulated human SW1353 cells incubated for 30 mins prior to IL-1beta-stimulation measured after 27 mins by ELISA	B	CC(C)N(C(=O)c1ccc(-c2ccc(Cl)cc2)o1)c1ccc(N2CCNCC2)cc1		CHEMBL2017461	=	EC50	nM	2700.0	CHEMBL2208	Homo sapiens	EC50	uM	2.7
	10850599	CHEMBL2019905	Inhibition of MK2-mediated HSP27 phosphorylation in IL-1beta stimulated human SW1353 cells incubated for 30 mins prior to IL-1beta-stimulation measured after 27 mins by ELISA	B	CCCCN(C(=O)c1ccc(-c2ccc(Cl)cc2)o1)c1ccc(N2CCNCC2)cc1		CHEMBL2017462	=	EC50	nM	1800.0	CHEMBL2208	Homo sapiens	EC50	uM	1.8
	10850600	CHEMBL2019905	Inhibition of MK2-mediated HSP27 phosphorylation in IL-1beta stimulated human SW1353 cells incubated for 30 mins prior to IL-1beta-stimulation measured after 27 mins by ELISA	B	Cn1ccnc1CN(C(=O)c1ccc(-c2ccc(Cl)cc2)o1)c1ccc(N2CCNCC2)cc1		CHEMBL2017463	=	EC50	nM	4000.0	CHEMBL2208	Homo sapiens	EC50	uM	4.0
	10850601	CHEMBL2019905	Inhibition of MK2-mediated HSP27 phosphorylation in IL-1beta stimulated human SW1353 cells incubated for 30 mins prior to IL-1beta-stimulation measured after 27 mins by ELISA	B	O=C(c1ccc(-c2ccc(Cl)cc2)o1)N(Cc1ccccn1)c1ccc(N2CCNCC2)cc1		CHEMBL1938681	=	EC50	nM	350.0	CHEMBL2208	Homo sapiens	EC50	uM	0.35
	10850602	CHEMBL2019905	Inhibition of MK2-mediated HSP27 phosphorylation in IL-1beta stimulated human SW1353 cells incubated for 30 mins prior to IL-1beta-stimulation measured after 27 mins by ELISA	B	O=C(c1ccc(-c2ccc(Cl)cc2)o1)N(Cc1ccncc1)c1ccc(N2CCNCC2)cc1		CHEMBL2017619	=	EC50	nM	530.0	CHEMBL2208	Homo sapiens	EC50	uM	0.53
Active	10850648	CHEMBL2019983	Non-competitive inhibition of MK2 using Acam peptide as substrate in presence of 100 uM ATP	B	O=C(Nc1ccc(N2CCNCC2)cc1)c1ccc(-c2ccc(Cl)cc2)o1		CHEMBL1938680		Inhibition	%		CHEMBL2208	Homo sapiens	INH		
Active	10850653	CHEMBL2019988	Binding affinity to MK2 at 50 uM after 2 hrs by NMR spectrophotometry in the presence of 225 uM ATP	B	O=C(Nc1ccc(N2CCNCC2)cc1)c1ccc(-c2ccc(Cl)cc2)o1		CHEMBL1938680		Activity			CHEMBL2208	Homo sapiens	Activity		
	10867557	CHEMBL2026612	Inhibition of MK2 by filter binding assay	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	IC50	nM	5000.0	CHEMBL2208	Homo sapiens	IC50	uM	5.0
	10902439	CHEMBL2040538	Inhibition of MK2 using 5TAMRA-KKLNRTLSVA-COOH as substrate incubated for 30 mins prior to substrate addition measured after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay in presence of 100 uM ATP	B	O=C(c1ccc(-c2ccc(Cl)cc2)o1)N(Cc1ccccn1)c1ccc(N2CCNCC2)cc1		CHEMBL1938681	=	IC50	nM	110.0	CHEMBL2208	Homo sapiens	IC50	nM	110.0
	10902440	CHEMBL2040538	Inhibition of MK2 using 5TAMRA-KKLNRTLSVA-COOH as substrate incubated for 30 mins prior to substrate addition measured after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay in presence of 100 uM ATP	B	Clc1ccc(-c2ccc(-c3nocc3-c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036449	=	IC50	nM	3400.0	CHEMBL2208	Homo sapiens	IC50	nM	3400.0
	10902441	CHEMBL2040538	Inhibition of MK2 using 5TAMRA-KKLNRTLSVA-COOH as substrate incubated for 30 mins prior to substrate addition measured after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay in presence of 100 uM ATP	B	Clc1ccc(-c2ccc(-c3cc(-c4ccc(N5CCNCC5)cc4)on3)o2)cc1		CHEMBL2036450	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	nM	10000.0
	10902442	CHEMBL2040538	Inhibition of MK2 using 5TAMRA-KKLNRTLSVA-COOH as substrate incubated for 30 mins prior to substrate addition measured after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay in presence of 100 uM ATP	B	O=c1onc(-c2ccc(-c3ccc(Cl)cc3)o2)n1-c1ccc(N2CCNCC2)cc1		CHEMBL2036451	=	IC50	nM	6200.0	CHEMBL2208	Homo sapiens	IC50	nM	6200.0
	10902443	CHEMBL2040538	Inhibition of MK2 using 5TAMRA-KKLNRTLSVA-COOH as substrate incubated for 30 mins prior to substrate addition measured after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay in presence of 100 uM ATP	B	Clc1ccc(-c2ccc(C3=NOC(c4ccccc4)N3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036452	=	IC50	nM	50.0	CHEMBL2208	Homo sapiens	IC50	nM	50.0
	10902444	CHEMBL2040538	Inhibition of MK2 using 5TAMRA-KKLNRTLSVA-COOH as substrate incubated for 30 mins prior to substrate addition measured after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay in presence of 100 uM ATP	B	Clc1ccc(-c2ccc(C3ON=C(c4ccccc4)N3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036453	=	IC50	nM	3700.0	CHEMBL2208	Homo sapiens	IC50	nM	3700.0
	10902445	CHEMBL2040538	Inhibition of MK2 using 5TAMRA-KKLNRTLSVA-COOH as substrate incubated for 30 mins prior to substrate addition measured after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay in presence of 100 uM ATP	B	N#Cc1ccc(-c2ccc(C3=NOCCN3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036454	=	IC50	nM	110.0	CHEMBL2208	Homo sapiens	IC50	nM	110.0
	10902446	CHEMBL2040538	Inhibition of MK2 using 5TAMRA-KKLNRTLSVA-COOH as substrate incubated for 30 mins prior to substrate addition measured after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay in presence of 100 uM ATP	B	Clc1ccc(-c2ccc(C3=NOCCCN3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036455	=	IC50	nM	1400.0	CHEMBL2208	Homo sapiens	IC50	nM	1400.0
	10902447	CHEMBL2040538	Inhibition of MK2 using 5TAMRA-KKLNRTLSVA-COOH as substrate incubated for 30 mins prior to substrate addition measured after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay in presence of 100 uM ATP	B	Clc1ccc(-c2ccc(C3=NOC(c4ccccn4)N3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036456	=	IC50	nM	30.0	CHEMBL2208	Homo sapiens	IC50	nM	30.0
	10902448	CHEMBL2040538	Inhibition of MK2 using 5TAMRA-KKLNRTLSVA-COOH as substrate incubated for 30 mins prior to substrate addition measured after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay in presence of 100 uM ATP	B	Clc1ccc(-c2ccc(C3=NOC(c4cccnc4)N3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036457	=	IC50	nM	50.0	CHEMBL2208	Homo sapiens	IC50	nM	50.0
	10902449	CHEMBL2040538	Inhibition of MK2 using 5TAMRA-KKLNRTLSVA-COOH as substrate incubated for 30 mins prior to substrate addition measured after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay in presence of 100 uM ATP	B	Clc1ccc(-c2ccc(C3=NOC(c4ccncc4)N3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036458	=	IC50	nM	30.0	CHEMBL2208	Homo sapiens	IC50	nM	30.0
	10902450	CHEMBL2040538	Inhibition of MK2 using 5TAMRA-KKLNRTLSVA-COOH as substrate incubated for 30 mins prior to substrate addition measured after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay in presence of 100 uM ATP	B	Fc1ccc(C2ON=C(c3ccc(-c4ccc(Cl)cc4)o3)N2c2ccc(N3CCNCC3)cc2)nc1		CHEMBL2036459	=	IC50	nM	60.0	CHEMBL2208	Homo sapiens	IC50	nM	60.0
	10902451	CHEMBL2040538	Inhibition of MK2 using 5TAMRA-KKLNRTLSVA-COOH as substrate incubated for 30 mins prior to substrate addition measured after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay in presence of 100 uM ATP	B	Clc1ccc(-c2ccc(C3=NOC(c4ccncn4)N3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036460	=	IC50	nM	60.0	CHEMBL2208	Homo sapiens	IC50	nM	60.0
	10902452	CHEMBL2040538	Inhibition of MK2 using 5TAMRA-KKLNRTLSVA-COOH as substrate incubated for 30 mins prior to substrate addition measured after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay in presence of 100 uM ATP	B	Clc1ccc(-c2ccc(C3=NOC(c4cncnc4)N3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036461	=	IC50	nM	70.0	CHEMBL2208	Homo sapiens	IC50	nM	70.0
	10902453	CHEMBL2040538	Inhibition of MK2 using 5TAMRA-KKLNRTLSVA-COOH as substrate incubated for 30 mins prior to substrate addition measured after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay in presence of 100 uM ATP	B	Fc1ccc(C2ON=C(c3ccc(-c4ccc(Cl)cc4)o3)N2c2ccc(N3CCNCC3)cc2)cc1		CHEMBL2036598	=	IC50	nM	160.0	CHEMBL2208	Homo sapiens	IC50	nM	160.0
	10902454	CHEMBL2040538	Inhibition of MK2 using 5TAMRA-KKLNRTLSVA-COOH as substrate incubated for 30 mins prior to substrate addition measured after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay in presence of 100 uM ATP	B	Fc1ccc(C2ON=C(c3ccc(-c4ccc(Cl)cc4)o3)N2c2ccc(N3CCNCC3)cc2)c(F)c1		CHEMBL2036599	=	IC50	nM	100.0	CHEMBL2208	Homo sapiens	IC50	nM	100.0
	10902455	CHEMBL2040538	Inhibition of MK2 using 5TAMRA-KKLNRTLSVA-COOH as substrate incubated for 30 mins prior to substrate addition measured after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay in presence of 100 uM ATP	B	Fc1cc(F)cc(C2ON=C(c3ccc(-c4ccc(Cl)cc4)o3)N2c2ccc(N3CCNCC3)cc2)c1		CHEMBL2036600	=	IC50	nM	190.0	CHEMBL2208	Homo sapiens	IC50	nM	190.0
	10902456	CHEMBL2040538	Inhibition of MK2 using 5TAMRA-KKLNRTLSVA-COOH as substrate incubated for 30 mins prior to substrate addition measured after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay in presence of 100 uM ATP	B	Clc1ccc(-c2ccc(C3=NOC(c4c[nH]cn4)N3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036601	=	IC50	nM	70.0	CHEMBL2208	Homo sapiens	IC50	nM	70.0
	10902457	CHEMBL2040538	Inhibition of MK2 using 5TAMRA-KKLNRTLSVA-COOH as substrate incubated for 30 mins prior to substrate addition measured after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay in presence of 100 uM ATP	B	Clc1ccc(-c2ccc(C3=NOC(c4cnc(-c5ccccc5)nc4)N3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036602	=	IC50	nM	1200.0	CHEMBL2208	Homo sapiens	IC50	nM	1200.0
	10902458	CHEMBL2040538	Inhibition of MK2 using 5TAMRA-KKLNRTLSVA-COOH as substrate incubated for 30 mins prior to substrate addition measured after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay in presence of 100 uM ATP	B	Clc1ccc(-c2ccc(C3=NOC(c4ccc(-c5ncccn5)cc4)N3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036603	=	IC50	nM	330.0	CHEMBL2208	Homo sapiens	IC50	nM	330.0
	10902459	CHEMBL2040538	Inhibition of MK2 using 5TAMRA-KKLNRTLSVA-COOH as substrate incubated for 30 mins prior to substrate addition measured after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay in presence of 100 uM ATP	B	Clc1ccc(-c2ccc(C3=NOC(c4ccc(-c5cncnc5)cc4)N3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036604	=	IC50	nM	100.0	CHEMBL2208	Homo sapiens	IC50	nM	100.0
	10902460	CHEMBL2040538	Inhibition of MK2 using 5TAMRA-KKLNRTLSVA-COOH as substrate incubated for 30 mins prior to substrate addition measured after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay in presence of 100 uM ATP	B	Clc1ccc(-c2ccc(C3=NOC(c4cccc(-c5cncnc5)c4)N3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036605	=	IC50	nM	380.0	CHEMBL2208	Homo sapiens	IC50	nM	380.0
	10902461	CHEMBL2040538	Inhibition of MK2 using 5TAMRA-KKLNRTLSVA-COOH as substrate incubated for 30 mins prior to substrate addition measured after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay in presence of 100 uM ATP	B	Clc1ccc(-c2ccc(C3=NOC(c4ccccc4-c4cncnc4)N3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036606	=	IC50	nM	40.0	CHEMBL2208	Homo sapiens	IC50	nM	40.0
	10902462	CHEMBL2040538	Inhibition of MK2 using 5TAMRA-KKLNRTLSVA-COOH as substrate incubated for 30 mins prior to substrate addition measured after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay in presence of 100 uM ATP	B	Clc1ccc(-c2ccc(C3=NOC(c4ccccc4-c4cccnc4)N3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036607	=	IC50	nM	180.0	CHEMBL2208	Homo sapiens	IC50	nM	180.0
	10902463	CHEMBL2040538	Inhibition of MK2 using 5TAMRA-KKLNRTLSVA-COOH as substrate incubated for 30 mins prior to substrate addition measured after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay in presence of 100 uM ATP	B	Clc1ccc(-c2ccc(C3=NOC(c4ccccc4-c4ccccc4)N3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036608	=	IC50	nM	480.0	CHEMBL2208	Homo sapiens	IC50	nM	480.0
	10902464	CHEMBL2040538	Inhibition of MK2 using 5TAMRA-KKLNRTLSVA-COOH as substrate incubated for 30 mins prior to substrate addition measured after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay in presence of 100 uM ATP	B	Clc1cccc(-c2ccc(C3=NOC(c4ccccc4-c4cncnc4)N3c3ccc(N4CCNCC4)cc3)o2)c1		CHEMBL2036609	=	IC50	nM	1300.0	CHEMBL2208	Homo sapiens	IC50	nM	1300.0
	10902465	CHEMBL2040538	Inhibition of MK2 using 5TAMRA-KKLNRTLSVA-COOH as substrate incubated for 30 mins prior to substrate addition measured after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay in presence of 100 uM ATP	B	Fc1ccc(-c2ccc(C3=NOC(c4ccccc4-c4cncnc4)N3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036610	=	IC50	nM	50.0	CHEMBL2208	Homo sapiens	IC50	nM	50.0
	10902466	CHEMBL2040538	Inhibition of MK2 using 5TAMRA-KKLNRTLSVA-COOH as substrate incubated for 30 mins prior to substrate addition measured after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay in presence of 100 uM ATP	B	Clc1ccc(-c2ccc(C3=NOC(c4ccccc4-c4cncnc4)N3c3ccc(N4CCNCC4)cc3)o2)cc1Cl		CHEMBL2036611	=	IC50	nM	970.0	CHEMBL2208	Homo sapiens	IC50	nM	970.0
	10902467	CHEMBL2040538	Inhibition of MK2 using 5TAMRA-KKLNRTLSVA-COOH as substrate incubated for 30 mins prior to substrate addition measured after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay in presence of 100 uM ATP	B	Fc1cc(-c2ccc(C3=NOC(c4ccccc4-c4cncnc4)N3c3ccc(N4CCNCC4)cc3)o2)ccc1Cl		CHEMBL2036612	=	IC50	nM	220.0	CHEMBL2208	Homo sapiens	IC50	nM	220.0
	10902468	CHEMBL2040538	Inhibition of MK2 using 5TAMRA-KKLNRTLSVA-COOH as substrate incubated for 30 mins prior to substrate addition measured after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay in presence of 100 uM ATP	B	c1ccc(C2ON=C(c3ccc(-c4ccncc4)o3)N2c2ccc(N3CCNCC3)cc2)c(-c2cncnc2)c1		CHEMBL2036613	=	IC50	nM	790.0	CHEMBL2208	Homo sapiens	IC50	nM	790.0
	10902469	CHEMBL2040538	Inhibition of MK2 using 5TAMRA-KKLNRTLSVA-COOH as substrate incubated for 30 mins prior to substrate addition measured after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay in presence of 100 uM ATP	B	COc1ccc(-c2ccc(C3=NOC(c4ccccc4-c4cncnc4)N3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036614	=	IC50	nM	310.0	CHEMBL2208	Homo sapiens	IC50	nM	310.0
	10902470	CHEMBL2040538	Inhibition of MK2 using 5TAMRA-KKLNRTLSVA-COOH as substrate incubated for 30 mins prior to substrate addition measured after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay in presence of 100 uM ATP	B	CNC(=O)c1ccc(-c2ccc(C3=NOC(c4ccccc4-c4cncnc4)N3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036615	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	nM	10000.0
	10902471	CHEMBL2040538	Inhibition of MK2 using 5TAMRA-KKLNRTLSVA-COOH as substrate incubated for 30 mins prior to substrate addition measured after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay in presence of 100 uM ATP	B	N#Cc1ccc(-c2ccc(C3=NOC(c4ccccc4-c4cncnc4)N3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036616	=	IC50	nM	8.0	CHEMBL2208	Homo sapiens	IC50	nM	8.0
	10902472	CHEMBL2040538	Inhibition of MK2 using 5TAMRA-KKLNRTLSVA-COOH as substrate incubated for 30 mins prior to substrate addition measured after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay in presence of 100 uM ATP	B	N#Cc1cccc(-c2ccc(C3=NOC(c4ccccc4-c4cncnc4)N3c3ccc(N4CCNCC4)cc3)o2)c1		CHEMBL2036617	=	IC50	nM	5300.0	CHEMBL2208	Homo sapiens	IC50	nM	5300.0
	10902473	CHEMBL2040538	Inhibition of MK2 using 5TAMRA-KKLNRTLSVA-COOH as substrate incubated for 30 mins prior to substrate addition measured after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay in presence of 100 uM ATP	B	Clc1ccc(-c2ccc(C3=NOC(c4ccncc4)N3c3ccc(C4CCNCC4)cc3)o2)cc1		CHEMBL2036618	=	IC50	nM	190.0	CHEMBL2208	Homo sapiens	IC50	nM	190.0
	10902474	CHEMBL2040538	Inhibition of MK2 using 5TAMRA-KKLNRTLSVA-COOH as substrate incubated for 30 mins prior to substrate addition measured after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay in presence of 100 uM ATP	B	FC1(F)CCN(c2ccc(N3C(c4ccc(-c5ccc(Cl)cc5)o4)=NOC3c3ccncc3)cc2)CC1		CHEMBL2036619	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	nM	10000.0
	10902475	CHEMBL2040538	Inhibition of MK2 using 5TAMRA-KKLNRTLSVA-COOH as substrate incubated for 30 mins prior to substrate addition measured after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay in presence of 100 uM ATP	B	Clc1ccc(-c2ccc(C3=NOC(c4ccncc4)N3Cc3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036620	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	nM	10000.0
	10902476	CHEMBL2040538	Inhibition of MK2 using 5TAMRA-KKLNRTLSVA-COOH as substrate incubated for 30 mins prior to substrate addition measured after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay in presence of 100 uM ATP	B	N#Cc1ccc(-c2ccc(C3=NOC(c4ccccc4-c4cncnc4)N3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036616	=	IC50	nM	6.0	CHEMBL2208	Homo sapiens	IC50	nM	6.0
	10902477	CHEMBL2040538	Inhibition of MK2 using 5TAMRA-KKLNRTLSVA-COOH as substrate incubated for 30 mins prior to substrate addition measured after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay in presence of 100 uM ATP	B	N#Cc1ccc(-c2ccc(C3=NOC(c4ccccc4-c4cncnc4)N3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036616	=	IC50	nM	340.0	CHEMBL2208	Homo sapiens	IC50	nM	340.0
	10902478	CHEMBL2040539	Inhibition of MK2 in human THP1 cells assessed as inhibition of LPS-induced HSP27 Ser78 phosphorylation incubated for 60 mins prior to LPS-induction measured after 60 mins	B	O=C(c1ccc(-c2ccc(Cl)cc2)o1)N(Cc1ccccn1)c1ccc(N2CCNCC2)cc1		CHEMBL1938681	=	EC50	nM	350.0	CHEMBL2208	Homo sapiens	EC50	nM	350.0
Not Determined	10902479	CHEMBL2040539	Inhibition of MK2 in human THP1 cells assessed as inhibition of LPS-induced HSP27 Ser78 phosphorylation incubated for 60 mins prior to LPS-induction measured after 60 mins	B	Clc1ccc(-c2ccc(-c3nocc3-c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036449		EC50			CHEMBL2208	Homo sapiens	EC50		
Not Determined	10902480	CHEMBL2040539	Inhibition of MK2 in human THP1 cells assessed as inhibition of LPS-induced HSP27 Ser78 phosphorylation incubated for 60 mins prior to LPS-induction measured after 60 mins	B	Clc1ccc(-c2ccc(-c3cc(-c4ccc(N5CCNCC5)cc4)on3)o2)cc1		CHEMBL2036450		EC50			CHEMBL2208	Homo sapiens	EC50		
Not Determined	10902481	CHEMBL2040539	Inhibition of MK2 in human THP1 cells assessed as inhibition of LPS-induced HSP27 Ser78 phosphorylation incubated for 60 mins prior to LPS-induction measured after 60 mins	B	O=c1onc(-c2ccc(-c3ccc(Cl)cc3)o2)n1-c1ccc(N2CCNCC2)cc1		CHEMBL2036451		EC50			CHEMBL2208	Homo sapiens	EC50		
	10902482	CHEMBL2040539	Inhibition of MK2 in human THP1 cells assessed as inhibition of LPS-induced HSP27 Ser78 phosphorylation incubated for 60 mins prior to LPS-induction measured after 60 mins	B	Clc1ccc(-c2ccc(C3=NOC(c4ccccc4)N3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036452	=	EC50	nM	6700.0	CHEMBL2208	Homo sapiens	EC50	nM	6700.0
Not Determined	10902483	CHEMBL2040539	Inhibition of MK2 in human THP1 cells assessed as inhibition of LPS-induced HSP27 Ser78 phosphorylation incubated for 60 mins prior to LPS-induction measured after 60 mins	B	Clc1ccc(-c2ccc(C3ON=C(c4ccccc4)N3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036453		EC50			CHEMBL2208	Homo sapiens	EC50		
Not Determined	10902484	CHEMBL2040539	Inhibition of MK2 in human THP1 cells assessed as inhibition of LPS-induced HSP27 Ser78 phosphorylation incubated for 60 mins prior to LPS-induction measured after 60 mins	B	N#Cc1ccc(-c2ccc(C3=NOCCN3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036454		EC50			CHEMBL2208	Homo sapiens	EC50		
Not Determined	10902485	CHEMBL2040539	Inhibition of MK2 in human THP1 cells assessed as inhibition of LPS-induced HSP27 Ser78 phosphorylation incubated for 60 mins prior to LPS-induction measured after 60 mins	B	Clc1ccc(-c2ccc(C3=NOCCCN3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036455		EC50			CHEMBL2208	Homo sapiens	EC50		
	10902486	CHEMBL2040539	Inhibition of MK2 in human THP1 cells assessed as inhibition of LPS-induced HSP27 Ser78 phosphorylation incubated for 60 mins prior to LPS-induction measured after 60 mins	B	Clc1ccc(-c2ccc(C3=NOC(c4ccccn4)N3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036456	=	EC50	nM	3000.0	CHEMBL2208	Homo sapiens	EC50	nM	3000.0
Not Determined	10902487	CHEMBL2040539	Inhibition of MK2 in human THP1 cells assessed as inhibition of LPS-induced HSP27 Ser78 phosphorylation incubated for 60 mins prior to LPS-induction measured after 60 mins	B	Clc1ccc(-c2ccc(C3=NOC(c4cccnc4)N3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036457		EC50			CHEMBL2208	Homo sapiens	EC50		
	10902488	CHEMBL2040539	Inhibition of MK2 in human THP1 cells assessed as inhibition of LPS-induced HSP27 Ser78 phosphorylation incubated for 60 mins prior to LPS-induction measured after 60 mins	B	Clc1ccc(-c2ccc(C3=NOC(c4ccncc4)N3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036458	=	EC50	nM	2700.0	CHEMBL2208	Homo sapiens	EC50	nM	2700.0
	10902489	CHEMBL2040539	Inhibition of MK2 in human THP1 cells assessed as inhibition of LPS-induced HSP27 Ser78 phosphorylation incubated for 60 mins prior to LPS-induction measured after 60 mins	B	Fc1ccc(C2ON=C(c3ccc(-c4ccc(Cl)cc4)o3)N2c2ccc(N3CCNCC3)cc2)nc1		CHEMBL2036459	=	EC50	nM	3700.0	CHEMBL2208	Homo sapiens	EC50	nM	3700.0
Not Determined	10902490	CHEMBL2040539	Inhibition of MK2 in human THP1 cells assessed as inhibition of LPS-induced HSP27 Ser78 phosphorylation incubated for 60 mins prior to LPS-induction measured after 60 mins	B	Clc1ccc(-c2ccc(C3=NOC(c4ccncn4)N3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036460		EC50			CHEMBL2208	Homo sapiens	EC50		
Not Determined	10902491	CHEMBL2040539	Inhibition of MK2 in human THP1 cells assessed as inhibition of LPS-induced HSP27 Ser78 phosphorylation incubated for 60 mins prior to LPS-induction measured after 60 mins	B	Clc1ccc(-c2ccc(C3=NOC(c4cncnc4)N3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036461		EC50			CHEMBL2208	Homo sapiens	EC50		
Not Determined	10902492	CHEMBL2040539	Inhibition of MK2 in human THP1 cells assessed as inhibition of LPS-induced HSP27 Ser78 phosphorylation incubated for 60 mins prior to LPS-induction measured after 60 mins	B	Fc1ccc(C2ON=C(c3ccc(-c4ccc(Cl)cc4)o3)N2c2ccc(N3CCNCC3)cc2)cc1		CHEMBL2036598		EC50			CHEMBL2208	Homo sapiens	EC50		
Not Determined	10902493	CHEMBL2040539	Inhibition of MK2 in human THP1 cells assessed as inhibition of LPS-induced HSP27 Ser78 phosphorylation incubated for 60 mins prior to LPS-induction measured after 60 mins	B	Fc1ccc(C2ON=C(c3ccc(-c4ccc(Cl)cc4)o3)N2c2ccc(N3CCNCC3)cc2)c(F)c1		CHEMBL2036599		EC50			CHEMBL2208	Homo sapiens	EC50		
Not Determined	10902494	CHEMBL2040539	Inhibition of MK2 in human THP1 cells assessed as inhibition of LPS-induced HSP27 Ser78 phosphorylation incubated for 60 mins prior to LPS-induction measured after 60 mins	B	Fc1cc(F)cc(C2ON=C(c3ccc(-c4ccc(Cl)cc4)o3)N2c2ccc(N3CCNCC3)cc2)c1		CHEMBL2036600		EC50			CHEMBL2208	Homo sapiens	EC50		
	10902495	CHEMBL2040539	Inhibition of MK2 in human THP1 cells assessed as inhibition of LPS-induced HSP27 Ser78 phosphorylation incubated for 60 mins prior to LPS-induction measured after 60 mins	B	Clc1ccc(-c2ccc(C3=NOC(c4c[nH]cn4)N3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036601	=	EC50	nM	2400.0	CHEMBL2208	Homo sapiens	EC50	nM	2400.0
Not Determined	10902496	CHEMBL2040539	Inhibition of MK2 in human THP1 cells assessed as inhibition of LPS-induced HSP27 Ser78 phosphorylation incubated for 60 mins prior to LPS-induction measured after 60 mins	B	Clc1ccc(-c2ccc(C3=NOC(c4cnc(-c5ccccc5)nc4)N3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036602		EC50			CHEMBL2208	Homo sapiens	EC50		
Not Determined	10902497	CHEMBL2040539	Inhibition of MK2 in human THP1 cells assessed as inhibition of LPS-induced HSP27 Ser78 phosphorylation incubated for 60 mins prior to LPS-induction measured after 60 mins	B	Clc1ccc(-c2ccc(C3=NOC(c4ccc(-c5ncccn5)cc4)N3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036603		EC50			CHEMBL2208	Homo sapiens	EC50		
	10902498	CHEMBL2040539	Inhibition of MK2 in human THP1 cells assessed as inhibition of LPS-induced HSP27 Ser78 phosphorylation incubated for 60 mins prior to LPS-induction measured after 60 mins	B	Clc1ccc(-c2ccc(C3=NOC(c4ccc(-c5cncnc5)cc4)N3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036604	=	EC50	nM	820.0	CHEMBL2208	Homo sapiens	EC50	nM	820.0
Not Determined	10902499	CHEMBL2040539	Inhibition of MK2 in human THP1 cells assessed as inhibition of LPS-induced HSP27 Ser78 phosphorylation incubated for 60 mins prior to LPS-induction measured after 60 mins	B	Clc1ccc(-c2ccc(C3=NOC(c4cccc(-c5cncnc5)c4)N3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036605		EC50			CHEMBL2208	Homo sapiens	EC50		
	10902500	CHEMBL2040539	Inhibition of MK2 in human THP1 cells assessed as inhibition of LPS-induced HSP27 Ser78 phosphorylation incubated for 60 mins prior to LPS-induction measured after 60 mins	B	Clc1ccc(-c2ccc(C3=NOC(c4ccccc4-c4cncnc4)N3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036606	=	EC50	nM	730.0	CHEMBL2208	Homo sapiens	EC50	nM	730.0
Not Determined	10902501	CHEMBL2040539	Inhibition of MK2 in human THP1 cells assessed as inhibition of LPS-induced HSP27 Ser78 phosphorylation incubated for 60 mins prior to LPS-induction measured after 60 mins	B	Clc1ccc(-c2ccc(C3=NOC(c4ccccc4-c4cccnc4)N3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036607		EC50			CHEMBL2208	Homo sapiens	EC50		
Not Determined	10902502	CHEMBL2040539	Inhibition of MK2 in human THP1 cells assessed as inhibition of LPS-induced HSP27 Ser78 phosphorylation incubated for 60 mins prior to LPS-induction measured after 60 mins	B	Clc1ccc(-c2ccc(C3=NOC(c4ccccc4-c4ccccc4)N3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036608		EC50			CHEMBL2208	Homo sapiens	EC50		
Not Determined	10902503	CHEMBL2040539	Inhibition of MK2 in human THP1 cells assessed as inhibition of LPS-induced HSP27 Ser78 phosphorylation incubated for 60 mins prior to LPS-induction measured after 60 mins	B	Clc1cccc(-c2ccc(C3=NOC(c4ccccc4-c4cncnc4)N3c3ccc(N4CCNCC4)cc3)o2)c1		CHEMBL2036609		EC50			CHEMBL2208	Homo sapiens	EC50		
	10902504	CHEMBL2040539	Inhibition of MK2 in human THP1 cells assessed as inhibition of LPS-induced HSP27 Ser78 phosphorylation incubated for 60 mins prior to LPS-induction measured after 60 mins	B	Fc1ccc(-c2ccc(C3=NOC(c4ccccc4-c4cncnc4)N3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036610	=	EC50	nM	760.0	CHEMBL2208	Homo sapiens	EC50	nM	760.0
Not Determined	10902505	CHEMBL2040539	Inhibition of MK2 in human THP1 cells assessed as inhibition of LPS-induced HSP27 Ser78 phosphorylation incubated for 60 mins prior to LPS-induction measured after 60 mins	B	Clc1ccc(-c2ccc(C3=NOC(c4ccccc4-c4cncnc4)N3c3ccc(N4CCNCC4)cc3)o2)cc1Cl		CHEMBL2036611		EC50			CHEMBL2208	Homo sapiens	EC50		
Not Determined	10902506	CHEMBL2040539	Inhibition of MK2 in human THP1 cells assessed as inhibition of LPS-induced HSP27 Ser78 phosphorylation incubated for 60 mins prior to LPS-induction measured after 60 mins	B	Fc1cc(-c2ccc(C3=NOC(c4ccccc4-c4cncnc4)N3c3ccc(N4CCNCC4)cc3)o2)ccc1Cl		CHEMBL2036612		EC50			CHEMBL2208	Homo sapiens	EC50		
Not Determined	10902507	CHEMBL2040539	Inhibition of MK2 in human THP1 cells assessed as inhibition of LPS-induced HSP27 Ser78 phosphorylation incubated for 60 mins prior to LPS-induction measured after 60 mins	B	c1ccc(C2ON=C(c3ccc(-c4ccncc4)o3)N2c2ccc(N3CCNCC3)cc2)c(-c2cncnc2)c1		CHEMBL2036613		EC50			CHEMBL2208	Homo sapiens	EC50		
Not Determined	10902508	CHEMBL2040539	Inhibition of MK2 in human THP1 cells assessed as inhibition of LPS-induced HSP27 Ser78 phosphorylation incubated for 60 mins prior to LPS-induction measured after 60 mins	B	COc1ccc(-c2ccc(C3=NOC(c4ccccc4-c4cncnc4)N3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036614		EC50			CHEMBL2208	Homo sapiens	EC50		
Not Determined	10902509	CHEMBL2040539	Inhibition of MK2 in human THP1 cells assessed as inhibition of LPS-induced HSP27 Ser78 phosphorylation incubated for 60 mins prior to LPS-induction measured after 60 mins	B	CNC(=O)c1ccc(-c2ccc(C3=NOC(c4ccccc4-c4cncnc4)N3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036615		EC50			CHEMBL2208	Homo sapiens	EC50		
	10902510	CHEMBL2040539	Inhibition of MK2 in human THP1 cells assessed as inhibition of LPS-induced HSP27 Ser78 phosphorylation incubated for 60 mins prior to LPS-induction measured after 60 mins	B	N#Cc1ccc(-c2ccc(C3=NOC(c4ccccc4-c4cncnc4)N3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036616	=	EC50	nM	1200.0	CHEMBL2208	Homo sapiens	EC50	nM	1200.0
Not Determined	10902511	CHEMBL2040539	Inhibition of MK2 in human THP1 cells assessed as inhibition of LPS-induced HSP27 Ser78 phosphorylation incubated for 60 mins prior to LPS-induction measured after 60 mins	B	N#Cc1cccc(-c2ccc(C3=NOC(c4ccccc4-c4cncnc4)N3c3ccc(N4CCNCC4)cc3)o2)c1		CHEMBL2036617		EC50			CHEMBL2208	Homo sapiens	EC50		
Not Determined	10902512	CHEMBL2040539	Inhibition of MK2 in human THP1 cells assessed as inhibition of LPS-induced HSP27 Ser78 phosphorylation incubated for 60 mins prior to LPS-induction measured after 60 mins	B	Clc1ccc(-c2ccc(C3=NOC(c4ccncc4)N3c3ccc(C4CCNCC4)cc3)o2)cc1		CHEMBL2036618		EC50			CHEMBL2208	Homo sapiens	EC50		
Not Determined	10902513	CHEMBL2040539	Inhibition of MK2 in human THP1 cells assessed as inhibition of LPS-induced HSP27 Ser78 phosphorylation incubated for 60 mins prior to LPS-induction measured after 60 mins	B	FC1(F)CCN(c2ccc(N3C(c4ccc(-c5ccc(Cl)cc5)o4)=NOC3c3ccncc3)cc2)CC1		CHEMBL2036619		EC50			CHEMBL2208	Homo sapiens	EC50		
Not Determined	10902514	CHEMBL2040539	Inhibition of MK2 in human THP1 cells assessed as inhibition of LPS-induced HSP27 Ser78 phosphorylation incubated for 60 mins prior to LPS-induction measured after 60 mins	B	Clc1ccc(-c2ccc(C3=NOC(c4ccncc4)N3Cc3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036620		EC50			CHEMBL2208	Homo sapiens	EC50		
	10902515	CHEMBL2040539	Inhibition of MK2 in human THP1 cells assessed as inhibition of LPS-induced HSP27 Ser78 phosphorylation incubated for 60 mins prior to LPS-induction measured after 60 mins	B	N#Cc1ccc(-c2ccc(C3=NOC(c4ccccc4-c4cncnc4)N3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036616	=	EC50	nM	170.0	CHEMBL2208	Homo sapiens	EC50	nM	170.0
Active	10903396	CHEMBL2037926	Non-competitive inhibition of MK2 using 5TAMRA-KKLNRTLSVA-COOH as substrate by immobilized metal ion affinity-based fluorescence polarization assay in presence of 1 to 100 uM ATP	B	N#Cc1ccc(-c2ccc(C3=NOC(c4ccccc4-c4cncnc4)N3c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL2036616		Inhibition	%		CHEMBL2208	Homo sapiens	INH		
	10903523	CHEMBL2037937	Inhibition of MAPKAPK2 at 10 times IC50 concentration after 90 mins in presence of ATP	B	N[C@H]1CC[C@H](Cn2nc(-c3ccc(N4CCNCC4)cc3)c3cnc(NCCCc4ccccc4)nc32)CC1		CHEMBL2036807	=	Inhibition	%	94.0	CHEMBL2208	Homo sapiens	INH	%	94.0
	10903524	CHEMBL2037937	Inhibition of MAPKAPK2 at 10 times IC50 concentration after 90 mins in presence of ATP	B	CCCCNc1ncc2c(-c3ccc(F)cc3)nn(C[C@H]3CC[C@H](N)CC3)c2n1		CHEMBL2036808	=	Inhibition	%	92.0	CHEMBL2208	Homo sapiens	INH	%	92.0
	10923962	CHEMBL2044156	Inhibition of MAPKAPK2 at 1 uM incubated for 30 mins prior to substrate addition study done at apparent ATP Km for enzyme	B	C[C@H](/C=C\C(F)(F)F)Oc1cc(-c2cc(-c3cc(CN(C)C)cs3)cnc2N)ccc1C(N)=O		CHEMBL2042135	=	Inhibition	%	6.0	CHEMBL2208	Homo sapiens	INH	%	6.0
	10926104	CHEMBL2046201	Inhibition of human MAPKAP-K2 assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting	B	CC(C)Nc1cc(-c2oc3ccccc3c(=O)c2-c2ccc(F)cc2)ccn1		CHEMBL2041958	=	Activity	%	104.0	CHEMBL2208	Homo sapiens	Activity	%	104.0
	10926105	CHEMBL2046201	Inhibition of human MAPKAP-K2 assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting	B	O=c1c(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)oc2ccccc12		CHEMBL2041962	=	Activity	%	99.0	CHEMBL2208	Homo sapiens	Activity	%	99.0
	10978458	CHEMBL2066249	Inhibition of human recombinant MAPKAPK2 expressed in Escherichia coli using CREBtide as substrate assessed as residual activity at 1 uM after 15 mins by Cerep assay	B	N#Cc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)cc1		CHEMBL2064515	>	Activity	%	80.0	CHEMBL2208	Homo sapiens	Activity	%	80.0
Not Active	10986542	CHEMBL2072219	Inhibition of MAPKAP-K2 at 10 uM	B	NS(=O)(=O)c1cc(-c2nc3ccccc3s2)cs1		CHEMBL2069711		Inhibition	%		CHEMBL2208	Homo sapiens	INH		
	12046352	CHEMBL2157279	Inhibition of MAPKAPK2 at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	12074644	CHEMBL2161206	Inhibition of MAPKAP-K2 at 1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	<	Inhibition	%	50.0	CHEMBL2208	Homo sapiens	INH	%	50.0
	12094333	CHEMBL2166133	Competitive inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP by Lineweaver-Burke plot analysis	B	N[C@H]1CC[C@H](Nc2cc(Nc3ccc(F)c(Cl)c3)n3nccc3n2)CC1		CHEMBL2163999	=	Ki	nM	6000.0	CHEMBL2208	Homo sapiens	Ki	uM	6.0
	12094334	CHEMBL2166136	Binding affinity to recombinant MAPKAP-K2 using KKKALSRQLSVAA as substrate after 4 mins by surface plasmon resonance spectroscopic analysis	B	Cc1ccc(-c2ccc3c(ccc4sc5c(c43)NC[C@@H](C)NC5=O)n2)cn1		CHEMBL1231206	=	IC50	nM	5.0	CHEMBL2208	Homo sapiens	IC50	uM	0.005
	12094335	CHEMBL2166135	Inhibition of MAPKAP-K2	B	N#Cc1c(N)nc2c(c1N)Cc1cc(O)c(O)cc1O2		CHEMBL1185204	=	IC50	nM	130.0	CHEMBL2208	Homo sapiens	IC50	uM	0.13
Active	12094340	CHEMBL2166139	Inhibition of human MAPKAP-K2 in THP1 cells assessed as inhibition of LPS-induced HSP27 phosphorylation at 3 and 30 uM incubated 1 hr prior to LPS challenge measured 1 hr post LPS challenge by Western blot analysis	B	CCOc1ccc(Nc2c(C)c(N[C@H]3CCCNC3)nc3ccnn23)cc1		CHEMBL1235213		Inhibition	%		CHEMBL2208	Homo sapiens	INH		
	12094354	CHEMBL2166146	Inhibition of MAPKAP-K2 in human whole blood assessed as inhibition of LPS-induced TNFalpha production by ELISA	B	CCOc1ccc(Nc2c(C)c(N[C@H]3CCCNC3)nc3ccnn23)cc1		CHEMBL1235213	=	IC50	nM	11000.0	CHEMBL2208	Homo sapiens	IC50	uM	11.0
	12094358	CHEMBL2166394	Inhibition of human MAPKAP-K2 in THP1 cells assessed as inhibition of LPS-induced TNFalpha production incubated 1 hr prior to LPS challenge measured 18 hrs post LPS challenge by HTRF assay	B	Cc1nc2ccc(Nc3c(C)c(N[C@H]4CCCNC4)nc4ccnn34)cc2s1		CHEMBL2163608	=	IC50	nM	8400.0	CHEMBL2208	Homo sapiens	IC50	uM	8.4
	12094359	CHEMBL2166394	Inhibition of human MAPKAP-K2 in THP1 cells assessed as inhibition of LPS-induced TNFalpha production incubated 1 hr prior to LPS challenge measured 18 hrs post LPS challenge by HTRF assay	B	COCCOc1ccc(Nc2c(C)c(N[C@H]3CCCNC3)nc3ccnn23)cc1		CHEMBL2163616	=	IC50	nM	7600.0	CHEMBL2208	Homo sapiens	IC50	uM	7.6
	12094360	CHEMBL2166394	Inhibition of human MAPKAP-K2 in THP1 cells assessed as inhibition of LPS-induced TNFalpha production incubated 1 hr prior to LPS challenge measured 18 hrs post LPS challenge by HTRF assay	B	CCOc1ccc(Nc2c(C)c(N[C@H]3CCCNC3)nc3ccnn23)cc1		CHEMBL1235213	=	IC50	nM	7200.0	CHEMBL2208	Homo sapiens	IC50	uM	7.2
	12094379	CHEMBL2166158	Inhibition of human MAPKAP-K2 at 10 uM	B	CCOc1ccc(Nc2c(C)c(N[C@H]3CCCNC3)nc3ccnn23)cc1		CHEMBL1235213	>	Inhibition	%	75.0	CHEMBL2208	Homo sapiens	INH	%	75.0
	12094458	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	400.0	CHEMBL2208	Homo sapiens	IC50	uM	0.4
	12094459	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	CCOc1ccc(Nc2c(C)c(N[C@@H]3CCCNC3)nc3ccnn23)cc1		CHEMBL2163604	=	IC50	nM	1200.0	CHEMBL2208	Homo sapiens	IC50	uM	1.2
	12094460	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	CCc1c(N[C@H]2CC[C@H](N)CC2)nc2ccnn2c1Nc1ccccc1Cl		CHEMBL2163605	=	IC50	nM	1500.0	CHEMBL2208	Homo sapiens	IC50	uM	1.5
	12094461	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	Cc1c(N[C@H]2CC[C@H](N)CC2)nc2ccnn2c1Nc1ccccc1Cl		CHEMBL2163606	=	IC50	nM	1700.0	CHEMBL2208	Homo sapiens	IC50	uM	1.7
	12094462	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	N[C@H]1CC[C@H](Nc2cc(Nc3ccccc3Cl)n3nccc3n2)CC1		CHEMBL2163607	=	IC50	nM	200.0	CHEMBL2208	Homo sapiens	IC50	uM	0.2
	12094463	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	Cc1nc2ccc(Nc3c(C)c(N[C@H]4CCCNC4)nc4ccnn34)cc2s1		CHEMBL2163608	=	IC50	nM	54.0	CHEMBL2208	Homo sapiens	IC50	uM	0.054
	12094464	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	Cc1c(N[C@H]2CCCNC2)nc2ccnn2c1Nc1ccc2c(cnn2C)c1		CHEMBL2163611	=	IC50	nM	76.0	CHEMBL2208	Homo sapiens	IC50	uM	0.076
	12094465	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	CC(=O)c1ccc(-c2ccc(Nc3c(C)c(N[C@H]4CCCNC4)nc4ccnn34)cc2)s1		CHEMBL2163610	=	IC50	nM	57.0	CHEMBL2208	Homo sapiens	IC50	uM	0.057
	12094466	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	Cc1c(N[C@H]2CCCNC2)nc2ccnn2c1Nc1ccc(C(=O)NC2CCCC2)cc1		CHEMBL2163609	=	IC50	nM	140.0	CHEMBL2208	Homo sapiens	IC50	uM	0.14
	12094467	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	Cc1c(N[C@H]2CCCNC2)nc2ccnn2c1Nc1ccc(OCCN2CCOCC2)cc1		CHEMBL2163612	=	IC50	nM	160.0	CHEMBL2208	Homo sapiens	IC50	uM	0.16
	12094468	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	COCCOc1ccc(Nc2c(C)c(N[C@H]3CCCNC3)nc3ccnn23)cc1		CHEMBL2163616	=	IC50	nM	130.0	CHEMBL2208	Homo sapiens	IC50	uM	0.13
	12094469	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	CCOc1ccc(Nc2c(C)c(N[C@H]3CCCNC3)nc3ccnn23)cc1		CHEMBL1235213	=	IC50	nM	130.0	CHEMBL2208	Homo sapiens	IC50	uM	0.13
	12094470	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	Cc1c(N[C@H]2CC[C@H](N)CC2)nc2ccnn2c1Nc1cccc(OCc2ccccc2)c1		CHEMBL2163615	=	IC50	nM	3000.0	CHEMBL2208	Homo sapiens	IC50	uM	3.0
	12094471	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	CCOC(=O)c1cccc(Nc2c(C)c(N[C@H]3CC[C@H](N)CC3)nc3ccnn23)c1		CHEMBL2163614	=	IC50	nM	1900.0	CHEMBL2208	Homo sapiens	IC50	uM	1.9
	12094472	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	CCOc1cccc(Nc2c(C)c(N[C@H]3CC[C@H](N)CC3)nc3ccnn23)c1		CHEMBL2163613	=	IC50	nM	1400.0	CHEMBL2208	Homo sapiens	IC50	uM	1.4
	12094473	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	Cc1c(N[C@H]2CC[C@H](N)CC2)nc2ccnn2c1Nc1ccc(OCc2ccccc2)cc1		CHEMBL2163617	=	IC50	nM	700.0	CHEMBL2208	Homo sapiens	IC50	uM	0.7
	12094474	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	CCOC(=O)c1ccc(Nc2c(C)c(N[C@H]3CC[C@H](N)CC3)nc3ccnn23)cc1		CHEMBL2163618	=	IC50	nM	700.0	CHEMBL2208	Homo sapiens	IC50	uM	0.7
	12094475	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	N[C@H]1CC[C@H](Nc2cc(NCc3ccccc3)n3nccc3n2)CC1		CHEMBL2163619	=	IC50	nM	7000.0	CHEMBL2208	Homo sapiens	IC50	uM	7.0
	12094476	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	N[C@H]1CC[C@H](Nc2cc(NCC3CCCCC3)n3nccc3n2)CC1		CHEMBL2163620	=	IC50	nM	11000.0	CHEMBL2208	Homo sapiens	IC50	uM	11.0
	12094477	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	CC(C)CCNc1cc(N[C@H]2CC[C@H](N)CC2)nc2ccnn12		CHEMBL2163621	=	IC50	nM	12000.0	CHEMBL2208	Homo sapiens	IC50	uM	12.0
	12094478	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	CN(c1ccc(F)c(Cl)c1)c1cc(N[C@H]2CC[C@H](N)CC2)nc2ccnn12	Outside typical range	CHEMBL2163622	>	IC50	nM	300000.0	CHEMBL2208	Homo sapiens	IC50	uM	300.0
	12094479	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	CCc1c(NC2CCCNC2)nc2ccnn2c1Nc1ccc(F)c(Cl)c1		CHEMBL2163623	=	IC50	nM	700.0	CHEMBL2208	Homo sapiens	IC50	uM	0.7
	12094480	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	Cc1c(NC2CCCNC2)nc2ccnn2c1Nc1ccc(F)c(Cl)c1		CHEMBL2163624	=	IC50	nM	510.0	CHEMBL2208	Homo sapiens	IC50	uM	0.51
	12094481	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	CCOc1ccc(Nc2c(C)c(O[C@H]3CC[C@H](N)CC3)nc3ccnn23)cc1		CHEMBL2163625	=	IC50	nM	570.0	CHEMBL2208	Homo sapiens	IC50	uM	0.57
	12094482	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	CCOc1ccc(Nc2c(C)c(N[C@H]3CCCNC3=O)nc3ccnn23)cc1		CHEMBL2163626	>	IC50	nM	100000.0	CHEMBL2208	Homo sapiens	IC50	uM	100.0
	12094483	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	CCOc1ccc(Nc2c(C)c(N(C)C3CCCNC3)nc3ccnn23)cc1		CHEMBL2163627	=	IC50	nM	26000.0	CHEMBL2208	Homo sapiens	IC50	uM	26.0
	12094484	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	CCOc1ccc(Nc2c(C)c(NC3CCCNC3)nc3ccnn23)cc1		CHEMBL2163628	=	IC50	nM	400.0	CHEMBL2208	Homo sapiens	IC50	uM	0.4
	12094485	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	CCOc1ccc(Nc2c(C)c(NCCO)nc3ccnn23)cc1		CHEMBL2163977	=	IC50	nM	83000.0	CHEMBL2208	Homo sapiens	IC50	uM	83.0
	12094486	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	CCOc1ccc(Nc2c(C)c(NCCCCN)nc3ccnn23)cc1		CHEMBL2163353	=	IC50	nM	4100.0	CHEMBL2208	Homo sapiens	IC50	uM	4.1
	12094487	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	CCOc1ccc(Nc2c(C)c(NCCCN)nc3ccnn23)cc1		CHEMBL2163978	=	IC50	nM	8700.0	CHEMBL2208	Homo sapiens	IC50	uM	8.7
	12094488	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	CCOc1ccc(Nc2c(C)c(NCCN)nc3ccnn23)cc1		CHEMBL2163979	=	IC50	nM	2500.0	CHEMBL2208	Homo sapiens	IC50	uM	2.5
	12094489	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	CCOc1ccc(Nc2c(C)c(N[C@H]3CC[C@H](O)CC3)nc3ccnn23)cc1		CHEMBL2163980	=	IC50	nM	89000.0	CHEMBL2208	Homo sapiens	IC50	uM	89.0
	12094490	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	CCOc1ccc(Nc2c(C)c(N[C@H]3CC[C@H](N)CC3)nc3ccnn23)cc1		CHEMBL2163981	=	IC50	nM	360.0	CHEMBL2208	Homo sapiens	IC50	uM	0.36
	12094491	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	Fc1ccc(Nc2cc(NCC3CCNCC3)nc3ccnn23)cc1Cl		CHEMBL2163982	>	IC50	nM	100000.0	CHEMBL2208	Homo sapiens	IC50	uM	100.0
	12094492	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	Nc1ccc(Nc2cc(Nc3ccc(F)c(Cl)c3)n3nccc3n2)cc1		CHEMBL2163983	>	IC50	nM	100000.0	CHEMBL2208	Homo sapiens	IC50	uM	100.0
	12094493	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	Fc1ccc(Nc2cc(NC3CCCNC3)nc3ccnn23)cc1Cl		CHEMBL2163984	=	IC50	nM	400.0	CHEMBL2208	Homo sapiens	IC50	uM	0.4
	12094494	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	Fc1ccc(Nc2cc(NC3CCNCC3)nc3ccnn23)cc1Cl		CHEMBL2163985	=	IC50	nM	25000.0	CHEMBL2208	Homo sapiens	IC50	uM	25.0
	12094495	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	NC1CCCC(Nc2cc(Nc3ccc(F)c(Cl)c3)n3nccc3n2)C1		CHEMBL2163986	>	IC50	nM	100000.0	CHEMBL2208	Homo sapiens	IC50	uM	100.0
	12094496	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	CC(=O)N[C@H]1CC[C@H](Nc2cc(Nc3ccc(F)c(Cl)c3)n3nccc3n2)CC1		CHEMBL2163987	>	IC50	nM	100000.0	CHEMBL2208	Homo sapiens	IC50	uM	100.0
	12094497	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	CCN(CC)[C@H]1CC[C@H](Nc2cc(Nc3ccc(F)c(Cl)c3)n3nccc3n2)CC1		CHEMBL2163988	>	IC50	nM	100000.0	CHEMBL2208	Homo sapiens	IC50	uM	100.0
	12094498	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	CCN[C@H]1CC[C@H](Nc2cc(Nc3ccc(F)c(Cl)c3)n3nccc3n2)CC1		CHEMBL2163989	=	IC50	nM	2000.0	CHEMBL2208	Homo sapiens	IC50	uM	2.0
	12094499	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	Fc1ccc(Nc2cc(NC3CCCCC3)nc3ccnn23)cc1Cl		CHEMBL2163990	>	IC50	nM	100000.0	CHEMBL2208	Homo sapiens	IC50	uM	100.0
	12094500	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	N[C@H]1CC[C@H](Nc2nc3ccnn3c(Nc3ccc(F)c(Cl)c3)c2-c2ccccc2)CC1		CHEMBL2163991	=	IC50	nM	1600.0	CHEMBL2208	Homo sapiens	IC50	uM	1.6
	12094501	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	CCCc1c(N[C@H]2CC[C@H](N)CC2)nc2ccnn2c1Nc1ccc(F)c(Cl)c1		CHEMBL2163992	=	IC50	nM	600.0	CHEMBL2208	Homo sapiens	IC50	uM	0.6
	12094502	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	CCc1c(N[C@H]2CC[C@H](N)CC2)nc2ccnn2c1Nc1ccc(F)c(Cl)c1		CHEMBL2163993	=	IC50	nM	400.0	CHEMBL2208	Homo sapiens	IC50	uM	0.4
	12094503	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	Cc1c(N[C@H]2CC[C@H](N)CC2)nc2ccnn2c1Nc1ccc(F)c(Cl)c1		CHEMBL2163994	=	IC50	nM	400.0	CHEMBL2208	Homo sapiens	IC50	uM	0.4
	12094504	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	N[C@H]1CC[C@H](Nc2cc(Nc3ccc(F)c(Cl)c3)n3ncc(Br)c3n2)CC1		CHEMBL2163995	=	IC50	nM	9200.0	CHEMBL2208	Homo sapiens	IC50	uM	9.2
	12094505	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	N[C@H]1CC[C@H](Nc2cc(Nc3ccc(F)c(Cl)c3)n3ncc(Cl)c3n2)CC1		CHEMBL2163996	=	IC50	nM	8100.0	CHEMBL2208	Homo sapiens	IC50	uM	8.1
	12094506	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	N#Cc1cnn2c(Nc3ccc(F)c(Cl)c3)cc(N[C@H]3CC[C@H](N)CC3)nc12		CHEMBL2163997	=	IC50	nM	3100.0	CHEMBL2208	Homo sapiens	IC50	uM	3.1
	12094507	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	CC(C)(C)c1cc2nc(N[C@H]3CC[C@H](N)CC3)cc(Nc3ccc(F)c(Cl)c3)n2n1	Outside typical range	CHEMBL2163998	>	IC50	nM	300000.0	CHEMBL2208	Homo sapiens	IC50	uM	300.0
	12094508	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	Cc1cc2nc(N[C@H]3CC[C@H](N)CC3)cc(Nc3ccc(F)c(Cl)c3)n2n1	Outside typical range	CHEMBL2164000	>	IC50	nM	300000.0	CHEMBL2208	Homo sapiens	IC50	uM	300.0
	12094509	CHEMBL2167126	Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counter	B	N[C@H]1CC[C@H](Nc2cc(Nc3ccc(F)c(Cl)c3)n3nccc3n2)CC1		CHEMBL2163999	=	IC50	nM	1300.0	CHEMBL2208	Homo sapiens	IC50	uM	1.3
	12145275	CHEMBL2186662	Inhibition of MAPKAPK2 using fluorescent labelled substrate at 5 uM by caliper method	B	Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1		CHEMBL2177819	>	Inhibition	%	25.0	CHEMBL2208	Homo sapiens	INH	%	25.0
	12145276	CHEMBL2186662	Inhibition of MAPKAPK2 using fluorescent labelled substrate at 5 uM by caliper method	B	Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CC(=O)Nc2ccccc2)cc1		CHEMBL2177818	>	Inhibition	%	25.0	CHEMBL2208	Homo sapiens	INH	%	25.0
	12150586	CHEMBL2188522	Inhibition of human recombinant MK2 by radiometric kinase assay	B	CN1CCN(c2ccc(Nc3ncc4nc(Nc5ccccc5)n(C5CCCC5)c4n3)cc2)CC1		CHEMBL2178352	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	12166116	CHEMBL2211588	Binding affinity to MAPKAPK2 at 1 uM	B	Cc1nc(N)nc(-c2cc(Cl)cnc2Nc2cnc(Cl)c(NS(=O)(=O)N(C)C)c2)n1		CHEMBL2206921	<	Activity	%	50.0	CHEMBL2208	Homo sapiens	Activity	%	50.0
	12170789	CHEMBL2209915	Inhibition of MAPKAP-K2 assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL2208	Homo sapiens	Activity	%	100.0
	12172090	CHEMBL2213916	Inhibition of MAPKAP-K2 assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	96.0	CHEMBL2208	Homo sapiens	Activity	%	96.0
	12172362	CHEMBL2210627	Inhibition of MAPKAPK2 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	74.0	CHEMBL2208	Homo sapiens	Activity	%	74.0
	12195602	CHEMBL2212381	Inhibition of human recombinant MAPKAP2 expressed in Escherichia coli using CKRREILSRRPSYRK as substrate assessed as residual activity at 1 uM after 15 mins relative to staurosporine	B	CCN(CC)CCOc1ccc(/C=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL2206008	=	Activity	%	95.3	CHEMBL2208	Homo sapiens	Activity	%	95.3
	12245937	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	104.0	CHEMBL2208	Homo sapiens	Residual Activity	%	104.0
	12245938	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	98.0	CHEMBL2208	Homo sapiens	Residual Activity	%	98.0
	12245939	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	89.0	CHEMBL2208	Homo sapiens	Residual Activity	%	89.0
	12245940	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	80.0	CHEMBL2208	Homo sapiens	Residual Activity	%	80.0
	12245941	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	119.0	CHEMBL2208	Homo sapiens	Residual Activity	%	119.0
	12245942	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	92.0	CHEMBL2208	Homo sapiens	Residual Activity	%	92.0
	12245943	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	83.0	CHEMBL2208	Homo sapiens	Residual Activity	%	83.0
	12245944	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	108.0	CHEMBL2208	Homo sapiens	Residual Activity	%	108.0
	12245945	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	104.0	CHEMBL2208	Homo sapiens	Residual Activity	%	104.0
	12245946	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	108.0	CHEMBL2208	Homo sapiens	Residual Activity	%	108.0
	12245947	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	89.0	CHEMBL2208	Homo sapiens	Residual Activity	%	89.0
	12245948	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	99.0	CHEMBL2208	Homo sapiens	Residual Activity	%	99.0
	12245949	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	88.0	CHEMBL2208	Homo sapiens	Residual Activity	%	88.0
	12245950	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	83.0	CHEMBL2208	Homo sapiens	Residual Activity	%	83.0
	12245951	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	96.0	CHEMBL2208	Homo sapiens	Residual Activity	%	96.0
	12245952	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	80.0	CHEMBL2208	Homo sapiens	Residual Activity	%	80.0
	12245953	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	95.0	CHEMBL2208	Homo sapiens	Residual Activity	%	95.0
	12245954	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	94.0	CHEMBL2208	Homo sapiens	Residual Activity	%	94.0
	12245955	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	70.0	CHEMBL2208	Homo sapiens	Residual Activity	%	70.0
	12245956	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	79.0	CHEMBL2208	Homo sapiens	Residual Activity	%	79.0
	12245957	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	75.0	CHEMBL2208	Homo sapiens	Residual Activity	%	75.0
	12245958	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	90.0	CHEMBL2208	Homo sapiens	Residual Activity	%	90.0
	12245959	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	84.0	CHEMBL2208	Homo sapiens	Residual Activity	%	84.0
	12245960	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	81.0	CHEMBL2208	Homo sapiens	Residual Activity	%	81.0
	12245961	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	103.0	CHEMBL2208	Homo sapiens	Residual Activity	%	103.0
	12245962	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	73.0	CHEMBL2208	Homo sapiens	Residual Activity	%	73.0
	12245963	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	64.0	CHEMBL2208	Homo sapiens	Residual Activity	%	64.0
	12245964	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	106.0	CHEMBL2208	Homo sapiens	Residual Activity	%	106.0
	12245965	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	99.0	CHEMBL2208	Homo sapiens	Residual Activity	%	99.0
	12245966	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	100.0	CHEMBL2208	Homo sapiens	Residual Activity	%	100.0
	12245967	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	101.0	CHEMBL2208	Homo sapiens	Residual Activity	%	101.0
	12245968	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	85.0	CHEMBL2208	Homo sapiens	Residual Activity	%	85.0
	12245969	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	107.0	CHEMBL2208	Homo sapiens	Residual Activity	%	107.0
	12245970	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	100.0	CHEMBL2208	Homo sapiens	Residual Activity	%	100.0
	12245971	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	84.0	CHEMBL2208	Homo sapiens	Residual Activity	%	84.0
	12245972	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	113.0	CHEMBL2208	Homo sapiens	Residual Activity	%	113.0
	12245973	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	75.0	CHEMBL2208	Homo sapiens	Residual Activity	%	75.0
	12245974	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	86.0	CHEMBL2208	Homo sapiens	Residual Activity	%	86.0
	12245975	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	92.0	CHEMBL2208	Homo sapiens	Residual Activity	%	92.0
	12245976	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	108.0	CHEMBL2208	Homo sapiens	Residual Activity	%	108.0
	12245977	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	115.0	CHEMBL2208	Homo sapiens	Residual Activity	%	115.0
	12245978	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	100.0	CHEMBL2208	Homo sapiens	Residual Activity	%	100.0
	12245979	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	95.0	CHEMBL2208	Homo sapiens	Residual Activity	%	95.0
	12245980	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	83.0	CHEMBL2208	Homo sapiens	Residual Activity	%	83.0
	12245981	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	73.0	CHEMBL2208	Homo sapiens	Residual Activity	%	73.0
	12245982	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	90.0	CHEMBL2208	Homo sapiens	Residual Activity	%	90.0
	12245983	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	80.0	CHEMBL2208	Homo sapiens	Residual Activity	%	80.0
	12245984	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	100.0	CHEMBL2208	Homo sapiens	Residual Activity	%	100.0
	12245985	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	117.0	CHEMBL2208	Homo sapiens	Residual Activity	%	117.0
	12245986	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	81.0	CHEMBL2208	Homo sapiens	Residual Activity	%	81.0
	12245987	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	94.0	CHEMBL2208	Homo sapiens	Residual Activity	%	94.0
	12245988	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	82.0	CHEMBL2208	Homo sapiens	Residual Activity	%	82.0
	12245989	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	82.0	CHEMBL2208	Homo sapiens	Residual Activity	%	82.0
	12245990	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	88.0	CHEMBL2208	Homo sapiens	Residual Activity	%	88.0
	12245991	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	85.0	CHEMBL2208	Homo sapiens	Residual Activity	%	85.0
	12245992	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	91.0	CHEMBL2208	Homo sapiens	Residual Activity	%	91.0
	12245993	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	108.0	CHEMBL2208	Homo sapiens	Residual Activity	%	108.0
	12245994	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	97.0	CHEMBL2208	Homo sapiens	Residual Activity	%	97.0
	12245995	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	108.0	CHEMBL2208	Homo sapiens	Residual Activity	%	108.0
	12245996	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	85.0	CHEMBL2208	Homo sapiens	Residual Activity	%	85.0
	12245997	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	67.0	CHEMBL2208	Homo sapiens	Residual Activity	%	67.0
	12245998	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	75.0	CHEMBL2208	Homo sapiens	Residual Activity	%	75.0
	12245999	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	94.0	CHEMBL2208	Homo sapiens	Residual Activity	%	94.0
	12246000	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	73.0	CHEMBL2208	Homo sapiens	Residual Activity	%	73.0
	12246001	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	104.0	CHEMBL2208	Homo sapiens	Residual Activity	%	104.0
	12246002	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	121.0	CHEMBL2208	Homo sapiens	Residual Activity	%	121.0
	12246003	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	101.0	CHEMBL2208	Homo sapiens	Residual Activity	%	101.0
	12246004	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	94.0	CHEMBL2208	Homo sapiens	Residual Activity	%	94.0
	12246005	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	87.0	CHEMBL2208	Homo sapiens	Residual Activity	%	87.0
	12246006	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	95.0	CHEMBL2208	Homo sapiens	Residual Activity	%	95.0
	12246007	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	117.0	CHEMBL2208	Homo sapiens	Residual Activity	%	117.0
	12246008	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	115.0	CHEMBL2208	Homo sapiens	Residual Activity	%	115.0
	12246009	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	108.0	CHEMBL2208	Homo sapiens	Residual Activity	%	108.0
	12246010	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	124.0	CHEMBL2208	Homo sapiens	Residual Activity	%	124.0
	12246011	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	75.0	CHEMBL2208	Homo sapiens	Residual Activity	%	75.0
	12246012	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	96.0	CHEMBL2208	Homo sapiens	Residual Activity	%	96.0
	12246013	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	93.0	CHEMBL2208	Homo sapiens	Residual Activity	%	93.0
	12246014	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	98.0	CHEMBL2208	Homo sapiens	Residual Activity	%	98.0
	12246015	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	101.0	CHEMBL2208	Homo sapiens	Residual Activity	%	101.0
	12246016	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	14.0	CHEMBL2208	Homo sapiens	Residual Activity	%	14.0
	12246017	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	97.0	CHEMBL2208	Homo sapiens	Residual Activity	%	97.0
	12246018	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	94.0	CHEMBL2208	Homo sapiens	Residual Activity	%	94.0
	12246019	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	98.0	CHEMBL2208	Homo sapiens	Residual Activity	%	98.0
	12246020	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	94.0	CHEMBL2208	Homo sapiens	Residual Activity	%	94.0
	12246021	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	81.0	CHEMBL2208	Homo sapiens	Residual Activity	%	81.0
	12246022	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	95.0	CHEMBL2208	Homo sapiens	Residual Activity	%	95.0
	12246023	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	79.0	CHEMBL2208	Homo sapiens	Residual Activity	%	79.0
	12246024	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	104.0	CHEMBL2208	Homo sapiens	Residual Activity	%	104.0
	12246025	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	100.0	CHEMBL2208	Homo sapiens	Residual Activity	%	100.0
	12246026	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	101.0	CHEMBL2208	Homo sapiens	Residual Activity	%	101.0
	12246027	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	102.0	CHEMBL2208	Homo sapiens	Residual Activity	%	102.0
	12246028	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	102.0	CHEMBL2208	Homo sapiens	Residual Activity	%	102.0
	12246029	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	98.0	CHEMBL2208	Homo sapiens	Residual Activity	%	98.0
	12246030	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	84.0	CHEMBL2208	Homo sapiens	Residual Activity	%	84.0
	12246031	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	90.0	CHEMBL2208	Homo sapiens	Residual Activity	%	90.0
	12246032	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	107.0	CHEMBL2208	Homo sapiens	Residual Activity	%	107.0
	12246033	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	90.0	CHEMBL2208	Homo sapiens	Residual Activity	%	90.0
	12246034	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	93.0	CHEMBL2208	Homo sapiens	Residual Activity	%	93.0
	12246035	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	85.0	CHEMBL2208	Homo sapiens	Residual Activity	%	85.0
	12246036	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	82.0	CHEMBL2208	Homo sapiens	Residual Activity	%	82.0
	12246037	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	79.0	CHEMBL2208	Homo sapiens	Residual Activity	%	79.0
	12246038	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	0.0	CHEMBL2208	Homo sapiens	Residual Activity	%	0.0
	12246039	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	99.0	CHEMBL2208	Homo sapiens	Residual Activity	%	99.0
	12246040	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	104.0	CHEMBL2208	Homo sapiens	Residual Activity	%	104.0
	12246041	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	69.0	CHEMBL2208	Homo sapiens	Residual Activity	%	69.0
	12246042	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	72.0	CHEMBL2208	Homo sapiens	Residual Activity	%	72.0
	12246043	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	72.0	CHEMBL2208	Homo sapiens	Residual Activity	%	72.0
	12246044	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	81.0	CHEMBL2208	Homo sapiens	Residual Activity	%	81.0
	12246045	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	88.0	CHEMBL2208	Homo sapiens	Residual Activity	%	88.0
	12246046	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	73.0	CHEMBL2208	Homo sapiens	Residual Activity	%	73.0
	12246047	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	92.0	CHEMBL2208	Homo sapiens	Residual Activity	%	92.0
	12246048	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	95.0	CHEMBL2208	Homo sapiens	Residual Activity	%	95.0
	12246049	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	57.0	CHEMBL2208	Homo sapiens	Residual Activity	%	57.0
	12246050	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	88.0	CHEMBL2208	Homo sapiens	Residual Activity	%	88.0
	12246051	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	103.0	CHEMBL2208	Homo sapiens	Residual Activity	%	103.0
	12246052	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	72.0	CHEMBL2208	Homo sapiens	Residual Activity	%	72.0
	12246053	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	92.0	CHEMBL2208	Homo sapiens	Residual Activity	%	92.0
	12246054	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	78.0	CHEMBL2208	Homo sapiens	Residual Activity	%	78.0
	12246055	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	79.0	CHEMBL2208	Homo sapiens	Residual Activity	%	79.0
	12246056	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	107.0	CHEMBL2208	Homo sapiens	Residual Activity	%	107.0
	12246057	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	98.0	CHEMBL2208	Homo sapiens	Residual Activity	%	98.0
	12246058	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	100.0	CHEMBL2208	Homo sapiens	Residual Activity	%	100.0
	12246059	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	91.0	CHEMBL2208	Homo sapiens	Residual Activity	%	91.0
	12246060	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	77.0	CHEMBL2208	Homo sapiens	Residual Activity	%	77.0
	12246061	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	78.0	CHEMBL2208	Homo sapiens	Residual Activity	%	78.0
	12246062	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	69.0	CHEMBL2208	Homo sapiens	Residual Activity	%	69.0
	12246063	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	81.0	CHEMBL2208	Homo sapiens	Residual Activity	%	81.0
	12246064	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	108.0	CHEMBL2208	Homo sapiens	Residual Activity	%	108.0
	12246065	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	89.0	CHEMBL2208	Homo sapiens	Residual Activity	%	89.0
	12246066	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	44.0	CHEMBL2208	Homo sapiens	Residual Activity	%	44.0
	12246067	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	96.0	CHEMBL2208	Homo sapiens	Residual Activity	%	96.0
	12246068	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	67.0	CHEMBL2208	Homo sapiens	Residual Activity	%	67.0
	12246069	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	79.0	CHEMBL2208	Homo sapiens	Residual Activity	%	79.0
	12246070	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	69.0	CHEMBL2208	Homo sapiens	Residual Activity	%	69.0
	12246071	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	71.0	CHEMBL2208	Homo sapiens	Residual Activity	%	71.0
	12246072	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	89.0	CHEMBL2208	Homo sapiens	Residual Activity	%	89.0
	12246073	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	75.0	CHEMBL2208	Homo sapiens	Residual Activity	%	75.0
	12246074	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	81.0	CHEMBL2208	Homo sapiens	Residual Activity	%	81.0
	12246075	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	96.0	CHEMBL2208	Homo sapiens	Residual Activity	%	96.0
	12246076	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	77.0	CHEMBL2208	Homo sapiens	Residual Activity	%	77.0
	12246077	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	70.0	CHEMBL2208	Homo sapiens	Residual Activity	%	70.0
	12246078	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	105.0	CHEMBL2208	Homo sapiens	Residual Activity	%	105.0
	12246079	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	86.0	CHEMBL2208	Homo sapiens	Residual Activity	%	86.0
	12246080	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	98.0	CHEMBL2208	Homo sapiens	Residual Activity	%	98.0
	12246081	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	100.0	CHEMBL2208	Homo sapiens	Residual Activity	%	100.0
	12246082	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	80.0	CHEMBL2208	Homo sapiens	Residual Activity	%	80.0
	12246083	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	87.0	CHEMBL2208	Homo sapiens	Residual Activity	%	87.0
	12246084	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	91.0	CHEMBL2208	Homo sapiens	Residual Activity	%	91.0
	12246085	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	75.0	CHEMBL2208	Homo sapiens	Residual Activity	%	75.0
	12246086	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	64.0	CHEMBL2208	Homo sapiens	Residual Activity	%	64.0
	12246087	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	99.0	CHEMBL2208	Homo sapiens	Residual Activity	%	99.0
	12246088	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	93.0	CHEMBL2208	Homo sapiens	Residual Activity	%	93.0
	12246089	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	112.0	CHEMBL2208	Homo sapiens	Residual Activity	%	112.0
	12246090	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	93.0	CHEMBL2208	Homo sapiens	Residual Activity	%	93.0
	12246091	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	86.0	CHEMBL2208	Homo sapiens	Residual Activity	%	86.0
	12246092	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	70.0	CHEMBL2208	Homo sapiens	Residual Activity	%	70.0
	12246093	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	87.0	CHEMBL2208	Homo sapiens	Residual Activity	%	87.0
	12246094	CHEMBL2219255	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	51.0	CHEMBL2208	Homo sapiens	Residual Activity	%	51.0
	12246095	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	91.0	CHEMBL2208	Homo sapiens	Residual Activity	%	91.0
	12246096	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	79.0	CHEMBL2208	Homo sapiens	Residual Activity	%	79.0
	12246097	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	71.0	CHEMBL2208	Homo sapiens	Residual Activity	%	71.0
	12246098	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	103.0	CHEMBL2208	Homo sapiens	Residual Activity	%	103.0
	12246099	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	112.0	CHEMBL2208	Homo sapiens	Residual Activity	%	112.0
	12246100	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	113.0	CHEMBL2208	Homo sapiens	Residual Activity	%	113.0
	12246101	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	71.0	CHEMBL2208	Homo sapiens	Residual Activity	%	71.0
	12246102	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	105.0	CHEMBL2208	Homo sapiens	Residual Activity	%	105.0
	12246103	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	114.0	CHEMBL2208	Homo sapiens	Residual Activity	%	114.0
	12246104	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	94.0	CHEMBL2208	Homo sapiens	Residual Activity	%	94.0
	12246105	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	92.0	CHEMBL2208	Homo sapiens	Residual Activity	%	92.0
	12246106	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	91.0	CHEMBL2208	Homo sapiens	Residual Activity	%	91.0
	12246107	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	95.0	CHEMBL2208	Homo sapiens	Residual Activity	%	95.0
	12246108	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	88.0	CHEMBL2208	Homo sapiens	Residual Activity	%	88.0
	12246109	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	49.0	CHEMBL2208	Homo sapiens	Residual Activity	%	49.0
	12246110	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	117.0	CHEMBL2208	Homo sapiens	Residual Activity	%	117.0
	12246111	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	63.0	CHEMBL2208	Homo sapiens	Residual Activity	%	63.0
	12246112	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	94.0	CHEMBL2208	Homo sapiens	Residual Activity	%	94.0
	12246113	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	88.0	CHEMBL2208	Homo sapiens	Residual Activity	%	88.0
	12246114	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	62.0	CHEMBL2208	Homo sapiens	Residual Activity	%	62.0
	12246115	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	87.0	CHEMBL2208	Homo sapiens	Residual Activity	%	87.0
	12246116	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	93.0	CHEMBL2208	Homo sapiens	Residual Activity	%	93.0
	12246117	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	108.0	CHEMBL2208	Homo sapiens	Residual Activity	%	108.0
	12246118	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	114.0	CHEMBL2208	Homo sapiens	Residual Activity	%	114.0
	12246119	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	102.0	CHEMBL2208	Homo sapiens	Residual Activity	%	102.0
	12246120	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	72.0	CHEMBL2208	Homo sapiens	Residual Activity	%	72.0
	12246121	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	51.0	CHEMBL2208	Homo sapiens	Residual Activity	%	51.0
	12246122	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	106.0	CHEMBL2208	Homo sapiens	Residual Activity	%	106.0
	12246123	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	110.0	CHEMBL2208	Homo sapiens	Residual Activity	%	110.0
	12246124	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	84.0	CHEMBL2208	Homo sapiens	Residual Activity	%	84.0
	12246125	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	109.0	CHEMBL2208	Homo sapiens	Residual Activity	%	109.0
	12246126	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	100.0	CHEMBL2208	Homo sapiens	Residual Activity	%	100.0
	12246127	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	103.0	CHEMBL2208	Homo sapiens	Residual Activity	%	103.0
	12246128	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	87.0	CHEMBL2208	Homo sapiens	Residual Activity	%	87.0
	12246129	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	96.0	CHEMBL2208	Homo sapiens	Residual Activity	%	96.0
	12246130	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	89.0	CHEMBL2208	Homo sapiens	Residual Activity	%	89.0
	12246131	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	93.0	CHEMBL2208	Homo sapiens	Residual Activity	%	93.0
	12246132	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	115.0	CHEMBL2208	Homo sapiens	Residual Activity	%	115.0
	12246133	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	96.0	CHEMBL2208	Homo sapiens	Residual Activity	%	96.0
	12248798	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	106.0	CHEMBL2208	Homo sapiens	Residual Activity	%	106.0
	12248799	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	133.0	CHEMBL2208	Homo sapiens	Residual Activity	%	133.0
	12248800	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	120.0	CHEMBL2208	Homo sapiens	Residual Activity	%	120.0
	12248801	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	85.0	CHEMBL2208	Homo sapiens	Residual Activity	%	85.0
	12248802	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	52.0	CHEMBL2208	Homo sapiens	Residual Activity	%	52.0
	12248803	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	66.0	CHEMBL2208	Homo sapiens	Residual Activity	%	66.0
	12248804	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	94.0	CHEMBL2208	Homo sapiens	Residual Activity	%	94.0
	12248805	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	91.0	CHEMBL2208	Homo sapiens	Residual Activity	%	91.0
	12248806	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	103.0	CHEMBL2208	Homo sapiens	Residual Activity	%	103.0
	12248807	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	94.0	CHEMBL2208	Homo sapiens	Residual Activity	%	94.0
	12248808	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	111.0	CHEMBL2208	Homo sapiens	Residual Activity	%	111.0
	12248809	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	105.0	CHEMBL2208	Homo sapiens	Residual Activity	%	105.0
	12248810	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	77.0	CHEMBL2208	Homo sapiens	Residual Activity	%	77.0
	12248811	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	67.0	CHEMBL2208	Homo sapiens	Residual Activity	%	67.0
	12248812	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	87.0	CHEMBL2208	Homo sapiens	Residual Activity	%	87.0
	12248813	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	77.0	CHEMBL2208	Homo sapiens	Residual Activity	%	77.0
	12248814	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	102.0	CHEMBL2208	Homo sapiens	Residual Activity	%	102.0
	12248815	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	98.0	CHEMBL2208	Homo sapiens	Residual Activity	%	98.0
	12248816	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	89.0	CHEMBL2208	Homo sapiens	Residual Activity	%	89.0
	12248817	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	90.0	CHEMBL2208	Homo sapiens	Residual Activity	%	90.0
	12248818	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	82.0	CHEMBL2208	Homo sapiens	Residual Activity	%	82.0
	12248819	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	71.0	CHEMBL2208	Homo sapiens	Residual Activity	%	71.0
	12248820	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	47.0	CHEMBL2208	Homo sapiens	Residual Activity	%	47.0
	12248821	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	87.0	CHEMBL2208	Homo sapiens	Residual Activity	%	87.0
	12248822	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	89.0	CHEMBL2208	Homo sapiens	Residual Activity	%	89.0
	12248823	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	120.0	CHEMBL2208	Homo sapiens	Residual Activity	%	120.0
	12248824	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	93.0	CHEMBL2208	Homo sapiens	Residual Activity	%	93.0
	12248825	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	85.0	CHEMBL2208	Homo sapiens	Residual Activity	%	85.0
	12248826	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	85.0	CHEMBL2208	Homo sapiens	Residual Activity	%	85.0
	12248827	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	85.0	CHEMBL2208	Homo sapiens	Residual Activity	%	85.0
	12248828	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	108.0	CHEMBL2208	Homo sapiens	Residual Activity	%	108.0
	12248829	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	93.0	CHEMBL2208	Homo sapiens	Residual Activity	%	93.0
	12248830	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	100.0	CHEMBL2208	Homo sapiens	Residual Activity	%	100.0
	12248831	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	73.0	CHEMBL2208	Homo sapiens	Residual Activity	%	73.0
	12248832	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	105.0	CHEMBL2208	Homo sapiens	Residual Activity	%	105.0
	12248833	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	95.0	CHEMBL2208	Homo sapiens	Residual Activity	%	95.0
	12248834	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	139.0	CHEMBL2208	Homo sapiens	Residual Activity	%	139.0
	12248835	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	87.0	CHEMBL2208	Homo sapiens	Residual Activity	%	87.0
	12248836	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	86.0	CHEMBL2208	Homo sapiens	Residual Activity	%	86.0
	12248837	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	80.0	CHEMBL2208	Homo sapiens	Residual Activity	%	80.0
	12248838	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	3.0	CHEMBL2208	Homo sapiens	Residual Activity	%	3.0
	12248839	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	93.0	CHEMBL2208	Homo sapiens	Residual Activity	%	93.0
	12248840	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	106.0	CHEMBL2208	Homo sapiens	Residual Activity	%	106.0
	12248841	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	93.0	CHEMBL2208	Homo sapiens	Residual Activity	%	93.0
	12248842	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	82.0	CHEMBL2208	Homo sapiens	Residual Activity	%	82.0
	12248843	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	92.0	CHEMBL2208	Homo sapiens	Residual Activity	%	92.0
	12248844	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	76.0	CHEMBL2208	Homo sapiens	Residual Activity	%	76.0
	12248845	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	98.0	CHEMBL2208	Homo sapiens	Residual Activity	%	98.0
	12248846	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	133.0	CHEMBL2208	Homo sapiens	Residual Activity	%	133.0
	12248847	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	85.0	CHEMBL2208	Homo sapiens	Residual Activity	%	85.0
	12248848	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	76.0	CHEMBL2208	Homo sapiens	Residual Activity	%	76.0
	12248849	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	71.0	CHEMBL2208	Homo sapiens	Residual Activity	%	71.0
	12248850	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	94.0	CHEMBL2208	Homo sapiens	Residual Activity	%	94.0
	12248851	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	92.0	CHEMBL2208	Homo sapiens	Residual Activity	%	92.0
	12248852	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	95.0	CHEMBL2208	Homo sapiens	Residual Activity	%	95.0
	12248853	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	85.0	CHEMBL2208	Homo sapiens	Residual Activity	%	85.0
	12248854	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	105.0	CHEMBL2208	Homo sapiens	Residual Activity	%	105.0
	12248855	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	78.0	CHEMBL2208	Homo sapiens	Residual Activity	%	78.0
	12248856	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	74.0	CHEMBL2208	Homo sapiens	Residual Activity	%	74.0
	12248857	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	87.0	CHEMBL2208	Homo sapiens	Residual Activity	%	87.0
	12248858	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	90.0	CHEMBL2208	Homo sapiens	Residual Activity	%	90.0
	12248859	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	89.0	CHEMBL2208	Homo sapiens	Residual Activity	%	89.0
	12248860	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	-6.0	CHEMBL2208	Homo sapiens	Residual Activity	%	-6.0
	12248861	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	78.0	CHEMBL2208	Homo sapiens	Residual Activity	%	78.0
	12248862	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	97.0	CHEMBL2208	Homo sapiens	Residual Activity	%	97.0
	12248863	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	50.0	CHEMBL2208	Homo sapiens	Residual Activity	%	50.0
	12248864	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	90.0	CHEMBL2208	Homo sapiens	Residual Activity	%	90.0
	12248865	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	86.0	CHEMBL2208	Homo sapiens	Residual Activity	%	86.0
	12248866	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	98.0	CHEMBL2208	Homo sapiens	Residual Activity	%	98.0
	12248867	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	94.0	CHEMBL2208	Homo sapiens	Residual Activity	%	94.0
	12248868	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	108.0	CHEMBL2208	Homo sapiens	Residual Activity	%	108.0
	12248869	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	102.0	CHEMBL2208	Homo sapiens	Residual Activity	%	102.0
	12248870	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	110.0	CHEMBL2208	Homo sapiens	Residual Activity	%	110.0
	12248871	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	39.0	CHEMBL2208	Homo sapiens	Residual Activity	%	39.0
	12248872	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	87.0	CHEMBL2208	Homo sapiens	Residual Activity	%	87.0
	12248873	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	126.0	CHEMBL2208	Homo sapiens	Residual Activity	%	126.0
	12248874	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	93.0	CHEMBL2208	Homo sapiens	Residual Activity	%	93.0
	12248875	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	83.0	CHEMBL2208	Homo sapiens	Residual Activity	%	83.0
	12248876	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	73.0	CHEMBL2208	Homo sapiens	Residual Activity	%	73.0
	12248877	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	93.0	CHEMBL2208	Homo sapiens	Residual Activity	%	93.0
	12248878	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	104.0	CHEMBL2208	Homo sapiens	Residual Activity	%	104.0
	12248879	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	112.0	CHEMBL2208	Homo sapiens	Residual Activity	%	112.0
	12248880	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	106.0	CHEMBL2208	Homo sapiens	Residual Activity	%	106.0
	12248881	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	92.0	CHEMBL2208	Homo sapiens	Residual Activity	%	92.0
	12248882	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	67.0	CHEMBL2208	Homo sapiens	Residual Activity	%	67.0
	12248883	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	61.0	CHEMBL2208	Homo sapiens	Residual Activity	%	61.0
	12248884	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	80.0	CHEMBL2208	Homo sapiens	Residual Activity	%	80.0
	12248885	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	88.0	CHEMBL2208	Homo sapiens	Residual Activity	%	88.0
	12248886	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	71.0	CHEMBL2208	Homo sapiens	Residual Activity	%	71.0
	12248887	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	109.0	CHEMBL2208	Homo sapiens	Residual Activity	%	109.0
	12248888	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	9.0	CHEMBL2208	Homo sapiens	Residual Activity	%	9.0
	12248889	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	81.0	CHEMBL2208	Homo sapiens	Residual Activity	%	81.0
	12248890	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	86.0	CHEMBL2208	Homo sapiens	Residual Activity	%	86.0
	12248891	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	69.0	CHEMBL2208	Homo sapiens	Residual Activity	%	69.0
	12248892	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	87.0	CHEMBL2208	Homo sapiens	Residual Activity	%	87.0
	12248893	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	82.0	CHEMBL2208	Homo sapiens	Residual Activity	%	82.0
	12248894	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	117.0	CHEMBL2208	Homo sapiens	Residual Activity	%	117.0
	12248895	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	102.0	CHEMBL2208	Homo sapiens	Residual Activity	%	102.0
	12248896	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	39.0	CHEMBL2208	Homo sapiens	Residual Activity	%	39.0
	12248897	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	90.0	CHEMBL2208	Homo sapiens	Residual Activity	%	90.0
	12248898	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	73.0	CHEMBL2208	Homo sapiens	Residual Activity	%	73.0
	12248899	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	69.0	CHEMBL2208	Homo sapiens	Residual Activity	%	69.0
	12248900	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	91.0	CHEMBL2208	Homo sapiens	Residual Activity	%	91.0
	12248901	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	95.0	CHEMBL2208	Homo sapiens	Residual Activity	%	95.0
	12248902	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	111.0	CHEMBL2208	Homo sapiens	Residual Activity	%	111.0
	12248903	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	106.0	CHEMBL2208	Homo sapiens	Residual Activity	%	106.0
	12248904	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	89.0	CHEMBL2208	Homo sapiens	Residual Activity	%	89.0
	12248905	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	93.0	CHEMBL2208	Homo sapiens	Residual Activity	%	93.0
	12248906	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	76.0	CHEMBL2208	Homo sapiens	Residual Activity	%	76.0
	12248907	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	95.0	CHEMBL2208	Homo sapiens	Residual Activity	%	95.0
	12248908	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	82.0	CHEMBL2208	Homo sapiens	Residual Activity	%	82.0
	12248909	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	99.0	CHEMBL2208	Homo sapiens	Residual Activity	%	99.0
	12248910	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	79.0	CHEMBL2208	Homo sapiens	Residual Activity	%	79.0
	12248911	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	92.0	CHEMBL2208	Homo sapiens	Residual Activity	%	92.0
	12248912	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	93.0	CHEMBL2208	Homo sapiens	Residual Activity	%	93.0
	12248913	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	102.0	CHEMBL2208	Homo sapiens	Residual Activity	%	102.0
	12248914	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	106.0	CHEMBL2208	Homo sapiens	Residual Activity	%	106.0
	12248915	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	105.0	CHEMBL2208	Homo sapiens	Residual Activity	%	105.0
	12248916	CHEMBL2219256	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	64.0	CHEMBL2208	Homo sapiens	Residual Activity	%	64.0
	12628455	CHEMBL2321178	Inhibition of MAPKAP-K2 (unknown origin) at 10 uM	B	N#Cc1c(N)nc2sc(C(=O)c3cccc(Cl)c3)c(N)c2c1-c1ccccc1Cl		CHEMBL2313853	>	Inhibition	%	50.0	CHEMBL2208	Homo sapiens	INH	%	50.0
	12629505	CHEMBL2319123	Inhibition of MAPKAP-K2 (unknown origin)	B	O=C(NCCCN1CCOC1=O)c1cnc(NCc2cc(Cl)ccc2Cl)nc1NC1CCCC1		CHEMBL2312304	>	IC50	nM	30000.0	CHEMBL2208	Homo sapiens	IC50	uM	30.0
	12629506	CHEMBL2319123	Inhibition of MAPKAP-K2 (unknown origin)	B	O=C(NCCCN1CCCC1=O)c1cnc(NCc2cc(Cl)ccc2Cl)nc1NC1CCCC1		CHEMBL2312303	>	IC50	nM	30000.0	CHEMBL2208	Homo sapiens	IC50	uM	30.0
	12629507	CHEMBL2319123	Inhibition of MAPKAP-K2 (unknown origin)	B	COc1ccccc1CNc1ncc(C(=O)NCCCN2CCCC2=O)c(NC2CCCC2)n1		CHEMBL2312301	>	IC50	nM	30000.0	CHEMBL2208	Homo sapiens	IC50	uM	30.0
	12629508	CHEMBL2319123	Inhibition of MAPKAP-K2 (unknown origin)	B	COc1ccc(CCNc2ncc(C(=O)NCCCN3CCCC3=O)c(NC3CCCC3)n2)cc1OC		CHEMBL2312290	>	IC50	nM	30000.0	CHEMBL2208	Homo sapiens	IC50	uM	30.0
	12631642	CHEMBL2319699	Inhibition of MAPKAP-K2 (unknown origin) in presence of ATP	B	Cc1cc(-c2cnc(Nc3cc(Cl)cc(Cl)c3)nc2NC2CCC(N(C)C)CC2)on1		CHEMBL2312654	=	IC50	nM	18570.0	CHEMBL2208	Homo sapiens	IC50	uM	18.57
	12631643	CHEMBL2319699	Inhibition of MAPKAP-K2 (unknown origin) in presence of ATP	B	CN1CCC(NC(=O)c2cnc(Nc3cc(Cl)cc(Cl)c3)nc2N[C@@H]2COC[C@H]2O)CC1		CHEMBL2312652	=	IC50	nM	30000.0	CHEMBL2208	Homo sapiens	IC50	uM	30.0
	12631644	CHEMBL2319699	Inhibition of MAPKAP-K2 (unknown origin) in presence of ATP	B	CN1CCC(NC(=O)c2cnc(Nc3cc(Cl)cc(Cl)c3)nc2NC2CCC(N(C)C)CC2)CC1		CHEMBL2312649	=	IC50	nM	30000.0	CHEMBL2208	Homo sapiens	IC50	uM	30.0
	12631645	CHEMBL2319699	Inhibition of MAPKAP-K2 (unknown origin) in presence of ATP	B	CN1CCC(NC(=O)c2cnc(NCc3cc(Cl)ccc3Cl)nc2NC2CCCC2)CC1		CHEMBL2312646	=	IC50	nM	30000.0	CHEMBL2208	Homo sapiens	IC50	uM	30.0
	12631646	CHEMBL2319699	Inhibition of MAPKAP-K2 (unknown origin) in presence of ATP	B	COc1ccccc1CNc1ncc(C(=O)NC2CCN(C)CC2)c(NC2CCCC2)n1		CHEMBL2312645	=	IC50	nM	30000.0	CHEMBL2208	Homo sapiens	IC50	uM	30.0
	12672999	CHEMBL2339726	Inhibition of recombinant MAPKAPK2 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336379	=	Activity	%	48.0	CHEMBL2208	Homo sapiens	Activity	%	48.0
	12673000	CHEMBL2339726	Inhibition of recombinant MAPKAPK2 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336377	=	Activity	%	41.0	CHEMBL2208	Homo sapiens	Activity	%	41.0
	12679738	CHEMBL2345849	Inhibition of MAPKAPK2 (unknown origin) at 1 uM	B	Cc1ccc(-c2ccc3ncc4c(c3n2)n(C2CCN(C(=O)[C@H](C)O)CC2)c(=O)n4C)cn1		CHEMBL2331664	=	Inhibition	%	-0.25	CHEMBL2208	Homo sapiens	INH	%	-0.25
	12693215	CHEMBL2343900	Inhibition of MAPK2 (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	nM	10000.0
	12700050	CHEMBL2344111	Inhibition of recombinant MAPKAPK2 (unknown origin) by FRET-based Z'-LYTE assay	B	CN1C/C(=C\c2ccccn2)C(=O)[C@@H](Cc2ccccn2)C1		CHEMBL2338335	>	IC50	nM	100000.0	CHEMBL2208	Homo sapiens	IC50	uM	100.0
	12700062	CHEMBL2344111	Inhibition of recombinant MAPKAPK2 (unknown origin) by FRET-based Z'-LYTE assay	B	CN1C/C(=C\c2ccccn2)C(=O)[C@H](Cc2ccccn2)C1		CHEMBL2338334	>	IC50	nM	100000.0	CHEMBL2208	Homo sapiens	IC50	uM	100.0
	12700074	CHEMBL2344111	Inhibition of recombinant MAPKAPK2 (unknown origin) by FRET-based Z'-LYTE assay	B	O=C1/C(=C/c2ccccn2)CSC/C1=C\c1ccccn1		CHEMBL2036343	=	IC50	nM	16000.0	CHEMBL2208	Homo sapiens	IC50	uM	16.0
	12700086	CHEMBL2344111	Inhibition of recombinant MAPKAPK2 (unknown origin) by FRET-based Z'-LYTE assay	B	CN1C/C(=C\c2ccccn2)C(=O)/C(=C/c2ccccn2)C1		CHEMBL2338333	=	IC50	nM	9800.0	CHEMBL2208	Homo sapiens	IC50	uM	9.8
	12700099	CHEMBL2344111	Inhibition of recombinant MAPKAPK2 (unknown origin) by FRET-based Z'-LYTE assay	B	O=C1/C(=C/c2ccccn2)CNC/C1=C\c1ccccn1		CHEMBL574646	=	IC50	nM	6700.0	CHEMBL2208	Homo sapiens	IC50	uM	6.7
	12700151	CHEMBL2342688	Inhibition of recombinant MAPKAPK2 (unknown origin) at 5 uM by FRET-based Z'-LYTE assay	B	O=C1/C(=C/c2ccccn2)CNC/C1=C\c1ccccn1		CHEMBL574646	=	Inhibition	%	85.0	CHEMBL2208	Homo sapiens	INH	%	85.0
	12700161	CHEMBL2344111	Inhibition of recombinant MAPKAPK2 (unknown origin) by FRET-based Z'-LYTE assay	B	O=C1/C(=C/c2ccccc2F)CNC/C1=C\c1ccccc1F		CHEMBL379849	>	IC50	nM	100000.0	CHEMBL2208	Homo sapiens	IC50	uM	100.0
	12716046	CHEMBL2350818	Inhibition of MAPK2 (unknown origin)	B	CNc1nc(C)c(-c2nc(Nc3cccc(N4CCCNCC4)c3)ncc2C#N)s1		CHEMBL2312185	>	IC50	nM	5000.0	CHEMBL2208	Homo sapiens	IC50	nM	5000.0
	12728784	CHEMBL2351174	Inhibition of MAPKAPK2 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	100.0	CHEMBL2208	Homo sapiens	Activity	%	100.0
	12729028	CHEMBL2351933	Inhibition of MAPKAPK2 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	98.0	CHEMBL2208	Homo sapiens	Activity	%	98.0
	12729913	CHEMBL2350058	Inhibition of MAPKAPK2 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	97.0	CHEMBL2208	Homo sapiens	Activity	%	97.0
	12730171	CHEMBL2351174	Inhibition of MAPKAPK2 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	104.0	CHEMBL2208	Homo sapiens	Activity	%	104.0
	13296914	CHEMBL2383893	Inhibition of human recombinant MK2 at 10 uM	B	NC(=O)c1cnc(NCC2CCCNC2)n2cc(-c3ccc(Cl)cc3)nc12		CHEMBL2381610	=	Inhibition	%	61.0	CHEMBL2208	Homo sapiens	INH	%	61.0
	13296915	CHEMBL2383893	Inhibition of human recombinant MK2 at 10 uM	B	CN1CCC(Nc2ncc(C(N)=O)c3nc(-c4ccc(Cl)cc4)cn23)CC1		CHEMBL2381609	=	Inhibition	%	69.0	CHEMBL2208	Homo sapiens	INH	%	69.0
	13296916	CHEMBL2383893	Inhibition of human recombinant MK2 at 10 uM	B	NC(=O)c1cnc(N[C@@H]2CCNC2)n2cc(-c3ccc(Cl)cc3)nc12		CHEMBL2381608	=	Inhibition	%	56.0	CHEMBL2208	Homo sapiens	INH	%	56.0
	13296917	CHEMBL2383893	Inhibition of human recombinant MK2 at 10 uM	B	NC(=O)c1cnc(N[C@H]2CCCNC2)n2cc(-c3ccc(Cl)cc3)nc12		CHEMBL2381606	=	Inhibition	%	67.0	CHEMBL2208	Homo sapiens	INH	%	67.0
	13296929	CHEMBL2383905	Inhibition of human recombinant MK2	B	NC(=O)c1ncc(N[C@H]2CC[C@H](N)CC2)c2nc(-c3ccc(Cl)cc3)cn12		CHEMBL2381612	=	IC50	nM	1980.0	CHEMBL2208	Homo sapiens	IC50	uM	1.98
	13296930	CHEMBL2383905	Inhibition of human recombinant MK2	B	NC(=O)c1ncc(N[C@H]2CCCNC2)c2nc(-c3ccc(Cl)cc3)cn12		CHEMBL2381611	=	IC50	nM	840.0	CHEMBL2208	Homo sapiens	IC50	uM	0.84
	13296931	CHEMBL2383905	Inhibition of human recombinant MK2	B	NC(=O)c1cnc(N[C@H]2CC[C@H](N)CC2)n2cc(-c3ccc(Cl)cc3)nc12		CHEMBL2381607	=	IC50	nM	4000.0	CHEMBL2208	Homo sapiens	IC50	uM	4.0
	13296932	CHEMBL2383905	Inhibition of human recombinant MK2	B	NC(=O)c1cnc(N[C@H]2CCCNC2)c2nc(-c3ccc(F)cc3)cn12		CHEMBL2381605	=	IC50	nM	910.0	CHEMBL2208	Homo sapiens	IC50	uM	0.91
	13296933	CHEMBL2383905	Inhibition of human recombinant MK2	B	NC(=O)c1cnc(N[C@H]2CCCNC2)c2nc(-c3ccc4ccccc4c3)cn12		CHEMBL2381604	=	IC50	nM	910.0	CHEMBL2208	Homo sapiens	IC50	uM	0.91
	13296934	CHEMBL2383905	Inhibition of human recombinant MK2	B	NC(=O)c1cnc(N[C@H]2CC[C@H](N)CC2)c2nc(-c3ccc(Cl)c(Cl)c3)cn12		CHEMBL2381603	=	IC50	nM	820.0	CHEMBL2208	Homo sapiens	IC50	uM	0.82
	13296935	CHEMBL2383905	Inhibition of human recombinant MK2	B	NC(=O)c1cnc(N[C@H]2CC[C@@H](N)CC2)c2nc(-c3ccc(Cl)cc3)cn12		CHEMBL2381602	=	IC50	nM	1900.0	CHEMBL2208	Homo sapiens	IC50	uM	1.9
	13296936	CHEMBL2383905	Inhibition of human recombinant MK2	B	NC(=O)c1cnc(N[C@H]2CC[C@H](N)CC2)c2nc(-c3ccc(Cl)cc3)cn12		CHEMBL2381601	=	IC50	nM	60.0	CHEMBL2208	Homo sapiens	IC50	uM	0.06
	13296937	CHEMBL2383905	Inhibition of human recombinant MK2	B	CN[C@H]1CC[C@H](Nc2ncc(C(N)=O)n3cc(-c4ccc(Cl)cc4)nc23)CC1		CHEMBL2381600	=	IC50	nM	400.0	CHEMBL2208	Homo sapiens	IC50	uM	0.4
	13296938	CHEMBL2383905	Inhibition of human recombinant MK2	B	NCCCNc1ncc(C(N)=O)n2cc(-c3ccc(Cl)cc3)nc12		CHEMBL2381599	=	IC50	nM	4090.0	CHEMBL2208	Homo sapiens	IC50	uM	4.09
	13296939	CHEMBL2383905	Inhibition of human recombinant MK2	B	NC(=O)c1cnc(NC2CCNCC2)c2nc(-c3ccc(Cl)cc3)cn12		CHEMBL2381598	=	IC50	nM	4150.0	CHEMBL2208	Homo sapiens	IC50	uM	4.15
	13296940	CHEMBL2383905	Inhibition of human recombinant MK2	B	NC(=O)c1cnc(Nc2cccnc2)c2nc(-c3ccc(Cl)cc3)cn12		CHEMBL2381597	=	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	13296941	CHEMBL2383905	Inhibition of human recombinant MK2	B	NC(=O)c1cnc(N[C@H]2CCCNC2)c2nc(-c3ccc(Cl)cc3)cn12		CHEMBL2381596	=	IC50	nM	650.0	CHEMBL2208	Homo sapiens	IC50	uM	0.65
	13321282	CHEMBL2389966	Inhibition of MK2 (unknown origin) phosphorylation using TAMRA labeled peptide as substrate incubated 30 mins before substrate addition measured after 30 mins	B	CCN(C(=O)c1ccc(-c2ccc(Cl)cc2)o1)c1ccc(N2CCNCC2)cc1		CHEMBL2017459	=	IC50	nM	130.0	CHEMBL2208	Homo sapiens	IC50	uM	0.13
	13321283	CHEMBL2389966	Inhibition of MK2 (unknown origin) phosphorylation using TAMRA labeled peptide as substrate incubated 30 mins before substrate addition measured after 30 mins	B	CN(C(=O)c1ccc(-c2ccc(Cl)cc2)o1)c1ccc(N2CCNCC2)cc1		CHEMBL2017458	=	IC50	nM	600.0	CHEMBL2208	Homo sapiens	IC50	uM	0.6
	13321284	CHEMBL2389966	Inhibition of MK2 (unknown origin) phosphorylation using TAMRA labeled peptide as substrate incubated 30 mins before substrate addition measured after 30 mins	B	O=C(Nc1ccc(N2CCNCC2)cc1)c1ccc(-c2ccc(Cl)cc2)o1		CHEMBL1938680	=	IC50	nM	5000.0	CHEMBL2208	Homo sapiens	IC50	uM	5.0
Active	13321308	CHEMBL2389963	Non-competitive inhibition of MK2 (unknown origin) using TAMRA labeled peptide as substrate in presence of ATP	B	N#Cc1ccc(-c2cc3c(o2)C(=O)N(Cc2ccccc2-c2cncnc2)c2ccc(N4CCNCC4)cc2C3)cc1		CHEMBL2385548		Inhibition	%		CHEMBL2208	Homo sapiens	INH		
	13321310	CHEMBL2389965	Inhibition of MK2 in human THP1 cells assessed as phosphorylation of HSP27 at serine78 after 60 mins	B	N#Cc1ccc(-c2cc3c(o2)C(=O)N(Cc2ccccc2-c2cncnc2)c2ccc(N4CCNCC4)cc2C3)cc1		CHEMBL2385548	=	EC50	nM	138.0	CHEMBL2208	Homo sapiens	EC50	nM	138.0
	13321311	CHEMBL2389966	Inhibition of MK2 (unknown origin) phosphorylation using TAMRA labeled peptide as substrate incubated 30 mins before substrate addition measured after 30 mins	B	N#Cc1ccc(-c2cc3c(o2)C(=O)N(Cc2ccccc2-c2cncnc2)c2ccc(C4CCNCC4)cc2C3(F)F)cc1		CHEMBL2385550	=	IC50	nM	8.9	CHEMBL2208	Homo sapiens	IC50	nM	8.9
	13321312	CHEMBL2389966	Inhibition of MK2 (unknown origin) phosphorylation using TAMRA labeled peptide as substrate incubated 30 mins before substrate addition measured after 30 mins	B	N#Cc1ccc(-c2cc3c(o2)C(=O)N(Cc2ccccc2-c2cncnc2)c2ccc(C4CCNCC4)cc2C3)cc1		CHEMBL2385549	=	IC50	nM	3.0	CHEMBL2208	Homo sapiens	IC50	nM	3.0
	13321313	CHEMBL2389966	Inhibition of MK2 (unknown origin) phosphorylation using TAMRA labeled peptide as substrate incubated 30 mins before substrate addition measured after 30 mins	B	N#Cc1ccc(-c2cc3c(o2)C(=O)N(Cc2ccccc2-c2cncnc2)c2ccc(N4CCNCC4)cc2C3)cc1		CHEMBL2385548	=	IC50	nM	1.9	CHEMBL2208	Homo sapiens	IC50	nM	1.9
	13321314	CHEMBL2389966	Inhibition of MK2 (unknown origin) phosphorylation using TAMRA labeled peptide as substrate incubated 30 mins before substrate addition measured after 30 mins	B	O=C1c2oc(-c3ccc(Cl)cc3)cc2Cc2cc(N3CCNCC3)ccc2N1Cc1ccccc1-c1cncnc1		CHEMBL2385547	=	IC50	nM	5.7	CHEMBL2208	Homo sapiens	IC50	nM	5.7
	13321315	CHEMBL2389966	Inhibition of MK2 (unknown origin) phosphorylation using TAMRA labeled peptide as substrate incubated 30 mins before substrate addition measured after 30 mins	B	COc1ccncc1-c1ccccc1CN1C(=O)c2oc(-c3ccc(C#N)cc3)cc2Cc2cc(N3CCNCC3)ccc21		CHEMBL2385546	=	IC50	nM	6.8	CHEMBL2208	Homo sapiens	IC50	nM	6.8
	13321316	CHEMBL2389966	Inhibition of MK2 (unknown origin) phosphorylation using TAMRA labeled peptide as substrate incubated 30 mins before substrate addition measured after 30 mins	B	COc1ncccc1-c1ccccc1CN1C(=O)c2oc(-c3ccc(C#N)cc3)cc2Cc2cc(N3CCNCC3)ccc21		CHEMBL2385545	=	IC50	nM	8.4	CHEMBL2208	Homo sapiens	IC50	nM	8.4
	13321317	CHEMBL2389966	Inhibition of MK2 (unknown origin) phosphorylation using TAMRA labeled peptide as substrate incubated 30 mins before substrate addition measured after 30 mins	B	N#Cc1ccc(-c2cc3c(o2)C(=O)N(Cc2ccccc2-c2cccnc2)c2ccc(N4CCNCC4)cc2C3)cc1		CHEMBL2385544	=	IC50	nM	21.0	CHEMBL2208	Homo sapiens	IC50	nM	21.0
	13321318	CHEMBL2389966	Inhibition of MK2 (unknown origin) phosphorylation using TAMRA labeled peptide as substrate incubated 30 mins before substrate addition measured after 30 mins	B	O=C1c2oc(-c3ccc(Cl)cc3)cc2Cc2cc(N3CCNCC3)ccc2N1Cc1ccccc1-c1cccnc1		CHEMBL2385543	=	IC50	nM	22.0	CHEMBL2208	Homo sapiens	IC50	nM	22.0
	13321319	CHEMBL2389966	Inhibition of MK2 (unknown origin) phosphorylation using TAMRA labeled peptide as substrate incubated 30 mins before substrate addition measured after 30 mins	B	O=C1c2oc(-c3ccc(Cl)cc3)cc2Cc2cc(N3CCNCC3)ccc2N1Cc1ccccc1-c1ccncc1		CHEMBL2385085	=	IC50	nM	39.0	CHEMBL2208	Homo sapiens	IC50	nM	39.0
	13321320	CHEMBL2389966	Inhibition of MK2 (unknown origin) phosphorylation using TAMRA labeled peptide as substrate incubated 30 mins before substrate addition measured after 30 mins	B	COc1cncc(-c2ccccc2CN2C(=O)c3oc(-c4ccc(C#N)cc4)cc3Cc3cc(N4CCNCC4)ccc32)c1		CHEMBL2385542	=	IC50	nM	4.9	CHEMBL2208	Homo sapiens	IC50	nM	4.9
	13321321	CHEMBL2389966	Inhibition of MK2 (unknown origin) phosphorylation using TAMRA labeled peptide as substrate incubated 30 mins before substrate addition measured after 30 mins	B	COc1cc(-c2ccccc2CN2C(=O)c3oc(-c4ccc(Cl)cc4)cc3Cc3cc(N4CCNCC4)ccc32)ccn1		CHEMBL2385541	=	IC50	nM	21.0	CHEMBL2208	Homo sapiens	IC50	nM	21.0
	13321322	CHEMBL2389966	Inhibition of MK2 (unknown origin) phosphorylation using TAMRA labeled peptide as substrate incubated 30 mins before substrate addition measured after 30 mins	B	N#Cc1ccc(-c2cc3c(o2)C(=O)N(Cc2ccccc2-c2cncc(F)c2)c2ccc(N4CCNCC4)cc2C3)cc1		CHEMBL2385540	=	IC50	nM	14.0	CHEMBL2208	Homo sapiens	IC50	nM	14.0
	13321323	CHEMBL2389966	Inhibition of MK2 (unknown origin) phosphorylation using TAMRA labeled peptide as substrate incubated 30 mins before substrate addition measured after 30 mins	B	N#Cc1ccc(-c2cc3c(o2)C(=O)N(Cc2ccccc2-c2cccc(F)c2)c2ccc(N4CCNCC4)cc2C3)cc1		CHEMBL2385539	=	IC50	nM	74.0	CHEMBL2208	Homo sapiens	IC50	nM	74.0
	13321324	CHEMBL2389966	Inhibition of MK2 (unknown origin) phosphorylation using TAMRA labeled peptide as substrate incubated 30 mins before substrate addition measured after 30 mins	B	N#Cc1ccc(-c2cc3c(o2)C(=O)Nc2ccc(C4CCNCC4)cc2C3)cc1		CHEMBL2385538	=	IC50	nM	28.0	CHEMBL2208	Homo sapiens	IC50	nM	28.0
	13321325	CHEMBL2389966	Inhibition of MK2 (unknown origin) phosphorylation using TAMRA labeled peptide as substrate incubated 30 mins before substrate addition measured after 30 mins	B	O=C1Nc2ccc(C3CCNCC3)cc2Cc2cc(-c3ccc(Cl)cc3)oc21		CHEMBL2385537	=	IC50	nM	14.0	CHEMBL2208	Homo sapiens	IC50	nM	14.0
	13321326	CHEMBL2389966	Inhibition of MK2 (unknown origin) phosphorylation using TAMRA labeled peptide as substrate incubated 30 mins before substrate addition measured after 30 mins	B	N#Cc1ccc(-c2cc3c(o2)C(=O)Nc2ccc(N4CCNCC4)cc2C3)cc1		CHEMBL1938683	=	IC50	nM	110.0	CHEMBL2208	Homo sapiens	IC50	nM	110.0
	13321327	CHEMBL2389966	Inhibition of MK2 (unknown origin) phosphorylation using TAMRA labeled peptide as substrate incubated 30 mins before substrate addition measured after 30 mins	B	O=C1c2oc(-c3ccc(Cl)cc3)cc2Cc2cc(N3CCNCC3)ccc2N1Cc1ccccc1Br		CHEMBL2385536	=	IC50	nM	52.0	CHEMBL2208	Homo sapiens	IC50	nM	52.0
	13321328	CHEMBL2389966	Inhibition of MK2 (unknown origin) phosphorylation using TAMRA labeled peptide as substrate incubated 30 mins before substrate addition measured after 30 mins	B	O=C1c2oc(-c3ccc(Cl)cc3)cc2Cc2cc(N3CCNCC3)ccc2N1Cc1ccccn1		CHEMBL2385535	=	IC50	nM	64.0	CHEMBL2208	Homo sapiens	IC50	nM	64.0
	13321329	CHEMBL2389966	Inhibition of MK2 (unknown origin) phosphorylation using TAMRA labeled peptide as substrate incubated 30 mins before substrate addition measured after 30 mins	B	O=C1c2oc(-c3ccc(Cl)cc3)cc2Cc2cc(N3CCNCC3)ccc2N1CC(F)F		CHEMBL2385534	=	IC50	nM	107.0	CHEMBL2208	Homo sapiens	IC50	nM	107.0
	13321330	CHEMBL2389966	Inhibition of MK2 (unknown origin) phosphorylation using TAMRA labeled peptide as substrate incubated 30 mins before substrate addition measured after 30 mins	B	O=C1c2oc(-c3ccc(Cl)cc3)cc2Cc2cc(N3CCNCC3)ccc2N1CC1CC1		CHEMBL2385533	=	IC50	nM	110.0	CHEMBL2208	Homo sapiens	IC50	nM	110.0
	13321331	CHEMBL2389966	Inhibition of MK2 (unknown origin) phosphorylation using TAMRA labeled peptide as substrate incubated 30 mins before substrate addition measured after 30 mins	B	C=CCN1C(=O)c2oc(-c3ccc(Cl)cc3)cc2Cc2cc(N3CCNCC3)ccc21		CHEMBL2385532	=	IC50	nM	12.0	CHEMBL2208	Homo sapiens	IC50	nM	12.0
	13321332	CHEMBL2389966	Inhibition of MK2 (unknown origin) phosphorylation using TAMRA labeled peptide as substrate incubated 30 mins before substrate addition measured after 30 mins	B	CN1C(=O)c2oc(-c3ccc(Cl)cc3)cc2Cc2cc(N3CCNCC3)ccc21		CHEMBL2385531	=	IC50	nM	79.0	CHEMBL2208	Homo sapiens	IC50	nM	79.0
	13321333	CHEMBL2389966	Inhibition of MK2 (unknown origin) phosphorylation using TAMRA labeled peptide as substrate incubated 30 mins before substrate addition measured after 30 mins	B	O=C1Nc2ccc(N3CCNCC3)cc2Cc2cc(-c3ccc(Cl)cc3)oc21		CHEMBL1938682	=	IC50	nM	96.0	CHEMBL2208	Homo sapiens	IC50	nM	96.0
Not Active	13328763	CHEMBL2388488	Inhibition of MAPKAPK2 (unknown origin)	B	Cc1cccc2nc(Cn3cnc4ccccc43)cc(=O)n12		CHEMBL2386917		Inhibition	%		CHEMBL2208	Homo sapiens	INH		
	13351566	CHEMBL2399782	Inhibition of human MAPKAP-K2 at 10 uM relative to control	B	Cl.O=c1[nH]nc2c(NCCCc3ccncc3)cc(Cl)cn12		CHEMBL2397859	=	Inhibition	%	19.0	CHEMBL2208	Homo sapiens	INH	%	19.0
	13375788	CHEMBL2404182	Inhibition of MAPKAPK2 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	1.0	CHEMBL2208	Homo sapiens	INH	%	1.0
	13415561	CHEMBL2424332	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Inhibition	%	46.0	CHEMBL2208	Homo sapiens	INH	%	46.0
	13415562	CHEMBL2424332	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=C(C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1)N1CCOCC1		CHEMBL2420907	=	Inhibition	%	11.0	CHEMBL2208	Homo sapiens	INH	%	11.0
	13415563	CHEMBL2424332	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	CN(C)C(=O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420906	=	Inhibition	%	10.0	CHEMBL2208	Homo sapiens	INH	%	10.0
	13415564	CHEMBL2424332	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	CNC(=O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420905	=	Inhibition	%	10.0	CHEMBL2208	Homo sapiens	INH	%	10.0
	13415565	CHEMBL2424332	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	OCC1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2417586	=	Inhibition	%	22.0	CHEMBL2208	Homo sapiens	INH	%	22.0
	13415566	CHEMBL2424332	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=C(O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420904	=	Inhibition	%	21.0	CHEMBL2208	Homo sapiens	INH	%	21.0
	13415567	CHEMBL2424332	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	COC(=O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420903	=	Inhibition	%	6.0	CHEMBL2208	Homo sapiens	INH	%	6.0
	13415568	CHEMBL2424332	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(C2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1		CHEMBL2420902	=	Inhibition	%	17.0	CHEMBL2208	Homo sapiens	INH	%	17.0
	13415569	CHEMBL2424332	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1		CHEMBL2420901	=	Inhibition	%	15.0	CHEMBL2208	Homo sapiens	INH	%	15.0
	13415570	CHEMBL2424332	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420900	=	Inhibition	%	3.0	CHEMBL2208	Homo sapiens	INH	%	3.0
	13415571	CHEMBL2424332	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(C2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420899	=	Inhibition	%	3.0	CHEMBL2208	Homo sapiens	INH	%	3.0
	13415572	CHEMBL2424332	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CC1)CC(O)CCN2		CHEMBL2420898	=	Inhibition	%	1.0	CHEMBL2208	Homo sapiens	INH	%	1.0
	13415573	CHEMBL2424332	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	OC1CCNC2(CCN(c3ncnc4[nH]cnc34)CC2)C1		CHEMBL2420897	=	Inhibition	%	8.0	CHEMBL2208	Homo sapiens	INH	%	8.0
	13415574	CHEMBL2424332	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCC(O)CN2)CC1		CHEMBL2420928	=	Inhibition	%	19.0	CHEMBL2208	Homo sapiens	INH	%	19.0
	13415575	CHEMBL2424332	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	OC1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420927	=	Inhibition	%	11.0	CHEMBL2208	Homo sapiens	INH	%	11.0
	13415576	CHEMBL2424332	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCOC3)CC2)c2nc[nH]c2n1		CHEMBL2420926	=	Inhibition	%	15.0	CHEMBL2208	Homo sapiens	INH	%	15.0
	13415577	CHEMBL2424332	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCCO3)CC2)c2nc[nH]c2n1		CHEMBL2420925	=	Inhibition	%	20.0	CHEMBL2208	Homo sapiens	INH	%	20.0
	13415578	CHEMBL2424332	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCCC3)CC2)c2nc[nH]c2n1		CHEMBL2420924	=	Inhibition	%	10.0	CHEMBL2208	Homo sapiens	INH	%	10.0
	13415579	CHEMBL2424332	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCCC12CCNCC2		CHEMBL2420923	=	Inhibition	%	10.0	CHEMBL2208	Homo sapiens	INH	%	10.0
	13415580	CHEMBL2424332	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCCC2(CCCNC2)C1		CHEMBL2420922	=	Inhibition	%	4.0	CHEMBL2208	Homo sapiens	INH	%	4.0
	13415581	CHEMBL2424332	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCCC2(CCNCC2)C1		CHEMBL2420921	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	13415582	CHEMBL2424332	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCNC2)CC1		CHEMBL2420920	=	Inhibition	%	13.0	CHEMBL2208	Homo sapiens	INH	%	13.0
	13415583	CHEMBL2424332	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCCNC2)CC1		CHEMBL2420919	=	Inhibition	%	8.0	CHEMBL2208	Homo sapiens	INH	%	8.0
	13415584	CHEMBL2424332	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCCN2)CC1		CHEMBL2420918	=	Inhibition	%	27.0	CHEMBL2208	Homo sapiens	INH	%	27.0
	13415585	CHEMBL2424332	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCCCN2)CC1		CHEMBL2420917	=	Inhibition	%	14.0	CHEMBL2208	Homo sapiens	INH	%	14.0
	13415586	CHEMBL2424332	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	NC1(Cc2ccccc2)CCN(S(=O)(=O)c2cccc3cnccc23)CC1		CHEMBL2420916	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	13415587	CHEMBL2424332	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCCC23CCNCC3)c2nc[nH]c2n1		CHEMBL2420915	=	Inhibition	%	17.0	CHEMBL2208	Homo sapiens	INH	%	17.0
	13415588	CHEMBL2424332	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCCC3(CCCNC3)C2)c2nc[nH]c2n1		CHEMBL2420914	=	Inhibition	%	11.0	CHEMBL2208	Homo sapiens	INH	%	11.0
	13415589	CHEMBL2424332	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCCC3(CCNCC3)C2)c2nc[nH]c2n1		CHEMBL2420913	=	Inhibition	%	19.0	CHEMBL2208	Homo sapiens	INH	%	19.0
	13415590	CHEMBL2424332	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCNC3)CC2)c2nc[nH]c2n1		CHEMBL2420912	=	Inhibition	%	66.0	CHEMBL2208	Homo sapiens	INH	%	66.0
	13415591	CHEMBL2424332	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCNC3)CC2)c2nc[nH]c2n1		CHEMBL2420911	=	Inhibition	%	74.0	CHEMBL2208	Homo sapiens	INH	%	74.0
	13415592	CHEMBL2424332	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCN3)CC2)c2nc[nH]c2n1		CHEMBL2420910	=	Inhibition	%	48.0	CHEMBL2208	Homo sapiens	INH	%	48.0
	13415593	CHEMBL2424332	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCCN3)CC2)c2nc[nH]c2n1		CHEMBL2420909	=	Inhibition	%	24.0	CHEMBL2208	Homo sapiens	INH	%	24.0
	13415594	CHEMBL2424332	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	NC1(Cc2ccccc2)CCN(c2ncnc3[nH]cnc23)CC1		CHEMBL2420908	=	Inhibition	%	23.0	CHEMBL2208	Homo sapiens	INH	%	23.0
	13439822	CHEMBL2426967	Competitive binding affinity to MAPKAPK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL2208	Homo sapiens	INH	%	50.0
	13440854	CHEMBL2429596	Inhibition of MAPKAP-K2 (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3cnc4c(N)ncnc43)cc2)cc1	Outside typical range	CHEMBL2425144	=	Inhibition	%	-13.0	CHEMBL2208	Homo sapiens	INH	%	-13.0
	13445655	CHEMBL2426967	Competitive binding affinity to MAPKAPK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL2208	Homo sapiens	INH	%	50.0
	13451642	CHEMBL2426967	Competitive binding affinity to MAPKAPK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL2208	Homo sapiens	INH	%	50.0
	13453032	CHEMBL2429596	Inhibition of MAPKAP-K2 (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-c3cccnc3)cc2)cc1		CHEMBL2425156	=	Inhibition	%	1.0	CHEMBL2208	Homo sapiens	INH	%	1.0
	13453080	CHEMBL2429596	Inhibition of MAPKAP-K2 (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3cnc(C)c3)cc2)cc1		CHEMBL2425145	=	Inhibition	%	-6.0	CHEMBL2208	Homo sapiens	INH	%	-6.0
	13465302	CHEMBL2433273	Inhibition of human MAPKAPK2 assessed as residual activity at 25 uM relative to control	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349	=	Activity	%	88.0	CHEMBL2208	Homo sapiens	Activity	%	88.0
	13465325	CHEMBL2433651	Inhibition of human MAPKAPK2 assessed as residual activity at 10 uM relative to control	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Activity	%	99.0	CHEMBL2208	Homo sapiens	Activity	%	99.0
	13465351	CHEMBL2433461	Inhibition of human MAPKAPK2 assessed as residual activity at 1 uM relative to control	B	CC(=O)Nc1nccc(-c2c(-c3ccccc3)noc2C)n1		CHEMBL2430324	=	Activity	%	94.66	CHEMBL2208	Homo sapiens	Activity	%	94.66
	13465382	CHEMBL2433651	Inhibition of human MAPKAPK2 assessed as residual activity at 10 uM relative to control	B	CC(=O)Nc1nccc(-c2c(-c3ccccc3)noc2C)n1		CHEMBL2430324	=	Activity	%	123.86	CHEMBL2208	Homo sapiens	Activity	%	123.86
	13465413	CHEMBL2433461	Inhibition of human MAPKAPK2 assessed as residual activity at 1 uM relative to control	B	CC(=O)Nc1cccc(-c2cnc3[nH]nc(C)c3c2)c1		CHEMBL2430323	=	Activity	%	63.77	CHEMBL2208	Homo sapiens	Activity	%	63.77
	13465444	CHEMBL2433651	Inhibition of human MAPKAPK2 assessed as residual activity at 10 uM relative to control	B	CC(=O)Nc1cccc(-c2cnc3[nH]nc(C)c3c2)c1		CHEMBL2430323	=	Activity	%	96.44	CHEMBL2208	Homo sapiens	Activity	%	96.44
	13507551	CHEMBL2443993	Inhibition of MK2 (unknown origin)	B	CN(C)c1ccc(Oc2cc(O)cc(O)c2-c2cc(C(=O)NC3CCN(C4CCC5(CC4)OCCO5)CC3)no2)cc1		CHEMBL2443026	>	IC50	nM	10.0	CHEMBL2208	Homo sapiens	IC50	nM	10.0
	13507552	CHEMBL2443993	Inhibition of MK2 (unknown origin)	B	CC(C)Nc1ccc(Oc2cc(O)cc(O)c2-c2cc(C(=O)NC3CCN(C)CC3)no2)cc1		CHEMBL2443139	>	IC50	nM	10.0	CHEMBL2208	Homo sapiens	IC50	nM	10.0
	13507553	CHEMBL2443993	Inhibition of MK2 (unknown origin)	B	CN1CCC(NC(=O)c2cc(-c3c(O)cc(O)cc3Oc3ccc(N(C)C)cc3)on2)CC1		CHEMBL2443138	>	IC50	nM	10.0	CHEMBL2208	Homo sapiens	IC50	nM	10.0
	13507554	CHEMBL2443993	Inhibition of MK2 (unknown origin)	B	CN1CCC(NC(=O)c2cc(-c3c(O)cc(O)cc3Oc3ccc([N+](=O)[O-])cc3)on2)CC1		CHEMBL2443044	>	IC50	nM	10.0	CHEMBL2208	Homo sapiens	IC50	nM	10.0
Not Active	13508500	CHEMBL2447375	Inhibition of MAPKAPK2 (unknown origin) at 30 uM	B	O=C(Nc1ccc2c(c1)B(O)OC2)c1c(C(F)(F)F)ccc(Cl)c1F		CHEMBL2441375		Inhibition	%		CHEMBL2208	Homo sapiens	INH		
	13872105	CHEMBL3101412	Inhibition of human MAPKAP-K2 assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	67.0	CHEMBL2208	Homo sapiens	Activity	%	67.0
	13953261	CHEMBL3130689	Inhibition of human MAPKAP-K2 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125727	=	Activity	%	101.0	CHEMBL2208	Homo sapiens	Activity	%	101.0
	13953276	CHEMBL3130689	Inhibition of human MAPKAP-K2 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125726	=	Activity	%	98.0	CHEMBL2208	Homo sapiens	Activity	%	98.0
	13954693	CHEMBL3130689	Inhibition of human MAPKAP-K2 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125728	=	Activity	%	94.0	CHEMBL2208	Homo sapiens	Activity	%	94.0
	13966040	CHEMBL3136655	Inhibition of human full length MAPKAPK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 1000 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	67.0	CHEMBL2208	Homo sapiens	INH	%	67.0
	13973315	CHEMBL3135053	Inhibition of human full length MAPKAPK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.1 uM after 90 mins by microfluidic peptide phosphorylation assay	B	C[C@H](CN(C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N		CHEMBL1928705	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	13974033	CHEMBL3136625	Inhibition of human full length MAPKAPK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.35 uM after 90 mins by microfluidic peptide phosphorylation assay	B	COC(=O)c1cnc(Nc2cnc(C#N)cn2)cc1NCC1CCNCC1		CHEMBL1928692	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	13974124	CHEMBL3135770	Inhibition of human full length MAPKAPK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 9 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]c4cnccc4c23)CCO1		CHEMBL1928677	=	Inhibition	%	19.5	CHEMBL2208	Homo sapiens	INH	%	19.5
	13974215	CHEMBL3135288	Inhibition of human full length MAPKAPK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 90 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]cnc23)CCO1		CHEMBL560373	=	Inhibition	%	54.0	CHEMBL2208	Homo sapiens	INH	%	54.0
	13974953	CHEMBL3136975	Inhibition of human full length MAPKAPK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 420 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1nc(N2CCOCC2)c2nc[nH]c2n1		CHEMBL271138	=	Inhibition	%	74.0	CHEMBL2208	Homo sapiens	INH	%	74.0
	13975044	CHEMBL3136122	Inhibition of human full length MAPKAPK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.02 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL598194	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	13975135	CHEMBL3135846	Inhibition of human full length MAPKAPK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.06 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL263664	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	13975226	CHEMBL3136384	Inhibition of human full length MAPKAPK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL259141	=	Inhibition	%	33.0	CHEMBL2208	Homo sapiens	INH	%	33.0
	13975869	CHEMBL3135484	Inhibition of human full length MAPKAPK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 8 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL261249	=	Inhibition	%	81.0	CHEMBL2208	Homo sapiens	INH	%	81.0
	13975962	CHEMBL3137016	Inhibition of human full length MAPKAPK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	Clc1ccc(C2(c3ccc(-c4ncnc5[nH]cnc45)cc3)CCNCC2)cc1		CHEMBL228133	=	Inhibition	%	10.5	CHEMBL2208	Homo sapiens	INH	%	10.5
	13976053	CHEMBL3136037	Inhibition of human full length MAPKAPK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 95 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL227727	=	Inhibition	%	56.5	CHEMBL2208	Homo sapiens	INH	%	56.5
	13976144	CHEMBL3135081	Inhibition of human full length MAPKAPK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 70 uM after 90 mins by microfluidic peptide phosphorylation assay	B	CNCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL376388	=	Inhibition	%	77.0	CHEMBL2208	Homo sapiens	INH	%	77.0
	14582543	CHEMBL3242544	Inhibition of human MAPKAP-K2 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	97.0	CHEMBL2208	Homo sapiens	Activity	%	97.0
	14645930	CHEMBL3270971	Inhibition of MK2 (unknown origin)	B	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1nc(Nc2ccc(C(=O)N3CCOCC3)cc2)c2nc[nH]c2n1		CHEMBL3263640	=	IC50	nM	13330.0	CHEMBL2208	Homo sapiens	IC50	uM	13.33
	14664224	CHEMBL3270890	Inhibition of MAPKAPK2 (unknown origin) at 1 uM relative to control	B	CCOC(=O)c1sc(-c2ccncc2)nc1O		CHEMBL3261228	=	Inhibition	%	94.0	CHEMBL2208	Homo sapiens	INH	%	94.0
	14664225	CHEMBL3270890	Inhibition of MAPKAPK2 (unknown origin) at 1 uM relative to control	B	NC(=O)c1sc(-c2ccnc(N)n2)nc1-c1ccc(Cl)cc1Cl		CHEMBL3261514	=	Inhibition	%	96.0	CHEMBL2208	Homo sapiens	INH	%	96.0
	14664226	CHEMBL3270890	Inhibition of MAPKAPK2 (unknown origin) at 1 uM relative to control	B	COc1ccc(-c2nc(-c3ccnc(N)n3)sc2C(N)=O)c(Cl)c1		CHEMBL3261517	=	Inhibition	%	100.0	CHEMBL2208	Homo sapiens	INH	%	100.0
	14668875	CHEMBL3269298	Inhibition of MAPK2 (unknown origin) assessed as residual activity at 1 uM	B	CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4ccnc(N)n4)c3c2)n1		CHEMBL3264257	=	Activity	%	67.0	CHEMBL2208	Homo sapiens	Activity	%	67.0
	14710310	CHEMBL3292190	Inhibition of human MAPKAP-K2 assessed as residual activity at 10 uM relative to control	B	CC1=CC(=O)N(Nc2nc(-c3cccs3)nc3scc(-c4ccccc4)c23)C1=O		CHEMBL3290628	=	Activity	%	102.0	CHEMBL2208	Homo sapiens	Activity	%	102.0
	14710311	CHEMBL3292190	Inhibition of human MAPKAP-K2 assessed as residual activity at 10 uM relative to control	B	CC1=CC(=O)N(Nc2nc(-c3cccs3)nc3scc(-c4cccc(OCCN5CCCCC5)c4)c23)C1=O.Cl		CHEMBL3290631	=	Activity	%	94.0	CHEMBL2208	Homo sapiens	Activity	%	94.0
	14751783	CHEMBL3300954	Inhibition of MAPKAPK2 (unknown origin)	B	CC(C)(C)CNC(=O)CC1CNC(=O)c2cc(-c3ccsc3)cn21		CHEMBL3298400	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	14751784	CHEMBL3300954	Inhibition of MAPKAPK2 (unknown origin)	B	CN1CCN(C[C@@H](NC(=O)C[C@H]2CNC(=O)c3cc(-c4cccc(Cl)c4)cn32)C2CCCCC2)CC1		CHEMBL3297762	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	14983184	CHEMBL3385015	Inhibition of MAPKAPK2 (unknown origin) at 1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	-1.0	CHEMBL2208	Homo sapiens	INH	%	-1.0
	14984426	CHEMBL3384365	Inhibition of MAPKAPK2 (unknown origin) at 0.1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	15008057	CHEMBL3369096	Inhibition of human MAPKAP-K2 at 1 uM by radiometric Assay	B	NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)Cc4ccccc4)cc23)c1		CHEMBL3330255	=	Inhibition	%	4.0	CHEMBL2208	Homo sapiens	INH	%	4.0
	15008058	CHEMBL3369096	Inhibition of human MAPKAP-K2 at 1 uM by radiometric Assay	B	COC(C(=O)Nc1ccc2[nH]nc(-c3cccc(S(N)(=O)=O)c3)c2c1)c1ccccc1	Outside typical range	CHEMBL3330401	=	Inhibition	%	-14.0	CHEMBL2208	Homo sapiens	INH	%	-14.0
	15008059	CHEMBL3369096	Inhibition of human MAPKAP-K2 at 1 uM by radiometric Assay	B	NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)C(c4ccsc4)N4CCCC4)cc23)c1	Outside typical range	CHEMBL3330410	=	Inhibition	%	-34.0	CHEMBL2208	Homo sapiens	INH	%	-34.0
	15018632	CHEMBL3361524	Inhibition of MAPKAPK2 (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	4.3	CHEMBL2208	Homo sapiens	INH	%	4.3
	15019186	CHEMBL3364379	Inhibition of MAPKAPK2 (unknown origin) at 1 uM in presence of 100 uM ATP	B	C=CC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C		CHEMBL3298512	=	Inhibition	%	-7.0	CHEMBL2208	Homo sapiens	INH	%	-7.0
	15036853	CHEMBL3381086	Inhibition of MAPKAPK2 (unknown origin)	B	Nc1nc2c3c(F)cccc3nc(Cc3ccc4c(c3)OCO4)n2n1		CHEMBL3309990	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	15036854	CHEMBL3381086	Inhibition of MAPKAPK2 (unknown origin)	B	Nc1ccc2c(c1)nc(Cc1ccc3c(c1)OCO3)n1nc(N)nc21		CHEMBL3309995	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	15036855	CHEMBL3381086	Inhibition of MAPKAPK2 (unknown origin)	B	OCCCNc1ccc2c(c1)nc(-c1ccc3c(c1)OCO3)n1ncnc21		CHEMBL3309997	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	15036856	CHEMBL3381086	Inhibition of MAPKAPK2 (unknown origin)	B	Nc1nc2c3ccc(NCCO)cc3nc(Cc3ccc4c(c3)OCO4)n2n1		CHEMBL3309998	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	15036857	CHEMBL3381086	Inhibition of MAPKAPK2 (unknown origin)	B	CN1CCN(c2cc(F)c3c(c2)nc(Cc2ccc4c(c2)OCO4)n2nc(N)nc32)CC1		CHEMBL3310151	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
Not Determined	15053944	CHEMBL3367279	Inhibition of MK2 in human THP1 cells assessed as reduction in LPS-induced HSP27 Ser78 phosphorylation after 60 mins	B	O=C1c2oc(-c3ccc(Cl)cc3)cc2Cc2cc(N3CCNCC3)ccc2N1Cc1ccccc1-c1cncnc1		CHEMBL2385547		IC50			CHEMBL2208	Homo sapiens	IC50		
	15053945	CHEMBL3367279	Inhibition of MK2 in human THP1 cells assessed as reduction in LPS-induced HSP27 Ser78 phosphorylation after 60 mins	B	Clc1ccc(-c2ccc(-c3nccn3-c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL3314140	=	IC50	nM	2139.0	CHEMBL2208	Homo sapiens	IC50	nM	2139.0
Active	15053972	CHEMBL3369593	Non-ATP competitive inhibition of MK2 (unknown origin) incubated for 30 mins in presence of 1 uM and 100 uM ATP by MK2 IMAP assay	B	Clc1ccc(-c2ccc(-c3nccn3-c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL3314140		Inhibition	%		CHEMBL2208	Homo sapiens	INH		
	15053973	CHEMBL3369592	Inhibition of MK2 (unknown origin) incubated for 30 mins by MK2 IMAP assay	B	O=C1c2oc(-c3ccc(Cl)cc3)cc2Cc2cc(N3CCNCC3)ccc2N1Cc1ccccc1-c1cncnc1		CHEMBL2385547	=	IC50	nM	5.7	CHEMBL2208	Homo sapiens	IC50	nM	5.7
	15053974	CHEMBL3369592	Inhibition of MK2 (unknown origin) incubated for 30 mins by MK2 IMAP assay	B	N#Cc1ccc(-c2ccc(-c3nccn3-c3ccc(C4(O)CCNCC4)cc3)o2)cc1		CHEMBL3315292	=	IC50	nM	26.0	CHEMBL2208	Homo sapiens	IC50	nM	26.0
	15053975	CHEMBL3369592	Inhibition of MK2 (unknown origin) incubated for 30 mins by MK2 IMAP assay	B	N#Cc1ccc(-c2ccc(-c3nccn3-c3ccc(C4(F)CCNCC4)cc3)o2)cc1		CHEMBL3315291	=	IC50	nM	24.9	CHEMBL2208	Homo sapiens	IC50	nM	24.9
	15053976	CHEMBL3369592	Inhibition of MK2 (unknown origin) incubated for 30 mins by MK2 IMAP assay	B	OC1(c2ccc(-n3ccnc3-c3ccc(-c4ccc(Cl)cc4)o3)cc2)CCNCC1		CHEMBL3315290	=	IC50	nM	25.8	CHEMBL2208	Homo sapiens	IC50	nM	25.8
	15053977	CHEMBL3369592	Inhibition of MK2 (unknown origin) incubated for 30 mins by MK2 IMAP assay	B	FC1(c2ccc(-n3ccnc3-c3ccc(-c4ccc(Cl)cc4)o3)cc2)CCNCC1		CHEMBL3315289	=	IC50	nM	66.5	CHEMBL2208	Homo sapiens	IC50	nM	66.5
	15053978	CHEMBL3369592	Inhibition of MK2 (unknown origin) incubated for 30 mins by MK2 IMAP assay	B	Clc1ccc(-c2ccc(-c3nccn3-c3ccc([C@@H]4CNCCO4)cc3)o2)cc1		CHEMBL3315288	=	IC50	nM	74.9	CHEMBL2208	Homo sapiens	IC50	nM	74.9
	15053979	CHEMBL3369592	Inhibition of MK2 (unknown origin) incubated for 30 mins by MK2 IMAP assay	B	Clc1ccc(-c2ccc(-c3nccn3-c3ccc([C@H]4CNCCO4)cc3)o2)cc1		CHEMBL3315287	=	IC50	nM	55.3	CHEMBL2208	Homo sapiens	IC50	nM	55.3
	15053980	CHEMBL3369592	Inhibition of MK2 (unknown origin) incubated for 30 mins by MK2 IMAP assay	B	Clc1ccc(-c2ccc(-c3nccn3-c3ccc(C4C=CCNC4)cc3)o2)cc1		CHEMBL3315286	=	IC50	nM	65.0	CHEMBL2208	Homo sapiens	IC50	nM	65.0
	15053981	CHEMBL3369592	Inhibition of MK2 (unknown origin) incubated for 30 mins by MK2 IMAP assay	B	Clc1ccc(-c2ccc(-c3nccn3-c3ccc(-c4cccnc4)cc3)o2)cc1		CHEMBL3315285	=	IC50	nM	3390.0	CHEMBL2208	Homo sapiens	IC50	nM	3390.0
	15053982	CHEMBL3369592	Inhibition of MK2 (unknown origin) incubated for 30 mins by MK2 IMAP assay	B	Clc1ccc(-c2ccc(-c3nccn3-c3ccc(-c4ccncc4)cc3)o2)cc1		CHEMBL3314158	=	IC50	nM	3730.0	CHEMBL2208	Homo sapiens	IC50	nM	3730.0
	15053983	CHEMBL3369592	Inhibition of MK2 (unknown origin) incubated for 30 mins by MK2 IMAP assay	B	Clc1ccc(-c2ccc(-c3nccn3-c3ccc(C4CCCCN4)cc3)o2)cc1		CHEMBL3314157	=	IC50	nM	160.0	CHEMBL2208	Homo sapiens	IC50	nM	160.0
	15053984	CHEMBL3369592	Inhibition of MK2 (unknown origin) incubated for 30 mins by MK2 IMAP assay	B	Clc1ccc(-c2ccc(-c3nccn3-c3ccc(C4CCCNC4)cc3)o2)cc1		CHEMBL3314156	=	IC50	nM	26.0	CHEMBL2208	Homo sapiens	IC50	nM	26.0
	15053985	CHEMBL3369592	Inhibition of MK2 (unknown origin) incubated for 30 mins by MK2 IMAP assay	B	Clc1ccc(-c2ccc(-c3nccn3-c3ccc(C4CCNCC4)cc3)o2)cc1		CHEMBL3314155	=	IC50	nM	36.7	CHEMBL2208	Homo sapiens	IC50	nM	36.7
	15053986	CHEMBL3369592	Inhibition of MK2 (unknown origin) incubated for 30 mins by MK2 IMAP assay	B	N#Cc1ccc(-c2ccc(-c3nccn3-c3ccc(N4CCNCC4)c(Br)c3)o2)cc1		CHEMBL3314154	=	IC50	nM	35.7	CHEMBL2208	Homo sapiens	IC50	nM	35.7
	15053987	CHEMBL3369592	Inhibition of MK2 (unknown origin) incubated for 30 mins by MK2 IMAP assay	B	N#Cc1ccc(-c2ccc(-c3nccn3-c3ccc(N4CCNCC4)c(Cl)c3)o2)cc1		CHEMBL3314153	=	IC50	nM	7.7	CHEMBL2208	Homo sapiens	IC50	nM	7.7
	15053988	CHEMBL3369592	Inhibition of MK2 (unknown origin) incubated for 30 mins by MK2 IMAP assay	B	N#Cc1ccc(-c2ccc(-c3nccn3-c3ccc(N4CCNCC4)cc3-c3cncnc3)o2)cc1		CHEMBL3314152	=	IC50	nM	43.5	CHEMBL2208	Homo sapiens	IC50	nM	43.5
	15053989	CHEMBL3369592	Inhibition of MK2 (unknown origin) incubated for 30 mins by MK2 IMAP assay	B	N#Cc1ccc(-c2ccc(-c3nccn3-c3ccc(N4CCNCC4)cc3C(F)(F)F)o2)cc1		CHEMBL3314151	=	IC50	nM	31.3	CHEMBL2208	Homo sapiens	IC50	nM	31.3
	15053990	CHEMBL3369592	Inhibition of MK2 (unknown origin) incubated for 30 mins by MK2 IMAP assay	B	N#Cc1ccc(-c2ccc(-c3nccn3-c3ccc(N4CCNCC4)cc3Br)o2)cc1		CHEMBL3314150	=	IC50	nM	22.3	CHEMBL2208	Homo sapiens	IC50	nM	22.3
	15053991	CHEMBL3369592	Inhibition of MK2 (unknown origin) incubated for 30 mins by MK2 IMAP assay	B	Cc1cc(N2CCNCC2)ccc1-n1ccnc1-c1ccc(-c2ccc(C#N)cc2)o1		CHEMBL3314149	=	IC50	nM	17.4	CHEMBL2208	Homo sapiens	IC50	nM	17.4
	15053992	CHEMBL3369592	Inhibition of MK2 (unknown origin) incubated for 30 mins by MK2 IMAP assay	B	N#Cc1ccc(-c2ccc(-c3nccn3-c3ccc(N4CCNCC4)cc3Cl)o2)cc1		CHEMBL3314148	=	IC50	nM	13.0	CHEMBL2208	Homo sapiens	IC50	nM	13.0
	15053993	CHEMBL3369592	Inhibition of MK2 (unknown origin) incubated for 30 mins by MK2 IMAP assay	B	N#Cc1ccc(-c2ccc(-c3nccn3-c3ccc(N4CCNCC4)cc3F)o2)cc1		CHEMBL3314147	=	IC50	nM	16.2	CHEMBL2208	Homo sapiens	IC50	nM	16.2
	15053994	CHEMBL3369592	Inhibition of MK2 (unknown origin) incubated for 30 mins by MK2 IMAP assay	B	Clc1ccc(-c2ccc(-c3nc4ccccc4n3-c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL3314146	=	IC50	nM	95.4	CHEMBL2208	Homo sapiens	IC50	nM	95.4
	15053995	CHEMBL3369592	Inhibition of MK2 (unknown origin) incubated for 30 mins by MK2 IMAP assay	B	N#Cc1ccc(-c2ccc(-c3nnnn3-c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL3314145	=	IC50	nM	450.1	CHEMBL2208	Homo sapiens	IC50	nM	450.1
	15053996	CHEMBL3369592	Inhibition of MK2 (unknown origin) incubated for 30 mins by MK2 IMAP assay	B	Clc1ccc(-c2ccc(-c3ncnn3-c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL3314144	=	IC50	nM	157.0	CHEMBL2208	Homo sapiens	IC50	nM	157.0
	15053997	CHEMBL3369592	Inhibition of MK2 (unknown origin) incubated for 30 mins by MK2 IMAP assay	B	N#Cc1ccc(-c2ccc(-c3nncn3-c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL3314143	=	IC50	nM	23.3	CHEMBL2208	Homo sapiens	IC50	nM	23.3
	15053998	CHEMBL3369592	Inhibition of MK2 (unknown origin) incubated for 30 mins by MK2 IMAP assay	B	Clc1ccc(-c2ccc(-c3nncn3-c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL3314142	=	IC50	nM	14.3	CHEMBL2208	Homo sapiens	IC50	nM	14.3
	15053999	CHEMBL3369592	Inhibition of MK2 (unknown origin) incubated for 30 mins by MK2 IMAP assay	B	N#Cc1ccc(-c2ccc(-c3nccn3-c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL3314141	=	IC50	nM	84.7	CHEMBL2208	Homo sapiens	IC50	nM	84.7
	15054000	CHEMBL3369592	Inhibition of MK2 (unknown origin) incubated for 30 mins by MK2 IMAP assay	B	Clc1ccc(-c2ccc(-c3nccn3-c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL3314140	=	IC50	nM	25.5	CHEMBL2208	Homo sapiens	IC50	nM	25.5
	15072465	CHEMBL3380109	Inhibition of MAPKAPK2 (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	84.0	CHEMBL2208	Homo sapiens	Activity	%	84.0
	15091083	CHEMBL3381546	Inhibition of human recombinant MAPKAPK2 expressed Escherichia coli using CREBtide (CKRREILSRRPSYRK) substrate assessed as remaining enzyme activity at 1 uM after 15 mins relative to control	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Br)c(O)c(Br)c1		CHEMBL2206014	=	Activity	%	83.0	CHEMBL2208	Homo sapiens	Activity	%	83.0
	15122472	CHEMBL3367694	Inhibition of human MAPKAP-K2 assessed as residual activity at 10 uM by KinaseProfiler assay	B	CCOC(=O)C1=C(C)N=c2s/c(=C\c3ccc(O)c(O)c3)c(=O)n2C1c1ccc(Cl)cc1		CHEMBL3331445	=	Activity	%	98.0	CHEMBL2208	Homo sapiens	Activity	%	98.0
	15126965	CHEMBL3367694	Inhibition of human MAPKAP-K2 assessed as residual activity at 10 uM by KinaseProfiler assay	B	CCOC(=O)C1=C(C)N=c2s/c(=C\c3cc(O)c(O)c(O)c3)c(=O)n2C1c1ccc(Cl)cc1		CHEMBL3331446	=	Activity	%	86.0	CHEMBL2208	Homo sapiens	Activity	%	86.0
	15126997	CHEMBL3367694	Inhibition of human MAPKAP-K2 assessed as residual activity at 10 uM by KinaseProfiler assay	B	Brc1c(Br)c(Br)c2[nH]nnc2c1Br		CHEMBL177820	=	Activity	%	78.0	CHEMBL2208	Homo sapiens	Activity	%	78.0
	15137719	CHEMBL3385161	Inhibition of MAPKAP-K2 (unknown origin) assessed as residual enzyme activity at 10 uM	B	CO[C@H]1CC[C@H](NC(=O)c2n[nH]cc2NC(=O)c2ccccc2)CC1		CHEMBL3335124	=	Activity	%	92.0	CHEMBL2208	Homo sapiens	Activity	%	92.0
	15137720	CHEMBL3385161	Inhibition of MAPKAP-K2 (unknown origin) assessed as residual enzyme activity at 10 uM	B	COc1cccc(OC)c1C(=O)Nc1c[nH]nc1C(=O)N[C@H]1CC[C@H](OC)CC1		CHEMBL3335141	=	Activity	%	33.0	CHEMBL2208	Homo sapiens	Activity	%	33.0
	15137721	CHEMBL3385161	Inhibition of MAPKAP-K2 (unknown origin) assessed as residual enzyme activity at 10 uM	B	CO[C@H]1CC[C@H](NC(=O)c2n[nH]cc2NC(=O)c2ccc(-c3ccccc3)o2)CC1		CHEMBL3335153	=	Activity	%	90.0	CHEMBL2208	Homo sapiens	Activity	%	90.0
	15137722	CHEMBL3385161	Inhibition of MAPKAP-K2 (unknown origin) assessed as residual enzyme activity at 10 uM	B	COc1cccc(OC)c1C(=O)Nc1c[nH]nc1C(=O)NCc1ccccc1		CHEMBL3335161	=	Activity	%	13.0	CHEMBL2208	Homo sapiens	Activity	%	13.0
	15150093	CHEMBL3396173	Inhibition of MK2 (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CC2)ccn1		CHEMBL3394102	<	Inhibition	%	50.0	CHEMBL2208	Homo sapiens	INH	%	50.0
	15150094	CHEMBL3396173	Inhibition of MK2 (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CCCCC2)ccn1		CHEMBL3394105	<	Inhibition	%	50.0	CHEMBL2208	Homo sapiens	INH	%	50.0
	15150095	CHEMBL3396173	Inhibition of MK2 (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2CC2CCCO2)ccn1		CHEMBL3394108	<	Inhibition	%	50.0	CHEMBL2208	Homo sapiens	INH	%	50.0
	15150096	CHEMBL3396173	Inhibition of MK2 (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	COC(Cn1c(SC2CCC(C(=O)O)CC2O)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1)OC		CHEMBL3394112	<	Inhibition	%	50.0	CHEMBL2208	Homo sapiens	INH	%	50.0
	15150097	CHEMBL3396173	Inhibition of MK2 (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(Sc3cccc(I)n3)n2C2CCCCC2)ccn1		CHEMBL3394118	<	Inhibition	%	50.0	CHEMBL2208	Homo sapiens	INH	%	50.0
Not Active	15150714	CHEMBL3395583	Binding affinity to phosphorylated full length 2H,15N-labeled MK2 (unknown origin) expressed in Escherichia coli by 2D-NMR analysis	B	N#Cc1ccccc1Oc1ccc(C(=O)NCc2ccncc2)cc1		CHEMBL1796293		Activity			CHEMBL2208	Homo sapiens	Activity		
Not Active	15150715	CHEMBL3395583	Binding affinity to phosphorylated full length 2H,15N-labeled MK2 (unknown origin) expressed in Escherichia coli by 2D-NMR analysis	B	CCCc1c(C(=O)Nc2cc(S(=O)(=O)N(C)C)ccc2C)cnn1-c1ccccc1		CHEMBL3393296		Activity			CHEMBL2208	Homo sapiens	Activity		
	15191011	CHEMBL3412793	Inhibition of MAPKAPK2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1NC(=S)Nc1ccccc1		CHEMBL3408381	=	Inhibition	%	1.0	CHEMBL2208	Homo sapiens	INH	%	1.0
	15191012	CHEMBL3412793	Inhibition of MAPKAPK2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=c1\sc(-c2ccccc2)nn1-c1ccccc1		CHEMBL3408382	=	Inhibition	%	67.0	CHEMBL2208	Homo sapiens	INH	%	67.0
	15191013	CHEMBL3412793	Inhibition of MAPKAPK2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)c1nn(-c2ccccc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408383	=	Inhibition	%	43.0	CHEMBL2208	Homo sapiens	INH	%	43.0
	15191014	CHEMBL3412793	Inhibition of MAPKAPK2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)c1nn(-c2ccc(C)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408384	=	Inhibition	%	21.0	CHEMBL2208	Homo sapiens	INH	%	21.0
	15191015	CHEMBL3412793	Inhibition of MAPKAPK2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	COc1ccc(-n2nc(C(C)=O)s/c2=N\c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)cc1		CHEMBL3408385	=	Inhibition	%	26.0	CHEMBL2208	Homo sapiens	INH	%	26.0
	15191016	CHEMBL3412793	Inhibition of MAPKAPK2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)c1nn(-c2ccc(Cl)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408386	=	Inhibition	%	38.0	CHEMBL2208	Homo sapiens	INH	%	38.0
	15191017	CHEMBL3412793	Inhibition of MAPKAPK2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)c1nn(-c2ccccc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408387	=	Inhibition	%	66.0	CHEMBL2208	Homo sapiens	INH	%	66.0
	15191018	CHEMBL3412793	Inhibition of MAPKAPK2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)c1nn(-c2ccc(C)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408388	=	Inhibition	%	21.0	CHEMBL2208	Homo sapiens	INH	%	21.0
	15191019	CHEMBL3412793	Inhibition of MAPKAPK2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)c1nn(-c2ccc(Cl)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408389	=	Inhibition	%	12.0	CHEMBL2208	Homo sapiens	INH	%	12.0
	15191020	CHEMBL3412793	Inhibition of MAPKAPK2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=c1\sc(C(=O)Nc2ccccc2)nn1-c1ccccc1		CHEMBL3408390	=	Inhibition	%	2.0	CHEMBL2208	Homo sapiens	INH	%	2.0
	15191021	CHEMBL3412793	Inhibition of MAPKAPK2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=C1\SCC(=O)N1c1ccccc1		CHEMBL3408391	=	Inhibition	%	1.0	CHEMBL2208	Homo sapiens	INH	%	1.0
	15191022	CHEMBL3412793	Inhibition of MAPKAPK2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=c1\scc(-c2ccccc2)n1-c1ccccc1		CHEMBL3408392	=	Inhibition	%	6.0	CHEMBL2208	Homo sapiens	INH	%	6.0
	15191023	CHEMBL3412793	Inhibition of MAPKAPK2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=C1\S/C(=C2\SC(c3ccccc3)=NN2c2ccccc2)C(=O)N1c1ccccc1		CHEMBL3408393	=	Inhibition	%	2.0	CHEMBL2208	Homo sapiens	INH	%	2.0
	15191024	CHEMBL3412793	Inhibition of MAPKAPK2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)C1=NN(c2ccccc2)/C(=C2/S/C(=N\c3nc(-c4ccccc4)cc(-c4ccccc4)c3C#N)N(c3ccccc3)C2=O)S1		CHEMBL3408394	=	Inhibition	%	4.0	CHEMBL2208	Homo sapiens	INH	%	4.0
	15191025	CHEMBL3412793	Inhibition of MAPKAPK2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)C1=NN(c2ccccc2)/C(=C2/S/C(=N\c3nc(-c4ccccc4)cc(-c4ccccc4)c3C#N)N(c3ccccc3)C2=O)S1		CHEMBL3408395	=	Inhibition	%	4.0	CHEMBL2208	Homo sapiens	INH	%	4.0
	15191026	CHEMBL3412793	Inhibition of MAPKAPK2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=C1\S/C(=C2\SC(C(=O)Nc3ccccc3)=NN2c2ccccc2)C(=O)N1c1ccccc1		CHEMBL3408396	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	15251832	CHEMBL3428249	Inhibition of MAPKAPK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL443738	=	Activity	%	38.0	CHEMBL2208	Homo sapiens	Activity	%	38.0
	15251965	CHEMBL3428249	Inhibition of MAPKAPK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427170	=	Activity	%	36.0	CHEMBL2208	Homo sapiens	Activity	%	36.0
	15252067	CHEMBL3428249	Inhibition of MAPKAPK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427171	=	Activity	%	92.0	CHEMBL2208	Homo sapiens	Activity	%	92.0
	15252712	CHEMBL3428249	Inhibition of MAPKAPK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427172	=	Activity	%	87.0	CHEMBL2208	Homo sapiens	Activity	%	87.0
	15252814	CHEMBL3428249	Inhibition of MAPKAPK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)CS3)sc2c1		CHEMBL3427173	=	Activity	%	79.0	CHEMBL2208	Homo sapiens	Activity	%	79.0
	15252916	CHEMBL3428249	Inhibition of MAPKAPK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)CS3)sc2c1		CHEMBL3427174	=	Activity	%	74.0	CHEMBL2208	Homo sapiens	Activity	%	74.0
	15253590	CHEMBL3428249	Inhibition of MAPKAPK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427175	=	Activity	%	77.0	CHEMBL2208	Homo sapiens	Activity	%	77.0
	15253692	CHEMBL3428249	Inhibition of MAPKAPK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427176	=	Activity	%	85.0	CHEMBL2208	Homo sapiens	Activity	%	85.0
	15253794	CHEMBL3428249	Inhibition of MAPKAPK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427177	=	Activity	%	93.0	CHEMBL2208	Homo sapiens	Activity	%	93.0
	15254460	CHEMBL3428249	Inhibition of MAPKAPK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427178	=	Activity	%	56.0	CHEMBL2208	Homo sapiens	Activity	%	56.0
	15254562	CHEMBL3428249	Inhibition of MAPKAPK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@H]1C(=O)O		CHEMBL3427179	=	Activity	%	89.0	CHEMBL2208	Homo sapiens	Activity	%	89.0
	15255252	CHEMBL3428249	Inhibition of MAPKAPK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@@H]1C(=O)O		CHEMBL3427180	=	Activity	%	74.0	CHEMBL2208	Homo sapiens	Activity	%	74.0
	15255355	CHEMBL3428249	Inhibition of MAPKAPK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427181	=	Activity	%	94.0	CHEMBL2208	Homo sapiens	Activity	%	94.0
	15255457	CHEMBL3428249	Inhibition of MAPKAPK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427182	=	Activity	%	101.0	CHEMBL2208	Homo sapiens	Activity	%	101.0
	15256189	CHEMBL3428249	Inhibition of MAPKAPK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427183	=	Activity	%	105.0	CHEMBL2208	Homo sapiens	Activity	%	105.0
	15256291	CHEMBL3428249	Inhibition of MAPKAPK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427184	=	Activity	%	107.0	CHEMBL2208	Homo sapiens	Activity	%	107.0
	15685898	CHEMBL3607974	Inhibition of human MAPKAPK2	B	NC(=O)c1cc(F)cc2c1C(=O)N(C1CCN(C3CCC(F)(F)CC3)CC1)C2		CHEMBL3606021	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	15747916	CHEMBL3630370	Inhibition of MK2 (unknown origin) at 50 uM by scintillation proximity assay	B	Nc1ncc(Cl)nc1-c1nc(N2CCc3ccccc32)no1		CHEMBL3629162	=	Inhibition	%	20.0	CHEMBL2208	Homo sapiens	INH	%	20.0
	15747917	CHEMBL3630370	Inhibition of MK2 (unknown origin) at 50 uM by scintillation proximity assay	B	Nc1ncc(Cl)nc1CNc1nc2ccccc2s1		CHEMBL3629158	=	Inhibition	%	36.0	CHEMBL2208	Homo sapiens	INH	%	36.0
	15747918	CHEMBL3630369	Inhibition of MK2 (unknown origin) at 20 uM by scintillation proximity assay	B	Nc1nccnc1CNC(=O)Nc1ccc(N(C(=O)c2ccccc2)c2ccccc2)cc1		CHEMBL3629336	=	Inhibition	%	25.0	CHEMBL2208	Homo sapiens	INH	%	25.0
	15748861	CHEMBL3630369	Inhibition of MK2 (unknown origin) at 20 uM by scintillation proximity assay	B	Cc1cnc(N)c(CNC(=O)Nc2ccc(N(C(=O)OCC(C)C)c3ccccc3)cc2)n1		CHEMBL3629335	=	Inhibition	%	20.0	CHEMBL2208	Homo sapiens	INH	%	20.0
	15748862	CHEMBL3630369	Inhibition of MK2 (unknown origin) at 20 uM by scintillation proximity assay	B	Nc1ncc(Cl)nc1CNC(=O)Nc1cccc(Cl)c1Cl		CHEMBL3629321	=	Inhibition	%	21.0	CHEMBL2208	Homo sapiens	INH	%	21.0
	15748863	CHEMBL3630369	Inhibition of MK2 (unknown origin) at 20 uM by scintillation proximity assay	B	Nc1ncc(Cl)nc1CNC(=O)Nc1ccc(Cl)c(Cl)c1		CHEMBL3629320	=	Inhibition	%	16.0	CHEMBL2208	Homo sapiens	INH	%	16.0
	15748864	CHEMBL3630369	Inhibition of MK2 (unknown origin) at 20 uM by scintillation proximity assay	B	Nc1ncc(Cl)nc1CNC(=O)Nc1ccc(C(F)(F)F)cc1		CHEMBL3629319	=	Inhibition	%	2.0	CHEMBL2208	Homo sapiens	INH	%	2.0
	15748865	CHEMBL3630369	Inhibition of MK2 (unknown origin) at 20 uM by scintillation proximity assay	B	Nc1ncc(Cl)nc1-c1nsc(Nc2ccccc2)n1		CHEMBL3629317	=	Inhibition	%	6.0	CHEMBL2208	Homo sapiens	INH	%	6.0
	15748866	CHEMBL3630369	Inhibition of MK2 (unknown origin) at 20 uM by scintillation proximity assay	B	CCCCc1cnc(N)c(-c2nc(Nc3ccc4[nH]c(=O)oc4c3)no2)n1		CHEMBL3629171	=	Inhibition	%	20.0	CHEMBL2208	Homo sapiens	INH	%	20.0
	15748867	CHEMBL3630369	Inhibition of MK2 (unknown origin) at 20 uM by scintillation proximity assay	B	CCc1cnc(N)c(-c2nc(Nc3ccc4[nH]c(=O)oc4c3)no2)n1		CHEMBL3629170	=	Inhibition	%	15.0	CHEMBL2208	Homo sapiens	INH	%	15.0
	15748868	CHEMBL3630369	Inhibition of MK2 (unknown origin) at 20 uM by scintillation proximity assay	B	Nc1ncc(Cl)nc1-c1nc(Nc2ccc3[nH]c(=O)oc3c2)no1		CHEMBL3629169	=	Inhibition	%	26.0	CHEMBL2208	Homo sapiens	INH	%	26.0
	15748869	CHEMBL3630369	Inhibition of MK2 (unknown origin) at 20 uM by scintillation proximity assay	B	CCCCc1cnc(N)c(-c2nc(Nc3ccc4c(c3)oc(=O)n4COCC[Si](C)(C)C)no2)n1		CHEMBL3629168	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	15748870	CHEMBL3630369	Inhibition of MK2 (unknown origin) at 20 uM by scintillation proximity assay	B	CCc1cnc(N)c(-c2nc(Nc3ccc4c(c3)oc(=O)n4COCC[Si](C)(C)C)no2)n1		CHEMBL3629167	=	Inhibition	%	9.0	CHEMBL2208	Homo sapiens	INH	%	9.0
	15748871	CHEMBL3630369	Inhibition of MK2 (unknown origin) at 20 uM by scintillation proximity assay	B	C[Si](C)(C)CCOCn1c(=O)oc2cc(Nc3noc(-c4nc(Cl)cnc4N)n3)ccc21		CHEMBL3629166	=	Inhibition	%	46.0	CHEMBL2208	Homo sapiens	INH	%	46.0
	15748872	CHEMBL3630369	Inhibition of MK2 (unknown origin) at 20 uM by scintillation proximity assay	B	CCCCc1cnc(N)c(-c2nc(Nc3ccccc3)no2)n1		CHEMBL3629165	=	Inhibition	%	6.0	CHEMBL2208	Homo sapiens	INH	%	6.0
	15748873	CHEMBL3630369	Inhibition of MK2 (unknown origin) at 20 uM by scintillation proximity assay	B	Nc1ncc(Cl)nc1-c1nc(Nc2ccccc2)no1		CHEMBL3629163	=	Inhibition	%	11.0	CHEMBL2208	Homo sapiens	INH	%	11.0
	15748874	CHEMBL3630369	Inhibition of MK2 (unknown origin) at 20 uM by scintillation proximity assay	B	CC(C)(C)OC(=O)Nc1ccc(N/C(=N/S(C)(=O)=O)NCc2nc(C3CC3)cnc2N)cc1		CHEMBL3629157	=	Inhibition	%	9.0	CHEMBL2208	Homo sapiens	INH	%	9.0
	15748875	CHEMBL3630369	Inhibition of MK2 (unknown origin) at 20 uM by scintillation proximity assay	B	CCCc1cnc(N)c(CN/C(=N\C(=O)c2ccc(Cl)cc2)Nc2ccc(N(C(=O)c3ccccc3)c3ccccc3)cc2)n1		CHEMBL3629156	=	Inhibition	%	19.0	CHEMBL2208	Homo sapiens	INH	%	19.0
	15748876	CHEMBL3630368	Inhibition of MK2 (unknown origin) by scintillation proximity assay	B	Nc1ncc(Cl)nc1CNC(=O)Nc1ccc(N(C(=O)c2ccccc2)c2ccccc2)cc1		CHEMBL3629334	=	IC50	nM	14500.0	CHEMBL2208	Homo sapiens	IC50	uM	14.5
	15748877	CHEMBL3630368	Inhibition of MK2 (unknown origin) by scintillation proximity assay	B	Nc1ncc(C2CC2)nc1CNC(=O)Nc1ccc(N(C(=O)c2ccccc2)c2ccccc2)cc1		CHEMBL3629333	=	IC50	nM	16200.0	CHEMBL2208	Homo sapiens	IC50	uM	16.2
	15748878	CHEMBL3630368	Inhibition of MK2 (unknown origin) by scintillation proximity assay	B	CCCc1cnc(N)c(CNC(=O)Nc2ccccc2Cl)n1		CHEMBL3629332	=	IC50	nM	19000.0	CHEMBL2208	Homo sapiens	IC50	uM	19.0
	15748879	CHEMBL3630368	Inhibition of MK2 (unknown origin) by scintillation proximity assay	B	CCCc1cnc(N)c(CNC(=O)Nc2ccc(N(C(=O)c3ccccc3)c3ccccc3)cc2)n1		CHEMBL3629331	=	IC50	nM	20000.0	CHEMBL2208	Homo sapiens	IC50	uM	20.0
	15748880	CHEMBL3630368	Inhibition of MK2 (unknown origin) by scintillation proximity assay	B	CCCc1cnc(N)c(CNC(=O)Nc2ccc(NC(=O)OCc3ccccc3)cc2)n1		CHEMBL3629330	=	IC50	nM	8000.0	CHEMBL2208	Homo sapiens	IC50	uM	8.0
	15748881	CHEMBL3630368	Inhibition of MK2 (unknown origin) by scintillation proximity assay	B	CCCc1cnc(N)c(CNC(=O)Nc2ccc(NC(=O)OC)cc2)n1		CHEMBL3629329	=	IC50	nM	11800.0	CHEMBL2208	Homo sapiens	IC50	uM	11.8
	15748882	CHEMBL3630368	Inhibition of MK2 (unknown origin) by scintillation proximity assay	B	CCCc1cnc(N)c(CNC(=O)Nc2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL3629328	=	IC50	nM	19000.0	CHEMBL2208	Homo sapiens	IC50	uM	19.0
	15748883	CHEMBL3630368	Inhibition of MK2 (unknown origin) by scintillation proximity assay	B	CCCc1cnc(N)c(CNC(=O)Nc2ccc(OC(=O)OC(C)(C)C)cc2)n1		CHEMBL3629327	=	IC50	nM	11000.0	CHEMBL2208	Homo sapiens	IC50	uM	11.0
	15748884	CHEMBL3630368	Inhibition of MK2 (unknown origin) by scintillation proximity assay	B	CCCc1cnc(N)c(CNC(=O)Nc2ccc(NC(=O)OC(C)(C)C)cc2)n1		CHEMBL3629326	=	IC50	nM	6700.0	CHEMBL2208	Homo sapiens	IC50	uM	6.7
	15748885	CHEMBL3630368	Inhibition of MK2 (unknown origin) by scintillation proximity assay	B	CCCc1cnc(N)c(CNC(=O)Nc2ccc3[nH]c(=O)oc3c2)n1		CHEMBL3629325	=	IC50	nM	750.0	CHEMBL2208	Homo sapiens	IC50	uM	0.75
	15748886	CHEMBL3630368	Inhibition of MK2 (unknown origin) by scintillation proximity assay	B	Nc1ncc(C2CC2)nc1CNC(=O)Nc1ccc2[nH]c(=O)oc2c1		CHEMBL3629324	=	IC50	nM	2200.0	CHEMBL2208	Homo sapiens	IC50	uM	2.2
	15748887	CHEMBL3630368	Inhibition of MK2 (unknown origin) by scintillation proximity assay	B	Nc1ncc(Cl)nc1CNC(=O)Nc1ccc2[nH]c(=O)oc2c1		CHEMBL3629323	=	IC50	nM	4500.0	CHEMBL2208	Homo sapiens	IC50	uM	4.5
	15748888	CHEMBL3630368	Inhibition of MK2 (unknown origin) by scintillation proximity assay	B	CC(C)(C)OC(=O)Nc1ccc(NC(=O)NCc2nc(Cl)cnc2N)cc1		CHEMBL3629322	=	IC50	nM	32000.0	CHEMBL2208	Homo sapiens	IC50	uM	32.0
	15748889	CHEMBL3630368	Inhibition of MK2 (unknown origin) by scintillation proximity assay	B	CCCc1cnc(N)c(CN/C(=N\C(=O)c2ccccc2)Nc2ccc3[nH]c(=O)oc3c2)n1		CHEMBL3629155	=	IC50	nM	8000.0	CHEMBL2208	Homo sapiens	IC50	uM	8.0
	15748890	CHEMBL3630368	Inhibition of MK2 (unknown origin) by scintillation proximity assay	B	COc1ccc(C(=O)/N=C(\NCc2nc(C3CC3)cnc2N)Nc2ccc3[nH]c(=O)oc3c2)cc1		CHEMBL3629154	=	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	15748891	CHEMBL3630368	Inhibition of MK2 (unknown origin) by scintillation proximity assay	B	Nc1ncc(C2CC2)nc1CN/C(=N\C(=O)c1ccc(Cl)cc1)Nc1ccc2[nH]c(=O)oc2c1		CHEMBL3629153	=	IC50	nM	1900.0	CHEMBL2208	Homo sapiens	IC50	uM	1.9
	15748892	CHEMBL3630368	Inhibition of MK2 (unknown origin) by scintillation proximity assay	B	Cc1ccc(C(=O)/N=C(\NCc2nc(C3CC3)cnc2N)Nc2ccc3[nH]c(=O)oc3c2)cc1		CHEMBL3629152	=	IC50	nM	2400.0	CHEMBL2208	Homo sapiens	IC50	uM	2.4
	15748893	CHEMBL3630368	Inhibition of MK2 (unknown origin) by scintillation proximity assay	B	CCOC(=O)/N=C(\NCc1nc(C2CC2)cnc1N)Nc1ccc2[nH]c(=O)oc2c1		CHEMBL3629151	=	IC50	nM	7800.0	CHEMBL2208	Homo sapiens	IC50	uM	7.8
	15748894	CHEMBL3630368	Inhibition of MK2 (unknown origin) by scintillation proximity assay	B	CC(C)(C)OC(=O)Nc1ccc(N/C(=N/C(=O)c2ccccc2)NCc2nc(Cl)cnc2N)cc1		CHEMBL3629150	=	IC50	nM	36000.0	CHEMBL2208	Homo sapiens	IC50	uM	36.0
	15748895	CHEMBL3630368	Inhibition of MK2 (unknown origin) by scintillation proximity assay	B	CCCc1cnc(N)c(CN/C(=N\C#N)Nc2ccc(N(C(=O)c3ccccc3)c3ccccc3)cc2)n1		CHEMBL3629148	=	IC50	nM	6900.0	CHEMBL2208	Homo sapiens	IC50	uM	6.9
	15748896	CHEMBL3630368	Inhibition of MK2 (unknown origin) by scintillation proximity assay	B	CCCc1cnc(N)c(CN/C(=N\C#N)Nc2ccc3[nH]c(=O)oc3c2)n1		CHEMBL3629147	=	IC50	nM	1700.0	CHEMBL2208	Homo sapiens	IC50	uM	1.7
	15748897	CHEMBL3630368	Inhibition of MK2 (unknown origin) by scintillation proximity assay	B	CC(C)(C)OC(=O)Nc1ccc(N/C(=N/C#N)NCc2nc(C3CC3)cnc2N)cc1		CHEMBL3629146	=	IC50	nM	3300.0	CHEMBL2208	Homo sapiens	IC50	uM	3.3
	15748898	CHEMBL3630368	Inhibition of MK2 (unknown origin) by scintillation proximity assay	B	Cc1cnc(N)c(CN/C(=N\C#N)Nc2ccc(NC(=O)OC(C)(C)C)cc2)n1		CHEMBL3629145	=	IC50	nM	31000.0	CHEMBL2208	Homo sapiens	IC50	uM	31.0
	15748899	CHEMBL3630368	Inhibition of MK2 (unknown origin) by scintillation proximity assay	B	CC(C)(C)OC(=O)Nc1ccc(N/C(=N/C#N)NCc2nc(Cl)cnc2N)cc1		CHEMBL3628993	=	IC50	nM	27000.0	CHEMBL2208	Homo sapiens	IC50	uM	27.0
	15748900	CHEMBL3630368	Inhibition of MK2 (unknown origin) by scintillation proximity assay	B	N#C/N=C(\NCc1nc(Cl)cnc1N)Nc1ccccc1		CHEMBL3628992	=	IC50	nM	26000.0	CHEMBL2208	Homo sapiens	IC50	uM	26.0
	15748901	CHEMBL3630368	Inhibition of MK2 (unknown origin) by scintillation proximity assay	B	CO/N=C(\NCc1nc(Cl)cnc1N)Nc1ccc(N(C(=O)c2ccccc2)c2ccccc2)cc1		CHEMBL3628991	=	IC50	nM	3600.0	CHEMBL2208	Homo sapiens	IC50	uM	3.6
	15748902	CHEMBL3630368	Inhibition of MK2 (unknown origin) by scintillation proximity assay	B	CO/N=C(\NCc1nc(Cl)cnc1N)Nc1ccc(NC(=O)OC(C)(C)C)cc1		CHEMBL3628990	=	IC50	nM	4200.0	CHEMBL2208	Homo sapiens	IC50	uM	4.2
	15748903	CHEMBL3630367	Inhibition of MK2 (unknown origin) at 40 uM by scintillation proximity assay	B	Nc1ncc(Cl)nc1CNC(=O)Nc1ccccc1		CHEMBL3629318	=	Inhibition	%	8.0	CHEMBL2208	Homo sapiens	INH	%	8.0
	15748904	CHEMBL3630367	Inhibition of MK2 (unknown origin) at 40 uM by scintillation proximity assay	B	Cc1cnc(N)c(-c2nc(Nc3ccc(NC(=O)OC(C)(C)C)cc3)no2)n1		CHEMBL3629316	=	Inhibition	%	8.0	CHEMBL2208	Homo sapiens	INH	%	8.0
	15748905	CHEMBL3630367	Inhibition of MK2 (unknown origin) at 40 uM by scintillation proximity assay	B	Cc1cnc(N)c(-c2nc(Nc3c(Cl)cccc3Cl)no2)n1		CHEMBL3629315	=	Inhibition	%	26.0	CHEMBL2208	Homo sapiens	INH	%	26.0
	15748906	CHEMBL3630367	Inhibition of MK2 (unknown origin) at 40 uM by scintillation proximity assay	B	Nc1ncc(Cl)nc1-c1nc(Nc2ccc([N+](=O)[O-])cc2)no1		CHEMBL3629164	=	Inhibition	%	43.0	CHEMBL2208	Homo sapiens	INH	%	43.0
	15748907	CHEMBL3630367	Inhibition of MK2 (unknown origin) at 40 uM by scintillation proximity assay	B	Cc1cc(NCc2nc(Cl)cnc2N)nc2ccc([N+](=O)[O-])cc12		CHEMBL3629161	=	Inhibition	%	14.0	CHEMBL2208	Homo sapiens	INH	%	14.0
	15748908	CHEMBL3630367	Inhibition of MK2 (unknown origin) at 40 uM by scintillation proximity assay	B	Nc1ncc(Cl)nc1CNc1ccc2cc([N+](=O)[O-])ccc2n1		CHEMBL3629160	=	Inhibition	%	34.0	CHEMBL2208	Homo sapiens	INH	%	34.0
	15748909	CHEMBL3630367	Inhibition of MK2 (unknown origin) at 40 uM by scintillation proximity assay	B	Nc1ncc(Cl)nc1CNc1ccc2ccccc2n1		CHEMBL3629159	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	15748910	CHEMBL3630367	Inhibition of MK2 (unknown origin) at 40 uM by scintillation proximity assay	B	CC(=O)/N=C(\NCc1nc(Cl)cnc1N)Nc1ccc(NC(=O)OC(C)(C)C)cc1		CHEMBL3629149	=	Inhibition	%	33.0	CHEMBL2208	Homo sapiens	INH	%	33.0
	15748911	CHEMBL3630367	Inhibition of MK2 (unknown origin) at 40 uM by scintillation proximity assay	B	CC/N=C(\NCc1nc(Cl)cnc1N)Nc1ccc(NC(=O)OC(C)(C)C)cc1		CHEMBL3628989	=	Inhibition	%	7.0	CHEMBL2208	Homo sapiens	INH	%	7.0
	15748912	CHEMBL3630367	Inhibition of MK2 (unknown origin) at 40 uM by scintillation proximity assay	B	C/N=C(\NCc1nc(Cl)cnc1N)Nc1ccc(NC(=O)OC(C)(C)C)cc1		CHEMBL3628988	=	Inhibition	%	14.0	CHEMBL2208	Homo sapiens	INH	%	14.0
	15748913	CHEMBL3630367	Inhibition of MK2 (unknown origin) at 40 uM by scintillation proximity assay	B	CC(C)(C)/N=C(\NCc1nc(Cl)cnc1N)Nc1ccccc1		CHEMBL3628987	=	Inhibition	%	4.0	CHEMBL2208	Homo sapiens	INH	%	4.0
	15748914	CHEMBL3630367	Inhibition of MK2 (unknown origin) at 40 uM by scintillation proximity assay	B	N=C(NCc1nc(Cl)cnc1N)Nc1ccccc1		CHEMBL3628986	=	Inhibition	%	7.0	CHEMBL2208	Homo sapiens	INH	%	7.0
	15748915	CHEMBL3630367	Inhibition of MK2 (unknown origin) at 40 uM by scintillation proximity assay	B	Nc1ncc(Cl)nc1CNS(=O)(=O)c1ccccc1		CHEMBL3628985	=	Inhibition	%	17.0	CHEMBL2208	Homo sapiens	INH	%	17.0
	15748916	CHEMBL3630367	Inhibition of MK2 (unknown origin) at 40 uM by scintillation proximity assay	B	Nc1ncc(Cl)nc1CNS(=O)(=O)Cc1ccccc1		CHEMBL3628984	=	Inhibition	%	13.0	CHEMBL2208	Homo sapiens	INH	%	13.0
	15748917	CHEMBL3630367	Inhibition of MK2 (unknown origin) at 40 uM by scintillation proximity assay	B	CC(C)(C)OC(=O)Nc1ccc(C(=O)NCc2nc(Cl)cnc2N)cc1		CHEMBL3628983	=	Inhibition	%	3.0	CHEMBL2208	Homo sapiens	INH	%	3.0
	15748918	CHEMBL3630367	Inhibition of MK2 (unknown origin) at 40 uM by scintillation proximity assay	B	CC(C)(C)OC(=O)Nc1ccc(CC(=O)NCc2nc(Cl)cnc2N)cc1		CHEMBL3628982	=	Inhibition	%	7.0	CHEMBL2208	Homo sapiens	INH	%	7.0
	15748919	CHEMBL3630367	Inhibition of MK2 (unknown origin) at 40 uM by scintillation proximity assay	B	Nc1ncc(Cl)nc1CNC(=O)Cc1ccccc1		CHEMBL3628981	=	Inhibition	%	14.0	CHEMBL2208	Homo sapiens	INH	%	14.0
	15748923	CHEMBL3630368	Inhibition of MK2 (unknown origin) by scintillation proximity assay	B	CC(C)(C)OC(=O)Nc1ccc(N/C(=N/S(C)(=O)=O)NCc2nc(C3CC3)cnc2N)cc1		CHEMBL3629157	>	IC50	nM	20000.0	CHEMBL2208	Homo sapiens	IC50	uM	20.0
	15748924	CHEMBL3630368	Inhibition of MK2 (unknown origin) by scintillation proximity assay	B	CCCc1cnc(N)c(CN/C(=N\C(=O)c2ccc(Cl)cc2)Nc2ccc(N(C(=O)c3ccccc3)c3ccccc3)cc2)n1		CHEMBL3629156	>	IC50	nM	20000.0	CHEMBL2208	Homo sapiens	IC50	uM	20.0
	15748925	CHEMBL3630368	Inhibition of MK2 (unknown origin) by scintillation proximity assay	B	CC(=O)/N=C(\NCc1nc(Cl)cnc1N)Nc1ccc(NC(=O)OC(C)(C)C)cc1		CHEMBL3629149	>	IC50	nM	40000.0	CHEMBL2208	Homo sapiens	IC50	uM	40.0
	15754246	CHEMBL3631011	Inhibition of MAPKAPK2 (unknown origin) at 1 uM by FRET method	B	N#Cc1ccnc(Nc2cc(C3CCN(C4COC4)CC3)n(C3CCCC3)n2)c1		CHEMBL3629013	=	Inhibition	%	6.7	CHEMBL2208	Homo sapiens	INH	%	6.7
	15755898	CHEMBL3630841	Inhibition of MAPKAPK2 (unknown origin) assessed as remaining activity at 10 uM by high-throughput assay relative to control	B	O=C1c2ccccc2-c2c1oc1ccccc1c2=O		CHEMBL3629616	=	Activity	%	88.0	CHEMBL2208	Homo sapiens	Activity	%	88.0
	15756929	CHEMBL3631281	Inhibition of MAPKAPK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	11.03	CHEMBL2208	Homo sapiens	INH	%	11.03
	15757794	CHEMBL3631281	Inhibition of MAPKAPK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	10.71	CHEMBL2208	Homo sapiens	INH	%	10.71
	15758773	CHEMBL3631281	Inhibition of MAPKAPK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	11.54	CHEMBL2208	Homo sapiens	INH	%	11.54
Not Active	15774421	CHEMBL3636795	Inhibition of MAPKAPK2 (unknown origin) after 120 mins by HotSpot assay	B	CC(=O)Nc1ccc2ncnc(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2c1		CHEMBL3633929		IC50			CHEMBL2208	Homo sapiens	IC50		
321193	16281776	CHEMBL3706225	IMAP Assay: The ability of compounds to inhibit activated phospho-p38alpha is evaluated using a p38alpha /MK2 and a p38alpha /PRAK cascade assay format. The kinase activity of p38alpha is determined by its ability to phosphorylate GST-MK2 or GST-PRAK. Activation of MK2 or PRAK by p38alpha is quantitated by measuring the phosphorylation of a fluorescently-labeled, MK2/PRAK specific peptide substrate, Hsp27 peptide (FITC-KKKALSRQLSVAA). The phosphorylation of the Hsp27 peptide is quantified using IMAP technology (Molecular Devices, Sunnyvale Calif.). Kinase reactions are carried out in a 384-well plate (Greiner, 781280) in 20 mM HEPES pH 7.5, 10 mM MgCl2, 0.01% Triton X-100, 0.01% BSA, 1 mM DTT, and 2% DMSO. The inhibitor concentration is varied between 0.02-30,000 nM, while the Hsp27 peptide substrate and MgATP are held constant at 1 uM and 10 uM, respectively. Activated p38alpha is added to a final concentration of 30 uM for reactions with nonphosphorylated 1 nM GST-MK2.	B	Cc1cnc(-c2ccnc(C(C)(C)O)n2)cc1-n1c(C)cc(OCc2ncc(F)cc2F)c(Cl)c1=O		CHEMBL3704901	=	IC50	nM	21.0	CHEMBL2208	Homo sapiens	IC50	nM	21.0
	16376460	CHEMBL3734484	Inhibition of recombinant human MAPKAPK2 using fluorescein-labeled peptide as substrate by fluorescence-electrophoretic mobility shift assay	B	Cl.NCCN1C(=O)S/C(=C\CCC2CCCCC2)C1=O		CHEMBL3732044	=	Inhibition	%	3.0	CHEMBL2208	Homo sapiens	INH	%	3.0
	16379667	CHEMBL3739150	Inhibition of MAPKAPK2 (unknown origin) at 200 nM by electrophoretic mobility shift assay	B	COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1n[nH]c3ncccc13)C2=O		CHEMBL3735816	=	Inhibition	%	-1.2	CHEMBL2208	Homo sapiens	INH	%	-1.2
	16379668	CHEMBL3739150	Inhibition of MAPKAPK2 (unknown origin) at 200 nM by electrophoretic mobility shift assay	B	COc1ccc2c(c1C(C)N1CCNCC1)O/C(=C\c1n[nH]c3ncccc13)C2=O	Outside typical range	CHEMBL3735890	=	Inhibition	%	-15.0	CHEMBL2208	Homo sapiens	INH	%	-15.0
	16388315	CHEMBL3737490	Inhibition of MAPKAPK2 (unknown origin) at 1 uM by selectscreen kinase profiling assay in presence of ATP	B	COc1cc2c(cc1OC)CN(CC(=O)Nc1ccc3c(c1)/C(=C/c1cnc[nH]1)C(=O)N3)CC2		CHEMBL3091673	=	Inhibition	%	-2.0	CHEMBL2208	Homo sapiens	INH	%	-2.0
	16397387	CHEMBL3743115	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	CC(=O)c1nn(-c2ccccc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3739750	=	Inhibition	%	2.0	CHEMBL2208	Homo sapiens	INH	%	2.0
	16397388	CHEMBL3743115	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	CC(=O)c1nn(-c2ccc(C)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3740247	=	Inhibition	%	45.0	CHEMBL2208	Homo sapiens	INH	%	45.0
	16397389	CHEMBL3743115	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	CC(=O)c1nn(-c2ccc(Cl)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3739587	=	Inhibition	%	33.0	CHEMBL2208	Homo sapiens	INH	%	33.0
	16397390	CHEMBL3743115	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	CCOC(=O)c1nn(-c2ccccc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3740131	=	Inhibition	%	57.0	CHEMBL2208	Homo sapiens	INH	%	57.0
	16397391	CHEMBL3743115	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	CCOC(=O)c1nn(-c2ccc(C)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3742349	=	Inhibition	%	35.0	CHEMBL2208	Homo sapiens	INH	%	35.0
	16397392	CHEMBL3743115	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	CCOC(=O)c1nn(-c2ccc(Cl)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3741526	=	Inhibition	%	88.0	CHEMBL2208	Homo sapiens	INH	%	88.0
	16397393	CHEMBL3743115	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1C(=O)c1cn(-c2ccccc2)nc1C(=O)Nc1ccccc1		CHEMBL3740930	=	Inhibition	%	26.0	CHEMBL2208	Homo sapiens	INH	%	26.0
	16397394	CHEMBL3743115	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1ccc(-n2cc(C(=O)c3c(C)[nH]c(-c4ccccc4)c3-c3ccccc3)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL3740713	=	Inhibition	%	45.0	CHEMBL2208	Homo sapiens	INH	%	45.0
	16397395	CHEMBL3743115	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1C(=O)c1cn(-c2ccc(Cl)cc2)nc1C(=O)Nc1ccccc1		CHEMBL3740385	=	Inhibition	%	15.0	CHEMBL2208	Homo sapiens	INH	%	15.0
	16397396	CHEMBL3743115	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1C(=O)c1cn(-c2ccccc2)nc1-c1ccccc1		CHEMBL3741069	=	Inhibition	%	34.0	CHEMBL2208	Homo sapiens	INH	%	34.0
	16397397	CHEMBL3743115	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1-c1nnc(C)c2nn(-c3ccccc3)cc12		CHEMBL3740582	=	Inhibition	%	37.0	CHEMBL2208	Homo sapiens	INH	%	37.0
	16397398	CHEMBL3743115	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1ccc(-n2cc3c(-c4c(C)[nH]c(-c5ccccc5)c4-c4ccccc4)nnc(C)c3n2)cc1		CHEMBL3742060	=	Inhibition	%	24.0	CHEMBL2208	Homo sapiens	INH	%	24.0
	16397399	CHEMBL3743115	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1-c1nnc(C)c2nn(-c3ccc(Cl)cc3)cc12		CHEMBL3741655	=	Inhibition	%	26.0	CHEMBL2208	Homo sapiens	INH	%	26.0
	16397400	CHEMBL3743115	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Oc1nnc(-c2c[nH]c(-c3ccccc3)c2-c2ccccc2)c2cn(-c3ccccc3)nc12		CHEMBL3740923	=	Inhibition	%	19.0	CHEMBL2208	Homo sapiens	INH	%	19.0
	16397401	CHEMBL3743115	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1ccc(-n2cc3c(-c4c[nH]c(-c5ccccc5)c4-c4ccccc4)nnc(O)c3n2)cc1		CHEMBL3739586	=	Inhibition	%	10.0	CHEMBL2208	Homo sapiens	INH	%	10.0
	16397402	CHEMBL3743115	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Oc1nnc(-c2c[nH]c(-c3ccccc3)c2-c2ccccc2)c2cn(-c3ccc(Cl)cc3)nc12		CHEMBL3742200	=	Inhibition	%	18.0	CHEMBL2208	Homo sapiens	INH	%	18.0
	16397403	CHEMBL3743115	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1-c1ccc(NC(=O)c2ccccc2)c(=O)o1		CHEMBL3740003	=	Inhibition	%	23.0	CHEMBL2208	Homo sapiens	INH	%	23.0
	16397404	CHEMBL3743115	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1c(C(=O)c2coc3ccc(O)cc23)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3741960	=	Inhibition	%	56.0	CHEMBL2208	Homo sapiens	INH	%	56.0
	16397405	CHEMBL3743115	Inhibition of MK2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1c(C(=O)c2coc3c2cc(O)c2ccccc23)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3740492	=	Inhibition	%	76.0	CHEMBL2208	Homo sapiens	INH	%	76.0
	16413473	CHEMBL3742707	Inhibition of MAPK-APK2 (unknown origin)	B	O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1		CHEMBL3741589	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	16421931	CHEMBL3750413	Inhibition of MK2 (unknown origin)	B	C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1		CHEMBL3651966	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	16425373	CHEMBL3751219	Inhibition of MAPKAPK2 (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	10.8	CHEMBL2208	Homo sapiens	INH	%	10.8
	16431889	CHEMBL3747982	Inhibition of human MAPKAPK2 using [KKLNRTLSVA] as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	16450900	CHEMBL3760624	Inhibition of MAPKAPK2 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	1.9	CHEMBL2208	Homo sapiens	INH	%	1.9
	16451738	CHEMBL3760624	Inhibition of MAPKAPK2 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4c(Cl)cccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758602	=	Inhibition	%	2.1	CHEMBL2208	Homo sapiens	INH	%	2.1
	16458504	CHEMBL3761590	Inhibition of MAPKAPK2 (unknown origin) at 500 nM	B	C[C@@H](Nc1ncnc2sc(-c3ccccc3C(N)=O)cc12)c1ccccc1		CHEMBL3759085	=	Inhibition	%	-8.0	CHEMBL2208	Homo sapiens	INH	%	-8.0
	16458505	CHEMBL3761590	Inhibition of MAPKAPK2 (unknown origin) at 500 nM	B	C[C@@H](Nc1ncnc2sc(-c3ccc(C(=O)NCCN(C)C)cc3)cc12)c1ccccc1	Outside typical range	CHEMBL3758800	=	Inhibition	%	-12.0	CHEMBL2208	Homo sapiens	INH	%	-12.0
	16458506	CHEMBL3761590	Inhibition of MAPKAPK2 (unknown origin) at 500 nM	B	CN(C)CCNC(=O)c1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3s2)cc1		CHEMBL3758376	=	Inhibition	%	2.0	CHEMBL2208	Homo sapiens	INH	%	2.0
	16458507	CHEMBL3761590	Inhibition of MAPKAPK2 (unknown origin) at 500 nM	B	COc1cc(C(N)=O)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1		CHEMBL3759480	=	Inhibition	%	-7.0	CHEMBL2208	Homo sapiens	INH	%	-7.0
	16458508	CHEMBL3761590	Inhibition of MAPKAPK2 (unknown origin) at 500 nM	B	COc1ccc(C(=O)NCCN(C)C)cc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1		CHEMBL3758582	=	Inhibition	%	-1.0	CHEMBL2208	Homo sapiens	INH	%	-1.0
	16458509	CHEMBL3761590	Inhibition of MAPKAPK2 (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1		CHEMBL3759559	=	Inhibition	%	1.0	CHEMBL2208	Homo sapiens	INH	%	1.0
	16458510	CHEMBL3761590	Inhibition of MAPKAPK2 (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1		CHEMBL3758682	=	Inhibition	%	8.0	CHEMBL2208	Homo sapiens	INH	%	8.0
	16458511	CHEMBL3761590	Inhibition of MAPKAPK2 (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(Nc3ccccc3)ncnc2s1		CHEMBL3758768	=	Inhibition	%	4.0	CHEMBL2208	Homo sapiens	INH	%	4.0
	16458512	CHEMBL3761590	Inhibition of MAPKAPK2 (unknown origin) at 500 nM	B	C#Cc1cccc(Nc2ncnc3sc(-c4ccc(CO)cc4OC)cc23)c1	Outside typical range	CHEMBL3758802	=	Inhibition	%	-16.0	CHEMBL2208	Homo sapiens	INH	%	-16.0
	16458513	CHEMBL3761590	Inhibition of MAPKAPK2 (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1		CHEMBL3758351	=	Inhibition	%	3.0	CHEMBL2208	Homo sapiens	INH	%	3.0
	16458514	CHEMBL3761590	Inhibition of MAPKAPK2 (unknown origin) at 500 nM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	-1.0	CHEMBL2208	Homo sapiens	INH	%	-1.0
	16474687	CHEMBL3767173	Inhibition of ERK2/MAPK2 (unknown origin) at 10 uM	B	CN1CCN(CCCOc2ccc(N3C(=O)/C(=C/c4ccc(Oc5ccc(F)cc5)cc4)SC3=S)cc2)CC1		CHEMBL3765499	=	Inhibition	%	6.8	CHEMBL2208	Homo sapiens	INH	%	6.8
	16474697	CHEMBL3767317	Inhibition of MAPKAPK2 (unknown origin) at 10 uM	B	CN1CCN(CCCOc2ccc(N3C(=O)/C(=C/c4ccc(Oc5ccc(F)cc5)cc4)SC3=S)cc2)CC1		CHEMBL3765499	=	Inhibition	%	42.0	CHEMBL2208	Homo sapiens	INH	%	42.0
	16485743	CHEMBL3771592	Inhibition of human recombinant MAPKAPK2 assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control	B	Cc1c(Cl)cccc1NC(=O)c1sc2nc3c(cc2c1N)C(=O)CC3		CHEMBL3771285	=	Activity	%	100.0	CHEMBL2208	Homo sapiens	Activity	%	100.0
	16495122	CHEMBL3776240	Inhibition of N-terminal His6-tagged recombinant human MAPKAP-K2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-4.0	CHEMBL2208	Homo sapiens	Activity	%	-4.0
	16496041	CHEMBL3776240	Inhibition of N-terminal His6-tagged recombinant human MAPKAP-K2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	4.0	CHEMBL2208	Homo sapiens	Activity	%	4.0
	16508228	CHEMBL3776240	Inhibition of N-terminal His6-tagged recombinant human MAPKAP-K2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	1.0	CHEMBL2208	Homo sapiens	Activity	%	1.0
Not Active	16514142	CHEMBL3782190	Inhibition of partial length human MAPKAPK2 expressed in bacterial system at 1 uM	B	Cc1cnc(N)nc1OCC(C)(C)CO		CHEMBL3780032		Inhibition	%		CHEMBL2208	Homo sapiens	INH		
	16540871	CHEMBL3790003	Inhibition of MAPKAPK2 (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL1614712	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	16540872	CHEMBL3790003	Inhibition of MAPKAPK2 (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OC[C@@H]3CCCO3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3787614	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	16540873	CHEMBL3790003	Inhibition of MAPKAPK2 (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3787112	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	16540874	CHEMBL3790003	Inhibition of MAPKAPK2 (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OCC34CCC(CC3)O4)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3785500	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	16540875	CHEMBL3790003	Inhibition of MAPKAPK2 (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cccc(OC[C@@H]5CCCO5)c4F)c4c(N)ncnc43)C2)CC1		CHEMBL3786167	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	16540876	CHEMBL3790003	Inhibition of MAPKAPK2 (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cc(OC[C@@H]5CCCO5)ccc4F)c4c(N)ncnc43)C2)CC1		CHEMBL3785951	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	16559721	CHEMBL3794937	Inhibition of full length human N-terminal GST-tagged MAPKAPK2 (1 to 400 residues) expressed in baculovirus expression system coexpressing human His-tagged p38beta (1 to 364 residues)/MAP2K6 (1 to 334 residues) using fluorescence labelled GS peptide substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccccc1)c1n[nH]c2ccccc12		CHEMBL508964	=	Inhibition	%	5.1	CHEMBL2208	Homo sapiens	INH	%	5.1
	16559722	CHEMBL3794937	Inhibition of full length human N-terminal GST-tagged MAPKAPK2 (1 to 400 residues) expressed in baculovirus expression system coexpressing human His-tagged p38beta (1 to 364 residues)/MAP2K6 (1 to 334 residues) using fluorescence labelled GS peptide substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccc(C(=O)N2CCN(c3ccccc3)CC2)cc1)c1n[nH]c2ccccc12		CHEMBL3793843	=	Inhibition	%	-7.5	CHEMBL2208	Homo sapiens	INH	%	-7.5
	16559723	CHEMBL3794937	Inhibition of full length human N-terminal GST-tagged MAPKAPK2 (1 to 400 residues) expressed in baculovirus expression system coexpressing human His-tagged p38beta (1 to 364 residues)/MAP2K6 (1 to 334 residues) using fluorescence labelled GS peptide substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccc(CN2CCN(c3ccccc3)CC2)cc1)c1n[nH]c2ccccc12		CHEMBL3792850	=	Inhibition	%	9.7	CHEMBL2208	Homo sapiens	INH	%	9.7
	16565469	CHEMBL3804493	Inhibition of N-terminal FLAG-tagged MAPKAPK2 (unknown origin) expressed in baculovirus preincubated for 5 mins using KKLNRTLSVA-NH2 as substrate measured after 10 mins in presence of [gamma-33P]ATP by scintillation counting method	B	C[C@H](c1ccccc1)N1c2cc(-n3c(=O)[nH]c4ncccc43)ccc2C(=O)NC1(C)C		CHEMBL3798011	>	IC50	nM	1000.0	CHEMBL2208	Homo sapiens	IC50	nM	1000.0
	16578340	CHEMBL3804394	Inhibition of partial length wild type human MAPKAPK2 expressed in bacterial system assessed as enzyme activity at 1 uM relative to control	B	CN(C)S(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F		CHEMBL3798256	=	Activity	%	83.0	CHEMBL2208	Homo sapiens	Activity	%	83.0
	16580656	CHEMBL3803133	Inhibition of N-terminal FLAG-tagged MAPKAPK2 (unknown origin) expressed in baculovirus preincubated for 5 mins using KKLNRTLSVA-NH2 as substrate at 1 uM measured after 60 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CCN1c2cc(-c3c[nH]c4ncccc34)ccc2C(=O)NC1(C)C		CHEMBL3798713	=	Inhibition	%	66.0	CHEMBL2208	Homo sapiens	INH	%	66.0
	16580657	CHEMBL3803133	Inhibition of N-terminal FLAG-tagged MAPKAPK2 (unknown origin) expressed in baculovirus preincubated for 5 mins using KKLNRTLSVA-NH2 as substrate at 1 uM measured after 60 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CCN1c2cc(-n3c(=O)[nH]c4ncccc43)ccc2C(=O)NC1(C)C		CHEMBL3798933	=	Inhibition	%	-1.0	CHEMBL2208	Homo sapiens	INH	%	-1.0
	16587029	CHEMBL3807441	Inhibition of MAPKAPK2 (unknown origin) in presence of gamma33-ATP	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	uM	10.0
	16593502	CHEMBL3812356	Inhibition of His-tagged full length human recombinant MAPKAPK2 expressed in Escherichia coli using Fluorescein-CREBtide as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	<	Inhibition	%	40.0	CHEMBL2208	Homo sapiens	INH	%	40.0
	16594872	CHEMBL3812446	Inhibition of human MAPKAPK2 (48 to 345 amino acid residues) expressed in bacterial system assessed as enzyme activity at 10 uM by KINOMEScan assay	B	O=C1C2=C(C(=O)c3c(O)ccc(O)c31)[C@@H](O)[C@@H](O)[C@@H](O)C2		CHEMBL1987813	=	Activity	%	93.0	CHEMBL2208	Homo sapiens	Activity	%	93.0
	16595534	CHEMBL3811136	Inhibition of recombinant human N-terminal GST-tagged MK2 (46 to 400 residues) expressed in Escherichia coli in presence of radiolabelled ATP by radiometric assay	B	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)C(C)C		CHEMBL3809901	=	IC50	nM	22000.0	CHEMBL2208	Homo sapiens	IC50	uM	22.0
	16595535	CHEMBL3811136	Inhibition of recombinant human N-terminal GST-tagged MK2 (46 to 400 residues) expressed in Escherichia coli in presence of radiolabelled ATP by radiometric assay	B	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)C(C)C		CHEMBL3809381	=	IC50	nM	5800.0	CHEMBL2208	Homo sapiens	IC50	uM	5.8
	16595536	CHEMBL3811136	Inhibition of recombinant human N-terminal GST-tagged MK2 (46 to 400 residues) expressed in Escherichia coli in presence of radiolabelled ATP by radiometric assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)C(C)C)[C@@H](C)CC		CHEMBL3808687	=	IC50	nM	740.0	CHEMBL2208	Homo sapiens	IC50	uM	0.74
	16595539	CHEMBL3811964	Inhibition of recombinant human N-terminal GST-tagged MK2 (46 to 400 residues) expressed in Escherichia coli assessed as reduction in recombinant human HSP27 phosphorylation at 200 uM after 30 mins by Western blot analysis relative to control	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)C(C)C)[C@@H](C)CC		CHEMBL3808687	=	Inhibition	%	80.0	CHEMBL2208	Homo sapiens	INH	%	80.0
	16595540	CHEMBL3811964	Inhibition of recombinant human N-terminal GST-tagged MK2 (46 to 400 residues) expressed in Escherichia coli assessed as reduction in recombinant human HSP27 phosphorylation at 200 uM after 30 mins by Western blot analysis relative to control	B	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)C(C)C		CHEMBL3810309	=	Inhibition	%	64.0	CHEMBL2208	Homo sapiens	INH	%	64.0
	16595551	CHEMBL3811955	Inhibition of MK2 in human U937 cells assessed as reduction in LPS-stimulated HSP27 phosphorylation at Ser82 preincubated for 1 hr followed by LPS addition measured after 30 mins by Western blot analysis	B	Cc1ccc(-c2ccc3c(ccc4sc5c(c43)NC[C@@H](C)NC5=O)n2)cn1		CHEMBL1231206	=	IC50	nM	201.0	CHEMBL2208	Homo sapiens	IC50	nM	201.0
	16611969	CHEMBL3815437	Inhibition of human MAPKAPK2 (46 to 400 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	-8.0	CHEMBL2208	Homo sapiens	Activity	%	-8.0
	16611970	CHEMBL3815437	Inhibition of human MAPKAPK2 (46 to 400 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncccc23)nc(N)n1		CHEMBL3814340	=	Activity	%	13.0	CHEMBL2208	Homo sapiens	Activity	%	13.0
	16611971	CHEMBL3815437	Inhibition of human MAPKAPK2 (46 to 400 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3814140	=	Activity	%	-3.0	CHEMBL2208	Homo sapiens	Activity	%	-3.0
	16611972	CHEMBL3815437	Inhibition of human MAPKAPK2 (46 to 400 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3815046	=	Activity	%	-23.0	CHEMBL2208	Homo sapiens	Activity	%	-23.0
	16614526	CHEMBL3816724	Inhibition of human MAPKAPK2 at 1 uM using [KKLNRTLSVA] as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1	Outside typical range	CHEMBL3815093	=	Inhibition	%	-13.0	CHEMBL2208	Homo sapiens	INH	%	-13.0
	16618171	CHEMBL3817260	Inhibition of full length recombinant human His-tagged MAPKAPK2 expressed in Escherichia coli at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL2208	Homo sapiens	INH	%	50.0
	16627542	CHEMBL3820347	Inhibition of recombinant human N-terminal GST-tagged MAPKAPK2 (46 to 400 residues) expressed in Escherichia coli at 1 uM by radiometric assay relative to control	B	Cc1cc(-c2cnn3c(NCC4CCOCC4)nc(Oc4ccccc4)nc23)ccc1C(=O)NC1CC1		CHEMBL3819210	=	Inhibition	%	-8.0	CHEMBL2208	Homo sapiens	INH	%	-8.0
	16627543	CHEMBL3820347	Inhibition of recombinant human N-terminal GST-tagged MAPKAPK2 (46 to 400 residues) expressed in Escherichia coli at 1 uM by radiometric assay relative to control	B	O=C(N[C@@H](c1ccccn1)C1CC1)c1ccc2[nH]nc(-c3ccc(N4C5CCC4CC(O)C5)cc3)c2c1	Outside typical range	CHEMBL3818239	=	Inhibition	%	-11.0	CHEMBL2208	Homo sapiens	INH	%	-11.0
	16628518	CHEMBL3820634	Inhibition of human recombinant full-length MAPKAPK2 (46 to 400 residues) expressed in Escherichia coli at 1 uM after 30 mins	B	O=C(Nc1cc(Nc2c(Cl)cnc3c2OCO3)ccn1)C1CC1		CHEMBL3818173	<	Inhibition	%	80.0	CHEMBL2208	Homo sapiens	INH	%	80.0
	16642007	CHEMBL3826418	Inhibition of His-tagged full-length recombinant human MAPKAPK2 expressed in Escherichia coli at 100 nM by Z-lyte assay	B	O=C(CNC(=O)c1cccn(Cc2ccc(F)c(F)c2)c1=O)Nc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL3824119	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	16654158	CHEMBL3830814	Inhibition of human MAPKAPK2 assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay	B	Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1		CHEMBL1077604	=	Activity	%	52.0	CHEMBL2208	Homo sapiens	Activity	%	52.0
	16737954	CHEMBL3856671	Inhibition of recombinant human MAPKAPK2 expressed in Escherichia coli assessed as remaining activity at 10 uM preincubated for 15 mins followed by MAPKAPK substrate peptide addition for 30 mins in presence of [gamma-32P]ATP by TR-FRET assay	B	CNCCOc1ccc(-c2sc3nc(-c4cccs4)nc(NN4C(=O)C=C(C)C4=O)c3c2C)cc1.Cl		CHEMBL3966536	=	Activity	%	63.0	CHEMBL2208	Homo sapiens	Activity	%	63.0
	16739421	CHEMBL3857066	Inhibition of His tagged recombinant full length human MAPKAPK2 expressed in Escherichia coli at 500 nM by Z'-LYTE assay	B	C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN(C)C)cc3)cc12)c1ccccc1		CHEMBL3901622	=	Inhibition	%	3.0	CHEMBL2208	Homo sapiens	INH	%	3.0
	16739422	CHEMBL3857066	Inhibition of His tagged recombinant full length human MAPKAPK2 expressed in Escherichia coli at 500 nM by Z'-LYTE assay	B	C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN4CCCCC4)cc3)cc12)c1ccccc1		CHEMBL3891846	=	Inhibition	%	4.0	CHEMBL2208	Homo sapiens	INH	%	4.0
	16739423	CHEMBL3857066	Inhibition of His tagged recombinant full length human MAPKAPK2 expressed in Escherichia coli at 500 nM by Z'-LYTE assay	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	-1.0	CHEMBL2208	Homo sapiens	INH	%	-1.0
	16837449	CHEMBL3876112	Inhibition of human recombinant full length His-tagged MAPKAPK2 expressed in Escherichia coli	B	CC1(C)C(=O)N([C@H]2CCc3c(O)cccc32)c2nc(Nc3ccccc3)ncc21		CHEMBL3884319	=	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	nM	10000.0
	16844201	CHEMBL3877222	Inhibition of recombinant MK2 (45 to 400 residues) (unknown origin) using fluorescein isothiocyanate-KKKALSRQLSVAA as substrate	B	Cc1ccc(-c2ccc3c(ccc4sc5c(c43)NC[C@@H](C)NC5=O)n2)cn1		CHEMBL1231206	=	Ki	nM	5.0	CHEMBL2208	Homo sapiens	Ki	nM	5.0
411204	17776020	CHEMBL3888628	Inhibition Assay: Kinase reactions is carried out in a 384-well plate (Matrical, MP101-1-PP) in 20 mM HEPES pH 7.5, 10 mM MgCl2, 0.0005% Tween-20, 0.01% BSA, 1 mM DTT, and 2% DMSO. The inhibitor concentration is varied between 0.02-30,000 nM, while the Hsp27 peptide substrate and MgATP are held constant at 1 μM and 10 μM, respectively. Activated p38α is added to a final concentration of 20 pM for reactions with nonphosphorylated 1 nM His6-MK2 in the cascade reaction. For the p38α/PRAK cascade, unactivated GST-PRAK is held constant at 1 nM while p38α is added in to a final concentration of 20 pM. Kinase reactions are incubated at room temperature and quenched after 30 minutes by the addition of stop buffer (180 mM HEPES, 30 mM EDTA, and 0.2% Coating Reagent-3). Under these conditions, approximately 20% of the substrate Hsp27 peptide is phosphorylated. Reactions are initiated by the addition of activated p38α except for preincubation experiments, where reactions are initiated by the addition of Hsp27 peptide and MgATP. Preincubation of p38α with inhibitor or p38α with unactivated His6-MK2 or unactivated GST-PRAK and inhibitor are performed at 2X final assay concentrations at room temperature 240 minutes prior to adding ATP and Hsp27 peptide to initiate catalysis.	B	Cc1cnc(-c2ccnc(C(C)(C)O)n2)cc1-n1c(C)cc(OCc2ccc(F)cc2F)c(Cl)c1=O		CHEMBL3902121	=	IC50	nM	6.4	CHEMBL2208	Homo sapiens	IC50	nM	6.4
411205	17776021	CHEMBL3888628	Inhibition Assay: Kinase reactions is carried out in a 384-well plate (Matrical, MP101-1-PP) in 20 mM HEPES pH 7.5, 10 mM MgCl2, 0.0005% Tween-20, 0.01% BSA, 1 mM DTT, and 2% DMSO. The inhibitor concentration is varied between 0.02-30,000 nM, while the Hsp27 peptide substrate and MgATP are held constant at 1 μM and 10 μM, respectively. Activated p38α is added to a final concentration of 20 pM for reactions with nonphosphorylated 1 nM His6-MK2 in the cascade reaction. For the p38α/PRAK cascade, unactivated GST-PRAK is held constant at 1 nM while p38α is added in to a final concentration of 20 pM. Kinase reactions are incubated at room temperature and quenched after 30 minutes by the addition of stop buffer (180 mM HEPES, 30 mM EDTA, and 0.2% Coating Reagent-3). Under these conditions, approximately 20% of the substrate Hsp27 peptide is phosphorylated. Reactions are initiated by the addition of activated p38α except for preincubation experiments, where reactions are initiated by the addition of Hsp27 peptide and MgATP. Preincubation of p38α with inhibitor or p38α with unactivated His6-MK2 or unactivated GST-PRAK and inhibitor are performed at 2X final assay concentrations at room temperature 240 minutes prior to adding ATP and Hsp27 peptide to initiate catalysis.	B	Cc1cnc(-c2ccnc(C(C)(C)O)n2)cc1-n1c(C)cc(OCc2ccc(F)cc2F)c(Cl)c1=O		CHEMBL3902121	=	IC50	nM	7.3	CHEMBL2208	Homo sapiens	IC50	nM	7.3
411206	17776022	CHEMBL3888628	Inhibition Assay: Kinase reactions is carried out in a 384-well plate (Matrical, MP101-1-PP) in 20 mM HEPES pH 7.5, 10 mM MgCl2, 0.0005% Tween-20, 0.01% BSA, 1 mM DTT, and 2% DMSO. The inhibitor concentration is varied between 0.02-30,000 nM, while the Hsp27 peptide substrate and MgATP are held constant at 1 μM and 10 μM, respectively. Activated p38α is added to a final concentration of 20 pM for reactions with nonphosphorylated 1 nM His6-MK2 in the cascade reaction. For the p38α/PRAK cascade, unactivated GST-PRAK is held constant at 1 nM while p38α is added in to a final concentration of 20 pM. Kinase reactions are incubated at room temperature and quenched after 30 minutes by the addition of stop buffer (180 mM HEPES, 30 mM EDTA, and 0.2% Coating Reagent-3). Under these conditions, approximately 20% of the substrate Hsp27 peptide is phosphorylated. Reactions are initiated by the addition of activated p38α except for preincubation experiments, where reactions are initiated by the addition of Hsp27 peptide and MgATP. Preincubation of p38α with inhibitor or p38α with unactivated His6-MK2 or unactivated GST-PRAK and inhibitor are performed at 2X final assay concentrations at room temperature 240 minutes prior to adding ATP and Hsp27 peptide to initiate catalysis.	B	Cc1cnc(-c2ccnc(C(C)(C)C)n2)cc1-n1c(C)cc(OCc2ccc(F)cc2F)c(Cl)c1=O		CHEMBL3962170	=	IC50	nM	18.0	CHEMBL2208	Homo sapiens	IC50	nM	18.0
411207	17776023	CHEMBL3888628	Inhibition Assay: Kinase reactions is carried out in a 384-well plate (Matrical, MP101-1-PP) in 20 mM HEPES pH 7.5, 10 mM MgCl2, 0.0005% Tween-20, 0.01% BSA, 1 mM DTT, and 2% DMSO. The inhibitor concentration is varied between 0.02-30,000 nM, while the Hsp27 peptide substrate and MgATP are held constant at 1 μM and 10 μM, respectively. Activated p38α is added to a final concentration of 20 pM for reactions with nonphosphorylated 1 nM His6-MK2 in the cascade reaction. For the p38α/PRAK cascade, unactivated GST-PRAK is held constant at 1 nM while p38α is added in to a final concentration of 20 pM. Kinase reactions are incubated at room temperature and quenched after 30 minutes by the addition of stop buffer (180 mM HEPES, 30 mM EDTA, and 0.2% Coating Reagent-3). Under these conditions, approximately 20% of the substrate Hsp27 peptide is phosphorylated. Reactions are initiated by the addition of activated p38α except for preincubation experiments, where reactions are initiated by the addition of Hsp27 peptide and MgATP. Preincubation of p38α with inhibitor or p38α with unactivated His6-MK2 or unactivated GST-PRAK and inhibitor are performed at 2X final assay concentrations at room temperature 240 minutes prior to adding ATP and Hsp27 peptide to initiate catalysis.	B	Cc1cnc(-c2ccnc(C(C)(C)C)n2)cc1-n1c(C)cc(OCc2ccc(F)cc2F)c(Cl)c1=O		CHEMBL3962170	=	IC50	nM	26.0	CHEMBL2208	Homo sapiens	IC50	nM	26.0
411208	17776024	CHEMBL3888628	Inhibition Assay: Kinase reactions is carried out in a 384-well plate (Matrical, MP101-1-PP) in 20 mM HEPES pH 7.5, 10 mM MgCl2, 0.0005% Tween-20, 0.01% BSA, 1 mM DTT, and 2% DMSO. The inhibitor concentration is varied between 0.02-30,000 nM, while the Hsp27 peptide substrate and MgATP are held constant at 1 μM and 10 μM, respectively. Activated p38α is added to a final concentration of 20 pM for reactions with nonphosphorylated 1 nM His6-MK2 in the cascade reaction. For the p38α/PRAK cascade, unactivated GST-PRAK is held constant at 1 nM while p38α is added in to a final concentration of 20 pM. Kinase reactions are incubated at room temperature and quenched after 30 minutes by the addition of stop buffer (180 mM HEPES, 30 mM EDTA, and 0.2% Coating Reagent-3). Under these conditions, approximately 20% of the substrate Hsp27 peptide is phosphorylated. Reactions are initiated by the addition of activated p38α except for preincubation experiments, where reactions are initiated by the addition of Hsp27 peptide and MgATP. Preincubation of p38α with inhibitor or p38α with unactivated His6-MK2 or unactivated GST-PRAK and inhibitor are performed at 2X final assay concentrations at room temperature 240 minutes prior to adding ATP and Hsp27 peptide to initiate catalysis.	B	Cc1cnc(-c2ccnc(C(C)(C)O)n2)cc1-n1c(C)cc(OCc2ccc(F)cc2F)c(Cl)c1=O		CHEMBL3902121	=	IC50	nM	138.0	CHEMBL2208	Homo sapiens	IC50	nM	138.0
411209	17776025	CHEMBL3888628	Inhibition Assay: Kinase reactions is carried out in a 384-well plate (Matrical, MP101-1-PP) in 20 mM HEPES pH 7.5, 10 mM MgCl2, 0.0005% Tween-20, 0.01% BSA, 1 mM DTT, and 2% DMSO. The inhibitor concentration is varied between 0.02-30,000 nM, while the Hsp27 peptide substrate and MgATP are held constant at 1 μM and 10 μM, respectively. Activated p38α is added to a final concentration of 20 pM for reactions with nonphosphorylated 1 nM His6-MK2 in the cascade reaction. For the p38α/PRAK cascade, unactivated GST-PRAK is held constant at 1 nM while p38α is added in to a final concentration of 20 pM. Kinase reactions are incubated at room temperature and quenched after 30 minutes by the addition of stop buffer (180 mM HEPES, 30 mM EDTA, and 0.2% Coating Reagent-3). Under these conditions, approximately 20% of the substrate Hsp27 peptide is phosphorylated. Reactions are initiated by the addition of activated p38α except for preincubation experiments, where reactions are initiated by the addition of Hsp27 peptide and MgATP. Preincubation of p38α with inhibitor or p38α with unactivated His6-MK2 or unactivated GST-PRAK and inhibitor are performed at 2X final assay concentrations at room temperature 240 minutes prior to adding ATP and Hsp27 peptide to initiate catalysis.	B	Cc1cnc(-c2ccnc(C(C)(C)O)n2)cc1-n1c(C)cc(OCc2ccc(F)cc2F)c(Cl)c1=O		CHEMBL3902121	=	IC50	nM	144.0	CHEMBL2208	Homo sapiens	IC50	nM	144.0
411210	17776026	CHEMBL3888628	Inhibition Assay: Kinase reactions is carried out in a 384-well plate (Matrical, MP101-1-PP) in 20 mM HEPES pH 7.5, 10 mM MgCl2, 0.0005% Tween-20, 0.01% BSA, 1 mM DTT, and 2% DMSO. The inhibitor concentration is varied between 0.02-30,000 nM, while the Hsp27 peptide substrate and MgATP are held constant at 1 μM and 10 μM, respectively. Activated p38α is added to a final concentration of 20 pM for reactions with nonphosphorylated 1 nM His6-MK2 in the cascade reaction. For the p38α/PRAK cascade, unactivated GST-PRAK is held constant at 1 nM while p38α is added in to a final concentration of 20 pM. Kinase reactions are incubated at room temperature and quenched after 30 minutes by the addition of stop buffer (180 mM HEPES, 30 mM EDTA, and 0.2% Coating Reagent-3). Under these conditions, approximately 20% of the substrate Hsp27 peptide is phosphorylated. Reactions are initiated by the addition of activated p38α except for preincubation experiments, where reactions are initiated by the addition of Hsp27 peptide and MgATP. Preincubation of p38α with inhibitor or p38α with unactivated His6-MK2 or unactivated GST-PRAK and inhibitor are performed at 2X final assay concentrations at room temperature 240 minutes prior to adding ATP and Hsp27 peptide to initiate catalysis.	B	Cc1cnc(-c2ccnc(C(C)(C)C)n2)cc1-n1c(C)cc(OCc2ccc(F)cc2F)c(Cl)c1=O		CHEMBL3962170	=	IC50	nM	121.0	CHEMBL2208	Homo sapiens	IC50	nM	121.0
411211	17776027	CHEMBL3888628	Inhibition Assay: Kinase reactions is carried out in a 384-well plate (Matrical, MP101-1-PP) in 20 mM HEPES pH 7.5, 10 mM MgCl2, 0.0005% Tween-20, 0.01% BSA, 1 mM DTT, and 2% DMSO. The inhibitor concentration is varied between 0.02-30,000 nM, while the Hsp27 peptide substrate and MgATP are held constant at 1 μM and 10 μM, respectively. Activated p38α is added to a final concentration of 20 pM for reactions with nonphosphorylated 1 nM His6-MK2 in the cascade reaction. For the p38α/PRAK cascade, unactivated GST-PRAK is held constant at 1 nM while p38α is added in to a final concentration of 20 pM. Kinase reactions are incubated at room temperature and quenched after 30 minutes by the addition of stop buffer (180 mM HEPES, 30 mM EDTA, and 0.2% Coating Reagent-3). Under these conditions, approximately 20% of the substrate Hsp27 peptide is phosphorylated. Reactions are initiated by the addition of activated p38α except for preincubation experiments, where reactions are initiated by the addition of Hsp27 peptide and MgATP. Preincubation of p38α with inhibitor or p38α with unactivated His6-MK2 or unactivated GST-PRAK and inhibitor are performed at 2X final assay concentrations at room temperature 240 minutes prior to adding ATP and Hsp27 peptide to initiate catalysis.	B	Cc1cnc(-c2ccnc(C(C)(C)C)n2)cc1-n1c(C)cc(OCc2ccc(F)cc2F)c(Cl)c1=O		CHEMBL3962170	=	IC50	nM	210.0	CHEMBL2208	Homo sapiens	IC50	nM	210.0
412032	17776747	CHEMBL3888675	Mobility Shift Assay: Agents: 1-fold kinase buffer without MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 2 mM DTT. 1-fold kinase buffer with MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 10 mM MnCl2, 2 mM DTT. Termination solution: 100 mM HEPES, pH 7.5, 0.0015% Brij-35, 0.2% Coating Reagent#3, 50 mM EDTA. 2.5-fold kinase solution: The kinase was added to the 1-fold kinase buffer to form a 2.5-fold kinase solution. 2.5-fold substrate solution: FAM fluorescence-labelled polypeptide and ATP were added to the 1-fold kinase buffer to form a 2.5-fold substrate solution. Compounds: The final test concentration of the compound was 10 μM at maximum. Firstly, a 50-fold concentration (i.e. 500 μM) was prepared with 100% DMSO. The compound was diluted with 100% DMSO by 5 folds at 5 concentrations (successively 500 μM, 100 μM, 20 μM, 4 μM, and 0.8 μM). After diluting with 1-fold kinase buffer by 10 folds, 5 μl of the samples were transferred to a 384-well reaction plate. Two negative control wells and two positive control wells were set at each line respectively. Replication was made in a 96-well plate in five concentrations of 5-fold compound. 10% DMSO was added to the positive control well, and 5 μl of EDTA (250 mM) was added to the negative control well. Procedure: To the 384-well reaction plate was added 5-fold compound dissolved in 10% DMSO at 5 μl/well. To the 384-well reaction plate was added 2.5-fold kinase solution at 10 Î¼l/well. The plate was incubated at room temperature for 10 mins. To the 384-well reaction plate was added 2.5-fold substrate solution at 10 μl/well. The plate was incubated at 28° C. for a certain period. 25 μl termination solution was added to terminate the reaction.	B	Nc1ccc(-c2ccc3ncc4c(=O)[nH]c(=O)n(-c5cccc(C(F)(F)F)c5)c4c3n2)cn1		CHEMBL3903725	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	nM	10000.0
Inactive	17916648	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916649	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916650	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916651	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17916652	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	=	Kd	nM	18.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	18.0
Inactive	17916653	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916654	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916655	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916656	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916657	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916658	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916659	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916660	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916661	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916662	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916663	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916664	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916665	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916666	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916667	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916668	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916669	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916670	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916671	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916672	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916673	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916674	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916675	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916676	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Active	17916677	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	=	Kd	nM	27.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	27.0
Inactive	17916678	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916679	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916680	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916681	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916682	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916683	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916684	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Active	17916685	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	=	Kd	nM	817.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	817.0
Active	17916686	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	538.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	538.0
Inactive	17916687	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916688	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916689	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916690	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916691	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916692	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Active	17916693	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	=	Kd	nM	0.3	CHEMBL2208	Homo sapiens	Kd apparent	nM	0.3
Inactive	17916694	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916695	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916696	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916697	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916698	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916699	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916700	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916701	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916702	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916703	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916704	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916705	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916706	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916707	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916708	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916709	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916710	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916711	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916712	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916713	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916714	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916715	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916716	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Active	17916717	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	=	Kd	nM	14742.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	14742.0
Inactive	17916718	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916719	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916720	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916721	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916722	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916723	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Active	17916724	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	=	Kd	nM	67.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	67.0
Inactive	17916725	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916726	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916727	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916728	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916729	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916730	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916731	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916732	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Active	17916733	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	=	Kd	nM	354.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	354.0
Inactive	17916734	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916735	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916736	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916737	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916738	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916739	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Active	17916740	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	Kd	nM	1224.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	1224.0
Inactive	17916741	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916742	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916743	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916744	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916745	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916746	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916747	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916748	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Active	17916749	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	=	Kd	nM	5298.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	5298.0
Inactive	17916750	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916751	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916752	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916753	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916754	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916755	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916756	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Active	17916757	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	=	Kd	nM	63.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	63.0
Active	17916758	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	=	Kd	nM	682.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	682.0
Inactive	17916759	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916760	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916761	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916762	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916763	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Active	17916764	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	=	Kd	nM	4691.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	4691.0
Inactive	17916765	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916766	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916767	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916768	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916769	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916770	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916771	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916772	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916773	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916774	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916775	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916776	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916777	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916778	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Active	17916779	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	=	Kd	nM	934.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	934.0
Inactive	17916780	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916781	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916782	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916783	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916784	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916785	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916786	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916787	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916788	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916789	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916790	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916791	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916792	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916793	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916794	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916795	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916796	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916797	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916798	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916799	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916800	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916801	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Active	17916802	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	Kd	nM	10078.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	10078.0
Inactive	17916803	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916804	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916805	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916806	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916807	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916808	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916809	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916810	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916811	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916812	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916813	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916814	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916815	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916816	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916817	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916818	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916819	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916820	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916821	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916822	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Active	17916823	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Kd	nM	468.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	468.0
Inactive	17916824	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916825	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916826	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916827	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916828	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916829	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916830	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916831	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916832	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916833	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916834	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916835	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916836	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Active	17916837	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	=	Kd	nM	304.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	304.0
Inactive	17916838	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916839	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Active	17916840	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	=	Kd	nM	490.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	490.0
Inactive	17916841	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916842	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916843	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916844	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916845	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916846	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916847	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916848	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916849	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916850	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Active	17916851	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	=	Kd	nM	1519.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	1519.0
Inactive	17916852	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916853	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916854	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916855	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916856	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916857	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916858	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17916859	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	=	Kd	nM	19.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	19.0
Inactive	17916860	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916861	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916862	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916863	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916864	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916865	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916866	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916867	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916868	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916869	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916870	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916871	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916872	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Active	17916873	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	=	Kd	nM	2686.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	2686.0
Inactive	17916874	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916875	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916876	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916877	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916878	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916879	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916880	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916881	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916882	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916883	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916884	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916885	CHEMBL3991778	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL2208	Homo sapiens	Kd apparent	nM	30000.0
	17964920	CHEMBL3995029	Inhibition of human MAPKAPK2 (V48 to D345 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by KINOMEscan assay relative to control	B	CNc1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)on3)c(C)c2)ncn1		CHEMBL4060295	=	Activity	%	53.0	CHEMBL2208	Homo sapiens	Activity	%	53.0
	17979262	CHEMBL3998068	Inhibition of full length recombinant human His-tagged MAPKAPK2 expressed in Escherichia coli at 10 uM by Z'-LYTE assay relative to control	B	CC1=Nc2c(Sc3ccccc3)ncnc2Sc2ccccc21		CHEMBL4061152	=	Inhibition	%	8.0	CHEMBL2208	Homo sapiens	INH	%	8.0
	18007235	CHEMBL4003443	Inhibition of human MAPKAPK2 expressed in Sf9 cells assessed as residual activity at 0.5 uM relative to control	B	C=CC(=O)Nc1cccc(C(=O)Nc2ccc(Nc3cc(-c4c(-c5ccc(F)cc5)nc(SC)n4C)ccn3)cc2)c1		CHEMBL4077018	=	Activity	%	30.0	CHEMBL2208	Homo sapiens	Activity	%	30.0
	18008352	CHEMBL4003705	Inhibition of MAPKAPK2 (unknown origin)	B	CN(C)CCn1cc(-c2ccn3c(-c4ccc(C(N)=O)c(OCc5cccc(F)c5)c4)cnc3c2)cn1		CHEMBL4062453	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	nM	10000.0
	18052918	CHEMBL4011930	Inhibition of MAPKAPK2 (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	Inhibition	%	-7.4	CHEMBL2208	Homo sapiens	INH	%	-7.4
	18114268	CHEMBL4025226	Inhibition of wild-type human partial length MAPKAPK2 (V48 to D345 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	88.0	CHEMBL2208	Homo sapiens	Activity	%	88.0
Not Active	18134446	CHEMBL4029531	Inhibition of MAPKAPK2 (unknown origin) at <1 uM using KKLNRTLSVA-NH2 as substrate preincubated for 5 mins followed by substrate addition measured after 10 mins in presence of [gamma33P]ATP by scintillation counter method	B	COCCNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1		CHEMBL4066819		Inhibition	%		CHEMBL2208	Homo sapiens	INH		
Not Active	18134477	CHEMBL4029531	Inhibition of MAPKAPK2 (unknown origin) at <1 uM using KKLNRTLSVA-NH2 as substrate preincubated for 5 mins followed by substrate addition measured after 10 mins in presence of [gamma33P]ATP by scintillation counter method	B	CSc1sc(C(N)=O)c2c1-c1sncc1CC2		CHEMBL4082469		Inhibition	%		CHEMBL2208	Homo sapiens	INH		
	18203750	CHEMBL4044037	Inhibition of wild-type human partial length MAPKAPK2 (V48 to D345 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	99.0	CHEMBL2208	Homo sapiens	Activity	%	99.0
	18232098	CHEMBL4050404	Inhibition of human MAPKAP-K2 assessed as residual activity at 1 uM in presence of [33P]ATP by filter binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	100.0	CHEMBL2208	Homo sapiens	Activity	%	100.0
	18243294	CHEMBL4052516	Inhibition of recombinant full-length human MAPKAPK2 (M1 to L370 residues) expressed in Baculovirus infected Sf9 cells assessed as residual activity at 1 uM in presence of [33-gamma]-ATP after 60 mins by scintillation counting method relative to control	B	C=CC(=O)Nc1cccc(-c2c[nH]c3nccc(-c4[nH]c(CCCO)nc4-c4ccc(F)cc4)c23)c1		CHEMBL4071827	=	Activity	%	48.0	CHEMBL2208	Homo sapiens	Activity	%	48.0
	18253861	CHEMBL4055215	Inhibition of wild-type human partial length MAPKAPK2 (V48 to D345 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	100.0	CHEMBL2208	Homo sapiens	Activity	%	100.0
	18253862	CHEMBL4055215	Inhibition of wild-type human partial length MAPKAPK2 (V48 to D345 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL2208	Homo sapiens	Activity	%	100.0
	18265895	CHEMBL4057345	Inhibition of MAPKAPK2 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	0.3	CHEMBL2208	Homo sapiens	INH	%	0.3
	18266089	CHEMBL4057539	Inhibition of MAPKAPK2 (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	2.7	CHEMBL2208	Homo sapiens	INH	%	2.7
	18266186	CHEMBL4057636	Inhibition of MAPKAPK2 (unknown origin) at 0.078 uM relative to control	B	COC(=O)Nc1noc2cc(-c3c(-c4ccccn4)n[nH]c3C)ccc12		CHEMBL4066592	=	Inhibition	%	4.7	CHEMBL2208	Homo sapiens	INH	%	4.7
	18282165	CHEMBL4120120	Inhibition of recombinant full length His-tagged human MAPKAPK2 expressed in Escherichia coli at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	7.8	CHEMBL2208	Homo sapiens	INH	%	7.8
	18282484	CHEMBL4120120	Inhibition of recombinant full length His-tagged human MAPKAPK2 expressed in Escherichia coli at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	4.2	CHEMBL2208	Homo sapiens	INH	%	4.2
	18282635	CHEMBL4120240	Inhibition of MAPKAPK2 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	0.3	CHEMBL2208	Homo sapiens	INH	%	0.3
	18282879	CHEMBL4120464	Inhibition of MAPKAPK2 (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	1.7	CHEMBL2208	Homo sapiens	INH	%	1.7
	18283093	CHEMBL4120678	Inhibition of MAPKAPK2 (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	7.0	CHEMBL2208	Homo sapiens	INH	%	7.0
	18420976	CHEMBL4153929	Inhibition of DNA-tagged MAPKAPK2 (unknown origin) expressed in HEK293 cells at 10 uM after 1 hr by real-time fluorescent quantitative PCR analysis	B	Fc1ccc(Nc2nc(N3CCOCC3)c3nc[nH]c3n2)cc1		CHEMBL4175978	=	Inhibition	%	18.0	CHEMBL2208	Homo sapiens	INH	%	18.0
	18440292	CHEMBL4157116	Binding affinity to wild-type human partial length MAPKAPK2 (V48 to D345 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	89.0	CHEMBL2208	Homo sapiens	Activity	%	89.0
	18449862	CHEMBL4178100	Inhibition of human MAPKAPK2 (46 to 400 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	108.0	CHEMBL2208	Homo sapiens	Activity	%	108.0
	18470584	CHEMBL4182578	Inhibition of human MAPKAPK2 at 10 uM by ADP-Glo kinase assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Inhibition	%	100.0	CHEMBL2208	Homo sapiens	INH	%	100.0
	18470759	CHEMBL4182578	Inhibition of human MAPKAPK2 at 10 uM by ADP-Glo kinase assay	B	Cc1nc(N)c2ccn(C3CCN(C(=O)c4ccc(S(=O)(=O)F)cc4)CC3)c2n1		CHEMBL4206295	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	18470760	CHEMBL4182578	Inhibition of human MAPKAPK2 at 10 uM by ADP-Glo kinase assay	B	Nc1ncnc2c1ccn2C1CCN(C(=O)c2ccc(S(=O)(=O)F)cc2)CC1		CHEMBL4218073	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	18484248	CHEMBL4185895	Binding affinity to wild-type human partial length MAPKAPK2 (V48 to D345 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	98.0	CHEMBL2208	Homo sapiens	Activity	%	98.0
	18484732	CHEMBL4185895	Binding affinity to wild-type human partial length MAPKAPK2 (V48 to D345 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	100.0	CHEMBL2208	Homo sapiens	Activity	%	100.0
	18489531	CHEMBL4187272	Inhibition of wild-type human partial length MAPKAPK2 (V48 to D345 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	Fc1cc(F)cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)c1		CHEMBL4207079	=	Activity	%	85.0	CHEMBL2208	Homo sapiens	Activity	%	85.0
	18507723	CHEMBL4191039	Inhibition of recombinant human MAPKAPK2 (46 to end residues) at 1 uM using KKLNRTLSVA as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	-4.0	CHEMBL2208	Homo sapiens	INH	%	-4.0
	18653537	CHEMBL4230135	Inhibition of MAPKAPK2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	-1.0	CHEMBL2208	Homo sapiens	INH	%	-1.0
	18653538	CHEMBL4230135	Inhibition of MAPKAPK2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	5.0	CHEMBL2208	Homo sapiens	INH	%	5.0
	18655440	CHEMBL4230795	Binding affinity to wild-type human partial length MAPKAPK2 (V48 to D345 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	92.0	CHEMBL2208	Homo sapiens	Activity	%	92.0
	18663927	CHEMBL4232911	Inhibition of human MAPKAPK2 (V48 to D345 residues) expressed in bacterial expression system assessed as residual activity at 5 uM by KINOMEscan assay relative to control	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	=	Activity	%	100.0	CHEMBL2208	Homo sapiens	Activity	%	100.0
	18664024	CHEMBL4233008	Binding affinity to human MAPKAPK2 (V48 to D345 residues) expressed in bacterial expression system by KINOMEscan assay	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	>=	Kd	nM	5000.0	CHEMBL2208	Homo sapiens	Kd	uM	5.0
	18665393	CHEMBL4233350	Inhibition of MAPKAPK2 (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	1000.0	CHEMBL2208	Homo sapiens	IC50	nM	1000.0
	18674743	CHEMBL4235382	Inhibition of MAPKAPK2 (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	>	Ki	nM	2000.0	CHEMBL2208	Homo sapiens	Ki	nM	2000.0
	18674744	CHEMBL4235382	Inhibition of MAPKAPK2 (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242	>	Ki	nM	2000.0	CHEMBL2208	Homo sapiens	Ki	nM	2000.0
Not Determined	18674745	CHEMBL4235382	Inhibition of MAPKAPK2 (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525		Ki			CHEMBL2208	Homo sapiens	Ki		
	18694004	CHEMBL4253457	Inhibition of recombinant human full length His-tagged MK2 expressed in Escherichia coli at 0.1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	18694086	CHEMBL4253539	Inhibition of recombinant human full length His-tagged MK2 expressed in Escherichia coli at 1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	-1.0	CHEMBL2208	Homo sapiens	INH	%	-1.0
	18697656	CHEMBL4254329	Inhibition of wild-type human partial length MAPKAPK2 (V48 to D345 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCNc1cc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2C(F)(F)F)ccn1		CHEMBL4281348	=	Activity	%	95.0	CHEMBL2208	Homo sapiens	Activity	%	95.0
	18702486	CHEMBL4255121	Inhibition of recombinant full length human His-tagged MAPKAPK2 expressed in Escherichia coli at 1 uM relative to control	B	COc1ccc(S(N)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4278211	=	Inhibition	%	13.0	CHEMBL2208	Homo sapiens	INH	%	13.0
	18702553	CHEMBL4255121	Inhibition of recombinant full length human His-tagged MAPKAPK2 expressed in Escherichia coli at 1 uM relative to control	B	COc1ccc(C(N)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4282644	=	Inhibition	%	10.0	CHEMBL2208	Homo sapiens	INH	%	10.0
	18702597	CHEMBL4255121	Inhibition of recombinant full length human His-tagged MAPKAPK2 expressed in Escherichia coli at 1 uM relative to control	B	COc1ccc(S(C)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4287097	=	Inhibition	%	6.0	CHEMBL2208	Homo sapiens	INH	%	6.0
	18702649	CHEMBL4255121	Inhibition of recombinant full length human His-tagged MAPKAPK2 expressed in Escherichia coli at 1 uM relative to control	B	COc1cc(C)c(S(N)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4283739	=	Inhibition	%	7.0	CHEMBL2208	Homo sapiens	INH	%	7.0
	18702693	CHEMBL4255121	Inhibition of recombinant full length human His-tagged MAPKAPK2 expressed in Escherichia coli at 1 uM relative to control	B	COc1cc(C)c(C(N)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4294318	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	18702736	CHEMBL4255121	Inhibition of recombinant full length human His-tagged MAPKAPK2 expressed in Escherichia coli at 1 uM relative to control	B	COc1cc(C)c(S(C)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4289040	=	Inhibition	%	-1.0	CHEMBL2208	Homo sapiens	INH	%	-1.0
	18708536	CHEMBL4256509	Inhibition of MK2 in anisomycin-stimulated human THP1 cells assessed as reduction in hsp27 phosphorylation at Ser78 by FACS analysis	B	COc1ccc(-c2ncc3c(c2F)-c2[nH]c4c(c2CC3)C(=O)NCC42CN(C)C2)cn1		CHEMBL4293121	=	IC50	nM	480.0	CHEMBL2208	Homo sapiens	IC50	uM	0.48
	18708537	CHEMBL4256509	Inhibition of MK2 in anisomycin-stimulated human THP1 cells assessed as reduction in hsp27 phosphorylation at Ser78 by FACS analysis	B	COc1ccc(-c2ncc3c(c2F)-c2[nH]c4c(c2CC3)C(=O)NCC42CN(C)C2)cc1F		CHEMBL4282514	=	IC50	nM	370.0	CHEMBL2208	Homo sapiens	IC50	uM	0.37
	18708538	CHEMBL4256509	Inhibition of MK2 in anisomycin-stimulated human THP1 cells assessed as reduction in hsp27 phosphorylation at Ser78 by FACS analysis	B	CN1CC2(CNC(=O)c3c2[nH]c2c3CCc3cnc(-c4cccc(F)c4)c(F)c3-2)C1		CHEMBL4277929	=	IC50	nM	370.0	CHEMBL2208	Homo sapiens	IC50	uM	0.37
	18708539	CHEMBL4256508	Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by TR-FRET assay	B	COc1ccc(-c2ncc3c(c2F)-c2[nH]c4c(c2CC3)C(=O)NCC42CN(C)C2)cn1		CHEMBL4293121	<	IC50	nM	3.0	CHEMBL2208	Homo sapiens	IC50	uM	0.003
	18708540	CHEMBL4256508	Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by TR-FRET assay	B	COc1ccc(-c2ncc3c(c2F)-c2[nH]c4c(c2CC3)C(=O)NCC42CN(C)C2)cc1F		CHEMBL4282514	<	IC50	nM	3.0	CHEMBL2208	Homo sapiens	IC50	uM	0.003
	18708541	CHEMBL4256508	Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by TR-FRET assay	B	CN1CC2(CNC(=O)c3c2[nH]c2c3CCc3cnc(-c4cccc(F)c4)c(F)c3-2)C1		CHEMBL4277929	<	IC50	nM	3.0	CHEMBL2208	Homo sapiens	IC50	uM	0.003
	18708937	CHEMBL4256657	Inhibition of MAPKAPK2 (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Nc1ccc[nH]c1=O		CHEMBL4286709	=	Inhibition	%	25.0	CHEMBL2208	Homo sapiens	INH	%	25.0
	18708968	CHEMBL4256657	Inhibition of MAPKAPK2 (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Cn1cc(-c2c[nH]c(=O)c(N)c2)cn1		CHEMBL4288628	=	Inhibition	%	97.0	CHEMBL2208	Homo sapiens	INH	%	97.0
	18708976	CHEMBL4256657	Inhibition of MAPKAPK2 (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Nc1cc(-c2ccncc2)c[nH]c1=O		CHEMBL12856	=	Inhibition	%	1.0	CHEMBL2208	Homo sapiens	INH	%	1.0
	18709027	CHEMBL4256657	Inhibition of MAPKAPK2 (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	COc1ncc(-c2ccncc2)cc1N		CHEMBL4291350	=	Inhibition	%	19.0	CHEMBL2208	Homo sapiens	INH	%	19.0
	18709056	CHEMBL4256657	Inhibition of MAPKAPK2 (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Nc1cc(-c2ccnc3ccccc23)c[nH]c1=O		CHEMBL4280308	=	Inhibition	%	32.0	CHEMBL2208	Homo sapiens	INH	%	32.0
	18709085	CHEMBL4256657	Inhibition of MAPKAPK2 (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	CNc1nccc(-c2c[nH]c(=O)c(N)c2)n1		CHEMBL4292538	=	Inhibition	%	79.0	CHEMBL2208	Homo sapiens	INH	%	79.0
	18709114	CHEMBL4256657	Inhibition of MAPKAPK2 (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Nc1cc(-c2ccnc(NC3CC3)n2)c[nH]c1=O		CHEMBL4282263	=	Inhibition	%	28.0	CHEMBL2208	Homo sapiens	INH	%	28.0
	18709161	CHEMBL4256657	Inhibition of MAPKAPK2 (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Cc1nc(O)c(N)cc1-c1ccncc1		CHEMBL302219	=	Inhibition	%	33.0	CHEMBL2208	Homo sapiens	INH	%	33.0
	18709191	CHEMBL4256683	Inhibition of MAPKAPK2 (unknown origin) at 30 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	O=C(Nc1cc(-c2ccncc2)c[nH]c1=O)c1ccccc1		CHEMBL1738828	=	Inhibition	%	29.0	CHEMBL2208	Homo sapiens	INH	%	29.0
	18709220	CHEMBL4256657	Inhibition of MAPKAPK2 (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	COc1cccc(C(=O)Nc2cc(-c3ccncc3)c[nH]c2=O)c1		CHEMBL4285109	=	Inhibition	%	9.0	CHEMBL2208	Homo sapiens	INH	%	9.0
	18709262	CHEMBL4256683	Inhibition of MAPKAPK2 (unknown origin) at 30 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	CN1CCN(c2ccc(C(=O)Nc3cc(-c4ccncc4)c[nH]c3=O)cc2)CC1		CHEMBL4286130	=	Inhibition	%	12.0	CHEMBL2208	Homo sapiens	INH	%	12.0
	18709295	CHEMBL4256683	Inhibition of MAPKAPK2 (unknown origin) at 30 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	O=C(Nc1cc(-c2ccnc(NC3CC3)n2)c[nH]c1=O)c1ccccc1		CHEMBL4291472	=	Inhibition	%	96.0	CHEMBL2208	Homo sapiens	INH	%	96.0
Not Active	18723845	CHEMBL4258705	Inhibition of human MAPKAPK2 using KKLNRTLSVA as substrate at 100 uM after 40 mins in presence of [gamma-33P-ATP] by scintillation counting analysis	B	CCOc1c(S(=O)(=O)NC2CC(C)(C)NC(C)(C)C2)ccc(Cl)c1Cl		CHEMBL1502722		Inhibition	%		CHEMBL2208	Homo sapiens	INH		
	18745337	CHEMBL4262880	Inhibition of human MK2 by [gamma33P]ATP assay	B	O=Cc1ccc2cccc(C(=O)Nc3ccc(C(F)(F)F)cn3)c2n1		CHEMBL4277111	=	IC50	nM	2300.0	CHEMBL2208	Homo sapiens	IC50	uM	2.3
Active	18745338	CHEMBL4262879	Inhibition of human MK2 at 10 uM by [gamma33P]ATP assay	B	O=Cc1ccc2cccc(C(=O)Nc3ccc(C(F)(F)F)cn3)c2n1		CHEMBL4277111		Inhibition	%		CHEMBL2208	Homo sapiens	INH		
	18751035	CHEMBL4263853	Inhibition of MAPKAPK2 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	18752013	CHEMBL4264384	Binding affinity to wild-type human partial length MAPKAPK2 (V48 to D345 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	99.0	CHEMBL2208	Homo sapiens	Activity	%	99.0
	18761533	CHEMBL4266586	Inhibition of human MAPKAPK2 at 1 uM relative to control	B	CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1		CHEMBL4279192	=	Inhibition	%	-8.0	CHEMBL2208	Homo sapiens	INH	%	-8.0
	18761804	CHEMBL4266586	Inhibition of human MAPKAPK2 at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	=	Inhibition	%	-10.0	CHEMBL2208	Homo sapiens	INH	%	-10.0
	18761967	CHEMBL4266586	Inhibition of human MAPKAPK2 at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1		CHEMBL4290222	=	Inhibition	%	-6.0	CHEMBL2208	Homo sapiens	INH	%	-6.0
Not Active	18847300	CHEMBL4304920	Inhibition of wild-type human partial length MAPKAPK2 (V48 to D345 residues) expressed in bacterial expression system at 1 uM by Kinomescan method	B	O=C(Nc1ccc2[nH]nc(-c3ccc4[nH]ccc4c3)c2c1)c1c(Cl)cccc1Cl		CHEMBL4517719		Inhibition	%		CHEMBL2208	Homo sapiens	INH		
	18851343	CHEMBL4305835	Inhibition of MAPKAPK2 (unknown origin)	B	Cc1nc2c(F)cc(-c3nc(Nc4ccc5c(n4)CCN(CCN(C)C)C5)ncc3F)cc2n1C(C)C		CHEMBL4448494	>	IC50	nM	30000.0	CHEMBL2208	Homo sapiens	IC50	nM	30000.0
	18858048	CHEMBL4307894	Binding affinity to wild-type human partial length MAPKAPK2 (V48 to D345 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	94.0	CHEMBL2208	Homo sapiens	Activity	%	94.0
	18938051	CHEMBL4327752	Inhibition of human MAPKAPK2 assessed as residual activity at 1 uM using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	101.43	CHEMBL2208	Homo sapiens	Activity	%	101.43
	18938052	CHEMBL4327752	Inhibition of human MAPKAPK2 assessed as residual activity at 1 uM using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	101.58	CHEMBL2208	Homo sapiens	Activity	%	101.58
	18938597	CHEMBL4328116	Inhibition of human MAPKAPK2 assessed as residual activity at 100 uM using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL2208	Homo sapiens	Activity	%	65.0
	18938977	CHEMBL4328480	Inhibition of human MAPKAPK2 using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	128.0	CHEMBL2208	Homo sapiens	IC50	10'-7M	1.28
	18958959	CHEMBL4333481	Binding affinity to wild-type human partial length MAPKAPK2 (V48 to D345 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	83.0	CHEMBL2208	Homo sapiens	Activity	%	83.0
	18985718	CHEMBL4340017	Inhibition of MAPKAPK2 (unknown origin)	B	COC[C@@H](C)Nc1cc(NC(=O)N2CCCc3cc(CN4CCCCOC4=O)c(C=O)nc32)ncc1C#N		CHEMBL4475216	>	IC50	nM	10000.0	CHEMBL2208	Homo sapiens	IC50	nM	10000.0
	19032198	CHEMBL4349791	Inhibition of recombinant human full length N-terminal GST/His6-tagged MAPKAPK2 (M1 to L370) expressed in Sf9 insect cells at 20 nM using phosphatidylserine as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cn1cc(-c2n[nH]c3ccc(NCc4cc(F)ccc4S(C)(=O)=O)cc23)cn1		CHEMBL4555442	=	Inhibition	%	19.0	CHEMBL2208	Homo sapiens	INH	%	19.0
Active	19041167	CHEMBL4352428	Inhibition of human MAPKAPK2 at 10 uM using KKLNRTLSVA as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL2208	Homo sapiens	INH		
	19059672	CHEMBL4357973	Binding affinity to wild-type human partial length MAPKAPK2 (V48 to D345 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL2208	Homo sapiens	Activity	%	100.0
	19090237	CHEMBL4365811	Inhibition of wild-type human partial length MAPKAPK2 (V48 to D345 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL2208	Homo sapiens	Activity	%	100.0
	19091989	CHEMBL4366463	Inhibition of human MAPKAPK2 at 100 nM using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1	Outside typical range	CHEMBL4528675	=	Inhibition	%	-21.25	CHEMBL2208	Homo sapiens	INH	%	-21.25
	19159500	CHEMBL4382604	Binding affinity to wild-type human partial length MAPKAPK2 (V48 to D345 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	100.0	CHEMBL2208	Homo sapiens	Activity	%	100.0
	19181073	CHEMBL4387284	Inhibition of recombinant full length human His-tagged MAPKAPK2 expressed in Escherichia coli expression system at 0.1 uM using serine/threonine-4 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	14.5	CHEMBL2208	Homo sapiens	INH	%	14.5
	19181299	CHEMBL4387284	Inhibition of recombinant full length human His-tagged MAPKAPK2 expressed in Escherichia coli expression system at 0.1 uM using serine/threonine-4 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	4.5	CHEMBL2208	Homo sapiens	INH	%	4.5
	19191507	CHEMBL4389323	Inhibition of wild-type human partial length MAPKAPK2 (V48 to D345 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	100.0	CHEMBL2208	Homo sapiens	INH	%	100.0
	19191986	CHEMBL4389800	Inhibition of wild-type human partial length MAPKAPK2 (V48 to D345 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	100.0	CHEMBL2208	Homo sapiens	INH	%	100.0
	19200242	CHEMBL4391426	Binding affinity to wild-type human partial length MAPKAPK2 (V48 to D345 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	100.0	CHEMBL2208	Homo sapiens	Activity	%	100.0
	19225475	CHEMBL4395895	Inhibition of human recombinant MAPKAPK2 at 1 uM using CREBtide as substrate measured after 15 mins in presence of ATP by LANCE assay relative to control	B	CCc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4536012	=	Inhibition	%	-4.86	CHEMBL2208	Homo sapiens	INH	%	-4.86
	19230860	CHEMBL4397161	Inhibition of MAPKAPK2 (unknown origin) at 100 nM by [gamma-33P]ATP-based radiometric or Alphascreen assay relative to control	B	Cc1cc(-n2cc(C(=O)N3CCO[C@@H](C)C3)c3ccc(O[C@@H](C)c4ccc(F)cn4)nc32)n[nH]1		CHEMBL4440381	=	Inhibition	%	3.0	CHEMBL2208	Homo sapiens	INH	%	3.0
	19266486	CHEMBL4405436	Inhibition of wild-type human partial length MAPKAPK2 (V48 to D345 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL2208	Homo sapiens	INH	%	50.0
	19272034	CHEMBL4406979	Inhibition of wild-type human partial length MAPKAPK2 (V48 to D345 residues) expressed in bacterial expression system assessed as enzyme remaining activity at 1000 nM by Kinomescan method relative to control	B	O=C(Nc1cccc(Br)c1)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F		CHEMBL4465561	=	Activity	%	100.0	CHEMBL2208	Homo sapiens	Activity	%	100.0
	19274907	CHEMBL4407584	Inhibition of recombinant human full-length His-tagged MAPKAPK2 expressed in Escherichia coli at 25 uM using FRET-labeled Ser/Thr 04 peptide as substrate measured after 1 hr by Z'-lyte assay relative to control	A	Nc1ncc2cc(-c3c(Br)cccc3Br)c(N)nc2n1		CHEMBL57531	=	Inhibition	%	10.0	CHEMBL2208	Homo sapiens	INH	%	10.0
	19274908	CHEMBL4407584	Inhibition of recombinant human full-length His-tagged MAPKAPK2 expressed in Escherichia coli at 25 uM using FRET-labeled Ser/Thr 04 peptide as substrate measured after 1 hr by Z'-lyte assay relative to control	A	Nc1ncc2cc(-c3c(Cl)cccc3-c3cccnc3)c(N3C[C@H]4[C@H](N)[C@H]4C3)nc2n1		CHEMBL4453148	=	Inhibition	%	26.0	CHEMBL2208	Homo sapiens	INH	%	26.0
	19274909	CHEMBL4407584	Inhibition of recombinant human full-length His-tagged MAPKAPK2 expressed in Escherichia coli at 25 uM using FRET-labeled Ser/Thr 04 peptide as substrate measured after 1 hr by Z'-lyte assay relative to control	A	CC(C)COc1cccc(Cl)c1-c1cc2cnc(N)nc2nc1N1C[C@H]2[C@H](N)[C@H]2C1		CHEMBL4546703	=	Inhibition	%	21.0	CHEMBL2208	Homo sapiens	INH	%	21.0
	19276029	CHEMBL4408032	Inhibition of recombinant human MAPKAPK2 (46 to end residues) at 1 uM using KKLNRTLSVA as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	12.0	CHEMBL2208	Homo sapiens	INH	%	12.0
Not Active	19296704	CHEMBL4412640	Inhibition of MAPKAPK2 (unknown origin) at 10 uM after 60 mins by ADP-Glo luminescence assay	B	COc1ccc(Cn2cc(C(=O)N/N=C3/C(=O)Nc4c(C)cccc43)nn2)cc1		CHEMBL4529234		Inhibition	%		CHEMBL2208	Homo sapiens	INH		
	19411456	CHEMBL4427709	Inhibition of MAPKAPK2 (unknown origin)	B	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21		CHEMBL4564126	>=	IC50	nM	5000.0	CHEMBL2208	Homo sapiens	IC50	uM	5.0
	19411512	CHEMBL4427653	Inhibition of MAPKAPK2 (unknown origin) at 1 uM relative to control	B	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21		CHEMBL4564126	<=	Inhibition	%	16.0	CHEMBL2208	Homo sapiens	INH	%	16.0
	19476601	CHEMBL4479749	Inhibition of full-length recombinant human His-tagged MAPKAPK2 expressed in Escherichia coli by Z'-LYTE assay	B	O=C(NCC(F)(F)F)c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)cs1		CHEMBL4569508	=	IC50	nM	55000.0	CHEMBL2208	Homo sapiens	IC50	nM	55000.0
	19476701	CHEMBL4479749	Inhibition of full-length recombinant human His-tagged MAPKAPK2 expressed in Escherichia coli by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)NCC(F)(F)F)c4)cnn3c2)cn1		CHEMBL4550702	>	IC50	nM	100000.0	CHEMBL2208	Homo sapiens	IC50	nM	100000.0
	19476801	CHEMBL4479749	Inhibition of full-length recombinant human His-tagged MAPKAPK2 expressed in Escherichia coli by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCCC[C@@H]5N)c4)cnn3c2)cn1		CHEMBL4568087	=	IC50	nM	390.0	CHEMBL2208	Homo sapiens	IC50	nM	390.0
	19476901	CHEMBL4479749	Inhibition of full-length recombinant human His-tagged MAPKAPK2 expressed in Escherichia coli by Z'-LYTE assay	B	Cc1sc(C(=O)N[C@@H]2[C@H](N)CCCC2(F)F)cc1-c1cnn2cc(Cl)cnc12		CHEMBL4552628	=	IC50	nM	7800.0	CHEMBL2208	Homo sapiens	IC50	nM	7800.0
	20604083	CHEMBL4604471	Inhibition of His-tagged human MAPKAPK2 expressed in Escherichia coli at 10 uM after 1 hr by Z'-LYTE assay relative to control	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COC(=O)c2ccc[nH]2)[C@@H](O)[C@H]1O		CHEMBL4633057	=	Inhibition	%	95.0	CHEMBL2208	Homo sapiens	INH	%	95.0
	20604084	CHEMBL4604471	Inhibition of His-tagged human MAPKAPK2 expressed in Escherichia coli at 10 uM after 1 hr by Z'-LYTE assay relative to control	B	O=C(OC[C@H]1O[C@@H](n2cnc3c(=O)[nH]cnc32)[C@H](O)[C@@H]1O)c1ccc[nH]1		CHEMBL4636133	=	Inhibition	%	42.0	CHEMBL2208	Homo sapiens	INH	%	42.0
	20604098	CHEMBL4604471	Inhibition of His-tagged human MAPKAPK2 expressed in Escherichia coli at 10 uM after 1 hr by Z'-LYTE assay relative to control	B	O=C(OC[C@H]1O[C@@H](n2cnc3c(=O)[nH]cnc32)[C@H](O)[C@@H]1O)c1cc[nH]c1		CHEMBL4637966	=	Inhibition	%	89.0	CHEMBL2208	Homo sapiens	INH	%	89.0
	20604099	CHEMBL4604471	Inhibition of His-tagged human MAPKAPK2 expressed in Escherichia coli at 10 uM after 1 hr by Z'-LYTE assay relative to control	B	Nc1nc2c(ncn2[C@@H]2O[C@H](COC(=O)c3ccc[nH]3)[C@@H](O)[C@H]2O)c(=O)[nH]1		CHEMBL4642516	=	Inhibition	%	88.0	CHEMBL2208	Homo sapiens	INH	%	88.0
	20604111	CHEMBL4604471	Inhibition of His-tagged human MAPKAPK2 expressed in Escherichia coli at 10 uM after 1 hr by Z'-LYTE assay relative to control	B	Nc1nc2c(ncn2[C@@H]2O[C@H](COC(=O)c3cc[nH]c3)[C@@H](O)[C@H]2O)c(=O)[nH]1		CHEMBL4634615	=	Inhibition	%	82.0	CHEMBL2208	Homo sapiens	INH	%	82.0
	20604112	CHEMBL4604471	Inhibition of His-tagged human MAPKAPK2 expressed in Escherichia coli at 10 uM after 1 hr by Z'-LYTE assay relative to control	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COC(=O)c2cc[nH]c2)[C@@H](O)[C@H]1O		CHEMBL4647499	=	Inhibition	%	87.0	CHEMBL2208	Homo sapiens	INH	%	87.0
	22391773	CHEMBL4666997	Inhibition of recombinant human His-tagged full length MAPKAPK2 expressed in Escherichia coli expression system using Ser/Thr 04 as substrate at 0.1 uM incubated for 60 mins by Z'-lyte assay relative to control	B	O=C(Nc1c[nH]nc1-c1cc(Cl)ccc1OC(F)F)c1cnn2cccnc12		CHEMBL4744172	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	22391774	CHEMBL4666997	Inhibition of recombinant human His-tagged full length MAPKAPK2 expressed in Escherichia coli expression system using Ser/Thr 04 as substrate at 0.1 uM incubated for 60 mins by Z'-lyte assay relative to control	B	Cn1cc(NC(=O)c2cnn3cccnc23)c(-c2cc(Cl)ccc2OC(F)F)n1		CHEMBL4777342	=	Inhibition	%	10.0	CHEMBL2208	Homo sapiens	INH	%	10.0
	22391775	CHEMBL4666997	Inhibition of recombinant human His-tagged full length MAPKAPK2 expressed in Escherichia coli expression system using Ser/Thr 04 as substrate at 0.1 uM incubated for 60 mins by Z'-lyte assay relative to control	B	O=C(Nc1c[nH]nc1-c1cc2ccccc2cc1OC(F)F)c1cnn2cccnc12		CHEMBL4745474	=	Inhibition	%	6.0	CHEMBL2208	Homo sapiens	INH	%	6.0
	22392093	CHEMBL4667188	Inhibition of recombinant human His-tagged full length MAPKAPK2 expressed in Escherichia coli expression system using Ser/Thr 04 as substrate at 10 uM incubated for 60 mins by Z'-lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	4.0	CHEMBL2208	Homo sapiens	INH	%	4.0
	22423493	CHEMBL4674322	Inhibition of human MAPKAPK2 using KKLNRTLSVA as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	101.29	CHEMBL2208	Homo sapiens	Activity	%	101.29
	22423494	CHEMBL4674322	Inhibition of human MAPKAPK2 using KKLNRTLSVA as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	94.81	CHEMBL2208	Homo sapiens	Activity	%	94.81
	22766974	CHEMBL4703353	Inhibition of MAPKAPK2 (unknown origin) at 100 nM	B	C=CC(=O)Nc1cccc(C)c1Nc1cc(-c2cccnc2Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL4744686	=	Inhibition	%	-2.0	CHEMBL2208	Homo sapiens	INH	%	-2.0
	22809789	CHEMBL4713324	Inhibition of recombinant human MAPKAPK2 (46 to end residues) assessed as residual activity at 1 uM using KKLNRTLSVA as substrate incubated for 40 mins in presence of Km ATP by radiometric scintillation counting analysis relative to control	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(Cl)cc2)[C@H](C)C1		CHEMBL4761365	=	Activity	%	97.0	CHEMBL2208	Homo sapiens	Activity	%	97.0
	22820516	CHEMBL4716260	Inhibition of human MAPKAPK2 expressed in Escherichia coli assessed as residual activity at 1 uM relative to control	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	Activity	%	105.0	CHEMBL2208	Homo sapiens	Activity	%	105.0
	22820517	CHEMBL4716260	Inhibition of human MAPKAPK2 expressed in Escherichia coli assessed as residual activity at 1 uM relative to control	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2		CHEMBL4782674	=	Activity	%	94.0	CHEMBL2208	Homo sapiens	Activity	%	94.0
	22826338	CHEMBL4717523	Inhibition of human MAPKAPK2 expressed in Escherichia coli at 10 uM relative to control	B	CN1CCN(CCCOc2cccc3nc(Nc4ccc(Cl)c(C(F)(F)F)c4)ccc23)CC1		CHEMBL4797203	<	Inhibition	%	60.0	CHEMBL2208	Homo sapiens	INH	%	60.0
	22836324	CHEMBL4718876	Inhibition of recombinant human His-tagged full length MAPKAPK2 expressed in Escherichia coli expression system at 500 nM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	-1.0	CHEMBL2208	Homo sapiens	INH	%	-1.0
	22836325	CHEMBL4718876	Inhibition of recombinant human His-tagged full length MAPKAPK2 expressed in Escherichia coli expression system at 500 nM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OCC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4786776	=	Inhibition	%	-1.0	CHEMBL2208	Homo sapiens	INH	%	-1.0
	22836326	CHEMBL4718876	Inhibition of recombinant human His-tagged full length MAPKAPK2 expressed in Escherichia coli expression system at 500 nM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CN(C)CCNCc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1F		CHEMBL4748367	=	Inhibition	%	-7.0	CHEMBL2208	Homo sapiens	INH	%	-7.0
	22836327	CHEMBL4718876	Inhibition of recombinant human His-tagged full length MAPKAPK2 expressed in Escherichia coli expression system at 500 nM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CCOc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4776396	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	22836328	CHEMBL4718876	Inhibition of recombinant human His-tagged full length MAPKAPK2 expressed in Escherichia coli expression system at 500 nM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	COc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4783569	=	Inhibition	%	8.0	CHEMBL2208	Homo sapiens	INH	%	8.0
	22836329	CHEMBL4718876	Inhibition of recombinant human His-tagged full length MAPKAPK2 expressed in Escherichia coli expression system at 500 nM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4780286	=	Inhibition	%	12.0	CHEMBL2208	Homo sapiens	INH	%	12.0
	22843687	CHEMBL4720673	Inhibition of human MAPKAPK2 using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	65.9	CHEMBL2208	Homo sapiens	IC50	10^-8M	6.59
	22844036	CHEMBL4721022	Inhibition of human MAPKAPK2 assessed as residual activity using KKLNRTLSVA as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	100.01	CHEMBL2208	Homo sapiens	Activity	%	100.01
	22844759	CHEMBL4721434	Inhibition of wild-type human partial length MAPKAPK2 (V48 to D345 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	91.64	CHEMBL2208	Homo sapiens	Activity	%	91.64
	22849861	CHEMBL4723263	Inhibition of MAPKAPK2 (unknown origin) by biochemical assay	B	COCCOc1cc(NC(=O)N2CCCc3cc(CN4CCN(C)CC4=O)c(C=O)nc32)ncc1C#N		CHEMBL3973674	=	IC50	nM	9400.0	CHEMBL2208	Homo sapiens	IC50	nM	9400.0
	22853444	CHEMBL4724263	Effect on human recombinant N-terminal GST-tagged MAPKAPK2 (46 to end residues) expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Activity	%	4.0	CHEMBL2208	Homo sapiens	Activity	%	4.0
	22853445	CHEMBL4724263	Effect on human recombinant N-terminal GST-tagged MAPKAPK2 (46 to end residues) expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	=	Activity	%	-1.0	CHEMBL2208	Homo sapiens	Activity	%	-1.0
	22853446	CHEMBL4724263	Effect on human recombinant N-terminal GST-tagged MAPKAPK2 (46 to end residues) expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	CN1CCN(CCCOc2ccc3ncnc(Nc4ccc(Oc5cccc(C(F)(F)F)c5)c(Cl)c4)c3c2)CC1		CHEMBL4749477	=	Activity	%	5.0	CHEMBL2208	Homo sapiens	Activity	%	5.0
	22853447	CHEMBL4724263	Effect on human recombinant N-terminal GST-tagged MAPKAPK2 (46 to end residues) expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	O=C(Nc1ccc2ncnc(Nc3ccc(Oc4cccc(F)c4)c(Cl)c3)c2c1)c1ccc(CNCCO)cc1		CHEMBL4782561	=	Activity	%	16.0	CHEMBL2208	Homo sapiens	Activity	%	16.0
	22853448	CHEMBL4724263	Effect on human recombinant N-terminal GST-tagged MAPKAPK2 (46 to end residues) expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	Cc1cccc(Oc2ccc(Nc3ncnc4ccc(NC(=O)CNCCO)cc34)cc2Cl)c1		CHEMBL4753194	=	Activity	%	16.0	CHEMBL2208	Homo sapiens	Activity	%	16.0
	22853449	CHEMBL4724263	Effect on human recombinant N-terminal GST-tagged MAPKAPK2 (46 to end residues) expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	O=C(CN1CCOCC1)Nc1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c2c1		CHEMBL4777529	=	Activity	%	13.0	CHEMBL2208	Homo sapiens	Activity	%	13.0
	22853450	CHEMBL4724263	Effect on human recombinant N-terminal GST-tagged MAPKAPK2 (46 to end residues) expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	O=C(CN1CCOCC1)Nc1ccc2ncnc(Nc3ccc(Oc4cccc(F)c4)c(Cl)c3)c2c1		CHEMBL4757576	=	Activity	%	23.0	CHEMBL2208	Homo sapiens	Activity	%	23.0
	22853451	CHEMBL4724263	Effect on human recombinant N-terminal GST-tagged MAPKAPK2 (46 to end residues) expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	O=C(CN1CCOCC1)Nc1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1		CHEMBL3637894	=	Activity	%	11.0	CHEMBL2208	Homo sapiens	Activity	%	11.0
	22853452	CHEMBL4724263	Effect on human recombinant N-terminal GST-tagged MAPKAPK2 (46 to end residues) expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	O=C(CNCCO)Nc1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1		CHEMBL4783947	=	Activity	%	13.0	CHEMBL2208	Homo sapiens	Activity	%	13.0
	22881584	CHEMBL4727237	Inhibition of human MAPKAPK2	B	CNCCOc1ccccc1C(C)(C)Nc1nccn(-c2cc(C(=O)NC3CC3)ccc2C)c1=O		CHEMBL4792347	=	IC50	nM	6.31	CHEMBL2208	Homo sapiens	pIC50		8.2
Not Active	22889528	CHEMBL4729047	Inhibition of wild-type human partial length MAPKAPK2 (V48 to D345 residues) expressed in bacterial expression system at 1 uM by Kinomescan method	B	COc1cc(OCc2ccnc(Nc3cnn(C)c3)n2)cc2sc(N[C@H]3CCCC[C@@H]3O)nc12		CHEMBL4748740		Inhibition	%		CHEMBL2208	Homo sapiens	INH		
	22952894	CHEMBL4766831	Inhibition of recombinant human MAPKAPK2 (46 to end residues) assessed as residual activity at 10 uM using KKLNRTLSVA as substrate incubated for 40 mins in presence of [gamma-33ATP by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	99.0	CHEMBL2208	Homo sapiens	Activity	%	99.0
	23120638	CHEMBL4804423	Inhibition of MAPKAPK2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	IC50	nM	2500.0	CHEMBL2208	Homo sapiens	IC50	uM	2.5
	23120639	CHEMBL4804423	Inhibition of MAPKAPK2 in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1	Outside typical range	CHEMBL4860979	=	IC50	nM	-5000.0	CHEMBL2208	Homo sapiens	IC50	uM	-5.0
	23120640	CHEMBL4804423	Inhibition of MAPKAPK2 in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1	Outside typical range	CHEMBL4867931	=	IC50	nM	-34300.0	CHEMBL2208	Homo sapiens	IC50	uM	-34.3
	23120641	CHEMBL4804423	Inhibition of MAPKAPK2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4855730	=	IC50	nM	-65200.0	CHEMBL2208	Homo sapiens	IC50	uM	-65.2
	23120642	CHEMBL4804423	Inhibition of MAPKAPK2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4868141	=	IC50	nM	-52200.0	CHEMBL2208	Homo sapiens	IC50	uM	-52.2
	23120643	CHEMBL4804423	Inhibition of MAPKAPK2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	IC50	nM	4000.0	CHEMBL2208	Homo sapiens	IC50	uM	4.0
	23121677	CHEMBL4804605	Inhibition of MAPKAPK2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	23121678	CHEMBL4804605	Inhibition of MAPKAPK2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	23121679	CHEMBL4804605	Inhibition of MAPKAPK2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	23121680	CHEMBL4804605	Inhibition of MAPKAPK2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	23121681	CHEMBL4804605	Inhibition of MAPKAPK2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	23121682	CHEMBL4804605	Inhibition of MAPKAPK2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	Inhibition	%	0.0	CHEMBL2208	Homo sapiens	INH	%	0.0
	23122658	CHEMBL4805009	Inhibition of human MAPKAPK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	91.0	CHEMBL2208	Homo sapiens	Activity	%	91.0
	23123353	CHEMBL4805597	Inhibition of human MAPKAPK2 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	100.0	CHEMBL2208	Homo sapiens	Activity	%	100.0
	23123812	CHEMBL4806056	Inhibition of DNA-tagged human MAPKAPK2 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	100.0	CHEMBL2208	Homo sapiens	Activity	%	100.0
	23124796	CHEMBL4806614	Inhibition of human MAPKAPK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	91.0	CHEMBL2208	Homo sapiens	Activity	%	91.0
	23124797	CHEMBL4806614	Inhibition of human MAPKAPK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	99.0	CHEMBL2208	Homo sapiens	Activity	%	99.0
	23128263	CHEMBL4807896	Inhibition of MAPKAPK2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL2208	Homo sapiens	Activity	%	75.0
	23128264	CHEMBL4807896	Inhibition of MAPKAPK2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL2208	Homo sapiens	Activity	%	75.0
	23128265	CHEMBL4807896	Inhibition of MAPKAPK2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL2208	Homo sapiens	Activity	%	75.0
Not Active	23317493	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	69.0	CHEMBL2208	Homo sapiens	% Control	%	69.0
Not Active	23317961	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	94.0	CHEMBL2208	Homo sapiens	% Control	%	94.0
Not Active	23318628	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	63.0	CHEMBL2208	Homo sapiens	% Control	%	63.0
Not Active	23319111	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	61.0	CHEMBL2208	Homo sapiens	% Control	%	61.0
Not Active	23319748	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23320223	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	84.2	CHEMBL2208	Homo sapiens	% Control	%	84.2
Not Active	23320901	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23321369	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	80.0	CHEMBL2208	Homo sapiens	% Control	%	80.0
Not Active	23321999	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23322467	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23323156	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23323624	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23324051	CHEMBL4880670	MAPKAP-K2 (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	-2.0	CHEMBL2208	Homo sapiens	% inhibition	%	-2.0
Not Active	23324478	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23325113	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	89.0	CHEMBL2208	Homo sapiens	% Control	%	89.0
Not Active	23325581	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23326228	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23326696	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	90.0	CHEMBL2208	Homo sapiens	% Control	%	90.0
Not Active	23327396	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23327864	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23328451	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	97.0	CHEMBL2208	Homo sapiens	% Control	%	97.0
Not Active	23328919	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23329407	CHEMBL4881114	MAPKAP-K2(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	81.0	CHEMBL2208	Homo sapiens	% residual kinase activity	%	81.0
Not Active	23329865	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23330333	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23331089	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23331557	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	97.0	CHEMBL2208	Homo sapiens	% Control	%	97.0
Not Active	23332144	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23332610	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23333328	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	82.6	CHEMBL2208	Homo sapiens	% Control	%	82.6
Not Active	23333967	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	83.0	CHEMBL2208	Homo sapiens	% Control	%	83.0
Not Active	23334435	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	80.0	CHEMBL2208	Homo sapiens	% Control	%	80.0
Not Active	23334915	CHEMBL4881538	MAPKAP-K2 (h) Upstate kinase activity assay	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		Inhibition	%	-6.0	CHEMBL2208	Homo sapiens	% inhibition	%	-6.0
Not Active	23335414	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23335882	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23336509	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23336977	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	72.0	CHEMBL2208	Homo sapiens	% Control	%	72.0
Not Active	23337672	CHEMBL4882043	MAPKAPK2 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	96.5	CHEMBL2208	Homo sapiens	% Ctrl	%	96.5
Not Active	23338058	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	92.0	CHEMBL2208	Homo sapiens	% Control	%	92.0
Not Active	23338526	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	99.0	CHEMBL2208	Homo sapiens	% Control	%	99.0
Not Active	23339138	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23339606	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23340243	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23340711	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23341368	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23341836	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23342452	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	97.0	CHEMBL2208	Homo sapiens	% Control	%	97.0
Not Active	23342920	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	87.0	CHEMBL2208	Homo sapiens	% Control	%	87.0
Active	23343270	CHEMBL4882455	MAPKAPK2 Invitrogen selectivity data (BI)	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Ctrl	%	1.0	CHEMBL2208	Homo sapiens	% Ctrl	%	1.0
Not Active	23343550	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	72.0	CHEMBL2208	Homo sapiens	% Control	%	72.0
Not Active	23344018	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	55.0	CHEMBL2208	Homo sapiens	% Control	%	55.0
Not Active	23344656	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23345229	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	60.0	CHEMBL2208	Homo sapiens	% Control	%	60.0
Not Active	23345697	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	89.0	CHEMBL2208	Homo sapiens	% Control	%	89.0
Not Active	23346274	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23346742	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	97.9	CHEMBL2208	Homo sapiens	% Control	%	97.9
Not Active	23347344	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23347834	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23348413	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23348881	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	80.0	CHEMBL2208	Homo sapiens	% Control	%	80.0
Not Active	23349468	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	93.0	CHEMBL2208	Homo sapiens	% Control	%	93.0
Not Active	23350086	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23350554	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	90.0	CHEMBL2208	Homo sapiens	% Control	%	90.0
Not Active	23351159	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23351627	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23352124	CHEMBL4882813	MAPKAPK2 Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	2.353	CHEMBL2208	Homo sapiens	% Inhibition	%	2.3532
Not Active	23352651	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	96.0	CHEMBL2208	Homo sapiens	% Control	%	96.0
Not Active	23353119	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	93.0	CHEMBL2208	Homo sapiens	% Control	%	93.0
Not Active	23354001	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	51.0	CHEMBL2208	Homo sapiens	% Control	%	51.0
Not Active	23354469	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	88.0	CHEMBL2208	Homo sapiens	% Control	%	88.0
Not Active	23355201	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	73.0	CHEMBL2208	Homo sapiens	% Control	%	73.0
Not Active	23355669	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	92.0	CHEMBL2208	Homo sapiens	% Control	%	92.0
Not Active	23356305	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23356773	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23357382	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	85.0	CHEMBL2208	Homo sapiens	% Control	%	85.0
Not Active	23358029	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	87.0	CHEMBL2208	Homo sapiens	% Control	%	87.0
Not Active	23358497	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23359083	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	64.3	CHEMBL2208	Homo sapiens	% Control	%	64.3
Not Active	23359681	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23360149	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	97.0	CHEMBL2208	Homo sapiens	% Control	%	97.0
Not Active	23360734	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	73.0	CHEMBL2208	Homo sapiens	% Control	%	73.0
Not Active	23361202	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23361775	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	95.0	CHEMBL2208	Homo sapiens	% Control	%	95.0
Not Active	23362311	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23362779	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23363286	CHEMBL4883259	MAPKAPK2 Kinase activity screen	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1		CHEMBL4531334		Inhibition	%	2.117	CHEMBL2208	Homo sapiens	% inhibition	%	2.1172
Not Active	23363287	CHEMBL4883259	MAPKAPK2 Kinase activity screen	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1		CHEMBL4531334		Inhibition	%	3.684	CHEMBL2208	Homo sapiens	% inhibition	%	3.6844
Not Active	23364421	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	93.0	CHEMBL2208	Homo sapiens	% Control	%	93.0
Not Active	23364889	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	81.0	CHEMBL2208	Homo sapiens	% Control	%	81.0
Not Active	23365628	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	88.0	CHEMBL2208	Homo sapiens	% Control	%	88.0
Not Active	23366171	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23366761	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23367229	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23367630	CHEMBL4883983	MAPKAPK2 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	80.0	CHEMBL2208	Homo sapiens	% Residual activity with Skepinone-L	%	80.0
Not Active	23368107	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	80.0	CHEMBL2208	Homo sapiens	% Control	%	80.0
Not Active	23368575	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	98.0	CHEMBL2208	Homo sapiens	% Control	%	98.0
Not Active	23369174	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23369642	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23370128	CHEMBL4884372	MAPKAP-K2(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	97.0	CHEMBL2208	Homo sapiens	% residual kinase activity	%	97.0
Not Active	23370610	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23371078	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	84.0	CHEMBL2208	Homo sapiens	% Control	%	84.0
Not Active	23371887	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	76.0	CHEMBL2208	Homo sapiens	% Control	%	76.0
Not Active	23372355	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
	23372806	CHEMBL4884771	MAPKAPK2(MPK2LGRH) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL2208	Homo sapiens	pIC50		6.0
	23373215	CHEMBL4885062	MAPKAPK2(MPK2LGRH) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL2208	Homo sapiens	pIC50		6.0
	23373573	CHEMBL4885350	MAPKAPK2(MPK2LGRH) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL2208	Homo sapiens	pIC50		6.0
Not Active	23375026	CHEMBL4886015	MAPKAPK2 Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	9.5	CHEMBL2208	Homo sapiens	% Inhibition	%	9.5
Not Active	23375293	CHEMBL4886275	mitogen-activated protein kinase-activated protein kinase 2 Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	-5.0	CHEMBL2208	Homo sapiens	% inhibition	%	-5.0
Not Active	23375782	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	99.0	CHEMBL2208	Homo sapiens	% Control	%	99.0
Not Active	23376250	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23376827	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23377295	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23378155	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	87.0	CHEMBL2208	Homo sapiens	% Control	%	87.0
Not Active	23378623	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23379790	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	75.0	CHEMBL2208	Homo sapiens	% Control	%	75.0
Not Active	23380258	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	84.0	CHEMBL2208	Homo sapiens	% Control	%	84.0
Not Active	23380952	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23381600	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23382068	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23382415	CHEMBL4887131	MAPKAPK2 Invitrogen kinase activity assay	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		Inhibition	%	2.0	CHEMBL2208	Homo sapiens	% inhibition	%	2.0
Not Active	23382692	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23383160	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
Not Active	23383877	CHEMBL4887497	MAPKAPK2 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	93.0	CHEMBL2208	Homo sapiens	% Ctrl	%	93.0
Not Active	23383878	CHEMBL4887497	MAPKAPK2 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	87.0	CHEMBL2208	Homo sapiens	% Ctrl	%	87.0
Not Active	23384046	CHEMBL4887644	MAPKAPK2 DUNDEE kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	94.5	CHEMBL2208	Homo sapiens	% Ctrl	%	94.5
Not Active	23384533	CHEMBL4888128	MAPKAP-K2(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	5.05	CHEMBL2208	Homo sapiens	% inhibition	%	5.05
Not Active	23384670	CHEMBL4888196	MAPKAPK2 SelectScreen Kinase panel (LifeTechnologies)	B	C=CC(=O)Nc1ccc2[nH]c(=O)n(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)c2c1		CHEMBL4795065		Inhibition	%	30.0	CHEMBL2208	Homo sapiens	% Inhibition	%	30.0
Not Active	23385075	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	90.0	CHEMBL2208	Homo sapiens	% Control	%	90.0
Not Active	23385542	CHEMBL4879799	KinomeScan assay: inhibition of MAPKAPK2	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	100.0	CHEMBL2208	Homo sapiens	% Control	%	100.0
